{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "gpt-oss-120b",
    "experiment": "e6_semantic_retrieval",
    "pattern": "qualitative_3hop_cross_company_type1",
    "total_questions_in_experiment": 600
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "How does the number of securities remaining available for future issuance under equity compensation plans approved by security holders at Colgate-Palmolive (CL) compare to the total number of securities related to stock options, restricted stock units, and performance stock units available for future issuance at Procter & Gamble (PG)?",
      "original_answer": "Colgate-Palmolive (CL) reported 37,028,000 securities remaining available under equity compensation plans approved by security holders. Procter & Gamble (PG) disclosed that under similar plans, they had 133,185,995 total securities related to stock options, restricted stock units, and performance stock units available for future issuance. This indicates that PG has significantly more securities available for future issuance compared to CL.",
      "llm_answer": "Colgate‑Palmolive reports that, as of December 31 2021, equity‑compensation plans approved by security holders have **37.0 million** securities (37,028 thousand) remaining available for future issuance.  \n\nProcter & Gamble’s 2019 Stock and Incentive Compensation Plan, the only plan that permits new grants, provides **about 119 million** shares (stock options, SARs, RSUs and PSUs) available for future issuance.  \n\nThus, PG’s pool of future‑issuable securities is roughly three times larger than CL’s (119 million vs. 37 million).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant quantitative error in the Procter & Gamble (PG) figure. The ground truth states that PG had 133,185,995 securities available for future issuance, while the LLM reports 'about 119 million', which is inaccurate by over 14 million shares. This discrepancy affects the comparison and undermines the conclusion that PG’s pool is 'roughly three times larger'—while still larger, the ratio is closer to 3.6x (133.2M / 37.0M), not 3.2x as implied by 119M / 37M. The Colgate-Palmolive (CL) number is correctly reported as 37,028,000 (rounded to 37.0 million), and the entity identification (CL and PG), metric relevance (securities available under shareholder-approved plans), and overall structure are accurate. The reasoning correctly compares the two companies’ available securities and draws a valid directional conclusion (PG > CL), but the use of outdated or incorrect data for PG—possibly from a different fiscal year (2019 plan cited, but not necessarily 2019 data)—impacts factual precision. The answer addresses all parts of the question and maintains semantic relevance, but the core numerical inaccuracy in a multi-hop quantitative comparison reduces overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 345,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the sensitivity of Google's foreign exchange forward contracts to a 10% weakening of the U.S. dollar compare with Disney's hedge coverage for forecasted foreign currency transactions in terms of notional exposure and risk mitigation horizon?",
      "original_answer": "Google's foreign exchange forward contracts would result in a $660 million impact on AOCI as of December 31, 2024, from a 10% weakening of the U.S. dollar, reflecting its net investment hedge strategy. In contrast, Disney hedges forecasted foreign currency transactions with a notional exposure of $9.9 billion as of September 28, 2024, and maintains coverage for periods generally not exceeding four years. While Google focuses on offsetting translation risk from foreign subsidiaries, Disney aims to stabilize earnings and cash flows by hedging forecasted transactions in major currencies like the euro and Japanese yen.",
      "llm_answer": "Google’s analysis shows that a 10 % weakening of the U.S. dollar would cut its after‑tax AOCI from foreign‑currency cash‑flow hedges by about **$1.5 billion (2023) to $1.6 billion (2024)** and would lower pretax income by roughly **$503 million (2023) and $135 million (2024)** after the effect of its forward and option contracts.  \n\nDisney, by contrast, reports **net foreign‑exchange cash‑flow hedge notional amounts of $9.9 billion (2024) and $8.3 billion (2023)**, which are used to hedge forecasted foreign‑currency transactions for **periods generally not to exceed four years**.  \n\nThus, Disney’s hedge program covers a much larger notional exposure and is explicitly designed to protect forecasted cash flows over a multi‑year horizon, whereas Google’s disclosed sensitivity is expressed as a dollar‑impact figure rather than a notional amount.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly regarding Google's sensitivity to a 10% weakening of the U.S. dollar. The ground truth states that Google's foreign exchange forward contracts would result in a $660 million impact on AOCI as of December 31, 2024, due to its net investment hedge strategy. However, the LLM claims a $1.5–1.6 billion reduction in after-tax AOCI and a $135 million (2024) pretax income impact, which contradicts the original answer and introduces figures not present in the ground truth. These numbers appear to conflate cash-flow hedges with net investment hedges and misrepresent both the magnitude and nature of the exposure. (2) For Disney, the LLM correctly reports the $9.9 billion notional exposure as of 2024 and the four-year risk mitigation horizon, aligning with the original answer. The 2023 figure of $8.3 billion is not in the ground truth but may be contextually plausible; however, the question only asks for current (2024) comparison, so this addition is extraneous but not necessarily incorrect. (3) The multi-hop reasoning is partially sound—comparing Google’s impact-based disclosure with Disney’s notional-based hedging approach—but fails because it mischaracterizes Google’s hedge type and magnitude. The original answer clarifies that Google uses net investment hedges (affecting AOCI) to offset translation risk, while Disney uses cash-flow hedges to stabilize earnings; the LLM incorrectly labels Google’s instruments as cash-flow hedges, undermining the conceptual distinction. (4) Despite correct framing of Disney’s program and relevant contextual structure, the severe quantitative and qualitative errors—especially the incorrect $1.5B–$1.6B AOCI impact and misattribution of hedge type—warrant a low correctness score. The answer is contextually relevant and attempts proper synthesis, but core facts are wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 510,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does the number of securities remaining available for future issuance under equity compensation plans approved by security holders at Procter & Gamble compare to Colgate-Palmolive’s available securities, considering both companies disclose these figures under similar categories?",
      "original_answer": "Procter & Gamble reports that there are 133,185,995 securities remaining available for future issuance under equity compensation plans approved by security holders, while Colgate-Palmolive discloses 37,028,000 securities remaining available under the same category. This indicates that P&G has a significantly larger pool of available securities for future equity compensation compared to Colgate-Palmolive.",
      "llm_answer": "Procter & Gamble reports that its equity‑compensation plans approved by security holders have **about 119 million shares** still available for future grants (the amount of shares that may be issued under the 2019 Stock and Incentive Compensation Plan). Colgate‑Palmolive reports **37,028 thousand shares** (≈ 37 million) remaining available under its approved plans. Thus, P&G’s pool of issuable securities is roughly three times larger than Colgate‑Palmolive’s.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Colgate-Palmolive's available securities as 37,028,000 (rounded to 37 million), which matches the ground truth. However, it reports Procter & Gamble's figure as 'about 119 million shares', whereas the ground truth is 133,185,995—this is a significant underreporting (~14 million fewer shares). While the answer correctly notes that P&G has a larger pool than Colgate, the magnitude is misrepresented. (2) The number for Colgate is accurate (37,028 thousand = 37,028,000). The P&G number is incorrect; 119 million vs. actual 133.2 million is a ~10.6% error. The claim that P&G’s pool is 'roughly three times larger' is also inaccurate: 133.2M / 37.0M ≈ 3.6x, but 119M / 37M ≈ 3.2x—still in the ballpark, but based on a flawed input. (3) The multi-hop reasoning is sound: the model correctly compares the two companies’ available securities under shareholder-approved equity compensation plans, which is the core of the question. It synthesizes data across both companies appropriately. (4) The contextual relevance is perfect—it directly addresses the comparison asked. Qualitative accuracy is high due to correct entity identification and logical structure, but quantitative accuracy is reduced due to the incorrect P&G figure. Correctness score is 7 because the core conclusion (P&G has significantly more) is valid, but key numerical accuracy is compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 391,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does AbbVie's patent litigation against Sandoz Inc. over upadacitinib relate to Amgen's legal strategy in defending its own patents against Sandoz's counterclaims regarding denosumab biosimilar development?",
      "original_answer": "AbbVie is actively enforcing its patents for upadacitinib (Rinvoq) by suing Sandoz Inc. and other generic drug manufacturers, seeking injunctive relief to prevent premature market entry of generic versions. Meanwhile, Amgen faces litigation from Sandoz Inc., which has filed counterclaims asserting that Amgen's asserted patents for denosumab are invalid or unenforceable. Both companies are engaged in high-stakes patent battles involving Sandoz Inc., but while AbbVie is in the offensive position protecting its drug exclusivity, Amgen is defending its intellectual property against Sandoz's legal challenges, revealing contrasting legal dynamics in the biopharmaceutical patent ecosystem.",
      "llm_answer": "Both companies have turned to the courts to block Sandoz from launching generic versions of their drugs.  AbbVie filed a Delaware suit in November 2023 alleging that Sandoz’s proposed generic upadacitinib products infringe AbbVie’s patents and is seeking declaratory and injunctive relief (AbbVie 10‑K Item 3, page 95).  Amgen is pursuing the same tactic with its denosumab biosimilar – it sued Sandoz for infringement, asked the New Jersey court for a permanent and preliminary injunction, and is actively moving to dismiss Sandoz’s counterclaims of invalidity (Amgen 10‑K Item 3, pages 156‑157).  Thus, AbbVie’s upadacitinib litigation mirrors Amgen’s broader strategy of using aggressive patent‑infringement suits and injunction requests to defend its patents against Sandoz’s biosimilar challenges.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly impact correctness, despite some accurate elements. (1) The claim that Amgen is suing Sandoz over denosumab biosimilar development is incorrect: in reality, Sandoz initiated the litigation by filing an Abbreviated Biologics License Application (aBLA) for a denosumab biosimilar, triggering Amgen's defensive posture and Sandoz's counterclaims of patent invalidity. Amgen did not proactively sue Sandoz to block entry; rather, it is defending its patents after Sandoz challenged them — a key distinction the LLM misrepresents. (2) The LLM incorrectly states that 'AbbVie’s upadacitinib litigation mirrors Amgen’s broader strategy,' implying both are in offensive positions, when the ground truth emphasizes a contrast: AbbVie is on the offense, while Amgen is on the defense. This mischaracterization undermines the core multi-hop reasoning required by the question. (3) The dates and locations (Delaware suit in November 2023, New Jersey court) are plausible and consistent with typical SEC filing disclosures, but cannot be fully verified without direct access to the cited 10-K pages; however, the citation format and general procedural claims (seeking injunctions, declaratory relief) align with standard patent litigation disclosures, so quantitative and procedural details are reasonably accurate. (4) The synthesis across companies and legal strategies is attempted but flawed: the LLM fails to recognize the opposing legal dynamics (offensive vs. defensive postures), which is the central insight of the original answer. While the answer is contextually relevant and uses appropriate legal terminology, the incorrect framing of Amgen’s strategy as 'aggressive' and 'mirroring' AbbVie’s approach leads to a materially inaccurate conclusion. Thus, despite correct citations and plausible procedural details, the answer earns a mid-range score due to significant qualitative and reasoning errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 529,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How does the voting power dilution mechanism in CMCSA's Class B to Class A common stock conversion compare with GOOGL's multi-class stock structure, particularly in light of the $62.2 billion in Class A and Class C shares repurchased by GOOGL in 2023?",
      "original_answer": "GOOGL repurchased $62.2 billion of its Class A and Class C shares in 2023, maintaining a multi-class structure where Class B shares carry 10 votes per share and convert automatically upon sale or transfer to Class A, which has 1 vote per share. In contrast, CMCSA's Class B shares carry 15 votes and are convertible share-for-share into Class A shares, with Class B's aggregate voting power capped at 33 1/3% and protected from dilution under its articles of incorporation. This means CMCSA has a stronger anti-dilution mechanism for its Class B shares compared to GOOGL, where Class B shares lose their enhanced voting rights upon conversion. Additionally, GOOGL's repurchase activity in 2023 may have concentrated voting control among remaining Class B shareholders by reducing the total number of Class A shares outstanding.",
      "llm_answer": "Comcast’s charter fixes the voting split between its two common‑stock series – Class A holders own 66 ⅔ % of the votes and Class B holders own the remaining 33 ⅓ %, a proportion that “is generally non‑dilutable” and cannot be altered by issuing additional shares (CMCSA 10‑K Note 12, p. 91).  Each Class B share carries 15 votes and can be converted share‑for‑share into Class A, but the conversion does not change the overall 33 ⅓ % voting power of the Class B tranche.\n\nAlphabet’s structure is three‑tiered (Class A = 1 vote, Class B = 10 votes, Class C = no vote).  In 2023 the company repurchased $62.2 billion of Class A and Class C shares (Alphabet 10‑K, p. 81), which reduces the total number of low‑ or non‑voting shares and thereby raises the relative influence of the insider‑controlled Class B stock.  Unlike Comcast’s fixed‑percentage mechanism, Alphabet’s repurchases effectively increase the voting concentration of the high‑vote Class B shares.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: CMCSA's Class B voting power is capped at 33 1/3%, with 15 votes per share and share-for-share convertibility into Class A; GOOGL has a three-class structure (Class A: 1 vote, Class B: 10 votes, Class C: 0 votes), and repurchased $62.2 billion of Class A and C shares in 2023. These numbers and percentages match the original answer exactly. (2) The answer correctly identifies that CMCSA has a non-dilutable voting structure protecting Class B's 33 1/3% voting power, while GOOGL’s repurchases of non- or low-voting shares increase the relative voting concentration of Class B shares. (3) Multi-hop reasoning is sound: the model synthesizes information across both companies’ stock structures and correctly infers the implications of share repurchases on voting control. (4) The LLM adds contextual precision by citing specific 10-K note and page numbers (e.g., CMCSA 10-K Note 12, p. 91; Alphabet 10-K, p. 81), enhancing credibility. Wording differs slightly but meaning is preserved and even enriched. No errors in entities, calculations, or logic. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 343,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How does the number of shares reserved for future issuance under Nike's Equity Compensation Plan compare to the number of shares represented by outstanding warrants at Tesla, based on their respective 2023 filings?",
      "original_answer": "Nike reported 97,567,370 shares remaining available for future issuance under its Equity Compensation Plan, while Tesla disclosed that 11 million shares were represented by outstanding warrants in 2023. Therefore, Nike's available shares under its equity plan are significantly higher than Tesla's outstanding warrants.",
      "llm_answer": "Nike’s 2023 filing shows that roughly **97.6 million shares** are still available for future issuance under its Equity Compensation Plan. Tesla’s 2023 filing reports that the outstanding warrants could be converted into about **11 million shares** of common stock. Thus, the number of shares Nike has set aside for future issuance is roughly nine times the number of shares represented by Tesla’s outstanding warrants.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: Nike's 97.6 million shares available (rounded from 97,567,370) and Tesla's 11 million shares from outstanding warrants are correctly reported. The comparison stating Nike's shares are 'roughly nine times' Tesla's is logically sound (97.6 / 11 ≈ 8.87, which rounds to ~9). (2) The answer is complete, addressing both companies, the correct metric (shares reserved vs. shares from warrants), and the correct year (2023). (3) Entities are accurate: Nike’s Equity Compensation Plan and Tesla’s outstanding warrants are correctly identified. (4) The multi-hop reasoning—comparing shares reserved for future issuance at one company to shares underlying warrants at another—is properly executed, with correct synthesis across two separate SEC filings. (5) The semantic meaning fully aligns with the original answer, with slightly more precise phrasing (including a quantitative ratio). All criteria for correctness, accuracy, reasoning, and relevance are satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 307,
        "total_tokens": 1508
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the number of shares issuable upon exercise of outstanding warrants disclosed by Tesla in 2023 compare to the number of shares remaining available for future issuance under Nike's equity compensation plans, based on their respective disclosures?",
      "original_answer": "Tesla disclosed that in 2023, there were 11 million shares issuable upon exercise of outstanding warrants. In contrast, Nike, through its equity compensation plan disclosures, indicated that 97,567,370 shares were remaining available for future issuance under compensation plans. This highlights a significant difference in scale between Tesla's warrant-related share exposure and Nike's available equity compensation pool.",
      "llm_answer": "- Tesla’s 2023 filing shows that the warrants outstanding could be exercised for **about 11 million shares** (see the “Warrants 11” line in the diluted‑EPS reconciliation).  \n- Nike’s 2023 filing reports **approximately 97.6 million shares** still available for future issuance under its equity‑compensation plans (the “shares remaining available for future issuance” column).  \n\nThus, Nike has roughly **nine times more shares** left for future issuance than the number of shares Tesla could issue by exercising its outstanding warrants.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: Tesla's 11 million shares from outstanding warrants and Nike's approximately 97.6 million shares available for future issuance (97,567,370 rounded to 97.6 million is acceptable and common in financial reporting). The comparison stating Nike has roughly nine times more shares is mathematically sound (97.6 / 11 ≈ 8.87, which rounds to ~9x). (2) The answer is complete, addressing both companies, the relevant financial instruments (warrants for Tesla, equity compensation plans for Nike), and the comparative scale. (3) Entity accuracy is correct: Tesla and Nike are properly identified, with accurate reference to their 2023 filings and the specific disclosures (diluted EPS reconciliation for Tesla, shares available under equity plans for Nike). (4) The multi-hop reasoning is sound—information from two different companies and filings is correctly synthesized to make a valid cross-company comparison. (5) Semantic equivalence is maintained: the LLM conveys the same core insight as the original answer—the significant difference in scale between Tesla’s warrant exposure and Nike’s equity compensation pool—using slightly different but equally valid phrasing. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 372,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How does the differential voting power per share in GOOGL's Class B common stock impact its corporate governance structure, compared to NFLX's uniform voting rights model where each share carries one vote?",
      "original_answer": "GOOGL's Class B common stock provides 10 votes per share, significantly enhancing the voting influence of its holders compared to the 1 vote per share for Class A and no voting rights for Class C stock. This structure allows key stakeholders holding Class B shares to maintain disproportionate control over corporate decisions. In contrast, NFLX provides uniform voting rights, where each share of common stock entitles the holder to exactly one vote, promoting a more egalitarian governance model. The difference in voting rights structures reflects contrasting philosophies in corporate governance between the two companies.",
      "llm_answer": "Alphabet’s (GOOGL) Class B shares carry ten votes per share, whereas its Class A shares have one vote and Class C shares have none【page_82】. This ten‑to‑one voting structure concentrates control in the hands of the relatively few owners of Class B stock—typically founders and insiders—allowing them to steer board elections and major corporate actions even if they hold a minority of the total equity. In contrast, Netflix grants every share one vote【page_60】, so voting power is directly proportional to share ownership and no single group can wield outsized influence absent a proportional equity stake.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: GOOGL's Class B shares carry 10 votes per share, Class A have 1 vote, Class C have none; NFLX provides one vote per share. These match the original answer exactly. (2) No calculations are required, but the comparative voting ratios (10:1 vs 1:1) are correctly represented. (3) The multi-hop reasoning is sound—LLM correctly synthesizes governance implications across two companies (GOOGL and NFLX), contrasting concentrated control (founders/insiders with disproportionate voting power) versus egalitarian, ownership-proportional voting. (4) The answer addresses all parts of the question: impact of differential voting in GOOGL, comparison with NFLX’s uniform model, and the resulting corporate governance differences. Wording differs slightly but meaning is preserved. Minor additions like 'founders and insiders' and 'board elections' add context without introducing error. All scores are 10 due to full factual correctness, completeness, and logical coherence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 307,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What percentage of Chevron's average daily net crude oil production in 2021 came from the QG3 project through its stake in Qatargas Operating Company Limited?",
      "original_answer": "Chevron's average daily net crude oil production from the QG3 project through its stake in Qatargas Operating Company Limited was 13 MBD in 2021. Since Chevron holds a 30% interest in Qatargas, this production volume reflects Chevron's proportional share of the crude oil output from the QG3 project.",
      "llm_answer": "Chevron’s 30 % ownership interest in QG3 means that roughly **30 % of its average‑daily net crude‑oil output in 2021 came from the QG3 project through its stake in Qatargas Operating Company Limited**【page_11†L13-L17】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that 30% of Chevron's average daily net crude oil production in 2021 came from the QG3 project. The ground truth states that Chevron's net production from the QG3 project was 13 thousand barrels per day (MBD), but the total volume of Chevron's overall crude oil production is not provided, so the percentage cannot be determined from the given information. The LLM incorrectly assumes that a 30% ownership stake in Qatargas translates directly to 30% of Chevron’s total crude oil production coming from this project, which is a logical and quantitative error. (2) The numeric values are not accurate: the LLM claims '30% of its average daily net crude oil production' came from QG3, but no such percentage is supported by the original data. The only correct number implied is the 30% ownership stake, which is accurate, but it is misapplied. (3) The multi-hop reasoning fails: the model must recognize that Chevron’s 30% stake leads to a net production of 13 MBD from QG3, but this does not equate to 30% of Chevron’s total production without knowing the total. The synthesis between stake percentage and company-wide production is flawed. (4) Contextual relevance is moderate because the answer addresses the right entities (Chevron, QG3, Qatargas, 30% stake) and time frame (2021), but draws an incorrect conclusion due to faulty reasoning. Thus, while the context is relevant, the factual and quantitative inaccuracies severely undermine correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1132,
        "completion_tokens": 418,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the adoption of ASU 2022-04 impact the transparency of supplier finance obligations for both 3M and Honeywell, particularly in terms of the new roll-forward disclosure requirements effective in 2024?",
      "original_answer": "The adoption of ASU 2022-04 enhances transparency for both 3M and Honeywell by mandating detailed annual disclosures about supplier finance program obligations, including a roll-forward of confirmed invoice amounts. For 3M, this includes reporting $1.5 billion of invoices confirmed and $1.5 billion of invoices paid or adjusted in 2024, which is now disclosed as part of the roll-forward requirement. Honeywell adopted the roll-forward provisions starting in 2024, aligning with the ASU’s phased implementation. Both companies now provide clearer visibility into their supplier finance activities, improving comparability and risk assessment for stakeholders.",
      "llm_answer": "Both Honeywell and 3M have adopted ASU 2022‑04, which requires a yearly description of the program’s terms, the balance‑sheet line where the amounts appear, and—starting January 1 2024—a roll‑forward of the outstanding supplier‑finance balances. Honeywell’s filing notes that the ASU was adopted on 1 Jan 2023 and that the roll‑forward requirement became effective in 2024, providing a transparent reconciliation of the program’s obligations without changing their measurement. 3M likewise adopted the guidance with the roll‑forward effective 1 Jan 2024, and its Note 16 now shows a roll‑forward of confirmed‑invoice balances (≈ $0.3 billion at year‑end) and the $1.5 billion of invoices confirmed and paid during the year, giving investors a clear, period‑by‑period view of its supplier‑finance liabilities.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that both 3M and Honeywell adopted ASU 2022-04 and that the roll-forward disclosure requirement became effective in 2024, aligning with the ground truth. It accurately notes that the standard enhances transparency through new roll-forward disclosures. However, there is a significant quantitative error regarding 3M's disclosed amounts. The LLM states that 3M confirmed and paid $1.5 billion of invoices during the year and had ≈$0.3 billion of confirmed invoice balances at year-end. The ground truth specifies that 3M reported $1.5 billion of invoices confirmed and $1.5 billion of invoices paid or adjusted in 2024 — implying a reconciliation where inflows and outflows are each $1.5 billion — but does not mention a $0.3 billion ending balance. This discrepancy suggests either a misinterpretation or incorrect data extraction, undermining the quantitative accuracy. (2) The date of adoption is slightly misrepresented: the LLM claims Honeywell adopted the ASU on January 1, 2023, while the ground truth only confirms that the roll-forward requirement became effective in 2024 due to phased implementation. The original answer does not specify full adoption in 2023, so this detail lacks support. (3) The multi-hop reasoning is generally sound — the model correctly synthesizes the impact of ASU 2022-04 across two companies and links it to enhanced transparency via roll-forward disclosures. It correctly identifies the nature of the new requirements and their implementation timing. (4) Despite the numerical inaccuracy and minor overstatement of adoption timing, the answer captures the core qualitative impact of the standard and addresses all parts of the question. Wording and intent are semantically close to the original, and the context is fully relevant. Hence, correctness is reduced primarily due to the incorrect $0.3 billion figure, which affects financial precision but not overall reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 529,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How does LMT's revenue recognition approach for U.S. Government contracts regulated by FAR compare to RTX's financial exposure to U.S. Government contract risks, particularly in relation to fixed-price contract structures?",
      "original_answer": "LMT recognizes revenue for U.S. Government contracts regulated by the FAR using a cost-plus-fixed-fee model, where the standalone selling price is typically equal to the contract price due to FAR-mandated cost-plus structures. RTX, on the other hand, faces financial exposure from its reliance on fixed-price contracts, especially firm fixed-price (FFP) contracts, where it bears the full burden of cost overruns. Both companies are subject to U.S. Government contract risks, but LMT's FAR-regulated contracts provide more predictable revenue due to cost reimbursement with a reasonable profit margin, whereas RTX's FFP contracts carry higher risk of negative profit adjustments, particularly in development programs.",
      "llm_answer": "Lockheed Martin says that its U.S.‑government contracts are governed by the FAR, so the contract price is normally “cost + reasonable profit” and the company records revenue over time as the work‑in‑process is transferred to the government (the contract is treated as a single performance‑obligation and the standalone selling price equals the contract price)【page_77】.  \n\nRaytheon Technologies notes that, although its contracts are also FAR‑subject, a large share are fixed‑price (firm‑fixed‑price or fixed‑price‑incentive). Under those structures any cost overruns are borne by the company and can erode or eliminate profit, and funding delays or terminations can create cash‑flow and earnings volatility, giving RTX a direct financial exposure to the risks of fixed‑price contracts【page_16】【page_15】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies LMT's revenue recognition under FAR using a cost-plus-fixed-fee (implied by 'cost + reasonable profit') model and explains that revenue is recognized over time with standalone selling price equal to contract price, aligning with the original answer. It also accurately describes RTX's exposure to fixed-price contracts, particularly firm fixed-price (FFP) and fixed-price-incentive types, noting that cost overruns are borne by the company, leading to profit erosion and financial volatility. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly contrasts LMT’s FAR-regulated, cost-plus-based, lower-risk revenue model with RTX’s higher-risk fixed-price contract exposure, synthesizing information across two companies and contract types. (4) Minor wording differences exist (e.g., 'cost + reasonable profit' vs 'cost-plus-fixed-fee'), but these are semantically equivalent. The LLM does not explicitly use the term 'cost-plus-fixed-fee' but describes it accurately. It also omits the explicit mention of 'negative profit adjustments in development programs' from the original, which is a minor omission but does not undermine the overall correctness. Hence, the answer is factually correct, complete in key aspects, and contextually fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 423,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How does the expiration timeline of BMY's Eliquis patent rights in Europe compare to MRK's Januvia family patent expiration in the U.S., and what impact does this have on their respective market exclusivity strategies?",
      "original_answer": "BMY is actively litigating to extend the market exclusivity of Eliquis in Europe, having secured final positive decisions in Norway, Sweden, and Switzerland, while facing negative outcomes in the UK and ongoing appeals in several other countries. Despite these efforts, generic competition has already entered in some markets like Finland and Portugal. In contrast, MRK's Januvia family lost its key U.S. patent in January 2023, but due to court rulings and settlements, exclusivity is maintained until May 2026 for Januvia and Janumet and July 2026 for Janumet XR. This difference in timelines and enforcement success highlights how BMY's fragmented European patent strategy faces more immediate generic erosion, while MRK has extended exclusivity in the U.S. through secondary patents, delaying generic entry and preserving revenue longer.",
      "llm_answer": "BMS’s Eliquis patents in Europe are still being litigated and have already been challenged – generic versions are on the market in several EU countries even though the composition‑of‑matter patent and its SPCs have not yet expired, so the exact expiration date is uncertain and BMS must rely on lawsuits, settlements and possible price‑adjustments to preserve any remaining exclusivity. By contrast, Merck’s key U.S. patents covering the Januvia/Janumet family are slated to expire in May 2026 (Janumet XR in July 2026), giving the company a known horizon and prompting it to plan for the inevitable loss of exclusivity (price cuts, rebate management and sales‑decline forecasts). Thus, BMS faces a more immediate, uncertain threat to European exclusivity, while Merck is managing a scheduled U.S. exclusivity expiry in 2026.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all dates are correct: MRK's Januvia/Janumet exclusivity until May 2026 and Janumet XR until July 2026 matches the original answer exactly. The LLM correctly notes that BMY's Eliquis exclusivity in Europe is uncertain due to litigation and generic entry, though it does not specify the exact countries where positive or negative rulings occurred (e.g., Norway, Sweden, UK, Finland, Portugal). This omission is minor and does not affect the overall correctness. (2) The LLM accurately captures that MRK extended exclusivity via secondary patents and settlements, resulting in a predictable 2026 expiry, while BMS faces fragmented, country-by-country challenges in Europe with some markets already lost to generics. (3) Multi-hop reasoning is sound: the model correctly synthesizes patent status, geographic differences (Europe vs. U.S.), litigation outcomes, and strategic implications for market exclusivity. (4) The only minor gap is that the LLM does not explicitly mention BMY's 'final positive decisions' in Norway, Sweden, and Switzerland or the 'ongoing appeals' in other countries, which adds slightly less detail than the original. However, the essence—that BMS is litigating with mixed outcomes and facing generic erosion—is preserved. Wording differs but semantic meaning aligns closely. No factual errors; minor detail omission prevents a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 405,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What is the total amount of appeal bonds posted by PM USA related to adverse verdicts on appeal, and how does this compare to the total payments made by PM USA for judgments and settlements in tobacco-related litigation since October 2004?",
      "original_answer": "PM USA has posted appeal bonds totaling $35 million related to adverse verdicts currently on appeal. Since October 2004, PM USA has paid approximately $1 billion in judgments and settlements (including related costs and fees) and approximately $241 million in interest related to tobacco litigation. This indicates that the current appeal bonds represent a small fraction of the total historical litigation-related payments made by PM USA.",
      "llm_answer": "PM USA has posted appeal bonds of roughly **$35 million** to secure stays of adverse verdicts that are on appeal. By contrast, since October 2004 the company has paid about **$1 billion** in judgments and settlements (plus roughly $241 million in related interest) for tobacco‑related litigation. Thus, the appeal‑bond amount is only a few percent of the total payments made on those judgments and settlements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key numbers are correct: $35 million in appeal bonds, $1 billion in judgments and settlements, and $241 million in interest since October 2004—matching the original answer exactly. Number formats are acceptable and semantically equivalent. (2) The quantitative accuracy is perfect: no calculation errors, and the comparison correctly frames the $35 million as a small fraction of the $1 billion, which is consistent with stating it is 'only a few percent.' While the exact percentage (3.5%) is not computed, the qualitative description is reasonable and does not misrepresent the scale. (3) The multi-hop reasoning is sound: the model correctly distinguishes between current appeal bonds and historical payments (including interest), synthesizing information across time and categories. (4) The answer addresses both parts of the question: the total appeal bonds and the comparison to historical payments. The only minor shortcoming is the omission of the phrase 'related costs and fees' mentioned in the original answer, which slightly reduces completeness but does not affect the core factual accuracy. Overall, the answer is contextually relevant, factually correct, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 353,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 205,
      "question": "How does the revenue contribution from Taiwan differ between Apple's Greater China segment in 2022 and NVIDIA's direct revenue reported from Taiwan in the same year?",
      "original_answer": "Apple's Greater China segment generated $74,200 million in net sales in 2022, which includes Taiwan along with China mainland and Hong Kong. In contrast, NVIDIA directly reported $8,544 million in revenue from Taiwan in 2022. Since Apple's figure for Taiwan is embedded within the broader Greater China segment, the exact revenue contribution from Taiwan alone for Apple cannot be determined precisely but is a subset of the $74,200 million. NVIDIA’s $8,544 million provides a direct and isolated measure of its Taiwan revenue.",
      "llm_answer": "Apple’s Greater China segment – which aggregates sales from mainland China, Hong Kong and Taiwan – generated **$74.2 billion** of net sales in fiscal 2022. In contrast, NVIDIA reported **$8.544 billion** of revenue that was billed to customers in Taiwan in the same year. Thus, Apple’s Taiwan‑related revenue is embedded in a much larger $74.2 billion segment, whereas NVIDIA’s Taiwan revenue is a distinct $8.5 billion amount.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Apple's Greater China segment net sales as $74.2 billion (equivalent to $74,200 million) and NVIDIA's Taiwan revenue as $8.544 billion (equal to $8,544 million), with accurate fiscal year 2022 alignment. Number formats are valid variations (billion vs million). (2) All quantitative values match the ground truth exactly when adjusted for unit representation—$74.2 billion = $74,200 million and $8.544 billion = $8,544 million. No calculation errors. (3) The reasoning correctly identifies that Apple’s revenue from Taiwan is embedded within a broader geographic segment, making it impossible to isolate, while NVIDIA reports Taiwan revenue directly. This captures the core multi-hop comparison: aggregated vs. direct reporting. The only minor shortcoming is a slight lack of explicit emphasis on the impossibility of extracting Apple’s exact Taiwan contribution, though the implication is clear from context. (4) The answer is fully relevant, directly addressing the comparative revenue contribution question. Scores reflect near-perfect factual accuracy, with a minor deduction in qualitative accuracy due to slightly less explicit clarification about Apple’s lack of granular disclosure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 348,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 233,
      "question": "How has the growth in NVDA's revenue from Taiwan between fiscal years 2020 and 2022 compared to the growth in AAPL's revenue from the Greater China region, which includes Taiwan?",
      "original_answer": "NVDA's revenue from Taiwan grew from $3,025 million in 2020 to $8,544 million in 2022, representing a 182.5% increase over two years. AAPL's revenue from Greater China, which includes Taiwan, grew from $40,308 million in 2020 to $74,200 million in 2022, representing an 84.1% increase over the same period. Therefore, NVDA experienced significantly higher growth in revenue from Taiwan (as part of its broader regional exposure) compared to AAPL's growth in the broader Greater China region.",
      "llm_answer": "- NVIDIA’s Taiwan revenue rose from $3.0 billion in FY 2020 to $8.5 billion in FY 2022 – an increase of roughly **182 %**.  \n- Apple’s Greater‑China revenue (which includes Taiwan) grew from $40.3 billion in FY 2020 to $74.2 billion in FY 2022 – an increase of about **84 %**.  \n\nSo NVIDIA’s Taiwan‑region revenue grew **more than twice as fast** as Apple’s Greater‑China revenue over the 2020‑2022 period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key financial figures: NVDA's revenue from Taiwan is accurately stated as $3.0 billion in FY2020 and $8.5 billion in FY2022 (matching $3,025M and $8,544M in original, with acceptable rounding). AAPL's Greater China revenue is correctly given as $40.3 billion (vs $40,308M) and $74.2 billion (vs $74,200M), again with reasonable rounding. (2) Percentage calculations are accurate: (8.5 - 3.0) / 3.0 ≈ 1.833 → 182% (original: 182.5%), and (74.2 - 40.3) / 40.3 ≈ 0.841 → 84% (original: 84.1%). These minor rounding differences do not affect factual correctness. (3) Multi-hop reasoning is sound: the model correctly compares growth rates across two companies and regions, noting that NVDA’s growth was more than twice that of AAPL’s, which is valid (182% > 2×84%). (4) Entity identification is correct: companies (NVDA, AAPL), regions (Taiwan, Greater China), and fiscal years (2020–2022) are all accurately referenced. The answer fully addresses the comparative growth question and synthesizes data across entities and years. All aspects match the ground truth in semantic and quantitative terms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 326,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 235,
      "question": "How does Microsoft's projected tax liability under the OECD's Pillar Two Model Rules compare to Broadcom's exposure from the global minimum tax, given their differing international tax structures?",
      "original_answer": "Microsoft projects no material impact from the OECD's Pillar Two Model Rules, which establish a 15% global minimum tax, as it begins applying to the company in fiscal year 2025. In contrast, Broadcom notes that global minimum tax provisions, such as Singapore's adoption effective for fiscal year 2026, may materially increase its effective tax rate and cash tax costs. This divergence reflects Microsoft's current lack of material operations in jurisdictions with tax rates below the 15% threshold, versus Broadcom's existing reliance on tax incentives in various jurisdictions that could be adversely affected by the global minimum tax.",
      "llm_answer": "Microsoft says that, although the OECD Pillar‑Two rules (the 15 % global minimum tax) will begin to apply to it in FY 2025, it does **not expect a material increase** to its tax expense – the impact is projected to be negligible. In contrast, Broadcom warns that the same global‑minimum‑tax regime “may materially increase our effective tax rate and cash‑tax costs,” indicating a **significant exposure** for Broadcom because its international tax mix makes it more vulnerable to the new rules.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that Microsoft does not expect a material impact from the OECD Pillar Two rules, which apply starting in fiscal year 2025, aligning with the original answer. Broadcom's exposure is accurately portrayed as potentially material, with a risk of increased effective tax rate and cash tax costs, consistent with the source. (2) All quantitative and temporal elements are correct: the 15% global minimum tax, FY2025 for Microsoft, and FY2026 for Singapore’s implementation (implied contextually). No numerical calculations are required, but the characterization of 'no material impact' vs. 'may materially increase' is preserved with precise qualitative descriptors. (3) The multi-hop reasoning is sound—correctly contrasting Microsoft’s and Broadcom’s differing exposures based on their international tax structures, even if the LLM does not explicitly mention Singapore or tax incentives, the inference of structural vulnerability is maintained. (4) The answer is fully relevant, directly addressing the comparative tax liability question with accurate, concise synthesis. Minor omission of specific jurisdictional detail (Singapore) does not detract from overall correctness as the core contrast in exposure and reasoning is preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 372,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 245,
      "question": "How does the difference in voting rights structure between NFLX common stock and GOOGL Class B common stock impact shareholder influence, given that GOOGL Class B shares carry 10 votes per share while NFLX shares carry only one vote per share?",
      "original_answer": "NFLX common stock provides one vote per share to all shareholders, granting equal influence per share. In contrast, GOOGL has a multi-tiered voting rights structure where Class B common stockholders receive 10 votes per share, significantly amplifying their voting power compared to Class A shareholders who receive one vote per share. This structural difference means that GOOGL's Class B shareholders have disproportionately greater influence over corporate decisions than any single group of shareholders at NFLX, where voting power is uniformly distributed across all shares.",
      "llm_answer": "Alphabet’s Class B shares give each share ten votes, whereas Netflix’s common shares provide only one vote per share【page_81】. Because a Class B share carries ten times the voting power of a Netflix share, holders of Alphabet’s Class B stock can exert substantially greater influence over board elections and other shareholder‑controlled matters than a typical Netflix shareholder.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) Quantitative accuracy: The statement that GOOGL Class B shares carry 10 votes per share and NFLX shares carry 1 vote per share is accurate, matching the original answer exactly. No calculations are required, but the comparison of voting power (10x) is correctly implied. (2) Completeness: The LLM addresses the core of the question—how the difference in voting rights impacts shareholder influence. It correctly identifies that GOOGL Class B shareholders have significantly greater influence than NFLX shareholders due to the 10:1 vote ratio. However, it does not explicitly mention that NFLX has a uniform voting structure across all shares (i.e., no multi-class structure), which is a minor omission but does not detract from the main point. (3) Entity accuracy: Correctly identifies NFLX and GOOGL (Alphabet), and refers to the correct share classes (Class B for GOOGL). (4) Reasoning: The logic is sound—more votes per share lead to greater influence over corporate decisions like board elections. The answer synthesizes the voting rights difference and draws the correct conclusion about influence. (5) Semantic equivalence: The meaning conveyed is effectively the same as the original answer, though slightly less detailed in describing the uniformity of NFLX's structure. Overall, the answer is concise, accurate, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 393,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does AMD's revenue from Taiwan in 2021 compare to Apple's 2022 revenue from the broader Greater China region, which includes Taiwan?",
      "original_answer": "AMD reported $1,187 million in revenue from Taiwan in 2021, while Apple reported $74,200 million in revenue from the Greater China region in 2022. Since Greater China includes Taiwan along with China mainland and Hong Kong, Apple's revenue from the broader region was significantly higher than AMD's revenue specifically from Taiwan.",
      "llm_answer": "AMD earned about **$2.1 billion** from sales to customers in Taiwan in 2021 (AMD 10‑K, “sales to external customers… Taiwan $ 2,091 million”)【page_78】.  \n\nApple’s 2022 net sales for the **Greater China** segment – which includes Taiwan – were **$74.2 billion** (Apple 10‑K, “Greater China $ 74,200 million”)【page_25】.  \n\nThus, AMD’s Taiwan revenue in 2021 was roughly **1/35th** the size of Apple’s 2022 Greater China revenue.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in AMD's 2021 revenue from Taiwan. The ground truth states $1,187 million, but the LLM reports $2,091 million (rounded to $2.1 billion), which is incorrect. Apple's revenue figure is accurate at $74,200 million ($74.2 billion) for Greater China in 2022. (2) The calculation comparing AMD’s revenue to Apple’s as 'roughly 1/35th' is based on incorrect input data. Using correct figures: $1,187M vs $74,200M gives a ratio of approximately 1/62.5, not 1/35. The LLM’s ratio would only be valid if AMD’s number were ~$2.1B, which matches its incorrect value but not ground truth. (3) The multi-hop reasoning structure is sound—correctly identifying that Apple’s Greater China includes Taiwan and making a comparative analysis—but it fails due to the initial data error. The entities (AMD, Apple, Taiwan, Greater China, correct years) are properly identified, and the 10-K citations appear contextually placed. (4) Correctness score is 4 due to major quantitative inaccuracy undermining the conclusion, though the framework of reasoning and contextual relevance is strong. Quantitative accuracy is low (3) due to wrong AMD revenue figure and derived ratio. Qualitative accuracy is moderate (6) because reasoning logic and entity identification are correct. Contextual relevance is high (9) as the answer directly addresses the comparison asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 389,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the availability of shares under Tesla's 2019 Equity Incentive Plan compare with Starbucks' remaining equity grant capacity, particularly in relation to their respective use of incentive stock options as a component of compensation strategy?",
      "original_answer": "Tesla's 2019 Equity Incentive Plan had 49.0 million shares reserved and available for issuance as of December 31, 2021, while Starbucks had 99.7 million shares available for future equity-based compensation awards as of October 2, 2022. Both companies utilize incentive stock options as part of their broader equity compensation structures, with Tesla's 2019 Plan explicitly including the provision for granting incentive stock options to employees, and Starbucks maintaining several equity incentive plans that include incentive stock options among other forms of equity compensation.",
      "llm_answer": "Tesla’s 2019 Equity Incentive Plan had **about 49 million shares** reserved and available for issuance as of 12/31/2021, and the plan expressly permits the grant of incentive stock options (along with non‑statutory options).  \nStarbucks, by contrast, reported **roughly 99.7 million shares** of common stock still available for future equity‑based compensation awards (including options and RSUs) as of Oct 2 2022, without a separate breakdown for incentive stock options.  \n\nThus, Starbucks’ remaining grant capacity is roughly double Tesla’s, and while Tesla’s plan highlights incentive stock options as a key component, Starbucks’ disclosed capacity reflects a broader mix of equity awards.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Tesla's 49.0 million shares (rounded to 'about 49 million') available under its 2019 Equity Incentive Plan as of December 31, 2021, and Starbucks' 99.7 million shares available as of October 2, 2022—both figures match the ground truth exactly in substance, with acceptable rounding. The dates are accurately cited. (2) Quantitative accuracy is perfect: both numbers are correct, and the observation that Starbucks' remaining capacity is 'roughly double' Tesla's is a reasonable qualitative comparison (99.7M vs 49M ≈ 2x). No calculations were required beyond this comparison, which is logically sound. (3) The multi-hop reasoning is strong: the model correctly synthesizes data from two different companies, different reporting dates, and different plan structures, and addresses both parts of the question—availability of shares and use of incentive stock options. It correctly notes that Tesla’s plan explicitly includes incentive stock options, and that Starbucks’ plans include them as part of a broader mix, even though the breakdown isn’t disclosed. This aligns with the ground truth. (4) The only minor shortcoming is that the LLM slightly downplays the explicit mention in the original answer that Starbucks maintains 'several equity incentive plans'—this contextual detail about structural complexity is omitted, but the core point about a 'broader mix of equity awards' captures the essence. Overall, the answer is factually accurate, complete, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy for minor omission of structural detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 451,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the use of valuation models incorporating broker/dealer quotes impact the fair value determination of Level 2 assets for GD compared to BA's approach for available-for-sale debt investments?",
      "original_answer": "GD determines the fair value of its Level 2 fixed-income securities using valuation models that incorporate observable inputs such as quoted prices for similar assets and broker/dealer quotes. Similarly, BA values its available-for-sale debt investments using broker/dealer quotes for identical or comparable instruments. Both companies rely on these observable inputs through third-party pricing services and industry-standard models, indicating a parallel approach in determining fair value for Level 2 assets, despite being in different industries.",
      "llm_answer": "General Dynamics (GD) values its Level 2 fixed‑income securities with a market‑approach model that uses observable inputs such as prevailing interest rates, bond yields and quoted prices for similar securities (see GD 10‑K p. 93‑94). Boeing (BA) values its available‑for‑sale debt securities with a comparable market‑approach model but explicitly incorporates broker‑dealer quotes, recent trades and issuer credit spreads as the observable inputs (see BA 10‑K p. 68‑69). Thus, while both companies rely on observable market data, BA’s use of broker‑dealer quotes ties its Level 2 fair‑value estimates more directly to current market pricing, whereas GD’s model relies on broader proxy inputs and similar‑asset quotes, which can produce a slightly less market‑specific valuation.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the core methodologies used by GD and BA for fair value determination of Level 2 assets, and correctly identifies that both companies use observable inputs such as broker/dealer quotes and prices for similar or identical instruments. There are no numeric inaccuracies, as the question does not involve specific dollar amounts, percentages, or dates—thus quantitative accuracy is perfect. The entities (GD, BA, Level 2 assets, available-for-sale debt investments) are correctly identified and contextually relevant. However, the LLM introduces a qualitative distinction not present in the original answer—namely, that BA’s use of broker/dealer quotes makes its valuation 'more directly tied to current market pricing' and that GD relies on 'broader proxy inputs,' implying a meaningful methodological divergence. The ground truth emphasizes that both companies have a 'parallel approach,' suggesting substantial similarity in practice despite potential differences in emphasis. This overstates the contrast and adds interpretive nuance not supported by the original synthesis. While the LLM correctly cites page numbers and input types, the reasoning slightly misrepresents the comparative conclusion, weakening the qualitative accuracy. Contextual relevance remains high as all information pertains directly to the question. Thus, the answer is largely correct but contains a subtle but notable deviation in interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 410,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the current zero percent setting of the Countercyclical Capital Buffer (CCyB) impact the total capital buffer requirements for both Morgan Stanley and American Express under Basel III, considering Morgan Stanley's inclusion of the Stress Capital Buffer (SCB) in its Advanced Approach calculation and American Express's explicit subjectivity to the SCB?",
      "original_answer": "Under the current zero percent Countercyclical Capital Buffer (CCyB), Morgan Stanley's total capital buffer requirement under the Advanced Approach includes the 2.5% Capital Conservation Buffer (CCB), the G-SIB capital surcharge, and the Stress Capital Buffer (SCB). American Express is also subject to the SCB under Basel III, which contributes to its minimum capital requirements. Since the CCyB is currently set at zero, neither firm is required to add additional capital under this buffer. Therefore, the SCB plays a key role in both firms’ capital planning and distribution constraints, despite differing regulatory calculation approaches.",
      "llm_answer": "Morgan Stanley’s capital‑buffer tables show that the Counter‑cyclical Capital Buffer (CCyB) is set at **0 %** (page 134). Because the CCyB is zero, the firm’s total buffer under the **Standardized Approach** is simply the sum of the Stress Capital Buffer (SCB) 5.4 % and the G‑SIB surcharge 3.0 % – **8.4 %** (0 % CCyB adds nothing). Under the **Advanced Approach** the buffer is the 2.5 % capital‑conservation buffer plus the 3.0 % G‑SIB surcharge – **5.5 %**, again with no contribution from the CCyB.\n\nAmerican Express’s regulatory‑capital disclosure notes that its “effective minimum” includes the **stress capital buffer for American Express Company”** (page 151, footnote (d)). Since the Federal Reserve also has the CCyB set at **0 %**, the CCyB does not increase American Express’s required buffer; the total buffer consists of the SCB (and any other applicable surcharges such as the G‑SIB surcharge), with the CCyB contributing **nothing**.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and misrepresentations in both quantitative and qualitative aspects, despite correctly noting that the CCyB is set at 0% and thus does not add to capital requirements for either firm. (1) The main error lies in the calculation and composition of Morgan Stanley’s capital buffers: the LLM incorrectly states that under the Advanced Approach, the total buffer is 5.5% (2.5% CCB + 3.0% G-SIB), but fails to include the Stress Capital Buffer (SCB), which the ground truth explicitly states is part of Morgan Stanley’s Advanced Approach calculation. The SCB must be included in the total buffer requirement under the Advanced Approach, yet the LLM omits it here, suggesting a misunderstanding of how buffers are aggregated. (2) The LLM introduces a breakdown of the Standardized Approach (SCB 5.4% + G-SIB 3.0% = 8.4%), but this level of specificity—including exact percentages like 5.4% and 3.0%—is not present in the original answer and cannot be verified from the ground truth. These numbers may be factually correct in external sources, but since the ground truth does not specify them, their inclusion introduces unverified data. (3) For American Express, the LLM correctly notes that the SCB applies and CCyB is zero, but again adds unspecified percentages (implying a calculable total buffer) without providing numbers, which creates inconsistency. (4) Multi-hop reasoning is partially sound—linking CCyB=0 to no additional capital requirement for both firms is correct—but fails in synthesizing the correct composition of total buffers, especially regarding the inclusion of SCB in both firms’ requirements under different frameworks. (5) While the contextual relevance is high (addresses both firms, correct buffer names, correct CCyB status), the quantitative accuracy is low due to unsupported percentages and incorrect buffer summations. The answer gives a false impression of precision with numbers not in the ground truth and misses key conceptual integration of SCB into Morgan Stanley’s Advanced Approach buffer. Thus, while core ideas are partially correct, significant errors reduce overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 578,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the $4.0 billion increased commitment under AMT's 2021 Credit Facility relate to its financing strategy for acquisitions, and how does this contrast with SPG's approach to financing through joint ventures as of December 31, 2021?",
      "original_answer": "AMT increased the commitment under its 2021 Credit Facility to $4.0 billion, which was used to finance acquisitions such as the CoreSite Acquisition, reflecting a strategy of leveraging large-scale credit facilities for major transactions. This contrasts with SPG's approach, where it provided $88.4 million in financing to joint ventures primarily in the form of interest-bearing construction loans, indicating a focus on internal financing and partnership structures to support real estate development and diversify risk.",
      "llm_answer": "American Tower raised the borrowing limit on its 2021 Credit Facility to $4.0 billion (up from $2.9 billion) and explicitly used the additional capacity, together with other revolving facilities, to fund its large‑scale purchases of Telxius and CoreSite — the company’s acquisition strategy is therefore built on sizable senior‑secured credit lines that can be drawn for deal financing and general corporate purposes【page_111】.  \n\nIn contrast, Simon Property Group does not rely on such large revolving credit for acquisitions; instead it finances property development and purchases through joint‑venture arrangements, providing construction loans and other advances that total about $88 million and earning management‑fee revenue from those JV partners【page_116】.  \n\nThus, AMT’s $4 billion credit‑facility increase reflects a direct, debt‑driven acquisition model, whereas SPG’s approach centers on partnership‑based financing with modest loan exposure and fee income.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AMT increased its 2021 Credit Facility to $4.0 billion (from $2.9 billion, though the original amount is extra detail), and used it to finance acquisitions like CoreSite (and also mentions Telxius, which is factually correct and adds context). SPG provided $88 million in financing to joint ventures, consistent with the ground truth's $88.4 million (rounding is acceptable). (2) Quantitative accuracy is excellent: $4.0 billion and ~$88 million are correctly reported; no calculation errors. (3) Multi-hop reasoning is sound: the model correctly contrasts AMT’s debt-financed acquisition strategy using large credit facilities with SPG’s joint-venture–based model involving construction loans and fee income. (4) The answer fully addresses both parts of the question and synthesizes information across two companies and strategies. The only minor shortcoming is that the ground truth specifically mentions the financing was 'interest-bearing construction loans' and emphasizes risk diversification, which the LLM touches on implicitly but could have stated more explicitly. However, the core reasoning and factual content are equivalent. Wording differs but meaning is preserved. Contextual relevance is perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 366,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does the growth in Starbucks' store count in Taiwan compare to Nike's revenue contribution from the Greater China region, considering Taiwan's inclusion within Greater China's geographic reporting?",
      "original_answer": "Starbucks added 21 net new stores in Taiwan from fiscal year 2021 to 2022, reflecting a growth in its operational footprint. Meanwhile, Nike reported $7,547 million in total revenues from the Greater China region in FY2022, which includes Taiwan. This indicates that while Starbucks is expanding its physical presence in Taiwan, Nike's revenue from the broader Greater China region—which encompasses Taiwan—represents a significant portion of its global revenue, highlighting different modes of market engagement and performance metrics across the two companies.",
      "llm_answer": "Starbucks’ licensed‑store data shows that Taiwan’s store base rose from 523 stores on Oct 3 2021 to 544 stores on Oct 2 2022 – a net increase of **21 stores** (about a 4 % rise).  \n\nNike’s segment reporting treats Taiwan as part of “Greater China,” which contributed **≈ $7.5 billion in total revenue** for the fiscal year ended May 31 2022 (footwear, apparel and equipment combined).  \n\nThus, while Starbucks added only a few dozen stores in Taiwan, Nike’s Greater‑China region (including Taiwan) generated multi‑billion‑dollar revenue, a scale far larger than the modest store‑count growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the net increase of 21 stores in Taiwan from FY2021 to FY2022 is accurately reported, with exact store counts (523 to 544) and a correctly calculated ~4% growth. Nike's Greater China revenue is reported as ≈$7.5 billion for FY2022 (ended May 31, 2022), which matches the ground truth of $7,547 million—rounding to $7.5 billion is acceptable and common. (2) The fiscal years are correctly aligned: Starbucks' fiscal year ends in October, and Nike's in May; the LLM correctly uses the relevant reporting dates for each company. (3) Entity accuracy is strong: both companies are correctly identified, the geographic segmentation (Taiwan within Greater China for Nike) is properly acknowledged, and the metrics (store count vs. revenue) are correctly attributed. (4) The reasoning is sound and synthesizes multi-hop information: it contrasts Starbucks’ physical expansion in Taiwan with Nike’s broader financial performance in Greater China, correctly noting the difference in scale and mode of market engagement. The only minor shortcoming is that the LLM does not explicitly state that Taiwan is included in Nike’s Greater China reporting in the same direct way as the original answer, though it is implied. This slight omission in clarity prevents a perfect 10 on qualitative accuracy, but the overall correctness, context, and numerical precision are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 406,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What percentage of Boeing's (BA) OPB plan assets are indirectly invested in equities through the balanced index fund, and how does this compare to the total fair value of equities held by 3M's (MMM) pension plan as of December 31, 2023?",
      "original_answer": "Boeing's OPB plan assets are approximately 60% invested in equities via the balanced index fund. Meanwhile, 3M's pension plan reported a total fair value of $785 million in equities as of December 31, 2023.",
      "llm_answer": "Boeing’s “Other Post‑retirement Benefit” (OPB) plan is invested mainly in a balanced index fund that is roughly **60 % equity‑weighted** (the other 40 % being debt securities).  \n\nIn contrast, 3M’s international pension plans reported a **fair‑value total for equities of about $785 million** at December 31, 2023.  \n\nSo, while Boeing’s OPB assets are about 60 % indirectly in equities, 3M’s pension plans hold roughly $785 million of equities outright.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the 60% equity weighting in Boeing's OPB plan via the balanced index fund is accurately reported, and the $785 million fair value of equities in 3M's pension plan as of December 31, 2023, is correctly stated. Format variations (e.g., 'about $785 million' vs '$785 million') are semantically equivalent and acceptable. (2) The answer is complete, addressing both parts of the multi-part question: the percentage of Boeing’s OPB assets indirectly in equities and the total fair value of equities in 3M’s pension plan. (3) Entity accuracy is correct—Boeing (BA), 3M (MMM), 'OPB plan', 'pension plan', and the date 'December 31, 2023' are all properly identified. (4) The reasoning is sound: the LLM correctly synthesizes information across two companies and two different retirement plans, distinguishing between indirect equity exposure (via a fund) and direct equity holdings, and makes a clear, logical comparison. No factual, numerical, or conceptual errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 304,
        "total_tokens": 1491
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does AMT's utilization of the 2021 USD Delayed Draw Term Loans for financing compare to SPG's use of financing mechanisms for real estate joint ventures, particularly in terms of dollar amounts and financing structure?",
      "original_answer": "AMT utilized the 2021 USD Delayed Draw Term Loans as part of a $10.5 billion financing structure to support the CoreSite Acquisition, ensuring funding availability without drawing on bridge loans. In contrast, SPG provided $88.4 million in financing to joint ventures through interest-bearing construction loans and other advances as of December 31, 2021, primarily to support real estate development and investment activities. While AMT's financing was large-scale and acquisition-focused, SPG's approach was smaller in scale and oriented toward real estate joint ventures.",
      "llm_answer": "American Tower (AMT) drew the full $3 billion 364‑day USD delayed‑draw term loan and the $1.5 billion two‑year USD delayed‑draw term loan – a combined $4.5 billion of unsecured term borrowing that was earmarked to fund the CoreSite acquisition and was priced off LIBOR + margin. In contrast, Simon Property Group (SPG) finances its real‑estate joint ventures with modest interest‑bearing construction loans and other advances that total only about $88 million, reflected as deferred‑cost assets rather than large revolving or term facilities.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains significant quantitative inaccuracies. It states that AMT utilized a combined $4.5 billion in delayed-draw term loans for the CoreSite acquisition, but the ground truth specifies a $10.5 billion financing structure. While the LLM correctly identifies the existence of delayed-draw term loans and their purpose (funding the CoreSite acquisition), the total amount is less than half the actual figure. The SPG financing amount is mostly accurate: $88 million vs. the correct $88.4 million — a minor and acceptable rounding difference.\n\n2) The quantitative accuracy is compromised primarily by the incorrect AMT financing total. The LLM breaks down $3 billion (364-day) and $1.5 billion (two-year) loans to reach $4.5 billion, but this does not align with the ground truth of a $10.5 billion structure. This could reflect a misinterpretation of the filing, possibly confusing committed capacity with actual utilization or omitting other tranches of financing. The SPG number is quantitatively sound.\n\n3) Entity accuracy is strong: AMT and SPG are correctly identified, the CoreSite acquisition is accurately referenced, and the context of real estate joint ventures for SPG is preserved. The time frame (2021) is implied correctly. However, the LLM fails to mention that AMT's structure avoided bridge loans, a key qualitative point in the original answer.\n\n4) The reasoning is partially sound. The model correctly contrasts AMT’s acquisition-focused financing with SPG’s smaller-scale real estate joint venture support. It appropriately highlights differences in scale and structure (term loans vs. construction advances). However, it misses the full scope of AMT’s financing mechanism and misrepresents its size, undermining the validity of the comparison. The characterization of SPG’s financing as 'modest' and reflected as deferred-cost assets adds useful context not in the original, but does not compensate for the major dollar amount error.\n\n5) Despite good contextual relevance and appropriate terminology, the significant underreporting of AMT’s financing amount leads to a misleading comparison in scale. This is a critical error in a financial comparison question, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 598,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does XOM's reliance on crude oil as a raw material intersect with CVX's 15% ownership in the Caspian Pipeline Consortium, considering the volume of crude oil transported through CPC from Chevron's operations in Kazakhstan?",
      "original_answer": "XOM depends on crude oil as a core raw material for its operations. Meanwhile, CVX holds a 15% interest in the Caspian Pipeline Consortium (CPC), which transports an average of 1.4 million barrels of crude oil per day, with 1.2 million barrels sourced from Kazakhstan—specifically from fields like Tengiz and Karachaganak in which Chevron operates or holds stakes. This means that a portion of the crude oil CVX produces or co-produces in Kazakhstan relies on CPC for export, linking upstream production to midstream logistics. Since crude oil is essential for XOM’s business, any disruption in supply chains like CPC could impact the availability or cost of crude oil for companies downstream, including XOM.",
      "llm_answer": "Exxon Mobil’s upstream and downstream cost tables show that the company’s operations depend heavily on crude‑oil purchases (e.g., $9.9 billion in U.S. crude‑oil and product purchases and $11.3 billion in non‑U.S. purchases in 2024) 【page_112】.  Chevron, which supplies the bulk of that crude from its Kazakhstan Tengiz‑Korolev fields, ships the oil through the Caspian Pipeline Consortium – a pipeline in which Chevron (and therefore CVX) holds a 15 % equity stake 【page_85】【page_16】.  The CPC moves an average of 1.4 million barrels per day, of which about 1.2 million barrels per day originate from Kazakhstan 【page_16】, so the pipeline that CVX partially owns carries a substantial portion of the crude that Exxon Mobil ultimately needs as a raw material.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is largely correct in its factual content and reasoning. It accurately states that XOM depends heavily on crude oil, citing specific 2024 purchase figures ($9.9B U.S., $11.3B non-U.S.) from page 112, which supports the claim of reliance. It correctly notes CVX's 15% stake in the CPC (pages 85, 16), the CPC’s average throughput of 1.4 million barrels per day, and that 1.2 million bpd originates from Kazakhstan (page 16), aligning with the ground truth. These numbers are quantitatively accurate and properly attributed.\n\n2) Quantitative accuracy is high: all cited numbers (1.4M bpd, 1.2M bpd, 15%, $9.9B, $11.3B) match or are consistent with the implied ground truth. The years and units are correctly used. No calculation errors are present.\n\n3) Qualitatively, the reasoning is sound but contains a minor overstatement: it claims Chevron 'supplies the bulk of that crude' to XOM from Kazakhstan, which is not supported by the original answer or typical market dynamics. The original answer does not assert that CVX’s Kazakh production directly supplies XOM, only that disruptions in CPC could indirectly affect crude availability for companies like XOM. This overreach weakens the multi-hop logic slightly, as it implies a direct supply chain link not present in the ground truth.\n\n4) Contextual relevance is excellent—the answer directly addresses the intersection of XOM’s crude dependence and CVX’s CPC ownership, synthesizing information across entities and documents. It correctly links upstream (Kazakhstan production), midstream (CPC transport), and downstream (XOM’s crude needs). The minor error in implying a direct supply relationship does not undermine the core insight but prevents a top score. Thus, correctness is 8/10: core facts and numbers are right, but with a notable interpretive overstep.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 496,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the decommissioning funding shortfall risk at NEE's nuclear facilities compare to Duke Energy's exposure to nuclear decommissioning trust fund volatility, given the shared environmental and financial risks associated with nuclear power plant operations?",
      "original_answer": "NEE faces potential decommissioning funding shortfalls due to the risk that decommissioning costs could exceed the amount available in its decommissioning funds, which are subject to market and operational uncertainties. Similarly, Duke Energy Carolinas, Duke Energy Progress, and Duke Energy Florida maintain Nuclear Decommissioning Trust Funds (NDTFs) whose values are subject to market fluctuations. A decline in the market value of these NDTF assets could significantly increase Duke Energy's funding requirements for decommissioning. Both companies are exposed to the financial risks of nuclear power plant decommissioning, with NEE highlighting potential shortfalls and Duke Energy emphasizing the impact of capital market performance on its NDTF investments.",
      "llm_answer": "- NEE warns that the actual cost to de‑commission its nuclear plants could be higher than the cash it has set aside in its de‑commissioning funds, creating a potential short‑fall that would have to be covered from other resources.  \n\n- Duke Energy’s risk is that the market‑value of the assets held in its nuclear de‑commissioning trust funds (NDTF) can fall because of market‑price fluctuations, which would increase the amount of additional funding the company may need to provide.  \n\nThus, NEE’s exposure is a possible insufficiency of its funded reserve, whereas Duke’s exposure is the volatility of the trust‑fund investments that could raise future funding requirements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original answer. (1) It correctly identifies NEE's risk as potential decommissioning cost overruns relative to its funded reserves and Duke Energy's risk as market-driven volatility in its Nuclear Decommissioning Trust Funds (NDTFs). All key entities—NEE, Duke Energy (including its subsidiaries implicitly), decommissioning funding shortfalls, and NDTF market risk—are accurately represented. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable in a numerical sense; however, the description of financial mechanisms is precise, earning full marks. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies face nuclear decommissioning risks, but the nature differs—NEE focuses on cost vs. reserve sufficiency, while Duke emphasizes investment performance volatility. The distinction is logically drawn and aligns with the original answer. (4) The LLM omits the explicit mention of Duke Energy’s subsidiaries (Duke Energy Carolinas, Duke Energy Progress, Duke Energy Florida), which were named in the original answer, but this is a minor omission that does not affect the overall correctness or clarity of the risk comparison. Wording differs slightly but conveys the same meaning. Thus, the answer is highly accurate, contextually relevant, and well-reasoned, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 430,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does LOW's use of pricing models for Level 3 fair value measurements compare to GM's application of unobservable inputs in Level 3 valuations, particularly in light of the stated accounting policy that classifies valuations based on the observability of inputs?",
      "original_answer": "LOW applies pricing models to determine fair value for Level 2 assets and uses an income approach with significant unobservable inputs like volatility and expected term for its Level 3 contingent consideration related to the Canadian retail business sale. This aligns with the accounting policy that defines Level 3 valuations as those using significant unobservable inputs, often involving pricing models or discounted cash flow methodologies. GM similarly relies on unobservable inputs for Level 3 valuations, particularly in its GM Financial receivables, where static pool modeling and economic forecasts such as unemployment rates and GDP growth are used to estimate expected credit losses. Both companies follow the same accounting hierarchy but apply it differently depending on the nature of their assets and business operations.",
      "llm_answer": "Both companies classify a fair‑value measurement as Level 3 when the valuation relies on inputs that are not observable in the market. Lowe’s explicitly states that its performance‑based contingent‑consideration is measured using an option‑pricing model that incorporates significant unobservable inputs such as total equity value, volatility and expected term (see LOW 10‑K p. 53). General Motors, by contrast, describes its Level 3 valuations more generally – they are generated with pricing models or discounted‑cash‑flow techniques that require material unobservable assumptions (e.g., estimated cash flows, credit spreads, pre‑payment speeds) and are classified as Level 3 whenever those unobservable inputs are significant (see GM 10‑K p. 63‑64).  Thus, Lowe’s Level 3 measurement is tied to a specific option‑pricing model, while GM’s Level 3 measurements encompass a broader set of model‑based valuations that also depend on unobservable inputs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) It correctly identifies that both LOW and GM classify Level 3 fair value measurements based on the use of significant unobservable inputs, consistent with accounting policy. It accurately states that LOW uses an option-pricing model for its performance-based contingent consideration with specific unobservable inputs like volatility and expected term, referencing the correct page (p. 53) in the 10-K. GM is correctly described as using pricing models or discounted cash flow techniques with unobservable assumptions such as credit spreads and prepayment speeds, with reference to pages 63–64. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or ground truth, so quantitative accuracy is not applicable in that sense, but all qualitative financial concepts (e.g., model types, input categories) are correctly reported—hence a score of 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes the accounting policies of two different companies (LOW and GM), compares their use of unobservable inputs in Level 3 valuations, and highlights the difference in specificity (LOW’s focused use in contingent consideration vs. GM’s broader application in receivables modeling). The only minor shortcoming is that the LLM omits GM’s use of macroeconomic forecasts like unemployment and GDP growth in static pool modeling, which is mentioned in the ground truth and adds context to GM’s unobservable inputs. This is a small but relevant detail affecting completeness. (4) The answer is highly relevant, directly addressing the comparison asked in the question and grounding each claim in the respective 10-K disclosures. Overall, the response is semantically equivalent to the ground truth with high accuracy and strong reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 501,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the $10.5 billion in committed financing under AMT's 2021 Multicurrency Credit Facility compare with SPG's financing activities in joint ventures, particularly in terms of capital deployment strategy and risk diversification?",
      "original_answer": "AMT secured $10.5 billion in committed financing through its 2021 Multicurrency Credit Facility and related facilities, which were used to fund acquisitions like CoreSite and Telxius, while SPG provided $88.4 million in financing to joint ventures primarily in the form of interest-bearing construction loans, aligning with its strategy to diversify risk and finance property development. This shows that AMT leveraged large-scale credit facilities for major acquisitions, whereas SPG used smaller, targeted financings to support joint venture operations and risk-sharing.",
      "llm_answer": "American Tower’s $10.5 billion of committed financing under its 2021 Multicurrency Credit Facility is a massive, multi‑currency revolving pool that the company taps for large‑scale acquisitions (CoreSite, Telxius), debt repayment and general corporate needs, giving it broad liquidity and the ability to spread borrowing risk across currencies and lenders.  By contrast, Simon Property Group’s joint‑venture financing is modest—about $88 million of interest‑bearing construction loans and other advances to 84 JV properties—and is used to fund specific development projects while sharing ownership and cash‑flow risk with partners, thereby diversifying operational exposure rather than relying on a large corporate credit facility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: $10.5 billion for AMT’s 2021 Multicurrency Credit Facility and $88.4 million for SPG’s joint venture financing are accurately reported (minor rounding to $88 million is acceptable and common in summaries). The years (2021) and entities (AMT, SPG, CoreSite, Telxius) are correctly identified. (2) The answer addresses both parts of the multi-hop question: it compares the scale and use of AMT’s large credit facility versus SPG’s smaller joint venture financings, and it explains the differing capital deployment and risk diversification strategies. (3) Reasoning is sound: the LLM correctly infers that AMT uses its facility for broad corporate purposes including major acquisitions and currency diversification, while SPG uses targeted loans to share development risk with partners. (4) Semantic equivalence is strong—though the LLM adds slight elaboration (e.g., '84 JV properties'), this does not contradict the original and may reflect additional context from the knowledge graph. The only minor shortcoming is the rounding of $88.4 million to $88 million without explicit qualification, but this does not materially affect correctness. Overall, the answer demonstrates accurate multi-hop synthesis across companies, financial instruments, and strategic intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 383,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does AMD's revenue exposure to Taiwan in 2023 compare to QCOM's operational dependency on foundry partners in Taiwan, given the geopolitical risks associated with the region?",
      "original_answer": "AMD reported $1,841 million in sales to external customers from Taiwan in 2023, indicating a notable but declining revenue exposure compared to previous years. Meanwhile, QCOM explicitly states that its business depends on consistent and reliable chipset supply from foundry partners, particularly in Taiwan. A significant or prolonged military or geopolitical conflict involving China and Taiwan could severely limit or prevent QCOM from receiving chipset supply, which would have a material adverse impact on its business. Given that both companies are exposed to Taiwan—AMD through revenue and QCOM through critical supply chain dependencies—geopolitical instability in the region poses a dual risk, impacting both revenue streams and manufacturing continuity.",
      "llm_answer": "AMD’s 2023 revenue from Taiwan was $1.84 billion, or roughly 8 percent of its total $22.7 billion net revenue. Qualcomm, by contrast, does not quote a specific revenue share but repeatedly warns that a “significant portion” of its chipset supply comes from its foundry partners in Taiwan – a core operational dependency that could materially affect its business if Taiwan‑related geopolitical tensions disrupt those fabs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $1.84 billion revenue figure for AMD in 2023 from Taiwan matches the original $1,841 million (equivalent). The total net revenue of $22.7 billion and the 8% exposure are not in the ground truth but are plausible calculations; assuming they are correct, they do not contradict the original answer and add useful context. (2) The entity identification is accurate: AMD and QCOM (Qualcomm) are correctly referenced with appropriate metrics—revenue exposure for AMD and supply chain dependency for QCOM. (3) The reasoning is sound: the LLM correctly distinguishes between AMD’s revenue risk and QCOM’s operational/supply chain risk in Taiwan, synthesizing the multi-hop aspect of the question by comparing two different types of exposure. (4) The answer is contextually relevant and directly addresses the comparison requested, including geopolitical risk implications. The only minor limitation is that the LLM does not explicitly state that AMD’s exposure is 'declining' as noted in the ground truth, and it omits the specific warning language about 'material adverse impact' from QCOM’s disclosures. However, the core facts, numbers, and comparative analysis are correct and semantically equivalent. Thus, the answer earns a 9/10 for correctness—excellent but with minor omissions in qualitative nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 386,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does the expected impact of the 15% global minimum tax under OECD's Pillar 2 on SBUX's consolidated financial statements compare to MCD's assessment, given the phased implementation timelines across jurisdictions?",
      "original_answer": "SBUX notes that the global minimum tax under Pillar 2 will not be effective for the company until fiscal 2025 and is not expected to result in a material impact on its consolidated financial statements. Similarly, MCD states that while numerous countries have enacted Pillar 2 with an effective date for taxable years beginning after December 31, 2023, it also does not expect a material impact on its consolidated financial statements. Both companies are monitoring regulatory developments and await further guidance, as the implementation of Pillar 2 varies across jurisdictions and could evolve over time.",
      "llm_answer": "Both companies say the 15 % global minimum tax is not expected to be material to their consolidated results. Starbucks notes that Pillar 2 will not become effective for it until fiscal 2025, so it foresees no material impact at all. McDonald’s, by contrast, already sees some jurisdictions applying Pillar 2 to taxable years beginning after 31 Dec 2023, but likewise concludes that the early‑stage roll‑out will not materially affect its consolidated financial statements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: SBUX expects no material impact with Pillar 2 effective in fiscal 2025; MCD acknowledges implementation in some jurisdictions from January 1, 2024 (i.e., after December 31, 2023), but also expects no material impact. (2) Quantitative accuracy is perfect: the 15% rate, fiscal 2025 for SBUX, and the December 31, 2023 cutoff for MCD jurisdictions are all correctly stated. Format variations (e.g., '31 Dec 2023') are acceptable and unambiguous. (3) Multi-hop reasoning is sound—correctly compares two companies’ assessments of Pillar 2 impact, synthesizing their timelines and conclusions. (4) Minor deduction in qualitative accuracy because the LLM omits that both companies are monitoring developments and await further guidance, which is part of the original answer and relevant to the 'phased implementation' aspect of the question. However, the core comparison of impact and timelines is fully accurate and contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 300,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does JPMorganChase's risk governance framework, which emphasizes firmwide ownership of risk assessment, influence its approach to stress testing methodologies compared to Goldman Sachs, which explicitly ties stress testing to capital adequacy assessments?",
      "original_answer": "JPMorganChase's risk governance framework emphasizes firmwide ownership of risk assessment, with Risk Management and Compliance functions overseeing risk identification and escalation across business lines and corporate functions. This structured governance leads to a comprehensive approach to risk, where stress testing is likely embedded within broader risk identification and mitigation processes. In contrast, Goldman Sachs explicitly uses stress testing to assess capital adequacy and quantify exposure to tail risks, performing firmwide stress tests regularly to evaluate vulnerabilities across financial and nonfinancial risks. The difference in emphasis—JPMorganChase’s governance-driven risk ownership versus Goldman Sachs’s scenario-based capital adequacy focus—suggests that while both firms use stress testing as a core risk tool, the integration and ultimate purpose of stress testing within their risk frameworks differ significantly.",
      "llm_answer": "JPMorgan Chase’s governance model puts the responsibility for identifying, measuring and escalating risk on every line‑of‑business and on the firm‑wide risk executives (FREs, LOB CROs and the CRO). Because risk assessment – including stress‑scenario analysis – is owned throughout the firm, its stress‑testing program is embedded in each business’s regular risk‑management processes and is overseen centrally rather than being driven solely by a capital‑planning exercise. Goldman Sachs, by contrast, conducts firm‑wide stress tests expressly as a component of its CCAR/DFAST capital‑adequacy framework, using the results to set balance‑sheet targets and to determine whether capital buffers are sufficient. Thus JPMorgan’s approach is a broader, ownership‑based risk‑assessment tool, while Goldman’s is a capital‑adequacy‑focused stress‑testing exercise.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: JPMorgan Chase's firmwide ownership model involving business lines and risk executives (FREs, LOB CROs, CRO) is accurately described, and the decentralized yet centrally overseen nature of its stress testing is correctly portrayed. Goldman Sachs’s use of stress testing within the CCAR/DFAST capital adequacy framework, including its role in setting balance-sheet targets and evaluating capital buffers, is factually sound. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but all qualitative metrics (e.g., 'capital adequacy', 'firmwide stress tests') are used correctly—hence a score of 10. (3) The multi-hop reasoning—comparing governance models and their influence on stress testing purpose and integration—is logically sound and well-synthesized across both firms. The LLM correctly infers that JPMorgan’s approach is embedded in broader risk ownership, while Goldman’s is more tightly linked to capital planning. (4) The only reason for not giving a perfect 10 in correctness and qualitative accuracy is minor: the LLM answer does not explicitly mention Goldman Sachs’s assessment of 'nonfinancial risks' or 'tail risks' as in the original, slightly reducing completeness in scope description. However, this is a minor omission and does not distort the core contrast. Overall, the answer is semantically equivalent, contextually precise, and factually robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 437,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does XOM's asset exposure in Kazakhstan compare to CVX's financial stake in Tengizchevroil, considering CVX's equity ownership and loan contributions to the joint venture?",
      "original_answer": "XOM had $8,463 million in long-lived assets in Kazakhstan as of 2021, while CVX holds a 50% equity interest in Tengizchevroil (TCO), which operates in the same country. In addition to its equity stake, CVX provided a $4,500 million loan to TCO to fund the Future Growth Project and Wellhead Pressure Management Project (FGP/WPMP). This indicates that CVX's financial exposure to Tengizchevroil in Kazakhstan includes both its proportional equity value and a significant direct loan, potentially exceeding the magnitude of XOM's reported asset base in the country when combined.",
      "llm_answer": "ExxonMobil’s 2021 balance sheet shows long‑lived assets in Kazakhstan of roughly **$8.5 billion**.  By contrast, Chevron reports a **50 % equity interest in Tengizchevroil valued at about $23.7 billion** (carrying amount) and an additional **$4.5 billion loan** to the joint‑venture, giving Chevron a total financial exposure of roughly **$28 billion**—well above Exxon’s Kazakhstan asset base.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the valuation of CVX's equity interest in Tengizchevroil. The original answer (ground truth) states that CVX holds a 50% equity interest in TCO but does not specify a $23.7 billion carrying amount—this figure is fabricated or misattributed. The only financial figures provided in the ground truth are XOM's $8,463 million in long-lived assets and CVX's $4,500 million loan. The LLM incorrectly introduces a $23.7 billion equity value not present in the original data, leading to a grossly inflated total exposure of $28 billion. (2) The calculation of 'total exposure' as $23.7B + $4.5B = $28B is mathematically correct but based on false inputs. XOM's asset figure is approximately correct ($8.5B vs $8,463M), and CVX's $4.5B loan matches exactly. However, the absence of any support for the $23.7B equity carrying amount makes this a critical error. (3) The multi-hop reasoning is partially sound—comparing XOM's direct assets to CVX's combined equity and loan exposure in Kazakhstan is appropriate and addresses the comparative financial stake question. However, the reasoning collapses due to reliance on an unsupported valuation figure. (4) Contextual relevance is high because the structure and intent align well with the question, and the concept of combining equity and loan exposure is valid. However, the quantitative inaccuracy severely undermines correctness, warranting a low score of 4. Qualitative accuracy is moderate due to correct identification of entities, projects, and structure, but flawed data sourcing. Quantitative accuracy is poor due to the invented equity value.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 458,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How might geopolitical tensions involving Taiwan impact both QCOM's chipset supply and NVDA's supply continuity, given their reliance on foundry partners operating in the region?",
      "original_answer": "QCOM's business depends on receiving consistent chipset supply from foundry partners, particularly in Taiwan, and a significant geopolitical conflict involving Taiwan could severely limit or prevent QCOM from receiving this supply, which would have a material adverse impact on its business. Similarly, NVDA notes that geopolitical tensions involving Taiwan and China, where it has critical suppliers, contract manufacturers, and assembly partners, could have a material adverse impact on its supply continuity. Both companies rely on foundry partners operating in Taiwan, and any disruption due to geopolitical instability could lead to supply constraints, affecting QCOM's ability to manufacture products and NVDA's ability to fulfill customer orders on time, ultimately harming their revenues and market positions.",
      "llm_answer": "Both companies warn that a flare‑up over Taiwan could choke the flow of chips from the island’s foundries. Qualcomm says its ability to obtain a “consistent and reliable chipset supply from our foundry partners, particularly in Taiwan” would be “severely limited or prevented” by a prolonged China‑Taiwan conflict (QUALCOMM 10‑K p. 35). Nvidia similarly notes that “geopolitical tensions… involving Taiwan and China… where we have suppliers, contract manufacturers and assembly partners… could have a material adverse impact on our supply continuity” (NVIDIA 10‑K p. 17).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies both QCOM and NVDA, their reliance on Taiwanese foundry partners, and the potential impact of geopolitical tensions involving Taiwan on their supply chains. The cited risks are directly aligned with the original answer. (2) There are no numerical values, dates, or financial metrics in the question or ground truth that require verification; the LLM does not introduce any incorrect numbers. (3) The multi-hop reasoning is sound: the model synthesizes risk disclosures from both companies' 10-K filings, correctly attributing QCOM's exposure to 'consistent and reliable chipset supply' disruptions (citing p.35) and NVDA's exposure to supply continuity risks due to suppliers and manufacturing partners in the region (citing p.17). (4) The answer is contextually precise, directly addressing how geopolitical tensions could disrupt supply for both firms due to regional dependencies. Minor stylistic differences (e.g., 'choke the flow of chips' as a metaphor) do not affect factual accuracy. All key elements—entities, risks, sourcing, and consequences—are correctly conveyed with proper citations, meeting the highest standard across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 355,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How might Southern Company's environmental compliance costs, driven by regulatory requirements, affect electricity demand from industrial customers, and how does this potential demand shift compare to Duke Energy's exposure to industrial customer demand volatility as outlined in their risk factors?",
      "original_answer": "Southern Company estimates that compliance with environmental regulations could result in increased costs that are recovered through regulated rates, but this may contribute to reduced demand for electricity and natural gas from industrial customers. Many of these industrial customers may also face their own compliance costs under the same environmental requirements, further reducing their energy consumption. Duke Energy, on the other hand, explicitly notes that declines in industrial production due to economic conditions will reduce electricity and natural gas consumption, directly impacting their revenues and cash flows. Both companies are exposed to industrial demand shifts, but Southern Company's exposure is tied to regulatory cost pass-through effects, while Duke Energy highlights direct economic sensitivity of industrial customers.",
      "llm_answer": "Southern Company warns that the costs it must recover to meet new air‑, water‑ and GHG‑related regulations will be passed through rates, and those higher rates could suppress electricity (and natural‑gas) usage by commercial and industrial customers 【page 89†L13-L18】【page 26†L13-L18】.  Duke Energy’s risk factors similarly flag that a slowdown in industrial production – whether from economic weakness or other market forces – can sharply cut electricity and gas sales and hurt cash flow 【page 27†L2-L7】.  In both cases the utilities see industrial demand as a key lever, but Southern Company’s concern is driven specifically by regulatory‑cost pass‑throughs, whereas Duke Energy’s exposure is framed more broadly as volatility in industrial demand.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key factual elements are correct: Southern Company's environmental compliance costs are passed through regulated rates, potentially reducing industrial demand due to higher prices, and industrial customers may face their own compliance costs. Duke Energy identifies industrial production declines—due to economic or market conditions—as a direct risk to electricity and gas sales and cash flows. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but all qualitative financial impacts (e.g., cash flow, demand suppression) are correctly represented. (3) The multi-hop reasoning is sound: the model correctly synthesizes risk factors from both companies and contrasts their exposure—Southern’s regulatory-cost-driven demand risk vs. Duke’s broader economic sensitivity. The only minor shortcoming is that the LLM answer mentions 'commercial and industrial customers' while the original answer focuses specifically on 'industrial customers'; this slight broadening does not materially distort the meaning but slightly reduces precision. (4) The answer is contextually fully relevant, directly addressing both parts of the question and providing a clear, accurate comparison. Thus, the correctness score is 9 due to this minor overgeneralization, but all other dimensions are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 407,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the $9.9 billion notional amount of foreign exchange cash flow hedges used by NKE compare to MCD's foreign currency net asset exposures in managing cross-border financial risk?",
      "original_answer": "NKE utilizes $9.9 billion in notional foreign exchange cash flow hedges to manage transactional exposures from product costs, external sales, and other foreign currency-denominated assets and liabilities. These hedges, primarily in euros, Canadian dollars, Japanese yen, British pounds, and Chinese yuan, are designed to offset earnings fluctuations from currency movements. Meanwhile, MCD manages its foreign currency risk by maintaining diversified net asset exposures across a broad basket of currencies. While NKE actively hedges forecasted transactions and exposures through derivatives, MCD's approach focuses on balancing foreign currency assets and liabilities directly on its balance sheet, reflecting differing strategies to mitigate cross-border financial risk.",
      "llm_answer": "Nike’s foreign‑exchange cash‑flow hedge program covers a notional $9.9 billion, which is roughly 2½‑3 times the size of McDonald’s disclosed foreign‑currency net‑asset exposures (about $3.8 billion in aggregate across its major currencies).  In other words, Nike is hedging a substantially larger amount of cross‑border cash‑flow risk than the amount of net foreign‑currency assets McDonald’s reports.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in the quantitative domain. The claim that MCD has $3.8 billion in foreign-currency net asset exposures is not supported by the ground truth, which does not provide any specific dollar amount for MCD's net asset exposures. This figure appears to be fabricated or incorrectly inferred. The comparison stating that NKE's $9.9 billion in hedges is '2½–3 times' the size of MCD's exposures is therefore invalid due to the unsupported denominator. There is no mention in the original answer of any numerical value for MCD’s exposures, only a qualitative description of their strategy. Thus, the quantitative accuracy is very low. Qualitatively, the LLM correctly identifies that NKE uses $9.9 billion in notional hedges and that these are used to manage cash flow risks, which aligns with the ground truth. It also correctly contrasts NKE’s derivative-based hedging strategy with MCD’s balance sheet-level management of foreign currency risk, though it oversimplifies and quantifies a comparison that the ground truth does not support. The reasoning is partially sound in structure but flawed due to the invented metric. Contextually, the answer addresses the core question about comparative risk management approaches, so relevance is moderate to high. However, the introduction of false numerical comparisons severely undermines correctness. The answer would have been acceptable if it had qualitatively contrasted the strategies without asserting unsupported quantitative comparisons.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 424,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the exposure of The Coca-Cola Company through Coca-Cola HBC's operations in Ukraine compare to Procter & Gamble's direct reliance on Ukraine for its manufacturing and supply chain stability?",
      "original_answer": "The Coca-Cola Company relies on Coca-Cola HBC for bottling and distribution operations in Ukraine, which is part of a broader network contributing to 41% of Coca-Cola's global unit case volume through its top five bottlers. Meanwhile, Procter & Gamble reports that its Ukraine-related assets account for less than 1% of net assets, with potential risks including physical damage to its two manufacturing facilities in Ukraine and disruptions in raw material sourcing or product distribution. While Coca-Cola's exposure is indirect through a key bottler, P&G's exposure is more direct but smaller in scale, with both companies facing similar regional supply chain risks tied to geopolitical instability.",
      "llm_answer": "Coca‑Cola’s only exposure to the war in Ukraine comes through its independent bottler Coca‑Cola HBC, which operates two plants in Ukraine.  Those plants employ about 500 people and generate **less than 1 percent of The Coca‑Cola Company’s consolidated net sales and net earnings** for fiscal 2022.  \n\nProcter & Gamble, by contrast, owns and operates its own manufacturing facilities in Ukraine and uses them as part of its core supply‑chain network; the company therefore **relies directly on Ukrainian production capacity for the stability of its manufacturing and distribution system**, making its exposure more immediate than Coca‑Cola’s indirect, sub‑1 % bottler‑related exposure.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Coca-Cola's exposure is indirect through Coca-Cola HBC, which operates in Ukraine, and that Procter & Gamble has direct ownership of manufacturing facilities there. It accurately frames the comparison in terms of indirect vs. direct exposure. However, the key quantitative claim that Ukraine contributes 'less than 1 percent' of Coca-Cola’s consolidated net sales and net earnings is not present in the original answer (ground truth), which instead states that Coca-Cola HBC is part of a broader network of top five bottlers contributing 41% of global unit case volume—but does not specify Ukraine’s individual financial contribution. This introduces a specific number not supported by the ground truth, reducing quantitative accuracy. (2) The original answer notes P&G’s Ukraine assets as less than 1% of net assets, which aligns with the LLM’s implied scale, but the LLM does not mention this exact figure, instead emphasizing operational reliance. While the LLM correctly conveys P&G's direct exposure, it omits the <1% net assets metric, missing a key data point. (3) The multi-hop reasoning is sound: the model correctly synthesizes that Coca-Cola relies indirectly via a bottler while P&G has direct operational control, and draws a logical comparison between the two exposure types. However, it fabricates a specific financial impact ('less than 1% of net sales and net earnings') for Coca-Cola’s Ukraine exposure that is not in the ground truth, which undermines factual precision. (4) Despite the invented percentage, the overall structure, relevance, and qualitative reasoning are strong. The answer addresses the core of the question—comparing exposure types and implications—and remains contextually focused. The correctness score is 7 due to accurate reasoning and entity identification but penalized for introducing unsupported quantitative claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 518,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What is the combined exposure of MET and BAC to commercial mortgage-backed securities (CMBS), and how does MET's fair value of CMBS compare to BAC's amortized cost for the same category as of December 31, 2023?",
      "original_answer": "MET's fair value exposure to CMBS was $4,551 million as of December 31, 2023, while BAC's amortized cost for commercial mortgage-backed securities was $10,922 million. The combined exposure of both companies to CMBS totals $15,473 million. MET's CMBS, as part of its Structured Securities portfolio, are reported at fair value, whereas BAC reports its CMBS at amortized cost, reflecting different accounting treatments for similar asset classes.",
      "llm_answer": "MetLife reported commercial‑mortgage‑backed securities (CMBS) with a **fair‑value carrying amount of $10.4 billion** at 31 December 2023.  Bank of America’s CMBS portfolio is carried at **amortized cost of $10.9 billion** as of the same date.  \n\nTogether, the two companies have **about $21.3 billion** of exposure to CMBS.  MetLife’s CMBS are valued at fair value, which is roughly **$0.5 billion lower** than Bank of America’s amortized‑cost amount for the same asset class.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key numeric values. According to the ground truth, MET's fair value exposure to CMBS was $4,551 million ($4.551 billion), but the LLM incorrectly states it as $10.4 billion—more than double the correct amount. BAC's amortized cost is correctly reported in the ground truth as $10,922 million ($10.922 billion), which the LLM approximates reasonably well as $10.9 billion (acceptable rounding). However, due to the incorrect MET value, the combined exposure is wrong: LLM reports $21.3 billion, while the correct total is $15,473 million ($15.473 billion). Additionally, the LLM claims MET’s fair value is $0.5 billion lower than BAC’s amortized cost, but in reality, MET’s $4.551B is about $6.371B lower than BAC’s $10.922B. (2) Quantitative accuracy is severely compromised: MET's value is off by over $5.8 billion, leading to a cascading error in the sum and comparison. Only BAC’s figure is approximately correct. (3) The qualitative reasoning structure is sound—the model identifies the need to report both companies’ CMBS exposures, recognizes the difference in accounting treatment (fair value vs. amortized cost), and attempts to compare and sum them. However, the multi-hop synthesis fails because it uses an incorrect value for MET. (4) Contextual relevance is high—the answer addresses all parts of the question (combined exposure, individual exposures, comparison, accounting treatment)—but the factual foundation is flawed. Thus, while the framework is correct, the answer is misleading due to major numerical inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 439,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How do cyber intrusion risks at nuclear power plants impact the financial obligations and operational strategies of both Duke Energy and Southern Company, given their respective exposures to decommissioning trusts and compliance costs?",
      "original_answer": "Duke Energy Carolinas, Duke Energy Progress, and Duke Energy Florida have significant obligations tied to decommissioning nuclear plants, with funded trusts subject to market fluctuations that could increase funding requirements if asset values decline. Southern Company's nuclear units, operated by Southern Nuclear, are subject to compliance costs related to cyber intrusion risks, which could increase licensing or security expenditures. Both companies face potential financial strain: Duke Energy may need to inject additional capital if decommissioning trusts underperform, while Southern Company could face higher operational costs due to mandatory cybersecurity standards and potential threats, both of which could materially affect their financial positions and cash flows.",
      "llm_answer": "Both companies say that a successful cyber‑intrusion at a nuclear site would force the Nuclear Regulatory Commission to impose additional security‑ and licensing‑related upgrades, which would raise operating and capital costs. For Duke Energy, those extra costs would have to be covered on top of the already‑required funding of its nuclear decommissioning trusts – a decline in trust‑asset values or higher compliance spending could force the company to increase cash contributions to the trusts and tighten cash‑flow margins. For Southern Company, the same cyber‑risk exposure adds to the already‑significant decommissioning‑trust obligations of Alabama Power and Georgia Power, prompting the firm to re‑allocate capital toward nuclear‑security compliance and potentially delay or reshape other construction programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: both Duke Energy and Southern Company face increased operational and compliance costs due to cyber intrusion risks at nuclear plants, which can trigger higher NRC-mandated security and licensing expenditures. Duke Energy's decommissioning trusts (for Duke Energy Carolinas, Progress, and Florida) are exposed to market fluctuations, and underperformance could necessitate additional cash contributions—this is correctly reflected. Southern Company, through its subsidiaries Alabama Power and Georgia Power, has significant decommissioning obligations and faces capital reallocation toward cybersecurity, potentially affecting other construction programs. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not compromised; all references to financial impacts are qualitative and consistent. (3) Multi-hop reasoning is sound: the LLM correctly links cyber intrusion risks → regulatory response (NRC) → increased compliance costs → impact on cash flow and capital allocation, while distinguishing Duke’s trust-funding pressures from Southern’s operational cost and capital re-prioritization challenges. (4) The only minor shortcoming is that the LLM slightly overemphasizes Alabama Power and Georgia Power’s decommissioning trusts for Southern Company, whereas the original answer focuses more broadly on Southern Nuclear’s compliance costs. However, this is a nuance rather than an error, as those subsidiaries are part of Southern Company and do hold such obligations. Overall, the semantic meaning, factual accuracy, and reasoning are excellent, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 475,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does the treatment of dividend equivalents on unvested restricted stock units at HD influence the issuance of additional shares, and how does this compare to LOW's delivery of additional shares under its ASR agreements in fiscal 2021?",
      "original_answer": "At HD, dividend equivalents accrue on unvested restricted stock units and are paid out in the form of additional shares upon vesting. This mechanism increases the total number of shares ultimately delivered to employees. For example, HD's 2022 10-K shows that dividend equivalents are reinvested and paid out as additional shares when RSUs vest. This practice results in a higher share count over time, as unvested units continue to accrue dividends. In contrast, LOW delivered additional shares in the context of accelerated share repurchase (ASR) agreements. In fiscal 2021, LOW executed ASR agreements in Q1, Q4, and Q2, under which it received additional shares at settlement—0.2 million, 1.6 million, and 4 million shares respectively—depending on the final calculation of the stock price during the settlement period. Therefore, while HD's additional shares arise from reinvested dividend equivalents tied to employee compensation, LOW's additional shares are a byproduct of its capital return strategy through ASR agreements.",
      "llm_answer": "At Home Depot, dividend equivalents that accrue on unvested restricted‑stock units are paid out as **additional shares when the units vest**, so each vesting event expands the pool of outstanding shares and therefore the diluted share count. By contrast, Lowe’s does not issue shares through RSU dividends; its only source of extra shares in fiscal 2021 comes from the **“additional shares delivered” under its variable‑notional accelerated share‑repurchase (ASR) agreements**, which were 0.2 million (Q1), 4 million (Q2), 1.7 million (Q3) and 1.6 million (Q4) – roughly 7.5 million shares in total for the year.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM correctly identifies the mechanism at HD: dividend equivalents on unvested RSUs are paid as additional shares upon vesting, increasing the diluted share count. This aligns with the ground truth. For LOW, it correctly ties additional shares to ASR agreements as part of capital return. However, there are quantitative discrepancies: the LLM reports Q3 ASR delivery of 1.7 million shares, which is not mentioned in the original answer (ground truth states ASRs in Q1: 0.2M, Q2: 4M, Q4: 1.6M — no Q3). The total of ~7.5 million is close but based on incorrect quarterly data. (2) Original answer specifies ASR deliveries in Q1, Q2, and Q4 only, totaling 5.8 million shares (0.2 + 4 + 1.6). LLM incorrectly adds a Q3 figure of 1.7 million (not in ground truth) and omits that Q2 was 4 million, not 4 million in Q2 and another in Q3. This affects quantitative accuracy. (3) The reasoning and synthesis across HD and LOW are sound: it distinguishes employee compensation-driven share issuance (HD) from capital return-driven ASR mechanics (LOW). The multi-hop logic — comparing two companies’ sources of additional shares — is well executed. (4) Despite the factual error in LOW’s ASR timing and amounts, the core conceptual contrast is preserved, warranting a 7 for correctness. Quantitative accuracy is penalized due to unsupported numbers, but qualitative and contextual scores remain high due to strong reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 395,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does AT&T's use of sensitivity analyses in auditing its $67,854 million goodwill balance compare to Netflix's application of similar analyses in evaluating content amortization assumptions, given both companies are audited by the same firm?",
      "original_answer": "AT&T utilized sensitivity analyses to evaluate the goodwill impairment testing for its $67,854 million goodwill balance, focusing on assumptions like terminal growth rates and weighted average cost of capital. Netflix, on the other hand, applied sensitivity analyses to assess the impact of changes in estimated viewing patterns on content amortization, a key accounting estimate given its content licensing and production model. Both companies are audited by the same firm, which performed these sensitivity analyses as part of their audit procedures to evaluate the reasonableness and robustness of management’s assumptions in each case.",
      "llm_answer": "Both companies rely on Ernst & Young to test the key assumptions underlying large, judgment‑heavy balances, but the focus of the sensitivity work differs. For AT&T, EY “performed independent sensitivity analyses” on the fair‑value inputs used in the annual goodwill‑impairment test for the $67,854 million goodwill balance (e.g., terminal growth rates, long‑term EBITDA margins and discount rates). For Netflix, EY “performed sensitivity analyses” on the assumptions that drive the amortization of content assets—specifically the historical and forecasted viewing‑hour patterns that determine the amortization schedule. Thus, AT&T’s analyses stress valuation of goodwill, whereas Netflix’s analyses stress the timing of content amortization, even though the same audit firm uses similar sensitivity‑testing techniques in both cases.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, the $67,854 million goodwill balance is accurately cited. (2) The entities—AT&T, Netflix, and Ernst & Young (implied as 'EY')—are correctly identified, and the audit firm consistency is properly noted. (3) The multi-hop reasoning is sound: the answer correctly distinguishes between AT&T’s use of sensitivity analyses for goodwill impairment (focusing on terminal growth rates, EBITDA margins, discount rates) and Netflix’s use for content amortization (based on viewing-hour patterns), while noting the common audit methodology by the same firm. (4) The semantic content is equivalent to the original answer—though the LLM adds slightly more detail (e.g., mentioning EBITDA margins), all additions are factually consistent and enhance clarity without introducing error. Wording differences do not affect meaning; the core facts, focus areas, and audit context align perfectly with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 287,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does Mastercard's concern about disintermediation from fintech-developed payment platforms compare to Visa's strategic partnership approach with fintechs in the context of regulatory-driven competition in the digital payments ecosystem?",
      "original_answer": "Mastercard expresses concern that fintechs could develop platforms or networks that disintermediate them from digital payments, especially when sharing data under partnerships, which could give fintechs a competitive advantage. This aligns with the broader risk that fintechs may develop competitive products that replace Mastercard’s offerings. In contrast, Visa actively partners with fintechs and emphasizes leveraging local financial institutions and tailored solutions to maintain a competitive edge. Visa sees fintechs as both partners and potential competitors, but strategically integrates them into its 'network of networks' approach. The regulatory environment, particularly in the EEA with PSD2, exacerbates these dynamics by enabling third-party providers to route transactions away from traditional networks like Mastercard, while Visa adapts by strengthening partnerships to remain central in the evolving digital payments ecosystem.",
      "llm_answer": "Mastercard warns that fintech‑built payment platforms could bypass its four‑party network – a disintermediation risk amplified by regulations such as PSD2 that let third‑party providers route transactions directly to issuers or acquirers (see pages 30‑31, 35). In contrast, Visa frames fintechs as collaborators, embedding them in its “network‑of‑networks” strategy through services like Visa Direct, B2B Connect, tokenization and digital‑wallet integrations, and positions regulatory‑driven new‑flow opportunities as a way to expand its ecosystem rather than a threat (see pages 10‑11, 16, 17).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with strong semantic equivalence. (1) It correctly identifies Mastercard's concern about disintermediation due to fintech platforms and regulatory pressures like PSD2, and contrasts this with Visa's strategic partnership model through its 'network of networks' approach. Key elements such as the four-party network risk, PSD2's role in enabling third-party routing, and Visa's use of services like Visa Direct and tokenization are factually consistent with the original answer. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the model synthesizes Mastercard’s risk perspective and Visa’s strategic response in the context of regulatory changes (especially PSD2), correctly linking how regulation affects both companies differently based on their strategies. (4) Minor deduction in qualitative accuracy (9/10) is due to slightly less explicit emphasis on Visa viewing fintechs as both partners *and* competitors—though implied, it's not stated outright. However, the 'network of networks' framing and ecosystem expansion accurately reflect Visa’s strategic intent. Contextual relevance is perfect—every part of the response addresses the comparative, regulatory, and strategic dimensions of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 394,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does the expected impact of the 15% global minimum tax under Pillar 2 differ between MCD and SBUX, considering the OECD's framework and the earliest effective dates for implementation?",
      "original_answer": "MCD stated that while the global minimum tax under Pillar 2 was enacted in several countries with the earliest effective date for taxable years beginning after December 31, 2023, it does not expect a material impact on its consolidated financial statements. SBUX, on the other hand, noted that Pillar 2 will not be effective for the company until fiscal 2025 and also does not expect a material impact to its consolidated financial statements. The OECD's framework proposes a 15% global minimum tax applied on a country-by-country basis, and although many countries are incorporating Pillar 2 model rule concepts into domestic laws, differences in implementation timelines and domestic tax adjustments may affect the tax's impact on multinational companies like MCD and SBUX differently.",
      "llm_answer": "Both companies cite the OECD‑led Pillar 2 rule that imposes a 15 % global minimum tax, but they differ on timing. McDonald’s notes that many jurisdictions have already adopted Pillar 2 for taxable years beginning after 31 December 2023 and, although it does not expect a material effect, the earliest possible impact could start in 2024. Starbucks says that, even though some countries have enacted the rule, the tax will not become effective for the company until fiscal 2025 and likewise is not expected to be material.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: both MCD and SBUX reference the OECD's 15% global minimum tax under Pillar 2; MCD acknowledges implementation in various jurisdictions starting after December 31, 2023 (i.e., 2024 onwards), while SBUX states it will not be effective until fiscal 2025; both companies indicate no material impact. (2) Quantitative accuracy is perfect: dates (December 31, 2023, fiscal 2025), percentages (15%), and company-specific timelines are correctly reported with no calculation errors. (3) Multi-hop reasoning is sound—LLM correctly synthesizes information across two companies, their respective implementation timelines, and the common OECD framework. (4) The only minor shortcoming is that the LLM omits a brief mention of country-by-country application and domestic implementation differences noted in the original answer, which adds contextual nuance about why impacts may differ. However, this does not detract from the core correctness. Semantic equivalence is maintained, and the answer fully addresses the comparative impact and timing as required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 332,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does the capital adequacy position of BlackRock Institutional Trust Company (BTC) as of December 31, 2024, compare to American Express's (AXP) regulatory capital ratios, given both entities are subject to U.S. banking regulatory requirements?",
      "original_answer": "As of December 31, 2024, BlackRock Institutional Trust Company (BTC) exceeded its applicable capital adequacy requirements, including minimum Common Equity Tier 1 (CET1), Tier 1 leverage, and risk-based capital ratios. Similarly, American Express (AXP) met all capital requirements and maintained regulatory capital ratios above the thresholds to qualify as 'well capitalized' under Federal Reserve and OCC guidelines. Both entities are subject to U.S. banking regulatory capital requirements, with BTC regulated by the Office of the Comptroller of the Currency (OCC) and AXP supervised by the Federal Reserve and its subsidiary AENB also regulated by the OCC.",
      "llm_answer": "BlackRock Institutional Trust Company (BTC) reported a total‑capital‑to‑risk‑weighted‑assets ratio of **153.2 %** (Common‑Equity‑Tier‑1 151.9 %) at 31 Dec 2024, far above the 8 % (CET1) and 6 % (Tier 1) minimums that apply to its banking charter. By contrast, American Express’s consolidated banking subsidiary reported CET1, Tier 1 and total‑capital ratios of **10.5 %**, **11.2 %** and **13.2 %**, respectively, which are only modestly above the regulatory minima (≈6 % CET1, 8 % Tier 1). Thus, BTC’s capital adequacy position is dramatically stronger than American Express’s, which is simply “well‑capitalized” under the required thresholds.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that both BTC and AXP exceeded capital requirements and were 'well capitalized,' but it does not provide specific numerical ratios for either entity. However, the LLM assigns precise percentages—153.2% total capital and 151.9% CET1 for BTC, and 10.5%, 11.2%, 13.2% for AXP—which are not present in the original answer and are implausibly high for a bank (especially CET1 of 151.9%, which is over 15x typical levels). These numbers are likely hallucinated. (2) Quantitative accuracy is very low: regulatory minimums are roughly correct (CET1 ~6-8%), but the reported ratios are grossly exaggerated, especially for BTC. A real CET1 ratio above 150% is economically nonsensical; actual well-capitalized banks typically report CET1 between 10-15%. The comparison is therefore invalid. (3) Qualitatively, the model correctly identifies that both entities are subject to U.S. banking regulation, with BTC under the OCC and AXP under the Fed/OCC, and attempts multi-hop reasoning by comparing capital strength. However, the conclusion that BTC's position is 'dramatically stronger' is unsupported by the ground truth, which only states both met requirements and were well capitalized—no relative strength is implied. (4) Contextual relevance is moderate: the answer addresses the right entities, time frame (Dec 31, 2024), and regulatory context, and attempts a direct comparison as asked. But due to fabricated numbers and an unsupported conclusion, the overall correctness is low. Minor note: 'AENB' is omitted in LLM answer but not critical to core question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 451,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does the $88.4 million in construction loans provided by SPG to joint ventures compare to AMT's utilization of the 2021 Multicurrency Credit Facility for acquisitions, and what does this reveal about their respective financing strategies for growth?",
      "original_answer": "SPG provided $88.4 million in construction loans to joint ventures as of December 31, 2021, indicating a strategy of internally financing development through joint ventures. In contrast, AMT borrowed $7.8 billion under the 2021 Multicurrency Credit Facility, including €2.4 billion ($2.9 billion), to fund major acquisitions like the Telxius and CoreSite deals. This reveals that AMT pursued a more aggressive, acquisition-driven growth strategy backed by large-scale credit facilities, while SPG focused on smaller-scale development financing through joint venture partnerships.",
      "llm_answer": "Simon Property Group’s joint‑venture financing is relatively modest – the company had $88.4 million of interest‑bearing construction loans and other advances to its JV partners at year‑end 2021【page_116】.  \n\nAmerican Tower, by contrast, drew down the vast majority of its 2021 Multicurrency Credit Facility to fund acquisitions, borrowing about $7.8 billion in 2021 (including roughly $5.1 billion used for the CoreSite purchase and additional amounts for the Telxius deal)【page_111】【page_49】.  \n\nThe comparison shows that SPG relies on small, project‑level loans to support growth within existing joint‑venture properties, whereas AMT employs a large revolving credit facility to finance major, platform‑wide acquisitions, reflecting a far more debt‑intensive expansion strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key numbers are correct: SPG's $88.4 million in construction loans (as of December 31, 2021) and AMT's $7.8 billion drawn from the 2021 Multicurrency Credit Facility are accurately reported. The LLM correctly notes that part of the $7.8 billion was used for CoreSite ($5.1 billion) and the Telxius deal, consistent with the ground truth's mention of these acquisitions. The conversion of €2.4 billion to $2.9 billion is omitted in the LLM answer, but this is a minor detail and does not affect the overall accuracy. (2) Quantitative accuracy is excellent—no calculation errors, and all figures match the original answer within acceptable format variations (e.g., $7.8 billion vs $7.8B). (3) The multi-hop reasoning is sound: the model correctly contrasts SPG’s project-level joint venture financing with AMT’s large-scale acquisition financing, synthesizing information across two companies and their respective strategies. (4) The qualitative interpretation is strong, correctly identifying SPG’s strategy as modest, project-level support versus AMT’s debt-intensive, acquisition-driven expansion. The only minor shortcoming is the lack of explicit mention of the €2.4 billion ($2.9 billion) component of AMT’s borrowing, which slightly reduces completeness but does not undermine the core conclusion. Overall, the answer is factually correct, well-reasoned, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 406,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does the $0.5 billion interest rate swap held by CSCO to hedge its fixed-rate senior notes compare with AVGO's exposure to $56.3 billion in fixed-rate senior notes in terms of sensitivity to interest rate fluctuations?",
      "original_answer": "CSCO uses a $0.5 billion interest rate swap to hedge a portion of its fixed-rate senior notes, converting the fixed interest rate to a floating rate based on SOFR, thereby reducing interest rate risk for that specific liability. In contrast, AVGO holds $56.3 billion in fixed-rate senior notes as of November 3, 2024, and a 50 basis point interest rate increase would decrease the fair value of these notes by $1.7 billion. This indicates that AVGO has significant interest rate exposure on its fixed-rate debt, while CSCO has mitigated part of its exposure through active hedging.",
      "llm_answer": "Cisco’s 10‑K notes that it entered into an interest‑rate swap with a **$0.5 billion notional amount** that is designated as a fair‑value hedge of a portion of its fixed‑rate senior notes (page 89). Broadcom’s 10‑K shows it has **$56.3 billion of fixed‑rate senior notes**, and a hypothetical 50‑basis‑point shift in market rates would change the fair value of those notes by about **$1.7 billion** (page 49). Thus, Cisco’s hedge protects only a very small slice of its debt and would generate a proportionally modest gain or loss, whereas Broadcom’s much larger exposure means its debt value is far more sensitive to interest‑rate movements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: CSCO's $0.5 billion interest rate swap as a fair-value hedge of a portion of its fixed-rate senior notes and AVGO's $56.3 billion in fixed-rate senior notes with a $1.7 billion fair value sensitivity to a 50 bps rate change. All numbers match the ground truth exactly, including the notional amount, total debt, and sensitivity impact. (2) Quantitative accuracy is perfect—$0.5 billion, $56.3 billion, and $1.7 billion are all correctly reported; the 50-basis-point sensitivity is accurately reflected. No calculation errors. (3) The multi-hop reasoning is sound: the model correctly contrasts CSCO’s limited hedging (reducing interest rate risk on a small portion of debt) with AVGO’s large unhedged exposure, leading to greater sensitivity. The conclusion that AVGO’s debt value is far more sensitive to rate movements is logically supported. (4) The only minor shortcoming is that the LLM does not explicitly state that CSCO’s swap converts fixed to floating rates via SOFR, which adds slight context to the hedging mechanism, but this does not detract from the core correctness. Overall, the answer is factually complete, well-reasoned, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 347,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does the use of option contracts by NKE to hedge foreign currency exposures compare to TSLA's exposure to foreign currency assets, given the impact of such hedging instruments on deferred gains and losses in other comprehensive income?",
      "original_answer": "NKE actively uses option contracts as part of its foreign currency risk management program to hedge exposures from product costs, external sales, and other costs, with $9.9 billion in notional amounts of net foreign exchange cash flow hedges as of September 28, 2024. These contracts are designated as cash flow hedges, with mark-to-market gains and losses deferred in AOCI, including $99 million in net deferred gains expected to mature in the next twelve months. In contrast, TSLA does not typically hedge foreign currency risk and instead experiences significant fluctuations in foreign exchange gains and losses from period to period, particularly on intercompany balances, which flow through 'Other income (expense), net.' This highlights a more proactive hedging strategy by NKE versus TSLA’s reactive exposure to foreign currency assets.",
      "llm_answer": "Nike (NKE) notes that it may use currency‑forward and **option contracts** to hedge the remaining foreign‑exchange effect on forecast cash flows, product‑cost and sales exposures, but the filing does not disclose any separate OCI line‑item for those hedges – the effect is described only as “delaying” the impact of exchange‑rate movements on the financial statements.  \n\nTesla (TSLA), by contrast, explicitly hedges its foreign‑currency assets and liabilities with **option and forward contracts** that are designated as cash‑flow hedges; the mark‑to‑market gains and losses on those contracts are first recorded in other‑comprehensive income (e.g., a $‑97 million OCI loss in 2024) and later re‑classified into earnings when the hedged transactions occur.  \n\nThus, while both companies employ option contracts for FX risk, Nike’s hedges are not shown to affect OCI, whereas Tesla’s hedging activity creates measurable deferred gains/losses in OCI that are subsequently re‑recognized in net income.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that severely undermine its correctness. (1) Quantitatively, the LLM incorrectly states that Tesla had a '$-97 million OCI loss in 2024' from cash flow hedges, which contradicts the ground truth: TSLA does not typically hedge foreign currency risk and instead reports FX gains/losses directly in 'Other income (expense), net.' The ground truth confirms NKE—not TSLA—has $99 million in net deferred gains in AOCI, not a $97 million loss. The $9.9 billion notional amount of NKE's hedges is omitted entirely. (2) The LLM reverses the core factual premise: it claims Tesla uses cash flow hedges with OCI recognition, while the ground truth states Tesla does *not* typically hedge FX risk. Conversely, it claims NKE’s hedges do not affect OCI, but the ground truth confirms NKE *does* defer gains/losses in AOCI as part of cash flow hedges. (3) The multi-hop reasoning fails: the comparison should highlight NKE’s proactive hedging (with OCI impact) vs. TSLA’s lack of hedging (with FX volatility in income), but the LLM inverts this logic. (4) While the answer addresses the question’s structure and mentions option contracts and OCI, the reversal of key facts renders the conclusion incorrect. Wording flexibility cannot compensate for fundamental misrepresentation of entities, strategies, and financial impacts.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 378,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does Boeing's use of Citibank, N.A. as administrative agent in its Five-Year Credit Agreement compare with Caterpillar's use of Citibank in its 5-Year Facility, particularly in terms of Citibank's role and the amendment timelines?",
      "original_answer": "Boeing's Five-Year Credit Agreement, dated October 30, 2019, and amended on August 25, 2022, lists Citibank, N.A. as the administrative agent. Similarly, Caterpillar's Third Amended and Restated Credit Agreement (5-Year Facility), dated September 1, 2022, also names Citibank, N.A. as the Agent. Both companies rely on Citibank in a leadership capacity—Boeing in a dual role as administrative agent and joint lead arranger, and Caterpillar as Agent. Boeing’s amendment occurred in August 2022, while Caterpillar’s Amendment No. 1 to the 5-Year Facility was dated August 31, 2023, showing staggered but comparable timelines for credit agreement adjustments.",
      "llm_answer": "Boeing’s five‑year credit agreement (dated Oct 30 2019) names **Citibank, N.A. as the “administrative agent”** and also as a joint lead arranger/book‑manager on the deal.  The agreement was first amended on **Aug 25 2022** (Amendment No. 1).\n\nCaterpillar’s five‑year facility (dated Sep 1 2022) lists **Citibank, N.A. simply as the “Agent”** (no administrative‑agent or arranger language).  That facility was later amended on **Aug 31 2023** (Amendment No. 1).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: All dates are correct — Boeing's agreement dated October 30, 2019, amended August 25, 2022; Caterpillar's agreement dated September 1, 2022, amended August 31, 2023. These match the original answer exactly. (2) Completeness: The response addresses both parts of the question — Citibank's role (administrative agent and joint lead arranger for Boeing; simply 'Agent' for Caterpillar) and amendment timelines (Aug 2022 vs Aug 2023). (3) Entity accuracy: Correctly identifies both companies, Citibank, N.A., and the respective credit agreements. (4) Reasoning: The multi-hop comparison across two companies and their credit facilities is sound, highlighting both similarities (use of Citibank) and differences (role specificity and amendment timing). (5) Semantic equivalence: Though phrased more concisely, the LLM conveys the same key facts — Citibank’s leadership role in both cases, the distinction in title (administrative agent vs. Agent), and the staggered amendment dates. No factual or interpretive errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 319,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does the difference in voting rights per share between Netflix's common stock and Meta's Class B common stock compare, given the structure of voting rights tied to different stock classes as disclosed by both companies?",
      "original_answer": "Netflix's common stock provides one vote per share, while Meta's Class B common stock provides 10 votes per share, reflecting a significant disparity in shareholder voting power between the two companies' stock structures.",
      "llm_answer": "Netflix’s common stock carries **one vote per share** (see “The holders of each share of common stock shall be entitled to one vote per share” – NFLX 10‑K page 60).  \n\nMeta’s Class B common stock is structured to carry **ten votes per share** (Meta’s charter provides that each Class B share is entitled to ten votes, while Class A shares have one vote each – Meta 10‑K page 1).  \n\nThus, a Meta Class B share has ten‑times the voting power of a Netflix common share.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the voting rights per share are accurately reported: Netflix common stock has 1 vote per share, and Meta Class B common stock has 10 votes per share. These numbers exactly match the original answer. (2) The answer is complete, addressing both companies' voting structures and making the correct comparison that a Meta Class B share has ten times the voting power of a Netflix common share. (3) Entity accuracy is perfect: both companies (Netflix and Meta), stock classes (common stock and Class B), and the source documents (10-K filings) are correctly identified. (4) The reasoning is sound and demonstrates proper multi-hop synthesis by retrieving and comparing data from two different companies’ filings. The conclusion logically follows from the facts presented. (5) The semantic meaning is equivalent to the original answer, with slightly more detail (e.g., citation to page numbers and charter language), which enhances clarity without introducing error. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 312,
        "total_tokens": 1503
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does BMY's reliance on Cardinal Health for 23% of its distribution in 2023 intersect with CVS’s financial consolidation of Red Oak Sourcing, given Cardinal Health’s 50% ownership stake in the same generic pharmaceutical sourcing entity?",
      "original_answer": "BMY relies on Cardinal Health, Inc. for 23% of its distribution network as of 2023, making Cardinal a critical third-party logistics partner. At the same time, CVS co-owns Red Oak Sourcing, LLC with Cardinal Health (each holding a 50% stake), and consolidates Red Oak’s operations into its financial statements due to its role as the primary beneficiary. This creates a complex interdependency where BMY’s supply chain is partially dependent on a company (Cardinal Health) that is structurally and financially tied to CVS through Red Oak Sourcing. The quarterly payments from Cardinal to CVS, totaling $183 million annually, influence CVS’s cost of goods sold, which could indirectly affect the pricing or efficiency of Cardinal’s distribution services to BMY.",
      "llm_answer": "Bristol‑Myers Squibb reported that Cardinal Health accounted for 23 % of its U.S. wholesale sales in 2023, making the distributor a key channel for BMY’s products【page_80】.  CVS Health, however, fully consolidates Red Oak Sourcing LLC – a generic‑drug sourcing venture that it co‑owns 50 % with Cardinal Health – because CVS is the primary beneficiary of that VIE【page_136】【page_20】.  Consequently, while BMY depends on Cardinal Health to move a sizable share of its drugs, CVS’s financial statements already reflect the joint ownership of the same Cardinal‑Health‑partnered sourcing entity, linking the two companies through Cardinal Health’s dual role as both BMY’s distributor and CVS’s co‑owner of Red Oak.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key figures are correct: BMY's 23% reliance on Cardinal Health in 2023 is accurately reported, and the 50% ownership stake in Red Oak Sourcing by both CVS and Cardinal Health is correctly stated. The LLM correctly notes CVS’s consolidation of Red Oak due to its status as primary beneficiary of the VIE, which matches the original answer. (2) The only minor omission is the absence of the $183 million annual payment from Cardinal to CVS, which is mentioned in the ground truth and adds a specific financial impact on CVS’s cost of goods sold. This detail is relevant to the 'intersection' aspect of the question and its indirect implications on BMY’s distribution efficiency or pricing. (3) The multi-hop reasoning is sound: the LLM correctly links BMY → Cardinal Health (distribution) → Red Oak Sourcing (joint venture) → CVS (consolidation), demonstrating a clear understanding of the structural interdependencies. (4) The answer is contextually fully relevant, directly addressing how BMY’s reliance on Cardinal intersects with CVS’s financial consolidation via shared ownership in Red Oak. Wording differs slightly but maintains semantic equivalence. The lack of the $183M figure prevents a perfect 10, but core facts, entities, and logic are correct. Hence, a 9 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 408,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does MetLife's exposure to interest rate scenarios in its Retirement and Income Solutions segment affect its Life Insurance product line, and how does this compare to AIG's experience with Life Insurance reserve updates under similar interest rate dynamics?",
      "original_answer": "MetLife's Retirement and Income Solutions segment includes life insurance products and is exposed to interest rate scenarios that could compress gross margins due to minimum crediting rate guarantees and reinvestment risks. In declining rate environments, this leads to margin compression, while rising rates allow for reinvestment in higher-yielding assets. Similarly, AIG experienced a $106 million favorable impact in 2021 from actuarial assumption updates in Life Insurance, driven by policy fee modeling, but also faced margin pressures from lower projected investment earnings. Both companies show sensitivity in their Life Insurance lines to interest rate dynamics, with MetLife managing through ALM strategies and AIG adjusting reserves and assumptions.",
      "llm_answer": "MetLife’s “Retirement and Income Solutions” (RIS) business is explicitly modelled in its interest‑rate stress tests; a rising‑rate scenario would cut RIS adjusted earnings by about $10 million in 2022 (turning positive in later years) while the company’s life‑insurance‑oriented “Group Benefits” business is largely insulated because its term and universal policies are renewable and can be repriced, and the firm uses interest‑rate derivatives to offset margin compression (see the hypothetical impact table for RIS (‑10) versus Group Benefits +5 in 2022). In contrast, AIG records the effect of interest‑rate moves directly in its life‑insurance reserves – a 2021 update to universal‑life reserves (driven by higher earned rates) produced a $166 million net unfavorable impact to pre‑tax income, and the company warns that higher market rates can erode capital ratios for its Life and Retirement subsidiaries (see the reserve‑update discussion and the interest‑rate risk commentary). Thus, MetLife’s RIS exposure mainly affects earnings through scenario‑based margin pressure, whereas AIG experiences tangible reserve‑strengthening charges on its life‑insurance books when rates rise.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in quantitative details. The ground truth states that AIG had a $106 million *favorable* impact in 2021 from actuarial assumption updates in Life Insurance, but the LLM claims a $166 million *unfavorable* impact, which is both incorrect in direction and magnitude. Additionally, the LLM introduces a $10 million cut in RIS adjusted earnings in 2022 under rising rates, which is not present in the original answer and lacks support from the provided truth. These are significant quantitative and directional errors. (2) The LLM references a 'hypothetical impact table for RIS (-10) versus Group Benefits +5 in 2022' and specific derivative hedging strategies not mentioned in the ground truth, introducing unsupported details. The original answer does not mention MetLife’s Group Benefits business or its insulation via repricing—this is an overextension. (3) While the LLM attempts multi-hop reasoning by comparing MetLife’s ALM and earnings sensitivity to AIG’s reserve accounting, it mischaracterizes AIG’s experience (unfavorable vs. favorable) and misattributes mechanisms. The core idea—that both firms are sensitive to interest rates but through different channels (earnings vs. reserves)—is partially aligned, but the flawed data undermines the comparison. (4) Despite these issues, the LLM correctly identifies that interest rate dynamics affect MetLife’s Retirement and Income Solutions and AIG’s Life Insurance reserves, and it attempts a relevant comparison, earning points for contextual relevance and partial qualitative accuracy. However, major quantitative errors reduce the correctness score to 5.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 462,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What specific battery supply agreements exist between Tesla and Panasonic Corporation, and how do these agreements compare to known battery sourcing dependencies reported by General Motors?",
      "original_answer": "Tesla has multiple agreements with Panasonic Corporation for battery supply, including the 2011 Supply Agreement, its 2019 and 2021 Pricing Agreements for Japan-sourced cells, and the 2020 Pricing Agreement for Gigafactory 2170 cells. These agreements are supported by ongoing amendments, investment letters, and shared facility leases that indicate a deep strategic partnership. In contrast, General Motors’ filings only state a general dependency on batteries without specifying agreements or suppliers, making Tesla’s battery sourcing strategy with Panasonic more explicitly defined and contractually secured.",
      "llm_answer": "Tesla’s 2023 filing lists a series of long‑term contracts with Panasonic Corporation – the original “Supply Agreement” dated October 5 2011, its first amendment (Oct 29 2013), a July 31 2014 agreement, the “General Terms and Conditions” (Oct 1 2014) and, more recently, a 2020 Production‑Pricing Agreement for Gigafactory 2170 cells (June 9 2020) and a 2021 Pricing Agreement for Japan‑produced cells (Dec 29 2020). These documents show that Tesla has secured multi‑year, price‑linked commitments for both its Nevada‑based and overseas Panasonic‑made battery cells.\n\nBy contrast, General Motors’ 2023 filing does not disclose any named battery‑supply contracts; it only notes that the company purchases component parts—including batteries—from non‑consolidated affiliates and joint‑venture partners, indicating a reliance on external suppliers but without the detailed, long‑term Panasonic agreements that Tesla reports.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. It correctly identifies Tesla's key agreements with Panasonic, including the 2011 Supply Agreement, amendments, and specific pricing agreements for Gigafactory 2170 cells (2020) and Japan-produced cells (2021), with precise dates that match or are consistent with the original answer. The only minor discrepancy is the LLM's reference to a '2020 Production-Pricing Agreement' dated June 9, 2020, while the ground truth refers to a '2020 Pricing Agreement' without specifying the date—this is a slight expansion but not factually incorrect. Similarly, the LLM cites a Dec 29, 2020 agreement for Japan-produced cells, whereas the ground truth says '2021 Pricing Agreement'; this could reflect a document dated late 2020 but effective in 2021, so it is not clearly erroneous. The LLM correctly contrasts this with General Motors’ lack of named supplier agreements, accurately reflecting GM’s general dependency without specific contracts. All entities (Tesla, Panasonic, General Motors), timeframes, and reasoning are correct. The multi-hop synthesis—comparing Tesla’s explicit, long-term contracts with GM’s vague sourcing disclosures—is logically sound and contextually appropriate. Quantitative accuracy is high: all dates and agreement types are consistent with filings. The answer is complete, addressing both parts of the question with strong qualitative reasoning and full contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 404,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How does MDLZ's use of commodity futures, which are classified as Level 1 financial assets, compare to COST's disclosure about holding no Level 1 financial assets, in the context of their respective risk management strategies involving financial instruments?",
      "original_answer": "MDLZ actively uses commodity futures, which are categorized as Level 1 financial assets based on quoted market prices, as part of its hedging strategy to manage exposure to input cost fluctuations such as cocoa, sugar, and energy. In contrast, COST disclosed that as of August 28, 2022, it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, indicating a different approach to financial risk management that does not involve exchange-traded futures. This contrast highlights that while MDLZ relies on Level 1 commodity futures for price risk mitigation, COST does not utilize such instruments in its financial strategy.",
      "llm_answer": "Mondelēz International reports that it holds commodity futures and listed options that are measured at Level 1 – $46 million of such contracts were recorded in 2022 – and uses these exchange‑traded futures to hedge the price risk of key raw‑material inputs such as cocoa, sugar, wheat and energy (see Note 10, Financial Instruments).  In contrast, Costco’s 2022 filing states that the company “did not hold any Level 1 or 3 financial assets or liabilities that were measured at fair value on a recurring basis” (Note 3‑Fair Value Measurement), indicating that it does not employ exchange‑traded commodity futures in its risk‑management program and relies on other, non‑Level 1 instruments for hedging.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies MDLZ's use of Level 1 commodity futures for hedging key inputs like cocoa, sugar, wheat, and energy, referencing Note 10 of its filing, and provides a specific dollar amount ($46 million) recorded in 2022. This quantitative detail is not in the original answer but is factually consistent and adds precision. (2) It accurately cites COST's 2022 disclosure (as of August 28, 2022) stating no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, referencing Note 3 on Fair Value Measurement. The date and wording are semantically equivalent to the original answer. (3) The multi-hop reasoning is sound: it contrasts MDLZ’s active use of exchange-traded (Level 1) futures with COST’s absence of such holdings, correctly inferring differing risk management strategies. (4) Minor difference: the original answer mentions 'energy' as a hedged input, while LLM adds 'wheat'—this is not incorrect, as MDLZ does hedge wheat, but it slightly extends beyond the original scope. However, this reflects accurate knowledge, not error. The LLM also correctly implies that COST uses non-Level 1 instruments without overclaiming. All entities (MDLZ, COST, Level 1 assets, commodity futures, hedging) and years (2022) are correct. The answer is contextually excellent, directly addressing the comparative risk management strategies. Quantitative accuracy is high—$46 million is correctly attributed and formatted. No calculation errors. One point deducted from correctness only because the original answer does not specify the $46M figure, and while the LLM’s inclusion is accurate, it introduces a detail not confirmed in the ground truth, slightly exceeding it without contradiction.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 489,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does the adoption of Rule 10b5-1(c) trading plans by Apple executives compare with Broadcom's use of similar plans in terms of volume and timing of potential stock sales?",
      "original_answer": "Apple executives Deirdre O'Brien and Jeff Williams entered into Rule 10b5-1(c) trading plans in August 2024, covering the sale of shares vesting between April 1, 2025, and October 1, 2026 (O'Brien) and up to 100,000 shares plus additional vesting shares through October 1, 2025 (Williams), with expiration dates in 2025 and 2026. Broadcom director Diane M. Bryant adopted a similar plan in September 2024, allowing for the sale of up to 15,000 shares of Broadcom common stock contingent on market price thresholds, expiring September 12, 2025. Both companies utilize Rule 10b5-1(c) plans to structure insider trading in compliance with SEC regulations, but Apple’s plans involve significantly larger volumes and longer time horizons.",
      "llm_answer": "Apple’s 2024 filing discloses two Rule 10b5‑1(c) plans: Jeff Williams’ plan authorizes the sale of **up to 100,000 shares** (with the shares that vest between April 1 2025 and October 1 2025) and expires December 15 2025, while Deirdre O’Brien’s plan covers the shares that vest from April 1 2025 through October 1 2026 and remains in effect until December 31 2026 (no specific share‑count limit is given).  \n\nBroadcom’s filing notes that board member Diane M. Bryant adopted a 10b5‑1(c) plan that permits the **sale of up to 15,000 shares** and expires September 12 2025, giving a much smaller potential volume and a shorter, single‑date window than the Apple executives’ plans.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: Jeff Williams' plan covers up to 100,000 shares plus vesting shares through October 1, 2025, expiring December 15, 2025; Deirdre O'Brien’s plan covers shares vesting from April 1, 2025, to October 1, 2026, expiring December 31, 2026, with no stated share limit; Diane M. Bryant’s plan allows sale of up to 15,000 shares, expiring September 12, 2025. These numbers, dates, and entities match the original answer exactly. (2) Quantitative accuracy is perfect—no calculation errors, and all numeric values (share counts, dates) are correct and properly attributed. (3) The multi-hop reasoning is sound: the model correctly compares Apple and Broadcom executives’ use of Rule 10b5-1(c) plans in terms of volume (100k vs 15k shares) and timing (longer duration for Apple), synthesizing across two companies and multiple individuals. (4) The only minor discrepancy is that the original answer notes Williams’ plan includes 'additional vesting shares' beyond the 100,000, which the LLM mentions parenthetically but could have emphasized more clearly. However, the core information is present and correctly interpreted. Wording differences do not affect semantic equivalence. The conclusion about Apple’s larger volume and longer time horizon is correctly drawn and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 383,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does the involvement of JPMorgan Chase Bank, N.A. as syndication agent in both 3M's May 11, 2023 Five-Year Credit Agreement and Honeywell’s March 20, 2023 Amended and Restated Five-Year Credit Agreement reflect a shared banking relationship in their respective credit facilities?",
      "original_answer": "JPMorgan Chase Bank, N.A. serves as syndication agent in both 3M’s May 11, 2023 Five-Year Credit Agreement and Honeywell’s March 20, 2023 Amended and Restated Five-Year Credit Agreement, indicating a shared banking relationship where JPMorgan plays a key coordinating role in managing the syndicate of lenders for both companies’ credit facilities. This suggests that both companies rely on JPMorgan Chase Bank, N.A. to help structure and administer large-scale financing arrangements, potentially reflecting a strategic alignment in how they access syndicated credit markets.",
      "llm_answer": "Both 3M’s May 11 2023 five‑year credit agreement and Honeywell’s March 20 2023 amended and restated five‑year credit agreement name JPMorgan Chase Bank, N.A. as a syndication agent – the bank that helped arrange and distribute the revolving credit facilities to a group of lenders. This common role shows that the two companies rely on the same major financial institution to structure and market their credit facilities. 【page 114】 【page 68】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) All key facts are accurate: JPMorgan Chase Bank, N.A. is correctly identified as the syndication agent in both 3M’s May 11, 2023 Five-Year Credit Agreement and Honeywell’s March 20, 2023 Amended and Restated Five-Year Credit Agreement. The dates and roles are precisely stated. (2) Quantitative accuracy is perfect—dates (May 11, 2023 and March 20, 2023) are correct, and no numerical calculations are required. Format variations are not an issue here. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two separate credit agreements from two different companies to identify a shared banking relationship. It accurately infers that JPMorgan plays a coordinating role in arranging and distributing credit facilities for both firms. (4) The answer captures the core implication—that both companies rely on the same institution for structuring and marketing credit facilities—though it omits the slight nuance in the original answer about JPMorgan’s role in 'administering' and 'strategic alignment in accessing syndicated credit markets.' This minor omission prevents a perfect 10 on qualitative accuracy, but the semantic meaning remains substantially equivalent. Contextual relevance is excellent, directly addressing the shared banking relationship as requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 381,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How might the EU and U.S. sanctions targeting the tobacco sector in Belarus impact Coca-Cola HBC's operations in the country, and what implications could this have for The Coca-Cola Company's overall unit case volume given its reliance on Coca-Cola HBC as a key bottler?",
      "original_answer": "The EU and U.S. sanctions targeting the tobacco sector in Belarus, including restrictions on trade of goods used for tobacco production, could disrupt local supply chains and economic activity, potentially affecting Coca-Cola HBC's operations in the country. Since Coca-Cola HBC is a major independent bottler representing 41% of The Coca-Cola Company’s total worldwide unit case volume in 2021 and operates in Belarus, any operational constraints or economic instability in Belarus could reduce its production and distribution capacity. This, in turn, could negatively impact The Coca-Cola Company’s overall unit case volume, especially since non-U.S. markets accounted for 83% of the company’s total volume in 2021 and bottlers like Coca-Cola HBC are contractually required to purchase concentrates from KO, forming a critical link in the supply chain.",
      "llm_answer": "The EU‑ and U.S. sanctions that prohibit trade in goods used to make tobacco products in Belarus require Coca‑Cola HBC – which bottles Coca‑Cola drinks in Belarus (see its territory list on page 7) – to curtail or suspend any activity that could be deemed a sanction violation, creating a compliance‑driven shutdown or slowdown of its Belarus operations. Because Coca‑Cola HBC is one of the five largest bottlers that together account for about 41 % of The Coca‑Cola Company’s worldwide unit‑case volume (page 7), any loss of production or sales in Belarus would shave off a portion of that volume and could modestly depress the Company’s total unit‑case volume, which is heavily reliant on HBC’s output.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key figures are correct: the 41% contribution of Coca-Cola HBC to The Coca-Cola Company’s total unit case volume is accurately cited and matches the original answer’s reference to 2021 data. No incorrect numbers, dates, or percentages are present. Format variations (e.g., '41 %' with space) do not affect accuracy. (2) The answer correctly identifies the entities: Coca-Cola HBC as a major bottler operating in Belarus, its role in the supply chain, and its importance to The Coca-Cola Company. The mention of page 7 as a source for territory and bottler volume is plausible in context, though not verifiable here, but does not detract from factual correctness. (3) Multi-hop reasoning is sound: the LLM connects sanctions on the tobacco sector in Belarus → potential operational disruption for Coca-Cola HBC → impact on production/sales → downstream effect on The Coca-Cola Company’s total unit case volume. It correctly infers that even a modest reduction in HBC’s output could affect overall volume due to HBC’s significant share. (4) The only minor shortcoming is that the LLM focuses narrowly on compliance-driven shutdowns without fully elaborating on broader economic spillovers (e.g., supply chain disruptions, macroeconomic instability in Belarus) mentioned in the original answer. However, the core causal chain and implications are preserved. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent—directly addresses both parts of the question: impact on HBC and implications for KO’s volume.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 444,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How might the proposed 28%-30% reduction in U.S. debit interchange rate caps impact Capital One’s interchange fee income, given its exposure to Mastercard’s four-party network and the ongoing legal challenges involving interchange fees that Visa and Mastercard face?",
      "original_answer": "The proposed 28%-30% reduction in U.S. debit interchange rate caps by the Federal Reserve could significantly lower Capital One’s interchange fee income, as COF relies on interchange fees from transactions processed through four-party networks like Mastercard. This impact could be exacerbated by the fact that merchants continue to pursue legal actions against Mastercard and Visa, as seen in the ongoing multidistrict litigation where interchange fee practices remain under scrutiny. Mastercard, being subject to regulatory oversight and interchange fee limitations, may be forced to further reduce fees or face additional settlements, which would directly affect Capital One’s revenue model tied to those networks.",
      "llm_answer": "The Federal Reserve’s October 2023 proposal to cut the U.S. debit‑interchange cap by roughly 28 %‑30 % would directly lower the fee rate that Capital One earns on the debit transactions it processes through Mastercard’s four‑party network.  Because Capital One’s fee revenue is tied to those interchange rates, a cap‑reduction of that magnitude would translate into a comparable decline in its interchange‑fee income (the company even warns that “lower interchange fees … could result in a loss of income” and “material adverse effect” on its results 【page 24】, 【page 39】).  That pressure is compounded by the ongoing multidistrict litigation in which Visa and Mastercard are defendants; any additional settlements or judgments arising from those cases would further erode Capital One’s fee earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 28%-30% reduction in debit interchange caps is correctly cited, and the reference to Capital One’s own risk disclosures (pages 24 and 39) supports the financial impact—this matches the expected exposure. The October 2023 proposal date is factually correct and adds precision not in the original answer but consistent with public record. (2) All entities—Capital One (COF), Mastercard, Visa, the Federal Reserve, and the multidistrict litigation—are correctly identified and contextually used. (3) The reasoning correctly synthesizes multi-hop connections: regulatory cap reduction → lower interchange rates → direct revenue impact on Capital One due to its reliance on Mastercard’s four-party network → compounding risk from ongoing litigation against Visa and Mastercard. The logic that settlements could further erode fee income is sound and supported by the original answer. (4) The only minor shortcoming is that the LLM does not explicitly mention Mastercard’s regulatory oversight or its potential obligation to reduce fees beyond the cap (a nuance in the original), but this does not detract significantly from the overall correctness. Wording differs but semantic equivalence is strong. The inclusion of specific document page references enhances credibility and precision. All criteria for high scores are met, with only a slight deduction in qualitative accuracy for missing a subtle regulatory nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 414,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does Duke Energy's exposure to LIBOR-indexed financial contracts influence its adoption timeline for ASU 2020-04 compared to Southern Company's approach, given both companies' assessments of the regulation's financial impact?",
      "original_answer": "Duke Energy is assessing LIBOR-indexed financial arrangements and evaluating the optional expedients in ASU 2020-04 for contracts extending beyond the LIBOR phase-out in 2023, with the transition not expected to have a material impact on its financial statements. Southern Company, similarly, is evaluating the provisions of ASU 2020-04 and the impact of transitioning to alternative rates, though the ultimate outcome remains uncertain. Both companies are applying the guidance as it relates to contract modifications and hedge accounting under the reform, but Duke Energy had until December 31, 2022, to apply the optional expedients, suggesting a time-bound evaluation window compared to Southern Company's ongoing assessment.",
      "llm_answer": "Duke Energy notes that a portion of its variable‑rate debt and interest‑rate swaps are indexed to LIBOR and is still evaluating those contracts and the optional expedients in the new guidance; it has not yet adopted ASU 2020‑04 and expects the transition to have no material effect on its statements. In contrast, Southern Company has already elected to apply the ASU 2020‑04 amendments to all debt‑modification arrangements that fall within its scope and likewise expects no material impact, indicating a more immediate adoption than Duke’s still‑under‑review approach.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several correct elements but introduces a significant factual inaccuracy in the qualitative reasoning that undermines the overall correctness. (1) Quantitatively, there are no explicit numbers, dates, or calculations in the original or LLM answer beyond general references to ASU 2020-04 and the LIBOR phase-out, so the quantitative accuracy is high—no incorrect figures are presented. The mention of Duke Energy’s expected immaterial impact and Southern Company’s similar expectation aligns with the ground truth. (2) However, the key error lies in the claim that 'Southern Company has already elected to apply the ASU 2020-04 amendments to all debt-modification arrangements'—this contradicts the original answer, which states Southern Company is still 'evaluating the provisions' and that 'the ultimate outcome remains uncertain.' This misrepresents Southern Company’s position as more advanced and decisive than it actually is. (3) The multi-hop reasoning is flawed: the question asks how Duke’s exposure influences its adoption timeline *compared* to Southern’s. The LLM incorrectly frames Southern as having adopted the standard immediately, while portraying Duke as still evaluating—implying Southern is ahead. But the ground truth indicates both are evaluating, with Duke having a defined deadline (December 31, 2022) for optional expedients, whereas Southern’s assessment is described as ongoing. The LLM reverses or distorts the comparative timeline. (4) Despite this, the answer is contextually relevant and captures the right companies, regulation, and financial impact assessment. The semantic equivalence fails on the critical point of adoption status. Hence, correctness is partially compromised—core facts about impact and evaluation are right, but the comparative adoption timeline is incorrect, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 502,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does the application of the Black-Scholes-Merton model for stock option valuation at KO compare to the use of weighted-average assumptions in pension plan cost calculations at CL, particularly in terms of the specific inputs and their financial reporting implications?",
      "original_answer": "KO uses the Black-Scholes-Merton model to estimate the fair value of stock option awards, with the weighted-average fair value of options granted in 2023 being calculated using assumptions such as volatility, risk-free interest rate, and expected term. These weighted-average assumptions are a key input in the model. CL also utilizes weighted-average assumptions, but in the context of pension plan cost calculations, where factors like discount rate (5.66% in 2023), expected long-term rate of return on plan assets (6.25% in 2023), and compensation increase (3.50% in 2023) directly impact the reported net periodic benefit cost. While both companies rely on weighted-average assumptions, KO applies them in equity compensation valuation using a formal pricing model, whereas CL integrates them into actuarial estimates for pension liabilities, highlighting different financial reporting applications of similar statistical inputs.",
      "llm_answer": "- **Coca‑Cola (KO)** – Stock‑option fair values are computed with the Black‑Scholes‑Merton model.  The model uses market‑derived inputs disclosed for each grant year: dividend yield (≈ 3 % in 2023), expected volatility (≈ 17.5 % in 2023), the risk‑free rate (4.1 % in 2023) and an expected term of six years.  The resulting fair‑value per option ($9.84 in 2023) is recorded as stock‑based compensation expense on a straight‑line basis over the four‑year vesting period, affecting the income statement and equity.\n\n- **Colgate‑Palmolive (CL)** – Pension costs are calculated using weighted‑average actuarial assumptions rather than a pricing model.  For 2023 the key inputs were a discount rate of 5.40 % (U.S.) and 4.35 % (international), an expected long‑term return on plan assets of 6.50 % (U.S.) and 4.66 % (international), a compensation‑increase rate of about 3.5 %, and related rates for ESOP growth, medical cost trends and interest crediting.  These assumptions determine the projected benefit obligation, the net periodic benefit cost and the actuarial gain/loss, which are reflected in pension liabilities on the balance sheet and pension expense on the income statement.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the use of the Black-Scholes-Merton model at KO and weighted-average assumptions in pension calculations at CL, and it accurately describes the financial reporting implications for both companies. However, there are discrepancies in specific numeric values. The ground truth states CL's 2023 discount rate as 5.66%, expected return on plan assets as 6.25%, and compensation increase as 3.50%. The LLM reports CL's U.S. discount rate as 5.40% and expected return as 6.50% (U.S.), which differ from the ground truth. These are material differences in a financial context. Additionally, the LLM introduces international rates and other factors (ESOP growth, medical cost trends) not mentioned in the original answer, adding detail but potentially conflating data. For KO, the LLM provides more granular inputs (dividend yield ≈3%, volatility ≈17.5%, risk-free rate 4.1%, term 6 years, fair value $9.84), which are plausible but not present in the ground truth—while not necessarily incorrect, their inclusion suggests over-specificity beyond the verified data. (2) The calculation of stock-based compensation expense over the vesting period and the impact on financial statements are correctly explained. However, the absence of direct mention of 'weighted-average fair value of options granted'—a key phrase in the original—is a minor omission. (3) The multi-hop reasoning is sound: the model correctly distinguishes between KO’s use of weighted-average assumptions in a pricing model for equity compensation versus CL’s use in actuarial valuations for pensions. The synthesis across companies and domains (equity compensation vs. pension accounting) is logically structured and contextually appropriate. (4) The correctness score is 7 because core facts and conceptual understanding are accurate, but quantitative deviations prevent a higher score. Quantitative accuracy is 6 due to mismatched percentages for CL’s key assumptions. Qualitative accuracy is 8 due to strong reasoning and correct entity identification (KO, CL, correct contexts). Contextual relevance is 9—response directly addresses the comparison question with appropriate depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1560,
        "completion_tokens": 587,
        "total_tokens": 2148
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does AMT's use of subsidiary equity interests as collateral for the $525.0 million Series 2015-2 Notes compare with SPG's strategy of monetizing equity interests through disposals, particularly in light of SPG's $18.8 million gain from such transactions?",
      "original_answer": "AMT utilized the equity interests in its subsidiary GTP Acquisition Partners as part of the collateral structure for the $525.0 million Series 2015-2 Notes, which were secured by a security interest in substantially all of the personal property of the GTP Entities, including GTP Acquisition Partners' equity interests in its subsidiaries. This approach allowed AMT to securitize cash flows from specific communications sites while retaining control over excess cash flows. In contrast, SPG pursued a strategy of actively monetizing its equity interests through disposals, as evidenced by a $18.8 million gain from the sale of equity interests in 2021, indicating a more direct capital realization approach. The comparison highlights different financial strategies: AMT leveraged equity interests for secured financing, while SPG liquidated equity interests for immediate financial gain.",
      "llm_answer": "American Tower’s $525 million Series 2015‑2 secured revenue notes are backed not only by mortgages on its tower sites but also by a security interest in the equity of its subsidiaries – the GTP entities’ ownership stakes are pledged as collateral for the debt【page_117】.  \nSimon Property Group, by contrast, has been converting equity holdings into cash through outright disposals, realizing a relatively modest $18.8 million gain from those sales in 2021【page_63】.  \n\nThus, AMT leverages subsidiary equity as a pledged asset to support borrowing, whereas SPG monetizes equity by selling it and records a realized gain.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: AMT's $525.0 million Series 2015-2 Notes are secured by subsidiary equity interests (specifically in the GTP entities), and SPG realized an $18.8 million gain from disposals of equity interests in 2021. The dollar amounts and years match the original answer exactly. (2) Quantitative accuracy is perfect: both figures ($525 million and $18.8 million) are correctly reported with appropriate context and year. (3) The multi-hop reasoning is sound—correctly contrasting AMT’s secured financing strategy (pledging equity as collateral) with SPG’s direct monetization via sales. The LLM correctly identifies the strategic difference: leveraging vs. liquidating equity interests. (4) The only minor shortcoming is a slight lack of detail compared to the original—e.g., not explicitly mentioning that AMT retained control over excess cash flows or that the collateral included substantially all personal property of the GTP Entities. However, these are contextual enhancements rather than critical omissions. The core comparison is logically and factually sound. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing the comparative financial strategies as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 370,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does ConocoPhillips' operational exposure in Nigeria compare to ExxonMobil's reliance on production-sharing contracts in terms of reserve reporting and contractual term structures?",
      "original_answer": "ConocoPhillips operates in Nigeria, where exploration and production activities are governed by production-sharing contracts (PSCs) with a typical term of 30 years, including a 10-year exploration period and a 20-year production period that may be extended under the Petroleum Industry Act. ExxonMobil reports that 12% of its total proved reserves (on an oil-equivalent basis) in 2021 were associated with PSC arrangements, where reserve volumes fluctuate inversely with price changes due to the fiscal terms of these contracts. This indicates that while both companies are exposed to PSCs in Nigeria, ExxonMobil's reserve reporting methodology must account for the dynamic nature of PSC-based reserves, whereas ConocoPhillips must manage its operations under fixed-term contractual obligations that include partial relinquishment requirements.",
      "llm_answer": "ExxonMobil’s proved‑reserve tables note that ≈ 12 % of its total proved reserves are held under production‑sharing contracts (PSCs), and the company describes those PSCs as 30‑year agreements (a 10‑year exploration phase that can be extended, followed by a 20‑year production phase) 【page_134】【page_31】.  \n\nConocoPhillips’ 2022 filing does not disclose any reserve amount or specific contractual term for its Nigerian assets, implying that its Nigerian operations are not material to its overall reserve reporting and that no long‑term PSC‑type structure is highlighted in the filing 【pages 96, 138, 153‑155】.  \n\nThus, ExxonMobil’s reserve reporting explicitly reflects a sizable, 30‑year PSC exposure, whereas ConocoPhillips’ Nigerian exposure is not quantified in its reserve disclosures and lacks a comparable PSC‑based term structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct quantitative information but fails in key aspects of multi-hop reasoning and completeness. (1) Quantitatively, the 12% figure for ExxonMobil's PSC-associated reserves and the 30-year PSC structure (10-year exploration, 20-year production) are correctly reported and align with the ground truth. However, the LLM incorrectly implies that ExxonMobil's 30-year PSC structure is explicitly tied to Nigeria, while the original answer does not make that geographic link for ExxonMobil—only for ConocoPhillips. (2) The LLM claims ConocoPhillips does not disclose reserve amounts or contractual terms for Nigeria, leading to the conclusion that its Nigerian operations are immaterial and lack a PSC structure. This contradicts the ground truth, which explicitly states that ConocoPhillips *does* operate in Nigeria under PSCs with a 30-year term. Thus, the LLM draws an incorrect inference from absence of disclosure, failing the multi-hop synthesis: both companies are exposed to PSCs in Nigeria, but with different reporting and operational implications. (3) The reasoning is flawed: lack of explicit reserve disclosure does not imply absence of PSC exposure, especially since the ground truth confirms ConocoPhillips operates under such contracts. (4) The original answer highlights a nuanced comparison: ExxonMobil’s reserve reporting must adjust for price-dependent PSC dynamics, while ConocoPhillips manages fixed-term obligations with relinquishment requirements. This key contrast is missed entirely. While the ExxonMobil data is accurate, the ConocoPhillips analysis is factually wrong, undermining the core comparison. Hence, partial credit for numbers but major deduction for incorrect entity synthesis and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 475,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does IBM's focus on generative AI innovation compare with QCOM's investment in edge-based generative AI and cloud computing, particularly in terms of their respective strategies for commercializing AI technologies in high-performance, low-power computing environments?",
      "original_answer": "IBM is actively investing in generative AI as part of its broader innovation initiatives, emphasizing cutting-edge R&D to differentiate itself in hybrid cloud and AI markets, with the goal of attracting a developer ecosystem and maintaining market share. In contrast, QCOM is embedding generative AI capabilities directly into edge devices, such as smartphones and PCs, to optimize performance, privacy, and personalization while coordinating with cloud applications. QCOM's cloud computing processing initiative supports this strategy by enabling intelligent data sharing between edge devices and cloud systems. While IBM focuses on enterprise-level AI innovation and ecosystem development, QCOM is commercializing generative AI through high-performance, low-power mobile platforms, projecting that 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024.",
      "llm_answer": "- **IBM** – IBM’s 2024 filing says its growth engine is a **hybrid‑cloud platform that bundles AI services**, including generative‑AI tools, into the same cloud‑based infrastructure it sells to enterprise customers.  The company stresses that “we help them leverage the power of **hybrid cloud and artificial intelligence (AI)**” and that a “failure of innovation initiatives … that incorporate … **hybrid cloud, AI and generative AI**” would hurt its business (IBM 10‑K p. 3; p. 5).  IBM therefore commercializes AI by delivering it as cloud‑hosted software and platform services that run on high‑performance data‑center hardware but are offered to clients as a managed, scalable service.\n\n- **Qualcomm** – Qualcomm’s filing highlights a **hardware‑first, edge‑centric approach**.  Its QCT segment builds “integrated‑circuit platforms … with **high‑performance, low‑power computing**” for phones, automotive and IoT, and the filing notes that “mobile handsets and PCs are becoming pervasive AI platforms, with **complex large generative‑AI algorithms running on‑device**” and that “edge device computing allows for more context‑aware processing” (Qualcomm 10‑K p. 7).  In addition, Qualcomm maintains a separate “cloud‑computing processing initiative” to complement the edge (p. 7).  Thus Qualcomm commercializes AI by embedding generative‑AI capabilities directly into its low‑power chips for edge devices while also supporting cloud‑based workloads.\n\n**Comparison:** IBM pursues AI commercialization through **software‑centric hybrid‑cloud services** that run on powerful data‑center infrastructure, whereas Qualcomm focuses on **on‑device, low‑power silicon** that brings generative AI to the edge, backed by a cloud‑processing effort to handle larger models. Both target high‑performance AI, but IBM leans on cloud scalability and enterprise SaaS, while Qualcomm leans on edge efficiency and hardware integration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: IBM's focus on hybrid cloud and AI services for enterprise clients, delivered via cloud-hosted platforms, matches the original answer. Qualcomm's edge-centric, hardware-first strategy—embedding generative AI into low-power chips for smartphones and PCs while supporting cloud integration—is accurately described. (2) Quantitative accuracy is perfect: the LLM does not introduce any incorrect numbers and correctly avoids fabricating statistics not in the source, though it omits the specific projection from the ground truth that '46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024.' This omission prevents a full 10 on correctness, as the question asks about commercialization strategies 'particularly in terms of' such forward-looking metrics. (3) Reasoning is sound and multi-hop: the model correctly synthesizes information from both IBM and Qualcomm filings, contrasting software- and hardware-centric commercialization models, and linking edge computing with cloud coordination. (4) Semantic equivalence is strong—wording differs but meaning matches. The answer is fully contextually relevant, directly addressing the comparison in high-performance, low-power environments. The only shortcoming is the missing smartphone AI adoption projection, which is a key differentiator in QCOM's commercialization strategy. Hence, correctness is 9 instead of 10 due to this partial omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1731,
        "completion_tokens": 419,
        "total_tokens": 2151
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does Duke Energy's exposure to nuclear decommissioning funding risks compare to NextEra Energy's financial risk management for nuclear generation, given both companies' reliance on market performance for trust-funded obligations?",
      "original_answer": "Duke Energy Carolinas, Progress, and Florida have significant obligations tied to decommissioning nuclear plants, with trust assets subject to market fluctuations that could increase funding requirements if returns fall below projections. Similarly, NextEra Energy and FPL maintain decommissioning funds and insurance coverage, but the cost of decommissioning could exceed available funds. Both companies are exposed to financial risks stemming from nuclear power plants, particularly as market performance directly affects their ability to meet long-term decommissioning obligations.",
      "llm_answer": "Duke Energy explicitly states that the value of the assets held in its nuclear‑decommissioning trust funds (NDTFs) is subject to market‑performance fluctuations; a decline in those values could force the company to fund additional decommissioning costs (DUK 10‑K page 35). NextEra Energy, by contrast, relies on a combination of funded decommissioning accounts, external insurance and derivative‑based risk‑management programs to cover nuclear‑related liabilities, and while it notes that decommissioning costs could exceed the funds available, it does not highlight the same direct market‑value sensitivity as Duke (NEE 10‑K pages 30‑31). Thus, Duke’s exposure to nuclear‑decommissioning funding risk is more directly tied to market swings in trust‑fund assets, whereas NextEra’s approach spreads the risk through insurance and hedging mechanisms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Duke Energy's exposure to market fluctuations in its nuclear decommissioning trust funds is accurately described, with a specific reference to its 10-K (page 35), and the risk of having to fund additional costs if market returns fall is properly highlighted. NextEra Energy’s use of funded accounts, insurance, and derivative-based risk management is also correctly stated, with appropriate citation (NEE 10-K pages 30–31). While both companies face risks if decommissioning costs exceed available funds, the LLM correctly distinguishes that NextEra does not emphasize direct market sensitivity to the same extent as Duke. (2) There are no numerical values (e.g., dollar amounts, percentages, years) in either the original or LLM answer, so quantitative accuracy is not compromised—score reflects absence of errors. (3) The multi-hop reasoning is sound: the model synthesizes information across two companies, compares their risk management approaches, and draws a valid conclusion about relative exposure to market performance. The distinction between Duke’s direct market exposure and NextEra’s diversified risk mitigation is a nuanced but correct interpretation supported by the filings. (4) The LLM adds analytical value by clarifying differences in risk management strategies not explicitly stated in the original answer, but does so without overreaching or introducing inaccuracies. The original answer emphasizes similarities in market-related risks; the LLM complements this by highlighting a strategic difference. This constitutes a minor qualitative enhancement rather than a deviation. Only a score of 9 is given because the LLM slightly downplays the shared core risk (both are still exposed to market performance in trust-funded obligations), but the overall correctness and insight remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 516,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does CAT's application of hedging relationship accounting under ASU 2020-04 compare to UPS's adoption of the same standard, particularly in terms of their respective derivative contract management strategies and transition timelines?",
      "original_answer": "CAT formally documents and designates derivatives as either fair value or cash flow hedges, using foreign currency forward and option contracts to manage up to five years of anticipated foreign currency cash flow exposure. Under ASU 2020-04, CAT applied optional expedients for contract modifications affected by reference rate reform through December 31, 2024, though the adoption did not have a material impact. In contrast, UPS transitioned its affected debt instruments and contracts to SOFR as the alternative reference rate by December 31, 2023, but did not elect to apply the practical expedients provided under ASU 2020-04, continuing to assess potential impacts through 2024. Both companies applied the standard to manage derivative and debt contract modifications, but CAT leveraged the extended relief period while UPS opted for direct transition without using the optional relief.",
      "llm_answer": "Caterpillar explicitly states that it has applied the hedge‑relationship guidance of ASU 2020‑04.  It designates foreign‑currency forwards and options as cash‑flow hedges and fixes‑to‑float or floating‑to‑fixed interest‑rate swaps as either fair‑value or cash‑flow hedges, using those contracts to match‑fund its debt portfolio and to offset cash‑flow variability; it completed the transition of all affected debt to the SOFR reference rate by 31 December 2023 and chose not to use the practical‑expedient reliefs.  United Parcel Service’s 2023 filing does not disclose any adoption of ASU 2020‑04 or a comparable hedging‑accounting policy, nor does it provide a transition timetable, indicating that the standard either is not material to UPS or has not yet been implemented.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) It incorrectly states that Caterpillar (CAT) completed its transition to SOFR by December 31, 2023, and chose *not* to use the practical expedients under ASU 2020-04. In reality, CAT *did* apply the optional expedients and extended relief through December 31, 2024, and the adoption did not have a material impact. (2) It falsely claims that UPS did not disclose any adoption of ASU 2020-04 or hedging policy, when in fact UPS *did* transition to SOFR by December 31, 2023, but explicitly chose *not* to apply the practical expedients—this is a key contrast with CAT. The LLM reverses the positions of the two companies: it says CAT did *not* use the relief (false) and implies UPS did nothing (false), while in truth CAT *used* the relief and UPS *opted out* of it despite transitioning early. (3) The multi-hop reasoning fails: the question asks for a comparison of hedging strategies and transition timelines under ASU 2020-04, but the LLM misrepresents both companies’ actions, preventing accurate synthesis. (4) While the mention of derivative types (forwards, options, swaps) is plausible, the core facts about adoption approach and timelines are inverted or incorrect. The answer is contextually relevant in structure and attempts to compare both firms, but the factual foundation is flawed, leading to a low correctness score. Minor formatting of dates (e.g., '31 December 2023') is acceptable, but the substance is not.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 416,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does Comcast's lack of voting rights in Atairos compare to Alphabet's dual-class stock structure, particularly in terms of control implications given Alphabet's significant share repurchase activity in Classes A and C?",
      "original_answer": "Comcast has no voting rights in Atairos and only certain consent rights, which means it lacks control over Atairos’s activities despite a remaining unfunded capital commitment of $1.4 billion as of December 31, 2024. In contrast, Alphabet maintains a dual-class stock structure where Class B shares have 10 votes per share, allowing key stakeholders to retain outsized voting power. Despite repurchasing $62.0 billion in Class A and Class C shares in 2024 alone, Alphabet has preserved the Class B structure, which ensures concentrated control while reducing public float in the lower-vote and no-vote classes.",
      "llm_answer": "Comcast’s investment in Atairos is held without any voting rights – the company “has no voting rights and only certain consent rights,” so it cannot direct Atairos’s activities or influence its governance. Alphabet, by contrast, issues a dual‑class structure in which only the 10‑vote Class B shares carry voting power; the company’s large repurchases of non‑voting Class C (and lower‑voting Class A) shares reduce the number of shares outstanding but do not diminish the voting control held by Class B holders. Thus, Comcast is effectively powerless in Atairos, whereas Alphabet’s control remains firmly with its high‑voting shareholders despite the share‑repurchase program.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: Comcast has no voting rights in Atairos, only consent rights, and lacks control despite a $1.4 billion unfunded commitment. Alphabet maintains a dual-class structure with Class B shares having 10 votes, and repurchased $62.0 billion in Class A and C shares in 2024. The LLM correctly notes that these repurchases reduce public float without diluting control. (2) Quantitative accuracy is perfect: the $1.4 billion commitment and $62.0 billion repurchase are correctly cited (implied from context, though the exact dollar amount for Alphabet’s repurchases is not explicitly repeated in the LLM answer, it is accurately referenced as 'large repurchases' and aligns with the ground truth). The absence of the exact $62.0B figure is a minor omission but does not detract from factual correctness given the qualitative emphasis. (3) Multi-hop reasoning is sound: the model correctly contrasts Comcast’s lack of control in an external investment with Alphabet’s internal governance structure and how share repurchases in lower-vote classes reinforce control. (4) The answer is contextually relevant and directly addresses the comparison in control implications. The only reason for not scoring a 10 is the slight omission of the exact $62.0 billion figure, though the magnitude is implied. Wording differences are semantically equivalent and acceptable.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 404,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How does the extension of reference rate reform accounting relief under ASU 2022-06 impact the transition timelines for both UPS and FedEx, given that UPS had already transitioned its affected debt to SOFR by December 31, 2023, while FedEx continued monitoring its contracts through May 31, 2024?",
      "original_answer": "The deferral of the sunset date of ASU 2020-04 from December 31, 2022, to December 31, 2024, via ASU 2022-06, allowed both UPS and FedEx to extend their evaluation and application of reference rate reform accounting relief. UPS had already transitioned its affected debt instruments and contracts to SOFR by December 31, 2023, and did not elect to apply the practical expedients under Topic 848, but continued to assess potential impacts through 2024. FedEx, on the other hand, had not experienced any material effect from reference rate reform as of May 31, 2024, and continued to monitor its contracts and transactions for potential application of ASUs 2020-04 and 2022-06. The extension provided FedEx additional time to evaluate whether to apply the optional expedients, while UPS used the period to ensure full alignment with the new rates and assess any residual effects.",
      "llm_answer": "The ASU 2022‑06 relief now remains available through December 31, 2024. UPS had already completed its LIBOR‑to‑SOFR conversion on all affected debt by December 31, 2023, so the extension does not alter UPS’s timeline. FedEx, however, was still evaluating contracts as of May 31, 2024; the extended relief gives FedEx up to the end of 2024 to finish any needed transitions without having to accelerate the change.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all dates and timelines are accurate: ASU 2022-06 extends relief to December 31, 2024; UPS completed transition by December 31, 2023; FedEx was still evaluating as of May 31, 2024. These match the original answer exactly. (2) The answer correctly identifies that the extension does not alter UPS’s timeline since transition was already complete, which is consistent with the ground truth stating UPS did not elect Topic 848 expedients but continued assessment. (3) For FedEx, the LLM correctly notes the extension provides additional time to evaluate transitions, which matches the original answer’s point about continued monitoring and potential application of ASUs 2020-04 and 2022-06. (4) However, the LLM omits key qualitative details: it does not mention that UPS continued to assess potential residual impacts through 2024, nor that FedEx had not experienced any material effect from reference rate reform. It also fails to specify that the relief in ASU 2022-06 amends ASU 2020-04 (sunset date change), which is a multi-hop element present in the original. While the core facts and reasoning are sound, these omissions reduce completeness and depth of synthesis, preventing a perfect score. Semantically, the answer captures the main implications for both companies accurately and is contextually fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 389,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How does PepsiCo's beverage revenue concentration in Africa, Middle East, and South Asia (29% in 2023) compare with Target's beverage sales geographic exposure, given that Target's merchandise segments only describe domestic operations in the U.S.?",
      "original_answer": "PepsiCo generated 29% of its beverage revenue from the Africa, Middle East, and South Asia (AMESA) region in 2023, indicating a significant international presence in this sector. In contrast, Target's 2023 10-K filing only describes its beverage offerings as part of grocery sales within its U.S. operations, with no mention of international retail presence or beverage sales outside the United States. This suggests that Target's beverage sales are entirely domestic, while PepsiCo maintains a substantial international footprint in beverages, particularly in the AMESA region.",
      "llm_answer": "PepsiCo’s 2023 results show that the AMESA (Africa, Middle East and South Asia) division generated **29 % of its net revenue from beverages**【page_72】. In contrast, Target’s 10‑K lists its beverage sales only within its U.S.‑focused merchandise categories (food and beverage, apparel, etc.) and does not break out any overseas exposure, indicating that Target’s beverage revenue is essentially **domestic‑only**【page_47】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that PepsiCo generated 29% of its beverage revenue from the AMESA region in 2023, matching the ground truth. It also accurately notes that Target’s 10-K only describes beverage sales within U.S. operations, with no international breakdown, leading to the conclusion that Target’s beverage sales are domestic-only. All factual elements are correct. (2) Quantitatively, the 29% figure is accurately reported, and no incorrect calculations are made. The year 2023 is correctly referenced. Format variations (e.g., '29 %' vs '29%') are minor and acceptable. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from PepsiCo’s international revenue exposure and Target’s domestic-only reporting to draw a valid comparison. The only minor shortcoming is that the LLM says '29% of its net revenue from beverages' which could be slightly clearer as '29% of its beverage revenue'—though contextually it's clear and likely a rephrasing rather than error. (4) The answer is highly relevant, directly addressing the comparison of geographic exposure in beverage sales between the two companies. The inclusion of citation placeholders 【page_72】 and 【page_47】 suggests source grounding, though not required, adds credibility. Overall, the answer is factually accurate, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 386,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How does the absence of the Countercyclical Capital Buffer impact the minimum capital requirements for SCHW compared to GS's TLAC to RWAs requirement, given both are subject to multi-layered regulatory buffers?",
      "original_answer": "For SCHW, the absence of the Countercyclical Capital Buffer (which was set to zero) still results in a minimum Common Equity Tier 1 Risk-Based Capital ratio of 7.0%, Tier 1 Risk-Based Capital ratio of 8.5%, and Total Risk-Based Capital ratio of 10.5%, inclusive of other buffers like the 2.5% stress capital buffer. For GS, the TLAC to RWAs requirement includes a 18% minimum, a 2.5% buffer, and also incorporates the Countercyclical Capital Buffer (also set to zero), along with a 1.5% G-SIB surcharge. Therefore, even without the Countercyclical Capital Buffer, both firms face layered capital requirements, but GS's baseline (18%) is significantly higher due to its global systemic importance and TLAC framework.",
      "llm_answer": "Schwab’s capital rules include a 2.5 % capital‑conservation buffer and a 2.5 % stress‑capital buffer, but the counter‑cyclical capital buffer is **zero** (page 118). Because the buffer is zero, Schwab’s minimum regulatory ratios are simply the regulatory minimum plus the two fixed buffers – 7.0 % CET1, 8.5 % Tier 1 and 10.5 % total risk‑based capital (page 118).\n\nGoldman Sachs’ TLAC‑to‑RWAs requirement is set at **22 %** (page 93). The TLAC calculation explicitly includes the 18 % TLAC minimum, a 2.5 % buffer, a 1.5 % G‑SIB surcharge and a **0 % counter‑cyclical buffer** (page 93). Thus, the absence of a counter‑cyclical buffer does not add to either firm’s requirement, but Schwab’s minimum capital ratios (≈7‑10.5 %) are far lower than Goldman Sachs’ TLAC‑to‑RWAs floor of 22 % because TLAC incorporates additional buffers (minimum, capital‑conservation and G‑SIB surcharge) that Schwab does not need to meet.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in reasoning and structure but contains a critical quantitative error: it states that Goldman Sachs' TLAC-to-RWAs requirement is 22%, while the ground truth indicates the requirement is 18% minimum plus buffers (2.5% + 1.5% + 0% CCyB), totaling 22% only if summed, but the baseline minimum is 18%, not 22%. The LLM incorrectly presents 22% as the 'TLAC-to-RWAs requirement' without clarifying that this is the total including buffers, whereas the original answer correctly distinguishes the 18% minimum from the additional buffers. This misrepresents the regulatory baseline. However, the explanation of Schwab’s capital ratios (7.0%, 8.5%, 10.5%) is accurate and correctly attributes the absence of the CCyB buffer (set to zero) to both firms. The reasoning correctly identifies that both firms are subject to layered buffers and that GS faces higher requirements due to TLAC and G-SIB surcharge. Entity names (SCHW, GS), metrics (CET1, Tier 1, TLAC, RWAs), and buffer types are correctly identified. The multi-hop synthesis—comparing SCHW’s capital framework to GS’s TLAC under the absence of CCyB—is logically sound and contextually relevant. Wording differences are acceptable under semantic equivalence, but the numerical misstatement of GS’s TLAC minimum as 22% instead of 18% (with total being 22% post-buffers) is a significant factual deviation, reducing quantitative accuracy. Hence, correctness is reduced to 7 due to this key miscalculation risk, though core logic and most facts are sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 419,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does Dalton's $5.3 million reimbursement from Georgia Power for Plant Vogtle construction reflect its involvement in self-owned generation facilities, and how does this ownership model contrast with NEE's approach to revenue generation through long-term contracts covering 94% of its capacity?",
      "original_answer": "Dalton receives $5.3 million in reimbursements from Georgia Power for its share of Plant Vogtle Units 3 and 4 construction costs, indicating its partial ownership stake in this nuclear generation facility. This aligns with Dalton’s broader strategy of serving its energy requirements through self-owned generation assets, some of which are jointly owned with Georgia Power. In contrast, NEE generates revenue by contracting 94% of its net generating capacity under long-term bilateral agreements, focusing on full-output commitments rather than joint ownership of facilities. This highlights a structural difference: Dalton participates in shared infrastructure ownership to meet its load needs, while NEE monetizes its generation assets through extensive contractual commitments in competitive markets.",
      "llm_answer": "Dalton, which serves MEAG Power’s load from self‑owned generation assets (including facilities it co‑owns with Georgia Power), is a participant in the Vogtle joint‑ownership structure; under that arrangement Georgia Power is reimbursing Dalton $5.3 million for its share of Plant Vogtle‑3/4 construction costs (see SO 10‑K p. 189 and the description of Dalton’s self‑owned generation on p. 17). In contrast, NextEra Energy (NEER) does not rely on such cost‑sharing ownership – about 94 % of its net generating capacity is already contracted out under long‑term power purchase agreements, so its revenue comes from fixed‑price contracts rather than from owning and being reimbursed for specific plant construction (see NEE 10‑K p. 19).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers are correct: the $5.3 million reimbursement and the 94% of net generating capacity under long-term contracts are accurately reported. Format variations (e.g., $5.3 million) are acceptable and semantically equivalent. (2) The answer correctly identifies the entities: Dalton, Georgia Power, and NextEra Energy (NEE, referenced as NEER, a minor ticker variation but contextually clear). The reference to MEAG Power is an additional contextual detail not in the original but factually consistent and enhances accuracy. (3) Multi-hop reasoning is sound: the model correctly links Dalton’s reimbursement to its co-ownership in Plant Vogtle, connects this to its self-owned generation strategy, and contrasts it with NEE’s revenue model based on long-term contracts rather than cost-sharing ownership. (4) The only minor shortcoming is the use of 'NEER' instead of 'NEE'—a ticker inaccuracy—but given the clear reference to NextEra Energy and correct contextual usage, this does not impair understanding. The explanation of revenue models and ownership structures is semantically equivalent to the ground truth. All parts of the question are addressed with strong synthesis across entities and documents. Thus, the answer earns a 9/10 for correctness, with full marks for quantitative accuracy and contextual relevance, and a 9 for qualitative accuracy due to the minor ticker discrepancy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 413,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How do RTX and BA differ in their approaches to managing customer financing obligations, particularly regarding RTX's $7.0 billion in credit facilities versus BA's long-term lease structures?",
      "original_answer": "RTX manages its customer financing obligations by leveraging its strong liquidity position, including $7.0 billion in available credit facilities, which provides flexibility for funding such obligations without relying on short-term commercial paper borrowings. In contrast, BA structures its customer financing through long-term lease arrangements, with terms ranging from 1 to 12 years, often including options to extend, terminate, or purchase the underlying asset. These lease-based financing strategies reflect BA's capital-intensive model, particularly in its BCC segment, and are accounted for under operating or finance leases, impacting both asset and liability balances on its balance sheet. The differing approaches highlight RTX's reliance on liquidity buffers versus BA's use of extended lease terms to manage financing commitments.",
      "llm_answer": "RTX keeps its customer‑financing capacity in a traditional liquidity pool – it maintains revolving credit facilities of up to $7 billion (a $5 billion revolving line plus a $2 billion supplemental line) that it can draw on if needed, although none of the facilities were outstanding at year‑end 2021【page_52】.  \n\nBoeing, by contrast, embeds financing directly in its sales‑type/finance and operating lease programs; it offers 1‑ to 12‑year lease contracts that include residual‑value guarantees and lease‑payment schedules, records the leased aircraft as assets and the corresponding lease obligations as liabilities, and generates lease income from these long‑term structures【page_93】【page_94】.  \n\nThus, RTX relies on external credit lines to meet financing needs, while Boeing manages customer financing through structured lease arrangements that are part of its core operating model.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: RTX's $7.0 billion in credit facilities is accurately broken down into a $5 billion revolving line and $2 billion supplemental line, consistent with the source. The absence of outstanding balances at year-end 2021 is an additional detail not in the original answer but does not contradict it. Boeing’s lease terms (1–12 years) match exactly. (2) The LLM correctly identifies the two companies (RTX and BA/Boeing), relevant financial structures (credit facilities vs. lease arrangements), and appropriate accounting treatments (recording leased assets and liabilities). (3) Multi-hop reasoning is sound: the model synthesizes RTX’s liquidity-based approach with Boeing’s embedded lease financing model, contrasting external credit reliance versus operational integration of financing. (4) Semantically, the core message matches the original: RTX uses available credit capacity for flexibility, while Boeing uses long-term leases as part of its business model, impacting balance sheet items. The only minor gap is that the LLM does not explicitly mention 'residual value guarantees' as a feature of Boeing’s leases being part of customer financing obligations, nor does it reference the BCC segment or differentiate operating vs. finance leases in depth—details present in the original. However, these omissions do not undermine the overall correctness. Wording differs slightly but meaning is preserved. Contextual relevance is excellent, directly addressing the comparative financing strategies asked in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 446,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How do Coca-Cola and Philip Morris differ in their application of weighted-average assumptions within their financial reporting frameworks?",
      "original_answer": "Coca-Cola uses the Black-Scholes-Merton option-pricing model to estimate the fair value of stock option awards, with the weighted-average assumptions applied specifically to these stock options granted during the years ended December 31, 2023, 2022, and 2021. In contrast, Philip Morris applies weighted-average assumptions to determine net pension and postretirement healthcare costs, which is a different financial reporting framework focused on employee benefits beyond stock compensation. The difference in application highlights how the same accounting methodology is used for distinct compensation components—equity-based incentives at Coca-Cola versus retirement and healthcare liabilities at Philip Morris.",
      "llm_answer": "Coca‑Cola’s 10‑K shows that its “weighted‑average” inputs are used mainly in stock‑based compensation – the company reports a weighted‑average dividend yield, expected volatility, risk‑free rate and option term that feed the Black‑Scholes‑Merton model for valuing stock options (page 95), and it also applies a weighted‑average amortisation period of 1.7 years to unvested stock‑based compensation expense (page 94).  \n\nPhilip Morris, by contrast, uses weighted‑average assumptions in its pension and post‑retirement cost calculations – discount rates, expected return on plan assets, compensation‑increase rates, etc., are presented as weighted‑average assumptions (page 122) – and it applies a weighted‑average performance‑cycle length (about 17 months) to recognize PSU award costs and to compute weighted‑average share counts for EPS (page 112).  \n\nThus, Coca‑Cola’s weighted‑average assumptions focus on option‑valuation and compensation‑amortisation, while Philip Morris applies weighted‑average assumptions to pension/post‑retirement costing and to the timing of performance‑share expense recognition.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. It correctly identifies that Coca-Cola applies weighted-average assumptions primarily in the context of stock-based compensation, specifically using the Black-Scholes-Merton model with inputs like expected volatility, risk-free rate, and dividend yield (matching the original answer). It also accurately notes the weighted-average amortization period for unvested awards, which adds detail beyond the ground truth but remains correct and relevant. For Philip Morris, the LLM correctly states that weighted-average assumptions are used in pension and post-retirement cost calculations, citing discount rates, expected return on assets, and compensation-increase rates—consistent with the original answer. It further enriches the response by mentioning the weighted-average performance-cycle length for PSU awards and EPS calculations, which is factually sound and contextually appropriate. All entities (Coca-Cola, Philip Morris), financial frameworks (stock compensation vs. pension/retirement), and models (Black-Scholes-Merton) are correctly identified. The reasoning is sound, demonstrating multi-hop synthesis across different compensation components and reporting frameworks. Minor deduction in quantitative accuracy is due to inclusion of specific page numbers and a 1.7-year amortization period not present in the ground truth; while plausible and likely correct based on actual filings, they cannot be verified from the provided truth. However, these details do not contradict the original answer and enhance precision without introducing error. Semantic equivalence is strong, and the core contrast—Coca-Cola focusing on equity valuation, Philip Morris on retirement benefits and performance-share timing—is fully preserved and well-articulated.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 493,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does the expiration timeline of regulatory exclusivity for Merck's Januvia family of products compare to Gilead's U.S. regulatory exclusivity expiration in 2032, and what impact might this have on their respective market positions given the role of exclusivity in delaying generic competition?",
      "original_answer": "Merck's Januvia family of products is expected to lose U.S. market exclusivity in May 2026 (Januvia and Janumet) and July 2026 (Janumet XR), while Gilead has a U.S. regulatory exclusivity that expires in 2032. According to the evidence, regulatory exclusivity provides a period during which generic competitors cannot rely on the innovator’s data for approval, thus delaying market entry of generics. Since Gilead benefits from a significantly longer exclusivity period, it may maintain a more protected market position through 2032, whereas Merck will face substantial sales declines starting in 2026 due to generic competition and pricing pressures, as seen in other markets post-expiry.",
      "llm_answer": "Merck’s Januvia/Janumet family is expected to lose U.S. market exclusivity in **May 2026 (Januvia/Janumet) and July 2026 (Janumet XR)**, after the later‑expiring sitagliptin‑salt patent runs out【page_58†L31-L38】. Gilead’s disclosed product retains **U.S. regulatory exclusivity until 2032**【page_8†L31-L33】—about six years longer than Merck’s protection. Because exclusivity blocks generic approval, Merck will face generic competition and likely sales decline starting in 2026, whereas Gilead can continue to enjoy protected pricing and market share through 2032, giving it a stronger near‑term market position.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Merck's Januvia/Janumet exclusivity ends in May 2026, Janumet XR in July 2026, and Gilead's U.S. regulatory exclusivity expires in 2032—consistent with the original answer. The six-year difference in protection periods is correctly implied. (2) Quantitative accuracy is perfect: dates (May 2026, July 2026, 2032) match exactly; no calculations are required beyond the comparison, which is accurately described as 'about six years longer.' (3) Multi-hop reasoning is sound: the model correctly synthesizes information across Merck and Gilead, compares their exclusivity timelines, and draws a logical conclusion about market position based on the role of exclusivity in delaying generics. (4) The explanation of impact—Merck facing generic competition and sales decline from 2026, while Gilead maintains protected pricing and market share through 2032—is fully aligned with the original answer. Wording differs slightly but meaning is preserved. Citations (e.g., page references) add support without affecting correctness. All evaluation criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 335,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How does Intel's amortization expense for developed technology used in cybersecurity compare with Cisco's revenue recognition timing for its cloud security offerings?",
      "original_answer": "Intel reported $1,283 million in amortization expenses for developed technology in 2021, which includes technology used for cybersecurity solutions like cloud security. Cisco recognizes revenue for its cloud security offerings ratably over the contract term, aligning with the ongoing delivery of updates and upgrades critical to the software’s performance. This contrasts with Intel’s cost recognition pattern, where developed technology is amortized over a 9-year weighted average useful life, reflecting a more fixed cost structure compared to Cisco’s recurring revenue model.",
      "llm_answer": "Intel records roughly **$1.3 billion of amortization expense** for its developed‑technology intangible assets (the “Developed technology” line shows $1,283 million for the year ended Dec 25 2021).  \n\nCisco, by contrast, does **not amortize a similar asset**; instead it treats the cloud‑security portion of its End‑to‑End Security offering as a SaaS performance obligation and **recognizes the related revenue ratably over the contract term** (i.e., over time rather than upfront).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the amortization expense of $1,283 million (rounded to $1.3 billion) for Intel in 2021 is correctly reported, matching the original answer. The date (year ended Dec 25, 2021) is precise and consistent with the knowledge graph. (2) The qualitative explanation correctly contrasts Intel’s amortization of developed technology — a cost recognition pattern over time (implied 9-year useful life, though not explicitly stated here) — with Cisco’s revenue recognition for cloud security offerings as SaaS, recognized ratably over the contract term. This captures the core comparison in cost vs. revenue timing models. (3) Multi-hop reasoning is sound: the model correctly synthesizes Intel’s intangible asset amortization (a cost-side item) with Cisco’s revenue recognition policy (a revenue-side item), even though they are different financial statement elements, and draws a meaningful contrast in timing and business model implications. (4) Minor deduction in qualitative accuracy because the LLM omits the explicit mention of the 9-year weighted average useful life, which adds context to Intel’s amortization pattern. However, the core contrast — fixed cost amortization vs. recurring revenue recognition — is clearly and correctly conveyed. Wording differs but semantic meaning is equivalent. All entities (Intel, Cisco, developed technology, cloud security, 2021) are correct. No irrelevant or incorrect information is introduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 417,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has the adoption of ASU 2022-02 affected MET's loan modification disclosures compared to JPM's reporting under the legacy TDR guidance, particularly in terms of the types and financial impact of modifications made to borrowers experiencing financial difficulty?",
      "original_answer": "MET adopted ASU 2022-02 on January 1, 2023, which eliminated the TDR accounting framework and introduced the concept of Financial Difficulty Modifications (FDMs), requiring expanded disclosures. MET reported that the adoption did not have a material impact on its financial statements, but it now discloses FDMs instead of TDRs. JPM, under the legacy TDR guidance prior to 2023, reported $362 million in new TDRs for 2022, with modifications typically involving interest rate reductions, term extensions, and payment delays. In 2023, under FDM reporting, JPM noted $136 million in FDMs, predominantly term extensions and rate reductions, which extended the weighted-average life of loans by 20 years and reduced the weighted-average interest rate from 7.21% to 4.44%. This shift reflects a more principles-based approach under ASU 2022-02, focusing on financial difficulty rather than concession-based criteria, resulting in more consistent and transparent reporting of loan modifications across both institutions.",
      "llm_answer": "- **MetLife (MET)** – After adopting ASU 2022‑02, MetLife now reports “financial‑difficulty modifications” (FDMs) with quantitative detail. For 2023 it disclosed $136 million of residential‑real‑estate FDMs, principally term extensions and interest‑rate reductions that lengthened the weighted‑average loan life by about 20 years and cut the weighted‑average contractual rate from 7.21 % to 4.44 %. It also listed $69 million of trial‑modifications and $9 million of Chapter 7 loans (treated as TDRs, not FDMs) (see MET pages 245‑247).  \n\n- **JPMorgan Chase (JPM)** – Under the legacy TDR guidance, JPM’s 2023 filing simply states that auto and other loan modifications granted to borrowers in financial difficulty were reported as FDMs after 1 Jan 2023 but were “not material” and that prior‑period TDRs were also “not material,” providing no dollar‑amount or breakdown of the types of concessions (see JPM pages 247‑248).  \n\n**Result:** MetLife’s new ASU 2022‑02 framework yields a detailed disclosure of the amount, types (rate cuts, extensions, principal reductions) and financial effect of the modifications, whereas JPMorgan’s legacy TDR reporting offers only a qualitative statement that the modifications were immaterial, with no quantitative impact disclosed.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the attribution of quantitative data. The ground truth states that JPM reported $136 million in FDMs in 2023 with specific financial impacts (20-year extension, rate drop from 7.21% to 4.44%), but the LLM incorrectly attributes these figures to MET, claiming MET disclosed $136 million in residential real estate FDMs with those exact metrics. This is a critical error. Additionally, the LLM claims MET disclosed $69 million in trial modifications and $9 million in Chapter 7 loans, which are not mentioned in the original answer and appear to be fabricated or misattributed. Conversely, the ground truth states that MET’s adoption of ASU 2022-02 had no material impact, but the LLM implies materiality by providing detailed numbers. For JPM, the LLM incorrectly states that modifications were 'not material' and no dollar amounts were provided, whereas the ground truth explicitly states JPM reported $362 million in TDRs for 2022 and $136 million in FDMs in 2023 with detailed impacts. (2) Quantitative accuracy is low: the $136 million figure, 20-year extension, and rate reduction from 7.21% to 4.44% belong to JPM’s 2023 FDM reporting, not MET. The LLM reverses the entities for key data points. The $362 million in 2022 TDRs for JPM is entirely omitted. (3) Multi-hop reasoning is flawed: the model fails to correctly synthesize across the two companies and time periods. It misattributes JPM’s post-adoption FDM data to MET and omits JPM’s pre- and post-adoption quantitative disclosures. The comparison between MET’s detailed reporting and JPM’s lack of detail is factually incorrect because it is JPM that provided the detailed FDM numbers in the ground truth. (4) Contextual relevance is high because the structure and intent align with the question—comparing disclosure changes under ASU 2022-02 vs. legacy TDR—but factual correctness undermines the response. The qualitative reasoning about improved transparency under ASU 2022-02 is sound in concept but unsupported by the misattributed data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1600,
        "completion_tokens": 562,
        "total_tokens": 2162
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How does CVX's upstream position in South American natural gas reserves compare with XOM's downstream footprint across the broader Americas region?",
      "original_answer": "CVX reported 329 billion cubic feet of natural gas reserves in South America as of December 31, 2022, reflecting its upstream exposure in the region. South America is geographically included within the broader 'Americas' reporting segment, which encompasses both North and South America. XOM maintains a large downstream presence across the Americas, with integrated refining, marketing, and logistics operations focused on delivering refined products like gasoline, diesel, and synthetic motor oils. While CVX's position centers on upstream resource extraction in South America, XOM's downstream operations span the entire Americas region, highlighting complementary but distinct strategic focuses within the energy value chain.",
      "llm_answer": "Chevron’s upstream portfolio includes roughly 455 billion cubic feet of proved natural‑gas reserves in “Other Americas” – i.e., South America – at year‑end 2021 (see CVX 10‑K page 108). In contrast, ExxonMobil’s downstream business is described as one of the largest and most integrated among IOCs, with a well‑established refining, logistics, trading and marketing footprint that spans the entire Americas region (both North and South America) (see XOM 10‑K page 63). Thus, Chevron’s South‑American presence is measured mainly by a specific upstream gas‑reserve volume, whereas ExxonMobil’s presence is a broad, integrated downstream network covering the whole Americas.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant quantitative inaccuracy: it reports CVX's South American natural gas reserves as 455 billion cubic feet as of year-end 2021, while the ground truth states 329 billion cubic feet as of December 31, 2022. This is a material discrepancy in both volume and reporting year. Additionally, the LLM cites 'Other Americas' as referring to South America, which may be contextually accurate, but the number and year do not align with the verified data. (2) The quantitative accuracy is compromised due to the incorrect reserve volume (455 vs 329 Bcf) and outdated year (2021 vs 2022). Even allowing for format flexibility, the numbers are factually inconsistent with the ground truth. No calculations were required, but the core metric is wrong. (3) The qualitative reasoning is sound: the LLM correctly identifies CVX’s upstream focus in South America and contrasts it with XOM’s integrated downstream footprint across the broader Americas. It accurately characterizes the strategic distinction in business segments and regions, citing appropriate sections of the 10-Ks (page 108 for CVX, page 63 for XOM), which supports the reasoning. (4) Contextual relevance is high—the answer directly addresses the comparison between CVX’s upstream reserves and XOM’s downstream operations across the Americas. Despite the factual error in numbers and dates, the conceptual framework and synthesis across companies and business segments are appropriate and well-structured. The answer would score higher if not for the critical error in the reserve figure and reporting period.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 441,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does the $25 million commercial paper exposure of Duke Energy Ohio compare with Tesla's $470 million commercial paper holdings in terms of their short-term liquidity strategies?",
      "original_answer": "Duke Energy Ohio reports a $25 million commercial paper exposure as part of its short-term liabilities, reflecting its reliance on modest short-term borrowing for operational needs. In contrast, Tesla holds $470 million in commercial paper as part of its short-term investments, indicating a cash deployment strategy rather than a funding need. This comparison highlights two distinct uses of commercial paper: Duke Energy utilizes it as a financing tool, while Tesla treats it as an investment to optimize liquidity returns.",
      "llm_answer": "Duke Energy Ohio reports only $25 million of commercial‑paper borrowings (shown in the “Short‑Term Obligations Classified as Long‑Term Debt” table), a modest slice of its overall short‑term financing that it treats as readily refinancable under its broader credit facilities. In contrast, Tesla holds $470 million of commercial paper (listed with its cash, cash equivalents and short‑term investments), a much larger amount that forms a core component of its working‑capital liquidity pool. Thus, Duke Energy’s short‑term liquidity relies only lightly on commercial paper, while Tesla’s short‑term strategy depends more heavily on commercial‑paper funding.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly reports the quantitative figures: $25 million for Duke Energy Ohio and $470 million for Tesla, matching the ground truth exactly. Thus, quantitative accuracy is perfect. However, the qualitative interpretation contains a critical error: it mischaracterizes Tesla's $470 million commercial paper holding as part of its 'funding' or liquidity strategy, stating Tesla's strategy 'depends more heavily on commercial-paper funding.' This is incorrect. According to the ground truth, Tesla holds commercial paper as a short-term investment (i.e., it is deploying cash, not borrowing), whereas Duke Energy Ohio has commercial paper exposure as a liability (i.e., it is borrowing). The LLM confuses the directionality—Tesla is a buyer, not an issuer, of commercial paper. This misrepresents the core financial concept and leads to flawed reasoning in the comparison. While the answer addresses the question's structure and entities correctly (Duke Energy Ohio and Tesla), and is contextually relevant by discussing short-term liquidity strategies, the fundamental misunderstanding of Tesla's position undermines the validity of the conclusion. Therefore, while numerically accurate, the qualitative reasoning score is low due to this significant conceptual error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 356,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does the voting power structure of META's Class A common stock compare to GOOGL's Class B common stock in terms of shareholder influence, given the dual-class stock structures described in their filings?",
      "original_answer": "META's Class A common stock has limited voting power compared to its Class B common stock, where a single shareholder (Mr. Zuckerberg) retains significant control, with Class B shares requiring majority approval for change-in-control transactions until they represent less than 35% of combined voting power. In contrast, GOOGL's Class B common stock provides 10 votes per share, significantly more than the 1 vote per share for Class A, though Class B shares automatically convert to Class A upon sale or transfer. CMCSA's example shows a similar dual-class structure where Class A holds 66 2/3% of voting power with 1 vote per share and Class B holds 33 1/3% with 15 votes per share, illustrating a pattern of concentrated voting control in dual-class structures like those of META and GOOGL.",
      "llm_answer": "Alphabet’s (GOOGL) Class B shares carry ten votes per share, while its Class A shares carry one vote per share【page_81】. Meta’s Class A shares have the ordinary “one‑vote‑per‑share” rights, and the company’s dual‑class structure gives the small‑percentage Class B holder (Mr. Zuckerberg) control of the combined voting power, meaning Class A shareholders have far less influence per share than GOOGL’s ten‑vote Class B shares【page_50】. Thus, a Meta Class A holder’s voting power is comparable to a single‑vote stock, whereas a GOOGL Class B holder wields ten times that voting power, giving GOOGL’s Class B shareholders substantially greater shareholder influence.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: GOOGL's Class B shares have 10 votes per share vs. 1 for Class A, and META's Class A has 1 vote per share while Class B (held by Mr. Zuckerberg) has superior voting rights. These figures match the original answer. (2) The answer correctly identifies the entities (META, GOOGL) and their respective dual-class structures, with accurate descriptions of voting rights. (3) The reasoning is sound: it compares the relative influence of Class A shareholders at META versus GOOGL’s Class B shareholders, noting that GOOGL’s Class B has 10x voting power, which is a valid inference. (4) The LLM omits the specific detail about META’s Class B requiring majority approval for change-in-control transactions until below 35% voting power and does not mention CMCSA as an illustrative example from the ground truth. However, these are supplementary details; the core comparison between META Class A and GOOGL Class B voting power is correctly synthesized and conveyed. The answer focuses on shareholder influence as asked, and the conclusion that GOOGL’s Class B shareholders have substantially greater influence is supported. Minor omission but no factual errors—hence a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 359,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does the dividend structure for non-voting share classes at Mastercard and Charles Schwab impact the alignment of shareholder returns between voting and non-voting equity holders, given Mastercard's explicit distinction in dividend rights for B Class Shares and Charles Schwab's statement that dividend rights are identical across voting and nonvoting stock classes?",
      "original_answer": "At Mastercard, both A Class (voting) and B Class (non-voting) shares have dividend rights, indicating equal treatment in shareholder returns through dividends despite differences in voting power. In contrast, Charles Schwab explicitly states that dividend and liquidation rights are identical between its voting and nonvoting stock classes, ensuring full alignment in shareholder returns across share types. This means that while both companies provide dividend rights to non-voting shares, Charles Schwab maintains a stronger structural alignment in returns between share classes, whereas Mastercard preserves dividend parity but separates voting control.",
      "llm_answer": "Mastercard’s charter creates two common‑stock classes: Class A shares carry one vote **and** dividend rights, while Class B shares are non‑voting but are expressly granted the same dividend‑receiving rights (see Note 16, “Dividend and Voting Rights”). Thus, non‑voting B shareholders receive cash dividends on a per‑share basis that is comparable to voting A shareholders, aligning their economic returns even though they lack voting power. Charles Schwab, by contrast, states that “participation rights, including dividend and liquidation rights, are identical between the voting and non‑voting stock classes” (Consolidated Statements of Income note), so both classes are fully aligned on all shareholder‑return metrics.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) It correctly states that Mastercard's Class A (voting) and Class B (non-voting) shares have equal dividend rights, citing Note 16 as evidence, which matches the original answer's claim of dividend parity despite voting differences. (2) For Charles Schwab, the LLM accurately quotes the company's disclosure that dividend and liquidation rights are identical across share classes, reinforcing full alignment in shareholder returns. There are no numeric values requiring calculation, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies and compares their dividend structures in relation to shareholder return alignment. (4) The only minor shortcoming is that the LLM does not explicitly state that Charles Schwab's structure provides 'stronger structural alignment' than Mastercard's, though this is implied by the comparison. The absence of this evaluative phrase slightly reduces qualitative accuracy, but the factual basis for that conclusion is fully present. Wording differs slightly but maintains semantic equivalence. Contextual relevance is perfect—every part of the question is addressed directly and accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 357,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How might the implementation of the OECD's Pillar Two global minimum tax differently affect Microsoft's and Oracle's effective tax rates, given Microsoft's expectation of no material impact and Oracle's concern about materially increased international tax costs?",
      "original_answer": "Microsoft expects no material impact from the OECD's Pillar Two global minimum tax due to its current operations not being concentrated in jurisdictions with tax rates below the 15% threshold. In contrast, Oracle explicitly notes that the adoption of Pillar Two in many jurisdictions could materially increase its international tax costs. While both companies are subject to the same global regulatory framework, their differing geographic footprints and tax planning strategies appear to lead to divergent expectations about the financial impact of the new rules.",
      "llm_answer": "Microsoft says that because it has little exposure to jurisdictions whose statutory rates fall below the 15 % Pillar‑Two floor, the new rules are “not expected to materially increase our global tax costs,” so its effective tax rate should remain essentially unchanged. In contrast, Oracle notes that the OECD‑G20 two‑pillar framework – which many countries are already implementing – could “materially increase the level of income tax on our international profits,” implying that its effective tax rate could rise as the global minimum tax is applied to its foreign earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all key facts are correct: the 15% Pillar Two threshold is accurately cited, and there are no numerical inaccuracies. (2) The answer correctly identifies Microsoft's expectation of no material impact due to limited exposure to low-tax jurisdictions, and Oracle's concern about materially increased international tax costs—both aligning with the original answer. (3) The multi-hop reasoning is sound: it synthesizes company-specific disclosures to explain divergent impacts under the same global framework, correctly attributing differences to geographic footprint and tax exposure. (4) The only minor shortcoming is that the LLM does not explicitly mention 'effective tax rates' for both companies in direct comparative terms, though it implies this by discussing global tax cost impacts. Wording differs slightly (e.g., 'OECD-G20 two-pillar framework' vs 'Pillar Two'), but this does not affect factual accuracy. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 321,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How do GM's and LOW's applications of Level 3 valuation techniques differ in their financial reporting, particularly regarding the unobservable inputs and methodologies used for fair value measurements?",
      "original_answer": "GM utilizes Level 3 valuation techniques primarily for marketable debt securities and finance receivables, relying on pricing models, discounted cash flow models, and industry-standard pricing models with unobservable inputs such as economic forecasts, including unemployment rates, interest rate spreads, disposable personal income, and GDP growth rates. LOW, on the other hand, applies Level 3 valuation specifically to contingent consideration from the fiscal 2022 sale of its Canadian retail business, using an income approach with unobservable inputs like total equity value, volatility, and expected term. While both companies use Level 3 valuations, GM focuses on macroeconomic assumptions across a range of financial instruments, whereas LOW applies it to a specific long-term investment with performance-based metrics.",
      "llm_answer": "Lowe Companies’ only Level 3 fair‑value item is the performance‑based contingent consideration tied to the sale of its Canadian retail business.  It is measured with an **income‑approach option‑pricing model**, and the significant unobservable inputs are the total equity value of the sold business, the assumed volatility, the expected term of the consideration and a risk‑adjusted discount rate that reflects operating‑performance assumptions (LOW 10‑K p. 53).  \n\nGeneral Motors, by contrast, classifies a variety of assets – such as lease‑vehicle residual values, long‑lived‑asset groups and certain equity investments – as Level 3 and values them with **discounted‑cash‑flow or other model‑based techniques** that rely on management’s forecasts of cash flows, economic conditions, unemployment rates, interest‑rate spreads, GDP growth, etc. (GM 10‑K p. 63‑64).  Thus, Lowe’s Level 3 measurement is limited to a single contingent‑consideration item using an option‑pricing framework, whereas GM applies Level 3 models more broadly, using extensive unobservable economic and cash‑flow assumptions to estimate fair value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that LOW applies Level 3 valuation to contingent consideration from the sale of its Canadian retail business, while GM uses Level 3 for a broader set of assets including lease-vehicle residuals and equity investments. The unobservable inputs for each company are accurately described: LOW uses total equity value, volatility, expected term, and a risk-adjusted discount rate; GM uses macroeconomic forecasts like unemployment rates, interest-rate spreads, GDP growth, and cash flow projections. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in either the original or LLM answer that conflict—both correctly reference fiscal 2022 for LOW’s transaction (implied in context), and the LLM cites correct page numbers from the 10-Ks, which supports traceability. (3) The multi-hop reasoning is sound: the model correctly synthesizes differences in scope (single item vs. multiple assets), methodologies (option-pricing vs. discounted cash flow), and nature of unobservable inputs (performance-based vs. macroeconomic). (4) The only minor deviation from the original answer is that the LLM mentions 'lease-vehicle residual values' and 'long-lived-asset groups' for GM, which are not explicitly listed in the ground truth, though these are consistent with GM’s 10-K disclosures and do not contradict the core facts. The original emphasizes marketable debt securities and finance receivables, while the LLM broadens slightly—but accurately—to other Level 3 items. This does not reduce factual correctness but introduces a slight variation in emphasis, justifying a 9 instead of 10 on qualitative accuracy. Overall, the answer is factually correct, well-reasoned, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 489,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA influence the potential conversion dynamics of Class A shares, especially in light of Alphabet's aggressive share repurchase strategy involving Class A and Class C shares?",
      "original_answer": "At CMCSA, Class B common stock holds 33 1/3% of the voting power, with each share entitled to 15 votes, and this voting power is non-dilutable under the company's articles of incorporation. This structure creates a concentrated voting control that could influence decisions regarding potential conversions of Class A shares, as Class B shares can be converted share-for-share into Class A under certain restrictions. Meanwhile, Alphabet (GOOGL) has been actively repurchasing Class A and Class C shares, spending $62.2 billion in 2023 alone and maintaining $36.3 billion in remaining authorization as of year-end. This aggressive repurchase strategy could reduce the number of outstanding shares in similar classes, potentially increasing the proportional influence of remaining shareholders, including those holding voting shares like CMCSA's Class B. The combination suggests that while CMCSA's Class A shareholders may see increased influence through potential Class B conversion, GOOGL's repurchase activity could further concentrate ownership and influence within its own capital structure.",
      "llm_answer": "Comcast’s charter gives Class B shareholders a fixed one‑third of the company’s voting power (33 ⅓ % of all votes) and each Class B share carries many votes (10‑15 per share) 【page_91】. Because that voting block is “generally non‑dilutable,” any share‑for‑share conversion of Class B into Class A simply adds low‑vote Class A shares to the pool without reducing the 33 % voting stake held by Class B 【page_81】. Alphabet’s aggressive buy‑back of Class A (and Class C) shares—over $62 billion in 2023 and up to $70 billion still authorized—shrinks the outstanding low‑vote share base, so if a similar high‑vote class were convertible, conversion would become relatively more attractive for investors seeking liquidity, yet the high‑vote class would still retain its fixed voting proportion regardless of the repurchases.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the core structural elements: CMCSA's Class B shares hold 33 1/3% of voting power with 15 votes per share (though it says '10-15', which is slightly imprecise), and this voting power is non-dilutable. It accurately notes that Class B can be converted share-for-share into Class A, and that such conversion does not dilute the fixed voting proportion. It also correctly references Alphabet's $62.2 billion repurchase in 2023 (rounding to $62 billion is acceptable), though it overstates the remaining authorization by citing 'up to $70 billion' instead of the correct $36.3 billion. 2) Quantitative accuracy is mostly correct: $62 billion in 2023 repurchases is close enough to $62.2 billion, but the remaining authorization of $36.3 billion is significantly misrepresented as $70 billion, which is a material error. The 33 1/3% voting share and non-dilutable nature are correct. The '10-15 votes' phrasing is vague but within reasonable range of the true 15 votes per share. 3) The reasoning is strong: the LLM correctly synthesizes how CMCSA’s voting structure insulates Class B control even upon conversion, and how Alphabet’s repurchases of low-vote shares could make conversion more attractive while preserving voting concentration. It draws a logical parallel between the two companies’ capital structures, even if Alphabet is used as an illustrative contrast rather than a direct influencer. 4) Contextual relevance is excellent—the answer directly addresses the interplay between voting power, conversion dynamics, and share repurchases. The comparison to Alphabet is appropriately framed to highlight structural incentives. Despite the overstated remaining buyback authorization, the core multi-hop logic (CMCSA structure + GOOGL repurchases → implications for conversion and influence) is sound and semantically aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 508,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What is the difference in remaining securities available for future issuance under equity compensation plans between MDLZ and CL, based on their 2022 10-K disclosures?",
      "original_answer": "MDLZ reported 48,932,017 securities remaining available for future issuance under equity compensation plans, while CL reported 37,028,000 securities (in thousands). The difference between the two companies' remaining issuance capacity is 11,904,017 securities.",
      "llm_answer": "- Mondelez International (MDLZ) reported **48,932,017** shares remaining available for future issuance under its equity‑compensation plans (Item 12, Table – 2021 data)【page_140】.  \n- Colgate‑Palmolive (CL) reported **37,028 thousand** shares (i.e., 37,028,000 shares) remaining available for future issuance under its equity‑compensation plans (Item 12, Table – 2021 data)【page_61】.  \n\n**Difference:** MDLZ has about **11.9 million more** shares available for future issuance than CL (48.9 million – 37.0 million ≈ 11.9 million).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the remaining securities available for future issuance for both MDLZ (48,932,017) and CL (37,028,000), matching the ground truth. The difference is accurately approximated as 11.9 million, which aligns with the exact difference of 11,904,017. Minor rounding is acceptable and does not affect correctness. (2) All numeric values are correct: MDLZ's 48,932,017 and CL's 37,028,000 (converted properly from 'thousands') are accurately reported. The calculation 48,932,017 - 37,028,000 = 11,904,017 is correct, and the LLM's rounded version (11.9 million) is reasonable and semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly extracted data from two different 10-K filings (MDLZ and CL), identified the relevant metric under equity compensation plans, and synthesized the comparison. However, the LLM incorrectly references '2021 data' in both cases despite the question and ground truth being based on 2022 10-Ks, which is a factual error affecting qualitative accuracy slightly. (4) The answer is contextually fully relevant, addresses all parts of the question, and conveys the same information as the ground truth with appropriate rounding. The only issue is the incorrect year citation, which prevents a perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 362,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the impact of Illinois' Clean Energy Law on ComEd's transmission rate structure compare to Tesla's exposure to state-level regulatory challenges in markets with direct sales restrictions?",
      "original_answer": "Illinois' Clean Energy Law directly affects ComEd's transmission rate structure by requiring a new four-year multi-year plan to establish rates after the expiration of its performance-based distribution formula rate, and accelerating the amortization of ComEd's unprotected excess deferred income taxes over approximately 39.5 years. These regulatory changes introduce uncertainty around ComEd’s rate of return on equity, which is currently set at 11.50% with a 50-basis-point incentive adder as a RTO member. In contrast, Tesla faces state-level regulatory challenges related to its direct-to-consumer sales model, where certain U.S. states have laws interpreted to restrict its ability to sell vehicles through company-owned stores or obtain dealer licenses. While ComEd’s exposure centers on rate-setting mechanisms and compliance with decarbonization mandates, Tesla’s risk is tied to legal interpretations of motor vehicle industry laws and potential legislative pushback from dealer associations. Both face significant regulatory uncertainty, but the financial implications differ: ComEd’s are embedded in its cost recovery and capital structure, while Tesla’s affect its go-to-market strategy and expansion potential.",
      "llm_answer": "Illinois’ Clean Energy Law adds a new regulatory layer for ComEd – it obligates the utility to file a new multi‑year rate case and could trigger legal challenges that would alter the transmission‑formula revenue requirement, the allowed return on the transmission rate base and the timing of cost recovery. Tesla’s risk is of a different nature: state‑level statutes that restrict or prohibit its direct‑to‑consumer sales model expose the company to possible litigation, limits on the number of dealer licenses it can obtain and the loss of sales in those markets. Both represent state‑driven regulatory uncertainty, but the Illinois law affects ComEd’s rate‑setting and earnings‑return structure, while the dealer‑law restrictions threaten Tesla’s ability to sell vehicles and generate revenue.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its qualitative description of both ComEd's and Tesla's regulatory challenges, with no incorrect numbers or entities, earning a high score. (1) QUANTITATIVE ACCURACY: There are no explicit numerical values (e.g., 11.50% ROE, 50-basis-point adder, 39.5-year amortization) mentioned in the LLM answer, so it does not contradict any numbers from the ground truth. Since it avoids making claims about specific figures, it maintains full quantitative accuracy by not introducing errors. (2) COMPLETENESS: The LLM captures the core regulatory impacts on both ComEd and Tesla but omits specific details present in the ground truth, such as the expiration of the performance-based distribution formula rate, the four-year multi-year plan requirement, and the accelerated amortization of deferred income taxes over 39.5 years. It also does not mention ComEd’s 11.50% ROE with the 50-basis-point incentive adder. These omissions reduce completeness but do not invalidate the overall correctness. (3) ENTITY ACCURACY: All entities—ComEd, Tesla, Illinois’ Clean Energy Law, transmission rate structure, direct sales restrictions—are correctly identified and contextually used. (4) REASONING: The multi-hop reasoning is sound: the model correctly distinguishes between utility rate-setting regulation (ComEd) and auto sales regulatory barriers (Tesla), and synthesizes that both face state-level regulatory uncertainty but of different financial natures. (5) SEMANTIC EQUIVALENCE: While the LLM answer is more concise and less detailed than the original, it conveys the essential contrast accurately. The absence of specific financial and temporal metrics prevents a top score, but the reasoning and framing remain aligned with the ground truth. Thus, the answer is substantially correct but slightly less comprehensive.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 498,
        "total_tokens": 2015
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How will the IRA-driven Medicare Part D redesign, which imposes manufacturer discounts and price caps starting in 2025, affect the gross-to-net rebate accruals for both AMGN's ENBREL and BMY's Medicare Part D-dependent products, given AMGN's regulatory exposure and BMY's accounting for GTN adjustments based on payer channel mix and contract prices?",
      "original_answer": "The IRA-driven Medicare Part D redesign, which introduces manufacturer discounts and caps beneficiary out-of-pocket costs starting in 2025, will increase the gross-to-net (GTN) rebate accruals for both AMGN and BMY. For AMGN, the redesign compounds the impact of the set price for ENBREL starting in 2026, which is significantly lower than current pricing, and the potential inclusion of Otezla in the next round of Medicare price setting in 2027. This will likely reduce profitability and necessitate larger GTN adjustments. For BMY, which depends on Medicare Part D and accounts for GTN rebates using assumptions like payer channel mix and contract prices, the new obligations under the IRA will increase rebate liabilities, particularly in the catastrophic phase where manufacturers absorb more costs. The combined effect will be a material adverse impact on both companies' revenues and financial reporting accuracy, as they must adjust accruals to reflect the new regulatory environment and pricing pressures.",
      "llm_answer": "The IRA‑driven Medicare Part D redesign adds mandatory manufacturer discounts and a price‑cap that will begin to apply in 2025, so Amgen expects the required rebate on ENBREL to rise sharply – the lower CMS‑set price that starts on 1 Jan 2026 will increase the gross‑to‑net (GTN) liability for ENBREL and amplify the company’s regulatory exposure to the new Medicare pricing rules【page_36】.  Bristol‑Myers Squibb already accounts for GTN U.S. rebate accruals by applying “significant assumptions and judgments” that include the payer‑channel mix and current contract prices; the same IRA‑mandated discounts and caps will therefore push its GTN adjustments for all Medicare Part D‑dependent products higher, resulting in larger rebate accruals on its balance sheet【page_125】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the IRA-driven Medicare Part D redesign starts in 2025, with a CMS-set price for ENBREL beginning January 1, 2026 (consistent with '2026' in original answer), and BMY accounts for GTN rebates using assumptions like payer channel mix and contract prices. (2) Quantitative accuracy is excellent: dates (2025, 2026) are correct and match the original; no numerical values (e.g., dollar amounts, percentages) are misstated. Format variations are acceptable and semantically equivalent. (3) Multi-hop reasoning is sound: the LLM correctly links the IRA policy change to increased GTN accruals for both AMGN and BMY, recognizes AMGN’s regulatory exposure via ENBREL’s price setting, and understands BMY’s accounting methodology and how it will be impacted by higher rebate liabilities. (4) The only minor omission is the mention of Otezla’s potential inclusion in 2027 price setting for AMGN, which adds forward-looking exposure but is not central to the core impact on GTN accruals starting in 2025–2026. This does not undermine the overall correctness. The LLM captures the material adverse impact on both firms’ rebate accruals and financial reporting, even if not explicitly stating 'catastrophic phase' cost absorption for BMY—though the implication of higher liabilities is clearly conveyed. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is perfect: directly addresses all parts of the question with precise, focused information.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 432,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How do AIG's and MET's differing accounting treatments for structured securities impact the valuation and reporting of ABS & CLO assets in their respective financial statements?",
      "original_answer": "AIG applies the effective yield method to structured securities, recalculating yields based on expected cash flows and adjusting amortized cost accordingly, with changes in expected cash flows either charged or credited to net investment income. MET, on the other hand, classifies ABS & CLO as available-for-sale (AFS) and measures them at estimated fair value, including those valued using Level 3 inputs, which are disclosed in recurring fair value measurements. These differing approaches—AIG's yield-based adjustments versus MET's fair value measurement—result in different financial statement presentations and sensitivity to market changes, affecting how investors assess the valuation and risk profile of each company's structured securities portfolio.",
      "llm_answer": "- **AIG** treats its ABS‑ and CLO‑type securities as available‑for‑sale (AFS) fixed‑maturity assets.  They are carried at amortized cost and the effective‑yield model is used to update cash‑flow expectations; any unrealised gain or loss is recorded in a separate AOCI component (unless the fair‑value option is elected, in which case the change flows through net investment income).  \n\n- **MetLife** records the same types of structured securities at fair value on a recurring basis.  The assets are placed in the fair‑value hierarchy (mostly Level 3) and the fair‑value changes are reflected directly in the pension‑plan asset valuation and ultimately in earnings rather than in AOCI.  \n\nThus, AIG’s approach keeps most ABS/CLO valuation swings out of earnings (in AOCI), while MetLife’s approach brings the fair‑value movements of those securities into earnings.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a significant factual error in the description of AIG's accounting treatment, which undermines the correctness of the multi-hop comparison. According to the ground truth, AIG applies the effective yield method to structured securities, adjusting amortized cost based on expected cash flows, with changes impacting net investment income. However, the LLM incorrectly states that AIG treats ABS/CLO as available-for-sale (AFS) and carries them at amortized cost with unrealized gains/losses going to AOCI—this contradicts the ground truth. AFS classification and AOCI treatment are characteristics of MET’s approach, not AIG’s. The LLM also introduces the fair-value option for AIG without grounding in the original answer, adding unsupported detail. In contrast, the description of MetLife’s approach is largely accurate: classifying ABS/CLO as fair value, using Level 3 inputs, and reflecting changes in earnings (via pension-plan assets) aligns with the ground truth. There are no numerical values to verify, so quantitative accuracy is scored as 10 by default. The reasoning is partially sound in contrasting two different accounting models, but the misattribution of AFS treatment to AIG breaks the validity of the comparison. The answer is contextually relevant and addresses the core question about differing impacts on valuation and reporting, but due to the key misrepresentation of AIG’s methodology, the qualitative and overall correctness scores are significantly reduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 412,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the percentage of Chevron's (CVX) reserves tied to production-sharing contracts (PSCs) compare with ExxonMobil's (XOM) operational exposure in Nigeria, given Nigeria's reliance on PSCs for deepwater offshore exploration and production?",
      "original_answer": "Chevron's (CVX) reserves tied to production-sharing contracts (PSCs) accounted for 8% of its consolidated reserves in 2021. ExxonMobil (XOM) operates in Nigeria, where deepwater offshore exploration and production are governed by PSCs with terms typically lasting 30 years, including a 10-year exploration period and a 20-year production period. This indicates that both companies are exposed to PSC frameworks, but while CVX quantifies its PSC exposure directly in terms of reserves, XOM's exposure in Nigeria is structural and long-term, embedded in the regulatory framework of a key operational region.",
      "llm_answer": "Chevron’s proved reserves that are tied to production‑sharing contracts amount to **about 8 % of its total proved reserves in 2021 (10 % in the prior two years)**【page_108】.  \n\nExxonMobil’s deep‑water offshore operations in Nigeria are **entirely conducted under production‑sharing contracts with the NNPC**, so its operational exposure in Nigeria is effectively **100 % of that country’s assets** (the filing notes that “exploration and production activities … are typically governed by production‑sharing contracts”【page_31】).  \n\nThus, Chevron’s PSC‑related reserves represent a modest single‑digit share of its portfolio, whereas ExxonMobil’s Nigerian exposure is fully dependent on PSCs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 8% figure for Chevron's PSC-tied reserves in 2021 is correct, and the additional context that it was 10% in the prior two years is a minor enhancement not contradicted by the original answer. The claim that ExxonMobil’s Nigerian operations are fully under PSCs is consistent with the original statement that exploration and production in Nigeria are 'typically governed by PSCs'—the LLM reasonably infers 100% exposure in that region, which is semantically aligned. (2) All numbers and dates are accurate; no calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes Chevron’s global reserve exposure (quantitative) with ExxonMobil’s operational structure in Nigeria (contextual), comparing both under the PSC framework. (4) The only minor gap is that the original emphasizes XOM’s exposure as 'structural and long-term' due to 30-year contract terms, which the LLM omits—this contextual nuance slightly reduces qualitative completeness but does not affect factual correctness. Overall, the answer is factually precise, relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 330,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How does Tesla's fixed share reservation under the 2019 Plan compare with HD's approach to stock appreciation rights in terms of long-term equity compensation flexibility, given Tesla's 49.0 million reserved shares and HD's forfeiture-adjusted vesting methodology?",
      "original_answer": "Tesla's 2019 Plan establishes a fixed reservation of 49.0 million shares for equity incentives including stock appreciation rights (SARs), indicating a structured long-term approach to compensation with defined capacity. In contrast, HD's SAR program incorporates estimated forfeitures into its compensation expense calculation and recognizes value on a straight-line basis as restrictions lapse, allowing for dynamic adjustment based on actual retention of talent. While both companies utilize SARs, Tesla's approach suggests greater predictability and constraint in equity issuance, whereas HD's method provides flexibility in response to workforce attrition and vesting outcomes.",
      "llm_answer": "Tesla’s 2019 Equity Incentive Plan sets aside a fixed pool of 49.0 million shares that can be issued for stock options, RSUs, SARs and other awards, so the amount of equity available for future grants is capped at that level. In contrast, Home Depot does not reserve a set number of shares for its SARs; instead, the SAR awards are accounted for on a forfeiture‑adjusted basis, meaning the number that actually vests (and could be settled in shares) fluctuates with employee turnover and other forfeitures, giving the company greater long‑term flexibility in managing its equity compensation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the 49.0 million share reservation for Tesla's 2019 Plan is correctly stated. No numerical errors are present. (2) The comparison between Tesla’s fixed share reservation and HD’s forfeiture-adjusted vesting methodology is accurately represented: Tesla has a capped pool, while HD adjusts based on actual forfeitures, leading to greater flexibility. (3) The multi-hop reasoning is sound—linking Tesla's fixed equity pool to predictability and constraint, and HD's dynamic adjustment to workforce attrition, correctly synthesizes the implications for long-term compensation flexibility. (4) Minor difference: the LLM does not explicitly mention HD's straight-line recognition of compensation expense, which is part of the ground truth and adds nuance to the accounting methodology. However, the core contrast in flexibility due to forfeiture adjustments is clearly and correctly communicated. Wording differs but semantic equivalence is strong. No irrelevant or incorrect information is introduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 313,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How does Chevron's financial exposure to Tengizchevroil in Kazakhstan, including its $4,500 million loan for the FGP/WPMP development, compare to ExxonMobil's reported long-lived asset value in Kazakhstan of $8,463 million as of 2021?",
      "original_answer": "Chevron holds a 50% equity stake in Tengizchevroil (TCO), which operates major oil fields in Kazakhstan, and has extended a $4,500 million loan to TCO specifically for the FGP/WPMP development. In 2021, Chevron's upstream earnings from TCO contributed positively to its income from equity affiliates. Meanwhile, ExxonMobil reported a total long-lived asset value in Kazakhstan of $8,463 million as of 2021. This suggests that while Chevron's exposure is primarily through equity investment and project-specific financing, ExxonMobil's presence is reflected in substantial asset holdings, indicating differing capital deployment strategies in the same geographic region.",
      "llm_answer": "Chevron’s equity investment in Tengizchevroil was $23.7 billion at year‑end 2021, and the company also carries a $4.5 billion loan to TCO for the FGP/WPMP development – a total exposure of roughly **$28 billion**. ExxonMobil’s long‑lived assets in Kazakhstan were reported at **$8.5 billion** for 2021. Thus, Chevron’s financial stake in Kazakhstan is more than three times the size of ExxonMobil’s reported long‑lived asset value there.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. The ground truth states that Chevron has a 50% equity stake in Tengizchevroil and provided a $4.5 billion loan, but it does not report Chevron's total equity investment as $23.7 billion. This figure is fabricated or misattributed and is not present in the original answer or implied by the knowledge graph. The $28 billion total exposure claim (sum of $23.7B + $4.5B) is therefore incorrect. ExxonMobil’s reported long-lived asset value of $8,463 million (~$8.5 billion) is accurately represented in the LLM answer, with acceptable rounding. (2) Quantitative accuracy fails on the Chevron equity investment number—no such figure appears in the ground truth. The $4.5 billion loan amount is correct (matching $4,500 million), and ExxonMobil’s $8.463 billion is correctly rounded to $8.5 billion. However, the erroneous $23.7 billion equity value invalidates the sum and comparison. (3) The multi-hop reasoning is partially sound—comparing Chevron’s exposure to ExxonMobil’s assets in Kazakhstan is appropriate—but the synthesis is based on a false premise. The conclusion that Chevron’s stake is 'more than three times' ExxonMobil’s is unsupported due to the incorrect total exposure. (4) Contextual relevance is high because the answer addresses the core comparison between Chevron and ExxonMobil in Kazakhstan and references the correct project (FGP/WPMP) and financial instruments (loan, long-lived assets). However, the severe quantitative error undermines correctness and qualitative accuracy, leading to a low overall score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 437,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How do Duke Energy's PPA negotiations for renewable facilities compare to Southern Power's PPA structures in wind facilities, particularly in terms of cash flow implications given Southern Power's utilization of production tax credits through 2024?",
      "original_answer": "Duke Energy negotiates PPAs as part of its commercial renewables strategy, where these agreements significantly influence the economic performance of its renewable energy VIEs. Southern Power, on the other hand, acts as a lessor in PPAs related to wind facilities, which are accounted for as operating leases with terms up to 25 years. These PPAs directly affect Southern Power's cash flows through lease income, which is further enhanced by production tax credits (PTCs) tied to the first 10 years of energy production from these wind facilities. Southern Power had approximately $0.8 billion in unutilized PTCs at the end of 2021, expected to be fully utilized by 2024. This creates a distinct cash flow dynamic: while Duke's PPAs are central to the performance of its consolidated VIEs, Southern Power's PPAs are structured to align with tax credit monetization strategies, directly shaping its lease income and tax equity partnership returns.",
      "llm_answer": "Duke Energy’s renewable projects are held in VIEs and the 2022 filing notes that the company’s primary role is to negotiate the PPAs and EPC contracts for those assets, but the agreements are not yet in place and therefore do not appear in the cash‑flow or lease‑income tables. In contrast, Southern Power’s wind facilities are already covered by PPAs that are accounted for as operating leases; the lease payments are largely variable and tied to the amount of electricity produced, and the wind PPAs also generate federal production‑tax‑credits (PTCs) for the first ten years of output. Because Southern Power expects to fully use those PTCs through 2024, the wind PPAs provide a material, near‑term cash‑flow benefit that Duke’s still‑negotiating PPAs have not yet delivered.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core distinctions between Duke Energy and Southern Power's PPA structures and their cash flow implications. (1) It correctly identifies that Duke Energy negotiates PPAs for VIEs but notes they are not yet in place (as of 2022), which aligns with the ground truth that these agreements influence VIE performance but are not yet active. (2) For Southern Power, it accurately states that wind PPAs are structured as operating leases with variable lease payments tied to production, and that PTCs apply for the first 10 years—this matches the ground truth. It also correctly notes Southern Power expects to fully utilize PTCs through 2024, which is consistent with the $0.8 billion unutilized credits at end-2021 being used by 2024. (3) The multi-hop reasoning is sound: it contrasts Duke’s pre-contract negotiation phase with Southern Power’s active lease income and PTC monetization, correctly inferring that Southern Power already realizes cash flow benefits while Duke does not yet. (4) The only minor shortcoming is that the LLM does not explicitly mention the $0.8 billion unutilized PTC figure from 2021, which is present in the ground truth—this omission prevents a perfect score but does not undermine the overall correctness. Wording differences (e.g., 'still-negotiating' vs 'not yet in place') are semantically equivalent. All entities, years, and financial mechanisms are correctly identified and synthesized. Thus, the answer is factually strong, contextually relevant, and logically coherent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 424,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How does LOW's receipt of additional shares through ASR agreements compare to HD's issuance of additional shares via dividend equivalents in deferred share awards for non-employee directors?",
      "original_answer": "LOW receives additional shares from third-party financial institutions as part of variable notional ASR agreements, where the final share delivery depends on the difference between the maximum notional amount paid and the final notional value of shares repurchased. In contrast, HD issues additional shares to non-employee directors through dividend equivalents that accrue on deferred shares and are paid out in stock upon termination of board service. While LOW's additional shares result from share repurchase efficiency, HD's additional shares are a structured compensation element tied to deferred share awards.",
      "llm_answer": "Lowe’s ASR agreements are structured so that the company pays the maximum notional amount up‑front, receives a block of its own stock, and then—when the final notional amount is lower—receives **additional shares** (plus a cash settlement) from the financing partner. In contrast, Home Depot’s deferred‑share awards for non‑employee directors accrue **dividend equivalents** that are settled by **issuing new shares** to those directors when the awards vest. Thus, Lowe’s ASRs bring shares into the company’s treasury, whereas Home Depot’s dividend‑equivalent payments create new shares that dilute existing shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly explains that LOW receives additional shares through ASR agreements due to the difference between the maximum notional amount paid and the final notional value, including receipt of extra shares and cash from the financial institution—this matches the original answer's description of variable notional ASRs and share repurchase efficiency. (2) It accurately describes HD's process: dividend equivalents accrue on deferred share awards and are settled in newly issued shares upon vesting/termination, which is consistent with the original answer’s characterization as a structured compensation element. (3) The multi-hop reasoning is sound—correctly contrasting LOW’s treasury share inflow (from repurchase efficiency) with HD’s share issuance (leading to dilution) demonstrates proper synthesis across two different companies, mechanisms, and financial implications. (4) All entities (LOW, HD, ASR, dividend equivalents, non-employee directors) are correctly identified and contextualized. The only minor shortcoming is that the LLM mentions a 'cash settlement' received by Lowe’s, which, while plausible in some ASR structures, is not explicitly stated in the ground truth and slightly extends beyond the provided information. However, this does not detract significantly from the overall correctness. No numerical inaccuracies exist—there are no specific numbers to verify, and qualitative descriptions are semantically equivalent. The answer is fully relevant and addresses both parts of the comparison question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 438,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How does Boeing's equity income from ULA in 2024 correlate with Lockheed Martin's commercial satellite launch revenue, given ULA's role in serving both government and commercial customers?",
      "original_answer": "Boeing reported equity income of $125 million from ULA in 2024, reflecting its stake in the joint venture. ULA, co-owned by Boeing and Lockheed Martin, provides expendable launch services to both the U.S. Government and commercial customers. Lockheed Martin’s Space segment includes revenue from commercial satellite launches facilitated through ULA. Additionally, Lockheed Martin reported $665 million in receivables from commercial customers as of December 31, 2024, which includes payments related to ULA’s commercial launch services. Therefore, Boeing’s equity income from ULA is directly tied to the revenue Lockheed Martin recognizes from commercial satellite launches via ULA’s dual customer base.",
      "llm_answer": "Boeing recorded **$125 million of equity‑method income from United Launch Alliance (ULA) in 2024** (its 50 % owned launch‑services joint venture)【page_42】.  \nLockheed Martin’s 10‑K does not break out a separate “commercial‑satellite‑launch” revenue line, but its Space segment’s results are driven in part by ULA’s launch services to both government and commercial customers. Thus, Boeing’s $125 million equity share reflects ULA’s overall earnings—including the commercial launch work that also underpins Lockheed’s commercial satellite‑launch activity—showing that both companies benefit from the same mixed government/commercial launch market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies Boeing's $125 million equity income from ULA in 2024, matching the ground truth exactly. It accurately notes ULA as a 50% owned joint venture between Boeing and Lockheed Martin, and correctly states that ULA serves both government and commercial customers. The LLM acknowledges that Lockheed Martin does not report a separate line item for commercial satellite launch revenue but correctly links ULA’s services to the Space segment’s performance, aligning with the original answer’s reasoning.\n\n2) All numeric values are accurate: $125 million is correctly cited with proper context (equity-method income, 2024, 50% ownership). No calculations are required, and the figure matches the ground truth. Format variations (e.g., $125 million vs $125 million) are acceptable and do not affect accuracy.\n\n3) The multi-hop reasoning is sound: the model connects Boeing’s equity income to ULA’s earnings, recognizes that those earnings stem from both government and commercial launches, and infers that Lockheed Martin benefits from the same revenue stream through its co-ownership and segment reporting. However, the LLM omits the specific detail from the ground truth that Lockheed Martin reported $665 million in receivables from commercial customers as of December 31, 2024, which includes payments related to ULA’s commercial launch services. This is a minor omission that slightly weakens completeness but does not invalidate the core logic.\n\n4) Despite the missing receivables detail, the LLM captures the essential correlation: Boeing’s equity income is tied to ULA’s overall profitability, which in turn is driven by commercial launch activity that also benefits Lockheed Martin. The answer is semantically equivalent in intent and factual core, with only a partial gap in completeness. Hence, a high score of 9 is justified—excellent accuracy with a minor shortfall in full multi-hop detail synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 523,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How does the loss of market exclusivity for LLY's pharmaceutical products, influenced by patent rights and regulatory data protection, compare to MRK's exposure to patent-related risks, particularly in light of the varying durations of exclusivity in major markets such as the U.S., Europe, and Japan?",
      "original_answer": "LLY faces a severe and rapid revenue decline when pharmaceutical products lose effective market exclusivity, which is often tied to patent expiration. However, LLY may retain exclusivity through later-expiring patents on formulations or methods of use, or through regulatory data protection, such as 12 years for biologics in the U.S., 10 years in Europe, and 8 years in Japan. This market exclusivity is determined by both patent rights and regulatory protections, as noted in the BMY evidence, which explains that patent coverage and data exclusivity (e.g., orphan drug exclusivity for 7 years or pediatric exclusivity for 6 months) are the two key determinants of exclusivity. MRK similarly depends on patent rights for market exclusivity and faces material adverse impacts if those rights are invalidated or circumvented. MRK frequently engages in patent litigation to defend its exclusivity, especially against generic manufacturers seeking to enter the market before patent expiration. Thus, both companies are highly exposed to patent-related risks, but LLY may have more nuanced opportunities to extend exclusivity through regulatory mechanisms, while MRK emphasizes legal defense of its patents as a core strategy.",
      "llm_answer": "Lilly’s 10‑K explains that the commercial life of its medicines is tied to two statutory “exclusivity” clocks – the patent term (which can be extended up to five years) and regulatory data‑protection periods that run 5 years in the United States, 10 years in Europe and 8 years in Japan (see LLY p.10).  When either of those clocks expires, generic or biosimilar competitors can enter, and even before that Lilly may lose protection if a patent is invalidated or a Paragraph IV challenge succeeds (LLY p.12).\n\nMerck’s filing flags the same fundamental risk – that its products rely on patents to secure market exclusivity and that any loss or invalidation of those patents (or compulsory‑license actions) would trigger a “significant and rapid loss of sales” (see MRK p.32‑33).  However, Merck’s discussion does not break out the statutory exclusivity lengths for the U.S., EU or Japan; it describes the exposure in broader terms, emphasizing the dependence on patent protection and the potential for generic competition to erode revenues.\n\nThus, while both companies face patent‑related loss of exclusivity, Lilly quantifies the exposure with specific data‑protection periods (5/10/8 years) and possible patent‑term extensions, whereas Merck’s risk narrative is more general, focusing on the consequences of any patent loss without detailing the exact exclusivity durations in each major market.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core concept that both LLY and MRK face significant risks from loss of market exclusivity due to patent expiration and generic competition, and correctly identifies that both rely on patent rights as a key mechanism for protection. It also correctly notes that LLY provides more detailed disclosures about regulatory data protection durations in major markets. However, there is a critical factual error in the quantitative accuracy: the LLM states that U.S. regulatory data protection is 5 years, but the ground truth specifies 12 years for biologics in the U.S., which is a major discrepancy. This error undermines the correctness of the comparison, especially since biologics are central to LLY’s portfolio. The LLM may be conflating small-molecule data exclusivity (5 years in the U.S.) with biologics (12 years), which is not clarified. Additionally, the ground truth highlights that LLY can extend exclusivity via formulation or method-of-use patents and mentions specific regulatory mechanisms like orphan drug (7 years) and pediatric exclusivity (6 months), which the LLM omits. The LLM correctly observes that MRK emphasizes broader patent risk without specifying regional exclusivity durations, aligning with the ground truth. While the reasoning structure is sound and contextually relevant, the significant error in U.S. data protection duration—central to the multi-hop comparison across markets—reduces the correctness score. Semantic equivalence is partially achieved, but key nuances in regulatory frameworks and exclusivity mechanisms are missing or incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1693,
        "completion_tokens": 437,
        "total_tokens": 2130
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How do the potential financial impacts of cyber intrusion-related compliance costs at Southern Company's nuclear facilities compare to Duke Energy's decommissioning trust fund funding risks given both companies' exposure to nuclear power plant operations?",
      "original_answer": "Southern Company highlights that cyber intrusions could result in increased nuclear licensing or compliance costs that are difficult to predict, particularly at its nuclear facilities where Alabama Power and Georgia Power hold ownership interests representing 26% and 28% of their total KWH generation in 2021, respectively. These compliance costs could rise unpredictably due to threats of cyber intrusions or physical attacks. Meanwhile, Duke Energy notes that a decline in the market value of assets in its Nuclear Decommissioning Trust Funds (NDTF) could increase funding requirements for decommissioning its nuclear plants. Both companies face distinct financial risks tied to nuclear power plant operations—Southern Company through potential cyber-related compliance costs and Duke Energy through market-dependent decommissioning funding obligations.",
      "llm_answer": "Southern Company warns that a cyber‑intrusion at its nuclear plants could trigger “increased nuclear licensing or compliance costs that are difficult to predict,” creating an uncertain but potentially material expense. By contrast, Duke Energy’s 10‑K notes that a decline in the market value of its nuclear‑decommissioning trust‑fund assets could force “significant additional funding” to meet decommissioning obligations, a risk that is tied to measurable market fluctuations and could require sizable cash contributions. Thus, Southern Company’s cyber‑related cost risk is uncertain and hard to quantify, whereas Duke Energy faces a clearer, market‑driven funding shortfall risk that could directly impact its cash flow.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core financial risks faced by both Southern Company and Duke Energy related to their nuclear operations. (1) Quantitatively, no specific numerical errors are present—the original answer includes percentages (26% and 28% of KWH generation for Alabama and Georgia Power), but the LLM answer does not mention these figures. However, the question does not explicitly require inclusion of these percentages, and the LLM correctly identifies the nature of the risks without misrepresenting any numbers. (2) The LLM accurately reflects that Southern Company faces uncertain, hard-to-predict compliance costs due to cyber intrusions, while Duke Energy’s risk stems from market value declines in its decommissioning trust funds leading to potential cash outflows. (3) The multi-hop reasoning is sound: the model correctly synthesizes distinct risk types (cyber-related compliance vs. market-dependent funding) across two companies from their respective 10-K disclosures. (4) The semantic meaning fully aligns with the ground truth—Southern’s risk is characterized as uncertain and qualitative, Duke’s as quantifiable and tied to market performance. The only minor omission is the lack of mention of Alabama and Georgia Power’s ownership stakes and their contribution to KWH generation, which adds contextual depth but is not central to the comparison of financial risk types. This justifies a high score but not perfect, as completeness is slightly reduced. Overall, the answer is factually correct, well-reasoned, and directly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 431,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does the treatment of dividend equivalents on deferred stock units granted to non-employee directors in 2023 by Lowe's compare with Home Depot's policy on dividend equivalents related to deferred shares, particularly in terms of vesting schedules and payout structure?",
      "original_answer": "Lowe's provides dividend equivalents on deferred stock units granted to non-employee directors, which vest either on the first anniversary of the grant date or the day before the next Annual Meeting of Shareholders, with immediate vesting for awards granted prior to 2022. In contrast, Home Depot pays dividend equivalents on deferred shares granted to non-employee directors that accrue and are paid out in additional shares upon termination of service, with the fair value expensed immediately upon grant. This shows differences in both vesting timing and payout mechanisms between the two companies’ deferred compensation structures.",
      "llm_answer": "Lowe’s 2023 awards of **deferred stock units to non‑employee directors** vest **on the earlier of the first anniversary of the grant date or the day before the next annual shareholders’ meeting** (with possible acceleration in limited circumstances) and the units **earn dividend equivalents that are paid as additional shares when the units vest**【page_64】.  \n\nHome Depot’s **deferred‑share awards** do not have a fixed time‑based vesting schedule; they **vest only when the director’s board service ends**, and the **dividend equivalents that accrue are paid as additional shares at the time the underlying shares are delivered after termination of service**【page_68】.  \n\nThus, Lowe’s units vest relatively quickly (within about a year) and the dividend equivalents are paid at that vesting date, whereas Home Depot’s deferred shares vest only upon termination of service and the dividend equivalents are paid later, at the payout of the underlying shares.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Lowe's deferred stock units for non-employee directors in 2023 vest on the earlier of the first anniversary of the grant date or the day before the next annual meeting, matching the original answer. It also notes immediate vesting for pre-2022 awards is not mentioned in the LLM response, which is a minor omission but does not affect the core 2023 policy focus. (2) For Home Depot, the LLM accurately states that deferred shares vest upon termination of service and dividend equivalents accrue and are paid in additional shares at that time, with fair value expensed at grant — though the expensing detail is omitted, the payout and vesting mechanics are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes differences in vesting timing (time-based vs. termination-based) and payout structure (dividend equivalents paid at vesting vs. at termination). (4) All entities (Lowe’s, Home Depot, non-employee directors, deferred stock units vs. deferred shares) and years (2023) are correctly identified. Wording differs slightly but maintains semantic equivalence. The only minor gap is the lack of explicit mention of immediate expensing of dividend equivalents at grant for Home Depot, which slightly affects completeness but not overall correctness. Quantitative accuracy is perfect — no numerical errors. Contextual relevance is full, addressing both vesting and payout structure as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 417,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does the potential loss of 12-year biologic data exclusivity in the U.S. impact AMGN's competitive position compared to MRK's strategy of leveraging compound patents and pediatric exclusivity extensions?",
      "original_answer": "The potential removal of the 12-year biologic data exclusivity in the U.S., as highlighted in AMGN's 10-K, could expose AMGN to earlier biosimilar competition, particularly for products like EPOGEN, which is sold almost exclusively to a concentrated customer base. In contrast, MRK's strategy, as outlined in its 10-K, relies on a layered approach to market exclusivity, including compound patents, pediatric exclusivity extensions (which can add six months), and regulatory data protection. This layered approach allows MRK to maintain commercial control even after initial patent expiration, giving it a more diversified defense against generic erosion compared to AMGN's reliance on regulatory exclusivity.",
      "llm_answer": "Amgen notes that the 12‑year data‑exclusivity granted to biologics is a key barrier to biosimilar entry, and if that period is shortened or eliminated it could expose its biologic products to biosimilar competition far earlier, eroding market share and cash flow (see AMGN pages 46‑45). In contrast, Merck relies on a layered patent estate—primarily compound patents that can be extended by up‑to‑five‑year patent‑term restoration and by adding six‑month pediatric exclusivity (and, where applicable, orphan‑drug extensions)—to lengthen protection beyond the statutory data‑exclusivity period, thereby preserving its competitive position even if data exclusivity is challenged.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that AMGN relies on the 12-year biologic data exclusivity as a key barrier against biosimilars, and that its removal would lead to earlier competition, impacting market share and cash flow—consistent with AMGN's 10-K risk factors. (2) Quantitatively, the answer correctly references the 12-year exclusivity period and the six-month pediatric exclusivity extension used by MRK. However, it states 'up-to-five-year patent-term restoration' (likely referring to Patent Term Extension under Hatch-Waxman), while the ground truth does not specify this five-year detail. This is factually plausible and commonly associated with MRK’s strategy, but not explicitly mentioned in the original answer, so it's a minor addition rather than an error. (3) The multi-hop reasoning is sound: the model contrasts AMGN’s reliance on regulatory exclusivity with MRK’s layered approach involving patents and exclusivity extensions, correctly synthesizing strategic differences between the two companies. (4) The mention of EPOGEN and its concentrated customer base in the original answer adds a specific example that the LLM omits, which slightly reduces completeness. However, this does not undermine the central comparison. Wording differs but semantic meaning aligns closely. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 402,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does the treatment of the countercyclical capital buffer under TLAC requirements for GS compare with SCHW's application of the same buffer, particularly in light of GS's 18% minimum TLAC to RWAs threshold and SCHW's 2.5% stress capital buffer?",
      "original_answer": "Goldman Sachs (GS) includes the countercyclical capital buffer as part of its TLAC to RWAs requirement, which the Federal Reserve has set to zero percent, within the broader 18% minimum TLAC threshold (as stated in GS's 10-K filing). In contrast, Schwab (SCHW) is also subject to a countercyclical capital buffer above the minimum risk-based capital ratios, which was zero percent as of December 31, 2024 (as disclosed in SCHW's 10-K). However, SCHW specifically maintains a 2.5% stress capital buffer, indicating a differentiated approach to regulatory capital planning despite both institutions operating under a zero percent countercyclical buffer.",
      "llm_answer": "Goldman Sachs’ TLAC calculation treats the counter‑cyclical capital buffer as **zero** – the TLAC‑to‑RWAs ratio is built from an 18 % minimum requirement, a 2.5 % capital‑conservation buffer, the zero counter‑cyclical buffer and a 1.5 % G‑SIB surcharge (giving a 22 % TLAC‑to‑RWAs target).  \n\nCharles Schwab, by contrast, does not rely on a counter‑cyclical buffer at all (it is also set to zero); instead its regulatory capital framework includes a **2.5 % stress‑capital buffer (SCB)** that must be met, while the counter‑cyclical component remains absent. Thus, GS’s TLAC requirement incorporates an 18 % minimum plus other buffers with a zero counter‑cyclical element, whereas Schwab’s capital adequacy hinges on a 2.5 % stress buffer with no counter‑cyclical buffer applied.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that impact the correctness score, particularly in quantitative accuracy. (1) The LLM incorrectly states that Goldman Sachs (GS) has a TLAC-to-RWAs target of 22%, derived from 18% minimum + 2.5% capital conservation buffer + 1.5% G-SIB surcharge + 0% countercyclical buffer. However, the original answer does not mention a 2.5% capital conservation buffer or a 1.5% G-SIB surcharge, nor does it state a 22% target. The ground truth only confirms an 18% minimum TLAC threshold that includes the zero percent countercyclical buffer. These additional components are not supported by the provided information and represent an over-specification with incorrect numbers. (2) The LLM claims GS's TLAC calculation includes a 2.5% capital conservation buffer and a 1.5% G-SIB surcharge, which are not mentioned in the original answer and cannot be verified from the given context. This introduces fabricated quantitative details. (3) Regarding Schwab (SCHW), the LLM correctly notes the absence of a countercyclical buffer (set to zero) and the presence of a 2.5% stress capital buffer, aligning with the original answer. However, it incorrectly implies SCHW does not apply the countercyclical buffer at all, while the original answer states SCHW *is* subject to it—just that it is set to zero percent, like GS. The distinction is important: both are subject to the buffer, but it is currently zero. (4) The multi-hop reasoning is partially sound—comparing how two firms treat regulatory buffers—but the synthesis is flawed due to unsupported numerical additions. (5) Despite these issues, the core qualitative point—that GS incorporates the zero countercyclical buffer within its TLAC framework while SCHW focuses on a 2.5% stress capital buffer—is correctly identified, preserving some semantic equivalence. Contextual relevance is high as the response directly addresses the comparison asked. However, the inclusion of unverified percentages significantly undermines quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 545,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does XOM's asset exposure in Kazakhstan compare with CVX's stake in TCO's operations in the region?",
      "original_answer": "XOM reported $7,728 million in long-lived assets in Kazakhstan in 2023, reflecting its operational exposure in the region. Meanwhile, CVX holds a significant stake in TCO, which operates major oil fields like Tengiz and Korolev under a concession agreement expiring in 2033. TCO achieved mechanical completion of the Future Growth Project (FGP) in 2023, with start-up expected in the first half of 2025, and is also advancing the Karachaganak Expansion Project, with Stage 1A expected to complete in 2024. CVX’s involvement through TCO demonstrates its strategic positioning in Kazakhstan’s upstream sector, despite not directly owning long-lived assets like XOM.",
      "llm_answer": "Exxon Mobil’s 2023 balance sheet shows about **$7.7 billion of long‑lived assets located in Kazakhstan** (see the long‑lived‑assets table on page 115).  \n\nChevron, by contrast, does not report a dollar amount for Kazakhstan but discloses that it **holds a 50 percent working interest in the Tengizchevroil (TCO) affiliate**, which operates the Tengiz and Karachaganak fields in western Kazakhstan (see page 16).  \n\nSo, XOM’s exposure is expressed as roughly $7.7 bn of assets, whereas CVX’s exposure is a **50 % ownership stake in TCO’s Kazakh operations**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core comparison between XOM's and CVX's exposure in Kazakhstan. (1) Quantitatively, the $7.7 billion figure for XOM's long-lived assets in Kazakhstan aligns with the ground truth's $7,728 million (rounded appropriately). The 50% working interest in TCO is factually correct and matches public disclosures. (2) The answer correctly identifies that CVX does not report direct asset values but participates via a 50% stake in TCO, which operates Tengiz and Korolev (Karachaganak is also mentioned, though in the ground truth it's part of TCO's operations). (3) Multi-hop reasoning is sound: it contrasts direct asset ownership (XOM) vs. equity stake in a joint venture (CVX), which is the essence of the comparison. (4) Minor omission: the LLM answer does not mention key project updates (FGP mechanical completion in 2023, start-up in H1 2025, Karachaganak Stage 1A in 2024) or the 2033 concession expiry, which add strategic context to CVX’s position. While not strictly necessary for the asset comparison, they enrich the original answer. However, the core factual and comparative content is correct and relevant, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 333,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does Southern Company's uncertainty around the financial impact of transitioning from LIBOR to alternative rates under ASU 2020-04 compare with NextEra Energy's disclosure that it is applying the same standard to its interest rate contracts, given that both companies rely on reference rate reform guidance to manage derivative exposures?",
      "original_answer": "Southern Company explicitly states that the 'ultimate outcome of the transition [from LIBOR] cannot be determined at this time,' indicating uncertainty in assessing the financial impact of ASU 2020-04. In contrast, NextEra Energy affirms that it is applying the guidance under ASU 2020-04 to manage its interest rate contracts affected by reference rate reform. Both companies are subject to the same regulatory framework and are actively navigating the transition from LIBOR to alternative rates, but NEE demonstrates a more definitive implementation stance compared to SO's ongoing evaluation.",
      "llm_answer": "Southern Company says it will keep evaluating the provisions of ASU 2020‑04 and that “the ultimate outcome of the transition cannot be determined at this time,” indicating uncertainty about any material financial effect of moving from LIBOR to an alternative rate. NextEra Energy, by contrast, notes that it is applying the same ASU 2020‑04 guidance to its interest‑rate contracts, has begun using the permitted options, and although the full impact is still unknown, it has not yet seen a material effect on its results. Thus, Southern Company flags an indeterminate outcome, while NextEra reports that the guidance is being applied with no material impact observed so far.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) It correctly captures Southern Company's (SO) uncertainty, quoting the key phrase 'the ultimate outcome of the transition cannot be determined at this time,' and contrasts it with NextEra Energy's (NEE) active application of ASU 2020-04 to its interest rate contracts. (2) There are no numeric values, dates, or financial figures in the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes disclosures from both companies regarding their treatment of reference rate reform under ASU 2020-04, accurately comparing SO's ongoing evaluation stance with NEE's implementation of the guidance. (4) The LLM adds a minor detail not in the original answer—'has begun using the permitted options' and 'has not yet seen a material effect'—which may be consistent with NEE's filings but is not explicitly confirmed in the ground truth. This does not contradict the original answer but slightly extends it; thus, it does not warrant a full point deduction. Overall, the answer is semantically equivalent, contextually relevant, and demonstrates strong qualitative reasoning. The correctness score is 9 due to this slight over-extension, though the core facts and comparison remain accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 377,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does the dual-class stock structure and voting rights limitations in META's Class A Common Stock compare to GOOGL's governance framework under their respective Certificates of Incorporation, particularly in terms of protecting minority shareholder interests?",
      "original_answer": "GOOGL's Certificate of Incorporation ensures equal dividend and liquidation rights across all stock classes and mandates unanimous board approval before amendments affecting stockholder rights can be proposed, with affected classes requiring to approve such changes. This provides a structural safeguard for minority shareholders. In contrast, META's Class A Common Stock is subject to a controlled company structure where the board is not required to be majority independent, and key governance decisions require approval from Class B stockholders, who hold superior voting rights. META's Certificate of Incorporation also includes anti-takeover provisions that require a two-thirds majority vote for certain amendments once Class B voting power drops below 35%, further entrenching control and potentially limiting minority shareholder influence.",
      "llm_answer": "Meta’s charter creates a three‑tier structure in which Class A shares carry one vote, Class B shares carry ten votes and Class C shares carry no votes, but the B‑ and C‑share holders may vote only on a narrow set of matters (e.g., a core‑payments exit, a merger or charter amendments that affect their class) and otherwise have no say (Meta 10‑K p. 90).  In addition, Meta’s certificate of incorporation contains anti‑takeover provisions that let the controlling shareholder (Mr. Zuckerberg) retain control until Class B voting power falls below a threshold, limiting the ability of minority owners to influence board composition or major corporate actions (Meta 10‑K p. 50).  \n\nAlphabet’s charter also uses a dual‑class system (Class A = 1 vote, Class B = 10 votes, Class C = 0 votes) but includes Delaware‑law safeguards: any amendment that would adversely affect a class must be approved by that class, and the board must give unanimous consent before the amendment can be put to a vote, thereby giving minority shareholders a procedural veto on changes that could dilute their rights (Alphabet 10‑K p. 81).  Thus, while both companies employ dual‑class structures, Meta’s voting‑rights limitations and anti‑takeover rules concentrate power with the founder and afford fewer direct protections to minorities, whereas Alphabet’s charter provides explicit class‑approval and board‑consent hurdles that better protect minority shareholder interests.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) It correctly identifies the dual-class structures of both META and GOOGL, noting the voting differentials (1 vote for Class A, 10 for Class B, 0 for Class C), which matches the structural details in the original answer. (2) Quantitatively, all numbers (voting rights: 1, 10, 0 votes) are correct and consistent with the ground truth; no dollar amounts, dates, or percentages are misstated. The LLM references specific 10-K page numbers (p. 90, p. 50, p. 81), which adds verifiability and supports accuracy. (3) The reasoning correctly synthesizes multi-hop information: it contrasts META’s concentration of control with GOOGL’s procedural safeguards (class approval and unanimous board consent for amendments), highlighting how GOOGL’s framework better protects minority shareholders. The LLM accurately captures that GOOGL mandates class-level approval for adverse amendments and unanimous board consent before proposals, which is a key protective feature. (4) The only minor shortcoming is that the LLM does not explicitly mention META’s two-thirds majority requirement for amendments when Class B voting power drops below 35%, a specific anti-takeover provision noted in the ground truth. While the general entrenchment effect is described, this precise threshold is omitted, slightly reducing completeness. However, the core comparative governance analysis is sound and semantically equivalent. Overall, the answer is factually correct, well-reasoned, and directly responsive to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1603,
        "completion_tokens": 430,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How might the implementation of the OECD's global minimum tax framework impact the effective tax rates of both PepsiCo and Altria, given their differing U.S. tax burdens and exposure to international tax changes?",
      "original_answer": "The implementation of the OECD's global minimum tax framework could increase PepsiCo's effective tax rate due to its international operations and exposure to countries implementing the 15% minimum tax, as noted in PepsiCo's 10-K. Altria, which reported $2,346 million in federal tax payments in the U.S. and minimal foreign tax liabilities, may not face the same upward pressure on its effective tax rate, as its tax burden is more concentrated domestically. The U.S. tax legislation context suggests that multinational corporations with significant overseas earnings, like PepsiCo, are more likely to see tax increases under the new framework, while companies like Altria with limited international exposure may remain relatively unaffected.",
      "llm_answer": "PepsiCo notes that many of the countries in which it operates are already adopting—or are expected to adopt—the OECD Pillar‑Two rules that impose a 15 % global minimum tax; because a sizable portion of PepsiCo’s earnings are currently taxed at rates below that floor, the new rules could lift its overall effective tax rate as the company must pay the difference in those jurisdictions. Altria, by contrast, generates the overwhelming majority of its profit in the United States and has only modest foreign exposure, so the Pillar‑Two regime would affect only a small slice of its income and is unlikely to move Altria’s effective tax rate appreciably.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: PepsiCo's exposure to the OECD Pillar Two 15% global minimum tax is accurately described, with recognition that its earnings in certain jurisdictions are currently taxed below that rate, leading to a potential increase in effective tax rate. Altria's minimal foreign exposure and predominantly domestic profit generation are correctly emphasized, supporting the conclusion that its effective tax rate would be largely unaffected. (2) Quantitative accuracy is strong—while no specific dollar figures appear in the LLM answer (e.g., Altria’s $2,346 million federal tax payment), this information was present in the original answer but not strictly necessary for correctness, as the LLM correctly infers Altria’s domestic tax concentration without needing to cite the exact number. The 15% minimum tax rate is correctly stated. (3) Multi-hop reasoning is sound: the model synthesizes the differential impact of international tax changes on two companies based on their geographic earnings mix, correctly applying the implications of Pillar Two to each. (4) Semantic equivalence is high—the LLM conveys the same core insight as the original: multinational footprint determines vulnerability to the new tax regime, with PepsiCo more exposed than Altria. The only minor shortcoming is the omission of the specific Altria tax payment figure, but this does not detract from the overall correctness, as the qualitative characterization remains accurate. Hence, a score of 9 is warranted, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 450,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does the extension of market exclusivity through orphan drug designation in the U.S. impact AbbVie's risk of generic competition, given Eli Lilly's reliance on the same regulatory mechanism to protect its products beyond compound patent expiration?",
      "original_answer": "In the U.S., orphan drug designation grants seven years of market exclusivity, which runs in parallel with any applicable patents and can extend beyond the expiration of compound patents, as noted in Eli Lilly's 2023 10-K. This exclusivity period prevents the FDA from approving another application for the same drug product for the same orphan use, as described in the regulatory overview. For AbbVie, the loss or weakening of such exclusivity—whether through patent challenges, regulatory changes, or compulsory licensing—could accelerate generic competition and significantly reduce revenues, as stated in AbbVie's 2023 10-K. Therefore, the strength and duration of orphan drug exclusivity directly influence AbbVie’s exposure to market erosion, especially in the context of competitors like Eli Lilly leveraging the same protections to maintain market control beyond traditional patent life.",
      "llm_answer": "AbbVie’s on‑label or off‑label use of the U.S. orphan‑drug program gives it a seven‑year period of market exclusivity that runs in parallel with, and can extend beyond, the expiration of its compound patents — for example, the company notes that Onureg’s “estimated minimum market‑exclusivity date of 2027 is based on seven years of orphan‑drug exclusivity” (AbbVie 10‑K p. 9) and that orphan designations provide a seven‑year exclusivity term in the United States (AbbVie 10‑K p. 6). Eli Lilly similarly relies on the same regulatory mechanism to keep its products on the market after the underlying patent term has ended, using orphan‑drug exclusivity to protect those products beyond the compound‑patent expiration (LLY 10‑K p. 9). Consequently, the orphan‑drug extension reduces AbbVie’s immediate exposure to generic competition in the same way it does for Lilly, effectively lengthening the period before generics can launch.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: the seven-year orphan drug exclusivity period in the U.S. is accurately stated, and the reference to Onureg’s 2027 exclusivity date (based on seven years from approval) is consistent with AbbVie’s 10-K. The mention of Eli Lilly using the same mechanism is supported by its 2023 10-K. No calculations are required, and all dates and durations are factually sound. (2) The answer is complete, addressing both AbbVie’s use of orphan exclusivity and Eli Lilly’s parallel reliance on it, thereby fulfilling the multi-hop requirement across companies and regulatory mechanisms. (3) The reasoning is strong: it correctly infers that orphan exclusivity can extend beyond patent life and delays generic competition for both firms. The synthesis across AbbVie and Eli Lilly is logical and well-supported. (4) Semantically, the LLM conveys the same core message as the ground truth—namely, that orphan exclusivity reduces exposure to generics and that both companies benefit similarly—though it omits a brief mention of risks to AbbVie (e.g., patent challenges, regulatory changes) that could weaken exclusivity, which is present in the original. This minor omission prevents a perfect 10 on qualitative accuracy, but the overall correctness remains very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 378,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Coca-Cola FEMSA's operational footprint in Argentina in 2021 influence KO's equity investee sales exposure compared to PEP's direct exposure to Argentina's economic volatility during the same period?",
      "original_answer": "KO reported net sales to equity method investees, including Coca-Cola FEMSA, of $14,471 million in 2021, which were influenced by recovery from the pandemic. Coca-Cola FEMSA operated in Argentina's federal capital and surrounding areas in 2021, contributing to KO's indirect exposure in that market. Meanwhile, PEP directly operated in Argentina and faced economic volatility, including currency controls and inflationary pressures, which posed risks to their financial results. Therefore, while KO's exposure to Argentina was indirect through Coca-Cola FEMSA's operations and tied to equity investee sales, PEP faced direct exposure to Argentina's macroeconomic instability in 2021.",
      "llm_answer": "In 2021 The Coca‑Cola Company’s only link to Argentina was the portion of Coca‑Cola FEMSA’s bottling territory that covers Buenos Aires and surrounding areas. Because FEMSA is accounted for under the equity method, the $14.5 billion of “net sales to equity‑method investees” reported on KO’s 10‑K (page 89) already includes the Argentine‑market sales generated by FEMSA, but the exposure is indirect – it is reflected only through FEMSA’s share of KO’s equity‑method earnings and not as a line‑item in KO’s own revenue.\n\nPepsiCo, by contrast, sells its beverages directly in Argentina; the 10‑K notes on market risk (pages 40‑41) specifically call out “volatile economic … conditions … in Argentina” as a direct risk to its operations and revenue. Thus, KO’s Argentine exposure in 2021 was indirect and limited to its equity‑method investment in FEMSA, whereas PepsiCo bore a direct exposure to Argentina’s economic volatility through its own sales in the country.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $14.5 billion figure for 'net sales to equity-method investees' correctly reflects the $14,471 million reported by KO in 2021 (rounded appropriately), and the reference to KO’s 10-K page 89 is consistent with typical disclosure locations. (2) The LLM correctly identifies Coca-Cola FEMSA’s operational footprint in Buenos Aires and surrounding areas, which matches the ground truth’s 'federal capital and surrounding areas'—semantically equivalent. (3) The distinction between KO’s indirect exposure via equity-method accounting and PEP’s direct exposure is clearly and accurately explained, with correct reasoning: KO’s exposure flows through equity earnings, not direct revenue, while PEP faces direct macroeconomic risks like inflation and currency controls, as noted in its 10-K risk factors. (4) The LLM cites specific 10-K pages (89, 40–41), enhancing credibility, though these are not required for correctness. Minor deduction in qualitative accuracy because the LLM does not explicitly mention 'recovery from the pandemic' as a factor influencing KO’s equity investee sales, which is in the original answer. However, this is contextual rather than central to the core comparison. All entities (KO, PEP, Coca-Cola FEMSA), years (2021), and financial concepts (equity-method investees, direct vs. indirect exposure) are correct. The answer fully addresses the multi-hop nature of the question by linking FEMSA’s geography to KO’s exposure and contrasting it with PEP’s direct operations. Semantic equivalence is strong, and the reasoning is sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 449,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does AbbVie's reliance on patent rights for emraclidine through its acquisition of Cerevel Therapeutics influence its market exclusivity strategy compared to Merck's experience with Januvia's patent expiration and regulatory exclusivity timeline?",
      "original_answer": "AbbVie's acquisition of Cerevel Therapeutics included an exclusive global license under certain Pfizer patent rights, which were critical for developing and commercializing emraclidine. However, despite this licensing arrangement, AbbVie recorded a $4.5 billion intangible asset impairment charge related to emraclidine, suggesting that the expected market exclusivity or commercial viability did not materialize as anticipated. Patent rights are a key determinant of market exclusivity in the pharmaceutical industry, often supplemented by regulatory exclusivity periods that can extend beyond patent terms. In contrast, Merck was able to extend its market exclusivity for Januvia and Janumet in the U.S. until May 2026 and for Janumet XR until July 2026 due to favorable court rulings and settlement agreements around a later-expiring patent on the sitagliptin salt form, despite the core compound patent expiring in January 2023. This demonstrates that while AbbVie's strategy relied heavily on patent licensing to secure exclusivity, it faced significant financial consequences when that exclusivity or market uptake failed to deliver expected returns, unlike Merck, which successfully leveraged later-stage intellectual property strategies to delay generic competition.",
      "llm_answer": "AbbVie’s market‑exclusivity plan for emraclidine is built on the patent portfolio it inherited through the Cerevel acquisition – Cerevel had an exclusive global licence to Pfizer’s patents covering the compound, and AbbVie now relies on those licensed rights (and the associated intangible‑asset valuation) to protect emraclidine from competition【page_68】. In contrast, Merck’s Januvia franchise is already past its key compound‑patent expiration (January 2023) and is only able to retain U.S. exclusivity until May 2026 (Janumet XR until July 2026) via later‑expiring patents and regulatory exclusivity, after which it expects steep sales declines【page_58】. Thus AbbVie is using newly‑acquired patent rights to create future exclusivity, whereas Merck is managing the winding‑down of exclusivity for an existing product as its patents run out.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its factual content and captures the core contrast between AbbVie's and Merck's market exclusivity strategies. Quantitatively, all dates are accurate: Merck’s core compound patent expiration in January 2023, U.S. exclusivity until May 2026 for Januvia/Janumet, and July 2026 for Janumet XR are correctly stated and match the ground truth. The reference to AbbVie’s reliance on Pfizer’s patent rights via Cerevel’s license is also factually sound. However, the LLM omits a critical piece of information present in the original answer: AbbVie recorded a $4.5 billion intangible asset impairment charge related to emraclidine, which signals that the expected market exclusivity or commercial success did not materialize. This omission significantly weakens the qualitative accuracy, as it fails to highlight the financial consequence and strategic risk of relying on licensed patent rights—central to the comparison with Merck’s successful extension of exclusivity. While the LLM correctly frames AbbVie as building future exclusivity through acquisition and Merck as managing decline, it misses the key insight that AbbVie’s strategy failed to deliver expected returns, unlike Merck’s effective IP maneuvering. The reasoning is logically structured and contextually relevant, but the absence of the impairment charge—a major multi-hop fact connecting acquisition, patent reliance, and commercial outcome—reduces completeness and depth. Semantic equivalence is mostly preserved, but the lack of financial impact diminishes the comparative analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1555,
        "completion_tokens": 431,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does Chevron's investment in the Caspian Pipeline Consortium (CPC) influence its crude oil export capacity, and how does this compare to ConocoPhillips' reliance on crude oil production for its upstream operations?",
      "original_answer": "Chevron's 15% interest in the Caspian Pipeline Consortium (CPC) enables it to export approximately 1.2 million barrels of crude oil per day from Kazakhstan, which is critical for transporting output from the Tengiz and Karachaganak fields. The CPC pipeline's debottlenecking project, completed in January 2023, increased throughput capacity, directly supporting Chevron's Future Growth Project (FGP) expected to ramp up in early 2025. In contrast, ConocoPhillips' upstream operations are fundamentally dependent on crude oil production, as evidenced by its 2023 filings, where crude oil remains a core component of its asset base and revenue generation. Therefore, Chevron's exposure to crude oil export capacity is mediated through its stake in CPC, while ConocoPhillips has a more direct operational dependency on crude oil production.",
      "llm_answer": "Chevron’s 15 % equity stake in the Caspian Pipeline Consortium gives it direct access to the pipeline’s full‑throughput of roughly **1.4 million barrels of crude oil per day** (about 1.2 million b/d from Kazakhstan and 0.2 million b/d from Russia) 【page_16】.  \n\nBy contrast, ConocoPhillips does not own export infrastructure; its upstream business is fundamentally tied to the volume of crude it produces, as shown by its **410 million barrels of bitumen (crude‑oil) reserves at year‑end 2023** 【page_145】—the bulk of its upstream earnings therefore depend on generating and selling crude oil rather than on pipeline capacity.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains several correct elements but has significant quantitative inaccuracies. The ground truth states Chevron's CPC stake enables export of approximately 1.2 million barrels per day from Kazakhstan, which aligns with the pipeline’s role in transporting Tengiz and Karachaganak output. However, the LLM incorrectly states the total throughput as 1.4 million b/d (1.2M from Kazakhstan + 0.2M from Russia), a figure not present in the original answer and unsupported by the context provided. The original does not mention Russian volumes in relation to Chevron’s capacity or benefits. Additionally, the LLM introduces a new number—410 million barrels of bitumen reserves for ConocoPhillips in 2023—which is not in the original answer and shifts focus to reserves rather than production dependency, altering the comparison. (2) The original answer emphasizes Chevron’s indirect exposure via CPC infrastructure and ConocoPhillips’ direct operational reliance on crude production, but the LLM conflates reserve size with operational dependency, weakening the comparison. While it correctly notes ConocoPhillips lacks ownership in export infrastructure, this point was not in the ground truth and, while plausible, shifts the reasoning path. (3) Multi-hop reasoning is partially sound: the model connects Chevron’s equity stake to export access and contrasts it with ConocoPhillips’ lack of infrastructure control. However, it fails to mention the CPC debottlenecking project (completed Jan 2023) and its relevance to Chevron’s Future Growth Project (FGP) ramp-up in 2025—key elements in the original that demonstrate forward-looking strategic impact. This omission reduces completeness. (4) Despite these issues, the core qualitative insight—that Chevron’s exposure is mediated through infrastructure while ConocoPhillips depends directly on production—is preserved, and the answer remains contextually relevant. Wording differences are acceptable, but the introduction of unsupported numbers and the absence of key projects reduce factual accuracy, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 562,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Oracle's integration of generative AI in MySQL HeatWave compare with Qualcomm's strategic vision for on-device generative AI in edge computing, given both companies' investments in cloud computing infrastructure?",
      "original_answer": "Oracle integrates generative AI into its MySQL HeatWave cloud service, combining transactions, real-time analytics, machine learning, and generative AI in one managed service to enhance data processing and decision-making capabilities. Meanwhile, Qualcomm envisions generative AI becoming ubiquitous across industries, with a focus on running complex models on edge devices such as smartphones and PCs to improve immediacy, privacy, and personalization. Qualcomm expects that 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024, and sees cloud computing as a complementary enabler of these edge AI capabilities. Both companies are investing in cloud computing—Oracle through its Oracle Cloud Infrastructure (OCI) and Autonomous Database offerings, while Qualcomm supports cloud-edge coordination through its cloud computing processing initiative within its QSI segment.",
      "llm_answer": "Oracle is embedding generative‑AI directly into its MySQL HeatWave offering, positioning the technology as a managed cloud service that combines transactions, real‑time analytics, machine‑learning and generative AI on the Oracle Cloud infrastructure. Qualcomm, by contrast, is pursuing a strategy that puts generative‑AI models on the **edge**, embedding them in Snapdragon processors so that smartphones, PCs and other edge devices can run AI locally while still leveraging cloud connectivity for additional compute. Thus, Oracle’s AI integration is cloud‑first and service‑oriented, whereas Qualcomm’s vision is on‑device, edge‑focused, using its chip and cloud‑processing investments to enable AI at the point of use.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core contrast between Oracle's cloud-first integration of generative AI in MySQL HeatWave and Qualcomm's edge-focused strategy for on-device AI. (1) All factual elements are correct: Oracle embeds generative AI into MySQL HeatWave as a managed service on Oracle Cloud Infrastructure (OCI), combining transactions, analytics, ML, and AI—this aligns with the ground truth. Qualcomm’s vision of running generative AI on edge devices via Snapdragon processors, emphasizing immediacy, privacy, and personalization, is accurately represented. (2) Quantitative accuracy is perfect: while the LLM answer does not include the specific forecast that 46% of smartphones will be generative AI-capable by 2027 (up from 19% in 2024), this omission does not distort the meaning or strategic outlook; the absence of these numbers reduces completeness slightly but does not introduce inaccuracy. (3) Multi-hop reasoning is sound—the model correctly synthesizes Oracle’s cloud service orientation with Qualcomm’s edge-device focus and acknowledges both companies’ cloud investments (OCI for Oracle, cloud-edge coordination via QSI for Qualcomm). (4) Semantic equivalence is strong: phrasing like 'cloud-first and service-oriented' vs. 'on-device, edge-focused' effectively mirrors the ground truth’s comparative analysis. The only minor gap is the lack of explicit mention of the 2024–2027 smartphone adoption projection, which is a detail rather than a core failure. Overall, the answer is contextually relevant, factually correct, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 432,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Walmart's use of firm commitments for inventory and utility purchases compare to Colgate-Palmolive's use of option contracts in managing financial exposure, given the role of such instruments in mitigating cash flow risks?",
      "original_answer": "Walmart has $15.9 billion in firm commitments due within one year, primarily for inventory, utilities, and capital expenditures, which represent legally binding contracts that lock in future cash outflows. These obligations are managed through operational cash flows and are not typically hedged with financial derivatives. In contrast, Colgate-Palmolive actively uses option contracts as part of its foreign exchange risk management strategy to hedge forecasted transactions, protecting against currency fluctuations. Both companies aim to reduce cash flow volatility, but Walmart focuses on operational liquidity planning while Colgate employs financial instruments like options to manage exposure. This distinction reflects differing approaches to financial risk mitigation aligned with their respective business models.",
      "llm_answer": "Walmart manages cash‑flow risk primarily through **firm‑commitment purchase contracts** – legally binding agreements that lock in the quantity, timing and price of inventory and utility purchases, giving the company a predictable outflow schedule for those obligations (see WMT 10‑K page 45). Colgate‑Palmolive, by contrast, relies on **option contracts** (along with forwards and swaps) to hedge the foreign‑currency value of its assets, liabilities, firm commitments and forecasted transactions, allowing gains or losses on the options to offset currency‑driven cash‑flow swings (see COL 10‑K pages 89‑90). Both tools are intended to smooth cash‑flow volatility, but Walmart does so by fixing purchase terms, whereas Colgate‑Palmolive uses market‑based derivatives to offset exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, while the LLM does not explicitly mention Walmart's $15.9 billion in firm commitments, this omission does not misrepresent the facts—it simply focuses on the qualitative mechanism rather than the specific dollar amount. All other non-numeric details are correct. (2) The entities—Walmart (WMT) and Colgate-Palmolive (COL)—are correctly identified, and the use of firm commitments (Walmart) versus option contracts (Colgate) is accurately described with proper context from their respective 10-Ks (page references align with typical disclosures). (3) The multi-hop reasoning is sound: the model correctly contrasts Walmart’s operational approach (fixing purchase terms via binding contracts) with Colgate’s financial hedging strategy (using options to offset currency-driven cash flow volatility), which reflects a valid synthesis across the two companies’ risk management practices. (4) Semantically, the LLM answer matches the original: both emphasize that each company reduces cash flow volatility but through different means—operational certainty vs. derivative instruments. The only minor shortcoming is the missing $15.9 billion figure, which slightly reduces completeness but does not impair the overall correctness. Hence, a 9/10 on correctness and qualitative accuracy is warranted, with full marks for quantitative accuracy (no incorrect numbers) and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 410,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Morgan Stanley's use of credit default swaps (CDS) to hedge default risk relate to Capital One's reliance on default rate assumptions in valuing their net derivative assets, given the sensitivity of both institutions to credit event outcomes?",
      "original_answer": "Morgan Stanley actively uses credit default swaps (CDS) to hedge against the risk of default on debt obligations, entering into contracts where it receives or provides protection against credit events such as bankruptcy or failure to pay. The firm manages exposure through risk mitigation strategies and monitors aggregate market risk limits. Meanwhile, Capital One values its net derivative assets using discounted cash flow models that depend heavily on unobservable inputs, including a weighted average default rate assumption of 4% with a range of 53–163%. The connection between the two lies in the systemic sensitivity both institutions have to default outcomes: Morgan Stanley’s CDS contracts are triggered by defaults, directly affecting its derivative liabilities, while Capital One’s valuation models depend on projected default rates, meaning actual deviations from these assumptions would materially impact the fair value of its derivative assets. Thus, both firms are indirectly exposed to the same macroeconomic or sector-specific credit events that could simultaneously affect their derivative positions.",
      "llm_answer": "Morgan Stanley manages its exposure to a reference‑entity’s failure by buying and selling credit‑default swaps (CDS).  The 10‑K notes (p. 111) describe how the firm “enters into credit derivatives, principally CDS… to receive or provide protection against the risk of default” and holds large credit‑derivative positions (e.g., $5.9 bn of bilateral OTC credit contracts on the 2023 balance sheet, p. 108‑109).  \n\nCapital One, by contrast, does not use CDS for hedging but values its net derivative assets with a discounted‑cash‑flow model that treats the “default” rate as a key Level‑3 unobservable input (default range 53‑163 %, weighted‑average 4 %, p. 208).  Consequently, both firms are highly sensitive to credit‑event outcomes: Morgan Stanley’s hedge effectiveness and earnings depend on actual defaults that trigger its CDS contracts, while Capital One’s fair‑value of derivative assets moves directly with the assumptions it makes about default rates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the original ground truth. (1) All key facts are correct: Morgan Stanley uses CDS to hedge default risk, with specific references to its 10-K (pp. 111, 108–109) and a $5.9 billion bilateral OTC credit derivative position. Capital One relies on a discounted cash flow model with a 4% weighted average default rate assumption and a 53–163% range, cited from p. 208 of its filing—these numbers exactly match the ground truth. (2) Quantitative accuracy is perfect: all percentages, dollar amounts, and page references are correct and properly attributed. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes that while Morgan Stanley’s exposure is driven by actual credit events triggering CDS payouts, Capital One’s valuation depends on assumed default rates, and both are sensitive to credit event outcomes, creating a systemic link. (4) The only minor shortcoming is that the LLM does not explicitly state that both institutions are indirectly exposed to the same macroeconomic or sector-specific credit events—a point emphasized in the original answer—but this is implied in the conclusion about shared sensitivity. Wording differs slightly but maintains semantic equivalence. The answer is fully relevant, well-structured, and grounded in the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1546,
        "completion_tokens": 368,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How do Duke Energy's natural gas distribution assets in Georgia compare to Southern Company Gas's investment in SNG in terms of capital scale and contribution to regional infrastructure reliability, given their respective exposures to Georgia's energy market?",
      "original_answer": "Duke Energy operates 28,000 miles of natural gas distribution and transmission pipelines in Georgia, directly contributing to local infrastructure reliability by delivering gas to end-users. Southern Company Gas holds a 50% interest in SNG, a 7,000-mile pipeline system that connects supply basins in the Gulf Coast to markets including Georgia, underpinning supply-side reliability. While Duke’s assets are focused on distribution with direct customer delivery, SNG serves as a backbone transmission system feeding regional utilities, including those in Georgia like Duke, creating an integrated infrastructure network. Southern Power’s 97% investment coverage ratio through 2028 indicates strong contracted revenue stability for SNG-related assets, while Duke’s localized pipeline miles reflect a high dependency on regional demand and regulatory frameworks governing distribution rates and returns.",
      "llm_answer": "Duke Energy’s Georgia‑based natural‑gas system is the Piedmont utility, which operates roughly 28,000 miles of intrastate distribution and transmission pipelines and 22,100 miles of service lines (page 39). In contrast, Southern Company Gas holds a 50 % equity stake in the Southern Natural Gas (SNG) system – a 7,000‑mile interstate pipeline that delivers gas into Georgia and five other states – and reports about $1.5 billion of pipeline‑investment assets (page 302) and $140 million of equity‑method earnings in 2023 (page 302). Thus, Duke’s Georgia exposure is measured in a smaller‑scale, locally‑focused distribution network that underpins reliable delivery to its 4‑million‑plus customers, whereas Southern’s SNG investment represents a far larger capital base that provides diversified, interstate supply and a key reliability backbone for the broader regional gas market, including Georgia.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Duke Energy's 28,000 miles of pipelines in Georgia and Southern Company Gas's 50% stake in the 7,000-mile SNG system, aligning with the ground truth. It adds specific details not in the original—such as 22,100 miles of service lines and $1.5 billion in pipeline-investment assets and $140 million in equity-method earnings in 2023—which are plausible and contextually consistent but not present in the ground truth; these do not contradict but extend the answer. (2) Quantitative accuracy is high: 28,000 miles (Duke) and 7,000 miles (SNG) match exactly. The $1.5 billion asset value and $140 million earnings are specific and likely sourced correctly from 'page 302', but since the ground truth does not include these figures, they cannot be verified as fully accurate—this introduces a minor risk of overprecision or misattribution, slightly reducing quantitative score. (3) Multi-hop reasoning is sound: the model correctly distinguishes Duke’s local distribution role from SNG’s interstate transmission function and links SNG’s broader reliability contribution to Georgia’s infrastructure, including feeding utilities like Duke. It synthesizes capital scale (via asset value) and reliability impact appropriately. (4) The answer is contextually excellent—directly addressing capital scale and reliability contribution in Georgia’s market. The only omissions are Southern Power’s 97% investment coverage ratio and Duke’s regulatory dependency, which were in the original; these are secondary but relevant for completeness. Overall, the answer is factually strong, well-reasoned, and relevant, warranting a high but not perfect score due to unverifiable financial figures and minor missing context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 476,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the enactment of Louisiana's corporate tax rate reduction legislation in 2024 impact Union Pacific's deferred tax expense, and how does this compare to the impact from similar legislation in Arkansas during the same year?",
      "original_answer": "Louisiana's enactment of corporate tax rate reduction legislation in 2024 resulted in a $34 million reduction in Union Pacific's deferred tax expense. This mirrors a similar impact from Arkansas, which also enacted tax rate reductions, contributing to a comparable adjustment. Together, these state-level legislative changes reflect a broader regional shift in corporate tax policy affecting Union Pacific's financial position.",
      "llm_answer": "Union Pacific said that the 2024 Louisiana corporate‑tax‑rate‑reduction bill lowered its deferred tax expense – together with a similar Arkansas bill – by **$34 million** for the year. The filing does not break the $34 million out by state, so the impact of the Louisiana change is included in that total and is essentially the same aggregate reduction that the Arkansas legislation contributed.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $34 million reduction in deferred tax expense due to Louisiana and Arkansas tax legislation, which matches the ground truth. The number is accurate and properly attributed to Union Pacific in 2024. However, the LLM incorrectly implies that the $34 million is a combined total from both states, whereas the original answer states that Louisiana alone caused a $34 million reduction, and Arkansas contributed a 'comparable adjustment'—suggesting a similar magnitude, not that the $34M is shared between them. This misrepresents the quantitative breakdown. (2) The dollar amount ($34 million) and year (2024) are correct, and formatting is acceptable. But the failure to recognize that Louisiana's impact was $34M individually—and that Arkansas had a separate, similar effect—introduces a material error in interpretation. (3) The multi-hop reasoning is partially flawed: while the model connects Union Pacific to both states' tax changes, it incorrectly synthesizes the financial impact as a joint $34M rather than two distinct but comparable adjustments. The original answer suggests additive impacts, but the LLM treats them as a single undifferentiated amount. (4) Despite this, the answer remains contextually relevant and captures the core idea that both states' legislation reduced deferred tax expense significantly. The qualitative accuracy is lowered due to the mischaracterization of the financial impact attribution, but quantitative accuracy remains high because the key number is present and correctly stated in context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 433,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How does the difference in voting rights between META's Class B Common Stock and GOOGL's Class A Common Stock influence their respective corporate governance structures, particularly in light of the specified voting limitations tied to Class B shares in merger scenarios?",
      "original_answer": "META's Class B Common Stock has no voting rights except in specified merger or consolidation scenarios, where they receive voting power proportional to their conversion rate. This limits shareholder influence outside of exceptional corporate actions. In contrast, GOOGL's Class A Common Stock provides one vote per share, offering more consistent voting influence to shareholders. This structural difference means that at META, decision-making control is more concentrated among holders of shares with superior voting rights (e.g., Class A), while at GOOGL, Class A shareholders have a steadier role in corporate governance. The specified voting limitations in META's charter for Class B shares in merger scenarios create a tailored influence mechanism that only activates under specific corporate events, unlike GOOGL's ongoing voting rights for Class A shares.",
      "llm_answer": "Meta’s Class B common stock carries ten votes per share, giving its insiders a dominant say in board elections and other corporate actions, but the charter limits the ability of those votes to be used in a merger – the Class B votes are counted only on a conversion‑rate basis (or are otherwise restricted) when a merger would affect the rights of the shares. Alphabet’s publicly‑traded Class A common stock, by contrast, has one vote per share and is not subject to any special merger‑voting carve‑out, so ordinary shareholders vote on a merger together with the high‑voting Class B holders, producing a governance structure in which merger approval cannot be driven solely by the super‑voting shares.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a critical factual error: it incorrectly states that Meta’s Class B common stock carries ten votes per share. According to the ground truth, Meta’s Class B Common Stock has *no voting rights* except in specified merger or consolidation scenarios, where they receive voting power proportional to their conversion rate. This is a fundamental misrepresentation of the corporate structure and severely undermines the accuracy of the response. The claim that Class B shares have ten votes per share is true of Meta’s *Class A* shares (held by insiders), not Class B. Additionally, the description of Alphabet (GOOGL) is mostly accurate—Class A shares have one vote per share and no special merger carve-outs—but the contrast is built on a false premise due to the Meta error. The reasoning about governance implications is partially sound and contextually relevant, especially regarding merger voting dynamics, but the core entity-level facts about voting rights are incorrect. While the answer addresses the multi-hop aspect (comparing two companies’ governance structures in merger contexts), the synthesis is flawed due to the foundational inaccuracy. Number formats are not at issue, but the vote count (10 vs. 1) is quantitatively wrong for Meta Class B. Thus, quantitative accuracy is low, qualitative accuracy is moderate due to correct framing but wrong facts, and contextual relevance is high as the structure and intent align with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 404,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How might U.S. payer restrictions on high-cost therapies like Repatha impact Pfizer's revenue recognition strategy for similar cardiovascular products, given both companies face challenges with formulary placement and patient affordability?",
      "original_answer": "U.S. commercial payer actions have significantly restricted access to high-cost therapies like Repatha through formulary exclusions, prior authorization requirements, and increased patient cost-sharing, which has directly limited sales despite price reductions. Pfizer faces similar risks, as it notes challenges in obtaining or maintaining favorable formulary placement and pricing for its products amid managed care and healthcare cost containment trends. Gilead's revenue recognition strategy accounts for these payer dynamics through complex gross-to-net deductions that factor in expected payer mix, rebate levels, and patient affordability trends. Therefore, if Pfizer markets similar high-cost cardiovascular therapies, it would likely face comparable pressures requiring careful estimation of rebates and chargebacks to align with payer realities and maintain revenue integrity.",
      "llm_answer": "Amgen notes that U.S. payers are increasingly using step‑therapy, high‑deductible plans and copay‑accumulator rules to limit access to the expensive PCSK9 antibody Repatha, forcing the company to cut the drug’s list price and offer larger rebates to keep it on formularies. Pfizer’s 10‑K explains that it records product revenue “net of estimated government and other rebates, chargebacks, cash‑discounts and fees” and that those estimates are driven by payer mix, discount rates and the likelihood of reversals ( p. 48 ). Consequently, if similar cardiovascular products face the same payer‑driven formulary and affordability pressures, Pfizer will likely have to deepen rebates and be more conservative in its gross‑to‑net assumptions—potentially lowering the price at which revenue is recognized and increasing the risk of revenue adjustments, much as Amgen is doing with Repatha.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that U.S. payers restrict access to high-cost therapies like Repatha through step-therapy, high-deductible plans, and copay accumulators—consistent with the original answer’s emphasis on formulary exclusions, prior authorizations, and cost-sharing. It notes Amgen’s response (price cuts, increased rebates), which is factually correct and contextually relevant. (2) There are no explicit numerical values in either answer, so quantitative accuracy is not compromised; all references to financial mechanisms (rebates, chargebacks, discounts) are consistent and correctly described. (3) The multi-hop reasoning is sound: the model connects Amgen’s experience with Repatha to Pfizer’s revenue recognition policy as disclosed in its 10-K, then infers that similar cardiovascular products would require more conservative gross-to-net estimates. This mirrors the original answer’s logic regarding Gilead’s strategy and applies it appropriately to Pfizer. (4) The LLM cites Pfizer’s 10-K page 48 accurately, reinforcing entity and contextual accuracy. The only minor gap is that the original answer references Gilead as an example of revenue strategy adaptation, while the LLM substitutes Amgen (which is actually more relevant given Repatha’s context), making the reasoning stronger. Wording differs slightly but semantic equivalence is maintained. No factual errors; excellent synthesis and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 410,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How does Chevron's 15% ownership stake in TCO's Kazakhstan crude oil operations influence its exposure to TCO's planned production ramp-up from the FGP project starting in 2025, especially when compared to COP's broader dependence on crude oil as a raw material?",
      "original_answer": "Chevron's 15% ownership in TCO provides it with partial exposure to TCO's planned production ramp-up from the FGP project in Kazakhstan, which is expected to start-up in the first half of 2025 and ramp up to full production within three months. This production increase will flow through the Caspian Pipeline Consortium (CPC), in which Chevron also holds a 15% interest, enabling increased throughput capacity. In contrast, COP has a direct and full dependency on crude oil as a raw material, indicating a more concentrated exposure to crude oil supply dynamics. Chevron’s partial ownership in TCO creates a more indirect exposure to crude oil production volumes and timelines in Kazakhstan, as opposed to COP’s direct reliance on crude oil for its operations.",
      "llm_answer": "Chevron’s 15 percent ownership of the Caspian Pipeline Consortium (CPC) – the export route for Tengizchevroil’s (TCO) Kazakh crude – means that only about one‑fifteenth of the additional oil that TCO expects to bring on line with the Future Growth Project (FGP) in the first half of 2025 will flow through to Chevron’s financial results.  The FGP is slated to start up in early 2025 and ramp to full production within three months, but Chevron’s exposure is limited to its 15 % share of that output (Chevron 10‑K p. 16).  \n\nConocoPhillips, by contrast, derives the bulk of its earnings from crude‑oil production and treats crude oil as the primary raw material for its upstream portfolio (see COP 10‑K reserve tables showing that the majority of its proved reserves are crude‑oil‑based bitumen – e.g., 410 million barrels in 2023, p. 145).  Consequently, COP’s overall results are far more sensitive to changes in total crude‑oil volumes and prices than Chevron’s modest, proportional stake in the Kazakh ramp‑up.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor error in reasoning that affects the completeness of the multi-hop synthesis. (1) Correct elements: The 15% ownership stake in TCO and CPC is accurately stated; the FGP project start-up in the first half of 2025 and ramp-up within three months is correctly reported; Chevron's partial exposure due to its 15% stake is properly conveyed; COP's heavy reliance on crude oil as a raw material is supported with a correct reference to its proved reserves (410 million barrels in 2023, p.145 of 10-K). (2) Quantitative accuracy: All numbers (15%, 2025, three months, 410 million barrels) match the ground truth or are consistent with it. The phrasing 'one-fifteenth' is a minor misstatement — 15% equals approximately 3/20, not 1/15 — but this does not significantly distort the magnitude and may be interpreted as approximate. (3) Multi-hop reasoning: The model correctly links Chevron’s ownership in TCO and CPC to its indirect exposure and contrasts it with COP’s direct crude oil dependence. However, it incorrectly frames Chevron’s financial exposure as being solely through the CPC pipeline, whereas the ground truth emphasizes Chevron’s 15% equity ownership in TCO itself as the primary source of exposure to production volumes. The CPC interest supports throughput but is secondary to equity ownership in determining production exposure. This misattribution slightly weakens the reasoning chain. (4) Despite this, the overall conclusion about Chevron’s limited, proportional exposure versus COP’s broad dependence is valid and well-supported. The answer is contextually excellent, directly addressing the comparative exposure question with relevant data. Hence, correctness is high but not perfect due to the structural misemphasis in exposure mechanism.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 498,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How does Goldman Sachs' exposure to hotel-related commercial real estate loans compare to MetLife's investment in real estate funds focused on hotels, given the role of real estate funds in both companies' strategies?",
      "original_answer": "Goldman Sachs has significant credit exposure to commercial real estate loans secured by hotels, as detailed in their 2024 10-K filing, which highlights the importance of this asset class in their lending portfolio. These loans are often channeled through or connected to real estate funds, which are also a key vehicle for investment in hotel assets. MetLife, on the other hand, holds $13.3 billion in real estate investments as of December 31, 2024, including interests in real estate funds that invest in hotel properties. While both companies are exposed to hotel real estate, Goldman Sachs' involvement is primarily through lending, whereas MetLife participates through direct ownership stakes in funds. This distinction reflects different risk profiles and strategic approaches to the hotel sector within the broader commercial real estate market.",
      "llm_answer": "Goldman Sachs reports that its commercial‑real‑estate portfolio totals $34.8 billion (loans $29.8 bn + commitments $5.0 bn) and that “hospitality” (i.e., hotels) makes up about 5 % of that mix – roughly $1.7 billion of hotel‑related loans and commitments.  \n\nMetLife’s real‑estate holdings are $13.3 billion in total, of which $700 million is directly in hotel properties and $3.46 billion is held in real‑estate funds (which include hotel assets).  Even the hotel‑only portion of MetLife’s fund portfolio therefore exceeds Goldman Sachs’s $1.7 billion hotel loan exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that Goldman Sachs has 'significant credit exposure' to hotel-related commercial real estate loans and that these are part of their lending portfolio, but it does not specify the total CRE portfolio size or the 5% allocation to hospitality. The $34.8 billion total CRE exposure and the 5% ($1.7 billion) hotel-related exposure are not present in the ground truth and appear to be fabricated or misattributed. Similarly, the LLM claims MetLife has $700 million directly in hotel properties and $3.46 billion in real estate funds including hotel assets — these specific sub-allocations are not in the original answer, which only states that MetLife holds $13.3 billion in real estate investments including interests in real estate funds that invest in hotels. The breakdown into $700M and $3.46B is unsupported. (2) Calculations: While the arithmetic (5% of $34.8B ≈ $1.7B) is correct, the inputs are not grounded in the original data. The comparison that MetLife’s 'hotel-only portion of fund portfolio' exceeds Goldman’s exposure is speculative and not supported — the original does not state how much of MetLife’s fund investments are hotel-specific. (3) Multi-hop reasoning: The LLM attempts to compare exposure types (lending vs. ownership) and uses fund structures, which aligns with the original’s strategic distinction. However, the reasoning is built on false quantitative premises, undermining the conclusion. (4) The contextual relevance is high because the answer addresses the core question about comparative exposure and strategy. However, due to major quantitative inaccuracies and unsupported disaggregation of portfolio components, the correctness score is low. The qualitative accuracy is moderate because the conceptual framework (lending vs. fund investment) is sound, but entity-specific details are incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 521,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How do the liquidity risk profiles of BA's limited partnership investments compare with UPS's pension fund commitments in real estate, particularly regarding the 10–15 year partnership terms and UPS's $3.3 billion in unfunded obligations?",
      "original_answer": "Both BA and UPS hold investments through limited partnerships, which expose them to long-term liquidity risks due to the structural characteristics of these vehicles. BA invests in limited partnerships that focus on real estate and private assets, with investment durations typically spanning 10–15 years, limiting liquidity until the end of the partnership term. Similarly, UPS has $3.3 billion in unfunded commitments to limited partnerships as of December 31, 2023, with redemption provisions restricted until the end of the fund’s life, also generally 10–15 years from inception. This shared structure implies both companies face limited short-term liquidity and are exposed to market risks over extended periods without the ability to exit early without discounts.",
      "llm_answer": "Boeing’s limited‑partnership holdings are treated as long‑term, ill‑liquid assets – they are valued at fair value (Level 3) and can generally be redeemed only when the partnership terminates, which for most private‑equity‑type funds is a 10‑ to 15‑year horizon. UPS’s pension‑plan real‑estate exposure is structured the same way: the plan’s private‑equity/real‑estate interests are limited‑partnership stakes that cannot be redeemed until the end of the partnership term (typically 10‑15 years) and the company currently carries about **$3.3 billion of unfunded commitments** that must be funded over that remaining period【page 89】. Thus, both companies face comparable liquidity risk from the long‑dated partnership structure, but UPS’s exposure is quantified by a sizable $3.3 billion unfunded liability, whereas Boeing’s filing does not disclose a specific unfunded amount for its LP investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Boeing (BA) has limited partnership investments with 10–15 year terms, valued at Level 3, with limited liquidity; UPS has $3.3 billion in unfunded commitments to limited partnerships as of December 31, 2023, also with 10–15 year terms and restricted redemption. The $3.3 billion figure is correctly cited and attributed to UPS’s pension fund real estate/private equity commitments. (2) Quantitative accuracy is perfect: the $3.3 billion unfunded obligation is correctly stated, and no incorrect numbers are introduced. Boeing’s lack of disclosed unfunded amount is accurately noted. (3) Multi-hop reasoning is sound: the model correctly synthesizes liquidity risk profiles across two companies, linking structural illiquidity in limited partnerships to long-term commitments, and contrasts disclosed vs. undisclosed unfunded amounts. (4) The only minor shortcoming is that the original answer emphasizes the shared structural risk more symmetrically, while the LLM slightly overemphasizes the difference in disclosure (Boeing not stating unfunded amount), which, while true, doesn’t detract from the core comparison. However, this nuance is still within acceptable qualitative accuracy. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is excellent—directly addresses all parts of the multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 400,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does the voting power distribution tied to Class A and Class B common stock at META compare to the voting structure at CMCSA, particularly in terms of control concentration and shareholder influence?",
      "original_answer": "At META, the dual-class structure gives Class B common stockholders, primarily Mark Zuckerberg, outsized control, requiring a majority of Class B shares to approve change-of-control transactions until they represent less than 35% of combined voting power. In contrast, CMCSA's structure grants Class A common stockholders 66 2/3% of the combined voting power, with each Class B share having 15 votes, but Class B stock is non-dilutable and owned entirely by Brian L. Roberts. This means both companies use dual-class structures to concentrate control, but META's governance rules and anti-takeover provisions make it harder for investors to influence corporate decisions compared to CMCSA, where Class A shareholders collectively hold significant voting influence.",
      "llm_answer": "Meta’s dual‑class structure gives its controlling shareholder, Mark Zuckerberg, effective control of the company even though he holds far less than a majority of the total shares – the 9 million‑share Class B stock carries 15 votes per share and, while it represents only about one‑third of the combined voting power, the charter provisions let Zuckerberg “control the outcome of matters requiring stockholder approval” (Meta 10‑K p. 50).  \n\nComcast also has a dual‑class system, but the voting power is less concentrated: Class A holders collectively own roughly 66 ⅔ % of the voting power, while the single holder of all Class B shares (Brian L. Roberts) controls the remaining 33 ⅓ % (Comcast 10‑K p. 33). Thus, at Meta control is heavily weighted toward a single insider, whereas at Comcast the majority of voting power is dispersed among many Class A shareholders, limiting any one holder’s dominance.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core comparison between META and CMCSA's dual-class voting structures. It correctly identifies that Mark Zuckerberg controls a disproportionate amount of voting power at Meta through Class B shares with 15 votes per share, and notes that Class B shares represent about one-third of voting power (consistent with the ground truth threshold of 35%). The answer accurately states that CMCSA's Class A shareholders hold approximately 66 2/3% of voting power, leaving 33 1/3% to Brian L. Roberts via Class B shares, which aligns with the ground truth. However, the LLM omits a key detail from the original answer: META’s charter requires a majority of Class B shares to approve change-of-control transactions until they fall below 35% of voting power—a significant anti-takeover provision that strengthens control concentration. This omission slightly weakens completeness. Additionally, while the LLM claims Comcast’s voting power is 'less concentrated,' it understates that Roberts still holds all Class B shares and thus a fixed 33 1/3%, which is still a strong control position, though not as dominant as Zuckerberg’s. The LLM also incorrectly implies that Roberts holds only 33 1/3% of voting power, but the ground truth clarifies that Class B shares have 15 votes each, and Roberts owns all of them—this nuance is missing. Despite these issues, the overall reasoning is sound, entities are correct, and the comparison effectively highlights greater control concentration at Meta versus more distributed influence at CMCSA. Minor quantitative and qualitative gaps prevent a perfect score, but the answer remains factually strong and contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 462,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does the allocation of PEP's U.S. qualified defined benefit plan assets to government securities compare with the investment profile of COST's short-term holdings in government and agency securities, particularly in terms of risk management and expected return strategy?",
      "original_answer": "PEP's U.S. qualified defined benefit plans allocated $1.812 billion to government securities in 2023 as part of a diversified investment strategy aiming for a 7.4% long-term return, while COST holds short-term investments in government and agency securities primarily for capital preservation with a focus on low volatility and effective maturities of three months to five years. PEP's approach includes active management and use of derivatives to mitigate risk, whereas COST limits exposure to interest rate fluctuations by investing in fixed-rate, short-duration instruments.",
      "llm_answer": "PepsiCo’s U.S. qualified defined‑benefit plan holds roughly $1.8 billion of government securities out of about $11.2 billion of total U.S. plan assets – a little over 15 percent of the plan’s assets and roughly one‑quarter of its overall fixed‑income allocation (the plan targets about 55 percent fixed income and expects a long‑term 7.4 percent return).  The government‑bond component is used to dampen volatility and help meet the plan’s long‑term return objective while still allowing exposure to higher‑yielding equities and real‑estate assets.  \n\nCostco’s short‑term investments, by contrast, are confined to U.S. government and agency securities (including money‑market funds and repos) with maturities of three months to five years.  These holdings are treated as cash equivalents, with the primary goal of preserving principal and generating modest yields rather than seeking the higher returns that underpin PepsiCo’s pension‑plan strategy.  Consequently, Costco’s approach is more conservative and liquidity‑focused, while PepsiCo’s pension allocation uses government securities as a risk‑mitigation layer within a broader, higher‑return, long‑term portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $1.8 billion figure for PEP's government securities allocation is correctly reported (ground truth: $1.812 billion — minor rounding acceptable). The 7.4% long-term return target is accurately cited. While the LLM adds contextual details not in the original (e.g., total plan assets of $11.2B, 15% allocation, 55% fixed-income target), these are consistent with plausible elaboration and do not contradict the ground truth. COST’s short-term holdings in government and agency securities with maturities from three months to five years are correctly described. (2) The LLM correctly captures the risk and return contrast: PEP uses government securities as part of a diversified, return-seeking strategy with active risk mitigation (implied through asset mix), while COST prioritizes capital preservation and liquidity. (3) Multi-hop reasoning is sound — the model successfully synthesizes information across PEP’s pension strategy and COST’s short-term investment policy, comparing their objectives (return vs. preservation), duration profiles, and risk management approaches. (4) The only minor gap is that the LLM does not explicitly mention PEP’s use of derivatives for risk mitigation, which is noted in the original answer. However, the concept of risk mitigation is conveyed through 'dampen volatility' and strategic asset allocation. Overall, the answer is factually correct, contextually appropriate, and semantically equivalent to the ground truth with only slight omission of a specific risk tool (derivatives).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 440,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How does Southern Company's actual allocation to mortgage-backed securities within its fixed income portfolio compare to NextEra Energy's target allocation framework for fixed income investments, given that both classify mortgage-backed securities under fixed income assets?",
      "original_answer": "Southern Company had only $9 million allocated to mortgage-backed securities as part of its $6,154 million in fixed income investments measured using significant other observable inputs (Level 2), representing less than 0.15% of its fixed income portfolio. In contrast, NextEra Energy's pension plan targets 32% allocation to fixed income investments as part of its broader pension asset strategy, which explicitly includes mortgage-backed securities under its fixed income classification. Both companies classify mortgage-backed securities under fixed income investments, with Southern Company valuing them at yields on comparable securities and NextEra Energy utilizing a combination of directly held securities and commingled investment arrangements.",
      "llm_answer": "Southern Company’s fair‑value schedule shows that only **$9 million** of its fixed‑income holdings are classified as mortgage‑ and asset‑backed securities (the “actual allocation” column on page 298). In contrast, NextEra Energy’s pension‑plan policy sets a **target allocation of 32 % of total assets to fixed‑income investments** (see page 101). Thus, Southern’s actual dollar amount in mortgage‑backed securities is a tiny, specific slice of its fixed‑income portfolio, whereas NextEra’s framework calls for roughly one‑third of its entire portfolio to be in fixed‑income assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: Southern Company's $9 million allocation to mortgage-backed securities and NextEra Energy's 32% target allocation to fixed income are both accurately reported. The LLM correctly distinguishes between Southern's actual allocation (a dollar amount within fixed income) and NextEra's strategic target (a percentage of total pension assets). (2) The answer correctly identifies both companies and the relevant financial context—Southern’s actual holdings and NextEra’s target framework—demonstrating proper entity accuracy. (3) The reasoning is sound: it contrasts a specific, small dollar allocation (Southern) with a broad portfolio-level target (NextEra), which is the core of the multi-hop comparison. (4) While the LLM omits the explicit percentage of Southern’s fixed income portfolio that $9 million represents (<0.15%), this quantitative detail is implied by describing it as a 'tiny, specific slice.' The omission is minor and does not undermine the correctness. The LLM also does not mention valuation methods (e.g., yields on comparable securities), but this is secondary to the main comparison. Overall, the answer captures the essential contrast accurately and clearly, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 369,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What specific pricing agreements and supply arrangements did Tesla and Panasonic Corporation formalize in their Gigafactory partnership, and how does GM’s dependency on batteries compare in terms of supplier integration and contractual depth?",
      "original_answer": "Tesla and Panasonic Corporation formalized multiple pricing agreements and supply arrangements under their Gigafactory partnership, including the Amended and Restated General Terms and Conditions for Gigafactory (June 10, 2020), the 2020 Pricing Agreement (Gigafactory 2170 Cells), and the 2021 Pricing Agreement (Japan Cells). These agreements establish detailed pricing mechanisms, production responsibilities, and shared facility leasing arrangements. In contrast, GM’s dependency on batteries is noted without equivalent supplier integration details or specific contractual commitments in the evidence provided, indicating a less transparent or structured supplier partnership compared to Tesla’s explicit agreements with Panasonic.",
      "llm_answer": "**Tesla‑Panasonic Gigafactory partnership**  \n- Tesla and Panasonic entered a long‑term **Supply Agreement** (dated Oct 5 2011) that was later amended (Oct 29 2013, Apr 5 2016, etc.) and supplemented by a **General Terms and Conditions** (Oct 1 2014) and a **Production Pricing Agreement** (Nov 7 2014) 【page 106】.  \n- The parties also executed a series of **cell‑specific pricing agreements**: the **2019 Pricing Agreement** for Japan‑cell production (Sept 20 2019), the **2020 Pricing Agreement** for Gigafactory 2170‑cell production (June 9 2020), and the **2021 Pricing Agreement** for Japan‑cell production (Dec 29 2020) 【page 107】.  \n- Together these documents create a vertically‑integrated, multi‑year framework that ties Panasonic’s cell supply, pricing, and factory lease arrangements directly to Tesla’s Gigafactory operations.\n\n**GM’s battery dependency**  \n- GM’s 2023 filing discusses component‑part purchases and transactions with non‑consolidated affiliates but does **not** disclose a comparable, dedicated battery‑supply contract or joint‑venture structure 【page 78】. The filing treats batteries as one of many purchased components rather than as a co‑owned production line.  \n\n**Comparison**  \n- Tesla’s relationship with Panasonic is a deep, contract‑rich partnership that includes a master supply agreement, detailed pricing accords for specific cell families, and joint lease/investment provisions—reflecting high supplier integration.  \n- GM’s approach is a more conventional buyer‑supplier model, with batteries sourced from external suppliers under ordinary purchase agreements and no disclosed joint‑ownership or long‑term pricing contracts, indicating a shallower level of contractual integration.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Correctness: The LLM correctly identifies the core pricing agreements and supply arrangements between Tesla and Panasonic, including the 2020 and 2021 Pricing Agreements, and notes the absence of equivalent detailed contracts for GM. While the LLM cites a '2019 Pricing Agreement' and slightly different dates (e.g., June 9, 2020 vs. June 10, 2020), these are minor discrepancies likely due to document versioning or timestamp interpretation and do not affect factual substance. The core agreements—Gigafactory 2170 cells and Japan cells—are correctly mapped. (2) Quantitative Accuracy: Dates and agreement names are nearly exact; only minor date variations (e.g., Dec 29, 2020 vs. implied 2021 agreement) exist, but the 2021 agreement could plausibly be dated late 2020. The LLM adds a '2019 Pricing Agreement' not in the original answer, which may be extra detail beyond the provided evidence but does not contradict it. (3) Qualitative Accuracy: The reasoning is sound—LLM correctly synthesizes that Tesla has a deep, multi-layered contractual integration with Panasonic, while GM lacks such disclosed depth. The comparison highlights vertical integration vs. conventional sourcing, matching the original's conclusion. (4) Contextual Relevance: The response fully addresses both parts of the multi-hop question—specific agreements and comparative supplier integration—and provides well-structured, relevant analysis. The only reason for not scoring 10 is the slight over-specification of earlier agreements (e.g., 2011 Supply Agreement) not emphasized in the ground truth, which, while potentially factual, shifts focus slightly from the specific agreements highlighted in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1639,
        "completion_tokens": 480,
        "total_tokens": 2119
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How does Chevron's ongoing tax audit exposure in Nigeria compare to Exxon's production-sharing contract risk in the same country, given the specific terms of Nigeria's PSCs and Chevron's unresolved tax positions?",
      "original_answer": "Chevron faces unresolved tax audits in Nigeria with $5,288 million in unrecognized tax benefits at year-end 2021, where the latest audit finalized was for the year 2007, leaving over a decade of tax exposure open to scrutiny. Meanwhile, Exxon operates in Nigeria under production-sharing contracts (PSCs) that typically last 30 years, with a 10-year exploration period followed by a 20-year production period, which may be extended subject to relinquishment provisions. Exxon also reports that 12% of its total proved reserves in 2021 were under PSC arrangements, where production volumes fluctuate inversely with price changes. Therefore, while Chevron's risk in Nigeria is tied to legacy tax liabilities and regulatory uncertainty, Exxon's exposure is more operational and tied to the fiscal terms and duration of its PSCs, which are sensitive to commodity price volatility.",
      "llm_answer": "Chevron’s Nigeria exposure is a tax‑audit matter.  The 2021 10‑K shows that the company still has an open audit for Nigeria (the last year examined was 2007) and carries $5.3 billion of unrecognised tax benefits – about 82 % of which would affect its effective tax rate if the positions were resolved.  By contrast, Exxon’s Nigeria risk is contractual: its deep‑water assets are held under 30‑year production‑sharing contracts that include a 10‑year exploration phase, a 20‑year production phase (extendable under the 2021 Petroleum Industry Act) and partial‑relinquishment requirements.  The risk is therefore tied to the PSC terms and possible changes in fiscal or relinquishment conditions, not to a quantified tax‑liability like Chevron’s unresolved tax positions.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core contrast between Chevron's tax-audit exposure and Exxon's PSC-related operational risk in Nigeria. Quantitatively, the $5.3 billion in unrecognized tax benefits is correctly reported (matching the ground truth $5,288 million, rounded appropriately), and the reference to the 2007 audit being the latest finalized is accurate. The 82% figure affecting the effective tax rate is not in the original answer but is plausible and does not contradict it; however, this detail is extraneous and not required, so its presence doesn't detract significantly. The description of Exxon’s 30-year PSCs with a 10-year exploration and 20-year production phase aligns with the ground truth, and the mention of extendability under the 2021 Petroleum Industry Act adds context not in the original but is factually consistent. The LLM correctly identifies that Exxon’s risk is contractual and price-sensitive, while Chevron’s is tax-related and regulatory. The only minor gap is the omission of the specific 12% of proved reserves under PSCs mentioned in the original, which adds granularity but does not undermine the overall correctness. Multi-hop reasoning is sound: the model synthesizes tax exposure (Chevron) vs. fiscal/contractual exposure (Exxon) across two companies and risk types. Wording differs but meaning is semantically equivalent. All entities (Chevron, Exxon, Nigeria, PSCs, 2021) are correct. The answer is fully relevant and directly addresses the comparative risk question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 419,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How does Tesla's use of commercial paper compare to companies with significant operations in Ohio, such as Duke Energy Ohio?",
      "original_answer": "Tesla reported $470 million in commercial paper holdings as of December 31, 2023, as part of its short-term investment strategy. In contrast, Duke Energy Ohio, a major company operating in the state, had $25 million in commercial paper outstanding as disclosed in its financial details. This comparison highlights different approaches to short-term financing and liquidity management between Tesla, a technology and automotive company, and Duke Energy Ohio, a utility provider.",
      "llm_answer": "Tesla’s 2023 10‑K shows it held **about $470 million of commercial paper** as part of its cash‑equivalents portfolio (see TSLA 10‑K p. 72). By contrast, Duke Energy’s Ohio operations reported **only $25 million of commercial paper** (listed under short‑term obligations classified as long‑term debt in Duke Energy Ohio’s 10‑K, p. 165). Thus, Tesla’s use of commercial paper is roughly 20 times larger than that of Duke Energy Ohio.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: Tesla's $470 million and Duke Energy Ohio's $25 million in commercial paper are correctly reported, with proper context on their classification (Tesla as part of cash equivalents, Duke as short-term obligations). The comparison stating Tesla's holding is 'roughly 20 times larger' is mathematically sound (470 / 25 = 18.8, which rounds to ~20). (2) The answer is complete, addressing the comparison between Tesla and a major Ohio-based company (Duke Energy Ohio) regarding commercial paper usage, as required. (3) Entities are correctly identified: Tesla (TSLA) and Duke Energy Ohio, with accurate references to their respective 10-K filings and page numbers. (4) The reasoning is sound and demonstrates multi-hop synthesis—pulling data from two different companies' filings, interpreting the role of commercial paper in each context, and drawing a valid comparative conclusion. (5) The semantic meaning fully aligns with the original answer, even enhancing it with specific document references. All criteria for correctness, accuracy, and relevance are met.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 332,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How does JPMorgan's exposure to transition risk, as outlined in its climate risk management framework, influence its compliance risk profile compared to Morgan Stanley's experience with regulatory scrutiny tied to climate-related disclosures?",
      "original_answer": "JPMorgan acknowledges transition risk as a key component of climate risk, which may amplify compliance risk due to increased regulatory scrutiny tied to climate-related disclosures. JPMorgan has established a Climate Risk Management function that integrates climate risk into its broader risk management framework, including developing metrics and stress testing mechanisms to assess potential financial impacts. According to Morgan Stanley’s disclosures, compliance risk includes exposure to legal sanctions or reputational damage from failure to meet climate-related regulatory requirements, such as increased disclosure mandates or carbon taxes. Furthermore, Morgan Stanley notes that transition risk can lead to reputational, compliance, and litigation risks due to heightened legal and regulatory scrutiny. Therefore, both firms recognize that transition risk directly influences compliance risk, but JPMorgan emphasizes proactive integration into risk frameworks, whereas Morgan Stanley highlights the regulatory enforcement dimension.",
      "llm_answer": "JPMorgan’s climate‑risk framework treats transition risk as a core component of its overall risk‑governance structure – it is overseen by the Climate Risk Committee, embedded in scenario‑analysis and integrated with the firm‑wide compliance program, and is explicitly called out as a source that can heighten compliance, litigation and regulatory‑scrutiny risk (see JPM 10‑K pages 148‑78). Morgan Stanley’s filing makes a similar point, noting that the transition‑risk side of climate change can “amplify … compliance and/or litigation risk due to increased legal and regulatory scrutiny” of its climate‑related disclosures (see MS 10‑K pages 78‑79). Thus, while both firms see transition risk feeding into compliance risk, JPMorgan does so through a formal, committee‑driven management framework, whereas Morgan Stanley highlights the risk as a consequence of external regulatory attention to its climate reporting.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: both JPMorgan and Morgan Stanley recognize transition risk as amplifying compliance risk due to regulatory scrutiny on climate disclosures. The LLM correctly identifies JPMorgan’s proactive integration via a Climate Risk Committee and firm-wide framework, while Morgan Stanley emphasizes external regulatory and legal scrutiny. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or the original answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes information from both firms’ 10-K filings (referencing specific page ranges), compares their approaches, and draws a valid contrast in emphasis—JPMorgan on internal governance structure, Morgan Stanley on external regulatory consequences. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., 'committee-driven management framework' vs 'proactive integration into risk frameworks'), the meaning matches the original. The only minor shortcoming is that the LLM does not explicitly mention 'reputational damage' or 'carbon taxes' as noted in Morgan Stanley’s disclosures, which slightly reduces completeness. However, the core insight about regulatory scrutiny and compliance risk is preserved. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 424,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What implications does Nigeria's 30-year production-sharing contract framework have for both ConocoPhillips' deepwater operations and Chevron's reserve accounting practices in the region?",
      "original_answer": "Nigeria's regulatory framework for deepwater offshore exploration establishes 30-year production-sharing contracts (PSCs) that include a 10-year exploration period followed by a 20-year production period, which may be extended under certain conditions. Since ConocoPhillips operates in Nigeria, this structure directly influences its long-term planning and investment decisions in the region. Chevron, which reports that 8-10% of its reserves are tied to PSCs like those in Nigeria, must align its reserve accounting and production forecasts with the specific terms of these contracts, including the partial relinquishment provisions under Nigeria's Petroleum Industry Act. Both companies must therefore manage exploration timelines, commercial discovery requirements, and reserve disclosures in accordance with this regulatory framework.",
      "llm_answer": "Nigeria’s deep‑water acreage is held under 30‑year production‑sharing contracts (PSCs) that give the operator a 10‑year exploration phase (with optional extensions) followed by a 20‑year production period that can be extended, subject to partial‑relinquishment requirements under the Petroleum Industry Act【page_31】.  \n\nFor ConocoPhillips, this framework means its deep‑water projects must be discovered, developed and, if needed, extended within that 30‑year horizon and must satisfy the relinquishment milestones, shaping its capital‑allocation and timing decisions for Nigerian assets.  \n\nFor Chevron, the same PSC regime means the Nigerian volumes are accounted for as “production‑sharing‑contract” reserves, which represent only a modest share of its total reserve portfolio (about 7 %–10 % of consolidated reserves) and are disclosed as a non‑material component of its reserve balances【page_107】【page_106】. This limited but defined PSC exposure dictates how Chevron records, reports and monitors those reserves under the 30‑year contract terms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all numbers and timeframes are correct: the 30-year PSC with a 10-year exploration and 20-year production period, and Chevron's 7%–10% of reserves tied to PSCs match the original answer (8–10% is semantically equivalent to 7%–10%, especially given reporting variability). The mention of partial relinquishment under the Petroleum Industry Act is correctly included. (2) The LLM accurately reflects ConocoPhillips' operational planning constraints and Chevron's reserve accounting practices under the PSC framework. (3) Multi-hop reasoning is sound: it synthesizes Nigeria’s regulatory structure with company-specific impacts on capital allocation (ConocoPhillips) and reserve disclosure practices (Chevron). (4) Minor wording differences exist (e.g., 'modest share' vs 'tied to PSCs'), but the semantic meaning and factual content are equivalent. The only slight shortfall is that the LLM does not explicitly mention 'commercial discovery requirements' or 'long-term planning' as in the original, but these are implied in 'capital-allocation and timing decisions'. Thus, the answer is excellent but not perfect, warranting a 9/10 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 347,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How does Boeing's exposure to U.S. government contract modifications influence its application of ASU 2022-06, and how does this compare to FedEx's use of the same standard in managing reference rate reform impacts on their contracts?",
      "original_answer": "Boeing faces significant risk from U.S. government contract modifications, which could impact 37% of its revenues earned under government contracts. While Boeing must apply accounting standards like ASU 2022-06, which extends relief for contract modifications related to reference rate reform (e.g., LIBOR), the evidence shows Boeing did not experience material impacts from such modifications. Similarly, FedEx, though not directly exposed to government contract risk like Boeing, also applies ASU 2022-06 to manage contract modifications related to reference rate reform, with no material effect on its financial condition or results of operations as of May 31, 2024. Both companies benefit from the extended sunset date of ASU 2022-06 through 2024, easing the burden of contract adjustments.",
      "llm_answer": "Boeing notes that a large share of its revenue comes from U.S.‑government contracts and that those contracts can be “modified, curtailed or terminated…without prior notice” (BA 10‑K p. 14). Because such modifications often require the replacement of reference rates (e.g., LIBOR), Boeing is positioned to rely on the optional expedients in ASU 2022‑06, which “reduce the operational and financial impacts of contract modifications that replace a reference rate” (MetLife 10‑K p. 167). FedEx, by contrast, also monitors the same ASU for its contracts but states that “there has been no material effect to our financial condition…from reference‑rate reform as of May 31 2024” and that the guidance simply “reduced the operational and financial impacts of contract modifications” (FedEx 10‑K p. 93). Thus, Boeing’s exposure to government‑contract changes drives a proactive use of ASU 2022‑06 to mitigate accounting effects, while FedEx’s use of the standard is largely precautionary and has not produced a material impact.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core comparison between Boeing and FedEx regarding ASU 2022-06 and reference rate reform, with generally sound reasoning and contextual relevance. However, there are key quantitative inaccuracies: the ground truth states that Boeing's government contract modifications could impact 37% of its revenues from government contracts, but the LLM answer omits this specific percentage entirely. This is a significant omission because the question specifically asks about the influence of exposure, and the 37% figure quantifies that exposure. While the LLM correctly notes Boeing’s vulnerability to government contract changes and the applicability of ASU 2022-06’s relief, it fails to include the precise risk magnitude documented in the original answer. On the qualitative side, the LLM accurately describes Boeing’s proactive rationale for relying on ASU 2022-06 due to its exposure and contrasts it with FedEx’s precautionary, non-material application of the standard—aligning with the original answer’s conclusion. It also correctly references the extended sunset date (implied through 2024) and the lack of material impact for FedEx as of May 31, 2024. The use of quotes from 10-K filings (e.g., from MetLife and FedEx) adds credibility, though citing MetLife as a source for Boeing’s context is odd and potentially misleading, even if the content is accurate. The multi-hop reasoning—linking Boeing’s government contract risk to its need for ASU relief, and contrasting with FedEx’s different risk profile—is logically sound and well-synthesized. Overall, the answer is factually plausible and contextually strong but loses points for missing the critical 37% exposure metric, which undermines full quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 473,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How does ExxonMobil's offshore acreage in Angola compare to Chevron's stake in Angola LNG, given Chevron's reported upstream earnings contributions from that asset in 2021?",
      "original_answer": "ExxonMobil held 2.9 million net offshore acres in Angola at year-end 2021, while Chevron reported a stake in Angola LNG, which contributed to upstream-related earnings improvements in 2021 due to higher performance from equity affiliates like Angola LNG. Chevron's volumes in Angola reflect its share of production through affiliates, including Angola LNG.",
      "llm_answer": "ExxonMobil reported roughly **2.9 million offshore acres in Angola** at the end of 2021. Chevron, by contrast, owns a **36.4 % stake in Angola LNG**, and that asset generated about **$336 million of upstream earnings for Chevron in 2021**.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies despite capturing the general structure of the question. (1) The original answer states that ExxonMobil held 2.9 million *net offshore acres* in Angola at year-end 2021 — this number is correctly reported in the LLM answer, so that part is accurate. (2) However, the LLM introduces specific figures not present in the ground truth: Chevron's '36.4% stake in Angola LNG' and '$336 million of upstream earnings' are not mentioned or supported by the original answer. The original only states that Chevron's stake in Angola LNG contributed to upstream earnings improvements in 2021 due to higher performance from equity affiliates, without specifying the percentage stake or dollar amount. These fabricated numbers significantly reduce quantitative accuracy. (3) The multi-hop reasoning is partially sound — the model attempts to compare ExxonMobil's acreage with Chevron's involvement in Angola LNG and links it to upstream earnings — but the unsupported specifics undermine the qualitative accuracy. (4) Contextually, the answer is relevant and addresses the comparison between ExxonMobil's physical assets and Chevron's financial interest in Angola, but the addition of unverified metrics harms correctness. While the direction of the answer is reasonable, the inclusion of unsupported precise figures results in a partial correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 384,
        "total_tokens": 1539
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does Accenture's $6.6 billion investment in 46 strategic acquisitions in fiscal 2024, focused on scaling industry solutions, compare to Microsoft's revenue from enterprise and partner services—which includes industry solutions—in the same period?",
      "original_answer": "Accenture invested $6.6 billion across 46 strategic acquisitions in fiscal 2024 to scale its industry solutions, while Microsoft reported $7.594 billion in revenue from 'Enterprise and partner services'—a category that includes 'Industry Solutions'—during the same fiscal year. This indicates that while Accenture is heavily investing in expanding its industry-specific offerings through acquisitions, Microsoft is generating substantial revenue from its own industry solutions and enterprise services, suggesting differing strategic approaches to growth in the enterprise technology space.",
      "llm_answer": "Accenture spent $6.6 billion on 46 strategic acquisitions in fiscal 2024 to scale its industry‑solution offerings【page_6】.  In the same year Microsoft reported $7.594 billion of revenue from “Enterprise and partner services,” a line‑item that includes its Industry Solutions business【page_93】.  Thus, Accenture’s acquisition outlay was slightly lower than Microsoft’s enterprise‑partner services revenue for fiscal 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Accenture's $6.6 billion investment in 46 acquisitions in fiscal 2024 and Microsoft's $7.594 billion in 'Enterprise and partner services' revenue for the same period. All numeric values match the ground truth exactly, including the precise revenue figure and investment amount. (2) Quantitative accuracy is perfect—both dollar amounts are correct, properly formatted, and correctly attributed to the respective companies and fiscal year. The comparison stating Accenture’s outlay was 'slightly lower' is factually sound given $6.6B vs $7.594B. (3) The multi-hop reasoning is sound: the model correctly synthesizes data from two different companies and financial contexts (investment vs revenue) to make a valid cross-company comparison. The only minor shortcoming is that the LLM does not explicitly interpret the strategic implications (e.g., investment vs revenue as differing growth strategies) as in the original answer, which slightly reduces qualitative depth. (4) Contextual relevance is excellent—the response directly addresses the comparison asked in the question, stays focused on fiscal 2024, and correctly identifies the relevant financial metrics and their significance. Overall, the answer is factually complete and semantically equivalent to the ground truth, with only a slight omission in strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 384,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How might Duke Energy's experience with maintaining a 30% equity threshold under FERC-approved dividend policies inform Southern Company's financial planning for its 50% cost share in the $3 billion SNG pipeline project requiring similar FERC approval?",
      "original_answer": "Duke Energy Ohio was required to maintain equity, adjusted to remove push-down accounting impacts, at no less than 30% of total capital as part of FERC and PUCO approval for dividend policies. Southern Company Gas has a 50% cost share in a $3 billion pipeline project through its stake in SNG, which also requires FERC approval. Given this regulatory overlap, Southern Company may reference Duke Energy's equity management strategies to structure its capital allocation and ensure compliance with potential FERC equity requirements for the SNG pipeline project.",
      "llm_answer": "Duke Energy Ohio was required by FERC and its state PUC to pay dividends only from earnings and to keep its adjusted equity at no less than 30 percent of total capital, which forced the company to limit distributions and retain sufficient capital to stay above the regulator‑set floor. Applying that lesson, Southern Company should structure its financing for the $3 billion SNG pipeline so that the 50 percent cost‑share does not push its equity ratio below the level FERC will require—by curbing dividend payouts, preserving earnings and, if needed, making additional capital contributions to maintain the mandated equity cushion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: Duke Energy's 30% equity threshold and Southern Company's 50% cost share in the $3 billion SNG pipeline are accurately stated. No calculations are required, but the financial implications are correctly interpreted. (2) The entity names—Duke Energy Ohio, FERC, PUC (referencing PUCO implicitly), and Southern Company Gas via its SNG stake—are correctly identified and contextually appropriate. (3) The reasoning is sound and reflects proper multi-hop synthesis: it connects Duke Energy’s regulatory requirement (30% equity floor) to Southern Company’s need to manage its capital structure under similar FERC oversight for a jointly funded pipeline project. The recommendation to curb dividends, retain earnings, or make capital contributions mirrors the strategic implications of the original answer. (4) The only minor shortcoming is that the LLM does not explicitly mention 'push-down accounting adjustments'—a specific nuance in the equity calculation noted in the ground truth—though the concept of maintaining an 'adjusted equity cushion' is implied. This omission slightly affects qualitative completeness but does not undermine the core correctness. Overall, the answer is factually solid, contextually relevant, and logically well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 377,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the use of matrix pricing for corporate debt instruments differ between UPS's fair value hierarchy disclosures and MMM's valuation methodologies, given that both companies rely on this pricing technique when broker quotes are unavailable?",
      "original_answer": "UPS categorizes its corporate debt instruments under Level 2 inputs in the fair value hierarchy and utilizes matrix pricing when broker quotes are not available, as seen in its 2022 disclosures. Similarly, MMM also applies matrix pricing for corporate debt instruments when broker quotes are unavailable, valuing them based on yields from comparable securities or discounted cash flow models. Both companies depend on matrix pricing as a fallback method for valuing these instruments, though MMM specifically notes adjustments for non-observable risks like credit and liquidity, unlike UPS, which does not mention such adjustments. This reveals a nuanced difference in how each company applies matrix pricing depending on the complexity of risk factors considered.",
      "llm_answer": "UPS discloses that corporate debt securities are measured at Level 2 and, when broker quotes are missing, their fair value is derived by “matrix pricing, yield‑curves and other observable inputs” (see UPS 10‑K p. 89‑93). 3M, by contrast, does not label the technique as “matrix pricing”; it values corporate debt by applying yields from comparable issuers or a discounted‑cash‑flow model that uses observable yields and then adjusts for credit‑ and liquidity‑risk factors (see 3M 10‑K p. 101). Thus, UPS explicitly places matrix pricing within its Level‑2 hierarchy, whereas 3M incorporates a comparable‑yield/DCF approach (functionally similar to matrix pricing) but without a Level‑2 designation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that UPS categorizes corporate debt instruments under Level 2 and uses matrix pricing when broker quotes are unavailable, citing observable inputs like yield curves—consistent with the original answer. (2) It accurately states that MMM (3M) does not explicitly label the method as 'matrix pricing' but instead uses yields from comparable issuers or discounted cash flow models, incorporating adjustments for credit and liquidity risk—this matches the ground truth's emphasis on MMM’s adjustments for non-observable risks, which UPS does not mention. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across both companies’ 10-K disclosures, compares their valuation methodologies, and highlights a key qualitative difference in risk adjustment practices. (4) The only minor shortcoming is that the LLM implies 3M does not use Level 2 for these instruments by saying 'without a Level-2 designation,' which could be misinterpreted—however, in reality, 3M does classify these instruments in Level 2; the difference lies in the transparency of methodology description, not hierarchy level. This nuance is slightly misrepresented, but the core factual content on methodology and risk adjustments remains correct. All entities (UPS, MMM/3M), financial concepts (matrix pricing, DCF, Level 2), and contextual details (use when broker quotes are unavailable) are accurate. Number formats and citations (page numbers, years) are consistent with expectations. Overall, the answer is factually strong, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 454,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the $2.8 billion upfront payment from Vertical Bridge REIT, LLC to VZ in 2024 compare to T's prior tower transaction with Crown Castle in 2013, particularly in terms of the financing structure and the retained operational control over the towers?",
      "original_answer": "The $2.8 billion upfront payment from Vertical Bridge to VZ in 2024 was primarily recorded as prepaid rent ($2.0 billion) and a financing obligation ($830 million), reflecting the retained operational control and right-of-use for a portion of the towers. In contrast, T's 2013 transaction with Crown Castle resulted in a $4.827 billion cash payment, which was fully accounted for as a financing obligation, with T retaining control and continuing to depreciate the tower assets ($608 million at the end of 2024). Both companies maintained ownership on their balance sheets and depreciated the assets, but VZ's arrangement included a dual treatment of prepaid rent and financing, while T's was entirely structured as a financing obligation with interest at approximately 3.9%.",
      "llm_answer": "The $2.8 billion that Vertical Bridge REIT paid Verizon in 2024 was recorded as a hybrid financing: $2.0 billion was treated as prepaid rent (an operating‑lease liability) and $830 million as a financing obligation, while Verizon kept the towers on its balance sheet, depreciated them and leased back capacity for an initial 10‑year term (with renewal options and a right to acquire the towers at lease‑end). In the 2013 Crown Castle transaction, AT&T booked the $4.8 billion cash receipt entirely as a financing liability (interest‑bearing debt) and continued to own the towers, sub‑leasing space to Crown Castle for about 20 years; no prepaid‑rent component was used and AT&T’s operational control was limited to the sublease. Both deals leave the carrier retaining ownership and depreciation of the towers, but the Vertical Bridge deal uses a split prepaid‑rent/financing structure and gives Verizon a longer‑term lease‑back and purchase option, whereas the Crown Castle deal was a pure financing‑obligation sale‑lease‑back with AT&T merely a sublessee.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Quantitatively, all key numbers are correct: $2.8 billion total, split into $2.0 billion prepaid rent and $830 million financing obligation for VZ's 2024 deal; $4.827 billion is correctly rounded to $4.8 billion in the LLM response, which is acceptable for semantic equivalence. The interest rate of ~3.9% mentioned in the original is omitted but not contradicted. (2) The qualitative analysis is strong: the LLM correctly identifies that both VZ and T (AT&T) retained ownership and depreciation of towers on their balance sheets, and accurately contrasts the financing structures—VZ’s hybrid prepaid rent/financing vs. AT&T’s pure financing obligation. (3) Multi-hop reasoning is sound: the model synthesizes information across two different companies (VZ and T), two different years (2024 vs. 2013), and two different counterparties (Vertical Bridge vs. Crown Castle), correctly comparing structural differences in lease terms, accounting treatment, and operational control. (4) Minor deductions: the LLM refers to 'AT&T' as 'T' without clarifying the ticker (though common), and slightly overstates differences in operational control—original answer notes T retained 'control and continuing to depreciate,' while LLM says 'operational control was limited to the sublease,' which may understate T's retained role. Also, the purchase option for VZ is mentioned but not in the original answer, introducing a plausible but unverified detail. Despite these small issues, the core facts, comparisons, and synthesis are correct, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 442,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the potential tax liability from MRK's TCJA-related IRS examination compare with MDT's BEAT-related tax impact in 2024, given the TCJA's introduction of BEAT as a minimum tax?",
      "original_answer": "MRK faces a potential significant tax liability if the IRS disagrees with its transition tax position under the TCJA, which includes BEAT as a component of its minimum tax framework. The TCJA introduced BEAT as a minimum tax based on cross-border service payments, directly linking it to the broader tax reform that both MRK and MDT are subject to. In 2024, MDT reported a 0.3% increase in effective tax rate due to BEAT, indicating a measurable but relatively small impact. Comparatively, MRK's exposure could be more substantial if the IRS challenges its TCJA transition tax calculations, potentially reversing unrecognized tax benefits that stood at $2.3 billion as of December 31, 2024. Thus, while MDT's BEAT impact is quantifiably modest, MRK's TCJA-related risk remains high and contingent on IRS resolution.",
      "llm_answer": "Merck says the IRS is still examining its 2017‑2018 returns, including the one‑time transition‑tax charge imposed by the TCJA, and that a disagreement could “result in a significant tax liability” (MRK 10‑K p. 127). By contrast, Medtronic’s 2024 tax footnote shows the Base‑Erosion Anti‑Abuse Tax (BEAT) – the minimum‑tax provision created by the TCJA – added only a modest 0.3 percentage‑point increase to its effective tax rate (MDT 10‑K p. 87). Thus, Merck’s exposure is uncertain but potentially large, whereas Medtronic’s BEAT impact is quantified and relatively small.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that MRK faces a potential significant tax liability from the IRS examination of its TCJA transition tax, specifically citing the 2017–2018 returns and referencing the risk of a 'significant tax liability' from the MRK 10-K. It accurately states that MDT’s BEAT impact in 2024 added a 0.3 percentage-point increase to its effective tax rate, matching the ground truth. All quantitative values (0.3 percentage-point increase) are correct and properly attributed. (2) The numbers and dates are accurate: the 0.3% impact for MDT in 2024 is correctly reported, and while the $2.3 billion unrecognized tax benefits for MRK are not mentioned in the LLM answer, this is a minor omission rather than an error—the core quantitative claim (modest vs. potentially large exposure) remains valid. (3) The multi-hop reasoning is sound: the LLM correctly links the TCJA’s introduction of BEAT to both companies, distinguishes MRK’s uncertain but high-risk exposure from MDT’s quantified and small impact, and synthesizes information from both 10-Ks appropriately. (4) The answer is contextually fully relevant, directly comparing the two companies’ tax exposures as asked. The only reason for not scoring a 10 is the omission of the $2.3 billion unrecognized tax benefits figure, which is part of the ground truth and adds material context to MRK’s exposure. However, the qualitative characterization of MRK’s risk as 'potentially large' and uncertain still aligns with the truth, so the omission does not undermine the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 433,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does Nigeria's 30-year production sharing contract framework influence both ConocoPhillips' operational footprint and Chevron's reserve disclosures in Africa?",
      "original_answer": "Nigeria's regulatory framework establishes 30-year production sharing contracts (PSCs) with a 10-year exploration period followed by a 20-year production period, requiring partial relinquishment at the end of exploration (from hop2_evidence). ConocoPhillips operates in Nigeria under this framework (from hop1_evidence), which shapes its exploration timelines and asset management strategy. Chevron's 2021 reserves in Africa totaled 106 million barrels (from hop3_evidence), indicating continued exposure to jurisdictions like Nigeria where regulatory terms directly affect reserve life and development planning. The 30-year PSC duration influences both companies' capital allocation decisions, reserve booking practices, and long-term operational strategies in the region.",
      "llm_answer": "Nigeria’s production‑sharing contracts are 30‑year agreements that give the operator a 10‑year exploration phase (which can be split into optional periods) followed by a 20‑year production phase that may be extended under the Petroleum Industry Act 【page_31】. Because ConocoPhillips’ African assets are held under such PSCs, its Nigerian operations are limited to that contractual horizon, which is reflected in a relatively small African footprint – the company reports only about 184–191 million barrels of proved oil reserves in Africa for 2020‑2021 【page_153】. Chevron’s 10‑K likewise notes that a portion of its African reserve numbers comes from PSCs (including Nigeria), stating that PSC‑related reserves account for 7 % of consolidated African reserves in 2021 (9 % in 2020 and 11 % in 2019) and are disclosed as “not material” for those years 【page_107】【page_106】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. While it correctly identifies Nigeria's 30-year PSC framework with a 10-year exploration and 20-year production period, it introduces details not present in the ground truth, such as optional periods and extension under the Petroleum Industry Act, which were not part of the original answer. The claim that ConocoPhillips has only 184–191 million barrels of proved reserves in Africa is unsupported by the ground truth, which does not provide ConocoPhillips' reserve figures. This number appears to be fabricated or misattributed. Additionally, the LLM states that Chevron's PSC-related reserves account for 7% of consolidated African reserves in 2021 (down from 11% in 2019), but the ground truth does not mention this percentage breakdown or any disclosure about PSCs being 'not material'—this information is absent from the original. The only correct quantitative fact is Chevron's 2021 African reserves totaling 106 million barrels, which aligns with the ground truth. (2) The calculation of percentages (7%, 9%, 11%) and the specific reserve number for ConocoPhillips (184–191 million barrels) are not corroborated by the ground truth and appear to be hallucinated or drawn from external sources not referenced in the evidence. The original answer does not include any such figures. (3) The multi-hop reasoning is partially sound—linking Nigeria’s PSC structure to operational and reserve implications for both companies—but fails in synthesis because it invents data points rather than relying on the provided evidence. The connection between PSCs and reserve booking is conceptually valid but misapplied due to incorrect attribution. (4) The contextual relevance is high because the answer addresses the regulatory framework and its influence on both companies. However, the correctness score is reduced significantly due to factual inaccuracies and invented metrics. The qualitative accuracy is moderate because the logic follows a plausible path, but entity and quantitative accuracy are compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 561,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How does the limited voting rights structure attached to AT&T's Series C Preferred Stock influence potential restructuring decisions compared to Netflix's one-share-one-vote governance model?",
      "original_answer": "AT&T's Series C Preferred Stockholders have no voting rights except in specific restructuring scenarios such as mergers or consolidations where their equity treatment might change, requiring their separate approval. This constraint limits their influence on broader corporate decisions but protects their interests in defined high-impact events. In contrast, Netflix grants one vote per share to common stockholders on all matters, enabling broader shareholder participation in governance and strategic direction. This difference means Netflix’s shareholders have more consistent influence over corporate decisions, whereas AT&T’s Series C Preferred Stockholders only exert influence in narrowly defined restructuring contexts.",
      "llm_answer": "AT&T’s Series C preferred shares are subject to a **limited‑voting structure** – the holders can vote only on a narrow set of “fundamental” matters such as a merger, liquidation or other transactions that would give them securities or cash different from what common‑stock holders receive, and they vote as a single class equal to the number of shares they own【page_90】. Because their voting power is confined to those specific events, preferred‑stock holders have little ability to influence ordinary restructuring proposals, leaving most decisions to the holders of AT&T’s common stock.  \n\nIn contrast, Netflix’s governance grants **one‑share‑one‑vote** to every holder of its common stock on all shareholder matters【page_61】, giving the broader shareholder base the ability to approve or block any restructuring plan. Thus, Netflix’s model provides more direct shareholder control over restructuring than AT&T’s constrained preferred‑stock voting rights.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that AT&T’s Series C Preferred Stockholders have limited voting rights, exercisable only in specific restructuring events such as mergers or liquidations where their equity treatment differs from common stockholders. This aligns with the original answer’s emphasis on 'specific restructuring scenarios' requiring separate approval. The contrast with Netflix’s one-share-one-vote model is accurately presented, highlighting broader shareholder influence. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a traditional sense—however, the absence of numerical errors and correct use of structural terms (e.g., 'one-share-one-vote', 'limited-voting structure') supports a perfect score. (3) The multi-hop reasoning—comparing governance models across two companies and assessing implications for restructuring decisions—is sound. The LLM correctly synthesizes governance differences and their impact on shareholder influence. (4) Minor deduction in qualitative accuracy due to slightly less explicit mention of the 'protection of interests in high-impact events' nuance present in the original, though the concept is implied. Otherwise, the answer is semantically equivalent, contextually precise, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 395,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How does the expiration timeline of key patent protections for Enbrel impact Pfizer's long-term revenue strategy for the product, particularly given AbbVie's broader approach to patent term restoration and regulatory exclusivity for biologics?",
      "original_answer": "Enbrel (etanercept) has multiple U.S. patents expiring at different points: fusion protein composition in 2028, DNA encoding the fusion protein in 2029, and formulations in 2037. This staggered expiration allows Pfizer to maintain some level of market protection until 2037, though biosimilar competition could begin as early as 2028. AbbVie, in contrast, actively pursues patent protection and patent term restoration under the Hatch-Waxman Act, which can extend exclusivity by up to five years, with total post-approval exclusivity potentially reaching 14 years. Given that AbbVie emphasizes both patent and regulatory exclusivity strategies for its biologics, Pfizer may need to adopt a similarly aggressive lifecycle management approach—such as filing secondary patents or seeking regulatory extensions—to preserve Enbrel's revenue stream beyond its core patent expirations.",
      "llm_answer": "Pfizer’s Enbrel portfolio is protected in the United States by a series of patents that run through November 2028, April 2029 and, most importantly, a formulation patent that does not expire until October 2037【page_11】. This long‑dated protection gives Pfizer a clear revenue runway of roughly two decades before biosimilar competition can erode sales, allowing the company to plan sustained marketing, pricing and reinvestment strategies around Enbrel through the late‑2030s. By contrast, AbbVie’s 10‑K notes that it routinely relies on patent‑term restoration (up to five years) and the 12‑year biologics regulatory exclusivity (plus possible pediatric extensions) to push back biosimilar entry for its own biologics【page_9】, underscoring that both firms depend on extending exclusivity periods to preserve long‑term revenue streams, but Pfizer’s Enbrel timeline is already anchored by a later‑expiring formulation patent rather than needing additional extensions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key dates are correct: November 2028 (fusion protein composition), April 2029 (DNA encoding), and October 2037 (formulation patent), which match the staggered expiration timeline in the original answer. The mention of 'up to five years' patent-term restoration and '12-year biologics regulatory exclusivity' correctly reflects AbbVie’s strategy under Hatch-Waxman and BPCIA frameworks. (2) The answer correctly identifies that Pfizer benefits from a later-expiring formulation patent (2037), reducing immediate reliance on extensions, while AbbVie actively uses patent-term restoration and regulatory exclusivity—this comparison is logically sound and factually accurate. (3) Multi-hop reasoning is strong: it synthesizes Enbrel’s patent timeline (Pfizer) with AbbVie’s broader biologic exclusivity strategy, then contrasts the two companies’ approaches to lifecycle management. (4) Minor deduction in qualitative accuracy due to slight overstatement: the claim that Pfizer has a 'revenue runway of roughly two decades' is contextually reasonable but imprecise (from 2023 to 2037 is ~14 years, not two decades); also, the original answer notes biosimilar competition could begin as early as 2028, which the LLM downplays. Otherwise, all entities (Pfizer, AbbVie, Enbrel, patent types), strategies, and implications are correctly represented. Semantic equivalence is maintained, and the answer fully addresses the impact on Pfizer’s long-term revenue strategy in light of AbbVie’s approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 433,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How does the ethylene production capacity of ExxonMobil's Singapore facility compare to the ethylene manufacturing capacity that Chevron indirectly supports through its ownership stake in the Map Ta Phut Olefins joint venture in Thailand?",
      "original_answer": "ExxonMobil's Singapore facility has an ethylene production capacity of 1.9 million metric tons per year. Chevron indirectly owns a 32.77% stake in the Map Ta Phut Olefins Company Limited in Thailand, which manufactures ethylene, although the exact ethylene capacity attributable to Chevron is not specified in the evidence provided.",
      "llm_answer": "ExxonMobil’s Singapore refinery‑based olefins complex is listed in its 2024 capacity table with **about 1.9 million metric tons of ethylene per year** (see XOM 10‑K, page 26).  \n\nChevron’s 2024 filing only notes that it holds a **32.77 % effective interest in the Map Ta Phut Olefins joint venture in Thailand** (see CVX 10‑K, page 19), but it does not provide a disclosed ethylene‑production figure for that venture. Consequently, a direct numeric comparison cannot be made from the information supplied.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: ExxonMobil's Singapore ethylene capacity is accurately reported as 1.9 million metric tons per year, and Chevron's 32.77% ownership stake in the Map Ta Phut Olefins joint venture is correctly cited. These match the original answer exactly, with acceptable formatting (e.g., '1.9 million metric tons' = '1.9 million metric tons per year'). (2) The answer is complete: it addresses both parts of the multi-hop question—ExxonMobil's capacity and Chevron's indirect stake—while correctly noting that the ethylene capacity attributable to Chevron is not disclosed, making a direct comparison impossible. (3) Entity accuracy is strong: correct company names (ExxonMobil, Chevron), correct facility locations (Singapore, Map Ta Phut, Thailand), and correct metric (ethylene production capacity). The references to the 10-K filings (XOM and CVX) add contextual fidelity. (4) Reasoning is sound: the model correctly synthesizes information across two separate corporate disclosures and concludes that a numeric comparison cannot be made due to missing data from Chevron’s side—this reflects accurate multi-hop logic. The only minor shortcoming is a slight lack of explicit mention that the joint venture itself produces ethylene (though it's implied), which slightly affects qualitative completeness. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 410,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How does the financial impact of Southern Company's disallowance of capital investments at Nicor Gas in Illinois compare to the scale of infrastructure assets that NextEra Energy operates in the same state?",
      "original_answer": "Southern Company recorded a pre-tax charge of $96 million related to the disallowance of capital investments at Nicor Gas, which operates in Illinois and serves approximately 2.3 million customers across 34.7 thousand miles of gas pipelines. Meanwhile, NextEra Energy operates 90 thousand miles of transmission lines in Illinois, Indiana, Kentucky, New Hampshire, and New York combined, with Illinois being a part of this footprint. This comparison highlights the relative scale of infrastructure assets under regulatory scrutiny versus those actively operated by NextEra in the same state.",
      "llm_answer": "Southern Company said the Illinois regulator’s disallowance of certain capital investments at Nicor Gas generated pre‑tax charges of about **$96 million** (about $72 million after tax)【page_302】.  \nBy contrast, NextEra Energy’s Illinois footprint is measured in physical assets – roughly **90 miles of rate‑regulated transmission lines and five substations** located in Illinois (and neighboring states)【page_16】.  \n\nThus, Southern’s impact is a dollar‑size charge of nearly $100 million, while NextEra’s presence in the same state is defined by a modest network of about 90 miles of transmission infrastructure.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the scale of NextEra Energy's infrastructure. It states that NextEra operates '90 miles of rate-regulated transmission lines' in Illinois and neighboring states, whereas the ground truth specifies '90 thousand miles of transmission lines' across multiple states, including Illinois. This is a two-order-of-magnitude error (90 vs 90,000 miles), which drastically misrepresents the scale of NextEra's assets. The $96 million pre-tax charge for Southern Company is correctly reported. (2) Quantitative accuracy is severely compromised due to the '90 miles' vs '90,000 miles' error. This mistake invalidates the comparison between Southern’s financial impact and NextEra’s infrastructure scale. The after-tax figure of $72 million is not in the original answer and may be an unsupported inference. (3) The multi-hop reasoning fails because the model incorrectly minimizes NextEra’s physical footprint, undermining the core comparison. The original answer emphasizes that NextEra’s 90,000 miles of transmission lines (across several states) include Illinois, providing context for a meaningful scale comparison. The LLM instead characterizes the presence as 'modest,' which is incorrect given the actual scale. (4) Contextual relevance is moderate because the answer attempts the right comparison and cites relevant entities and financial impact, but the severe data error in infrastructure length renders the conclusion misleading. The qualitative reasoning is flawed due to incorrect data synthesis, and the comparison lacks validity. Correctness is low due to this central inaccuracy, despite correct mention of the $96 million charge.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 463,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "What percentage of KO's equity method investments as of December 31, 2021, was represented by its stake in CCEP, and how does this relate to CCEP's operational presence in Iceland, where COST also operates?",
      "original_answer": "KO owned approximately 19% of CCEP as of December 31, 2021. CCEP operates in Iceland, which is also a market where COST operates through its wholly owned subsidiaries. This shared presence in Iceland indicates both companies have exposure to the same geographic market, with KO indirectly participating in the Icelandic beverage market through its equity stake in CCEP, while COST directly operates retail warehouses there.",
      "llm_answer": "Coca‑Cola’s equity‑method holdings show that, as of December 31 2021, the company owned roughly **19 % of Coca‑Cola Europacific Partners plc (CCEP)** – the same percentage it reported for each of its other major bottling partners【page_88】. CCEP’s bottling and distribution footprint includes **Iceland** among its listed territories【page_7】, which is also a country where Costco Wholesale (COST) operates its membership‑warehouse business【page_63】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly states that KO (Coca-Cola) owned approximately 19% of CCEP as of December 31, 2021, which matches the ground truth exactly—satisfying quantitative accuracy. It correctly identifies that CCEP operates in Iceland and that COST also operates in Iceland, establishing the shared geographic market. The answer cites appropriate pages for each claim, indicating proper grounding. However, while the original answer elaborates on the nature of the exposure—KO's indirect participation via equity stake versus COST's direct retail operations—the LLM answer omits this nuanced comparison, slightly weakening the qualitative reasoning and synthesis. Despite this, the core multi-hop logic (KO → CCEP → Iceland operations ↔ COST in Iceland) is sound and factually accurate. The omission is minor and does not detract from the essential correctness, hence a 9/10 on qualitative accuracy. Contextual relevance is full, as all parts of the question are addressed with precise, relevant information.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 288,
        "total_tokens": 1521
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does Duke Energy's direct exposure to electricity price volatility compare with Southern Company's indirect exposure through its subsidiaries' ownership stake in PowerSouth, which receives 100 MW of capacity from Alabama Power under a 2021 agreement?",
      "original_answer": "Duke Energy directly manages exposure to electricity price volatility through fuel adjustment clauses, formula-based contracts, and hedging programs that defer cost differences as regulatory assets or liabilities. In contrast, Southern Company's exposure is indirect through its subsidiaries' ownership stake in PowerSouth, which receives 100 MW of year-round capacity service from Alabama Power starting in 2024 under a 2021 agreement. This arrangement, combined with a 10-year coordinated planning and operations agreement, allows Southern Company to mitigate some volatility through shared dispatch and cost-offsetting mechanisms, rather than direct hedging. While Duke Energy actively hedges its exposure using financial instruments, Southern Company's risk is mediated through contractual agreements and operational coordination with PowerSouth.",
      "llm_answer": "Duke Energy states that its registrants are **directly exposed** to the volatility of electricity prices because they buy and sell power in bulk‑power markets (see Duke 10‑K, “COMMODITY PRICE RISK” – page 179). In contrast, Southern Company’s exposure is **indirect** – it comes only through its subsidiaries’ 8.16 % ownership in PowerSouth’s Plant Miller units and the 2021 agreement that gives PowerSouth about 100 MW of year‑round capacity from Alabama Power (see Southern 10‑K, PowerSouth description – page 17). Thus Duke faces market‑price risk on its own transactions, whereas Southern’s risk is limited to the performance of PowerSouth’s jointly‑owned assets and the contracted capacity.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, with only minor omissions affecting completeness. (1) Quantitatively, all key numbers are accurate: the 100 MW capacity, the 2021 agreement, and the indirect exposure via an 8.16% ownership stake in PowerSouth’s Plant Miller units are correctly cited. The mention of page references (e.g., Duke 10-K page 179, Southern 10-K page 17) adds verifiability and matches the source documentation. (2) The core comparison between Duke Energy’s direct exposure and Southern Company’s indirect exposure is sound and factually correct. However, the LLM omits key mechanisms mentioned in the original answer—specifically, Duke Energy’s use of fuel adjustment clauses, formula-based contracts, and hedging programs that defer cost differences as regulatory assets or liabilities, and Southern Company’s use of a 10-year coordinated planning and operations agreement enabling shared dispatch and cost-offsetting mechanisms. These omissions reduce completeness but do not invalidate the central claim. (3) The multi-hop reasoning is logically sound: the model correctly synthesizes information across Duke Energy’s and Southern Company’s 10-K filings, identifying the structural difference in exposure (direct vs. indirect) and grounding it in specific contractual and ownership arrangements. (4) The answer is contextually highly relevant, directly addressing the comparison asked in the question. While the LLM captures the essence of the exposure difference, the lack of detail on risk mitigation strategies (hedging vs. operational coordination) prevents a top score. Semantic equivalence is mostly preserved, but the original answer provides a richer, more nuanced explanation of how each company manages volatility.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 481,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does the growth in Starbucks' store count in Taiwan compare to Nike's revenue contribution from the Greater China region, considering that Taiwan is included within the Greater China geographic segment?",
      "original_answer": "Starbucks reported a net increase of 21 stores in Taiwan from fiscal year 2021 to 2022, bringing its total store count in Taiwan to 544. Nike, which includes Taiwan within its Greater China segment, reported total revenues of $7.547 billion from that region in fiscal year 2022. Given that Greater China includes mainland China, Hong Kong, and Taiwan, Starbucks’ store presence in Taiwan is a component of the broader regional market that contributes to Nike’s revenue, though the specific revenue contribution from Taiwan alone is not disclosed by Nike.",
      "llm_answer": "Starbucks’ licensed store count in Taiwan rose from 523 stores at the end of fiscal 2021 to 544 stores at the end of fiscal 2022 – a net increase of 21 stores (about a 4 % rise). In the same year, Nike reported Greater China revenues of $7.5 billion, which represented roughly 16 % of Nike’s total FY 2022 revenue of $46.7 billion. Thus, while Starbucks’ Taiwan footprint grew by only a few dozen locations, Nike’s Greater China market contributed a multi‑billion‑dollar share of its overall sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Starbucks' store count in Taiwan increasing from 523 to 544, a net increase of 21 stores, matching the ground truth. It accurately states Nike's Greater China revenue as $7.5 billion in FY2022, which is a rounded version of the exact $7.547 billion in the original answer—this minor rounding is acceptable under format variation. The LLM adds that this represented about 16% of Nike’s total FY2022 revenue of $46.7 billion, which is contextually accurate and enhances the answer without contradicting the ground truth. (2) All calculations are correct: 544 - 523 = 21 stores; the ~4% growth rate is accurate (21/523 ≈ 4.01%). The $7.5 billion figure is a reasonable rounding of $7.547 billion. The additional context about Nike’s total revenue and percentage contribution is factually sound and not present in the original, but does not detract from accuracy. (3) The multi-hop reasoning is sound: the LLM correctly links Starbucks’ Taiwan store growth to Nike’s Greater China revenue segment, acknowledging that Taiwan is part of that region, even though Taiwan-specific revenue is not disclosed. It appropriately compares a physical expansion metric (store count) with a financial performance metric (revenue) in a way that addresses the comparative intent of the question. (4) The answer is highly factually accurate, complete, and relevant. The only reason for not scoring a 10 is the slight rounding of $7.547 billion to $7.5 billion without indicating approximation, though this is minor and common in reporting. All entities (Starbucks, Nike, Taiwan, Greater China, fiscal years 2021–2022) are correctly identified and synthesized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 460,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How do the supplier finance disclosures required by ASU 2022-04 affect the visibility of 3M's $0.3 billion in confirmed invoice obligations, and how does FedEx's adoption of the same standard compare in terms of transparency?",
      "original_answer": "ASU 2022-04 significantly enhances the visibility of 3M's supplier finance obligations, which stood at $0.3 billion as of December 31, 2024, by mandating detailed disclosures such as key terms, balance sheet presentation, and roll-forward information. This requirement was adopted by 3M starting in 2023, with full roll-forward reporting effective in 2024. Similarly, FedEx adopted ASU 2022-04 effective June 1, 2023, and also included disclosures related to its supplier finance program obligations. Both companies now provide stakeholders with clearer insights into their supplier finance activities, aligning their reporting practices under the new standard to enhance transparency.",
      "llm_answer": "ASU 2022‑04 forces a buyer to disclose the size and activity of any supplier‑finance program. 3M complies by presenting the balance of confirmed invoices — about $0.3 billion at year‑end — in Note 16 and describing the program’s terms and roll‑forward, so the obligation is clearly visible on the balance sheet. FedEx also adopted the same ASU (effective June 1 2023) but its filing only notes the adoption and that it had no material effect, without giving a specific dollar amount or detailed roll‑forward, making the disclosure far less transparent than 3M’s.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies ASU 2022-04's impact on supplier finance disclosures and accurately states 3M's $0.3 billion in confirmed invoice obligations as of year-end (consistent with December 31, 2024, in the ground truth). It also correctly notes 3M’s adoption starting in 2023 with detailed disclosures in Note 16, including balance sheet presentation and roll-forward—aligning with the enhanced transparency described in the original answer. The date of FedEx’s adoption (June 1, 2023) is also correct. However, the LLM diverges significantly in its assessment of FedEx’s transparency, claiming that FedEx only noted adoption with no material effect and did not disclose a dollar amount or roll-forward. This contradicts the ground truth, which states that FedEx *did* include disclosures related to its supplier finance program obligations. Thus, the claim of 'far less transparent' is unsupported and factually incorrect. (2) Quantitative accuracy is high: $0.3 billion and June 1, 2023, are correct; no calculations were required. (3) Multi-hop reasoning is partially sound—correctly linking ASU 2022-04 to both companies and evaluating disclosure practices—but fails in synthesizing the correct conclusion about FedEx due to incorrect input or inference. (4) Scores reflect mostly accurate data (8 for quantitative), but reduced qualitative and overall correctness due to the significant error in characterizing FedEx’s disclosure as lacking detail when the ground truth confirms it included required disclosures. Contextual relevance remains high as the response directly addresses both parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 447,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How might the dual-class stock structures at CMCSA and META, particularly the 15-vote-per-share advantage for Class B stockholders at CMCSA and the 35% Class B voting power threshold for blocking change-of-control transactions at META, similarly expose minority shareholders to governance risks?",
      "original_answer": "At CMCSA, Class B common stockholders, led by Brian L. Roberts, hold 33⅓% of the combined voting power due to a 15-vote-per-share advantage, which can influence corporate decisions disproportionately relative to their economic stake. Similarly, at META, Class B stockholders control key governance decisions, including blocking change-of-control transactions, as long as they hold at least 35% of the combined voting power. Both structures concentrate decision-making authority in a small group, potentially undermining minority shareholder influence and making the companies less attractive to investors, which could depress stock valuations.",
      "llm_answer": "Both companies give a tiny group of insiders outsized voting power. At Comcast, the single holder of Class B stock (Mr. Roberts) controls 15 votes per share, giving the Class B shares about 33 % of the total voting power and making that voting power “generally non‑dilutable” (CMCSA 10‑K p. 33). Meta’s charter likewise requires that, until Class B shares fall below 35 % of the combined voting power, any change‑of‑control transaction must be approved by a majority of the Class B votes as a separate class (Meta 10‑K p. 50). In each case the concentrated voting right lets the controlling shareholder block or dictate major corporate actions, exposing ordinary (Class A) shareholders to governance risk because their ability to influence directors, mergers or other key decisions is effectively overridden by the dual‑class structure.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: CMCSA's Class B stockholders have a 15-vote-per-share advantage, resulting in approximately 33⅓% of combined voting power (correctly rounded to 'about 33%' in the answer), and META requires Class B holders to maintain at least 35% of voting power to retain special approval rights over change-of-control transactions. These numbers match the original answer and are cited with correct document sources (10-K pages). (2) Quantitative accuracy is perfect: the percentages (33⅓% and 35%) are correctly reported or appropriately approximated, and no calculations are required beyond what is accurately stated. (3) The multi-hop reasoning is sound—LLM correctly synthesizes governance risks across two companies, identifying that both structures concentrate control in a small group (Roberts at CMCSA, Zuckerberg-aligned holders at META), which undermines minority shareholder influence. (4) The answer addresses all parts of the question: it explains the specific voting advantages, ties them to governance risks (blocking/dictating major decisions), and highlights the impact on Class A shareholders. Wording differs slightly but meaning is preserved, including the risk of depressed valuations due to reduced minority influence. No factual errors, omissions, or misstatements.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 387,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What percentage of V's U.S. pension plan assets classified as Level 2 in 2022 consists of investments in collective investment funds, and how does this allocation strategy compare to COF's use of 'other securities' in terms of investment focus and yield profile?",
      "original_answer": "In 2022, V reported $319 million in collective investment funds under Level 2 assets, out of a total of $960 million in U.S. pension plan assets, representing approximately 33.2%. These funds are described as unregistered investment vehicles that commingle assets from multiple fiduciary clients to invest in portfolios of stocks, bonds, or other securities, including equity and debt instruments. In contrast, COF held $2,834 million in 'other securities' as part of its available-for-sale securities, with a weighted-average yield of 1.57%. While V's collective investment funds focus on diversified portfolios for institutional investors, COF's 'other securities' likely reflect a different risk-return profile given the lower yield and potentially different asset composition.",
      "llm_answer": "Visa’s U.S. pension plan held $733 million of Level 2 assets in 2022, of which $319 million were in collective‑investment funds – about **43.5 % of its Level 2 portfolio**. Capital One’s “other securities” (a mix of corporate, agency and non‑agency debt) total $2.8 billion and earn a **weighted‑average yield of roughly 1.6 %** (the overall yield for securities available for sale). Thus, Visa’s Level 2 allocation is heavily weighted toward collective‑investment funds that are not measured by a disclosed yield, while Capital One emphasizes income‑producing debt securities with a modest, clearly stated yield profile.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the denominator used for percentage calculation. The question asks for the percentage of V's U.S. pension plan assets classified as Level 2 that consists of collective investment funds. The ground truth states that V's total U.S. pension plan assets were $960 million, with $319 million in collective investment funds under Level 2, resulting in 33.2%. However, the LLM incorrectly calculates the percentage as 43.5% by dividing $319M by $733M (Level 2 assets), implying that $733M is the total Level 2 amount. This $733M figure is not present in the original answer and contradicts the ground truth, which does not specify total Level 2 assets but does state total U.S. pension assets as $960M. This is a major quantitative error. (2) The $319 million in collective investment funds is correct, and COF's $2,834 million (rounded to $2.8 billion) in 'other securities' and the 1.57% yield (rounded to ~1.6%) are accurately reported with acceptable formatting. (3) The multi-hop reasoning is partially sound: the model correctly identifies V and COF as the two entities, extracts relevant asset classes, and attempts a qualitative comparison between investment focus and yield. However, the incorrect percentage undermines the core quantitative claim. The characterization of COF’s 'other securities' as debt instruments aligns with context, and the observation about yield disclosure is reasonable. (4) The contextual relevance is high—response structure matches the question’s dual focus on V’s allocation and COF’s yield profile. Qualitative accuracy is moderate due to correct entity identification and reasonable interpretation, but the flawed calculation significantly reduces overall correctness. Quantitative accuracy is low due to the incorrect base for percentage calculation, despite correct individual values.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 508,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How do Adobe's compliance costs related to Saudi Arabia's data localization laws compare to Microsoft's financial exposure from similar regulations, and what does this reveal about their respective cloud service strategies?",
      "original_answer": "Adobe faces significant compliance costs due to its global operations, including exposure to Saudi Arabia's data localization requirements, which could 'adversely impact our business and our enterprise customers' business, our financial condition and our results of operations in those jurisdictions' (ADBE_10k_2024.pdf). Saudi Arabia is explicitly mentioned as one of the jurisdictions implementing data localization requirements that mandate data to remain stored within national borders (MA_10k_2024.pdf). Microsoft discloses that such localization laws globally 'may require changes in services, business practices, or internal systems that result in increased costs, lower revenue, reduced efficiency' and specifically references compliance engineering costs that 'involve substantial expense and the diversion of engineering resources from other projects' (MSFT_10k_2024.pdf). The comparison reveals Adobe's vulnerability through its enterprise customer contracts in Saudi Arabia, while Microsoft faces broader systemic challenges due to its cloud infrastructure and AI services that rely heavily on cross-border data flows.",
      "llm_answer": "Adobe’s filing notes that Saudi‑Arabia’s data‑localisation rules are one of many privacy‑and‑data‑protection requirements it must meet, but it does not quantify a specific dollar cost – the company simply says compliance will “require changes… and could increase the cost and complexity of delivering our products” (Adobe 10‑K p. 31). Microsoft, by contrast, flags that complying with similar data‑sovereignty regimes could create “substantial expense” and expose the firm to “significant monetary penalties” and other financial impacts (Microsoft 10‑K p. 29). The contrast suggests Adobe treats Saudi localisation as a routine compliance item within its broader cloud‑service model, whereas Microsoft views such regulations as a material financial risk that shapes a more guarded, risk‑mitigation‑focused cloud strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of qualitative disclosures from both Adobe and Microsoft, correctly noting that neither company quantifies exact dollar amounts for Saudi Arabia-specific compliance costs. It accurately reflects Adobe’s general statement about increased cost and complexity (citing p.31 of its 10-K) and Microsoft’s stronger language around 'substantial expense' and 'significant monetary penalties' (citing p.29), which aligns with the original answer’s emphasis on Microsoft’s broader systemic exposure. The quantitative accuracy is perfect—no numerical claims are made, and the absence of specific figures is correctly represented. However, the LLM answer misses a key multi-hop element: the original answer explicitly connects Saudi Arabia’s data localization laws to both companies via cross-document synthesis (noting Saudi Arabia is named in Microsoft’s filing as an example jurisdiction). The LLM implies but does not confirm that Saudi Arabia is specifically mentioned in Microsoft’s filing, weakening the comparative analysis. Additionally, the original answer draws a strategic distinction—Adobe’s vulnerability through enterprise contracts vs. Microsoft’s infrastructure- and AI-scale challenges—that the LLM simplifies into a 'routine compliance' vs. 'material risk' framing, which captures part of the insight but omits the deeper strategic contrast related to cloud architecture and cross-border data flows. Thus, while the reasoning is plausible and contextually relevant, it falls short on full qualitative accuracy due to incomplete synthesis and slightly reductive interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 449,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does Duke Energy's divestiture of KO Transmission's pipeline facilities impact its FERC regulatory exposure, and how does this contrast with Southern Company's ongoing capital expenditure risks tied to FERC rule changes?",
      "original_answer": "Duke Energy Ohio divested all of KO Transmission's pipeline facilities on February 1, 2023, for approximately book value, which reduces its direct exposure to FERC-regulated interstate pipeline operations. This contrasts with Southern Company’s ongoing capital expenditure programs, which are subject to FERC rule changes that could materially affect construction costs and recovery of investments. Southern Company specifically notes uncertainty in recovering costs related to capital expenditures due to potential changes in FERC regulations. While Duke Energy has mitigated its FERC-related risk in the pipeline business through divestiture, Southern Company remains exposed to regulatory shifts that could impact its construction programs and cost recovery.",
      "llm_answer": "Duke Energy eliminated its direct FERC‑regulated exposure for the KO Transmission natural‑gas pipeline by selling the 90‑mile system (and the co‑owned 70‑mile portion) to Columbia Gas Transmission on Feb. 1 2023, removing the asset from its balance sheet and the associated FERC compliance and rate‑recovery obligations. In contrast, Southern Company’s 2024‑2028 capital‑expenditure program remains vulnerable to future FERC rule changes, which could alter construction costs, delay projects or limit cost recovery, thereby creating ongoing regulatory‑related capital‑risk exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the date of divestiture (February 1, 2023) is correct, and while the LLM adds specific details like the pipeline length (90-mile system and 70-mile co-owned portion) and counterparty (Columbia Gas Transmission), these are consistent with plausible details not contradicted by the original answer. The absence of 'book value' in the LLM response is a minor omission but does not affect factual correctness. (2) The reasoning correctly contrasts Duke Energy’s risk reduction via divestiture with Southern Company’s ongoing exposure to FERC rule changes affecting capital expenditures, cost recovery, and project timelines—this synthesis across two companies and regulatory implications is sound. (3) Entities are accurate: Duke Energy Ohio (implied under Duke Energy), Southern Company, FERC, and correct timeframes (2024–2028 capex program). (4) The LLM enhances the original answer with additional operational detail (e.g., removal from balance sheet, compliance obligations) without introducing errors. The only reason for not scoring a 10 is the slight omission of the 'approximately book value' aspect of the sale, which is present in the original and relevant to financial impact. However, this does not undermine the core correctness of the regulatory exposure analysis. Semantic equivalence is strong, and the answer fully addresses both parts of the multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 404,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does the $2.7 billion in unfunded commitments to private debt and private equity funds reported by UPS compare to Caterpillar's allocation of $55 million in NAV-measured assets for its other postretirement benefit plans, in terms of liquidity and investment strategy?",
      "original_answer": "UPS reports $2.7 billion in unfunded commitments to private debt and private equity funds, which are illiquid and typically have redemption restrictions for 10–15 year terms, indicating a long-term investment horizon. In contrast, Caterpillar allocates $55 million in NAV-measured assets for its other postretirement benefits, which include less complex instruments like U.S. corporate bonds and short-term instruments, suggesting a more liquid and conservative investment approach. The difference highlights UPS's focus on alternative investments for long-term growth versus Caterpillar's preference for liquidity and stability in managing postretirement obligations.",
      "llm_answer": "UPS reports about $2.7 billion of unfunded commitments to private‑debt and private‑equity limited‑partnership funds, which are long‑term, ill‑iquid positions that can only be redeemed after 10‑15 years and rely on a secondary market that may not provide a guaranteed price. By contrast, Caterpillar’s $55 million of NAV‑measured assets for its other post‑retirement benefit plans is a modest allocation to relatively liquid securities—U.S. and non‑U.S. equities, corporate bonds and cash—reflecting a strategy focused on short‑term liquidity rather than long‑term private‑market exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all numbers are correct: $2.7 billion for UPS's unfunded commitments and $55 million for Caterpillar's NAV-measured assets are accurately reported. No calculations were required, and the figures match exactly. (2) The entities—UPS and Caterpillar—are correctly identified, and the financial metrics (unfunded commitments, NAV-measured assets) are properly attributed. (3) The reasoning is sound: the LLM correctly contrasts UPS’s illiquid, long-term private market investments (with 10–15 year redemption restrictions) against Caterpillar’s more liquid portfolio, noting asset types like corporate bonds and cash. The only minor discrepancy is in asset composition: the ground truth specifies U.S. corporate bonds and short-term instruments, while the LLM mentions U.S. and non-U.S. equities, which is slightly broader but still consistent with a liquid, conservative strategy. This does not materially misrepresent the investment approach. (4) The multi-hop synthesis—comparing liquidity and strategy across two companies’ retirement-related investments—is well executed, and the conclusion about differing strategic focuses (long-term growth vs. liquidity/stability) is implied. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually correct, complete, and contextually appropriate, meriting a 9/10 for correctness and qualitative accuracy due to the slight imprecision in describing Caterpillar’s asset mix.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 422,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does Alphabet's selective repurchase of Class A and Class C shares, while retaining Class B shares with enhanced voting rights, contrast with Netflix's uniform voting rights structure, and what might this imply about Alphabet's governance strategy?",
      "original_answer": "Alphabet selectively repurchased $62.2 billion of Class A and Class C shares in 2023 while retaining Class B shares, which carry 10 votes per share, suggesting a strategy to maintain concentrated voting control. In contrast, Netflix provides one vote per share across all common stock, indicating a more egalitarian governance approach. This contrast implies that Alphabet's repurchase strategy may be designed to preserve the influence of stakeholders holding Class B shares, which could include insiders or long-term investors, rather than diluting their control through broader ownership.",
      "llm_answer": "Alphabet’s 2023 filing makes clear that the Board’s share‑repurchase program is limited to its one‑vote Class A and non‑voting Class C shares, while the 10‑vote Class B shares – which are held mainly by founders and insiders – are **not** bought back and remain in place to preserve concentrated voting power (see GOOGL 10‑K p. 81). In contrast, Netflix’s proxy statement notes that all of its common stock carries the same voting right – one vote per share – with no dual‑class structure (see NFLX 10‑K p. 58). This difference implies that Alphabet’s governance strategy is to use its dual‑class structure to retain control with the high‑voting Class B while still returning capital to all shareholders via repurchases, whereas Netflix adopts a uniform‑voting model that distributes voting influence equally among shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Alphabet repurchased Class A and C shares (one-vote and non-voting) while excluding Class B shares (10 votes per share), which are held by insiders. Netflix has a uniform voting structure with one vote per share and no dual-class shares. (2) Quantitative accuracy is perfect: although the exact $62.2 billion figure is not mentioned in the LLM answer, the omission is minor and does not affect the core reasoning or conclusion; the focus is on the structural aspect of the repurchase rather than the dollar amount, and the year (2023) is correctly implied via context. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across Alphabet’s and Netflix’s 10-K filings, contrasting governance models and inferring strategic intent—preservation of insider control vs. egalitarian voting. (4) Semantic equivalence is strong: the LLM conveys the same implication as the ground truth—Alphabet’s strategy maintains concentrated voting power among insiders—using slightly different but equally valid phrasing (e.g., 'preserving concentrated voting power' vs. 'preserve the influence of stakeholders holding Class B shares'). The only minor shortcoming is the omission of the $62.2 billion figure, which slightly reduces completeness but does not impair the overall correctness. Hence, a score of 9 is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 397,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the Tax Reform Act's GILTI provisions impact Coca-Cola's 2022 effective tax rate, and how does this compare to Philip Morris International's 2021 effective tax rate benefit from the corporate income tax reduction enacted in the Philippines where it operates and completed business combinations?",
      "original_answer": "The Tax Reform Act's GILTI provisions impacted Coca-Cola's 2022 effective tax rate by requiring the company to account for these taxes in the period subject to such tax, contributing to a $431 million net tax expense (4.4% impact on effective tax rate). For Philip Morris International, the corporate income tax rate reduction enacted in the Philippines in Q1 2021 contributed to a 0.1 percentage point decrease in its 2021 effective tax rate, which stood at 21.8%. This tax benefit occurred in a jurisdiction where PMI completed business combinations, including in the Philippines, as part of its global expansion strategy.",
      "llm_answer": "The 2022 Form 10‑K for Coca‑Cola notes that the Global Intangible Low‑Taxed Income (GILTI) rules created by the Tax Reform Act added to the company’s U.S. tax expense, pushing its 2022 effective tax rate higher than it would have been without the provision (the filing attributes a modest upward‑bias to GILTI).  \n\nBy contrast, Philip Morris International’s 2021 filing says that the corporate‑income‑tax reduction enacted in the Philippines – where the company operates and completed several business combinations – lowered its overall effective tax rate, partially offsetting the upward pressure from GILTI‑related foreign‑tax‑credit limitations.  \n\nIn short, GILTI caused Coca‑Cola’s 2022 effective tax rate to rise, whereas the Philippines tax cut gave PMI a net tax‑rate benefit that reduced its 2021 effective tax rate.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the directional impact of the GILTI provisions on Coca-Cola's 2022 effective tax rate (increasing it) and the beneficial effect of the Philippines corporate tax reduction on Philip Morris International's 2021 effective tax rate. It also correctly notes that PMI operates in the Philippines and has completed business combinations there, which aligns with the multi-hop requirement linking tax changes, geography, and corporate activity. However, the LLM answer fails to include specific quantitative figures that are central to the ground truth: Coca-Cola's $431 million net tax expense and the 4.4 percentage point increase in its effective tax rate due to GILTI, and PMI's 0.1 percentage point decrease in its 2021 effective tax rate (which was 21.8%). These omissions significantly reduce quantitative accuracy. While the qualitative reasoning is sound—correctly contrasting the two companies' tax impacts and linking PMI's tax benefit to its operational and acquisition activities in the Philippines—the lack of precise numbers undermines the completeness and factual precision required for full correctness. The answer is well-structured and contextually relevant, addressing both parts of the multi-part question and synthesizing information across entities and jurisdictions, but the absence of key metrics prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 379,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does the $3.1 billion in mortgage loans sold by BAC to GSEs in 2023 influence the risk exposure of MET's $12.392 billion portfolio of pass-through mortgage-backed securities, given that these securities are directly secured by mortgage loans serviced by institutions like BAC?",
      "original_answer": "BAC sold $3.1 billion in mortgage loans to GSEs in 2023, which are part of the broader pool of loans that can be securitized into pass-through mortgage-backed securities (MBS). MET holds $12.392 billion in such pass-through MBS as of 2023, which are directly secured by mortgage loans—often serviced by institutions like BAC. If BAC, as a servicer, experiences issues in fulfilling its obligations (e.g., due to cybersecurity incidents or servicing breaches), this could lead to disruptions in cash flows or increased credit risk for the underlying loans, which in turn affects the value and performance of MET’s pass-through MBS portfolio.",
      "llm_answer": "MetLife’s pass‑through mortgage‑backed‑securities represent $12.392 billion of assets that are “directly secured by a mortgage loan or collection of mortgage loans” and the cash‑flows from those loans are serviced by banks such as Bank of America (BAC) 【page_98】.  In 2023 BAC sold roughly $3.1 billion of conforming loans to the government‑sponsored enterprises—primarily Freddie Mac—removing those loans from its own balance sheet and therefore reducing the credit risk that BAC’s own loan‑portfolio performance could impose on the securities it services 【page_18】.  However, because the pass‑through securities remain backed by loans that BAC continues to service, any uncertainty about the GSEs’ future role (which BAC notes could increase credit risk and affect securities portfolios) still influences the overall risk profile of MetLife’s $12.4 billion pass‑through portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all numbers are accurate: $3.1 billion in mortgage loans sold by BAC to GSEs in 2023 and MET’s $12.392 billion (rounded to $12.4 billion, which is acceptable) portfolio of pass-through MBS are correctly reported. (2) The entity identification is accurate—BAC, GSEs (specifically naming Freddie Mac), and MET are correctly referenced with appropriate roles. (3) The reasoning correctly identifies that BAC sold conforming loans to GSEs, which are then potentially pooled into MBS that MET holds, and that BAC acts as a servicer. The answer also appropriately notes that while BAC offloaded credit risk by selling loans, it still services them, so operational or systemic risks (e.g., from GSE policy uncertainty) can affect MET’s portfolio. (4) However, the LLM slightly misses the emphasis in the ground truth on BAC’s potential servicing failures (e.g., due to cybersecurity or breaches) directly disrupting cash flows. Instead, it focuses on uncertainty about the GSEs’ future role, which is mentioned in BAC’s filing but is a more indirect risk factor. This omission of the direct servicer risk mechanism prevents a perfect score, though the core multi-hop logic—linking BAC’s actions and role to MET’s risk exposure via servicing—is sound. Overall, the answer is factually accurate, contextually relevant, and well-reasoned with only minor qualitative gaps.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 400,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How does the valuation complexity of NKE's embedded derivatives, which result in Level 3 classification, compare to LOW's use of unobservable inputs for fair value measurements, particularly in terms of reliance on non-market-based assumptions?",
      "original_answer": "NKE disclosed $5 million in embedded derivatives as of May 31, 2022, which resulted in Level 3 classification due to the use of significant unobservable inputs such as extrapolation beyond observable limits and policyholder behavior assumptions. Similarly, Level 3 classifications—as described in MET_10k_2022—rely on non-market-based assumptions like actuarial inputs for policyholder behavior and mortality, which cannot be corroborated by observable market data. LOW, however, reported no material fair value measurements on a nonrecurring basis and emphasized that its financial assets and liabilities not measured at fair value on a recurring basis (such as long-term debt) primarily use observable inputs like quoted market prices or discounted cash flow analyses with incremental borrowing rates, indicating a lesser reliance on unobservable assumptions compared to NKE's Level 3 embedded derivatives.",
      "llm_answer": "Nike’s embedded derivatives are recorded as Level 3 fair‑value items because their valuation relies on pricing models that require significant unobservable inputs—such as extrapolated yield curves, implied volatilities and actuarial assumptions about policyholder behavior—rather than quoted market prices (see the discussion of Level 3 valuation approaches and the need for non‑observable inputs)【page_264】【page_265】. In contrast, Lowe’s fair‑value measurements are based on quoted market prices or observable market inputs (e.g., benchmark yields, broker‑dealer quotes), and the company reports no Level 3 items, indicating that its valuations depend far less on non‑market‑based assumptions【page_56】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, no specific dollar amounts or dates are misstated—the original answer mentions NKE's $5 million in embedded derivatives as of May 31, 2022, but this figure is not included in the LLM response. However, since the LLM does not make any numerical claim about the size of the derivatives, its omission does not constitute a factual error. All other qualitative details are consistent. (2) The LLM correctly identifies that NKE’s Level 3 classification stems from significant unobservable inputs such as extrapolated yield curves, implied volatilities, and actuarial assumptions about policyholder behavior—matching the ground truth’s emphasis on non-market-based assumptions like policyholder behavior. (3) For LOW, the LLM accurately states that it reports no Level 3 items and relies on observable inputs like quoted market prices, benchmark yields, and broker-dealer quotes, which is consistent with the original answer’s claim that LOW uses discounted cash flows with incremental borrowing rates and observable inputs, indicating lesser reliance on unobservable assumptions. (4) The multi-hop reasoning is sound: the model correctly contrasts NKE’s use of Level 3 inputs with LOW’s lack of Level 3 classifications and reliance on more observable data. The only minor shortcoming is the absence of explicit mention of MET_10k_2022 as a source for the general Level 3 context (though this may be beyond the expected synthesis), and the lack of reference to LOW’s nonrecurring fair value measurements. However, the core comparison on reliance on non-market-based assumptions is correctly and clearly drawn. Wording differs slightly but maintains semantic equivalence. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 510,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "As defense industry peers managing significant pension assets, how do GD's and LMT's approaches to Level 3 asset valuations differ, given GD's use of valuation models with observable inputs for fixed-rate notes versus LMT's reliance on unobservable inputs for its $4,951 million private equity fund holdings?",
      "original_answer": "GD values its Level 3 assets, including fixed-rate notes, using valuation models that incorporate observable inputs such as interest rates and quoted prices for similar assets. In contrast, LMT's $4,951 million in private equity funds, which are also Level 3 assets, are valued using NAV based on valuation models that rely on unobservable inputs not corroborated by verifiable market data. This highlights a key difference in their fair value accounting methodologies for similar asset classifications, with GD relying on more market-validated inputs while LMT uses internally-derived assumptions for its private equity investments.",
      "llm_answer": "Gulfstream (GD) values its fixed‑rate notes with a market‑approach model that uses observable market data—interest‑rate curves, bond yields and quoted prices for comparable securities—so those assets fall in Level 2 of the fair‑value hierarchy. Lockheed Martin (LMT), by contrast, classifies its $4.951 billion of private‑equity fund holdings as Level 3 and measures them using valuation models that rely on unobservable inputs (e.g., projected cash‑flows and discount rates) because no active market prices exist.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its quantitative details: the $4.951 billion private equity holding by LMT matches the ground truth ($4,951 million), and the description of valuation methods is directionally correct. The answer correctly identifies that GD uses observable inputs (interest-rate curves, bond yields, comparable prices), though it incorrectly classifies GD's fixed-rate notes as Level 2 assets, while the ground truth explicitly states these are Level 3 assets. This is a significant qualitative error because the question centers on how two companies value Level 3 assets, and misclassifying GD's assets undermines the comparison. The ground truth emphasizes that both companies have Level 3 assets but differ in input observability—GD’s models use observable inputs within Level 3, which the LLM answer misses by reclassifying them to Level 2. This reflects a failure in multi-hop reasoning: the model did not reconcile that observable inputs can still result in Level 3 classification if they are used in models rather than direct market quotes. The contrast with LMT is well-articulated, including the use of unobservable inputs like projected cash flows and discount rates for private equity, which aligns with the original answer. Despite the misclassification, the core insight about differing reliance on observable vs. unobservable inputs is preserved, and all numbers are accurate (with correct unit conversion). Wording differs but maintains semantic relevance. However, due to the incorrect fair value hierarchy level assignment for GD, which is central to the question, the answer cannot score higher than 7 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 451,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How does the legal exposure from Slack's shareholder litigation, including the timeline and procedural history of the motion to dismiss, compare to Disney's recent antitrust litigation strategy involving motions to dismiss in the Biddle and Fendelander actions?",
      "original_answer": "Slack faced a multi-year shareholder litigation process beginning in 2019, with the motion to dismiss filed in January 2020, partial denial in April 2020, and eventual reversal by the Ninth Circuit on February 10, 2025, leading to dismissal with prejudice. In contrast, Disney filed motions to dismiss in both the Biddle and Fendelander actions on January 31, 2023, which were granted in part and denied in part by September 30, 2023. Disney then filed another motion to dismiss the consolidated amended complaint on December 1, 2023, which was also granted in part and denied in part on June 25, 2024. While Slack’s litigation reached the U.S. Supreme Court and resulted in a definitive dismissal, Disney’s antitrust cases remain ongoing with class certification deadlines set for March 27, 2026.",
      "llm_answer": "Slack’s shareholder litigation has been ongoing for almost six years.  The company first moved to dismiss the federal complaint in January 2020, saw a mixed ruling in April 2020, pursued a series of appeals that reached the Supreme Court in 2023, and finally obtained a dismissal‑with‑prejudice from the Ninth Circuit on February 10 2025 after a lengthy interlocutory‑appeal process.  By contrast, Disney’s antitrust suits were filed in late 2022; Disney filed motions to dismiss in January 2023, received a partial grant/denial in September 2023, filed a second motion on the consolidated complaint in December 2023, and saw a mixed ruling on that motion on June 25 2024, with the case still in early stages and a future class‑certification deadline set for 2026.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key dates and procedural milestones are correct: Slack's motion to dismiss in January 2020, partial denial in April 2020, Ninth Circuit dismissal with prejudice on February 10, 2025. Disney's motions to dismiss on January 31, 2023, partial rulings by September 30, 2023, second motion on December 1, 2023, and ruling on June 25, 2024—all align with the original answer. The class certification deadline of March 27, 2026, is correctly implied as '2026' in the LLM answer, which is acceptable for semantic equivalence. (2) Quantitative accuracy is perfect: all dates and timelines are factually correct. (3) The multi-hop reasoning is sound—correctly contrasting Slack’s completed litigation trajectory (including Supreme Court involvement and final dismissal) with Disney’s ongoing process involving multiple motions and future deadlines. (4) The only minor shortcoming is that the LLM states the Supreme Court was reached in 2023, while the original answer does not specify when the Supreme Court stage occurred—this detail is plausible but slightly extrapolated. However, since it doesn’t contradict and fits the timeline (preceding the 2025 Ninth Circuit ruling), it doesn’t constitute a factual error. Overall, the answer is complete, factually precise, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 378,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does Intel's tax benefit from operations in Hong Kong compare to Apple's revenue contribution from the Greater China region, considering the inclusion of Hong Kong within Apple's Greater China reporting?",
      "original_answer": "Intel reported deriving effective tax rate benefits from operations in Hong Kong, where statutory tax rates range from 12.5% to 24.0%, as part of its broader non-US tax strategy. Meanwhile, Apple reported $74.2 billion in net sales from the Greater China region in 2022, which includes Hong Kong. This indicates that while Intel leverages Hong Kong for tax optimization, Apple generates significant revenue from the broader Greater China region, which encompasses Hong Kong.",
      "llm_answer": "Intel says that the lower tax rates on its non‑U.S. operations – principally those in Hong Kong (along with Ireland, Israel and Malaysia) – reduce its effective tax rate by **about 5.9 percentage points**.  \n\nApple’s Greater China segment, which **includes Hong Kong**, generated **approximately $74.2 billion of net sales in 2022** (up from $68.4 billion in 2021).  \n\nSo Intel’s Hong Kong‑related advantage is a modest 5.9‑point tax‑rate benefit, whereas Apple’s Hong Kong‑included Greater China market contributes tens of billions of dollars in revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Intel benefits from lower tax rates in Hong Kong as part of its non-U.S. tax strategy, specifying a precise 5.9-percentage-point reduction in its effective tax rate, which aligns with known disclosures (though not explicitly mentioned in the ground truth, this figure is consistent with Intel's public filings and represents a reasonable inference). Apple's Greater China net sales of $74.2 billion in 2022 are accurately reported, matching the ground truth exactly. The inclusion of Hong Kong in Apple’s Greater China reporting is correctly noted. (2) All numeric values—5.9 percentage points, $74.2 billion, $68.4 billion—are quantitatively accurate and properly contextualized with the correct year (2022). No calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (Intel and Apple), two different financial metrics (tax rate benefit vs. regional revenue), and acknowledges the geographic overlap (Hong Kong included in Greater China for Apple). It draws a logical comparison between tax optimization (a cost-side benefit) and revenue generation (an income-side contribution), clarifying that these are different types of financial impacts. (4) The answer is semantically equivalent to the ground truth, adding slightly more precision (the 5.9-point tax benefit) than the original answer, which only generally references tax rate benefits. The only minor limitation is that the ground truth mentions the statutory tax rate range in Hong Kong (12.5%–24.0%), which the LLM omits, but this detail is not critical to answering the comparative question. Overall, the response is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 477,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does the 70% CO₂ emissions reduction target set by North Carolina's HB 951 impact Duke Energy's Carolinas Resource Plan, and how does this regulatory requirement compare with NextEra Energy's operational exposure in North Carolina?",
      "original_answer": "North Carolina passed HB 951 in 2021, directing the NCUC to develop and approve a carbon reduction plan targeting a 70% reduction in CO₂ emissions from Duke Energy Progress' and Duke Energy Carolinas' electric generation by 2030. In response, Duke Energy filed its 2023 Carolinas Resource Plan, recommending Portfolio 3 as the most prudent path forward, which includes retiring coal by 2035 and leveraging nuclear and energy storage to meet the emissions targets. Meanwhile, NextEra Energy operates in North Carolina, exposing it to the same regulatory environment, though it is not directly subject to HB 951. This creates a differentiated regulatory burden and transition pathway between the two companies in the same state.",
      "llm_answer": "- HB 951 requires a 70 % cut in CO₂ emissions from Duke Energy’s Carolinas‑generation fleet by 2030 and carbon‑neutrality by 2050.  In response, Duke’s 2023 Carolinas Resource Plan (the “Plan”) selected **Portfolio 3** as the preferred path – a mix of expanded renewables, energy‑efficiency and demand‑response programs, additional nuclear and pumped‑hydro storage, and an accelerated retirement of coal plants (by 2035) – specifically to meet the state‑mandated emissions target and the carbon‑plan requirements of HB 951【page_71】.  \n\n- NextEra Energy’s North‑Carolina exposure is limited to its competitive‑generation business (NEER), which operates under long‑term contracts in various RTO/ISO markets and is not a regulated utility subject to the HB 951 carbon‑plan mandate【page_18】.  Consequently, the 70 % emissions‑reduction requirement that drives Duke’s resource‑plan redesign does **not** directly constrain NextEra’s operations in the state.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: HB 951 sets a 70% CO₂ reduction target by 2030 for Duke Energy's Carolinas operations, Duke Energy's 2023 Carolinas Resource Plan selects Portfolio 3, and coal retirement is targeted by 2035. The mention of carbon neutrality by 2050, while not in the original answer, is consistent with broader context and not factually incorrect, though slightly beyond the scope of the original answer. (2) Quantitative accuracy is perfect: the 70% reduction target, 2030 deadline, and 2035 coal retirement are all correctly stated. (3) Multi-hop reasoning is sound: the LLM correctly distinguishes Duke Energy’s regulated obligation under HB 951 from NextEra Energy’s competitive, non-regulated operations in North Carolina via NEER, accurately noting that NextEra is not subject to the mandate despite operational exposure. (4) The only minor gap is that the original answer emphasizes the NCUC’s role in approving the plan, which the LLM omits, but this does not detract significantly from the core response. Wording differs but semantic equivalence is maintained. Contextual relevance is excellent, directly addressing both parts of the question with precise, focused information.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 355,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How do MDLZ's use of weighted-average assumptions for measuring postretirement healthcare costs differ from KO's application of these assumptions in the Black-Scholes-Merton model for stock option valuation?",
      "original_answer": "MDLZ uses weighted-average assumptions to determine its net periodic postretirement healthcare costs, which resulted in costs of $14 million in 2021, $12 million in 2022, and a benefit of $5 million in 2023. These assumptions are applied to liability cash flows using spot rates along a yield curve to measure service and interest costs. In contrast, KO uses weighted-average assumptions as inputs in the Black-Scholes-Merton option-pricing model to estimate the fair value of stock options granted, which are then expensed on a straight-line basis over a four-year vesting period. The key difference lies in the financial valuation context: MDLZ applies the assumptions for postretirement benefit accounting, while KO uses them for equity compensation valuation.",
      "llm_answer": "MDLZ uses weighted‑average actuarial assumptions – a discount rate and a health‑care cost‑trend rate – to discount the projected cash‑flows of its post‑retirement health‑care plans and to calculate service and interest costs (e.g., 5.53 % discount and 7.0 % cost‑trend for U.S. plans in 2023)【page_107】.  \n\nKO applies weighted‑average inputs (dividend yield, expected volatility, risk‑free rate and expected term) in a Black‑Scholes‑Merton model to estimate the fair value of stock‑option awards (e.g., 4.1 % risk‑free rate, 17.5 % volatility, 3.0 % dividend yield for 2023)【page_95】【page_108】.  \n\nThus, MDLZ’s assumptions are used for actuarial discounting of benefit obligations, while KO’s assumptions are used as pricing inputs for valuing employee stock options.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor omissions. (1) Quantitatively, the LLM correctly identifies MDLZ's use of weighted-average assumptions for postretirement healthcare costs and provides specific 2023 actuarial assumptions (5.53% discount rate, 7.0% cost-trend rate), which align with typical disclosures, though the exact dollar amounts ($14M, $12M, -$5M) from the original answer are not included. These figures are important for completeness but not central to the conceptual distinction being asked. KO’s Black-Scholes inputs (4.1% risk-free rate, 17.5% volatility, 3.0% dividend yield) are accurately reported for 2023. (2) The LLM correctly distinguishes the application contexts: MDLZ for actuarial discounting of benefit obligations and KO for stock option valuation using Black-Scholes-Merton. (3) The multi-hop reasoning is sound—correctly synthesizing information across two companies and two distinct financial models (postretirement accounting vs. equity compensation valuation). (4) The answer is semantically equivalent to the original in terms of the key conceptual contrast, though it omits the explicit mention of the $14M, $12M, and -$5M costs/benefits and the straight-line expensing over four years for KO. These omissions slightly reduce completeness but do not undermine the correctness of the core comparison. Wording differences are acceptable and do not affect meaning. The answer is fully contextually relevant and well-structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 419,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does JPMorgan Chase's exposure to derivatives under the Dodd-Frank Act compare to Bank of America's resolution planning obligations under the Orderly Liquidation Authority, particularly in terms of liquidity risk management during financial distress?",
      "original_answer": "JPMorgan Chase is subject to Dodd-Frank regulations that govern its use of derivatives through enforceable set-off and close-out netting provisions under ISDA Master Agreements, which are constrained by the Orderly Liquidation Authority (OLA) under Title II of Dodd-Frank. Similarly, Bank of America must submit resolution plans under the OLA that outline a 'single point of entry' strategy, restricting liquidity flows from subsidiaries to the parent company during financial distress. Both firms face regulatory constraints on liquidity: JPMorgan through enforceable netting limitations and Bank of America through intercompany liquidity contribution arrangements that prioritize subsidiary solvency over parent company funding needs.",
      "llm_answer": "JPMorgan Chase’s derivative positions are modest in net terms – at 31 December 2023 the firm reported net derivative assets of about $183 million and net derivative liabilities of only $19 million – and they are governed by Dodd‑Frank’s Orderly‑Liquidation Authority, which requires close‑out netting and collateral posting to preserve liquidity if a counter‑party defaults. By contrast, Bank of America’s resolution‑planning obligations under the Orderly‑Liquidation Authority focus on ensuring that its key subsidiaries retain enough capital and liquid assets to operate through severe stress; if the parent’s liquidity deteriorates, the firm could be barred from drawing on subsidiary funding and would have to contribute its remaining assets to a holding company, creating a far tighter liquidity constraint in a distress scenario.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It states that JPMorgan Chase had net derivative assets of $183 million and net derivative liabilities of $19 million as of December 31, 2023. These figures are factually incorrect and grossly underestimate JPMorgan's actual derivatives exposure, which is in the trillions of gross notional value, though net exposure is smaller. The ground truth does not provide specific numbers, but known public filings confirm that JPMorgan's net derivative assets are typically in the tens of billions, not millions. This represents a major error in scale. (2) The qualitative aspects partially align with the ground truth: both firms are correctly linked to the Orderly Liquidation Authority (OLA) under Dodd-Frank, and the concept of restricted liquidity flows during distress is addressed. The mention of close-out netting for JPMorgan and subsidiary capital retention for Bank of America reflects elements of the correct regulatory framework. However, the LLM misattributes the source of JPMorgan’s constraints—while it mentions OLA governing derivatives, the ground truth emphasizes Dodd-Frank’s impact via ISDA agreements and enforceable netting limitations under Title II, not OLA directly regulating derivatives. (3) The multi-hop reasoning is partially sound: the model attempts to compare two banks’ liquidity risk management under Dodd-Frank mechanisms, linking derivatives exposure to resolution planning. However, it fails to accurately synthesize the specific regulatory mechanisms—JPMorgan’s constraint is on netting enforceability, while Bank of America’s is on intercompany liquidity flows. The LLM conflates these with general liquidity preservation language. (4) Contextual relevance is strong—the response stays on topic, addresses both banks, and discusses liquidity risk in distress. Despite incorrect numbers and some mischaracterization of regulatory mechanics, it captures the high-level idea of tighter liquidity constraints under resolution planning. Thus, the correctness score is moderate due to severe quantitative flaws but partial qualitative alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 576,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does Ohio's continued reliance on coal influence the contrasting energy transition strategies of XOM and CVX, particularly considering XOM's European coal tax burden and CVX's 2024 renewable natural gas investments in the state?",
      "original_answer": "XOM faced a significant $1.8 billion after-tax charge in 2022 due to the EU's new tax on coal and other energy sectors, which targeted companies with surplus profits, signaling regulatory pressure to reduce fossil fuel dependency. Meanwhile, Duke Energy Ohio, a subsidiary operating in the state, held only $23 million in coal inventory as of December 31, 2024, suggesting a cautious but ongoing reliance on coal. In contrast, CVX made targeted investments in Ohio through Brightmark RNG Holdings LLC, achieving commercial operations at renewable natural gas projects in 2024, aligning with a cleaner energy transition. This divergence highlights how regulatory penalties in Europe are pushing XOM toward compliance, while CVX is proactively investing in low-carbon alternatives like RNG in coal-reliant states such as Ohio.",
      "llm_answer": "Ohio’s power system still leans heavily on coal – Duke Energy’s 2024 inventory shows ≈ 23 million dollars of coal stock in its Ohio utility (page 124) – so the state’s generation mix remains carbon‑intensive. ExxonMobil (XOM) therefore bears a sizable “coal‑surplus‑profits” levy in Europe, where an EU regulation imposed a mandatory 33 % tax on coal‑related earnings that cost the company about $1.8 billion in 2022 and $0.2 billion in 2023 (page 115). In contrast, Chevron (CVX) is using Ohio’s continued coal use as a market for low‑carbon alternatives, expanding its renewable‑natural‑gas (RNG) footprint with new Brightmark RNG projects in Ohio (and other Mid‑west states) in 2024 (page 19). Thus, while XOM’s transition is hampered by an external coal‑tax burden, CVX is actively pivoting the same coal‑dependent region toward RNG‑based clean energy.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, the key figures are correct: the $1.8 billion after-tax charge for XOM in 2022 is accurately reported, and Duke Energy Ohio's $23 million coal inventory as of December 31, 2024, is correctly cited. However, the LLM adds a detail not in the original answer — a $0.2 billion tax cost for XOM in 2023 — which, while plausible, is not present in the ground truth and introduces unverified information, slightly reducing quantitative accuracy. (2) The entity identification is correct: XOM, CVX, Duke Energy Ohio, Brightmark RNG Holdings LLC (implied via 'Brightmark RNG projects'), and the EU regulatory context are all properly referenced. (3) The multi-hop reasoning is sound: the answer correctly links Ohio’s ongoing coal reliance (via Duke Energy) to contrasting corporate strategies — XOM facing external regulatory penalties in Europe, while CVX leverages the same market for RNG investments. (4) The semantic meaning fully captures the original answer’s intent: regulatory pressure is pushing XOM toward compliance, while CVX is proactively investing in low-carbon alternatives in coal-reliant regions. The only minor deviation is the inclusion of the 2023 tax figure and the 33% tax rate, which, while contextually reasonable, are not in the original and slightly affect precision. Overall, the answer is factually strong, well-reasoned, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 404,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How does the structure of MS's CLNs, which embed credit protection sold by the issuer, compare with JPM's credit-related notes in terms of payout mechanics upon a credit event, given that both instruments involve the transfer of credit risk on reference entities?",
      "original_answer": "Morgan Stanley structures CLNs as hybrid instruments where it purchases credit protection from the issuer, and if a credit event occurs with the reference entity, the principal balance of the note may not be repaid in full. JPMorgan, on the other hand, sells credit protection through credit-related notes, where the issuer pays the investor the difference between the par value and the fair value of the defaulted reference obligation upon a credit event. Both instruments transfer credit risk on reference entities, but MS acts as the buyer of protection while JPM often acts as the seller, affecting payout obligations differently based on their respective positions in the transaction.",
      "llm_answer": "Morgan Stanley’s CLNs are hybrid securities in which the issuer sells credit protection to the note‑holder; if a reference entity suffers a credit event the issuer is not required to return the full principal and the investor receives only the recovery‑value of the underlying reference obligation (the note’s principal is reduced accordingly). JPMorgan’s credit‑related notes work the same way – the issuer purchases protection from the investor, pays periodic coupons and would repay par at maturity, but on a credit event it only pays the shortfall between the note’s par value and the fair‑value (recovery) of the defaulted reference asset. Thus, in both structures the payout on a credit event is limited to the difference between par and the reference‑entity recovery amount, leaving the investor with a reduced principal repayment.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a fundamental misrepresentation of the roles of Morgan Stanley (MS) and JPMorgan (JPM) in their respective credit-linked note (CLN) structures, which severely undermines the correctness of the comparison. According to the ground truth, MS acts as the *buyer* of credit protection in its CLNs, meaning it (as issuer) is protected against a credit event and the investor bears the loss. In contrast, JPM acts as the *seller* of credit protection in its credit-related notes, meaning JPM assumes credit risk and pays investors upon a credit event. However, the LLM answer incorrectly reverses these roles: it states that in MS's CLNs, the *issuer sells protection to the investor*, implying MS is the seller (like JPM), when in fact MS is the buyer. Similarly, it claims in JPM's notes the *issuer purchases protection from the investor*, which would make JPM the buyer — again contradicting the ground truth where JPM is the seller. This role reversal leads to an incorrect explanation of payout mechanics, even though the description of the payout *amount* (par minus recovery value) is semantically similar. There are no numeric values in the question or answers, so quantitative accuracy is not at issue (score 10 by default). The answer is contextually relevant and addresses the comparison of payout mechanics, but the flawed reasoning in counterparty roles breaks the multi-hop logic required to correctly contrast the two structures. Thus, while the surface-level description of payouts appears plausible, the underlying economic relationships are misrepresented, leading to a correctness score of 4 (partially correct but with significant conceptual errors).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 458,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the application of the reduced disclosure format differ between Georgia Power Company (a subsidiary of Southern Company) and Florida Power & Light Company (a subsidiary of NextEra Energy) in their respective 2022 Form 10-K filings, particularly in terms of their compliance with General Instruction I.(1)(a) and (b) of Form 10-K?",
      "original_answer": "Georgia Power Company, as part of Southern Company's consolidated 10-K filing, explicitly states that it meets the conditions in General Instructions I(1)(a) and (b) of Form 10-K and therefore uses the reduced disclosure format specified in General Instructions I(2)(b), (c), and (d). Similarly, Florida Power & Light Company also asserts compliance with General Instruction I.(1)(a) and (b), qualifying for the reduced disclosure format in its 2022 Form 10-K filing. However, while Georgia Power is one of multiple registrants in a combined filing with Southern Company, Florida Power & Light Company is one of only two registrants in its combined filing, the other being NextEra Energy, Inc., which holds all 1,000 shares of its common stock. Both companies file information only on their own behalf and disclaim responsibility for the other registrants’ data.",
      "llm_answer": "Both companies state that they satisfy General Instruction I.(1)(a) and (b) and therefore qualify to use the reduced‑disclosure format. Georgia Power’s filing, however, adds that the combined Form 10‑K is being filed “with the reduced disclosure format specified in General Instructions I.(2)(b), (c) and (d)” because it is one of several subsidiary registrants in a single filing. Florida Power & Light’s filing simply notes that it “meets the conditions … and is therefore filing this Form with the reduced disclosure format,” without referencing the specific I.(2) subsections.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and captures the core similarities and differences between Georgia Power Company and Florida Power & Light Company regarding their use of the reduced disclosure format under General Instruction I.(1)(a) and (b) of Form 10-K in their 2022 filings. It correctly states that both companies qualify for the reduced disclosure format by meeting the conditions in I.(1)(a) and (b). It accurately highlights that Georgia Power explicitly references the specific subsections I.(2)(b), (c), and (d) due to being one of several subsidiaries in a combined filing with Southern Company, while Florida Power & Light makes a more general reference to the reduced disclosure format without citing those subsections. The only minor omission is that the LLM answer does not mention the structural difference in the filings—specifically, that Florida Power & Light files as one of only two registrants with NextEra Energy, Inc., which owns all of its common stock, whereas Georgia Power is part of a larger group filing. This contextual detail is present in the ground truth and adds nuance to the comparison, but its absence does not undermine the essential correctness of the response. All entities, instructions, and filing behaviors are correctly identified. There are no numerical inaccuracies (no numbers involved), and the reasoning correctly synthesizes multi-hop information from both filings. The answer is semantically equivalent to the ground truth in substance, with slightly less structural detail on the composition of the combined filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 430,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does RTX's revenue recognition timing on U.S. government fixed-price contracts, influenced by FAR guidelines, compare to GD's cost allocation practices under the same regulatory framework, particularly in relation to performance-based payments and contract modifications?",
      "original_answer": "RTX recognizes revenue in excess of billings on U.S. government fixed-price contracts due to performance-based payments (PBPs) or progress payments, where the customer retains a portion of the contract price until completion. This practice is guided by the Federal Acquisition Regulation (FAR), which outlines allowable cost structures and payment mechanisms. Similarly, GD operates under the FAR and Cost Accounting Standards (CAS), which regulate cost allowability and allocation across contracts. GD's cost allocation practices are subject to audits and reviews by the government, ensuring that costs charged to contracts comply with FAR stipulations. Both companies must manage contract modifications and revenue or cost adjustments in response to FAR-mandated acquisition phases, including planning, competition, and contractor qualifications, though RTX specifically highlights the impact of these regulations on contract assets and liabilities, while GD emphasizes compliance and auditability under FAR and CAS.",
      "llm_answer": "RTX treats its U.S.‑government fixed‑price work as “cost‑type” contracts governed by the FAR: revenue is recorded on a percentage‑of‑completion basis using costs incurred to date, and the company books a contract‑asset when performance‑based or progress payments are earned but not yet billed (the FAR‑mandated “cost‑plus‑award‑fee” treatment). GD, by contrast, follows the FAR and the Cost Accounting Standards to allocate only allowable costs to each contract; its focus is on cost‑allowability and cost‑allocation rather than on timing of revenue, and any contract modification is reflected by re‑allocating the allowable costs (cumulatively or prospectively) to the revised contract rather than by shifting revenue recognition.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains no explicit numerical data, so quantitative accuracy is not applicable in a traditional sense; however, since there are no numbers to verify or miscalculate, it is scored as 10 by default. Contextually, the answer addresses the core comparison between RTX and GD regarding revenue recognition and cost allocation under FAR, making it relevant (score 8). However, significant qualitative inaccuracies undermine correctness. First, the claim that RTX treats fixed-price contracts as 'cost-type' contracts is incorrect—fixed-price contracts are distinct from cost-type contracts under FAR, and RTX does not reclassify them. Instead, RTX applies percentage-of-completion revenue recognition on fixed-price contracts using incurred costs as a measure of progress, which is permissible under GAAP and consistent with FAR guidelines, but this does not make the contract 'cost-type.' The reference to 'FAR-mandated cost-plus-award-fee treatment' is also misleading—PBPs and progress payments on fixed-price contracts are not the same as cost-plus-award-fee contracts, which involve cost reimbursement plus incentive fees. This mischaracterization reflects a fundamental misunderstanding of FAR contract types. On GD’s side, the emphasis on cost allowability and allocation under FAR and CAS is accurate, as is the point about re-allocating allowable costs upon contract modification. However, the contrast is overstated: both companies deal with revenue timing and cost allocation, and the original answer correctly notes that both respond to FAR-mandated phases and modifications, though with different reporting emphases (RTX on contract assets/liabilities, GD on auditability). The LLM answer creates a false dichotomy by suggesting RTX focuses on revenue timing while GD does not, when in reality both must account for it. Thus, while some elements are correct—such as the use of percentage-of-completion and cost allocation—the misrepresentation of contract types and payment mechanisms leads to a correctness score of 5 due to significant factual and conceptual errors in multi-hop reasoning and entity-specific practices.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 572,
        "total_tokens": 2041
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the difference in voting rights structure between Class A and Class B shares at GOOGL compare to CMCSA's disclosure regarding its lack of voting rights in Atairos, and what implications does this have for corporate governance control in both entities?",
      "original_answer": "At GOOGL, Class A shares carry one vote per share while Class B shares carry ten votes per share, creating a dual-class structure that concentrates voting power among holders of Class B shares. This structure allows certain shareholders to maintain control over corporate decisions despite owning a minority of shares. In contrast, CMCSA explicitly discloses that it has no voting rights in Atairos, which is accounted for as an equity method investment, limiting its influence over Atairos’s operations. While GOOGL uses differentiated voting rights to preserve control through a structured share class system, CMCSA lacks such control mechanisms entirely in its investment in Atairos, affecting its corporate governance influence in that entity.",
      "llm_answer": "Alphabet’s capital structure gives Class B shares ten votes per share while Class A shares have only one vote (Class C shares have none), concentrating voting power in the holders of Class B stock.  By contrast, Comcast’s filing states that it holds **no voting rights** in its investment in Atairos – it only has limited consent rights and therefore cannot direct Atairos’s economic‑performance decisions.  The result is that Alphabet’s dual‑class system concentrates corporate‑governance control in a small group of Class B shareholders, whereas Comcast’s lack of voting rights leaves it without governance control over Atairos, limiting its influence to that of a passive equity‑method investor.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: Class B shares at GOOGL (Alphabet) have 10 votes per share, Class A have 1 vote, and Class C (not mentioned in the original but factually accurate) have none—this addition is correct and adds context without distorting the answer. CMCSA's lack of voting rights in Atairos is accurately stated. (2) The comparison correctly identifies that GOOGL uses a dual-class structure to concentrate voting power and governance control among Class B holders, while CMCSA lacks voting rights and thus governance influence over Atairos. (3) Multi-hop reasoning is sound: the model synthesizes information across two companies (GOOGL and CMCSA), their respective share structures, and implications for corporate governance. (4) The only minor shortcoming is that the original answer specifies Atairos is accounted for under the equity method, which the LLM mentions implicitly by calling it a 'passive equity-method investor' but could have been more explicit. However, this does not detract significantly from the overall correctness. Wording differs slightly but maintains semantic equivalence. No calculation errors. All entities (GOOGL, CMCSA, Atairos) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 363,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does Amgen's reliance on McKesson Corporation for 33% of its gross product sales in 2021 compare to Merck's risk disclosures about pharmaceutical product distribution concentration, given Amgen's specific exposure to wholesaler distribution risks outlined in its 2022 filing?",
      "original_answer": "Amgen's 2022 filing reveals that McKesson Corporation accounted for 33% of its gross product sales in 2021, highlighting a significant dependency on a single wholesaler. This concentration risk is explicitly acknowledged in Amgen's disclosure that the substantial majority of its U.S. product sales are made to just three distributors, including McKesson, and that financial or operational difficulties at any of these could significantly disrupt its business. Merck's 2022 filing similarly warns that 'pharmaceutical products can develop unexpected safety or efficacy concerns' and that 'reliance on third-party relationships and outsourcing arrangements could materially adversely affect the business,' reinforcing the industry-wide sensitivity to distribution chain vulnerabilities. Together, these disclosures underscore the material financial and operational risk both companies face from overreliance on a concentrated pharmaceutical distribution network.",
      "llm_answer": "Amgen’s 2021 filing shows that a single wholesaler—McKesson Corporation—accounted for roughly one‑third (33 %) of the company’s total gross product sales, highlighting a material concentration risk in its distribution channel. Merck’s 2022 filing contains a similar warning, noting that its business “relies on third‑party relationships and outsourcing arrangements” and that consolidation among a small number of distributors and payors could “materially adversely affect” its results, indicating that Merck also faces a distribution‑concentration risk, though it does not quantify the exposure as Amgen does.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all numbers and dates are correct: Amgen's 33% reliance on McKesson in 2021 is accurately reported, and the reference to Merck's 2022 filing is correct. The percentage (33%) and year (2021) match the original answer. (2) The answer correctly identifies both companies (Amgen and Merck), the relevant metric (distribution concentration risk), and the correct timeframes (Amgen’s 2021 data cited in 2022 filing; Merck’s 2022 disclosure). (3) The multi-hop reasoning is sound: it synthesizes Amgen’s specific quantitative exposure with Merck’s qualitative risk disclosure about third-party distribution reliance and industry consolidation, drawing a valid cross-company comparison. (4) The only minor shortcoming is that the LLM answer does not explicitly mention Amgen’s broader dependence on three distributors (beyond just McKesson), which is a key contextual detail in the original answer that strengthens the risk assessment. However, this omission does not undermine the core correctness. The LLM captures the central comparison—Amgen quantifies its risk, Merck acknowledges similar risk qualitatively—and conveys the same overall message about industry-wide distribution vulnerabilities. Wording differences are acceptable and do not affect semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 377,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "What is ConocoPhillips' financial exposure from its ownership in Alba Plant LLC, given Chevron's production of condensate and the plant's role in processing natural gas from the Alba Unit in Equatorial Guinea?",
      "original_answer": "ConocoPhillips has a 56.0% ownership interest in EG LNG and a 52.2% interest in Alba Plant LLC, which processes natural gas from the Alba Unit and extracts condensate and LPG for sale at market prices. According to COP's 2024 10-K, ConocoPhillips has $116 million in maximum potential future payments related to guarantees for Alba Plant LLC’s agreements to process third-party gas. This exposure is tied to Chevron’s upstream production of condensate, which feeds into the Alba Unit’s gas stream, and the downstream monetization through the LPG plant and EG LNG’s liquefaction facility.",
      "llm_answer": "ConocoPhillips’ guarantee related to its 52.2 % stake in Alba Plant LLC (the LPG plant that processes natural‑gas from the Alba Unit and receives condensate from Chevron) carries a maximum potential liability of **about $116 million** (the guarantee’s fair‑value exposure), with a recorded carrying amount of roughly **$4 million** as of December 31 2024【page_102】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: $116 million maximum potential future payments (liability) and $4 million carrying amount as of December 31, 2024, are consistent with typical disclosures in 10-K filings. The ownership interest of 52.2% in Alba Plant LLC is correctly stated. (2) The mention of Chevron’s condensate feeding into the Alba Unit is accurately reflected, and the role of Alba Plant LLC in processing natural gas and extracting LPG is properly contextualized. (3) The multi-hop reasoning is sound: the model connects ConocoPhillips’ ownership stake to its financial guarantee, links the plant’s input (gas and condensate) to Chevron’s upstream production, and correctly identifies the exposure in terms of both fair-value and carrying amount. (4) The only minor omission is that the original answer also notes ConocoPhillips’ 56.0% interest in EG LNG and the broader monetization pathway through EG LNG’s liquefaction facility, which adds context but is not central to the specific question about Alba Plant LLC exposure. This does not detract significantly from correctness. Wording differs but semantic meaning and key facts match. Thus, the answer is factually complete and precise, earning a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 385,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How does the use of valuation models incorporating observable market inputs by General Dynamics' Level 2 assets compare with Union Pacific's disclosure of real estate funds at NAV, given that real estate funds are typically valued using unobservable inputs over 8-10 year terms?",
      "original_answer": "General Dynamics values its Level 2 fixed-income assets using valuation models with observable inputs like interest rates and bond yields, contrasting with Union Pacific's $30 million allocation to real estate funds that are valued at NAV based on unobservable inputs according to LMT's explanation of real estate fund valuation practices which involve long-term valuations over 8-10 year periods.",
      "llm_answer": "General Dynamics reports that its Level 2 assets are valued with a market‑approach valuation model that uses observable inputs such as interest‑rate curves, bond yields and quoted prices for comparable securities (Lockheed Martin 10‑K, p. 83). In contrast, Union Pacific’s pension‑plan disclosures show its real‑estate fund holdings are measured at net‑asset value (NAV) based on property appraisals and other unobservable inputs, a method typical for private‑real‑estate investments that have 8‑ to 10‑year terms (Union Pacific 10‑K, p. 58; p. 57). Thus, GD relies on observable market data for Level 2 valuations, whereas Union Pacific relies on NAV calculations that depend on unobservable, appraisal‑driven inputs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: General Dynamics uses observable market inputs (e.g., interest-rate curves, bond yields, comparable securities) for Level 2 assets, while Union Pacific values its real estate fund holdings at NAV using unobservable inputs like appraisals. The $30 million figure from the original answer is missing in the LLM response, which is a minor omission but does not distort the overall comparison. (2) No explicit numerical calculation is required; the absence of the $30 million is the only quantitative gap, but it doesn't affect the core reasoning. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes valuation practices from General Dynamics (via Lockheed Martin’s 10-K as a source for methodology) and contrasts them with Union Pacific’s real estate fund disclosures, correctly attributing NAV-based valuation to long-term, unobservable inputs. (4) Semantic equivalence is strong—wording differs but meaning matches. The use of Lockheed Martin’s 10-K to explain valuation models is consistent with the original’s reference to 'LMT's explanation.' The LLM adds specific page citations (p. 83, p. 58, etc.), which enhance credibility. Only the missing dollar amount prevents a perfect 10. Contextual relevance is excellent, directly addressing the comparison between observable vs. unobservable inputs and the role of NAV in long-term real estate funds.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 405,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "Given Citibank's co-branding role in Costco's credit card program and its administrative role in Colgate's five-year credit agreement, how does the nature of Citibank's involvement differ in these two financial arrangements?",
      "original_answer": "Citibank's involvement with Costco is characterized by a co-branded credit card program that has undergone twelve amendments since 2015, most recently on October 11, 2023, indicating an ongoing consumer financial product partnership. In contrast, Citibank's role with Colgate is as administrative agent and arranger for a five-year credit agreement most recently amended on November 4, 2022, which represents a corporate lending facility rather than a consumer credit product. The Costco relationship centers on a retail financial service partnership while the Colgate arrangement involves managing a syndicated corporate credit facility.",
      "llm_answer": "Citibank’s role with Costco is that of a **co‑branded credit‑card partner** – it issues and services the Costco‑brand credit card under a “Citibank, N.A. Co‑Branded Credit Card Agreement” (see Exhibit 10.8 in Costco’s 10‑K [page 68]). In contrast, with Colgate‑Palmolive Citibank is not a card issuer but the **administrative agent and arranger** for a corporate loan facility, acting only to manage the five‑year credit agreement and related lender communications (see Exhibit 10‑I describing Citibank as “administrative agent” [pages 126 & 67]). Thus, Citibank’s involvement shifts from a consumer‑facing card‑issuing partnership with Costco to a back‑office, loan‑administration function for Colgate.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Citibank's co-branded credit card role with Costco and its administrative agent/arranger role for Colgate's five-year credit agreement are accurately described. The nature of the two arrangements—consumer-facing card issuance vs. corporate loan administration—is correctly contrasted. (2) Quantitative accuracy is perfect: while no specific dates or amendment counts are mentioned in the LLM answer (e.g., 12 amendments since 2015, last amendment dates of Oct 11, 2023 for Costco and Nov 4, 2022 for Colgate), these omissions do not introduce inaccuracy—only a slight reduction in completeness. The absence of these dates is not a factual error but a narrowing of detail. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two different financial arrangements (retail co-branding vs. corporate lending), identifies the distinct roles of Citibank, and draws a valid qualitative distinction between consumer and corporate financial services. (4) Semantic equivalence is strong: terms like 'co-branded credit-card partner' and 'administrative agent and arranger' match the original, and the explanation of functional differences is clear and contextually appropriate. The reference to specific exhibits (10.8, 10-I) and page numbers adds precision and sourcing, enhancing credibility. The only reason for not scoring a 10 is the omission of the amendment history and exact dates present in the ground truth, which provide additional context about the longevity and evolution of the agreements. However, since the question did not explicitly ask for dates or number of amendments, this does not constitute a major gap. Overall, the answer is factually correct, well-reasoned, and highly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 496,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "What is Chevron's net daily crude oil production contribution from its stake in QatarEnergy LNG, considering the average daily net production and Chevron's ownership percentage in 2023?",
      "original_answer": "Chevron's net daily crude oil production from its stake in QatarEnergy LNG in 2023 was 3.9 MBD (thousand barrels per day), calculated as 30% ownership of the 13 MBD average daily net crude oil production from QatarEnergy LNG.",
      "llm_answer": "Chevron’s share of the QatarEnergy LNG (N3) project produces 13 thousand barrels of crude oil per day on a net‑basis. Applying Chevron’s 30 % ownership stake in 2023, the contribution is:\n\n**13 × 30 % ≈ 3.9 thousand barrels of crude oil per day**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual elements are accurate: Chevron's 30% ownership stake in QatarEnergy LNG and the 13 thousand barrels per day (MBD) average daily net crude oil production are correctly stated. (2) The calculation is accurate: 13 × 30% = 3.9 thousand barrels per day, which matches the ground truth. Minor formatting such as '≈' instead of '=' is acceptable and does not affect correctness. (3) The multi-hop reasoning—combining ownership percentage with production volume to derive net contribution—is sound and properly articulated. (4) The answer is semantically equivalent to the original, conveying the same information with clear, relevant, and precise wording. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1127,
        "completion_tokens": 234,
        "total_tokens": 1361
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How does Caterpillar's use of pricing models for valuing Level 3 non-U.S. pension assets compare to Lockheed Martin's valuation methodology for fixed income investments categorized as Level 3, particularly in terms of the inputs and approaches used?",
      "original_answer": "Caterpillar values its Level 3 non-U.S. pension assets, which include insurance contracts, using pricing models that reflect management's judgment of assumptions a market participant would use. In contrast, Lockheed Martin categorizes fixed income investments as Level 3 when observable inputs are unavailable and uses discounted cash flow approaches or indicative quotes from vendors and brokers, with significant inputs including projected annuity payments and discount rates. Both companies rely on unobservable inputs for Level 3 assets, but Caterpillar focuses on pricing models based on management assumptions, while Lockheed Martin employs a broader set of valuation techniques including discounted cash flows and third-party indicative quotes.",
      "llm_answer": "Caterpillar values its Level 3 non‑U.S. pension assets – which consist mainly of insurance‑contract‑type obligations – with **internal pricing models** that management says incorporate the assumptions a market participant would use (e.g., projected cash‑flow patterns, discount rates, mortality and other actuarial factors). Lockheed Martin, by contrast, values Level 3 fixed‑income investments with a **mixed approach** that first seeks indicative quotes or broker bids and, when those are unavailable, applies a **discounted‑cash‑flow model** whose key inputs are the projected annuity‑type payments and the discount rate applied to those payments. Thus, Caterpillar’s methodology is model‑driven and based on market‑participant assumptions, while Lockheed’s combines market‑derived quotes with a DCF model that explicitly uses projected cash flows and discount rates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Caterpillar uses internal pricing models based on management's judgment of market-participant assumptions for its Level 3 non-U.S. pension assets (specifically insurance contracts), while Lockheed Martin uses a mixed approach involving indicative quotes from brokers/vendors and, when necessary, discounted cash flow (DCF) models for Level 3 fixed income investments. The key inputs mentioned—projected annuity-type payments and discount rates for Lockheed Martin—are consistent with the original answer. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable in a numerical sense, but all qualitative metrics and terms are correctly used. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two different companies (Caterpillar and Lockheed Martin), two different asset types (non-U.S. pension assets vs. fixed income investments), and compares their Level 3 valuation methodologies, inputs, and approaches. (4) The only minor shortcoming is that the LLM answer does not explicitly state that both companies rely on unobservable inputs (a point emphasized in the original answer), though this is implied by the focus on Level 3 assets and unobservable assumptions like mortality and actuarial factors. This omission slightly affects completeness but does not detract from the core accuracy. Overall, the answer is semantically equivalent and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 435,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How might the expiration of Enbrel's formulation patents in 2037 impact Pfizer's Specialty Care segment revenue concentration risk, especially considering Bristol Myers Squibb's external innovation strategy focused on future pipeline assets?",
      "original_answer": "Enbrel remains a key product in Pfizer's Specialty Care segment, where it is listed among major inflammation & immunology offerings. The expiration of its formulation patents in 2037 could expose Pfizer to increased generic competition, potentially exacerbating revenue concentration risk if other pipeline or partnered products have not sufficiently diversified the segment's portfolio by then. Meanwhile, Bristol Myers Squibb's external innovation strategy, which emphasizes acquiring and developing disruptive therapies beyond internal R&D, may position it to enter the post-patent market with new assets, assuming favorable clinical and regulatory outcomes. This dynamic could shift competitive positioning in the inflammation & immunology space if BMY successfully brings alternative therapies to market ahead of the 2037 timeline.",
      "llm_answer": "Enbrel’s U.S. formulation patent does not expire until 10 October 2037, but the looming loss of that protection will eventually allow biosimilar competitors to enter the market and erode the sales of one of the flagship biologics in Pfizer’s Specialty‑Care (Inflammation & Immunology) portfolio. Because Enbrel currently accounts for a sizable share of Specialty‑Care revenue, its post‑patent decline would heighten Pfizer’s concentration risk unless other specialty products can replace it. At the same time, Bristol‑Myers Squibb is pursuing an “external‑innovation” model that leans on partnerships and acquisitions to build a pipeline of future assets, meaning BMS is positioning new therapies to capture market share that Pfizer could lose as Enbrel’s exclusivity wanes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the patent expiration date of October 10, 2037, is correctly stated and matches the knowledge graph's timeline, satisfying the quantitative accuracy requirement. There are no calculations, but the date precision is exact. (2) The answer addresses all key parts of the question: Enbrel's role in Pfizer's Specialty Care segment, the risk of revenue concentration post-2037 due to biosimilar competition, and Bristol Myers Squibb's external innovation strategy as a competitive threat. (3) Entity accuracy is strong: Pfizer, Bristol Myers Squibb (correctly referred to as BMS), Enbrel, Specialty Care segment, inflammation & immunology portfolio, and the external innovation model are all correctly identified and contextualized. (4) The reasoning is sound and reflects multi-hop synthesis: it connects patent expiration to revenue risk, acknowledges the need for portfolio diversification, and contrasts Pfizer’s reliance on existing blockbusters with BMS’s proactive external strategy to enter the space with new assets. The only minor shortcoming is that the LLM does not explicitly mention that BMS may enter *after* or *around* the 2037 timeline with alternative therapies, slightly reducing the depth of competitive dynamics compared to the original. However, the implication is clear. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 410,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How do AIG's market risk stress testing practices compare with COF's credit loss forecasting methods in terms of their reliance on scenario-based modeling and sensitivity analysis?",
      "original_answer": "AIG employs stress testing as part of its market risk management to evaluate the impact of adverse market developments, including through sensitivity analysis and scenario analysis, which are aligned with its corporate risk appetite. This includes analyzing the effects of hypothetical shocks to interest rates, credit spreads, and equity prices. On the other hand, COF uses scenario-based forecasting models to estimate its allowance for credit losses (ACL), which totaled $13.0 billion as of December 31, 2024, incorporating both quantitative forecasts and qualitative adjustments for current and forward-looking economic conditions. Both firms rely on scenario and sensitivity analysis, but AIG applies these techniques to market risk exposures while COF integrates them into credit risk modeling for consumer loan portfolios.",
      "llm_answer": "AIG’s market‑risk framework is built around explicit scenario‑based testing and sensitivity analysis – it routinely runs stress‑test, scenario‑analysis and factor‑sensitivity runs to gauge how changes in interest rates, credit spreads, equity, FX and commodity markets would affect its portfolio (see AIG 10‑K p. 83). In contrast, Capital One’s credit‑loss methodology for its credit‑card portfolio is driven primarily by statistical loss‑forecasting models (historical loss data, probability‑of‑default/loss‑given‑default estimates) supplemented by qualitative management judgments, with no explicit reliance on scenario‑based or sensitivity‑type modeling (see COF 10‑K p. 135).",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains no numeric values, so quantitative accuracy is not applicable—however, since there are no incorrect numbers, it does not detract from accuracy. The core issue lies in qualitative inaccuracy: the LLM incorrectly claims that Capital One (COF) does *not* use scenario-based or sensitivity modeling in its credit loss forecasting, which directly contradicts the ground truth. The original answer states that COF *does* use scenario-based forecasting models for its allowance for credit losses (ACL), incorporating forward-looking economic conditions—this is a central part of its methodology. The LLM’s assertion that COF relies only on historical data and qualitative judgments 'with no explicit reliance on scenario-based or sensitivity-type modeling' is factually wrong. This misrepresents a key multi-hop comparison: both AIG and COF use scenario and sensitivity analysis, but in different risk domains (market vs. credit risk). The LLM fails to recognize the commonality in methodology while incorrectly differentiating the two. Contextual relevance is moderate—the response addresses the right companies and general topic, but the erroneous contrast undermines the analysis. Correctness is severely compromised due to this fundamental error in reasoning and entity-specific fact retrieval.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 365,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does Qualcomm's exposure to EAR regulations on advanced semiconductor technologies compare with AMD's specific constraints on exporting Versal VC2602 and VE2602 FPGAs to China, given both companies' involvement in high-performance computing markets?",
      "original_answer": "Qualcomm's business and products, including those of its customers and licensees, are subject to a broad range of regulations, including the U.S. Export Administration Regulations (EAR), which govern the export and re-export of advanced technologies, potentially affecting its business operations and results. In contrast, AMD faces specific export constraints under EAR, including requirements to file a Notified Advanced Computing (NAC) notification 25 days before shipping certain Versal VC2602 and VE2602 FPGAs to China or to customers outside the U.S. whose ultimate parent is headquartered in a D5 country, including China. These FPGAs are part of AMD's Data Center segment, which includes Field Programmable Gate Arrays (FPGAs) and other adaptive computing products. While both companies are impacted by EAR regulations, AMD's exposure is more directly constrained in terms of specific product lines and geographic markets, particularly affecting its ability to serve Chinese customers without prior regulatory approval, whereas Qualcomm's exposure is more diffuse across its broader regulatory risk profile.",
      "llm_answer": "Qualcomm notes that its entire advanced‑semiconductor business is subject to U.S. export‑control rules, including the Export Administration Regulations (EAR) administered by the Commerce Department, so any of its high‑performance chips could be restricted by those rules【page_6】. In contrast, AMD’s filing spells out a narrow, product‑specific limitation: shipments of its Versal VC2602 and VE2602 FPGAs to China (or to customers whose ultimate parent is in a “D5” country) require a Notified Advanced Computing (NAC) filing and may need a BIS license, and a failure to obtain one could block those particular FPGA exports【page_33】. Thus Qualcomm faces a broader, portfolio‑wide EAR exposure, while AMD’s risk is confined to a few FPGA models that are subject to additional NAC‑notification and licensing requirements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Qualcomm's broad exposure to EAR regulations across its semiconductor portfolio and AMD's specific constraints on Versal VC2602 and VE2602 FPGAs are accurately described. The requirement for AMD to file a Notified Advanced Computing (NAC) notification before shipping to China or D5-country-linked customers is correctly stated. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification—thus, quantitative accuracy is perfect by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes regulatory exposure differences between Qualcomm (broad, portfolio-wide) and AMD (narrow, product-specific), drawing appropriate contrast based on their respective filings. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., 'portfolio-wide EAR exposure' vs 'more diffuse across its broader regulatory risk profile'), the meaning matches the original answer. One minor point preventing a perfect 10 is the omission of the explicit mention that these FPGAs belong to AMD’s Data Center segment—an element present in the ground truth that adds contextual precision, though not critical to the core comparison. Otherwise, the answer is factually complete, logically structured, and directly responsive to the comparative regulatory question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 398,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does CMCSA's relinquishment of voting rights in Hulu contrast with META's dual-class stock structure in terms of control retention strategies?",
      "original_answer": "CMCSA relinquished substantially all voting rights associated with its investment in Hulu in 2019, including board seats, in exchange for a put/call arrangement with Disney that guaranteed a minimum equity value of $27.5 billion for its interest and resulted in an $8.6 billion payment from Disney in 2023. This contrasts with META's dual-class stock structure where Class B shares carry 10 votes per share compared to 1 vote for Class A shares, allowing certain stockholders to maintain significant voting power while owning a minority of economic interests. CMCSA's approach involved transferring control to Disney in exchange for financial guarantees, whereas META retains internal control differentiation through its stock classification framework.",
      "llm_answer": "- Comcast’s 2019 agreements with Disney required it to **give up its board seats and “substantially all voting rights” in Hulu**, leaving Disney with full operational control while Comcast kept only an economic interest (≈33 %) and put‑/call options to sell or buy that stake later【page_85】.  \n\n- Meta’s 10‑K shows that the company is capitalized with **Class A and Class B common stock**, a classic dual‑class structure that concentrates voting power in the high‑voting Class B shares held by insiders, allowing those shareholders to retain control even though most shares outstanding are the lower‑voting Class A stock【page_1】.  \n\nThus, Comcast surrendered voting power to relinquish control of Hulu, whereas Meta preserves control by issuing a dual‑class share scheme that gives a small group disproportionate voting rights.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core contrast between CMCSA's relinquishment of Hulu voting rights and META's dual-class structure. (1) Correctly identifies CMCSA giving up board seats and 'substantially all voting rights' in 2019, aligning with the ground truth; notes the economic interest (approximated as 33%) and put/call arrangement, though it omits the specific $27.5 billion minimum equity value guarantee and the $8.6 billion Disney payment in 2023—minor omissions affecting completeness but not core correctness. (2) Quantitatively, the 33% economic interest is a reasonable approximation (actual stake was ~33% pre-exit), and the 2019 date is correct; the missing $27.5B and $8.6B figures are important specifics but not central to the control strategy comparison. (3) Qualitatively, the reasoning is sound: CMCSA transferred control for financial guarantees, while META retains control via Class B shares with 10x voting power—this synthesis across two companies and structures is accurate and logically presented. (4) Contextually, the answer directly addresses the question about control retention strategies, clearly contrasting external control surrender (CMCSA) vs. internal control preservation (META). The use of 'classic dual-class structure' and correct reference to insider control via high-vote shares shows strong understanding. Only a 9 due to missing key financial terms of the Hulu deal, but the strategic contrast remains fully intact.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 406,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does Goldman Sachs' $113.9 billion in broker-dealer assets influence its approach to managing conflicts of interest under Regulation Best Interest, compared to Morgan Stanley's compliance framework for the same regulatory obligations?",
      "original_answer": "Goldman Sachs manages $113.9 billion in broker-dealer assets as of December 2024, which necessitates a robust compliance framework under Regulation Best Interest to ensure recommendations align with retail customers' best interests, especially given the SEC's requirement that broker-dealers avoid placing their own interests ahead of clients. This asset size increases the complexity of conflict management, particularly in areas like variable insurance product sales and investment strategy recommendations. Similarly, Morgan Stanley explicitly states it is subject to Regulation Best Interest, which governs its broker-dealer sales practices and customer relationships, including conflict mitigation. Both firms must maintain stringent internal controls, but Goldman's larger broker-dealer asset base may require more extensive monitoring and disclosure protocols to satisfy the same impartial conduct standards outlined in the regulation, particularly as both firms face potential litigation and regulatory scrutiny tied to compliance.",
      "llm_answer": "Goldman Sachs’ 2024 filing shows that its broker‑dealer subsidiaries hold roughly **$113.9 billion** of assets (see GS 10‑K page 106).  Because that pool is earmarked for each subsidiary’s own liquidity needs and is not freely transferable to the parent (the GCLA “is intended for use only by that subsidiary…unless legally provided for” – page 106, 107), Goldman Sachs builds its Regulation Best Interest controls around strict internal firewalls, capital‑allocation and liquidity‑segregation frameworks that isolate broker‑dealer activities from other lines of business and limit any incentive‑based conflicts.  \n\nMorgan Stanley’s 10‑K (page 8) addresses Regulation Best Interest by noting that its U.S. broker‑dealer entities (MS Co. LLC and MSSB LLC) are registered with the SEC and FINRA and are subject to the full suite of broker‑dealer and investment‑adviser rules, with compliance overseen through its broader broker‑dealer‑adviser regulatory regime rather than through a large, dedicated asset base.  Consequently, Morgan Stanley’s conflict‑of‑interest approach relies more on registration‑based supervision and firm‑wide policies, whereas Goldman Sachs leverages the size and segregation of its $113.9 billion broker‑dealer balance sheet to enforce additional internal controls under Regulation Best Interest.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $113.9 billion figure for Goldman Sachs' broker-dealer assets is correct and matches the original answer, with the correct time reference implied by the 2024 filing. No other numerical data is present, and no calculations are required. (2) The LLM correctly identifies both Goldman Sachs and Morgan Stanley as subject to Regulation Best Interest, accurately citing their respective regulatory frameworks. It adds granular detail from the 10-Ks (e.g., page numbers, subsidiary names like MS Co. LLC and MSSB LLC), which enhances credibility and precision beyond the original answer. (3) The reasoning is sound and represents a valid multi-hop synthesis: it contrasts Goldman’s asset-segregation and firewall-based conflict management (tied to its $113.9B balance sheet) with Morgan Stanley’s reliance on registration and firm-wide policies, which is a logical and supported inference. The original answer notes that Goldman’s larger asset base may require more extensive controls; the LLM expands this with specific mechanisms (liquidity segregation, firewalls) that are consistent with the regulation and the firm’s structure. (4) The only minor gap is that the original answer emphasizes both firms face litigation and regulatory scrutiny, a point not mentioned in the LLM response—this is a small omission but does not undermine the core correctness. Overall, the LLM provides a more detailed, document-grounded response while maintaining factual and semantic alignment with the ground truth. Hence, a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1612,
        "completion_tokens": 465,
        "total_tokens": 2078
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How might Intel's IDM 2.0 strategy, which includes expanding manufacturing capacity with the aim of attracting foundry customers, be affected by Samsung's development of in-house integrated circuits, and what implications could this have for Qualcomm's semiconductor business given its reliance on external integrated circuit customers?",
      "original_answer": "Intel's IDM 2.0 strategy involves significant capital expenditures to expand manufacturing capacity with the goal of attracting foundry customers (chunk 1). However, Samsung, a key potential customer for Intel's foundry services, is developing its own integrated circuit products, which it may increasingly use in its own devices and potentially sell to third parties in competition with others in the market (chunk 2). This vertical integration by Samsung could limit Intel's ability to secure foundry business from Samsung, making Intel's IDM 2.0 capacity investments riskier and potentially leading to underutilized facilities or increased pricing pressure to attract other customers. Qualcomm, which derives a significant portion of its revenues from sales of its own integrated circuit products to OEMs (chunk 3), could face intensified competition if Samsung's in-house chips gain market traction, particularly in segments like mobile and automotive. Additionally, if Intel responds by lowering prices to attract other foundry clients, it could indirectly affect the broader semiconductor pricing environment, potentially impacting Qualcomm's cost structure or competitive positioning.",
      "llm_answer": "Intel’s IDM 2.0 plan counts on selling excess fab capacity (IFS) to third‑party customers, but the filing notes that Intel must compete “against well‑established competitors such as TSMC and Samsung” (page 54). If Samsung continues to move more of its own products onto internally‑designed and –produced chips, the pool of potential foundry customers for Intel shrinks and Intel could face lower utilization of the new capacity it is building. Qualcomm’s 10‑K warns that “certain of our largest integrated‑circuit customers (for example, Samsung) develop their own integrated‑circuit products,” which could reduce the external IC business that underpins Qualcomm’s QCT segment; thus Samsung’s vertical integration threatens both Intel’s foundry‑growth ambitions and Qualcomm’s semiconductor revenue stream that depends on such outside customers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Intel's IDM 2.0 strategy relies on attracting external foundry customers, but faces competition from Samsung, which is developing in-house ICs, thereby reducing the pool of potential foundry clients for Intel. Qualcomm’s semiconductor business (specifically its QCT segment) is exposed because Samsung’s vertical integration could reduce its reliance on external suppliers like Qualcomm. (2) There are no numeric values in the question or answers requiring verification, so quantitative accuracy is not applicable in a strict sense—however, the absence of any incorrect numbers or miscalculations supports a perfect score. (3) The multi-hop reasoning is sound: the LLM correctly links Samsung’s in-house development → reduced foundry opportunity for Intel → risk to Intel’s capacity utilization, and separately, Samsung’s self-sufficiency → reduced external IC purchases → threat to Qualcomm’s revenues. It also implicitly connects the competitive dynamics among Intel, Samsung, and TSMC. (4) The only minor shortcoming is that the LLM does not explicitly mention the potential downstream effect of Intel lowering prices to attract customers, which could impact the broader pricing environment and indirectly affect Qualcomm’s cost or pricing power—this nuance is present in the original answer but omitted here. However, the core causal链条 are preserved, and the answer remains semantically equivalent in substance. Thus, the correctness score is 9 due to this slight omission in secondary implication, but all other dimensions are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1556,
        "completion_tokens": 449,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How does VZ's monetization of wireless tower infrastructure through exclusive arrangements with American Tower Corporation compare to NFLX's reliance on exclusive content rights in terms of upfront capital impact and long-term strategic control?",
      "original_answer": "VZ received an upfront payment of $5.0 billion from American Tower Corporation in 2015 for exclusive rights to 11,300 wireless towers, while retaining operational control through subleased capacity and continuing depreciation of the towers. This allowed VZ to monetize infrastructure assets while maintaining network usage flexibility. In contrast, NFLX pursues exclusive content rights to differentiate its service, which requires ongoing licensing costs and exposes the company to risks of content withdrawal and increased programming expenses. Unlike VZ's capital-generating tower arrangement, NFLX's exclusive content strategy represents a cost center rather than a revenue source, with no upfront payments received and instead involves financial commitments to secure programming advantages.",
      "llm_answer": "Verizon’s tower‑monetization transactions generate a sizable cash inflow – $2.8 billion from the Vertical Bridge deal and a $5.0 billion upfront payment from the 2015 American Tower agreement – recorded as prepaid rent and a financing obligation, giving Verizon immediate capital while retaining the right to lease back capacity and an option to reacquire the sites after roughly 30 years (so control is partially ceded but still preserved through lease‑back and ground‑lease obligations). In contrast, Netflix’s business model requires large upfront outlays for exclusive licensing fees and original‑content production, which are cash‑draining rather than cash‑generating, and its strategic advantage hinges on maintaining those exclusive rights; those rights can be withdrawn or become more costly, making long‑term control less certain than Verizon’s retained lease‑back position.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $5.0 billion upfront payment from American Tower Corporation in 2015, which matches the ground truth. However, it introduces an additional $2.8 billion from a 'Vertical Bridge deal' that is not mentioned in the original answer and is extraneous to the question, potentially confusing the quantitative basis. This addition is factually questionable in this context and not supported by the ground truth, though it may reflect other real transactions not relevant here. (2) The core financial figure of $5.0 billion is accurate in amount and year, and correctly attributed to the American Tower transaction. The mention of prepaid rent and financing obligation accounting treatment adds detail beyond the ground truth but is plausibly accurate and does not contradict it. The error lies in including an unrelated transaction (Vertical Bridge), which affects quantitative accuracy. (3) The multi-hop reasoning is strong: the model correctly contrasts VZ's capital-generating infrastructure monetization (upfront cash inflow, retained usage) with NFLX's cost-heavy exclusive content strategy (cash outflows, uncertain long-term control). It accurately captures the strategic distinction—VZ retains operational control via lease-backs, while NFLX faces risk of content loss or rising costs. The synthesis across business models and financial implications is sound. (4) Despite the extra $2.8B figure, the core comparison is factually aligned, semantically equivalent, and contextually appropriate. The answer addresses both upfront capital impact and long-term control as required. The inclusion of unverified information reduces quantitative accuracy slightly, but the qualitative reasoning and overall correctness remain high. Hence, correctness_score is 8 due to partial factual overreach, but other dimensions are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 507,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the Tax Reform Act's GILTI provisions impact KO's effective tax rate in 2022, and how does this contrast with the effect of the corporate income tax rate reduction in the Philippines on PEP's operations in that market?",
      "original_answer": "KO's effective tax rate in 2022 was impacted by the Tax Reform Act's GILTI provisions, which required the inclusion of foreign subsidiaries' excess earnings in U.S. income tax returns, contributing to a 1.2% impact on KO's effective tax rate through pretax charges of $710 million related to equity method investee impairments. In contrast, PEP's operations in the Philippines experienced low-single-digit growth, and the corporate income tax rate reduction enacted in the Philippines in Q1 2021 contributed to a favorable impact on PEP's effective tax rate, lowering it by an unspecified but notable amount. This illustrates how the same U.S. tax reform had divergent effects—raising KO's tax burden through GILTI while enabling PEP to benefit from lower local corporate taxes.",
      "llm_answer": "The Tax Reform Act’s Global Intangible Low‑Taxed Income (GILTI) rules forced Coca‑Cola Hellenic (KO) to recognize the U.S. tax on foreign subsidiary earnings in the year the earnings were earned, which added roughly a **3‑percentage‑point increase to KO’s effective tax rate for 2022**. In contrast, PepsiCo’s (PEP) 2022 filing notes that the **corporate‑income‑tax‑rate cut in the Philippines lowered the company’s tax burden there, partially offsetting other tax‑rate pressures and improving the profitability of its Philippine operations**.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It states that GILTI caused a '3-percentage-point increase' in KO's effective tax rate, whereas the ground truth specifies a 1.2% impact. This is a substantial overstatement. Additionally, the LLM does not mention the $710 million pretax charges related to equity method investee impairments, a key factual detail. On PEP's side, while it correctly notes the tax rate reduction in the Philippines had a favorable effect, it fails to specify that the reduction occurred in Q1 2021 (not 2022) and omits that the impact on PEP's effective tax rate was 'unspecified but notable'—instead vaguely stating it 'partially offsetting other tax-rate pressures.' (2) Number verification: The correct impact on KO is 1.2% (not 3%), and the $710M charge is missing. The Philippines tax cut timing (Q1 2021) is misaligned. (3) Multi-hop reasoning is partially sound: the model correctly contrasts U.S. GILTI provisions affecting KO with local tax changes benefiting PEP, showing understanding of divergent tax impacts. However, it fails to accurately synthesize the specific financial and temporal details from both companies' filings. (4) Contextual relevance is high as the answer addresses both parts of the question and draws a meaningful comparison. Qualitative accuracy is moderate due to correct entity identification (KO, PEP, GILTI, Philippines tax cut) and general direction of effects, but weakened by missing and incorrect specifics. Quantitative accuracy is low due to the incorrect percentage and missing dollar amount. Correctness score reflects partial credit for correct direction and entities but significant deductions for factual and numerical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 472,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How does the $1.3 billion in restricted retained earnings at Nicor Gas impact Southern Company's ability to receive dividends from its subsidiaries, given that Nicor Gas is a key subsidiary under Southern Company Gas?",
      "original_answer": "Nicor Gas, as a regulated subsidiary under Southern Company Gas, has $1.3 billion in retained earnings that are restricted from being distributed as dividends or loans to affiliates. This restriction directly limits Southern Company's ability to receive dividend payments from Nicor Gas, which in turn affects the consolidated cash flows and financial flexibility of Southern Company, especially since Southern Company relies on equity earnings and dividends from its subsidiaries for a significant portion of its income.",
      "llm_answer": "The 10‑K notes state that, by regulation, Nicor Gas may pay dividends or make loans only out of its **unrestricted** retained earnings. At 12/31/2021 the portion of Southern Company Gas’s subsidiary retained earnings that is **restricted for dividend payment is $1.3 billion** (page 261). Because those earnings cannot be distributed, Nicor Gas’s ability to send cash up to Southern Company (through dividends from Southern Company Gas) is limited to the amount of its unrestricted earnings, reducing the total dividend pool that Southern Company can receive from its key gas‑distribution subsidiary.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $1.3 billion restricted retained earnings figure is correct, and the reference to page 261 and the date 12/31/2021 adds precise sourcing, which is consistent with the knowledge graph's data. The format variation ($1.3 billion) is acceptable and matches the ground truth. (2) The answer correctly identifies that Nicor Gas can only distribute dividends from unrestricted retained earnings, and the $1.3 billion restriction limits dividend transfers to Southern Company. This captures the core financial constraint described in the original answer. (3) The multi-hop reasoning is sound: it connects Nicor Gas → Southern Company Gas → Southern Company, recognizing the subsidiary structure and the flow of dividends. It correctly infers that restricted earnings reduce the dividend pool available to the parent, which impacts Southern Company’s cash inflows. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the broader impact on Southern Company’s consolidated cash flows and financial flexibility, nor does it note Southern Company’s reliance on subsidiary dividends for income—details present in the original answer. While implied, their omission slightly reduces completeness. However, the core logic, entities, numbers, and causal chain are correct. Hence, a score of 9 is warranted for correctness, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 411,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How do Tesla's and GM's compliance costs related to evolving vehicle safety standards compare, given the increasing regulatory complexity under the National Traffic and Motor Vehicle Safety Act?",
      "original_answer": "Tesla faces rising compliance costs due to evolving international vehicle safety standards, particularly for its Autopilot and FSD (Supervised) features, which must meet varying requirements across jurisdictions and may delay or restrict functionality. GM similarly notes that compliance with the National Traffic and Motor Vehicle Safety Act is costly, with global regulatory divergence—especially between North American and UN-ECE based standards—adding complexity and expense to vehicle development. Both companies emphasize the financial burden of maintaining compliance as safety standards evolve and expand globally, with GM specifically highlighting the lack of harmonization as a key driver of increased costs.",
      "llm_answer": "Both companies say that the expanding web of safety‑regulation requirements under the 1966 Safety Act is driving higher compliance spending. GM quantifies that risk – it notes that a 10 % rise in the “take‑rate” for its recall campaigns would add roughly **$0.4 billion** to its costs (and it repeatedly flags “substantial” recall‑related expenses). Tesla, by contrast, merely acknowledges that meeting and exceeding the increasingly complex U.S. and global safety standards is costly and adds development complexity, but its 10‑K does not disclose a comparable dollar amount.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative claims not supported by the ground truth. The $0.4 billion cost increase tied to a 10% rise in GM's recall 'take-rate' is not present in the original answer and appears to be fabricated or misattributed; the ground truth does not provide any specific dollar figures for compliance costs for either company. This major quantitative error undermines the factual reliability of the response. While the LLM correctly identifies that both Tesla and GM face rising compliance costs due to evolving safety standards and regulatory complexity under the National Traffic and Motor Vehicle Safety Act, it incorrectly suggests that GM quantifies its compliance burden in financial terms in a way that Tesla does not—this comparison is not supported by the original answer. The original answer emphasizes regulatory divergence (e.g., North America vs. UN-ECE) and lack of harmonization as key cost drivers for GM, and highlights Tesla's challenges with Autopilot and FSD across jurisdictions, but does not mention recalls or take-rates. The LLM introduces 'recall campaigns' and 'take-rate' as central cost factors, which are absent from the ground truth, indicating a failure in multi-hop reasoning and source synthesis. Entity identification (Tesla, GM, National Traffic and Motor Vehicle Safety Act) is correct, and the general theme of increasing compliance costs is relevant, hence the moderate contextual relevance. However, the inclusion of unsupported financial figures and misrepresentation of the nature of compliance costs (recall-related vs. development and global standard divergence) severely reduces correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 467,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How does General Dynamics' deferral of $305 million in other contract costs under FAR regulations compare to Raytheon Technologies' exposure to cost overruns under its fixed-price U.S. government contracts, given the differing financial risk profiles associated with these contract cost management approaches?",
      "original_answer": "General Dynamics defers $305 million in other contract costs under FAR regulations that govern cost allowability and allocation to U.S. government contracts, with recovery expected through existing backlog and follow-on contracts. These costs are not currently allocable but are maintained as assets pending future allocation. In contrast, Raytheon Technologies faces financial risk on its fixed-price contracts, particularly firm fixed-price (FFP) contracts, where it bears the full burden of cost overruns without reimbursement. This creates a more direct financial exposure compared to General Dynamics’ deferred cost model. The difference in risk stems from the fact that FAR-regulated cost recovery allows General Dynamics to defer recognition of certain costs until allocable, while Raytheon must absorb overruns on fixed-price contracts, which constitute a significant portion of its U.S. government contract portfolio.",
      "llm_answer": "General Dynamics’ $305 million of “other contract costs” is a balance‑sheet deferral that it expects to recover through future U.S. government work, so the risk is largely postponed rather than borne today. Raytheon Technologies, by contrast, notes that its fixed‑price U.S. government contracts leave it exposed to any cost overruns – a risk that would be absorbed immediately and could compress margins – but the filing does not quantify that exposure in dollar terms.  Consequently, GD’s approach shifts the risk to later periods, while RTX’s fixed‑price contracts expose it to immediate profitability risk, albeit without a disclosed monetary amount.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $305 million deferral by General Dynamics is correctly stated, and the absence of a dollar-quantified exposure for Raytheon Technologies is accurately noted—consistent with the original answer, which also does not provide a specific dollar amount for Raytheon’s risk. (2) The qualitative reasoning correctly contrasts General Dynamics’ FAR-regulated cost deferral model (where costs are deferred and expected to be recovered in future periods) with Raytheon’s firm fixed-price (FFP) contract exposure, where cost overruns are absorbed immediately. The characterization of GD’s risk as 'postponed' and RTX’s as 'immediate profitability risk' captures the core distinction in financial risk profiles. (3) Multi-hop reasoning is sound: the model synthesizes information about two different companies, their respective contract types (cost-deferral under FAR vs. fixed-price), and the implications for financial risk and timing of exposure. (4) The only minor shortcoming is that the LLM does not explicitly mention that General Dynamics’ deferred costs are maintained as assets pending future allocation, nor does it specify that Raytheon’s fixed-price contracts constitute a 'significant portion' of its government portfolio—details present in the original. However, these omissions do not undermine the core factual accuracy or the logical comparison. Wording differs but semantic meaning and analytical insight are equivalent. All entities (General Dynamics, Raytheon Technologies, FAR, fixed-price contracts) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 450,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does the compound annual growth rate (CAGR) of Intel's Taiwan revenue from 2019 to 2021 compare to Apple's Greater China segment revenue growth over the same period, given that Taiwan is included within Apple's Greater China reporting?",
      "original_answer": "Intel's Taiwan revenue grew from $10,058 million in 2019 to $13,461 million in 2021, representing a CAGR of approximately 15.6%. Apple's Greater China revenue increased from $40,308 million in 2019 to $68,366 million in 2021, yielding a CAGR of approximately 30.8%. Therefore, Apple's Greater China segment revenue grew at more than double the rate of Intel's Taiwan-specific revenue during this period.",
      "llm_answer": "Intel’s Taiwan revenue rose from $10.1 billion in 2019 to $13.5 billion in 2021, giving a compound‑annual growth rate of roughly **15 %‑16 %** over the two‑year span.  \n\nApple’s Greater‑China segment (which includes Taiwan) grew from $40.3 billion in 2020 to $68.4 billion in 2021 – an **≈70 %** increase in a single year (far outpacing Intel’s Taiwan CAGR).  \n\nSo Apple’s Greater‑China growth over the period was **much faster** than Intel’s Taiwan CAGR.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer gets several key facts approximately correct: Intel's Taiwan revenue is close ($10.1B vs $10.058B in 2019, $13.5B vs $13.461B in 2021), and Apple's Greater China revenue is also near the truth ($40.3B vs $40.308B, $68.4B vs $68.366B). However, the major error is in the time period used for Apple's growth calculation — the LLM incorrectly uses 2020–2021 instead of 2019–2021, which invalidates the CAGR comparison. The question explicitly asks for 2019 to 2021, but the model uses only a one-year change (from 2020 to 2021), leading to an erroneous ≈70% increase claim. (2) The CAGR for Intel is correctly estimated at ~15–16% (true value: ~15.6%), which is acceptable. However, Apple’s actual CAGR from 2019 to 2021 is ~30.8%, not 70%. The 70% figure reflects a single-year growth from 2020 to 2021, not the two-year compound rate. This is a critical quantitative and reasoning flaw. (3) The multi-hop reasoning fails because the model does not compute Apple’s growth over the correct period. It should have pulled Apple’s 2019 and 2021 figures and calculated the CAGR over two years, just as it did (correctly) for Intel. By using 2020 instead of 2019, it breaks the comparison. (4) Despite this, the answer is contextually relevant and identifies the right companies, regions, and metrics. The conclusion that Apple grew faster is correct, but the magnitude (‘much faster’ due to 70% vs 15%) is misleading. The ground truth shows Apple grew at more than double Intel’s rate (30.8% vs 15.6%), which is significant but not nearly as extreme as implied. Thus, while some data points are close and the general direction is right, the incorrect time frame and resulting miscalculation severely undermine the quantitative and qualitative accuracy, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 490,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "Given Alphabet's $70 billion share repurchase authorization targeting Class A and Class C shares in 2024, how might the repurchase activity influence Class B shareholders' decisions to convert shares to Class A, especially in light of Meta's disclosure of a significantly larger Class A share base compared to Class B outstanding shares?",
      "original_answer": "Alphabet's $70 billion share repurchase program, which includes Class A shares, could reduce the supply of Class A shares in the market, potentially increasing their relative value. This may incentivize Class B shareholders—who hold shares with 10x voting rights but often face restrictions on holding Class A shares after conversion—to convert and sell Class A shares before further scarcity and price appreciation occur. However, Meta's 2024 disclosure shows that it has 2,189,898,148 Class A shares and only 343,761,117 Class B shares outstanding, indicating a much larger float of Class A shares in the market. This abundance of Class A shares at Meta may temper conversion urgency compared to Alphabet, as Class A shares at Meta are likely more liquid and less affected by repurchase-induced scarcity.",
      "llm_answer": "Alphabet’s board approved an additional $70 billion repurchase program that can be used only for Class A and Class C shares (the program had $44.7 billion still available at year‑end 2024) 【page_82】. Because Class B shares can be converted at any time into one‑for‑one Class A shares, a large‑scale buy‑back that removes Class A stock from the market tends to lift the price and earnings‑per‑share of the remaining Class A shares. That makes a conversion more attractive to Class B holders who want to capture the higher market price, the new quarterly dividend that now applies to Class A (and Class B) shares, and the potential EPS boost that the repurchase creates 【page_82】.\n\nMeta’s filing shows a far larger pool of Class A shares (≈2.19 billion) than Class B shares (≈0.34 billion) 【page_1】, underscoring that Class A is the primary, liquid equity class. Seeing that a comparable company (Meta) relies on a dominant Class A base, Alphabet’s Class B shareholders may view conversion as a way to join the more liquid, widely‑traded Class A market, especially when the company is actively shrinking that class through repurchases. In short, the $70 billion repurchase program is likely to encourage Class B owners to convert to Class A to benefit from higher share prices, dividend eligibility, and greater market liquidity, mirroring the dynamics evident in Meta’s capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Alphabet's $70 billion repurchase program applies to Class A and Class C shares, Class B shares convert 1:1 to Class A, and the program had $44.7 billion remaining at year-end 2024 (per citation). Meta's Class A and Class B share counts are accurately represented as approximately 2.19 billion and 0.34 billion, matching the ground truth (2,189,898,148 and 343,761,117). These numbers are correctly interpreted and formatted with acceptable rounding. (2) The reasoning correctly identifies the multi-hop logic: Alphabet’s repurchase reduces Class A supply, increasing value and incentivizing Class B conversions; Meta’s capital structure (large Class A float) provides a comparative benchmark that reinforces the attractiveness of Class A liquidity. The LLM adds value by noting the new dividend and EPS boost, which are plausible incentives supported by context (though not in the original answer), without contradicting it. (3) The synthesis across Alphabet and Meta is sound and addresses the comparative element of the question. (4) The only minor shortcoming is that the original answer emphasizes Meta’s structure may *temper* conversion urgency relative to Alphabet due to greater Class A abundance, whereas the LLM suggests Meta’s structure reinforces conversion—slightly overstating the parallel. This is a nuanced difference in interpretation, not a factual error, so the answer remains highly accurate overall. Quantitative accuracy is perfect; contextual relevance and completeness are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1596,
        "completion_tokens": 439,
        "total_tokens": 2035
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does the treatment of dividend equivalents in RSU awards differ between PepsiCo and Philip Morris International in terms of vesting conditions and financial obligations as of 2023?",
      "original_answer": "PepsiCo accrues dividend equivalents during the vesting period for both RSUs and PSUs, which are paid out in cash when the award vests. Philip Morris International also accrues dividend equivalents on RSU awards, but its RSUs generally vest on the third anniversary of the grant date and do not carry voting rights. As of December 31, 2023, PMI had $160 million of total unrecognized compensation costs related to non-vested RSU awards, which are being amortized over the restriction period or upon specific life events.",
      "llm_answer": "PepsiCo states that RSUs (and PSUs) **accrue dividend equivalents that are paid in cash – without interest – only when the award actually vests**, so the dividend‑equivalent liability is recognized only at vesting.  \n\nPhilip Morris International’s RSUs also earn dividend equivalents, but the awards vest on the **third anniversary of the grant and are subject to forfeiture if employment conditions are not met**; the company carries a **$160 million “unrecognized compensation cost” for non‑vested RSUs**, reflecting a pending financial obligation that exists even before the vesting date.  \n\nThus, PepsiCo’s dividend equivalents are a cash outflow triggered at vesting, whereas PMI’s RSU program creates a pre‑vest liability (the unrecognized cost) and ties dividend‑equivalent treatment to a fixed‑date vesting schedule with forfeiture risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PepsiCo accrues dividend equivalents paid in cash upon vesting; PMI also accrues dividend equivalents on RSUs that vest on the third anniversary of the grant date, with no voting rights mentioned but forfeiture conditions correctly noted. The $160 million unrecognized compensation cost for PMI as of December 31, 2023, is accurately reported. (2) Quantitative accuracy is perfect: the $160 million figure matches the original answer exactly, and no calculations were required beyond correct reporting. (3) Multi-hop reasoning is sound—LLM correctly contrasts PepsiCo’s vesting-triggered cash payout with PMI’s pre-vesting financial liability (unrecognized compensation cost) and links it to vesting conditions. The synthesis across both companies and financial treatments is logical and complete. (4) Minor omission: the original answer notes PMI RSUs do not carry voting rights, which the LLM omits; however, this detail is not central to the question about dividend equivalents and financial obligations. Wording differences (e.g., 'unrecognized compensation cost' vs 'pending financial obligation') are semantically equivalent. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 374,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does DHR's use of NAV and discounted cash flow in valuing private investments compare to LLY's reliance on fair value estimation for acquired intangible assets, considering the inherent subjectivity in both approaches as highlighted in their respective disclosures?",
      "original_answer": "DHR utilizes NAV based on fund manager inputs and applies discounted cash flows, earnings multiples, and third-party appraisals to estimate the fair value of private investments, acknowledging that these methods may not reflect net realizable value or future fair values. LLY, on the other hand, applies fair value estimation to acquired intangible assets such as IPR&D, which required $3.80 billion in charges in 2023 alone, and admits that final valuations may change significantly as fair values are finalized within one year post-acquisition. Both companies recognize the subjectivity involved in fair value estimation, with DHR noting that different methodologies can yield materially different results and LLY emphasizing the need for considerable judgment in determining the fair value of acquired assets, especially under limited access to pre-acquisition data.",
      "llm_answer": "DHR values its venture‑capital, partnership and other private‑investment holdings by applying a net‑asset‑value (NAV) approach and, where appropriate, discounted‑cash‑flow, earnings‑multiple or appraisal methods, and it warns that different assumptions or methodologies can produce materially different fair‑value estimates. Lilly, by contrast, records the intangible assets acquired in business combinations at estimated fair value using the market, income and cost approaches and the three‑level fair‑value hierarchy, which also depends on significant unobservable inputs and management judgment. Thus, both companies acknowledge that their valuation techniques are inherently subjective, but DHR’s process is framed around NAV and DCF calculations, whereas Lilly’s is framed around fair‑value estimation of intangibles using the hierarchy of observable and unobservable inputs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core comparison between DHR and LLY's valuation approaches as outlined in the ground truth. (1) All factual elements are correct: DHR uses NAV, discounted cash flow, earnings multiples, and appraisals for private investments, and acknowledges subjectivity due to assumptions and methodologies. LLY uses fair value estimation for acquired intangibles (specifically referencing IPR&D implicitly through context), relying on market, income, and cost approaches within the fair value hierarchy, with significant judgment and unobservable inputs. Both recognize subjectivity—DHR notes materially different results from different methods, and LLY emphasizes judgment due to limited pre-acquisition data. (2) Quantitatively, while the LLM answer does not mention the $3.80 billion charge in 2023 for LLY, this is the only omission. However, this specific figure is quantitative and present in the ground truth; its absence prevents a perfect score, but since the overall reasoning and qualitative framework are preserved, the impact is minor. (3) The multi-hop reasoning is sound: the model correctly synthesizes DHR’s private investment valuation with LLY’s intangible asset valuation, compares their reliance on subjective inputs, and contrasts their methodological framing (NAV/DCF vs. fair value hierarchy). (4) The answer is contextually relevant and semantically equivalent to the original in all key aspects except the missing dollar amount. Wording differences (e.g., 'warns' vs. 'acknowledges') do not affect meaning. The omission of the $3.80 billion charge slightly reduces completeness but does not distort the conclusion about subjectivity. Hence, correctness is rated 9, with full marks for quantitative accuracy (since no incorrect numbers are stated), high qualitative accuracy, and full contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 503,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How does NVIDIA's revenue from Taiwan in 2022 compare to Apple's reported revenue from the Greater China segment, given that Apple's geographic reporting includes Taiwan within Greater China?",
      "original_answer": "NVIDIA reported $8,544 million in revenue from Taiwan in 2022, while Apple reported $74,200 million in net sales from the Greater China segment in the same year. Since Apple explicitly includes Taiwan within its Greater China geographic reporting, NVIDIA's Taiwan-specific revenue constitutes a subset of the broader regional revenue that Apple reports, reflecting different levels of geographic granularity in their respective segment disclosures.",
      "llm_answer": "In fiscal 2022 NVIDIA reported **$8.5 billion** of revenue from customers in Taiwan (NVDA 10‑K, “Revenue: Taiwan” $ 8,544 million)【page_100】.  \nApple’s “Greater China” segment – which by definition includes mainland China, Hong Kong and **Taiwan** – generated **$74.2 billion** of net sales (Apple 10‑K, “Greater China” net sales $ 74,200 million)【page_52】.  \n\nTherefore Apple’s Greater China revenue is about **$65 billion larger**, roughly nine times the amount NVIDIA earned from Taiwan alone.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: $8.5 billion (rounded from $8,544 million) for NVIDIA's Taiwan revenue and $74.2 billion (from $74,200 million) for Apple's Greater China revenue are correctly reported with acceptable formatting variations. The difference of approximately $65.7 billion is accurately reflected as 'about $65 billion larger', which is a reasonable rounding. The statement that Apple's revenue is 'roughly nine times' that of NVIDIA's Taiwan revenue is logically sound (74.2 / 8.5 ≈ 8.7), supporting the comparison. (2) The answer is complete, addressing both companies, the correct fiscal year (2022), and the geographic inclusion of Taiwan within Apple’s Greater China segment. (3) Entity accuracy is perfect: correct company names (NVIDIA, Apple), correct tickers implied (NVDA, AAPL), correct financial metrics (revenue from Taiwan, net sales from Greater China), and correct fiscal year. (4) The multi-hop reasoning is sound: the model correctly synthesizes data from two different 10-K filings, acknowledges differing geographic reporting granularities, and draws a valid comparative conclusion. (5) The semantic meaning fully aligns with the original answer, conveying that NVIDIA's Taiwan-specific revenue is a subset of Apple’s broader Greater China reporting, despite different disclosure levels. All aspects meet or exceed expectations.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 400,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How does the concentrated voting power in CMCSA's Class B common stock compare to the shareholder structure disclosed for GOOGL's Class A common stock in terms of control and ownership distribution?",
      "original_answer": "CMCSA's Class B common stock, held entirely by Brian L. Roberts, represents 33⅓% of the combined voting power with each share carrying 15 votes, creating significant control concentration. In contrast, GOOGL's Class A common stock, with 300,754,904 shares outstanding as of January 25, 2022, is broadly distributed among non-affiliates, with voting rights presumably more dispersed given the large number of shares and absence of similar super-voting structures described for CMCSA. This indicates a stark difference in governance dynamics, with CMCSA maintaining centralized control through Class B shares, while GOOGL's structure suggests more distributed shareholder influence.",
      "llm_answer": "Comcast’s Class B shares concentrate control: each share carries 15 votes and the three outstanding shares (all owned by Brian L. Roberts) represent 33 ⅓ % of the company’s total voting power, giving one insider effective control of the firm. Alphabet’s Class A shares, by contrast, have the standard one‑vote‑per‑share structure and the roughly 300 million Class A shares outstanding are held by a broad base of investors, so voting power is far more widely distributed and no single holder wields a comparable disproportionate influence.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: CMCSA's Class B stock has 15 votes per share, three shares owned by Brian L. Roberts, representing 33⅓% of total voting power—this aligns with the original answer. GOOGL's Class A shares have one vote per share, with approximately 300 million outstanding (specifically 300,754,904 as of Jan 25, 2022), held by a broad base of non-affiliates. The LLM correctly notes the absence of super-voting rights in Class A and the resulting dispersed control. (2) Quantitative accuracy is perfect: the 33⅓% voting power, 15-vote structure, and ~300 million shares are all correctly reported or appropriately rounded (300 million is a valid approximation of 300,754,904). (3) Multi-hop reasoning is sound—LLM synthesizes ownership concentration at CMCSA with distributed ownership at GOOGL, correctly contrasting governance dynamics. (4) The answer fully addresses the question’s focus on control and ownership distribution, with precise entity identification (CMCSA, GOOGL, Brian L. Roberts), correct share class structures, and accurate implications for corporate control. Wording differs slightly but meaning is preserved. No errors in logic, entities, or numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 355,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How does the ratio of securities remaining available for future issuance to those issuable upon exercise of outstanding options differ between UnitedHealth Group and Johnson & Johnson under their respective equity compensation plans approved by security holders?",
      "original_answer": "For UnitedHealth Group, the ratio is approximately 9.64 (241 million remaining available / 25 million issuable upon exercise), while for Johnson & Johnson, the ratio is approximately 1.79 (240,344,013 remaining available / 133,794,708 issuable upon exercise). This indicates that UnitedHealth Group has a significantly higher proportion of remaining available securities compared to those already issuable, relative to Johnson & Johnson.",
      "llm_answer": "UnitedHealth Group’s equity‑compensation table (Item 12, Table – approved plans) shows 25 million shares that would be issued on exercise of outstanding options and 241 million shares still available for future grants, giving a ratio of roughly **241 ÷ 25 ≈ 9.6 to 1**【page_77】.  \n\nJohnson & Johnson’s comparable table (Item 12, Equity‑Compensation Plan Information) reports about 133.8 million shares issuable on exercise and 240.3 million shares remaining available, yielding a ratio of **240.3 ÷ 133.8 ≈ 1.8 to 1**【page_118】.  \n\nThus, UnitedHealth’s “available‑for‑future‑issuance ÷ issuable‑upon‑exercise” ratio (~9.6) is far higher than Johnson & Johnson’s (~1.8).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers used are accurate: 241 million and 25 million for UnitedHealth Group, resulting in a ratio of approximately 9.6 (241 ÷ 25 = 9.64), and 240.3 million ÷ 133.8 million ≈ 1.8 (actual ground truth calculation: 240,344,013 ÷ 133,794,708 ≈ 1.795, which rounds to 1.8). The LLM correctly reports these with appropriate rounding. (2) The answer is complete, addressing both companies, the two components of the ratio (securities remaining available and issuable upon exercise), and computes the correct comparative ratios. (3) Entity accuracy is perfect: UnitedHealth Group and Johnson & Johnson are correctly identified with data tied to their respective equity compensation plans from Item 12 of their filings. (4) The multi-hop reasoning—extracting data from two different companies’ filings, computing ratios, and comparing them—is sound and clearly explained. (5) The semantic meaning fully aligns with the original answer, including the conclusion that UnitedHealth has a significantly higher ratio than Johnson & Johnson. Minor formatting differences (e.g., '9.6' vs '9.64', '1.8' vs '1.79') are within acceptable rounding and presentation variation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 351,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How does AMD's reliance on third-party motherboard suppliers compare to Intel's dependency on Dell Inc. as a major customer, particularly in terms of revenue concentration risk?",
      "original_answer": "AMD depends on third-party companies for the design, manufacture, and supply of motherboards that support its microprocessor, GPU, and APU offerings, making it vulnerable to supply chain disruptions. In contrast, Intel reports that Dell Inc. accounted for 21% of its net revenue in 2021, highlighting a significant revenue concentration risk tied to a single customer. While AMD's risk centers on supply chain limitations that could prevent product delivery, Intel's exposure is tied directly to customer dependency, with Dell representing a substantial portion of both revenue and accounts receivable.",
      "llm_answer": "AMD’s 10‑K notes that it “depends on third‑party companies for the design, manufacture and supply of motherboards…If the designers, manufacturers… cease or reduce… our business could be materially adversely affected” (p. 28).  This risk is spread across many OEM and AIB partners rather than a single buyer.  \n\nIntel, by contrast, discloses that its three largest customers generated 43 % of net revenue in 2021, with Dell alone accounting for about 21 % of revenue (p. 87).  Thus Intel faces a more pronounced revenue‑concentration risk from one major customer, whereas AMD’s risk is tied to a broader supplier base rather than a single large buyer.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AMD's reliance on third-party motherboard suppliers is accurately described, and Intel's 21% revenue from Dell in 2021 is correctly cited. The statement that Intel's top three customers accounted for 43% of revenue (with Dell ~21%) is consistent with the original answer's focus on Dell's significant share. (2) Quantitative accuracy is perfect: the 21% figure for Dell is correct, and the 43% for top three customers, while not in the original answer, does not contradict it and adds context without error. No calculations were required, but the comparative framing is sound. (3) Multi-hop reasoning is strong: the model correctly contrasts AMD’s supply-side risk (multiple third-party suppliers) with Intel’s demand-side risk (concentration in a major customer), synthesizing information across both companies’ 10-Ks. (4) The answer is contextually relevant and directly addresses the comparison of revenue concentration risk. The only minor limitation is that the original answer also mentions Intel’s accounts receivable exposure to Dell, which the LLM omits—this is a small completeness gap, but the core insight on revenue concentration is fully captured. Hence, a score of 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 384,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How do Louisiana's corporate tax rate reductions impact the financial exposure of both Boeing and Union Pacific, given Boeing's dependence on federal appropriations influenced by broader legislative dynamics and Union Pacific's direct operations in the state?",
      "original_answer": "Louisiana enacted legislation to reduce its corporate income tax rate for future years, resulting in a $34 million reduction of Union Pacific’s deferred tax expense in 2024. Union Pacific directly benefits from this tax reduction due to its operational presence in Louisiana, as evidenced by its major classification yard in Livonia. Boeing, on the other hand, does not directly benefit from Louisiana’s tax changes but faces exposure to broader legislative uncertainty, particularly in terms of federal appropriations for the U.S. Department of Defense and other government agencies. A lapse or delay in federal funding could disrupt Boeing’s operations, delay aircraft certifications, or impact future orders. Therefore, while Union Pacific experiences a quantifiable financial benefit ($34 million reduction in deferred tax expense) from Louisiana’s tax legislation, Boeing’s exposure is indirect and tied to the uncertainty of federal budget dynamics influenced by the same legislative environment.",
      "llm_answer": "Both companies record a $34 million reduction in deferred‑tax expense from the Louisiana (and Arkansas) corporate‑tax‑rate cuts. For Boeing, the cut merely trims a modest portion of its overall tax burden while the firm’s larger financial exposure still hinges on the timing and size of U.S. defense appropriations and other federal‑legislative actions. For Union Pacific, the same reduction directly lowers the tax cost of its Louisiana‑based rail operations (e.g., the Livonia yard), shrinking its state‑tax exposure and boosting cash‑flow and earnings from those assets.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that both Boeing and Union Pacific recorded a $34 million reduction in deferred-tax expense due to Louisiana's tax cuts. According to the ground truth, only Union Pacific received this benefit due to its operational presence in Louisiana (e.g., the Livonia yard). Boeing does not benefit directly from Louisiana’s tax changes, so attributing the $34 million reduction to Boeing is factually incorrect. (2) The $34 million figure is accurate for Union Pacific and correctly tied to deferred tax expense in 2024, but the erroneous extension of this benefit to Boeing and the mention of Arkansas (not referenced in the original answer) introduce significant quantitative and factual inaccuracies. There is no mention in the ground truth of Arkansas tax changes or any benefit to Boeing from Louisiana’s legislation. (3) The multi-hop reasoning is partially sound: the model correctly identifies that Boeing’s financial exposure is tied to federal appropriations and legislative dynamics, particularly for defense funding, which aligns with the original answer. It also correctly links Union Pacific’s benefit to its physical operations in Louisiana. However, the failure to distinguish that only Union Pacific benefits from the state tax change breaks the logical synthesis required for full accuracy. (4) The contextual relevance is high because the answer addresses both companies, the tax legislation, and the distinction between direct and indirect exposures. However, the core factual error—assigning the $34M tax benefit to Boeing—severely undermines correctness and quantitative accuracy, warranting a mid-range score of 5. The qualitative reasoning is reasonable but flawed in key entity-to-event mapping.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 478,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How does Netflix's one-vote-per-share governance model contrast with Meta's dual-class stock structure, particularly in relation to Charter Communications' disclosure about the link between Class A common stock and voting rights?",
      "original_answer": "Netflix operates under a one-vote-per-share governance model for its common stock, as explicitly stated in its 2024 10-K filing. In contrast, Charter Communications' 2024 financial statements clarify that its Class A common stock carries one vote per share, while its Class B common stock has variable voting rights tied to A/N's economic interests. Meta's 2024 10-K filing discloses the existence of both Class A and Class B common stock, a dual-class structure that suggests differentiated voting rights similar to Charter's framework, though Meta does not specify the exact voting power of each class in the provided chunk. This creates a contrast between Netflix's egalitarian voting model and the more complex, tiered voting structures used by both Charter and Meta.",
      "llm_answer": "Netflix’s proxy statement (NFLX 10‑K p. 60) states that “the holders of each share of common stock shall be entitled to one vote per share,” giving every shareholder equal voting power. In contrast, Meta’s charter creates a dual‑class system in which the publicly‑traded Class A shares carry one vote per share while the founder‑controlled Class B shares carry multiple votes per share, concentrating control in the hands of insiders. Charter Communications’ notes (CHTR 10‑K p. 95) similarly disclose that its Class A common stock is “entitled to one vote per share,” whereas its single Class B share carries voting power tied to Charter Holdings units, underscoring that Netflix’s one‑vote‑per‑share model aligns with Charter’s Class A voting rights but differs from Meta’s dual‑class structure that separates economic ownership from voting control.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Netflix's one-vote-per-share model is accurately cited from its 10-K, Charter's Class A common stock carries one vote per share (per CHTR 10-K p.95), and Meta has a dual-class structure. The LLM correctly identifies that Meta’s Class B shares carry multiple votes per share, which is consistent with known governance structures, even if not explicitly detailed in the provided chunk. (2) There are no numeric values requiring calculation, but all references to voting rights (one vote per share, multiple votes for Class B) are factually sound and match the ground truth in meaning. Format and citation styles (e.g., page numbers) are consistent with source documents. (3) Multi-hop reasoning is strong: the model synthesizes governance models across Netflix, Meta, and Charter, correctly contrasting Netflix’s egalitarian model with Meta’s insider-controlled dual-class system and noting alignment between Netflix and Charter’s Class A shares. The only minor gap is that the ground truth notes Meta does *not specify exact voting power* in the provided chunk, while the LLM asserts Class B has 'multiple votes per share'—a likely correct inference but not explicitly confirmed in the source material, slightly reducing qualitative accuracy. (4) The answer is contextually excellent, directly addressing the contrast in governance models and linking Charter’s disclosure appropriately. Overall, the response is factually correct, well-reasoned, and semantically equivalent to the original answer with only a minor overstatement regarding Meta's voting specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 455,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How does the daily cash-settlement mechanism for exchange-traded commodity futures described in PEP's 2022 filing impact the valuation methodology used by MDLZ for its Level 1 financial liabilities, given that both companies rely on quoted market prices from commodity exchanges?",
      "original_answer": "The daily cash-settlement mechanism for exchange-traded commodity futures described in PEP's 2022 filing aligns with the valuation methodology used by MDLZ for its Level 1 financial liabilities, which are also based on quoted market prices from commodity exchanges. PEP notes that exchange-traded commodity futures are 'cashsettled on a daily basis' and therefore not included in the balance sheet table as of year-end, indicating a standard market practice. MDLZ explicitly states that the fair value of its Level 1 financial assets and liabilities 'is determined based on quoted market prices on commodity exchanges.' This shows that the market standard of daily cash settlement directly informs MDLZ's valuation approach for Level 1 liabilities, as both companies are subject to the same pricing and settlement mechanisms in commodity futures markets.",
      "llm_answer": "PEP explains that its exchange‑traded commodity futures are **cash‑settled each day**, so the contracts are not carried on the balance sheet at period‑end – their value is reflected by the daily settlement price rather than by a standing liability (PEP 10‑K p. 107). MDLZ values its Level 1 financial liabilities – which also consist of exchange‑traded commodity futures – **using the quoted market price on the commodity exchange** at the measurement date (MDLZ 10‑K p. 112). Because both companies rely on the same exchange‑quoted prices, the daily cash‑settlement mechanism simply means that MDLZ’s Level 1 valuation is based on the same day‑by‑day settlement price that PEP uses to determine fair value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: PEP's daily cash-settlement mechanism is accurately described, and it correctly notes that such contracts are not carried on the balance sheet at year-end due to daily settlement. MDLZ's use of quoted market prices on commodity exchanges for Level 1 financial liabilities is correctly cited. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or answers, so quantitative accuracy is not applicable in a numerical sense, but all references to filing pages (p. 107 for PEP, p. 112 for MDLZ) are consistent with expected sourcing and do not contradict the ground truth. (3) The multi-hop reasoning is sound: the model correctly links PEP's description of market practice to MDLZ's valuation methodology, recognizing that both rely on the same exchange-traded, quoted prices shaped by daily settlement. (4) The only minor shortcoming is that the LLM answer does not explicitly state that this alignment reflects a broader 'market standard' or that the daily settlement mechanism 'informs' MDLZ’s approach in a normative way, as emphasized in the original answer. However, this is a nuance in framing rather than a factual gap. Wording differs but semantic equivalence is strong. The answer is contextually precise, directly addressing the impact of the settlement mechanism on valuation methodology.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 404,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does Apple's 2022 net sales performance in the Greater China region, which includes Taiwan, compare with AMD's 2022 sales in Taiwan alone, given both companies' exposure to the technology market in that geographic area?",
      "original_answer": "Apple reported $74,200 million in net sales in the Greater China region in 2022, which includes China mainland, Hong Kong, and Taiwan. AMD, on the other hand, reported $2,091 million in sales specifically in Taiwan for the same year. This indicates that while Apple has a significantly larger overall presence in the broader Greater China region, AMD's direct sales in Taiwan are much smaller in scale.",
      "llm_answer": "Apple’s 2022 Greater China segment – which includes mainland China, Hong Kong and Taiwan – generated **$74.2 billion** in net sales (Apple 10‑K, Note 11, segment data).  \n\nAMD’s 2022 sales to customers in Taiwan were **$2.091 billion** (AMD 10‑K, sales to external customers by geography).  \n\nThus Apple’s Greater China sales were roughly **35 times larger** than AMD’s Taiwan‑only sales, reflecting Apple’s far greater exposure to the technology market in that region.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: Apple's $74.2 billion (i.e., $74,200 million) in Greater China and AMD's $2.091 billion (i.e., $2,091 million) in Taiwan are correctly reported, with appropriate unit conversions (billion vs. million) preserved. The comparison stating Apple's sales were roughly 35 times larger is mathematically sound: 74.2 / 2.091 ≈ 35.5, which rounds to 'roughly 35 times'. (2) The answer is complete, addressing both companies, the correct geographic regions (Greater China for Apple, Taiwan-only for AMD), and the 2022 time frame. (3) Entity accuracy is perfect: both companies (Apple and AMD), the correct financial metric (net sales), and the source documents (10-K filings) are correctly identified. (4) The multi-hop reasoning is strong—synthesizing data from two different companies, geographic scopes, and filings to make a valid comparative conclusion about market exposure. (5) Semantic equivalence is maintained: while the LLM uses 'billion' and slightly more concise phrasing, all key facts and nuances from the original answer are preserved. The addition of source references (e.g., 'Note 11') enhances credibility without altering meaning. No factual, numerical, or logical errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 365,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does Duke Energy's exposure to environmental remediation liabilities compare to Southern Company's ability to recover similar costs through regulatory mechanisms, given that Duke Energy's remediation costs are typically expensed as incurred unless recovery is probable, while Southern Company Gas' natural gas utilities specifically include environmental remediation in their approved cost recovery mechanisms?",
      "original_answer": "Duke Energy faces environmental remediation liabilities at multiple sites, with costs typically expensed as incurred unless regulatory recovery is deemed probable. In contrast, Southern Company Gas explicitly includes environmental remediation among the costs eligible for recovery through regulatory riders in its natural gas distribution utilities. This means that while Duke may bear these costs directly unless recovery is approved, Southern Company has a more structured pathway to recover such expenses through approved rate mechanisms, reducing its direct financial exposure to environmental remediation liabilities.",
      "llm_answer": "Duke Energy records its environmental‑remediation costs as operating expenses and only treats them as a recoverable regulatory charge when recovery is deemed “probable”; the company carries a $73 million reserve for probable remediation liabilities but the bulk of any future cleanup costs will be absorbed unless a regulator allows a cost‑recovery filing. In contrast, Southern Company’s natural‑gas distribution utilities (Southern Company Gas) have explicit rate‑recovery mechanisms that permit environmental‑remediation expenses to be included in the approved cost‑of‑service base, allowing those costs to be passed through to customers through regulated rates.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states Duke Energy's policy of expensing remediation costs unless recovery is probable and notes the $73 million reserve for probable liabilities—this specific figure is not in the original answer but is factually consistent with known disclosures and does not contradict the ground truth; such reserves are commonly reported in filings, so its inclusion enhances precision without introducing error. (2) The contrast with Southern Company Gas is accurately portrayed: the LLM correctly identifies that Southern Company’s natural gas utilities have explicit regulatory mechanisms allowing environmental remediation costs to be included in cost-of-service and passed through to customers via regulated rates. (3) Multi-hop reasoning is sound—comparing Duke’s contingent recovery approach with Southern’s structured recovery mechanism demonstrates proper synthesis across the two companies’ regulatory frameworks. (4) Minor deduction in quantitative accuracy only because the $73 million figure, while plausible and likely correct, is not present in the original ground truth answer and thus cannot be fully verified from the provided context; however, it does not distort the comparison. Overall, the answer is semantically equivalent, contextually complete, and factually robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 379,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does LOW's use of broker/dealer quotes for Level 2 fair value measurements compare to GM's reliance on valuation models for product warranty reserves, given the role of industry-standard models in both companies' financial reporting?",
      "original_answer": "LOW uses broker/dealer quotes as inputs to Level 2 fair value measurements for financial assets when quoted prices in active markets are not available, relying on third-party pricing models with observable market inputs like issuer spreads and benchmark securities. GM, on the other hand, applies valuation models to estimate product warranty reserves, incorporating significant assumptions such as warranty claims frequency, average cost per claim, and historical claims data. Both companies utilize industry-standard valuation models, but LOW's approach is market-driven with observable inputs (Level 2), while GM's involves more management judgment and forward-looking assumptions. This highlights different applications of valuation models: LOW's fair value measurements are more directly tied to current market data, whereas GM's depend on internal forecasts and historical performance.",
      "llm_answer": "Lowe’s fair‑value measurements for Level 2 assets and liabilities are derived from pricing models that are fed with observable market inputs—including reported trades, benchmark yields and **broker‑dealer quotes** (see LOW 10‑K p. 54). In contrast, General Motors does not use market quotes for its warranty reserves; it **relies on internal actuarial valuation models** that forecast claim frequency and cost per claim based on historical experience and management assumptions (see GM 10‑K p. 56). Both companies therefore depend on industry‑standard valuation models, but Lowe’s models are anchored to observable market data such as broker‑dealer quotes, whereas GM’s models are driven by actuarial assumptions and internal data rather than external market prices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that LOW uses broker/dealer quotes as inputs to pricing models with observable market data (e.g., benchmark yields, reported trades), placing its Level 2 fair value measurements within a market-driven framework. It accurately contrasts this with GM's use of internal actuarial valuation models for warranty reserves, which rely on assumptions about claim frequency and cost per claim based on historical data and management judgment. (2) There are no numerical values in the question or answer requiring calculation, so quantitative accuracy is not compromised—no figures are misstated. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (LOW and GM), two distinct financial reporting areas (fair value measurements vs. warranty reserves), and two types of valuation approaches (market-observable inputs vs. management-driven assumptions). It correctly notes that both use industry-standard models but differ in input types and reliance on external vs. internal data. (4) The only minor shortcoming is a slight lack of specificity regarding the types of observable inputs LOW uses (e.g., issuer spreads, benchmark securities) and the explicit mention of 'forward-looking assumptions' in GM’s case, which are present in the original answer but only implied in the LLM version. However, the core meaning and factual content remain semantically equivalent. The answer is fully relevant, directly addressing the comparison requested and the role of industry-standard models in both contexts.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 447,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How would the implementation of the Basel III Finalization Proposal's Expanded Risk-Based Approach impact both Capital One and Citigroup's regulatory capital requirements, considering the phased-in effective date of July 1, 2025, and the requirement to use the lower of the two calculated risk-based capital ratios?",
      "original_answer": "The Basel III Finalization Proposal introduces a new Expanded Risk-Based Approach that would require both Capital One and Citigroup to calculate their risk-based capital ratios under both this new framework and the existing Basel III standardized approach, using the lower of the two ratios for compliance. For Capital One, this includes a three-year transition period starting July 1, 2025, during which risk-weighted assets under the Expanded Risk-Based Approach would be phased in. Citigroup has indicated that, if the proposal is finalized as written, it would materially increase its required regulatory capital. Both banks must also comply with all capital buffer requirements regardless of which approach yields the lower ratio, further constraining capital flexibility.",
      "llm_answer": "Both Capital One and Citigroup would have to calculate their risk‑weighted assets under the new Expanded Risk‑Based Approach **and** under the existing Basel III standardized approach, and for each capital ratio (CET1, Tier 1, total‑capital, leverage) the **lower** of the two results would become the binding requirement.  The rule is slated to take effect on **July 1 2025** with a three‑year transition, so the impact will be phased in over 2025‑2028; the firms expect the expanded approach to produce higher RWA, meaning that the lower‑ratio constraint will likely **increase** each institution’s required regulatory capital throughout the transition period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: both banks must calculate risk-based capital under the Expanded Risk-Based Approach and the existing Basel III standardized approach, using the lower of the two ratios as the binding requirement. The effective date of July 1, 2025, and the three-year transition period (phased in through 2028) are correctly stated. (2) Quantitative accuracy is perfect: dates (July 1, 2025), time frame (2025–2028), and the direction of impact (higher RWA leading to increased capital requirements) are all factually correct. Format variations (e.g., 'phased in over 2025–2028' vs. 'three-year transition period starting July 1, 2025') are semantically equivalent. (3) Multi-hop reasoning is sound: the model correctly infers that higher risk-weighted assets under the new approach will likely result in lower capital ratios, thus triggering the 'lower of' rule and increasing required regulatory capital. It also correctly generalizes the impact to both institutions. (4) Minor omission: the LLM does not explicitly mention that Citigroup has stated the proposal would 'materially increase' its capital requirements, which is a specific point in the original. Also, the capital buffer requirements (e.g., G-SIB, CCAR) are not mentioned, which constrains capital flexibility—this is a small but relevant detail. However, these omissions do not undermine the core correctness. The answer is contextually relevant, directly addressing the impact on both banks under the specified timeline and rule structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 435,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does ConocoPhillips' exposure to condensate production through its ownership in Alba Plant LLC compare to Chevron's direct condensate production volumes in 2024, given Chevron reports zero condensate reserves in its 2024 10-K filing?",
      "original_answer": "ConocoPhillips holds a 52.2% interest in Alba Plant LLC, which extracts condensate from the Alba Unit natural gas stream and sells it at market prices, with COP's share reflected in 'Equity in earnings of affiliates.' In contrast, Chevron's 2024 10-K shows no condensate production or reserves across all categories, including both consolidated and affiliated companies. This indicates that while COP has exposure to condensate through its Alba Plant investment, Chevron had no direct condensate production in 2024.",
      "llm_answer": "ConocoPhillips is indirectly exposed to condensate through its 52.2 % equity interest in Alba Plant LLC, the joint‑venture that processes the Alba Unit’s gas (≈ 1 MBD of crude‑oil‑equivalent and 14 MMCFD of natural gas) and extracts condensate and LPG for sale. Chevron, by contrast, reports **zero condensate reserves** in its 2024 Form 10‑K, meaning it has no direct condensate production in 2024. Thus ConocoPhillips retains a material, albeit joint‑venture‑based, condensate exposure, while Chevron’s condensate output is effectively nil.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: ConocoPhillips' 52.2% interest in Alba Plant LLC is accurately stated, and Chevron's zero condensate reserves in its 2024 10-K are correctly cited. The conclusion that Chevron had no direct condensate production in 2024 is sound. (2) Quantitative accuracy is excellent—no calculations were required, but the percentage (52.2%) is exact and properly attributed. The additional production figures (≈1 MBD crude-oil-equivalent, 14 MMCFD gas) are not in the original answer but are contextually relevant and do not contradict the ground truth; they enhance detail without introducing error. (3) Multi-hop reasoning is strong: the model correctly synthesizes ConocoPhillips’ indirect exposure via equity investment with Chevron’s lack of direct production, drawing a valid comparison. (4) Semantic equivalence is high—the LLM conveys the same core message: COP has indirect condensate exposure through a JV, while Chevron has none in 2024. The only minor limitation is that the original answer notes COP's share is reflected in 'Equity in earnings of affiliates,' a detail omitted in the LLM response, slightly reducing completeness. However, this does not affect the overall correctness. Hence, a score of 9 is warranted—excellent accuracy with a minor omission in financial statement linkage.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 385,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the application of ASU 2020-04 to contract modifications impact both AVGO's revenue recognition practices and ORCL's financial reporting, particularly in relation to reference rate reform?",
      "original_answer": "AVGO evaluates contract modifications to determine whether additional products or services should be accounted for as a separate contract or part of the existing contract, using standalone selling prices adjusted for specific contract circumstances. ORCL adopted ASU 2020-04 related to reference rate reform, which allowed optional expedients for contract modifications affected by changes in reference rates such as LIBOR. According to the evidence, AVGO uses standalone selling prices to allocate consideration in bundled arrangements, and modifications are accounted for prospectively, cumulatively, or a combination depending on the nature of the change. ASU 2020-04 applied to contract modifications made between March 12, 2020, and December 31, 2024, and both AVGO and ORCL reported no material impact on their consolidated financial statements from applying this guidance. ORCL finalized its adoption of ASU 2020-04 in Q1 of fiscal 2024, with no material effect on its financial statements or notes.",
      "llm_answer": "- Broadcom (AVGO) says that, when a contract is modified, it first determines whether the added goods or services are distinct.  If they are, the modification is accounted for as a **separate contract**; if not, the additional price is allocated to the existing contract on a prospective or catch‑up basis, which changes the timing of when the related revenue is recognized 【page_63】.  \n\n- Oracle (ORCL) reports that it completed its adoption of **ASU 2020‑04, Reference Rate Reform** in the first quarter of fiscal 2024 and that the update “had no material impact to our consolidated financial statements or notes” 【page_72】.  Thus, while Broadcom’s revenue‑recognition timing is affected by how contract modifications are treated, Oracle’s overall financial reporting was essentially unchanged by the reference‑rate‑reform guidance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: AVGO evaluates contract modifications for distinct goods/services and accounts for them as separate contracts or adjusts existing ones using prospective/catch-up methods, impacting revenue timing. ORCL adopted ASU 2020-04 in Q1 of fiscal 2024 with no material impact. (2) Quantitatively, all dates and fiscal periods match: ORCL’s adoption timing (fiscal 2024 Q1) is correctly stated, and the absence of material financial impact for both companies is accurately reported. There are no numerical inaccuracies. (3) The multi-hop reasoning is sound—correctly linking ASU 2020-04 to both AVGO’s revenue recognition practices and ORCL’s financial reporting in the context of reference rate reform. The answer synthesizes across entities and correctly notes that while AVGO’s revenue timing may change due to modification accounting, ORCL experienced no material effect. (4) Minor omission: the ground truth mentions that AVGO uses standalone selling prices adjusted for contract circumstances in allocation, which the LLM answer does not explicitly include. Also, the effective period of ASU 2020-04 (March 12, 2020 – December 31, 2024) is missing. However, these are secondary details that do not undermine the core correctness. Wording differs but meaning is semantically equivalent. Contextual relevance is perfect—directly addresses both companies and the impact on revenue and financial reporting.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 412,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does the dual-class stock structure at META, which negatively impacts the attractiveness of its Class A Common Stock, compare to CMCSA's Class B Common Stock convertibility policy in terms of governance control and shareholder influence?",
      "original_answer": "META's dual-class structure gives disproportionate voting control to Class B shareholders like Mark Zuckerberg, requiring a majority of Class B shares to approve change-of-control transactions until they fall below 35% of combined voting power. In contrast, CMCSA allows Class B Common Stock (with 15 votes per share) to convert share-for-share into Class A Common Stock, maintaining a non-dilutable 33⅓% aggregate voting power for Class B shares. While both structures concentrate governance influence, META's system entrenches control more rigidly through class-vote requirements, whereas CMCSA enables gradual dilution through conversion.",
      "llm_answer": "Meta’s dual‑class system gives its controlling shareholder (Mr. Zuckerberg) a disproportionate voting stake – Class B shares carry 35 % of the combined voting power and can block or direct matters even though they represent a small fraction of the equity – so Class A holders have limited ability to affect governance or defend against a change of control. Comcast’s structure, by contrast, allocates a fixed 33⅓ % of the total voting power to its Class B shares (each share worth 15 votes) and makes those shares convertible, share‑for‑share, into Class A stock, giving B‑shareholders a protected minority vote that can be turned into ordinary voting rights but does not concentrate overall control in the same way as Meta’s dual‑class arrangement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers are correct: Meta's Class B shares having disproportionate voting power (implied 35% threshold for change-of-control, though not explicitly stated as a trigger) and CMCSA's Class B shares holding a fixed 33⅓% voting power with 15 votes per share are accurately reported. The share-for-share convertibility is correctly noted. (2) The answer correctly contrasts Meta’s entrenched control via class-specific voting requirements with CMCSA’s more flexible, convertible structure that allows gradual dilution. (3) Multi-hop reasoning is sound: it synthesizes governance mechanisms across two companies, compares their impact on shareholder influence, and correctly identifies that Meta’s structure is more rigid. (4) Minor omission: the ground truth specifies that Meta requires a majority of Class B shares to approve change-of-control transactions until their voting power falls below 35%, which adds a procedural detail slightly beyond the LLM’s general description of disproportionate control. However, this does not undermine the overall correctness. Wording differs but meaning is semantically equivalent. No factual errors; high contextual relevance and strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 364,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does PEP's use of exchange-traded commodity futures, which are cash-settled daily, compare with COST's disclosure regarding the absence of Level 1 financial assets measured at fair value on a recurring basis, given that Level 1 financial assets typically include exchange-traded commodity futures?",
      "original_answer": "PEP utilizes exchange-traded commodity futures that are cash-settled daily to manage market risk, and these are excluded from the fair value table as of December 25, 2021. These commodity futures fall under Level 1 financial assets, as defined by MDLZ's disclosure, which includes exchange-traded commodity futures valued at quoted market prices. However, COST explicitly states that as of August 28, 2022, it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, indicating a distinct difference in financial instrument usage between PEP and COST.",
      "llm_answer": "PepsiCo notes that it does hold exchange‑traded commodity futures, but because those contracts are cash‑settled each day they are omitted from its fair‑value hierarchy tables (“Exchange‑traded commodity futures are cash‑settled on a daily basis and therefore not included” – PEP 10‑K, p. 107). Costco, by contrast, explicitly states that it did not hold any Level 1 (or Level 3) financial assets measured at fair value on a recurring basis (“the Company did not hold any Level 1 … financial assets or liabilities that were measured at fair value on a recurring basis” – COST 10‑K, p. 51). Thus, while PepsiCo actively uses cash‑settled commodity futures, Costco reports having none of the Level 1 assets that would normally include such exchange‑traded futures.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies that PEP uses exchange-traded commodity futures that are cash-settled daily and are therefore excluded from fair value tables, aligning with the original answer's claim about omission as of December 25, 2021 (implied by context). (2) It accurately cites COST’s disclosure as of August 28, 2022, stating no Level 1 or Level 3 financial assets measured at fair value on a recurring basis, matching the ground truth. (3) The reasoning correctly synthesizes multi-hop information: it links the definition of Level 1 assets (exchange-traded instruments at quoted prices) — implied via PEP’s and COST’s disclosures — and contrasts PEP’s active use of such instruments with COST’s absence of Level 1 holdings. (4) All entities (PEP, COST), financial instruments (exchange-traded commodity futures), valuation levels (Level 1), and settlement terms (daily cash settlement) are correctly identified and logically compared. Minor differences in wording (e.g., 'not included' vs 'excluded') do not affect meaning. No numeric inaccuracies; no dates or figures are misstated. The answer fully addresses the comparative aspect of the question with precise, well-supported reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 360,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does the value of securities loaned with maturities of 31-90 days at Goldman Sachs compare to the total securities loaned value reported by Morgan Stanley, and what does this suggest about their relative exposure to short-term securities lending risk?",
      "original_answer": "Goldman Sachs reports $1,634 million in securities loaned with maturities of 31-90 days, while Morgan Stanley reports a total of $281 million in securities loaned (U.S. and Non-U.S. combined). This suggests that Goldman Sachs has a significantly higher exposure to short-term securities lending risk compared to Morgan Stanley.",
      "llm_answer": "Goldman Sachs reports $1.6 billion of securities loaned that mature in the 31‑90‑day bucket (see GS 10‑K p. 187). Morgan Stanley’s total securities‑loaned portfolio is $34.3 billion (see MS 10‑K p. 200). Thus, Goldman Sachs’ short‑term (31‑90‑day) lending exposure is only about 5 percent of Morgan Stanley’s entire securities‑lending book, indicating that Goldman Sachs has a far lower relative exposure to short‑term securities‑lending risk than Morgan Stanley.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. According to the ground truth, Goldman Sachs reports $1,634 million (i.e., $1.634 billion) in securities loaned with maturities of 31-90 days, which the LLM approximates reasonably as $1.6 billion—this part is acceptable. However, the LLM claims Morgan Stanley’s total securities loaned is $34.3 billion, which directly contradicts the ground truth value of $281 million. This is a massive overstatement by more than 100x. (2) The calculation comparing Goldman Sachs’ 31-90 day loans to Morgan Stanley’s total is therefore completely incorrect: the LLM concludes that Goldman’s exposure is only 5% of Morgan Stanley’s, implying lower risk for Goldman, when in reality, Goldman’s $1,634 million is nearly 6 times larger than Morgan Stanley’s total $281 million. This reverses the correct conclusion. (3) The multi-hop reasoning fails because the model incorrectly retrieves Morgan Stanley’s securities loaned value, leading to flawed synthesis. The comparison should show that Goldman Sachs has significantly higher short-term securities lending risk than Morgan Stanley, not lower. (4) Due to the severe quantitative inaccuracy and the resulting reversal of the correct conclusion, the correctness score is very low. The answer is contextually relevant in structure and attempts the right comparison, but the factual foundation is entirely wrong, undermining all reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 397,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What percentage of PowerSouth's owned generating capacity comes from its undivided interest in Alabama Power's Plant Miller Units 1 and 2, and how does this compare to Duke Energy's total electricity generation in GWh for 2021?",
      "original_answer": "PowerSouth owns an undivided 8.16% interest in Alabama Power's Plant Miller Units 1 and 2, which contributes to its total generating capacity of over 1,600 MWs. In comparison, Duke Energy generated a combined total of 22,344 GWh of electricity in 2021 across all its operating segments. This comparison highlights the relative scale of PowerSouth’s partial ownership in a specific plant versus Duke Energy’s full system-wide electricity generation.",
      "llm_answer": "PowerSouth’s undivided stake in Alabama Power’s Plant Miller Units 1 and 2 represents **8.16 %** of the cooperative’s owned generating capacity (PowerSouth owns >1,600 MW, of which 8.16 % is the Miller interest)【page_17】.  \n\nIn contrast, Duke Energy reported **22,344 GWh** of electricity generation for 2021【page_187】.  \n\nSo, while PowerSouth’s Miller interest is a modest 8.16 % of its capacity, Duke Energy’s overall output was about 22,344 GWh in the same year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies PowerSouth's 8.16% undivided interest in Plant Miller Units 1 and 2 and accurately states that this stake is part of its over 1,600 MW of owned generating capacity. It also correctly reports Duke Energy's total electricity generation of 22,344 GWh in 2021. All numeric values match the ground truth exactly, with correct units and years. (2) Quantitative accuracy is perfect: 8.16% and 22,344 GWh are both correctly cited from the source. There are no calculation errors. (3) The multi-hop reasoning is mostly sound—comparing PowerSouth’s partial ownership stake (as a percentage of its capacity) to Duke Energy’s total system-wide generation is contextually appropriate, though the LLM slightly mischaracterizes the 8.16% as being 'of the cooperative’s owned generating capacity' rather than clarifying it is 8.16% ownership in Plant Miller units (which contribute to that capacity). This is a subtle but important distinction; however, the overall synthesis across entities (PowerSouth, Alabama Power, Duke Energy) and documents is accurate. (4) The answer is highly relevant, directly addressing both parts of the question and providing meaningful comparison. The minor phrasing ambiguity does not undermine factual correctness, warranting a 9/10 on correctness and qualitative accuracy, while quantitative and contextual scores are perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 386,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How does NIKE's exposure to interest rate risk in its $11.6 billion portfolio of fixed-income investments compare to McDonald's sensitivity to market inputs like interest rate yield curves, given both companies rely on pricing models that use observable market data for valuation?",
      "original_answer": "NIKE holds $11.6 billion in short-term investments, including investment-grade fixed-income securities, which are exposed to interest rate risk. These investments are valued using pricing models that incorporate observable market data such as interest rates and yield curves. Similarly, McDonald’s discloses that its derivatives are valued using pricing models that rely on observable market parameters, including interest rate yield curves. While NIKE’s risk stems from changes in interest rates affecting investment returns, McDonald’s exposure is tied to derivative valuations that reflect market fluctuations. Both companies depend on observable inputs for fair value measurements, though the nature and magnitude of risk differ based on the type of financial instrument involved.",
      "llm_answer": "Nike’s $11.6 billion cash‑equivalents and short‑term investment portfolio is composed of investment‑grade fixed‑income securities with a very short weighted‑average maturity (about 65 days).  The company notes that this portfolio is “exposed to both credit and interest‑rate risk,” but the short duration limits the magnitude of any rate‑movement impact and the exposure is largely managed through modest interest‑rate swaps.\n\nMcDonald’s, by contrast, values its debt, lease liabilities and certain derivatives with pricing models that use observable market inputs such as interest‑rate yield curves and incremental borrowing rates.  Because those models feed directly into the fair‑value measurement of liabilities and lease discount rates, changes in the yield curve can affect earnings and AOCI more immediately and across a broader set of balances.  \n\nThus, Nike’s interest‑rate risk is confined to a relatively small, short‑duration fixed‑income portfolio, whereas McDonald’s financial statements are more sensitive to market‑driven interest‑rate inputs, making its overall exposure to rate changes materially larger.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key figures are correct: NIKE's $11.6 billion portfolio is accurately cited, and while the '65-day weighted-average maturity' is more specific than the original answer, it does not contradict it and is consistent with typical short-term investment portfolios. No calculations were required, and all financial figures match or are reasonably inferred. (2) The entities—NIKE and McDonald’s—are correctly identified, and the financial instruments (fixed-income securities, derivatives, debt, lease liabilities) are accurately attributed. (3) The reasoning is sound and improves upon the original by providing a clearer comparative analysis: it correctly identifies that both companies use observable market inputs (e.g., yield curves) in pricing models, but differ in exposure—NIKE’s risk is asset-side (investments), short-duration, and partially hedged, while McDonald’s exposure is liability-side and more broadly impacts financial statements through fair value measurements. This constitutes valid multi-hop synthesis across both companies’ disclosures. (4) The LLM adds nuanced context not in the original (e.g., use of interest-rate swaps, impact on AOCI, lease discount rates), which is factually plausible and enhances the comparison without introducing inaccuracies. The only reason for not scoring a 10 is that the original answer emphasizes the similarity in reliance on observable inputs more explicitly, while the LLM focuses more on the difference in exposure magnitude—still valid, but slightly shifts emphasis. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 463,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How does the difference in voting rights structure between Netflix's common stock and Alphabet's Class A common stock potentially influence their respective shareholder governance dynamics, given Netflix's uniform one-vote-per-share policy and Alphabet's multi-class structure with differential voting rights?",
      "original_answer": "Netflix's common stock provides each share with one vote, promoting a more egalitarian shareholder governance model. In contrast, Alphabet's multi-class structure, where Class A common stock grants one vote per share while Class B common stock grants 10 votes per share, concentrates voting power among holders of Class B shares. This structural difference means Alphabet's governance is more susceptible to control by a smaller group of insiders or major shareholders, while Netflix maintains a more evenly distributed voting environment.",
      "llm_answer": "Netflix’s charter provides that “the holders of each share of common stock shall be entitled to one vote per share” 【page_60】, so every shareholder has an equal voting stake in corporate matters. Alphabet, by contrast, has a dual‑class system in which “each share of Class A common stock is entitled to one vote per share…each share of Class B common stock is entitled to 10 votes per share…Class C capital stock has no voting rights” 【page_82】. Consequently, Netflix’s governance is more uniformly democratic, whereas Alphabet’s structure concentrates voting power in the hands of insiders who own Class B shares, giving public Class A shareholders comparatively less influence over board and policy decisions.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies Netflix's one-vote-per-share policy and Alphabet's multi-class structure with Class A having one vote and Class B having ten votes per share, which aligns exactly with the original answer. (2) There are no numerical values requiring calculation, but the voting rights (1 and 10 votes per share) are reported accurately, with proper contextualization. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance implications from the structural differences—highlighting that Alphabet’s Class B concentration empowers insiders, while Netflix’s uniform voting promotes egalitarian governance. (4) The answer addresses all parts of the question: it contrasts the two companies’ voting structures and explains how these influence shareholder governance dynamics. Wording differs slightly but meaning is preserved, with added precision (e.g., mentioning Class C having no voting rights, which enriches the response without introducing error). All entities (Netflix, Alphabet, Class A/B/C shares) are correctly identified. Citations to page numbers (though not evaluated for correctness here) further support fidelity to source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 353,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How might the IRA's price-setting provisions for Medicare Part D drugs like Imbruvica and XARELTO differently impact AbbVie and Johnson & Johnson's revenue strategies, given their respective exposure to the Medicare program?",
      "original_answer": "The IRA's price-setting provisions for Medicare Part D drugs will likely impact AbbVie and Johnson & Johnson differently due to their distinct product portfolios and revenue strategies. AbbVie has Imbruvica selected for price-setting starting in 2026, which could significantly affect its revenue stream, especially if more high-revenue products are selected in the future. Johnson & Johnson has XARELTO selected under the same program, a major anticoagulant with substantial Medicare utilization. Both companies face uncertainty around the final government-set prices, but J&J has already filed litigation challenging the constitutionality of the IRA’s pricing mechanism, suggesting a more aggressive stance to protect revenue. AbbVie, on the other hand, is more focused on evaluating the broader strategic impact of the IRA, including potential acceleration of revenue erosion prior to patent expirations. The differing responses reflect their respective risk exposure and strategic priorities within the Medicare program.",
      "llm_answer": "The Inflation‑Reduction Act will impose a statutory ceiling on Medicare Part D prices for the drugs named in the first “selected‑drug” list—Imbruvica (AbbVie) and Xarelto (Johnson & Johnson)—with the caps taking effect in 2026. AbbVie notes that Imbruvica’s inclusion “could accelerate revenue erosion prior to expiration of intellectual‑property protections,” so the company may have to trim its Medicare‑related earnings forecasts and look for other growth or pricing offsets. J&J also faces a price‑cap on Xarelto, but because its revenue base is broader and it can rely on litigation, diversified product lines and other pricing‑adjustment tools, the IRA’s price‑setting is likely to be a less concentrated hit to its overall revenue strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Imbruvica (AbbVie) and XARELTO (J&J) are correctly identified as selected for IRA price-setting with implementation in 2026. The impact on revenue strategies is accurately portrayed—AbbVie faces potential acceleration of revenue erosion before patent expiry, while J&J has a broader revenue base and is pursuing litigation. (2) Quantitative accuracy is perfect: the 2026 start date is correct, and no numerical errors are present. Format variations (e.g., '2026' used consistently) are acceptable. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across companies, drugs, and strategic responses—linking drug selection under the IRA to differing corporate strategies based on portfolio diversification and legal action. (4) The only minor shortcoming is that the LLM does not explicitly mention J&J’s actual filing of litigation (it implies legal recourse but doesn’t state it as a factual action taken), which slightly reduces qualitative completeness compared to the original. However, the core reasoning and strategic contrast are preserved. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth with only slight omission of a specific detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 371,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How does Citi's governance structure for managing compliance risk specifically address the potential amplification of credit and liquidity risks stemming from transition climate risks as outlined in Morgan Stanley's risk disclosures?",
      "original_answer": "Citi's governance structure includes the Board and Executive Management Team, which oversee enterprise risk management (ERM) and hold management accountable for the effectiveness of internal controls and compliance with legal and regulatory requirements. This includes ensuring that compliance risk is effectively managed across the organization. Transition climate risks, as outlined in Morgan Stanley's disclosures, may amplify credit and liquidity risks by reducing customers' operating income or the value of their assets. These risks also expose firms to reputational, compliance, and litigation risks due to increased legal and regulatory scrutiny. Citi’s Internal Audit, which reports functionally to the Chair of the Citi Audit Committee, provides independent assurance over the effectiveness of governance, risk management, and controls, including those addressing climate-related risks. This structure ensures that compliance risk management processes are aligned with evolving regulatory expectations, such as those related to climate risk, which Morgan Stanley notes are increasingly focused on disclosure and regulation of carbon emissions.",
      "llm_answer": "Morgan Stanley notes that “the impacts of transition risk may lead to and amplify credit or liquidity risk” (MS 10‑K p. 75). Citi addresses that possibility through its three‑lines‑of‑defense ERM framework: the Independent Risk Management (IRM) function sets firm‑wide risk‑and‑control standards for credit, liquidity, market and climate risk, while the Independent Compliance Risk Management (ICRM) unit, reporting to the Chief Compliance Officer (who has unrestricted access to the Board and the Risk Management Committee), monitors and escalates compliance‑related climate‑risk issues and ensures they are embedded in the firm’s risk‑appetite and control processes (Citi 10‑K p. 70; p. 55). Together, the board‑level BRC oversight, IRM’s aggregate risk monitoring, and ICRM’s compliance‑risk oversight create a governance layer that specifically flags and mitigates any transition‑climate‑driven amplification of credit or liquidity exposures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Citi’s governance structure is accurately described with reference to its three-lines-of-defense ERM framework, Independent Risk Management (IRM), Independent Compliance Risk Management (ICRM), and Board-level oversight. The citation of Morgan Stanley’s disclosure about transition risks amplifying credit and liquidity risks is correctly attributed (MS 10-K p.75), and Citi’s governance mechanisms are tied to managing these risks through compliance and risk-appetite frameworks (Citi 10-K pp.70, 55). (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from two different firms (Citi and Morgan Stanley), linking Morgan Stanley’s identification of transition risk impacts to Citi’s governance mechanisms designed to address such cross-cutting risks. The explanation of how ICRM and IRM interact under Board and BRC oversight to manage climate-related compliance, credit, and liquidity risks demonstrates strong qualitative reasoning. (4) The only minor shortcoming is that the LLM answer does not explicitly mention Citi’s Internal Audit function or its reporting line to the Citi Audit Committee, which is included in the ground truth and adds another layer of independent assurance. While the three-lines-of-defense model implicitly includes internal audit, the omission of this specific control is a slight gap in completeness. However, the core of the governance structure and its application to climate-driven risk amplification is accurately and relevantly conveyed. Hence, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for contextual relevance and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1546,
        "completion_tokens": 512,
        "total_tokens": 2058
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does QCOM's reliance on Chinese OEMs for 30% of its licensing revenue create different supply chain risks compared to TXN's strategy of expanding internal 300mm wafer fabrication capacity?",
      "original_answer": "QCOM derives a significant portion of its licensing revenues from Chinese OEMs, with 30% of total licensing revenue coming from this group of manufacturers. Delays or disputes in license agreements with these OEMs can directly impact QCOM's revenue and cash flows. In contrast, TXN is expanding internal 300mm wafer fabrication capacity through investments in RFAB2, LFAB1, and SM1 facilities, aiming to achieve greater supply chain control and reduce dependency on external foundries. While QCOM's business model depends heavily on maintaining licensing agreements with external manufacturers, particularly in China, TXN's strategy reduces exposure to external supply chain disruptions by vertically integrating manufacturing. This creates different risk profiles: QCOM faces higher exposure to geopolitical and contractual risks in China, while TXN mitigates manufacturing risks through capital investments in internal capacity.",
      "llm_answer": "Qualcomm’s licensing model ties about 30 % of its royalty stream to a handful of Chinese OEMs. Because those OEMs control the devices that generate the royalties, Qualcomm is exposed to geopolitical‑trade actions, possible export‑control bans, and the risk that the OEMs‑or‑the Chinese government‑could curtail payments, change licensing terms, or develop their own chips (QCOM ‑ Risk Factors, p. 19).  \n\nIn contrast, Texas Instruments is reducing supply‑chain exposure by building more of its own 300 mm wafer capacity (RFAB2, LFAB1, SM1/SM2, LFAB2) so that it can meet demand internally, lower unit costs and avoid reliance on external foundries (TXN ‑ p. 7). That strategy shifts risk from external political or partner‑related disruptions to internal ones such as high fixed‑cost investments, capacity‑utilisation pressure and the need to manage its own fab operations (TXN ‑ p. 24‑25).  \n\nThus, Qualcomm’s risk is driven by dependence on foreign OEMs and related regulatory‑political factors, whereas TI’s risk stems from the capital‑intensive nature of expanding its own manufacturing footprint.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 30% licensing revenue from Chinese OEMs is correctly stated, and there are no numerical inaccuracies. The facilities mentioned (RFAB2, LFAB1, SM1) are accurate, though SM2 and LFAB2 are mentioned in the LLM answer but not in the original; however, these are plausible extensions of TXN's known fab expansion and do not contradict the ground truth. (2) The core reasoning correctly contrasts QCOM's exposure to geopolitical and contractual risks in China with TXN's shift toward vertical integration to reduce external supply chain risks. The LLM accurately identifies that QCOM’s risk stems from reliance on external OEMs and regulatory uncertainty, while TXN assumes operational and capital investment risks. (3) Multi-hop synthesis is sound: it connects QCOM’s licensing model to geopolitical risk and contrasts it with TXN’s capital-intensive internal manufacturing strategy. (4) Minor deduction in qualitative accuracy due to slight overstatement of TXN facilities (SM2, LFAB2 not in original), but the overall logic and risk comparison remain valid and insightful. Wording differs but semantic meaning matches. Contextual relevance is perfect—directly addresses the comparative supply chain risk question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 363,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does Southern Company's evaluation of ASU 2020-04 in relation to interest rate derivatives compare with Duke Energy's assessment of the same accounting standard's impact on its LIBOR-indexed financial contracts?",
      "original_answer": "Southern Company continues to evaluate the provisions of ASU 2020-04 and its impact on transitioning to alternative interest rates, particularly in relation to its interest rate derivatives as noted in Note 14, while Duke Energy is assessing the optional expedients provided by the same standard to manage contractual amendments or terminations for LIBOR-indexed financial arrangements, including variable-rate debt and interest rate swaps, which may extend beyond the 2023 LIBOR phase-out. Both companies recognize the uncertainty around the ultimate financial impact, with Duke Energy specifically noting it is not expected to be material.",
      "llm_answer": "Southern Company says it has already elected to apply the ASU 2020‑04 expedients to any debt‑modification transactions that fall within the scope of the guidance and, while it will keep evaluating the transition to an alternative reference rate, it does not expect a material impact on its financial statements. By contrast, Duke Energy notes that it has not yet adopted the new standard, is still assessing how its LIBOR‑indexed interest‑rate swaps and other contracts will be amended or terminated, and likewise expects the transition to be immaterial, though the ultimate outcome remains uncertain.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect assertions, leading to a partially accurate response. (1) Correct elements: Both companies acknowledge uncertainty and expect immaterial financial impact, which aligns with the ground truth—Duke Energy explicitly states the impact is not expected to be material, and Southern Company implies it. The mention of LIBOR-indexed instruments like interest rate swaps and variable-rate debt for Duke Energy is consistent. (2) Quantitative accuracy: There are no specific numbers (e.g., dollar amounts, percentages, dates) in either the question or ground truth, so no numeric inaccuracies exist—this aspect is acceptable. (3) Multi-hop reasoning issues: The LLM incorrectly claims that Southern Company 'has already elected to apply the ASU 2020-04 expedients,' which contradicts the ground truth stating Southern is 'continuing to evaluate' the standard. Conversely, it says Duke Energy 'has not yet adopted the new standard,' but the original answer does not state adoption status—only that Duke is assessing optional expedients for managing contractual changes. Thus, the comparison is flawed in directionality and timing. (4) Semantic mismatch: The ground truth emphasizes ongoing evaluation by both firms, with Duke further along in applying expedients, while the LLM reverses or overstates the progress. Despite correct context about instruments and immateriality, the core reasoning about each company’s status under ASU 2020-04 is inaccurate, warranting a mid-range correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 421,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does the exposure of AMZN's foreign currency assets to British Pounds and Euros compare to NKE's reliance on option contracts for managing similar currency risks, given their differing approaches to foreign exchange risk management?",
      "original_answer": "AMZN holds foreign currency assets in British Pounds, Euros, and other currencies, and is exposed to foreign exchange risk due to fluctuations that may materially impact translated values of these assets. NKE actively manages its foreign exchange risk using option contracts, specifically hedging exposures related to product costs, external sales, and other costs denominated in currencies like the British Pound and Euro. While AMZN discloses its exposure to these currencies, it does not specify the use of derivative instruments like options to hedge this risk. In contrast, NKE explicitly states its use of option contracts as part of its foreign currency risk management program to hedge forecasted transactions and balance sheet exposures. This suggests that NKE takes a more proactive and structured approach to mitigating foreign exchange impacts through financial instruments, while AMZN's strategy remains less transparent in terms of derivative usage.",
      "llm_answer": "Amazon’s 10‑K notes that it “holds cash equivalents and/or marketable securities in foreign currencies such as British Pounds … and Euros,” so a portion of its balance‑sheet assets is directly exposed to GBP and EUR movements and the company’s results swing with those translation changes. Nike, by contrast, “enters into option and forward contracts to protect the value of its existing foreign‑currency assets, liabilities, firm commitments and forecasted transactions,” using option‑based hedges to offset the same currency risk rather than relying on un‑hedged foreign‑currency balances. Thus Amazon’s exposure is a passive holding of GBP/EUR assets, while Nike’s approach is an active, option‑driven hedging program.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) It correctly identifies that AMZN holds foreign currency assets in British Pounds and Euros, exposing it to translation risk, while NKE uses option and forward contracts to hedge foreign exchange risk. The characterization of AMZN's approach as passive and NKE's as active and structured is semantically equivalent to the original answer's conclusion. (2) There are no numerical values, dates, or percentages in the question or ground truth, so quantitative accuracy is not applicable in a traditional sense; however, the LLM does not introduce any incorrect figures and accurately reflects disclosed information from the 10-Ks. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (AMZN and NKE), compares their differing FX risk management strategies (exposure vs. hedging), and draws a valid contrast between holding foreign currency assets versus using derivative instruments. The only minor shortcoming is that the LLM mentions 'forward contracts' in addition to options for NKE, while the original answer emphasizes 'option contracts' specifically. However, since options are a subset of derivative instruments and Nike’s 10-K typically discloses both options and forwards, this inclusion does not constitute a factual error but adds slightly more detail than in the original. (4) The answer is fully contextually relevant, directly addressing the comparison of AMZN's exposure to GBP/EUR with NKE's use of options for managing similar risks. Overall, the response is factually correct, well-reasoned, and captures the core contrast in risk management approaches.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 465,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does the voting power distribution between Class A and Class B common stock at META compare to GOOGL's structure, given the dynamic relationship between share class voting rights?",
      "original_answer": "At META, Class A common stockholders hold 66 2/3% of the combined voting power, while Class B common stockholders hold 33 1/3%, with each share of Class B having 15 votes. In contrast, at GOOGL, each share of Class A has one vote and each share of Class B has 10 votes, with no specific percentage provided for their distribution. This indicates that META grants significantly more voting influence to Class B shares relative to Class A compared to GOOGL's structure.",
      "llm_answer": "Meta Platforms, Inc. has 2,189,898,148 shares of Class A stock and 343,761,117 shares of Class B stock outstanding (Meta 10‑K, page 1).  Under Meta’s charter each Class A share carries one vote and each Class B share carries ten votes, so the Class B shares (though only about 14 % of the total shares) control roughly 61 % of the total voting power.  Alphabet’s (Google) structure is the same in principle – Class A shares have one vote and Class B shares have ten votes, giving the much‑smaller Class B pool a controlling voting majority (Alphabet 10‑K, page 82).  Thus, both companies use a dual‑class system in which the high‑voting Class B shares dominate voting power despite representing a minority of the total shares.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both the voting power distribution and share class vote weights for META and GOOGL. According to the ground truth, at META, Class B shares have 15 votes per share, not 10 as stated by the LLM. Additionally, the ground truth specifies that Class A holds 66 2/3% and Class B holds 33 1/3% of voting power, whereas the LLM incorrectly claims Class B controls roughly 61% of voting power—this contradicts the ground truth and suggests a miscalculation or misinterpretation. The LLM also fails to mention that GOOGL’s Class B shares have 10 votes per share (which it does correctly state), but omits that no specific voting power percentage is provided in the original answer, making its assertion about a 'controlling voting majority' less substantiated than presented. (2) The quantitative inaccuracies are critical: the LLM reports 10 votes for META Class B shares instead of 15, and calculates ~61% voting power for Class B based on flawed assumptions. The actual voting structure implies Class B has disproportionate influence relative to its share count, but the ground truth explicitly gives the split as 66.67% (Class A) to 33.33% (Class B), meaning Class A holds the majority of voting power—directly contradicting the LLM’s claim that Class B controls 61%. This is a major error in both numbers and interpretation. (3) The multi-hop reasoning is partially sound in that the model recognizes both companies use dual-class structures with high-vote Class B shares, and attempts to compare them. However, due to incorrect vote ratios and miscalculated voting power distributions, the synthesis is flawed. The conclusion that both are 'the same in principle' overlooks the key distinction highlighted in the ground truth: META grants significantly more relative influence to Class B than GOOGL does, which cannot be assessed correctly with wrong vote counts. (4) Scores reflect that while the general context and intent are relevant (dual-class structures, comparison of voting control), the core factual content—especially numerical values and resulting voting power—is incorrect, undermining the answer's reliability. Minor credit is given for identifying the existence of dual-class systems and attempting quantitative analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 615,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Southern Company's (SO) investment in SNG and SNG's need for FERC approval on its pipeline project compare to Duke Energy Ohio's (DUK) experience with FERC approval in terms of regulatory constraints and capital implications?",
      "original_answer": "Southern Company's (SO) investment in SNG was $1,245 million as of December 31, 2024. SNG is developing a $3 billion pipeline project requiring FERC approval, with Southern Company Gas owning 50% of the project. This regulatory dependency could delay the project until 2029 if approvals are not met. Similarly, Duke Energy Ohio (DUK) requires FERC and PUCO approval to pay dividends from specific equity accounts, with a condition to maintain equity at no less than 30% of total capital. Both entities face regulatory constraints from FERC, but while SNG's challenge centers on project execution and timing, DUK's is tied to capital structure and dividend policy.",
      "llm_answer": "Southern Company’s gas‑utility arm is investing about $1.5 billion (50 % of an estimated $3 billion) in the SNG pipeline, but the project cannot move forward until all required regulator approvals – notably FERC’s – are obtained, so the capital outlay remains conditional on that approval. By contrast, Duke Energy Ohio has already secured FERC (and PUC) approval to pay dividends, so its regulatory hurdle is satisfied; the remaining constraint is a capital‑structure covenant that equity (adjusted for push‑down accounting) must stay above 30 % of total capital, limiting how much of its existing capital can be used for distributions rather than a large, uncertain capital project.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $3 billion SNG pipeline project and Southern Company's 50% ownership, implying a $1.5 billion investment. However, the ground truth states Southern Company's investment in SNG was $1,245 million as of December 31, 2024, which is a specific factual figure not reflected in the LLM's 'about $1.5 billion'—this is a quantitatively inaccurate approximation. The LLM also omits the key detail that delays could push the project to 2029, which is a material point about regulatory timing. (2) The $1.5 billion figure is a reasonable estimate based on 50% of $3 billion, but it does not match the actual disclosed investment of $1,245 million, making it factually imprecise. The 30% equity threshold for Duke Energy Ohio is correctly stated. (3) The multi-hop reasoning is sound: the model correctly contrasts SNG’s regulatory hurdle (FERC approval needed to proceed) with DUK’s post-approval capital structure constraint. It synthesizes that FERC plays a role for both, but in different contexts—project execution vs. dividend policy—which aligns with the original answer. (4) Despite the numerical inaccuracy and omission of the 2029 delay, the core qualitative comparison is accurate and relevant. The answer addresses both regulatory constraints and capital implications, fulfilling the question’s intent. Hence, correctness is reduced primarily due to quantitative inaccuracy, but qualitative and contextual scores remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 409,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Lowe's share repurchase activity through financial institutions in 2021-2022 compare with Home Depot's use of dividend equivalents in terms of shareholder value distribution mechanisms?",
      "original_answer": "Lowe's authorized $13.0 billion in additional share repurchases in December 2021, bringing total authorization to $28.0 billion since 2020, and executed a $3.0 billion accelerated share repurchase (ASR) with a financial institution, receiving 11.9 million shares. Meanwhile, Home Depot pays dividend equivalents on unvested restricted stock units and performance shares, which accrue and are paid out in the form of additional shares upon vesting or payout. This shows Lowe's prioritized direct share reduction through financial intermediaries, while Home Depot focused on equity-based dividend equivalent compensation aligned with vesting timelines.",
      "llm_answer": "Lowe’s 2021‑22 capital‑return strategy centered on buying back stock.  In November 2021 the company entered an accelerated‑share‑repurchase (ASR) agreement with a third‑party financial institution, paid $3 billion up‑front and received an initial 10.3 million shares (later an additional 1.6 million), and ultimately repurchased $13.1 billion of common stock during fiscal 2021【page_23】.  \n\nHome Depot, by contrast, does not use buy‑backs for that period; it returns value to shareholders through **dividend equivalents** that accrue on performance‑share awards, restricted‑stock awards and restricted‑stock units and are paid as additional shares when the awards vest【page_69】.  \n\nThus, Lowe’s distributes cash by repurchasing shares via a financial‑institution‑mediated ASR, whereas Home Depot distributes shareholder value by issuing extra shares through dividend‑equivalent provisions attached to its equity‑based compensation.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor discrepancies in numerical precision and timing. (1) Quantitatively: The LLM states Lowe's repurchased $13.1 billion of stock in fiscal 2021, while the ground truth notes a $13.0 billion authorization in December 2021 (not necessarily fully executed). This is a minor difference in framing—authorization vs. execution—but the figures are close and contextually aligned. The ASR details are mostly correct: the LLM reports an initial delivery of 10.3 million shares and later 1.6 million, totaling 11.9 million, which matches the ground truth’s total of 11.9 million. However, the ground truth does not specify the timing of share deliveries, so the LLM adds slight detail not in the original, but plausibly consistent. The date is cited as November 2021 vs. December 2021 in the ground truth—close but slightly off. (2) Completeness: The LLM fully addresses both companies’ shareholder distribution mechanisms—Lowe’s ASR via financial institutions and Home Depot’s dividend equivalents on unvested equity awards. It correctly contrasts share reduction (Lowe’s) vs. share issuance (Home Depot). (3) Entity accuracy: Both companies are correctly identified, as are the mechanisms (ASR, dividend equivalents), award types (RSUs, performance shares), and time frame (2021–2022). (4) Reasoning: The multi-hop synthesis is sound—linking Lowe’s use of financial institutions for repurchases with Home Depot’s use of dividend equivalents as a value distribution method. The conclusion that Lowe’s reduces shares while Home Depot issues more via equity compensation is logically and factually supported. (5) Semantic equivalence: Despite wording differences (e.g., 'capital-return strategy' vs. 'shareholder value distribution'), the meaning is equivalent. The LLM enhances clarity by specifying 'third-party financial institution' and 'additional shares upon vesting.' Only a 9 due to the slight date discrepancy and conflation of $13.1B executed vs. $13.0B authorized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 553,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does the adoption of ASU 2022-04 impact the disclosure of supplier finance program obligations for both Caterpillar and Honeywell, particularly in terms of the rollforward requirement effective in 2024?",
      "original_answer": "Caterpillar and Honeywell both adopted ASU 2022-04, which mandates enhanced disclosures for supplier finance programs. The guidance requires annual disclosure of key terms, balance sheet presentation, and a rollforward of obligations, with the rollforward specifically becoming effective on January 1, 2024. Caterpillar included the rollforward in its 2024 disclosures, showing $830 million in obligations at year-end. Honeywell also adopted the rollforward requirement for 2024, aligning with the new standard. Both companies now provide more transparent reporting of their supplier finance obligations, which were $830 million for Caterpillar and would be similarly detailed for Honeywell under the new rules.",
      "llm_answer": "Both companies now have to show the supplier‑finance balances that sit inside accounts‑payable and to present a year‑end “roll‑forward” of those balances. Honeywell’s filing states that it adopted ASU 2022‑04 on 1 Jan 2023 and began providing the required roll‑forward as of 1 Jan 2024 (see Honeywell page 60). Caterpillar’s 10‑K likewise includes a roll‑forward table – beginning balance $803 million, ending balance $830 million (see Caterpillar page 112) – which reflects the same ASU requirement that became effective in 2024, even though the Caterpillar note does not repeat the adoption language. In short, the ASU forces both firms to disclose the program’s key terms, locate the liability in accounts‑payable, and present a 2024 roll‑forward of the outstanding obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the key numbers are correct: Caterpillar's ending balance of $830 million is accurately reported, and the mention of a beginning balance of $803 million adds detail not in the original answer but does not contradict it. The effective date of January 1, 2024, for the rollforward requirement is correctly stated for both companies. The only minor discrepancy is that the original answer does not mention Caterpillar’s beginning balance, so this added detail is plausible but unverifiable from the ground truth; however, it does not reduce accuracy. (2) The adoption timeline is correctly interpreted: Honeywell adopted the standard on January 1, 2023, with the rollforward effective in 2024, which matches the guidance and ground truth. The LLM correctly infers that Caterpillar complied with the rollforward in 2024 even if the adoption language isn't repeated, which is a sound interpretation. (3) Entity accuracy is perfect: both Caterpillar and Honeywell are correctly identified, along with the correct ASU (2022-04), the correct financial metric (supplier finance obligations), and the correct year (2024) for the rollforward requirement. (4) Multi-hop reasoning is strong: the LLM synthesizes information across both companies, connects the ASU adoption to the disclosure requirements, and correctly identifies the rollforward as a new 2024 requirement. The explanation of enhanced transparency, inclusion in accounts payable, and key terms disclosure matches the original answer’s intent. (5) Semantic equivalence is high—wording differs but meaning is preserved and even enriched with specific filing page references and balance details. The answer fully addresses all parts of the question. Only a perfect 10 is avoided due to the unverified $803M beginning balance, which, while plausible, introduces a minor unconfirmed detail. Overall, this is a factually correct, complete, and well-reasoned response.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 538,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does the $49,549 million in credit card loans due within 1 year reported by Company C compare to Visa's strategy of driving growth through credit card issuance, given the $20 trillion global opportunity they identify in converting non-card payments to digital credentials?",
      "original_answer": "Company C reports holding $49,549 million in credit card loans due within 1 year, indicating a significant portion of short-term consumer credit exposure. This aligns with Visa's strategic focus on expanding credit card usage to capture a share of the $20 trillion global opportunity in converting non-card payments to digital credentials on their network. Visa's emphasis on growing credit card programs through financial institution partnerships suggests a continued push to increase the volume and velocity of credit card transactions, which would likely feed into larger short-term loan balances across institutions like Company C.",
      "llm_answer": "Company C (Citigroup) reports $49.5 billion of credit‑card loans that mature within one year (see page 86).  By contrast, Visa’s growth plan is built on tapping a $20 trillion global opportunity to convert non‑card payments into Visa‑issued cards and digital credentials (see page 8).  Thus, Citigroup’s short‑term credit‑card loan balance is only a tiny fraction of the market size Visa is targeting with its credit‑card issuance strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is quantitatively accurate: $49,549 million is correctly converted to $49.5 billion, and the $20 trillion global opportunity aligns with the original answer. The entity identification is mostly correct, with Company C correctly inferred as Citigroup (though not explicitly stated in the ground truth). The contextual relevance is strong, as it addresses both Company C's short-term credit card loans and Visa's growth strategy. However, the qualitative reasoning is weaker because it frames Citigroup’s $49.5 billion as 'only a tiny fraction' of the $20 trillion market, which, while numerically true, mischaracterizes the relationship. The original answer emphasizes alignment—how Company C’s exposure reflects the broader trend that Visa is strategically capitalizing on through partnerships and network expansion. The LLM instead creates a size comparison that wasn’t the focus of the question, missing the nuanced synthesis that short-term loan balances like Citigroup’s are an outcome of the very growth strategy Visa is driving. This reflects a partial failure in multi-hop reasoning: it identifies both facts but synthesizes them incorrectly. The answer is factually sound but conceptually imprecise in linking the two entities’ roles in the ecosystem.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 354,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the impact of weather conditions on Southern Company's gas distribution revenues compare to the exposure of NextEra Energy's electricity demand, considering their respective risk mitigation strategies?",
      "original_answer": "Southern Company Gas' earnings are affected by customer consumption patterns that are largely a function of weather conditions and natural gas price levels. For example, in 2023, Southern Company Gas experienced a 6.2% decrease in net income compared to 2022, partly due to lower gas volumes sold driven by weather patterns. However, the company utilizes mechanisms like weather normalization and weather derivative instruments to limit exposure to typical weather variations. In contrast, NextEra Energy (NEE) faces more direct and severe operational risks from weather conditions, such as hurricanes, extreme temperatures, and disruptions to power generation from wind and solar facilities. NEE's Florida-based operations are particularly vulnerable to hurricanes, which can cause power outages, infrastructure damage, and increased costs for service restoration. While NEE also seeks cost recovery through regulatory mechanisms, its exposure to unpredictable weather events poses a more immediate threat to both operations and financial performance compared to Southern Company Gas' structured risk management approach.",
      "llm_answer": "Southern Company’s gas‑distribution earnings can rise or fall with weather‑driven heating‑season demand, but the company limits that exposure through revenue‑normalization mechanisms and weather‑derivative contracts that “limit its exposure to weather changes within typical ranges” (see SO 10‑K p.86, p.200). In contrast, NextEra Energy’s electricity demand is directly tied to weather‑induced load swings, and while the firm relies on hedging, trading and other risk‑management tools to blunt the impact, those tools “may not protect against significant losses” and the company remains substantially exposed to severe‑weather‑driven demand volatility (see NEE 10‑K p.26, p.27).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its representation of both companies' exposure to weather conditions and their risk mitigation strategies, with no incorrect numbers or entities. It correctly identifies Southern Company's use of weather normalization and derivatives to manage typical weather variation, citing appropriate risk mitigation tools. It also accurately characterizes NextEra Energy's exposure to weather-driven demand volatility and notes the limitations of its risk management tools. However, the LLM omits the specific quantitative impact mentioned in the ground truth—Southern Company Gas’s 6.2% net income decrease in 2023 due to weather-related lower gas volumes—making the response less complete in terms of multi-hop synthesis from the original data. While the qualitative reasoning is sound and the comparison between the two companies’ risk profiles is logically presented, the absence of this key statistic reduces completeness. The entities (Southern Company Gas, NextEra Energy), their respective sectors (gas distribution vs. electricity), and risk mechanisms are correctly identified. The answer is contextually relevant and well-supported by cited 10-K pages. Wording differs from the original but maintains semantic equivalence on all points except the missing 2023 performance impact.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 366,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does McDonald's revenue model relying on affiliates compare to General Motors' production strategy for crossovers through nonconsolidated affiliates, particularly in terms of revenue contribution and operational structure?",
      "original_answer": "McDonald's generates revenue from affiliates through royalty payments based on a percentage of sales, along with initial fees, as part of its franchise model. This structure allows McDonald's to maintain a steady income stream tied directly to the performance of affiliate-operated restaurants. In contrast, General Motors produces crossovers through nonconsolidated affiliates involved in development, manufacturing, and marketing, where GM engages in purchasing and selling transactions with these entities. While McDonald's affiliate model centers on brand licensing and royalty income, GM's affiliate relationships focus on vehicle production and distribution. This results in distinct revenue contributions: McDonald's sees recurring revenue from affiliate royalties, whereas GM's revenue from affiliates is transactional and tied to the volume of crossover production and sales.",
      "llm_answer": "McDonald’s earns most of its $25.9 billion 2024 revenue from franchisees and other affiliates – royalties, rent and initial fees from franchised restaurants total $15.7 billion (about 60 % of revenue) and the company also records equity‑in‑earnings of unconsolidated affiliates (‑$157 million in 2024). In contrast, General Motors’ cross‑overs that are built by non‑consolidated joint‑venture affiliates generate only a tiny slice of its automotive sales – automotive sales to affiliates were $90 million in 2024 versus $144 billion total automotive net sales, and the affiliates are accounted for as non‑consolidated VIEs with limited control and exposure. Thus McDonald’s revenue model relies heavily on affiliate‑derived royalties and fees that form a major portion of its top line, whereas GM’s affiliate production of cross‑overs contributes a negligible amount to revenue and is treated as a peripheral, non‑consolidated operation.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness, despite addressing the right conceptual comparison. (1) Quantitative Accuracy: The financial figures cited are not supported by the ground truth and appear fabricated. The ground truth does not provide specific revenue numbers (e.g., $25.9 billion), franchise revenue ($15.7 billion), equity-in-earnings (-$157 million), or GM’s affiliate sales ($90 million vs $144 billion). These precise figures, especially with 2024 data, are absent from the original answer and cannot be verified. The 60% franchise revenue claim is an unsupported calculation. (2) Completeness: The LLM attempts to address both companies’ affiliate models and compares revenue contribution and operational structure, satisfying the multi-part nature of the question. (3) Entity Accuracy: McDonald's and General Motors are correctly identified, as are the concepts of nonconsolidated affiliates and crossovers. However, the use of '2024' data is speculative—the original answer contains no time-specific figures. (4) Reasoning: The LLM correctly identifies that McDonald's relies more significantly on affiliate-related income (royalties, fees) versus GM’s transactional, minor role of affiliates in crossover production. The qualitative distinction between recurring royalty-based revenue and transactional production revenue aligns with the ground truth. (5) Semantic Equivalence: While the core idea—that McDonald's revenue model is heavily dependent on affiliates while GM's is not—is reasonably conveyed, the inclusion of false quantitative data severely compromises factual correctness. The answer overstates precision with made-up numbers, leading to a misleading impression of accuracy. Thus, while contextually relevant and partially sound in logic, the answer fails on factual integrity, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 509,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the voting power dilution protection for Class B Common Stock at CMCSA compare with the automatic conversion provisions for Class B Common Stock at GOOGL, particularly in light of CMCSA's share-for-share conversion restriction and GOOGL's voluntary and transfer-triggered conversion policy?",
      "original_answer": "At CMCSA, the Class B Common Stock has a non-dilutable 33 1/3% aggregate voting power, which cannot be diluted by additional issuances of any other class of common stock, and is convertible share-for-share into Class A Common Stock, subject to certain restrictions. In contrast, at GOOGL, Class B Common Stock is entitled to 10 votes per share and can be voluntarily converted to Class A Common Stock at any time, with automatic conversion upon sale or transfer. This means CMCSA’s Class B shares maintain structural voting protection unaffected by issuance volumes, while GOOGL’s Class B shares lose enhanced voting rights upon transfer, making CMCSA's Class B shares more resilient to voting dilution.",
      "llm_answer": "Comcast’s charter guarantees that the 33 ⅓ % voting power held by its Class B shareholders “is generally non‑dilutable” and that the Class B shares may be converted **share‑for‑share** into Class A stock only under the limited restrictions set out in its certificate of incorporation (i.e., the conversion cannot be used to increase the number of voting shares). Alphabet’s charter, by contrast, allows Class B shares to be **converted at any time at the holder’s option and to convert automatically into Class A shares upon any sale or transfer**, so the high‑vote Class B position can be eliminated whenever the shares change hands. Thus, Comcast’s structure preserves voting‑power protection, whereas Google’s automatic‑and‑voluntary conversion provisions expose its Class B voting power to dilution.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: CMCSA's Class B has non-dilutable 33 1/3% voting power, share-for-share conversion into Class A with restrictions (specifically, not to increase voting shares), and GOOGL's Class B has 10 votes per share (implied by context though not explicitly stated in the LLM answer) with voluntary and transfer-triggered automatic conversion. The absence of the explicit '10 votes per share' detail in the LLM answer is a minor omission but does not undermine the correctness of the comparison. (2) Quantitative accuracy is perfect: the 33 1/3% voting power is correctly cited, and no erroneous numbers are introduced. (3) Multi-hop reasoning is sound—LLM correctly synthesizes structural differences in voting protection and conversion policies between CMCSA and GOOGL, concluding that CMCSA’s structure better preserves voting power. (4) The answer is contextually relevant, directly addressing the comparison of dilution protection and conversion mechanisms. The only reason for not scoring a 10 is the slight omission of GOOGL’s 10-vote-per-share feature, which is present in the ground truth and relevant to understanding the value of maintaining Class B status. However, since the focus of the question is on conversion and dilution dynamics rather than vote magnitude, this does not severely impact correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 394,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does AXP's valuation methodology for Level 3 investment securities expose it to the risks of illiquid market conditions, and how might this impact MS's ability to manage market risk during periods of asset devaluation?",
      "original_answer": "AXP relies on internal credit models and third-party valuations for its Level 3 investment securities, which include debt securities from Community Development Financial Institutions and an embedded derivative in GBT JerseyCo Limited valued using Monte Carlo simulations. These valuation techniques are sensitive to changes in market inputs and assumptions, particularly in illiquid market conditions where observable data is scarce. JPM_10k_2024.pdf confirms that illiquid markets make it extremely difficult to value financial instruments, and valuations may materially change when market conditions shift, leading to potential losses upon disposition. MS_10k_2024.pdf further states that during periods of market volatility and illiquidity, the firm faces challenges in valuing and monetizing financial instruments, which can negatively affect its results of operations and risk management strategies, including hedging inefficiencies and increased counterparty risk.",
      "llm_answer": "American Express treats its Level 3 debt securities – the holdings of Community Development Financial Institution bonds – as fair‑value approximations by using the carrying amount unless its internal credit model flags cash‑flow problems. Because that proxy does not rely on observable market prices, a sudden loss of liquidity can leave the securities markedly mis‑valued and force a material write‑down when market prices re‑emerge. For Morgan Stanley, such devaluations in illiquid markets constrain its ability to unwind or hedge positions, making it harder to offset market‑risk exposures and increasing the likelihood of losses during periods of rapid asset price declines.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies AXP's use of internal credit models for Level 3 securities and links illiquid market conditions to valuation risk, which aligns with the ground truth. It accurately references Community Development Financial Institution (CDFI) bonds as part of AXP's Level 3 holdings and notes the lack of observable market prices, correctly associating this with potential misvaluation during liquidity shocks. However, the LLM omits key elements from the original answer: (1) it does not mention the embedded derivative in GBT JerseyCo Limited valued via Monte Carlo simulations, a critical component of AXP’s Level 3 valuation methodology; (2) it fails to cite third-party valuations as part of AXP’s approach; and (3) it does not reference JPM_10k_2024.pdf or MS_10k_2024.pdf, missing the multi-hop support from these external sources that validate the broader market implications. While the reasoning about MS’s constrained hedging ability and increased risk during volatility is directionally correct and contextually relevant, it lacks the specific grounding in MS’s disclosed challenges (e.g., hedging inefficiencies, counterparty risk) from its own 10-K. There are no numerical inaccuracies (hence full quantitative accuracy), but the qualitative synthesis across entities and documents is incomplete. The answer captures the core risk mechanism but falls short on completeness and multi-source support required for high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 400,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the valuation approach for Chevron's Level 2 derivatives compare to Exxon's use of discounted cash flow models in valuing upstream assets acquired from Pioneer, particularly in terms of observable market inputs and management judgment?",
      "original_answer": "Chevron classifies its derivatives as Level 2 when valued using third-party broker quotes, industry pricing services, and exchanges, relying on observable market data like interest rates and foreign exchange rates, with minimal adjustments. In contrast, Exxon used discounted cash flow models incorporating management judgment and unobservable inputs—such as projected production volumes, commodity prices based on third-party industry experts, and risk-adjusted discount rates—to determine the fair value of upstream assets acquired from Pioneer. While Chevron's Level 2 derivatives rely on largely consistent and observable inputs, Exxon's valuation required significant assumptions about future market conditions and asset performance, reflecting a higher degree of subjectivity and forward-looking judgment.",
      "llm_answer": "Chevron values its Level 2 derivatives using quoted prices from third‑party brokers, industry pricing services and exchanges—observable market data that the company does not materially adjust—so the fair‑value measurement is driven largely by market inputs with little management discretion. In contrast, Exxon’s valuation of the Pioneer upstream assets is based on discounted‑cash‑flow models that require estimates of future production, commodity prices (averaged from third‑party experts), development costs and risk‑adjusted discount rates, and the company notes that these inputs involve considerable management judgment. Thus Chevron’s approach is more market‑observable, while Exxon’s relies heavily on judgment‑driven DCF assumptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Chevron's Level 2 derivatives are valued using observable inputs like third-party broker quotes, pricing services, and exchange data with minimal adjustments—this aligns with Level 2 classification under fair value hierarchy. Exxon's use of discounted cash flow (DCF) models for valuing Pioneer upstream assets involving management judgment on production forecasts, commodity prices (from third-party experts), development costs, and risk-adjusted discount rates is accurately described. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable in a numerical sense—however, the absence of any incorrect numbers or miscalculations supports a perfect score here. (3) The multi-hop reasoning is sound: the model correctly contrasts Chevron’s reliance on observable market inputs (Level 2) with Exxon’s use of unobservable, judgment-heavy DCF assumptions, synthesizing information across two companies and valuation methodologies. (4) The only minor shortcoming is that the LLM does not explicitly mention 'unobservable inputs' or 'subjectivity related to future market conditions' as strongly as the original, but it does convey 'considerable management judgment' and 'judgment-driven DCF assumptions,' which captures the essence. Wording differs slightly but maintains semantic equivalence. Contextual relevance is perfect—the response directly addresses the comparison in terms of observable inputs and management judgment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 445,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How does Duke Energy's negotiation of PPAs for renewable facilities compare with Southern Power's investment in solar facilities in terms of financial structure and tax credit utilization, given the role of PPAs in financing solar assets?",
      "original_answer": "Duke Energy negotiates PPAs as part of its commercial renewables strategy, which significantly influences the economic performance of its renewable energy VIEs, particularly through siting, PPA negotiation, and ongoing operations. These PPAs are also central to Southern Power's financial structure, where they are accounted for as operating leases with terms up to 25 years for solar facilities. Southern Power utilizes federal tax credits (ITCs and PTCs), with $1.2 billion of unutilized credits at the Southern Company level as of December 31, 2021, largely tied to solar and wind investments. This indicates that while both companies rely on PPAs in the development and operation of solar facilities, Southern Power integrates tax equity partnerships and federal incentives more directly into its investment model, affecting cash flows and net income differently than Duke’s VIE and guarantee-based financing.",
      "llm_answer": "Duke Energy treats the PPAs it negotiates for its renewable‑energy VIEs as a core operating‑revenue contract, but the projects are financed through debt guarantees it provides and through separate tax‑equity partnerships that capture the federal investment‑tax credits (the company notes that “tax equity arrangements … are entered into with third‑party investors in order to finance the cost of renewable assets eligible for tax credits”). By contrast, Southern Power’s solar investments are funded largely by tax‑equity partners who take the ITCs (Southern Power “has been utilizing tax‑equity partnerships for wind, solar, and battery … projects, where the tax partner takes significantly all of the respective federal tax benefits”) and the solar output is sold under PPAs that are accounted for as operating leases, providing a lease‑cash‑flow stream that supports the financing of the assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Duke Energy's use of PPAs in conjunction with debt guarantees and tax-equity partnerships for financing renewable VIEs, and notes that tax equity investors capture federal tax credits—consistent with the original answer's emphasis on financing structure and tax credit utilization. (2) There are no explicit numerical values in the LLM answer, but the original answer includes a $1.2 billion figure for unutilized tax credits at Southern Company as of December 31, 2021. The LLM omits this specific number, which is a minor gap, but correctly describes Southern Power’s use of tax-equity partnerships and the transfer of federal tax benefits (ITCs), so quantitative accuracy is not compromised in terms of incorrect numbers—just incompletely detailed. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across Duke Energy and Southern Power, contrasting their financial structures—Duke’s guarantee-based and tax-equity model vs. Southern Power’s lease-based PPA model with tax-equity partners taking the majority of tax benefits. (4) The LLM captures the core distinction: both use PPAs and tax equity, but Southern Power’s model more directly integrates tax equity into project financing with operating lease cash flows, while Duke uses guarantees and separate tax-equity arrangements. The omission of the $1.2B figure and the specific mention of PTCs slightly reduces completeness, but the semantic meaning and comparative analysis remain correct and relevant. Hence, high scores across all dimensions with a 9 on correctness due to minor omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 457,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How does the concentration of voting power in NKE's Class A Common Stock, which elects three-quarters of the Board of Directors, compare with HD's treatment of voting rights for restricted stock awards in terms of governance influence?",
      "original_answer": "NKE's Class A Common Stockholders elect three-quarters of the Board of Directors, consolidating governance control within a single class of shares. In contrast, HD grants voting rights to recipients of restricted stock awards at the grant date, allowing them to vote on matters even before the restrictions lapse. This indicates that HD distributes voting influence more broadly across equity compensation recipients, while NKE centralizes it among Class A shareholders. Neither company allows Class B or C common stockholders to vote on most matters, but HD’s approach introduces earlier voting participation through restricted shares.",
      "llm_answer": "Nike’s dual‑class structure concentrates governance power in the Class A shares – the holders of those shares alone elect three‑quarters of the Board of Directors, giving a single shareholder class dominant control (see NKE page 27). Home Depot, by contrast, grants voting rights on the restricted‑stock awards that it issues to employees, so those shares vote on corporate matters from the grant date even while unvested (see HD page 67). Thus, Nike’s voting power is highly concentrated in one class, whereas Home Depot’s voting rights are more broadly distributed among award‑recipients, providing a more diffuse influence on governance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: NKE's Class A Common Stock elects three-quarters of the Board, and HD grants voting rights on restricted stock awards from the grant date. No numerical inaccuracies or calculation errors are present. (2) The answer correctly identifies both companies (NKE and HD) and the relevant governance mechanisms—dual-class structure at Nike and voting rights for unvested restricted stock at Home Depot. (3) The multi-hop reasoning is sound: it synthesizes governance influence across two different companies and equity structures, correctly contrasting centralized vs. distributed voting power. (4) The LLM omits the minor detail that neither company allows Class B or C shareholders to vote on most matters, which is included in the original answer, but this does not detract significantly from the core comparison. Wording differs slightly (e.g., 'dominant control' vs 'consolidating governance control'), but semantic equivalence is maintained. The inclusion of page references (27 and 67) suggests fidelity to source documents, though not required. Overall, the answer is factually correct, well-reasoned, and contextually appropriate, meriting a high score with only a slight deduction for minor incompleteness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 369,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How does the foreign exchange risk exposure of Netflix's forecasted revenue transactions compare to Disney's VAR model estimates, given both companies' use of financial instruments to hedge against currency fluctuations?",
      "original_answer": "Netflix uses forward contracts to hedge foreign exchange risk on forecasted revenue transactions denominated in non-U.S. dollar currencies, while Disney employs a VAR model that excludes forecasted transactions from its risk estimation. Netflix's foreign currency transactions resulted in a $293 million loss in 2023, indicating volatility in unhedged positions, whereas Disney's VAR estimate for maximum one-day loss decreased to $255 million in 2024 from $284 million in 2023 due to lower interest rate volatility. This suggests that while both companies manage FX risk, Disney's modeled approach excludes certain forecasted exposures that Netflix explicitly hedges.",
      "llm_answer": "Netflix explicitly hedges the foreign‑currency component of its forecast revenue by entering into short‑term forward contracts that are designated as cash‑flow hedges; the resulting gains or losses stay in AOCI until the underlying revenue is recognized, effectively neutralising most of the FX risk on those transactions. In contrast, Disney does not report a comparable hedge for forecasted revenue but instead measures the residual currency risk that remains after its hedging program with a VAR model, which estimates a one‑day potential loss of roughly **$40 million (year‑end 2024) to $45 million (year‑end 2023)** for its currency‑sensitive financial instruments. Thus, Netflix’s forecast‑revenue FX exposure is largely offset by designated hedges, whereas Disney’s remaining exposure is modest and quantified by a $40‑$45 million VAR figure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. It reports Disney's VAR estimate as $40 million in 2024 and $45 million in 2023, which is drastically different from the ground truth values of $255 million in 2024 and $284 million in 2023. This is a major error in magnitude and undermines the core comparison. Additionally, the LLM claims Disney's VAR applies to 'currency-sensitive financial instruments' with a $40–45M range, which contradicts the ground truth stating Disney's VAR decreased to $255M in 2024 from $284M in 2023 due to lower interest rate volatility. (2) The Netflix loss of $293 million in 2023 is not mentioned in the LLM answer, which omits a key data point showing volatility in unhedged positions. Instead, the LLM suggests Netflix 'effectively neutralises most of the FX risk,' which may be directionally correct but contradicts the reported $293M loss, indicating significant residual risk. (3) The multi-hop reasoning is partially sound—correctly identifying Netflix's use of forward contracts for forecasted revenue hedges and Disney's use of VAR—but fails in synthesis by misrepresenting Disney's VAR figures and omitting Netflix's actual loss. The conclusion that Disney's exposure is 'modest' at $40–45M is incorrect given the true scale of $255M. (4) Contextual relevance is fair because the answer addresses hedging strategies and risk measurement for both companies, but the severe quantitative inaccuracies and omission of key facts (Netflix's loss, correct VAR values) result in a low correctness score. The qualitative understanding of hedging mechanisms is present but flawed in application.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 462,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How do the Value at Risk (VAR) calculations for MDLZ and PM differ in terms of the time periods used to estimate expected return distributions under normal market conditions, and what does this imply about their respective risk assessment horizons?",
      "original_answer": "MDLZ uses the prior quarter's interest rate, currency exchange, and commodity price movements to estimate return distributions for VAR calculations at year-end (December 31, 2024 and 2023), and the four prior quarters for average VAR amounts. In contrast, PM primarily uses the preceding quarter for year-end VAR calculations and the four preceding quarters for average, high, and low VAR amounts. This indicates that while both companies rely on recent market data, MDLZ explicitly applies a multi-quarter approach for average VAR, suggesting a slightly more extended risk assessment horizon compared to PM.",
      "llm_answer": "Both Mondelēz International (MDLZ) and Philip Morris International (PM) calculate VAR by looking at market moves in the **most recent quarter** to build the expected‑return distribution for the point‑in‑time (December 31) VAR, and they use **the four most recent quarters** to derive the average/high/low VAR figures for the year. Because each company relies on a one‑quarter “look‑back” for the current‑date estimate and a four‑quarter look‑back for the annual averages, their risk‑assessment horizon is essentially short‑term – a one‑day loss estimate based on very recent market behavior.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that both MDLZ and PM use the most recent quarter for year-end VAR calculations and the four preceding quarters for average VAR figures. This aligns with the ground truth, which states MDLZ uses the prior quarter for year-end VAR and four prior quarters for averages, and PM uses the preceding quarter for year-end and four quarters for average, high, and low VAR. However, the LLM answer misses a key distinction: the ground truth notes that MDLZ 'explicitly applies a multi-quarter approach for average VAR,' implying a slightly longer risk assessment horizon, while the LLM treats both companies as equivalent in this regard. This omission reduces completeness and qualitative accuracy. (2) All time periods (one quarter, four quarters) and their applications (point-in-time vs. average) are correctly stated, with no numerical or temporal inaccuracies—quantitative accuracy is high. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes the look-back periods for both companies but fails to draw the correct comparative implication about risk assessment horizons. The conclusion that 'their risk-assessment horizon is essentially short-term' and 'essentially' the same overlooks the nuanced difference highlighted in the original answer about MDLZ’s more extended approach. (4) Contextual relevance is strong as the answer addresses the core methodology of VAR estimation for both firms. However, the failure to capture the subtle but important distinction in risk horizon implications prevents a higher score. Thus, correctness is 7 due to accurate facts but incomplete comparative insight.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 456,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How does the $0.6 billion goodwill impairment charge recorded by DIS in fiscal 2024 relate to the auditor's evaluation of significant assumptions, and how does this compare to the auditor's approach in testing significant assumptions at NFLX related to content amortization estimates?",
      "original_answer": "The $0.6 billion goodwill impairment charge recorded by DIS in fiscal 2024 was directly tied to the fair value assessment of the entertainment linear networks reporting unit, which relied on significant assumptions such as future revenues, operating margins, terminal growth rates, and discount rates. The auditor, PricewaterhouseCoopers LLP, evaluated the reasonableness of these assumptions by comparing them to historical performance, external market data, and evidence obtained elsewhere in the audit. Similarly, at NFLX, the auditor (also PricewaterhouseCoopers LLP) tested significant assumptions used in content amortization estimates, including forecasted viewing hour consumption and historical viewing patterns, by comparing them to current trends and prior actual results. Both audits involved sensitivity analyses and the use of professionals with specialized skills to assess the impact of changes in these assumptions on financial outcomes.",
      "llm_answer": "The Walt Disney Company’s $0.6 billion goodwill impairment recorded in fiscal 2024 stemmed from management’s quantitative fair‑value test of its linear‑networks and DTC reporting units; the auditor treated this as a critical audit matter and specifically evaluated the reasonableness of the key assumptions in the discounted‑cash‑flow model (future revenues, operating expenses, margins, terminal growth and discount rates) and the controls surrounding the impairment assessment. By contrast, Netflix’s auditor did not focus on a goodwill test but on the content‑amortization model, testing the design and operating effectiveness of controls and the significant assumptions used to develop estimated viewing‑hour patterns, and performing sensitivity analyses to gauge the impact of those assumptions. Both audits required substantive testing of management’s significant estimates, but Disney’s audit centered on fair‑value assumptions for an impairment charge, while Netflix’s audit centered on viewing‑pattern assumptions for content amortization.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: the $0.6 billion goodwill impairment by DIS in fiscal 2024 is accurately stated, and there are no numerical inaccuracies. The format '$0.6 billion' matches the original. (2) The LLM correctly identifies that the auditor (implied to be PricewaterhouseCoopers LLP, though not explicitly named) evaluated significant assumptions in Disney’s goodwill impairment test, including future revenues, margins, terminal growth, and discount rates—consistent with the original. It also correctly contrasts this with NFLX’s audit focus on content amortization assumptions like viewing-hour patterns. (3) The multi-hop reasoning is sound: the answer synthesizes information across two companies (DIS and NFLX), two different financial estimates (goodwill impairment vs. content amortization), and compares auditor approaches—both involving sensitivity analyses and evaluation of management assumptions. (4) The only minor shortcoming is that the LLM does not explicitly name the auditor (PwC) for both companies, which is present in the original answer and adds precision. However, this omission does not undermine the factual correctness or the comparative analysis. The LLM captures the core similarities (substantive testing, sensitivity analysis, use of estimates) and differences in focus (fair value vs. viewing patterns). Wording differs but semantic meaning is equivalent. Thus, the answer is excellent but not perfect—justifying a 9/10 on correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1535,
        "completion_tokens": 451,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How does the cost-sharing structure between Gilead and Merck for long-acting HIV injectable products compare to Gilead's other collaboration agreements, such as the one with Arcellx, in terms of financial commitment and milestone-based payments?",
      "original_answer": "Gilead and Merck share global development and commercialization costs for long-acting HIV injectable products at 60% and 40%, respectively, with no material expenses recognized under the agreement through 2024. This contrasts with Gilead's collaboration with Arcellx, where Gilead made a $313 million upfront payment and a $299 million equity investment in 2023, and paid $68 million in development milestones in 2024. Unlike the Merck agreement, which involves shared costs and revenue splits upon approval, the Arcellx collaboration includes significant upfront and milestone-based payments, profit sharing in the U.S., and royalties outside the U.S., indicating a more financially committed and risk-shared structure with Arcellx compared to the cost-sharing model with Merck.",
      "llm_answer": "The Merck‑Gilead HIV‑injectable collaboration is structured mainly as a cost‑share: Gilead funds about 60 % of global development and commercialization costs (Merck 40 %) and the parties split product revenue 50/50 until a $3.5 billion sales threshold is reached, after which Gilead’s share rises to 65 %; the agreement does not disclose any material upfront cash or milestone payments. By contrast, the Arcellx collaboration required a $313 million upfront payment (recorded as an acquired‑in‑process R&D charge) plus a $299 million equity investment, and it provides for up to $1.5 billion in performance‑based development and regulatory milestones (with additional commercial milestones and royalties), indicating a far larger financial commitment and milestone‑based payout structure than the Merck deal.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core contrast between the Merck and Arcellx collaborations in terms of financial structure and milestone payments, showing good contextual understanding and relevance. However, there are significant quantitative inaccuracies that reduce correctness. First, the LLM incorrectly states a 50/50 revenue split with a $3.5 billion threshold increasing Gilead's share to 65%—this detail is not present in the ground truth and appears fabricated. The original answer states only that costs are shared 60/40 (Gilead/Merck) with no material expenses recognized through 2024, and that revenue splits exist upon approval, but does not specify thresholds or percentages. This is a major factual error. Second, while the $313 million upfront and $299 million equity investment in Arcellx are correctly reported, the LLM adds 'up to $1.5 billion in performance-based milestones'—a figure not present in the ground truth. The original answer only confirms a $68 million milestone payment in 2024, with no total cap disclosed. This overstates the financial commitment. The qualitative reasoning is sound in comparing a cost-sharing model (Merck) versus an upfront/milestone-heavy deal (Arcellx), and entities (Gilead, Merck, Arcellx) and years (2023, 2024) are accurate. The answer addresses both parts of the question—financial commitment and milestone structure—though with inflated numbers. Thus, while the direction of the comparison is correct, the inclusion of unverified financial terms and thresholds reduces quantitative accuracy significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 427,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How do Tesla's multi-year pricing agreements with Panasonic for Gigafactory 2170 and Japan-sourced battery cells compare to GM's battery procurement cost exposure in terms of contractual stability and long-term cost predictability?",
      "original_answer": "Tesla has structured long-term pricing agreements with Panasonic Corporation for both Gigafactory 2170 cells (executed June 9, 2020) and Japan-sourced cells (executed December 29, 2020), providing multi-year cost predictability. In contrast, GM's 2023 10-K filing on page 78 indicates a dependency on battery procurement costs without equivalent visibility into long-term pricing agreements, suggesting greater exposure to market volatility. This creates a differentiated risk profile where Tesla has locked in pricing through 2020+ agreements while GM's battery cost structure appears more variable.",
      "llm_answer": "Tesla’s filings list a series of multi‑year pricing agreements with Panasonic – a 2020 “Pricing Agreement (Gigafactory 2170 Cells)” and 2019/2021 “Pricing Agreements (Japan‑sourced cells)” that lock in cell prices for several years (see Exhibit 10.36‑10.38 on pages 106‑107). These contracts give Tesla a stable, pre‑negotiated cost base for its battery supply and therefore a high degree of long‑term cost predictability. In contrast, GM’s 2023 Form 10‑K does not disclose comparable long‑term battery‑supply contracts; its battery‑procurement costs are presented only as part of general automotive purchases and are therefore exposed to market price swings, providing far less contractual stability and predictability.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies Tesla's multi-year pricing agreements with Panasonic for both Gigafactory 2170 and Japan-sourced cells, citing the relevant 2020 agreements. The mention of '2019/2021' agreements slightly deviates from the ground truth's specific December 29, 2020 execution date for Japan-sourced cells, but the overall time frame is reasonable and does not materially misrepresent the facts. (2) Quantitatively, no explicit numbers (e.g., dollar amounts) are involved, but the dates are mostly correct—only a minor imprecision in the Japan-sourced agreement timing. The reference to Exhibit 10.36–10.38 and page numbers adds detail not in the ground truth but does not contradict it. (3) The reasoning is sound: it correctly contrasts Tesla’s disclosed long-term contracts with GM’s lack of equivalent disclosures in its 2023 10-K (page 78 in ground truth, not cited in LLM but conceptually accurate), concluding that GM has less cost predictability. (4) The answer fully addresses the question’s focus on contractual stability and long-term cost predictability, synthesizing across Tesla and GM filings appropriately. The only minor shortcoming is the slightly less precise dating for the Japan-sourced agreement, which prevents a perfect 10. Overall, the answer is factually correct, well-reasoned, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 394,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How does Coca-Cola's use of non-derivative instruments to hedge foreign exchange risk compare to Procter & Gamble's exposure to foreign exchange fluctuations, given that both operate in similar international markets such as the United Kingdom and Germany?",
      "original_answer": "Coca-Cola actively uses non-derivative instruments, such as foreign currency-denominated third-party debt, to hedge foreign exchange risk related to its net investments in foreign subsidiaries, with these instruments designated in hedging relationships to offset currency exposure. In contrast, Procter & Gamble discloses that it is significantly exposed to foreign exchange fluctuations due to its international operations — particularly in the United Kingdom and Germany, which are among its largest markets — and while it employs strategies to manage these risks, it explicitly acknowledges that exchange rate movements have historically negatively impacted its net sales, earnings, and cash flows. Therefore, while Coca-Cola appears to have a more structured hedging approach, Procter & Gamble reports a more direct and material financial sensitivity to FX volatility.",
      "llm_answer": "Coca‑Cola explicitly states that it designates certain non‑derivative instruments – such as foreign‑currency‑denominated senior notes – as hedges of its net foreign‑currency investments, using those instruments to offset the effect of exchange‑rate movements on its balance‑sheet and earnings【page_81】. In contrast, Procter & Gamble notes that it has “significant exposure to exchange‑rate fluctuations” from both translation and transaction sources in its major overseas markets (including the United Kingdom and Germany) and relies on a combination of non‑derivative and derivative contracts to mitigate, but does not eliminate, those foreign‑exchange impacts【page_21】. Thus, Coca‑Cola’s strategy centers on non‑derivative hedges, whereas P&G’s exposure is broader and managed through a mix of hedging tools, leaving it more vulnerable to FX swings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Coca-Cola uses non-derivative instruments, specifically foreign-currency-denominated senior notes, to hedge foreign exchange risk, which matches the original answer's reference to third-party debt. (2) It accurately states that Procter & Gamble has significant exposure to exchange-rate fluctuations in key markets like the UK and Germany and employs a mix of derivative and non-derivative instruments to manage—but not eliminate—FX risk. (3) The reasoning correctly contrasts Coca-Cola’s focused use of non-derivative hedges with P&G’s broader exposure and mixed hedging approach, concluding that P&G remains more vulnerable, which is semantically equivalent to the original answer’s conclusion about P&G’s material sensitivity. (4) No numerical data (e.g., dollar amounts, percentages) are present in either answer, so quantitative accuracy is not compromised. (5) The multi-hop synthesis across two companies, their hedging strategies, and exposure in shared international markets is sound and well-articulated. The only minor limitation is that the LLM answer does not explicitly mention P&G’s historical negative impacts on net sales, earnings, and cash flows, which slightly reduces completeness but does not affect the core factual accuracy. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 403,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How does Amgen's exposure to state-level drug affordability regulations in Maryland, through PDAB laws, compare to Gilead's operational risks in the same state, particularly in relation to their respective biopharma manufacturing and pricing strategies?",
      "original_answer": "Amgen is subject to Maryland’s PDAB laws that grant authority to set upper payment limits on certain drugs for in-state patients, payers, and providers, which affects its pricing strategy and rebate obligations under Medicaid and the 340B Drug Pricing Program. These laws are part of a broader regulatory framework that includes the Inflation Reduction Act’s Medicare price-setting provisions, which began with ENBREL being selected among the first ten drugs for Medicare price negotiation. Meanwhile, Gilead operates a CAR T-cell therapy manufacturing facility in Maryland, exposing it to operational risks such as quality control, production delays, and regulatory compliance. Unlike Amgen, whose primary risk in Maryland is regulatory and pricing-related, Gilead faces logistical and manufacturing risks tied to the complexity of cell therapy production and delivery. Both companies are impacted by Maryland’s healthcare ecosystem, but through different risk vectors—Amgen through pricing regulation and Gilead through manufacturing execution.",
      "llm_answer": "Amgen’s 2023 filing notes that Maryland is one of the seven states that have enacted Prescription‑Drug‑Affordability Boards (PDABs) and that, in four of those states—including Maryland—the PDAB can actually set upper‑payment limits on drugs (page 18). Because Amgen also operates a CAR‑T manufacturing site in Maryland (page 19), the company is exposed to both the pricing caps that a Maryland PDAB could impose and to any operational disruption at that facility.  \n\nGilead’s 2023 filing does not identify any Maryland‑based manufacturing or supply‑chain assets, and its discussion of state‑level affordability rules is limited to general pricing‑pressure concerns (no Maryland‑specific manufacturing risk is disclosed). Thus, Gilead’s risk in Maryland is principally regulatory‑pricing ‑‑‑the possibility of state‑mandated price limits or rebates – whereas Amgen faces a combined pricing‑and‑manufacturing exposure in the same state.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a critical factual error that undermines its correctness: it incorrectly states that Amgen operates a CAR-T manufacturing site in Maryland. According to the ground truth, it is Gilead—not Amgen—that operates a CAR T-cell therapy manufacturing facility in Maryland. This misattribution leads to a fundamental reversal of the risk profiles between the two companies. The LLM claims Amgen faces both pricing and manufacturing exposure in Maryland, while asserting Gilead only faces regulatory-pricing risk. In reality, the ground truth states that Gilead faces manufacturing/operational risks due to its Maryland facility, while Amgen’s exposure is primarily regulatory and pricing-related. This inversion of the core multi-hop comparison severely compromises the qualitative accuracy. Quantitatively, the LLM correctly identifies Maryland as having a PDAB with authority to set upper payment limits, and correctly situates this within broader state-level affordability efforts—these details align with the original answer and reflect accurate interpretation of Amgen’s 2023 filing. Contextually, the response addresses the question’s focus on comparing exposure in Maryland and attempts to differentiate risk vectors, so relevance is high. However, due to the incorrect assignment of manufacturing operations, the reasoning and final conclusion are flawed, resulting in a low correctness score despite some accurate contextual and quantitative elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1521,
        "completion_tokens": 404,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How does AIG's use of separate accounts for policyholder-directed investments compare to MET's utilization of investment management firms in managing ERISA plan assets, particularly in terms of asset diversification strategies and risk mitigation through sub-advisory discretion?",
      "original_answer": "AIG discloses that its separate accounts are legally segregated funds where investment gains and losses accrue directly to policyholders who bear the investment risk, with assets primarily including fixed maturity securities, equity securities, and derivatives. MET utilizes separate accounts backed by similar asset classes (cash, fixed maturities, equities, derivatives, real estate, and private equity) for its ERISA pension and postretirement plans, engaging investment management firms with discretionary authority to manage these assets. Both companies emphasize diversification across asset categories and multiple managers to minimize risk concentration, with MET explicitly stating that its investment policies aim to maximize funded status and minimize volatility, aligning with the long-term nature of benefit obligations. The use of derivatives is restricted to risk mitigation and duration management in both contexts.",
      "llm_answer": "AIG’s variable‑annuity and universal‑life products are funded through **policy‑holder‑directed separate accounts** that are legally segregated from the insurer’s other assets; each account is run to meet a specific investment objective and the policyholder bears the investment risk, with diversification achieved mainly by the account’s own asset‑allocation guidelines and fair‑value accounting rather than by external sub‑advisors.  \n\nMetLife’s ERISA‑qualified pension and post‑retirement plans also use **insurance separate accounts**, but the assets are **managed by outside investment‑management firms (“Managers”) that have discretionary authority over security selection**.  MetLife explicitly diversifies plan assets across many asset classes and across multiple managers to limit concentration risk, using that sub‑advisory discretion as a key risk‑mitigation tool.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: AIG's separate accounts are properly described as legally segregated, policyholder-directed, and bearing investment risk by policyholders, with diversification managed through internal asset allocation rather than external sub-advisors. MET’s use of external investment management firms with discretionary authority for ERISA plan assets is accurately portrayed. (2) There are no numeric values in the question or answers requiring verification, so quantitative accuracy is not compromised—no figures were misstated. (3) The multi-hop reasoning is sound: the model correctly contrasts AIG’s policyholder-directed, internally diversified separate accounts with MET’s externally managed, manager-diversified ERISA separate accounts, capturing the distinction in risk mitigation via sub-advisory discretion. (4) The LLM omits minor details present in the original answer—such as the specific mention of derivatives being restricted to risk mitigation and duration management in both cases, and MET’s explicit goal of maximizing funded status and minimizing volatility—but these omissions do not undermine the core accuracy. The key concepts of asset diversification, risk mitigation, legal segregation, and use of external managers are all correctly conveyed. Wording differs but semantic equivalence is maintained. Thus, a high score of 9 is justified, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 418,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How might the structural differences in voting rights between NKE's Class B Common Stock, which grants no voting rights except on certain defined matters, and HD's restricted stock awards, which grant voting rights from the grant date, impact investor influence on corporate governance decisions such as board composition or takeover defenses?",
      "original_answer": "NKE's Class B Common Stockholders have limited voting rights, only participating on certain defined matters such as exiting the core payments business or major corporate transactions, and do not influence the election of the Board of Directors, which is controlled by Class A Common Stockholders. In contrast, HD's restricted stock recipients are granted voting rights immediately upon grant, allowing them to influence governance matters throughout the vesting period. This structural difference means that NKE's Class B investors have significantly less influence over corporate governance, including board composition and takeover defenses, compared to HD shareholders who hold restricted stock and can exercise voting rights from the outset.",
      "llm_answer": "Nike’s Class B common stock “grants no voting rights except on certain defined matters” and, even when it can vote, those votes are limited to a narrow set of actions such as merger approvals (see NKE 10‑K p.27). Because the board is elected primarily by Class A shareholders (who elect three‑quarters of the directors), Class B holders have little ability to shape board composition or to mount or block a takeover (NKE 10‑K p.27‑28).  \n\nIn contrast, Home Depot’s restricted‑stock awards give recipients voting rights “at the grant date” and even allow them to receive dividends on unvested shares (HD 10‑K p.67). Those award holders can vote on all ordinary shareholder matters, including director elections and merger votes, giving them a much stronger voice in corporate‑governance decisions and in any anti‑takeover defenses.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies that NKE's Class B Common Stock has no voting rights except on certain defined matters (e.g., mergers), and explicitly notes that board election is controlled by Class A shareholders, aligning with the original answer. It accurately contrasts this with HD's restricted stock awards, which grant immediate voting rights upon grant date. (2) There are no numeric values requiring verification (e.g., percentages, dollar amounts, dates), so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance implications across two companies (NKE and HD), linking stock structure to investor influence on board composition and takeover defenses. It references specific pages from the 10-Ks (p.27–28 for NKE, p.67 for HD), indicating proper grounding. (4) The answer is contextually relevant, directly addressing how structural differences in voting rights impact corporate governance. Wording differs slightly but meaning is preserved: 'little ability to shape board composition' = 'significantly less influence'; 'can vote on all ordinary shareholder matters' = 'exercise voting rights from the outset'. No omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 365,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the voting structure for Class B common stock at META compare to NFLX's general voting rights framework, considering the specific limitations outlined in the voting rights policies of both companies?",
      "original_answer": "NFLX provides one vote per share to all common stockholders on all matters, while META restricts voting rights for Class B common stockholders to specific defined matters such as amendments to the certificate of incorporation affecting Class B or C stock, decisions to exit the core payments business, or certain consolidation or merger transactions. In these limited cases, Class B stockholders vote together either as a single class or alongside Class A stockholders, but they do not have voting rights on all matters like NFLX's common stockholders.",
      "llm_answer": "Meta Platforms gives each Class B share ten votes – ten times the voting power of a Class A share – and those votes are exercised like any other share (the only limitation noted is that Class B shares are not listed on a public market). Netflix, by contrast, has a single‑class common stock in which every share carries one vote on all shareholder matters, with no special voting‑power provisions or additional restrictions.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitatively, the claim that Meta Class B shares have 'ten votes' is incorrect according to the ground truth, which does not specify vote magnitude but instead emphasizes restricted voting *scope*—i.e., Class B shares only vote on specific matters like amendments affecting their rights or core business exits. The ground truth does not state a 10:1 voting ratio, so this number is unsupported. (2) The answer fails on completeness and qualitative accuracy: it misrepresents the nature of Meta's voting structure by focusing on vote *weight* rather than the critical *limitation in voting scope*—the core differentiator from Netflix. The ground truth states Meta Class B shares do not vote on all matters, unlike NFLX, where all common stock has one vote per share on all matters. The LLM incorrectly implies Meta Class B shares have broad voting rights with higher weight, when in fact their voting rights are narrowly circumscribed. (3) Multi-hop reasoning is flawed: the comparison hinges on a false equivalence—vote count vs. vote eligibility. The LLM conflates voting power per share with the range of issues subject to voting, missing the key distinction that Meta Class B shares are excluded from voting on most corporate matters altogether. (4) Contextual relevance is moderate because the answer addresses both companies and the topic of voting rights, but the substance is misleading. While Netflix's one-vote-per-share description is accurate, the Meta characterization is fundamentally wrong, leading to an incorrect comparison. Thus, despite some relevant framing, the answer fails to convey the actual structural difference outlined in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 477,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the use of the parametric delta-gamma approximation technique under normal market conditions by PM compare to MDLZ's application of the same method in their VAR model for estimating potential one-day losses in pre-tax earnings?",
      "original_answer": "PM uses the parametric delta-gamma approximation technique under normal market conditions to estimate the risk of underlying positions in its portfolio, observing interest rate and forward currency rate movements primarily over the preceding quarter for determining value at risk (VAR) at year-end. Similarly, MDLZ applies the same technique to estimate the expected return distribution in interest rates, currencies, and commodity prices for calculating VAR, also observing movements over the prior quarter for year-end calculations. Both companies estimate potential one-day losses using a 95% confidence interval and a one-day holding period, with MDLZ specifically reporting the estimated potential one-day loss in pre-tax earnings from currency and commodity instruments as part of its VAR computation.",
      "llm_answer": "Both companies state that their VAR calculations are performed under normal market conditions, using a 95 % confidence interval and a one‑day holding period, and that they rely on a **parametric delta‑gamma approximation** to model the relationships among interest‑rate, currency and (for MDLZ) commodity movements. Philip Morris (PM) applies the technique to estimate the fair‑value VaR of its interest‑rate and foreign‑currency positions (e.g., $297 million and $77 million impacts at year‑end), whereas Mondelēz International (MDLZ) uses the same method to translate those risk exposures into an estimated **pre‑tax earnings loss** (e.g., $14 million from foreign‑currency and $21 million from commodity instruments) in addition to the fair‑value impacts.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that both PM and MDLZ use the parametric delta-gamma approximation under normal market conditions, with a 95% confidence interval and one-day holding period for VAR estimation. It accurately notes that PM focuses on fair-value VaR for interest-rate and foreign-currency positions, while MDLZ extends the method to estimate pre-tax earnings losses from currency and commodity instruments. However, the specific dollar amounts mentioned ($297M, $77M for PM; $14M, $21M for MDLZ) are not present in the original answer (ground truth), which does not include any numerical impacts. These figures may be factually accurate but are extraneous and not supported by the provided ground truth, introducing unverified quantitative claims. (2) Since the ground truth contains no dollar amounts, the inclusion of specific numbers reduces quantitative accuracy despite plausible formatting. The core metrics (95%, one-day, delta-gamma, prior quarter observation) are correct, but the unsupported figures undermine precision. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both firms use the same technique, observe the prior quarter, and apply it to similar risk factors, while distinguishing PM’s focus on fair value versus MDLZ’s emphasis on pre-tax earnings impact. This reflects proper cross-company comparison. (4) Contextual relevance is perfect—the answer directly addresses the comparison asked in the question. Qualitative accuracy is high due to correct entity identification and logical synthesis, but quantitative accuracy is reduced due to unsupported numeric values not present in the ground truth. Hence, correctness is partially impacted, warranting a 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 473,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the application of the 2.5% Capital Conservation Buffer for Bank of America under the Advanced Approach compare with American Express's reliance on the Stress Capital Buffer under the Standardized Approach for meeting Basel III regulatory requirements?",
      "original_answer": "Bank of America applies a 2.5% Capital Conservation Buffer under the Advanced Approach as part of its CET1 capital regulatory minimum to meet Basel III requirements, while American Express uses the Stress Capital Buffer under the Standardized Approach, which is also a component of its Basel III compliance framework. The two institutions thus rely on different buffer mechanisms depending on their regulatory frameworks, with BAC using the Capital Conservation Buffer and AXP referencing the Stress Capital Buffer as part of their respective capital adequacy strategies.",
      "llm_answer": "Bank of America meets the Basel III capital‑adequacy rule by adding a **2.5 % capital‑conservation buffer** that is built into its Advanced‑Approach calculations (the buffer is listed under “Capital conservation buffer 2.5 %” for the Advanced approach in its 10‑K)【page_134】.  \n\nAmerican Express, by contrast, satisfies the same Basel III minimums by relying on a **stress‑capital buffer** of **2.5 %** (3.4 % in 2022) that is applied under the Standardized‑Approach framework – the stress buffer is the component used in its CET1 regulatory minimum instead of the capital‑conservation buffer【page_146】.  \n\nThus, both firms use a 2.5 % buffer, but Bank of America’s is a capital‑conservation buffer under the Advanced Approach, while American Express’s is a stress‑capital buffer under the Standardized Approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Bank of America applies a 2.5% Capital Conservation Buffer under the Advanced Approach and that American Express uses a Stress Capital Buffer under the Standardized Approach, which aligns with the ground truth. The key factual elements—buffer types, percentages, regulatory approaches, and institutions—are all accurate. (2) Quantitatively, the 2.5% buffer for both institutions is correct; the additional note that American Express’s buffer was 3.4% in 2022 is extra contextual detail not contradicted by the ground truth and likely derived from the cited 10-K page, thus enhancing accuracy without introducing error. No calculations are required, and all numbers match or appropriately supplement the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two different companies, regulatory approaches (Advanced vs. Standardized), and buffer mechanisms to draw a valid comparison. It distinguishes the structural difference in how each firm meets Basel III requirements despite both using a 2.5% buffer. (4) The only minor shortcoming is that the LLM answer emphasizes the numerical equivalence of the 2.5% buffers more than the conceptual distinction in buffer types and frameworks, which is the core point in the original answer. However, it still clearly differentiates the two mechanisms. Thus, the answer is semantically equivalent and highly accurate, warranting a 9/10 on correctness and qualitative accuracy, with full marks for quantitative and contextual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 434,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does LMT's use of a discounted cash flow approach in valuing certain fixed income investments compare with HON's application of the same methodology in testing goodwill and intangible asset impairments, particularly in terms of the significance and sensitivity of the discount rate assumptions used?",
      "original_answer": "LMT applies the discounted cash flow approach to value certain Level 3 fixed income investments, where significant inputs include projected annuity payments and the discount rate applied to those payments. This valuation method introduces sensitivity due to the reliance on unobservable inputs. Similarly, HON uses a discounted cash flow approach to estimate the fair value of goodwill and indefinite-lived intangible assets during impairment testing, incorporating strategic and annual operating plans with terminal value assumptions. HON also acknowledges the sensitivity of these valuations to changes in assumptions, particularly the discount rate, and performs sensitivity analyses to address uncertainty. Both companies rely on the discounted cash flow method with key assumptions around discount rates, making the valuation outcomes at both firms sensitive to changes in these inputs, though applied in different asset contexts—fixed income investments at LMT and intangible assets at HON.",
      "llm_answer": "Lockheed Martin (LMT) values Level‑3 fixed‑income securities with a discounted‑cash‑flow model, where the projected cash‑flows and the discount rate applied to them are identified as “significant inputs” to the valuation. Honeywell (HON) also uses a discounted‑cash‑flow model to estimate the fair value of goodwill and indefinite‑life intangibles, but it explicitly states that changes to the discount‑rate (and other) assumptions could materially affect the results and that it performs sensitivity analyses on those key inputs. Thus, while both companies rely on the discount rate as a crucial driver, HON places greater emphasis on testing the sensitivity of that rate, whereas LMT simply notes its importance without describing a formal sensitivity analysis.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that LMT uses a discounted cash flow (DCF) approach for valuing Level 3 fixed income investments, with significant inputs including projected cash flows and the discount rate. It also accurately states that HON uses DCF for goodwill and indefinite-lived intangible asset impairment testing, relying on strategic plans and terminal value assumptions. The answer correctly highlights that both companies treat the discount rate as a key assumption, making their valuations sensitive to changes in this input. The key distinction noted—that HON performs sensitivity analyses while LMT does not explicitly describe such analyses—is supported by the original answer, which states HON 'performs sensitivity analyses to address uncertainty' while LMT only 'acknowledges sensitivity' without detailing formal tests. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (LMT, HON, goodwill, fixed income, Level 3, discount rate) are correctly identified and contextualized. The reasoning is sound and synthesizes information across both companies appropriately. The only minor limitation is that the LLM slightly underemphasizes that both firms acknowledge sensitivity to discount rates, though it correctly notes HON goes further with formal testing. This nuance is present but could be more balanced. Overall, the answer is semantically equivalent to the ground truth with high completeness and precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 420,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA influence the potential impact of share repurchases on voting control, given Alphabet's dual-class share structure where Class B shares convert to Class A with voting dilution?",
      "original_answer": "At CMCSA, holders of Class B common stock maintain a non-dilutable 33 1/3% of the voting power, with each Class B share entitled to 15 votes, whereas voting rights for Class A shares fluctuate based on the number of shares outstanding. This contrasts with Alphabet (GOOGL), where Class B shares convert to Class A shares with a 10:1 voting dilution, and repurchases of Class A and Class C shares totaled $62.0 billion in 2024. Since CMCSA’s Class B shares are convertible share-for-share into Class A stock, but retain a fixed voting percentage, repurchases of Class A shares could increase the relative voting power of Class B holders, unlike Alphabet’s structure where repurchases of Class A and C shares do not create a similar fixed voting skew due to the dilutive conversion mechanism.",
      "llm_answer": "Comcast’s capital structure gives the nine‑million‑share Class B block a fixed one‑third of all voting power (33 ⅓ % of the total votes) that cannot be diluted by issuing additional Class A or Class C shares, and each Class B share may be converted into a single Class A share (which carries only one vote) 【page_91】. Because the company’s share‑repurchase program targets only Class A and Class C shares 【page_82】, every share that is bought back and retired reduces the pool of one‑vote shares, so the immutable 33 ⅓ % voting stake held by Class B shareholders represents a larger share of the remaining votes – effectively increasing the influence of the Class B holders.\n\nAlphabet’s dual‑class system also gives its Class B shares super‑voting rights, but a Class B share can be converted into a Class A share; the conversion spreads the ten‑vote share into the much larger pool of one‑vote Class A shares, thereby diluting the voting power of the remaining Class B shares 【GOOGL 10‑K, p.62‑66】. Consequently, while Comcast’s buy‑backs concentrate voting power in the unchanged Class B block, Alphabet’s structure means that any conversion of Class B to Class A reduces the voting weight of the remaining Class B shares, so share repurchases of Class A have the opposite effect on voting control.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: CMCSA Class B shares hold a fixed 33 1/3% voting power with 15 votes per share (though the LLM simplifies this to 'one-third' without specifying the 15-vote detail, which is a minor omission), and they are convertible share-for-share into Class A. The answer correctly notes that repurchases of Class A and C shares increase the relative voting power of Class B holders due to the fixed voting block. For Alphabet, it accurately describes the 10:1 voting dilution upon conversion of Class B to Class A and correctly contrasts the effect of repurchases. (2) Quantitatively, all percentages (33 1/3%) and structural mechanics are correct. The $62.0 billion repurchase amount in 2024 from the original answer is not mentioned in the LLM response, which is a minor gap in completeness, but no incorrect numbers are presented. (3) The multi-hop reasoning is sound: the model correctly synthesizes how share repurchases affect voting control differently in CMCSA vs Alphabet due to their distinct dual-class structures. It captures the core contrast: fixed voting block concentration at CMCSA vs dilutive conversion at Alphabet. (4) The answer is contextually relevant and directly addresses the question’s focus on voting power dynamics under repurchase programs. The only minor shortcomings are the omission of the 15-vote weight for CMCSA Class B shares and the lack of mention of Alphabet’s $62.0 billion repurchase figure, but these do not undermine the overall correctness. Hence, a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1549,
        "completion_tokens": 462,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does TGT's beverage sales mix compare to PEP's beverage revenue contribution in the APAC region, given both companies' exposure to this market?",
      "original_answer": "TGT includes beverages as part of its grocery segment, which is a key category within its retail operations. PEP, on the other hand, reports that beverages contribute 23% of its revenue in the APAC region. Additionally, PEP's APAC segment generated $10 million in reported revenue for 2024. This indicates that while both companies operate in the beverages category in APAC, PEP provides a specific quantification of its beverage exposure in the region, whereas TGT does not break down beverage sales separately from its broader grocery offering.",
      "llm_answer": "Target’s 2024 filing shows that food‑and‑beverage sales were $23.8 billion of total net sales of $106.6 billion – roughly **22 % of its overall revenue** comes from the beverage category.  \n\nPepsiCo’s 2024 segment breakdown indicates that **beverages represent 23 % of net revenue in the APAC region** (with the remaining 77 % coming from convenient foods).  \n\nThus, Target’s beverage mix (≈22 % of total sales) is only slightly lower than PepsiCo’s beverage contribution in APAC (23 %), indicating a comparable level of exposure to beverage demand in that market.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that TGT does not break down beverage sales separately from its broader grocery segment, yet the LLM claims Target's beverage sales are $23.8 billion (22% of $106.6 billion), which is fabricated and not supported by the original answer or any cited data. This number appears to be invented or misattributed. Additionally, while PEP’s beverage contribution of 23% in APAC is correctly stated, the LLM omits the critical context that PEP’s APAC revenue was only $10 million in 2024—making the comparison with Target’s global beverage mix misleading and contextually invalid. (2) Quantitative accuracy fails because the $23.8B beverage figure for Target has no basis in the provided truth; no such breakdown exists. The 22% beverage mix is therefore incorrect. PEP’s 23% and APAC revenue of $10M are accurate, but the LLM does not reference the latter. (3) Multi-hop reasoning is flawed: the model incorrectly equates Target’s implied global beverage mix (which isn’t reported) with PEP’s regional beverage revenue contribution, despite different geographies (global vs. APAC only) and reporting granularity (aggregated grocery vs. itemized segment data). The conclusion of 'comparable exposure' is unjustified due to mismatched scopes and unsupported data. (4) Scores reflect major factual errors in numbers and synthesis, though the mention of PEP’s 23% is accurate and the attempt to compare exposure shows relevance, hence moderate contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 426,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How might the Medicare price negotiation under the IRA, which will apply to Otezla starting in 2027, impact Amgen's $5.2 billion intangible asset valuation for Otezla, considering that Bristol-Myers Squibb (BMY) also markets Otezla under a licensing agreement?",
      "original_answer": "The Medicare price negotiation under the IRA, which will apply to Otezla starting January 1, 2027, introduces regulatory and financial risk that could impair Amgen's $5.2 billion intangible asset valuation for Otezla. Since BMY also markets Otezla under a licensing agreement, the negotiated price could affect overall revenue from the drug, further influencing Amgen's ability to recover the carrying value of the asset. Amgen has explicitly stated that future changes in estimates related to IRA price negotiations could unfavorably impact the intangible asset's recoverability.",
      "llm_answer": "Amgen’s 10‑K notes that the developed‑product‑technology rights for Otezla are recorded at a $5.2 billion carrying amount and that “future changes to the Company’s estimates of the impact of the price negotiations under the IRA… could unfavorably impact the Company’s ability to recover the carrying value of the related intangible asset” (Amgen 2024 10‑K, p. 137).  Because Otezla was placed on CMS’s Medicare‑price‑setting list for 2027 (Amgen 10‑K, p. 36) and is also sold by Bristol‑Myers Squibb under a licensing agreement (BMS 10‑K, p. 140 notes Otezla is a trademark of Amgen), any mandatory price reductions or rebate obligations imposed by the IRA will lower the drug’s revenue and royalty streams for both partners.  That reduction in expected cash flows raises the risk that Amgen will have to impair part of the $5.2 billion intangible asset valuation.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: Amgen's $5.2 billion intangible asset valuation for Otezla, the 2027 effective date of Medicare price negotiation under the IRA, and BMY's role via a licensing agreement are all accurately represented. (2) Quantitative elements—specifically the $5.2 billion carrying amount and the 2027 start date—are correctly cited, with no calculation errors. Format variations (e.g., $5.2 billion vs. $5.2B) are acceptable and do not affect accuracy. (3) The multi-hop reasoning is sound: the answer correctly synthesizes information from Amgen’s and BMS’s 10-K filings to explain how IRA-imposed price reductions could reduce revenue and royalty streams, thereby threatening the recoverability of Amgen’s intangible asset. It references specific pages in the 10-Ks (e.g., Amgen 2024 10-K p. 137 and 36, BMS 10-K p. 140), demonstrating proper cross-document synthesis. (4) The reasoning mirrors the original answer’s logic: regulatory risk from IRA price negotiation may lead to impairment due to reduced expected cash flows, especially given BMY’s co-marketing role. The LLM adds contextual precision (e.g., mentioning CMS’s price-setting list and royalty streams) that enhances clarity without deviating from the truth. All scoring categories warrant full marks.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 382,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does AMD's production of FPGAs for hyperscale data centers compare to Altera's FPGA offerings, given Intel's strategic decision to operate Altera as a standalone business?",
      "original_answer": "Altera, now operated as a standalone business by Intel, offers programmable semiconductors primarily FPGAs, targeting embedded, communications, and cloud and enterprise markets. Intel is pursuing monetization opportunities with Altera, including a potential IPO. Meanwhile, AMD produces FPGAs and Adaptive SOCs that are directly incorporated into servers and data center appliances used by hyperscale customers, including for AI workloads such as generative AI models. This positions both companies in competitive yet distinct roles within the FPGA market, with AMD directly serving hyperscale data centers and Intel seeking to unlock value through Altera's standalone structure.",
      "llm_answer": "AMD’s 2024 filing shows that its FPGA and Adaptive‑SoC families (Versal, Kria, etc.) are sold to hyperscale cloud operators as part of the data‑center product mix that also includes CPUs, GPUs, DPUs and other accelerators. By contrast, Intel’s Altera business – which it has now placed in a “stand‑alone” operating unit – supplies programmable‑semiconductor (FPGA) products for a broad set of markets, including cloud and enterprise, but is being run separately from Intel’s core CPU and foundry businesses. Thus, AMD’s FPGAs are directly marketed within its integrated data‑center portfolio, whereas Altera’s FPGA offerings remain a distinct, stand‑alone line under Intel’s overall strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: AMD produces FPGAs (specifically Versal, Kria) and Adaptive SOCs that are integrated into data center solutions for hyperscale customers, including AI workloads. Intel operates Altera as a standalone unit, focusing on programmable semiconductors for cloud, enterprise, and other markets. The distinction between AMD’s integrated approach and Altera’s standalone positioning is correctly captured. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification—both mention strategic structures without specific numbers, so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model correctly synthesizes information about AMD’s product integration in data centers and contrasts it with Altera’s structural separation under Intel, reflecting the strategic divergence. (4) The only minor shortcoming is that the LLM answer omits mention of Intel’s potential IPO or monetization plans for Altera, which is part of the original answer and relevant to the 'standalone' strategy. However, this does not undermine the core comparison. Wording differs but semantic meaning is equivalent. Thus, correctness is high at 9/10, with full marks for contextual relevance and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 380,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA compare to the ownership structure of Class A common stock at GOOGL, given the relative number of shares outstanding and holder concentration?",
      "original_answer": "At CMCSA, the Class B common stock represents 33⅓% of the combined voting power, with all shares beneficially owned by Brian L. Roberts, and only 3 record holders as of December 31, 2021. In contrast, GOOGL’s Class A common stock had 300,754,904 shares outstanding as of January 25, 2022, with a much broader base of non-affiliate ownership contributing to a market value of approximately $1,451.1 billion as of June 30, 2021. Both structures tie voting rights to distinct stock classes, but CMCSA’s Class B shares grant concentrated control to a single individual, while GOOGL’s Class A shares are more widely distributed.",
      "llm_answer": "Comcast’s Class B shares, which each carry 15 votes, represent about 33 ⅓ % of the company’s total voting power even though only three record holders own all of the Class B stock (the shares are effectively controlled by a single insider). In contrast, Alphabet’s Class A common stock – which carries one vote per share – has roughly 300.8 million shares outstanding, indicating a very large, broadly‑dispersed shareholder base with no comparable concentration of ownership. Thus, a tiny, highly concentrated block of Comcast Class B shares wields a third of the voting power, whereas Alphabet’s Class A voting power is spread across hundreds of millions of shares held by many investors.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in precision. (1) Quantitatively, the LLM correctly states that CMCSA's Class B shares represent approximately 33⅓% of voting power and are held by only three record holders, effectively controlled by one individual (Brian L. Roberts, though not named). The number of GOOGL Class A shares is reported as 'roughly 300.8 million,' which closely matches the ground truth figure of 300,754,904—this rounding is acceptable. The LLM omits the $1,451.1 billion market value figure from June 30, 2021, which is a minor omission but not critical to the comparison. (2) The dates (December 31, 2021, for CMCSA; January 25, 2022, for GOOGL) are not explicitly mentioned, but the LLM does not contradict them, and the data aligns temporally. (3) The reasoning is sound: the LLM correctly synthesizes the contrast between concentrated control at CMCSA via high-vote Class B shares (15 votes per share, though this detail is not in the ground truth and appears to be extraneous or potentially incorrect unless from an external source) and the broad distribution of GOOGL’s one-vote-per-share Class A stock. The mention of 15 votes per share is not in the original answer and cannot be verified from the provided ground truth, introducing a potential inaccuracy, hence the deduction. (4) The entities (CMCSA, GOOGL, Class B and Class A common stock) are correctly identified, and the multi-hop comparison of ownership concentration and voting power distribution is logically structured and relevant. The conclusion effectively captures the essence of the original answer. The omission of the exact market value and slight overprecision on vote count per share prevent a perfect score, but overall, the answer is factually strong and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 502,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the change in Keytruda royalty structure post-2023 impact Bristol-Myers Squibb's revenue dependency on Merck, considering Merck's co-development and financial obligations tied to Keytruda in combination therapies?",
      "original_answer": "The royalty rate Merck pays to Bristol-Myers Squibb (BMS) and Ono for Keytruda drops from 6.5% to 2.5% starting January 1, 2024, which will reduce BMS’s royalty income from Merck. This is significant because Merck co-develops Keytruda-based combination therapies like V940 (mRNA-4157) with Moderna, where Merck bears 50% of development costs and receives 50% of any future profits. Since BMS's revenue from Merck is partly tied to Keytruda's global sales through this licensing agreement and has been a growing component of BMS's income (noted by the 2023 increase in royalties), the reduced royalty rate may diminish the financial upside BMS experiences from Keytruda's continued use in these new combination regimens.",
      "llm_answer": "The 10‑K notes that Merck’s patent‑license agreement with BMS will cut the royalty on worldwide Keytruda sales from 6.5 % (through 31 Dec 2023) to 2.5 % (1 Jan 2024‑31 Dec 2026) and that the royalty is split 75 % to BMS after legal‑fee adjustments【page_90】. Because the royalty rate falls by more than a third, BMS’s future royalty‑income stream from Merck’s Keytruda sales – a major source of its “royalty and licensing income” – will be substantially smaller, reducing BMS’s overall revenue dependence on Merck. Nonetheless, BMS remains tied to Merck through co‑development of combination regimens (e.g., the V940‑Keytruda program) in which Merck shares development costs and profits equally and assumes large upfront, continuation‑payment and milestone obligations, so the partnership still generates significant, though less royalty‑driven, financial exposure to Merck【page_90】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key quantitative facts: the royalty rate drops from 6.5% to 2.5% effective January 1, 2024, with the new rate applying through 2026. It accurately notes the 75% split of the royalty to BMS after legal-fee adjustments, which aligns with the structure implied in the ground truth (though the original answer does not specify the split, this detail is consistent with known public agreements and adds precision without contradicting). All numbers, dates, and percentages are correct. (2) Quantitative accuracy is perfect: the drop from 6.5% to 2.5% is correctly stated, and the timeframes (through Dec 31, 2023, and Jan 1, 2024–Dec 31, 2026) match the ground truth. The claim that the royalty is split 75% to BMS is a specific addition supported by external knowledge and SEC filings, and does not conflict with the original answer. (3) The multi-hop reasoning is sound: the LLM connects the reduced royalty rate to lower royalty income, identifies this as a major component of BMS’s royalty and licensing income, and correctly assesses that this reduces BMS’s revenue dependency on Merck. It also correctly incorporates the ongoing financial exposure via co-development (e.g., V940-Keytruda), where Merck shares costs and profits equally and has milestone obligations—this synthesizes the continued interdependence despite reduced royalties. (4) The only minor gap is that the original answer emphasizes BMS’s income growth from royalties in 2023 as context for the impact, which the LLM mentions indirectly ('major source') but could have explicitly referenced. However, this does not detract significantly from correctness. Overall, the LLM answer is factually accurate, contextually complete, and semantically equivalent with added precision. Hence, a high score of 9 is justified, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 515,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does the adoption of ASU 2022-06, which CAT has listed as applicable to its financial reporting, impact the treatment of contract modifications under U.S. government agreements that BA identified as a material risk in its 2023 disclosures?",
      "original_answer": "ASU 2022-06 extends the sunset date for optional expedients and exceptions related to reference rate reform through December 31, 2024. This allows companies like BA to apply simplified accounting treatments for contract modifications made in response to reference rate changes, such as replacing LIBOR, during that period. BA, which reported that 37% of its 2023 revenues came from U.S. government contracts—where modifications can occur without prior notice—benefits from reduced operational complexity and financial impact when adjusting contracts affected by reference rate reform. CAT, in its 2023 10-K, listed ASU 2022-06 under recently adopted accounting standards, confirming its applicability and alignment with broader corporate practices around reference rate reform.",
      "llm_answer": "CAT notes that it adopted ASU 2022‑06 (Reference‑Rate Reform) which “reduces the operational and financial impacts of contract modifications that replace a reference rate… and extends the optional‑expedient sunset to 31 Dec 2024” (​CAT 10‑K p. 67). BA’s 2023 risk disclosure flags that U.S.‑government contracts “may be modified, curtailed or terminated” as a material risk (​BA 10‑K p. 14). Thus, CAT’s adoption of ASU 2022‑06 lessens the accounting impact of any government‑contract modifications that involve a reference‑rate change, but it does not eliminate the broader risk of contract modification, curtailment or termination that BA identified.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All entities—CAT, BA, ASU 2022-06, U.S. government contracts—are correctly identified, and the dates (December 31, 2024 sunset) are accurate. (2) There are no numeric values in the LLM answer that conflict with the ground truth; while the ground truth mentions BA’s 37% of 2023 revenues from U.S. government contracts, the LLM omits this specific percentage but still correctly characterizes the risk related to government contract modifications. This omission is minor and does not affect the core correctness. (3) The multi-hop reasoning is sound: the LLM correctly links CAT’s adoption of ASU 2022-06 (from its 10-K) to the accounting relief for contract modifications due to reference rate reform, and connects it to BA’s disclosed risk about U.S. government contract modifications. It appropriately clarifies that ASU 2022-06 reduces accounting complexity for rate-related modifications but does not mitigate the broader operational risk BA highlighted. (4) The semantic meaning matches the original answer: both emphasize that the ASU provides temporary relief for reference-rate-related modifications, benefiting firms with government contracts subject to sudden changes. The LLM answer is slightly less detailed than the ground truth (missing the 37% revenue figure and explicit mention of LIBOR), but retains the essential factual and logical structure. Thus, it earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 430,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does the $4.8 billion transaction with Crown Castle in 2013 compare to Verizon's 2024 $2.8 billion deal with Vertical Bridge REIT in terms of asset treatment and financing obligations, particularly given both companies retained depreciation responsibilities and structured payments as financing obligations?",
      "original_answer": "Both AT&T’s 2013 transaction with Crown Castle and Verizon’s 2024 deal with Vertical Bridge REIT involved transferring exclusive rights to operate wireless towers while retaining depreciation responsibilities on their balance sheets. AT&T received $4.827 billion from Crown Castle, accounted for as a financing obligation with an effective interest rate of ~3.9%, and continues to sublease space on the towers. Similarly, Verizon received $2.8 billion from Vertical Bridge, of which $830 million was recorded as a financing obligation related to the towers Verizon continues to use, with the remainder treated as prepaid rent. Both arrangements reflect a structured financing model where the original owner maintains accounting control and depreciation charges, rather than achieving sale-leaseback treatment.",
      "llm_answer": "AT&T’s 2013 Crown Castle transaction was accounted for as a financing liability – the $4.8 billion cash received was recorded as a financing obligation, the 9,048 towers remained on AT&T’s PP&E balance sheet and were depreciated (‑$39 million per year), and the periodic lease‑payments to Crown Castle are treated as reductions of that financing liability. Verizon’s 2024 Vertical Bridge REIT deal likewise leaves the ~6,000 towers on Verizon’s PP&E and subject to depreciation, but the $2.8 billion cash received is split: $2.0 billion is recorded as prepaid rent (operating‑cash‑flow item) and $830 million is recorded as a financing obligation for the portion of the towers Verizon continues to occupy, with the lease‑payments on that portion reflected as financing outflows. Thus both transactions retain depreciation of the assets, but AT&T’s entire proceeds are a financing liability, whereas Verizon’s are partially prepaid rent and a smaller financing liability.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Correctly identifies both transactions, their years, counterparties (Crown Castle, Vertical Bridge REIT), and key financial treatments. (2) Quantitative accuracy: The $4.8 billion (approximation of $4.827B) and $2.8 billion figures are correct; $830 million financing obligation for Verizon is exact. The $2.0 billion prepaid rent is a reasonable approximation (since $2.8B - $830M = $1.97B). AT&T's depreciation of -$39 million/year is not in the original answer but is plausible supplemental detail and does not contradict. (3) Multi-hop reasoning is sound: correctly synthesizes that both deals retain towers on the balance sheet, continue depreciation, and are structured as financing obligations rather than sale-leasebacks. It accurately contrasts AT&T’s full financing liability treatment vs. Verizon’s split between prepaid rent and financing obligation. (4) Minor deduction in quantitative accuracy due to rounding of AT&T’s $4.827B to $4.8B without clarification and the $2.0B prepaid rent figure being a rounded-up version of $1.97B. However, these are acceptable in context. The answer is semantically equivalent and captures all key comparative elements: asset treatment, financing obligations, depreciation, and accounting distinctions. Contextual relevance is perfect—directly addresses the comparison asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 386,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does PEP's direct operational presence in New Zealand's beverage market compare to KO's financial influence through its 19% stake in CCEP, which bottles and distributes Coca-Cola products in the same region?",
      "original_answer": "PEP operates in New Zealand through its APAC regional structure, selling branded beverages and convenient foods directly and through partners. CCEP, in which KO holds a 19% stake, is responsible for bottling and distributing Coca-Cola products in New Zealand under a bottler's agreement. KO's financial stake allows it to influence CCEP's operations indirectly, while PEP maintains full operational control over its New Zealand beverage activities. This creates two distinct models—direct operation for PEP and equity influence for KO through CCEP—both active in the New Zealand beverage market.",
      "llm_answer": "PepsiCo’s 2022 filing shows that its Asia‑Pacific, Australia‑New Zealand‑China segment “makes, markets, distributes and sells” its beverage brands and “operates its own bottling plants and distribution facilities” in the region, which includes New Zealand【page_5】.  \n\nCoca‑Cola, by contrast, does not operate its own bottling in New Zealand; instead it holds an equity‑method investment of about 19 % in Coca‑Cola Europacific Partners plc, the independent bottler that “has bottling and distribution operations … New Zealand”【page_7】【page_88】. Thus PepsiCo’s presence is a direct, owned‑and‑operated bottling and distribution network, whereas Coca‑Cola’s influence is indirect, coming solely from its minority ownership stake in the bottler that serves the market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PEP operates directly in New Zealand through its APAC segment, including owning bottling and distribution facilities, while KO holds a ~19% equity stake in CCEP, which bottles and distributes Coca-Cola products in New Zealand. The 19% stake is correctly cited. (2) Quantitative accuracy is perfect: the percentage (19%) matches the ground truth, and no other numerical errors exist. Format and sourcing (e.g., page references) are consistent with document-based evidence. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across PEP’s operational model and KO’s financial investment via CCEP, contrasting direct operation vs. indirect influence through a bottler. The conclusion that PEP has a direct, owned-and-operated network while KO relies on minority equity influence is logically derived and semantically equivalent to the original answer. (4) Minor deduction in qualitative accuracy due to slightly less explicit mention of 'full operational control' (vs. 'operates its own') and less emphasis on KO’s indirect influence being financial and strategic via equity-method accounting, though this is implied. Overall, the answer is factually complete, contextually relevant, and conveys the same core comparison as the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 379,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does AIG's use of internal valuation models for mortgage-backed securities compare to SCHW's reliance on broker/dealer quotes for similar asset classes like commercial mortgage-backed securities in determining fair value?",
      "original_answer": "AIG utilizes internal valuation models and third-party asset managers to determine fair values for mortgage-backed securities, subject to management review to ensure model reasonableness. These models incorporate inputs like interest rates, borrower creditworthiness, collateral, and market pricing for comparable loans. In contrast, SCHW primarily relies on broker/dealer quotes and third-party pricing services for similar asset classes such as commercial mortgage-backed securities, using observable market data like trades, spreads, and maturity information to validate pricing. GILD’s evidence further supports that broker/dealer quotes are commonly used alongside valuation models with observable inputs for fair value estimation, indicating a shared industry practice that bridges AIG's internal modeling and SCHW's external pricing reliance.",
      "llm_answer": "AIG values its residential‑ and commercial‑mortgage‑backed securities (RMBS and CMBS) primarily with **internal valuation models**—supplemented, when available, by dealer quotations and discounted‑cash‑flow analyses that are reviewed by management for reasonableness (see AIG 10‑K p. 113).  \n\nIn contrast, Charles Schwab determines the fair value of comparable fixed‑income assets, including non‑agency CMBS, **largely from broker‑dealer quotes and other observable market data** supplied by independent pricing services; Schwab only adjusts those prices when they appear inconsistent with its fair‑value definition (see Schwab 10‑K p. 81).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) It correctly identifies that AIG uses internal valuation models for mortgage-backed securities, supplemented by dealer quotes and management review, which matches the ground truth description involving internal models, third-party inputs, and management oversight. The mention of inputs like discounted cash flows and management review (citing AIG’s 10-K p.113) adds fidelity. (2) For SCHW, the LLM accurately states reliance on broker/dealer quotes and independent pricing services, adjusting only when necessary—consistent with the original answer’s emphasis on observable market data and external pricing. (3) The LLM cites specific page numbers from the 10-Ks (p.113 for AIG, p.81 for SCHW), enhancing verifiability and contextual grounding. (4) While the original answer includes a synthesis point about GILD supporting industry practice (broker/dealer quotes used alongside models), this additional context is omitted in the LLM response—hence a minor completeness gap, but not a factual error. This missing link slightly weakens the multi-hop synthesis but does not detract from the core comparison. (5) No numbers, dates, or financial metrics are incorrect; there are no quantitative inaccuracies. (6) The entities (AIG, SCHW, RMBS, CMBS) and asset classes are correctly identified. (7) The reasoning is sound, clearly contrasting AIG’s model-centric approach with SCHW’s market-data-centric method. Overall, the answer is factually correct, well-structured, and contextually precise—just short of full completeness in multi-source synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 448,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How does AVGO's valuation methodology for Level 2 securities compare to ADBE's reliance on matrix pricing, given the use of observable market inputs like yield curves and benchmark rates in their fair value determinations?",
      "original_answer": "AVGO categorizes its investments, including equity and short-term money market instruments, as Level 2 securities when they are valued using inputs such as interest rates, yield curves, and broker quotes. These inputs are observable but not quoted prices in active markets, distinguishing them from Level 1 securities. Matrix pricing, which is used for Level 2 securities like corporate bonds and asset-backed securities, relies on observable market data such as yield curves to estimate fair value. ADBE also categorizes its fixed income available-for-sale debt securities as Level 2 and explicitly uses matrix pricing techniques that incorporate benchmark yields, issuer spreads, interest rates, and U.S. Treasury or swap curves to determine fair value. Both companies rely on similar observable inputs, indicating a shared dependence on market-derived data rather than direct quotations for active trading in valuing their Level 2 portfolios.",
      "llm_answer": "Both companies place their corporate‑bond and other non‑quoted investments in the Level 2 fair‑value hierarchy and base the measurements on observable market data.  \n\nBroadcom (AVGO) says its Level 2 securities are valued “using market‑corroborated pricing, matrix pricing **or other models that utilize observable inputs such as yield curves**” (AVGO 10‑K p. 80).  \n\nAdobe (ADBE) likewise classifies its fixed‑income securities as Level 2 and “values these securities based on pricing from independent vendors who use **matrix‑pricing** techniques … including **benchmark yields, issuer spreads, interest‑rate and U.S. Treasury or swap curves**” (ADBE 10‑K p. 71).  \n\nThus, while both rely on observable inputs like yield curves and benchmark rates, AVGO describes a broader set of valuation approaches (market‑corroborated, matrix or other models), whereas ADBE’s methodology leans more specifically on matrix‑pricing supplied by external vendors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: both AVGO and ADBE classify their fixed-income securities as Level 2, and both use observable inputs such as yield curves, benchmark rates, interest rates, and issuer spreads. The LLM correctly identifies that AVGO uses a broader set of valuation methods (market-corroborated pricing, matrix pricing, or other models), while ADBE specifically relies on matrix pricing via third-party vendors. These details are consistent with the original answer and supported by the cited 10-K pages. (2) There are no numerical values (e.g., dollar amounts, percentages, dates) in the question or ground truth, so quantitative accuracy is not applicable in a numerical sense, but the references to specific inputs and methodologies are factually precise. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (AVGO and ADBE), compares their valuation methodologies, and highlights both similarities (use of observable inputs like yield curves) and a nuanced difference (AVGO’s broader approach vs. ADBE’s specific reliance on matrix pricing). This demonstrates strong qualitative reasoning. (4) The answer is contextually relevant and fully addresses the comparative aspect of the question. The only minor limitation is that the original answer emphasizes the shared dependence on market-derived data more explicitly, but the LLM implies this through parallel descriptions. No factual errors or omissions affect the core correctness. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 467,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "What percentage of Coca-Cola's non-U.S. unit case volume is managed by Coca-Cola HBC, and in how many of its operational countries—including the Czech Republic—does it coordinate distribution for Coca-Cola's trademark beverages?",
      "original_answer": "Coca-Cola HBC manages 17% of Coca-Cola's non-U.S. unit case volume and coordinates distribution for Coca-Cola's trademark beverages in 30 countries, including the Czech Republic.",
      "llm_answer": "Coca‑Cola HBC AG handles roughly **17 % of Coca‑Cola’s non‑U.S. unit‑case volume**, and it coordinates the distribution of Coca‑Cola trademark beverages in **28 countries** – a list that includes the Czech Republic.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that Coca-Cola HBC manages 17% of Coca-Cola's non-U.S. unit case volume, which matches the ground truth exactly—this quantitative figure is accurate and properly contextualized. However, the answer states that distribution is coordinated in 28 countries, while the ground truth specifies 30 countries, including the Czech Republic. This is a factual discrepancy in a key numeric claim, though the Czech Republic is correctly included. The entity identification (Coca-Cola HBC) and metric (non-U.S. unit case volume) are accurate, and the answer addresses both parts of the multi-hop question. The reasoning appears sound in structure—linking Coca-Cola HBC to both volume share and geographic distribution scope—but the country count is off by 2, which may indicate outdated or incomplete data. Wording and formatting variations (e.g., 'unit-case volume' vs 'unit case volume') are acceptable and do not affect meaning. The answer is highly relevant and well-structured, but the error in the number of countries reduces quantitative and overall correctness. Hence, a score of 7 is warranted for correctness, with high marks for qualitative reasoning and full relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1118,
        "completion_tokens": 337,
        "total_tokens": 1456
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How do Duke Energy's 50% equity stake in Hardy Storage in West Virginia and NextEra Energy's 31.9% ownership in a 303-mile pipeline under construction in the same region reflect divergent strategic approaches to natural gas infrastructure investment, particularly in light of regulatory and market challenges?",
      "original_answer": "Duke Energy's 50% equity stake in Hardy Storage, an interstate underground natural gas storage facility in West Virginia, indicates a strategic focus on stable, long-term infrastructure assets that support regulated gas operations. This aligns with Duke's broader approach of investing in FERC-regulated infrastructure such as Pine Needle and Hardy Storage to ensure reliable supply and service. In contrast, NextEra Energy's 31.9% ownership in a 303-mile pipeline project in West Virginia and Virginia reflects a more ambitious and risk-exposed strategy aimed at expanding transportation capacity into new markets, despite facing regulatory delays and legal challenges. While both companies are investing in West Virginia's natural gas ecosystem, Duke's approach emphasizes secure, operational assets, whereas NextEra's involvement in a pipeline under construction—subject to permitting and legal hurdles—suggests a higher tolerance for uncertainty in pursuit of future capacity and market access.",
      "llm_answer": "Duke Energy’s 50 % stake in the Hardy underground storage facility (a FERC‑regulated asset in Hardy and Hampshire counties, W.Va.) reflects a strategy of investing in mature, regulated infrastructure that generates steady, rate‑approved returns and avoids construction‑phase risk. In contrast, NextEra Energy’s 31.9 % interest in a 303‑mile interstate pipeline that is still being built in West Virginia and Virginia – whose completion depends on pending regulatory approvals and the outcome of legal challenges – shows a more aggressive, growth‑oriented approach that accepts higher regulatory and market uncertainty to secure future transport capacity. These positions illustrate Duke’s preference for low‑risk, regulated storage versus NextEra’s willingness to pursue higher‑risk, development‑stage pipeline projects despite the attendant regulatory hurdles. 【page_19】【page_17】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Duke Energy's 50% stake in Hardy Storage and NextEra Energy's 31.9% ownership in a 303-mile pipeline under construction in West Virginia and Virginia are accurately reported. (2) Quantitative elements—percentages (50%, 31.9%), pipeline length (303 miles)—match the original answer exactly. Format variations (e.g., '31.9%' vs '31.9 %') are stylistic and do not affect accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes that Duke’s investment in a FERC-regulated, operational storage facility reflects a low-risk, regulated-asset strategy, while NextEra’s stake in a pipeline facing regulatory and legal challenges indicates a higher-risk, growth-oriented approach. (4) The contrast in strategic approaches—Duke favoring stable returns and operational assets versus NextEra accepting construction and regulatory risk for future capacity—is clearly and correctly articulated. The inclusion of specific locations (Hardy and Hampshire counties, W.Va.) adds precision. The answer fully addresses the question’s focus on divergent strategies in light of regulatory and market challenges. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 359,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How does the difference in voting rights between Class A and Class B shares at META compare to GOOGL's dual-class structure, and what implications might this have on ownership concentration given META's 2,189,898,148 Class A shares and 343,761,117 Class B shares outstanding as of January 24, 2025, versus GOOGL's 10:1 voting ratio for Class B shares and $62.0 billion in 2024 share repurchases?",
      "original_answer": "META discloses two classes of stock—Class A and Class B—with the latter carrying greater voting rights, though the exact ratio is not quantified in the filing. As of January 24, 2025, META had 2,189,898,148 Class A shares and 343,761,117 Class B shares outstanding, indicating a significant concentration of voting power within Class B. In contrast, GOOGL explicitly states that each Class B share carries 10 votes, creating a defined 1:10 voting disparity. GOOGL also repurchased $62.0 billion in shares during 2024, predominantly from Class A and Class C, which may further consolidate voting control in Class B shares held by insiders. This suggests that while both companies utilize dual-class structures to concentrate voting power, GOOGL's is more explicitly weighted and reinforced through aggressive capital allocation, whereas META’s structure lacks detailed disclosure on voting disparity but similarly reflects a concentrated ownership base through disproportionate Class B shareholding.",
      "llm_answer": "Meta’s charter gives each Class A share one vote and each Class B share ten votes – the same 10‑to‑1 voting premium that Alphabet gives its non‑public Class B shares (Alphabet’s 10‑K note 82 says “each share of Class A … one vote… each share of Class B … ten votes”). Meta had 2,189,898,148 Class A shares and 343,761,117 Class B shares on Jan 24 2025, which translates to roughly 5.6 billion total votes, with the Class B holders (about 61 % of the voting power) still out‑voting the public but less concentrated than Alphabet, where the privately held Class B stock (also 10‑to‑1) together with $62 billion of 2024 share repurchases has dramatically reduced the public float and gives insiders a far larger share of voting control.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding META's voting structure. The ground truth states that META does not disclose the exact voting ratio between Class A and Class B shares, yet the LLM confidently asserts a 10-to-1 voting ratio (1 vote for Class A, 10 for Class B), which is not supported by the filing. This is a critical error in both entity and qualitative accuracy. In contrast, GOOGL’s 10:1 voting ratio is correctly stated. (2) Quantitatively, the LLM correctly reports META’s share counts (2,189,898,148 Class A and 343,761,117 Class B) and GOOGL’s $62.0 billion 2024 repurchases (rounded to $62 billion). However, the claim of 'roughly 5.6 billion total votes' is miscalculated: assuming 10 votes per Class B share, total votes would be (2.189B × 1) + (0.343B × 10) = 2.189B + 3.437B = 5.616B — this calculation is numerically correct *only if* the 10:1 ratio were true, which it is not per the original answer. The 61% voting power attribution to Class B is approximately correct *under that assumption*, but since the ratio is unverified for META, the conclusion is unfounded. (3) Multi-hop reasoning is partially sound: the model attempts to compare ownership concentration using share counts and voting rights, and correctly notes that GOOGL’s repurchases reduce public float, increasing insider control. However, it incorrectly equates META’s structure with GOOGL’s due to the unsupported 10:1 assumption, undermining the comparative analysis. (4) Contextual relevance is high — the response addresses all parts of the question: voting structures, share counts, repurchases, and implications for ownership concentration. But due to the foundational error about META’s voting ratio, the qualitative and overall correctness scores are significantly reduced. The model fabricates a precise detail that the source material explicitly says is not disclosed, leading to a misleading comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 528,
        "total_tokens": 2023
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did the enactment of TRAF in Switzerland impact JNJ's effective tax rate in 2020, and how does this compare to MRK's tax benefit from its Swiss tax holiday that began in 2021?",
      "original_answer": "The enactment of TRAF in Switzerland allowed JNJ to adjust the tax basis of certain assets to fair value under transitional provisions, resulting in an incremental Swiss tax deduction and contributing to a 1.9% decrease in JNJ's 2020 effective tax rate compared to 2019. Meanwhile, MRK benefited from a Swiss tax holiday for a newly active legal entity, effective through 2030, which began yielding favorable tax impacts starting in 2021. These provisions in Switzerland contributed to both companies experiencing lower effective tax rates due to localized tax incentives, albeit through different mechanisms and in different fiscal years.",
      "llm_answer": "The Federal Act on Tax Reform and AHV Financing (TRAF) that took effect in Switzerland at the start of 2020 gave Johnson & Johnson a net tax benefit of about **$0.4 billion**, which translated into a **≈ 2.6‑percentage‑point reduction in its effective tax rate for 2020** (the filing notes a 2.6 % benefit to the rate).  \n\nMerck’s filing notes that, beginning in 2021, it received a **Swiss “tax‑holiday” incentive for a newly‑active legal entity** that will run through 2030, but the 2022 10‑K does not quantify the dollar or percentage impact of that holiday. Consequently, while JNJ’s TRAF effect can be measured (‑2.6 % of the effective rate), Merck’s Swiss tax‑holiday benefit is disclosed only qualitatively and cannot be directly compared in magnitude from the information provided.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains key factual inaccuracies in the quantitative details. The ground truth states that JNJ's effective tax rate decreased by 1.9 percentage points due to TRAF, but the LLM claims a 2.6-percentage-point reduction. While the LLM cites a $0.4 billion tax benefit, this figure is not present in the original answer and cannot be verified against the ground truth, making it potentially incorrect or unsupported. (2) The date for TRAF enactment (2020) and MRK’s tax holiday start (2021) are correct, as is the duration through 2030. However, the core numerical impact on JNJ’s tax rate is off by 0.7 percentage points, which is a significant error in the context of effective tax rate calculations. The absence of quantification for MRK’s benefit is correctly noted, aligning with the original answer’s qualitative description. (3) The multi-hop reasoning is sound: the model correctly identifies that JNJ benefited from TRAF in 2020 via transitional provisions affecting asset basis and tax deductions, and that MRK began benefiting from a Swiss tax holiday in 2021 under different mechanisms. It appropriately distinguishes between the two companies’ tax incentives and avoids making a direct quantitative comparison due to lack of data. (4) Despite correct entity identification (JNJ, MRK), years (2020, 2021), and general mechanisms (TRAF vs. tax holiday), the incorrect magnitude of JNJ’s tax rate impact reduces factual accuracy. The answer adds a specific dollar amount and percentage not in the ground truth, which undermines quantitative reliability. However, the structure, relevance, and logical flow are strong, and the conclusion about non-comparability due to disclosure limitations is valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 472,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How do MCD's foreign currency asset hedging practices compare with NKE's transactional FX risk management strategies using options, particularly regarding notional amounts and objectives?",
      "original_answer": "MCD manages FX exposure by holding diversified foreign currency net asset positions, with its largest exposures denominated in major global currencies (chunk_1). To mitigate associated risks, MCD uses option and forward contracts to hedge forecasted foreign currency transactions, with $9.9 billion in notional amounts of net foreign exchange cash flow hedges as of September 28, 2024 (chunk_2). NKE also uses option contracts as part of its FX risk management, focusing on transactional exposures such as product costs and external sales in non-functional currencies, with hedging strategies aimed at stabilizing U.S. Dollar inventory costs amid FX fluctuations (chunk_3). While both companies use options, MCD's strategy centers on protecting existing foreign currency assets, whereas NKE's approach is more transaction-focused, targeting forecasted cash flows and cost stability.",
      "llm_answer": "MCD’s filing does not give a dollar‑amount for the foreign‑currency hedges it uses on its asset portfolio; it simply notes that the company’s net‑asset exposure is spread across a “broad basket of currencies” (e.g., $1.5 bn of Australian‑dollar exposure, $1.1 bn of British‑pound exposure, etc.) and that the exposure is managed through diversification and internal risk‑analysis rather than through a disclosed notional‑amount hedge program.  \n\nIn contrast, Nike describes a transactional‑FX program that employs forward and option contracts (including options on forecast‑ed transactions) with a disclosed net cash‑flow‑hedge notional of **$9.9 billion in 2024** (up from $8.3 billion in 2023).  The objective of Nike’s program is to protect the U.S.‑dollar value of existing assets, liabilities, firm commitments and forecasted cash flows, thereby reducing earnings and cash‑flow volatility from foreign‑currency movements.  \n\nThus, MCD’s practice is broadly described and lacks a specific notional figure, focusing on diversification of net‑asset exposures, whereas Nike’s strategy is explicitly quantified (≈ $10 bn of hedges) and is aimed at smoothing transactional FX impacts through options and forwards.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misattributions that undermine its correctness. (1) QUANTITATIVE INACCURACY: The LLM incorrectly states that MCD does not disclose a dollar amount for its hedges and attributes the $9.9 billion notional amount to Nike. In reality, the ground truth confirms that MCD has $9.9 billion in notional amounts of net foreign exchange cash flow hedges as of September 28, 2024, while NKE’s filing does not specify a notional amount. The LLM reverses the companies' disclosures, assigning Nike the $9.9B figure that actually belongs to MCD. This is a critical error in both entity and quantitative accuracy. (2) COMPLETENESS: While the question asks for a comparison of MCD and NKE regarding notional amounts and objectives, the LLM fails to correctly report notional amounts for either company. It falsely claims Nike disclosed $9.9B in 2024, which is not supported by the original answer. (3) ENTITY ACCURACY: The attribution of the $9.9 billion notional hedge to Nike instead of MCD is a major entity-metric mismatch. Additionally, the LLM claims Nike increased from $8.3B in 2023, a detail absent from both the original answer and knowledge base, introducing fabricated data. (4) REASONING: The multi-hop comparison fails because the core data is inverted. The reasoning framework (comparing asset-based vs. transaction-focused strategies) aligns partially with the original answer, but the flawed data renders the conclusion invalid. (5) SEMANTIC EQUIVALENCE: The overall meaning is distorted due to incorrect assignments of numbers and strategies. Although the general idea of MCD focusing on asset diversification and NKE on transactional hedges has some alignment, the reversal of the $9.9B figure and invention of Nike’s hedging program size severely compromise factual integrity. The answer is contextually relevant in structure but factually incorrect in execution.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1533,
        "completion_tokens": 516,
        "total_tokens": 2050
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the exclusive use of RTX's PW800 engine on Gulfstream's G500 support General Dynamics' strategy to position the G500 as a next-generation replacement for the G450 and G550 models?",
      "original_answer": "The G500, developed by General Dynamics, is positioned as a next-generation replacement for the G450 and G550 models with a clean-sheet design that includes a new wing and advanced avionics. RTX's Pratt & Whitney Canada produces the PW800 engine, which exclusively powers the G500 (along with the G400 and G600). This exclusive engine-airframe pairing enhances the G500's performance with improved fuel efficiency, range, and speed, aligning with General Dynamics' investment in new technologies to differentiate the G500 as a modern, high-performance aircraft in the business jet market.",
      "llm_answer": "The G500 is being marketed as the clean‑sheet, next‑generation successor to the legacy G450 and G550 families — “These clean‑sheet aircraft replace the G450 and G550 models” (GD 10‑K p. 4) and are “faster, more fuel‑efficient…with greater cabin volume, reduced emissions, more range” than the aircraft they replace (GD 10‑K p. 5).  By equipping the G500 (as well as the G400 and G600) with Pratt & Whitney Canada’s PW800 engine on an exclusive basis (RTX 10‑K p. 5), General Dynamics can guarantee a modern, high‑efficiency powerplant that delivers the performance, range and fuel‑burn reductions needed to make the G500 a compelling, next‑generation replacement for the G450/G550 lineup.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: the G500 is a clean-sheet design replacing the G450 and G550, the PW800 engine is exclusively used on the G500 (along with G400 and G600), and it is produced by Pratt & Whitney Canada, a subsidiary of RTX. The performance benefits—fuel efficiency, range, speed, reduced emissions, and greater cabin volume—are accurately described and supported by cited 10-K references. (2) There are no numeric values requiring calculation in this question; thus, quantitative accuracy is not applicable beyond correct referencing of qualitative performance metrics, which are accurately represented. (3) Multi-hop reasoning is sound: the model correctly links General Dynamics’ aircraft strategy (from GD 10-K) with RTX’s engine production (from RTX 10-K), synthesizing across entities to explain how exclusive engine use supports strategic positioning. (4) The only minor shortcoming is that the LLM does not explicitly name RTX as the parent company of Pratt & Whitney Canada, though this is implied via citation of the RTX 10-K. Otherwise, the answer is semantically equivalent to the ground truth, with strong contextual relevance and accurate reasoning. Hence, a score of 9 is justified—excellent but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 366,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the voting power distribution in META's dual-class structure compare to CMCSA's, particularly regarding the non-dilutable provisions under their respective articles of incorporation and the specific voting percentages allocated to Class A and Class B shareholders?",
      "original_answer": "META's Class B common stock is not publicly traded and as of December 31, 2023, there were only 23 stockholders of record of Class B common stock, suggesting concentrated voting control. In contrast, CMCSA explicitly states that holders of Class A common stock hold 66 2/3% of the combined voting power, while Class B common stockholders (beneficially owned entirely by Brian L. Roberts) hold 33 1/3% of the voting power. CMCSA's Class B common stock has 15 votes per share and its non-dilutable nature is specifically tied to the terms of its articles of incorporation, which preserves the voting power percentage regardless of additional Class A share issuances.",
      "llm_answer": "Meta Platforms’ charter creates a dual‑class system in which each Class A share carries one vote and each Class B share carries ten votes.  With about 2.2 billion Class A shares and 350 million Class B shares outstanding, the ten‑vote shares control roughly 61 % of the total voting power (≈39 % for Class A), and the charter states that the Class B voting power is “generally non‑dilutable.”  \n\nComcast’s charter also provides a dual‑class structure, but each Class B share has fifteen votes and only one Class B share is outstanding.  Consequently, the single Class B share represents 33 ⅓ % of the combined voting power, while Class A shares hold the remaining 66 ⅔ %; the 33 ⅓ % Class B voting share is expressly non‑dilutable under Comcast’s articles of incorporation.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core structural differences between META and CMCSA's dual-class voting systems and correctly identifies key qualitative aspects, such as the non-dilutable nature of Class B shares in both companies and the higher voting power per share for Class B in each case. However, there are significant quantitative inaccuracies that reduce factual correctness. First, the LLM claims Meta has 'about 2.2 billion Class A shares and 350 million Class B shares,' which is not supported by the ground truth and leads to an incorrect calculation of ~61% voting power for Class B. The original answer does not provide share counts or a calculated percentage for META, instead emphasizing the concentrated control via only 23 stockholders of record for Class B as of December 31, 2023. The LLM's numerical breakdown appears speculative and introduces a calculation not present or verifiable in the ground truth. In contrast, the CMCSA portion is mostly accurate: it correctly states that Class A holds 66 2/3% and Class B 33 1/3% of voting power, that Class B has 15 votes per share, and that the voting power is non-dilutable per the articles of incorporation. The mention of a single Class B share outstanding is consistent with CMCSA's structure where one share conveys 33 1/3% voting power. The reasoning is logically sound in comparing the two structures and highlighting non-dilution provisions, but the unsupported numbers for Meta undermine quantitative accuracy. The answer is contextually relevant and addresses all parts of the question, including voting percentages, non-dilutable provisions, and class distinctions. While the semantic intent is aligned, the fabrication of share counts and derived voting percentages for Meta prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 479,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the risk of losing market exclusivity due to patent challenges for BMY's Revlimid in Europe compare to LLY's reliance on data protection for orphan drug designations, given that both companies depend on intellectual property frameworks to extend commercial exclusivity?",
      "original_answer": "BMY faces earlier-than-expected market exclusivity loss for Revlimid in Europe due to patent settlements allowing generic entry in the UK starting January 18, 2022, and in other European countries beginning February 18, 2022. This highlights the vulnerability of market exclusivity when patent rights are challenged or settled. In contrast, LLY leverages regulatory data protection, including orphan drug designations that provide seven years of market exclusivity independent of patent expiration. While BMY's exclusivity is determined largely by patent rights and settlements, LLY benefits from parallel regulatory protections that do not rely solely on patent enforcement, especially in markets where orphan designations apply.",
      "llm_answer": "Bristol Myers Squibb says that Revlimid’s European exclusivity is already being eroded by patent‑settlement and “generic entry … in the United Kingdom beginning Jan 18 2022 and in other European countries … Feb 18 2022” (BMY 10‑K p. 36). Thus the company faces a near‑term risk that patent challenges will cut off its market rights in Europe earlier than the original patent term.\n\nEli Lilly, by contrast, notes that its future revenue from orphan‑drug products depends on the regulatory data‑protection regime that grants seven‑year orphan exclusivity; if that data‑protection is weakened or challenged, the exclusivity could be lost (LLY 10‑K p. 12). Hence Lilly’s risk is tied to the stability of the data‑protection framework rather than an imminent patent‑litigation‑driven generic launch.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: BMY's Revlimid faced generic entry in the UK on January 18, 2022, and in other European countries on February 18, 2022, due to patent settlements—this matches the original answer exactly. The dates are correctly cited and formatted. (2) The contrast with LLY is also accurate: Eli Lilly relies on regulatory data protection, specifically seven-year orphan drug exclusivity, which is independent of patents. The LLM correctly identifies that LLY’s risk lies in potential weakening of the data-protection framework, not patent litigation. (3) Multi-hop reasoning is sound—LLM synthesizes information across two companies (BMY and LLY), two types of IP protection (patents vs. regulatory exclusivity), and two risk profiles (imminent generic entry vs. systemic regulatory risk). (4) Minor deduction in qualitative accuracy due to slightly less explicit emphasis on the structural difference that orphan exclusivity operates 'in parallel' to patents, though the contrast in risk sources is clearly conveyed. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is perfect—directly addresses the comparative risk question with precise, document-supported reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 363,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the sensitivity of MS's asset management revenues to fixed income market fluctuations compare with PYPL's exposure to market risk through its use of pricing models for derivatives and debt securities?",
      "original_answer": "MS's asset management revenues are sensitive to changes in fixed income markets due to their reliance on fee-based client assets, which include fixed income investments valued using pricing models with observable market data like interest rates and credit spreads. MS specifically notes that revenues may not fully correlate with market changes due to factors like client behavior and asset mix. Meanwhile, PYPL also depends on pricing models for valuing its derivatives and available-for-sale debt securities, using observable inputs such as currency rates, interest rate yield curves, and equity prices. However, unlike MS, PYPL has elected the fair value option for foreign currency-denominated debt securities, directly tying gains and losses to market fluctuations. Both firms face market risk through their use of pricing models, but MS's exposure is more indirect through asset management fees, while PYPL's is direct through its investment and derivative valuations.",
      "llm_answer": "Morgan Stanley notes that a portion of its Wealth‑Management and Investment‑Management revenues comes from fee‑based assets that are “primarily composed of equity, fixed‑income and alternative investments and are sensitive to changes in related markets,” so a decline in fixed‑income values can directly erode those management‑fee revenues, although the impact may not track market moves one‑for‑one. PayPal, by contrast, does not earn fees that fluctuate with bond prices; its market‑risk exposure stems from the valuation of its derivative contracts and debt‑security holdings, which are measured with pricing models (Level 2/Level 3 inputs) and therefore generate gains or losses that flow through other‑income (or OCI) rather than revenue. Thus, MS’s asset‑management income is directly tied to fixed‑income market swings, whereas PYPL’s risk is confined to model‑driven valuation changes on its financial‑instrument portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that MS's asset management revenues are sensitive to fixed income market fluctuations due to fee-based assets, including fixed income, and acknowledges that the impact may not perfectly track market moves—consistent with the original answer's note on client behavior and asset mix. It accurately contrasts this with PYPL, which does not have revenue tied to market performance but instead faces market risk through valuation of derivatives and debt securities using pricing models. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes that MS’s exposure is indirect via fee-based revenues linked to asset values, while PYPL’s exposure is direct via fair value changes in financial instruments, even if not explicitly stating PYPL’s election of the fair value option (a minor omission). The LLM correctly notes that PYPL’s gains/losses flow through other income or OCI, which implies fair value accounting. (4) The semantic meaning matches the original answer: both convey that MS has indirect revenue sensitivity to fixed income markets, while PYPL has direct valuation risk from market-driven pricing models. The only minor gap is that the LLM does not explicitly mention PYPL’s fair value option election, which is a nuance but not central to the comparison. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 444,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How do Oracle's integration of generative AI in MySQL HeatWave and Qualcomm's investment in IoT applications reflect their respective strategies for on-device AI processing in enterprise and consumer markets?",
      "original_answer": "Oracle integrates generative AI into Oracle MySQL HeatWave, offering it as a managed cloud service that combines transactions, real-time analytics, machine learning, and generative AI capabilities. This enables enterprise customers to deploy AI-driven analytics and applications more efficiently. In contrast, Qualcomm is investing heavily in expanding generative AI into IoT and edge devices, projecting that 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024. Qualcomm’s QCT segment develops integrated circuits for IoT applications, including consumer electronics, industrial devices, and edge networking products, emphasizing on-device processing for immediacy, privacy, and personalization. While Oracle focuses on cloud-native AI integration for enterprise database workloads, Qualcomm is driving AI capabilities into edge devices across multiple industries, particularly IoT, to capitalize on the growing demand for on-device intelligence.",
      "llm_answer": "Oracle is turning its database platform into an AI‑enabled service: MySQL HeatWave now bundles “transactions, real‑time analytics, machine learning **and generative AI** in one managed cloud offering” so that enterprise customers can run AI models directly where their data lives, extending Oracle’s cloud‑centric, on‑premise‑or‑cloud AI strategy for business workloads【page_12】.  \n\nQualcomm, by contrast, is pouring money into the hardware that powers AI at the edge of consumer and IoT devices.  Its Snapdragon‑based **AI Engine and Hexagon NPU** are built “to run complex AI use cases at high‑performance and low‑power **on‑device**,” and the company says it will “continue to make substantial investments … in new and expanded product areas … such as automotive and **IoT**” to embed AI directly in phones, wearables and other edge products【page_7】【page_9】【page_20】.  \n\nTogether, Oracle’s generative‑AI‑enhanced database reflects a strategy of delivering enterprise‑grade AI inside cloud/on‑premise data services, while Qualcomm’s IoT investment reflects a strategy of pushing generative AI onto low‑power consumer and edge devices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: Oracle integrates generative AI into MySQL HeatWave as a managed cloud service combining transactions, analytics, ML, and generative AI for enterprise workloads. Qualcomm is investing in on-device AI for IoT and edge devices, particularly through its Snapdragon AI Engine and Hexagon NPU. These points match the original answer's core claims. (2) Quantitative accuracy is perfect: the LLM does not introduce any incorrect numbers, percentages, or dates. While the ground truth mentions specific projections (19% of smartphones in 2024 and 46% in 2027 being generative AI-capable), the LLM omits these figures but does not contradict them. This omission prevents a perfect 10 on correctness but does not constitute an error. (3) Multi-hop reasoning is sound: the model correctly synthesizes Oracle’s cloud-centric enterprise strategy with Qualcomm’s edge-focused consumer/IoT strategy, drawing a valid contrast between on-premise/cloud data services and on-device processing. (4) Semantic equivalence is strong—though the LLM uses different phrasing (e.g., 'AI Engine and Hexagon NPU' instead of 'QCT segment'), it accurately reflects Qualcomm’s hardware-driven AI strategy. The answer is fully relevant to the question, addressing both companies’ strategies in enterprise vs. consumer markets. Minor deduction from correctness due to missing the specific smartphone AI adoption projection, which is a notable detail in the ground truth, but not critical to the overall strategic comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1544,
        "completion_tokens": 437,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How might the compliance costs associated with the EU AI Act, which Adobe anticipates will require costly changes to its AI development practices, affect its competitive positioning against Salesforce, which relies heavily on its AI-powered Agentforce platform for sales and service offerings?",
      "original_answer": "Adobe anticipates that the EU AI Act, which will be implemented in phases through 2030, may require costly changes to its AI development practices, including delays or halts in development, changes to monetization strategies, and increased compliance costs. Meanwhile, Salesforce relies heavily on its AI-powered Agentforce platform across sales, service, and marketing offerings to drive productivity and growth. If Adobe is forced to divert resources to comply with the new regulations, it could slow the pace of its AI innovation, potentially giving Salesforce a competitive edge through its more established and integrated AI capabilities like Agentforce for Sales and Service. The GS_10k_2024 chunk reinforces that evolving AI regulations increase compliance costs and operational risks for companies relying on AI, suggesting both firms face similar pressures, but Salesforce’s deeper integration of AI across its platform may make it better positioned to absorb such regulatory changes.",
      "llm_answer": "Adobe warns that the EU AI Act and similar regulations will force “costly changes” to its AI‑development practices, raising compliance, governance and R&D expenses and potentially delaying or curtailing new AI features (ADBE 10‑K p. 23). Because Salesforce’s growth strategy is built around its AI‑powered Agentforce platform for sales and service (CRM 10‑K p. 6), higher Adobe costs and slower AI roll‑outs could weaken Adobe’s ability to compete on price, speed of innovation and feature breadth, eroding its competitive positioning relative to Salesforce.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) All factual elements are correct: Adobe anticipates costly changes due to the EU AI Act, including increased compliance, governance, and R&D expenses, and potential delays in AI development (supported by ADBE 10-K p.23). Salesforce's reliance on its AI-powered Agentforce platform for sales and service is accurately noted (CRM 10-K p.6). (2) There are no numeric values, dates, or calculations in the question or answers that conflict; all references to financial or temporal metrics are consistent with the source material. The LLM correctly avoids asserting specific dollar amounts or timelines beyond what’s in the filings. (3) The multi-hop reasoning is sound: it connects Adobe’s anticipated regulatory burden with its innovation pace and competitive positioning, then contrasts this with Salesforce’s AI-dependent growth strategy, logically concluding that Adobe may lose competitive ground. The only minor omission is that the original answer notes the EU AI Act will be implemented in phases through 2030 and that both companies face similar regulatory pressures (per GS_10k_2024), which the LLM answer does not mention—this slightly reduces completeness but does not undermine the core reasoning. (4) The answer is contextually relevant, directly addressing how compliance costs might affect Adobe’s competitive positioning against Salesforce. Wording differs but semantic meaning and factual content are equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 451,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How does the payout structure of HD's deferred shares, which includes dividend equivalents paid in additional shares, compare with LOW's receipt of additional shares through ASR agreements, in terms of stock-based value distribution to stakeholders?",
      "original_answer": "HD issues additional shares as dividend equivalents to non-employee directors upon the payout of deferred shares following termination of service, based on accrued dividends. This represents a stock-based compensation mechanism tied to director retention and long-term alignment. In contrast, LOW receives additional shares from third-party financial institutions as part of variable notional ASR agreements, which are tied to repurchase efficiency and final notional value calculations. These additional shares in LOW's case are not compensation-related but are part of capital return strategy execution. Both companies issue additional shares, but the context, stakeholders, and triggers differ significantly, reflecting distinct financial strategies.",
      "llm_answer": "Home Depot’s deferred‑share awards give non‑employee directors a right to one share each plus “dividend equivalents that accrue and are paid out in the form of additional shares of stock” when the underlying shares are delivered after the director’s service ends (19 000 shares were granted in fiscal 2023)【page_68】.  \n\nLowe’s, by contrast, enters variable‑notional “accelerated share‑repurchase” (ASR) agreements in which it pays the maximum notional amount up‑front, receives an initial block of shares, and then at settlement receives **additional** shares (and cash equal to the difference between the pre‑payment and the final notional amount)【page_62】.  \n\nThus, Home Depot’s structure distributes stock‑based value directly to directors as a compensation component, whereas Lowe’s structure returns extra shares to the company as part of a buy‑back transaction that ultimately benefits all shareholders by reducing outstanding equity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and references are correct: the mention of 19,000 shares granted in fiscal 2023 for HD is consistent with the source (page 68), and the description of LOW’s ASR mechanics on page 62 is accurately reflected. No calculation errors are present. (2) The answer fully addresses the comparison between HD’s dividend equivalents (paid in additional shares to non-employee directors) and LOW’s receipt of additional shares via ASR agreements. It correctly identifies the stakeholders (directors vs. the company/shareholders), the triggers (payout upon termination vs. repurchase settlement), and the strategic context (compensation vs. capital return). (3) Multi-hop reasoning is sound: the model synthesizes information across two companies, two distinct financial instruments (deferred shares with dividend equivalents vs. ASR agreements), and two stakeholder groups, drawing a clear contrast in purpose and mechanism. (4) The only minor shortcoming is a slight lack of explicit mention that HD’s dividend equivalents are accrued over time and paid upon termination—though this is implied. Otherwise, the semantic meaning fully matches the original answer, with precise use of terms like 'variable-notional ASR', 'initial block of shares', and 'reducing outstanding equity'. Wording differs slightly but meaning is equivalent. The answer is contextually excellent, directly addressing the question about stock-based value distribution to stakeholders.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 424,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How does AT&T's adoption of ASU 2020-04, which facilitates contract modifications triggered by reference rate reform, compare to Verizon's disclosure of contract modifications in terms of impact on their respective revenue recognition timing and contract performance obligations?",
      "original_answer": "AT&T adopted ASU 2020-04, which provides optional expedients for contract modifications triggered by reference rate reform (e.g., LIBOR transition), and stated that the adoption did not materially impact its financial statements. Meanwhile, Verizon disclosed that contract modifications affect the timing and scope of performance obligations, with $25.7 billion, $18.7 billion, and $7.5 billion expected to be recognized in 2024, 2025, and beyond, respectively. The connection through ASU 2020-04 to contract modifications shows that while AT&T experienced minimal financial impact from reference rate-related modifications, Verizon's broader contract modification landscape significantly influences its future revenue recognition patterns.",
      "llm_answer": "AT&T notes that its adoption of ASU 2020‑04 – which gives optional expedients for contract modifications caused by the transition away from LIBOR – “did not have a material impact on the Company’s consolidated financial statements” (AT&T 10‑K p. 53). In contrast, Verizon explicitly describes how contract modifications and the amount of unsatisfied performance obligations shift revenue to future periods, stating that “the timing of revenue recognition may differ from the time of billing” and that a large portion of the transaction price is allocated to performance obligations that will be recognized in 2024, 2025 and beyond (Verizon 10‑K p. 67). Thus, AT&T’s ASU 2020‑04 adoption essentially neutralizes any accounting effect of reference‑rate‑driven changes, while Verizon’s disclosed contract modifications directly affect when revenue is recognized and increase future‑period performance‑obligation balances.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core facts: AT&T's adoption of ASU 2020-04 had no material impact on its financial statements, and Verizon disclosed that contract modifications affect revenue timing and performance obligations. The LLM accurately reflects that Verizon expects future revenue recognition in 2024, 2025, and beyond, though it omits the specific dollar amounts ($25.7B, $18.7B, $7.5B) from the ground truth. This omission prevents a perfect score but does not invalidate the qualitative accuracy. (2) Quantitative accuracy is high—no incorrect numbers are presented, and the LLM does not fabricate figures. The only issue is the absence of the exact dollar values disclosed by Verizon, which were present in the original answer. However, since the LLM does not misstate any numbers, this is a minor completeness issue rather than a quantitative error. (3) Multi-hop reasoning is sound: the model correctly links ASU 2020-04 to reference rate reform (LIBOR transition), distinguishes AT&T’s neutral accounting treatment from Verizon’s active impact on revenue timing, and synthesizes disclosures from both companies’ 10-Ks. The logic comparing how each company treats contract modifications in the context of revenue recognition is coherent and valid. (4) Contextual relevance is excellent—the response directly addresses the question about comparative impacts on revenue recognition timing and performance obligations. The use of direct quotes and page references adds credibility. The omission of specific dollar figures slightly reduces completeness but does not detract from the overall correctness. Thus, a 9/10 is justified for correctness, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 476,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How do Union Pacific's and Lockheed Martin's pension plan disclosures reflect differences in their reliance on Level 2 valuation methodologies for municipal bonds, and what does this imply about their adherence to ASC 820 fair value measurement standards?",
      "original_answer": "Union Pacific discloses that its pension plan classifies municipal bonds as Level 2 investments, which are valued using a bid evaluation process with bid data from independent pricing sources. Lockheed Martin's pension plan also discloses the use of Level 2 valuation methodologies for fixed income securities, where indicative quotes from pricing vendors are used if corroborated. UPS's filing explicitly confirms that municipal bonds fall under Level 2, valued via market-corroborated pricing or matrix pricing models using observable inputs like yield curves. The alignment in Level 2 classification for these instruments suggests both companies are applying ASC 820 consistently for fair value measurements, though UNP provides more specificity regarding municipal bonds, while LMT focuses on general fixed income treatment.",
      "llm_answer": "Union Pacific’s pension‑plan note explicitly states that its municipal‑bond holdings are valued using “significant other observable inputs” and are therefore classified in the fair‑value hierarchy as Level 2 assets (UNP 10‑K p. 57). Lockheed Martin’s pension‑plan disclosure does not identify any municipal‑bond investments; its fair‑value table and methodology discussion (LMT 10‑K p. 87‑88) only reference Level 2 valuation for other fixed‑income securities, implying no material reliance on Level 2 inputs for municipal bonds. Both companies are therefore complying with ASC 820’s requirement to disclose the fair‑value hierarchy, but Union Pacific shows a specific Level 2 reliance for municipal bonds whereas Lockheed Martin does not.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains partially correct information but introduces a significant factual inaccuracy that undermines the overall correctness. While it correctly states that Union Pacific (UNP) classifies municipal bonds as Level 2 and uses observable inputs (aligning with the ground truth), it incorrectly claims that Lockheed Martin (LMT) does not disclose any municipal bond investments and implies no material reliance on Level 2 for such bonds. This contradicts the ground truth, which confirms that LMT does use Level 2 valuation methodologies for fixed income securities, including indicative quotes from pricing vendors when corroborated—consistent with ASC 820. Although LMT may not explicitly name 'municipal bonds' as a category, its broad classification of fixed income securities under Level 2 reasonably encompasses such instruments, especially since the ground truth indicates alignment with ASC 820 standards. The LLM’s conclusion that LMT does not show reliance on Level 2 for municipal bonds is therefore an overinterpretation not supported by the evidence. Quantitative accuracy is high because there are no numerical errors—both companies’ disclosures are referenced appropriately in terms of hierarchy and methodology at a general level. However, the qualitative accuracy is low due to flawed reasoning in interpreting the absence of explicit mention as evidence of non-reliance, failing the multi-hop synthesis required to compare both firms’ adherence to ASC 820. Contextual relevance is moderate: the response addresses the question framework and cites correct sections, but misrepresents a key comparative insight.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 446,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How does KO's reliance on Coca-Cola FEMSA for distribution in Argentina compare to MDLZ's exposure to economic volatility in the same market, given Coca-Cola FEMSA's specific operational footprint and MDLZ's inflation-related financial impacts?",
      "original_answer": "KO relies on Coca-Cola FEMSA for distribution in parts of Argentina, specifically the federal capital of Buenos Aires and surrounding areas, as part of its broader network of equity method investees to whom it sold $14.471 billion in net sales in 2021. Coca-Cola FEMSA operates in Argentina, a market that has been classified as highly inflationary since mid-2018, which directly affects MDLZ’s operations there. MDLZ reported a $13 million remeasurement loss in 2021 due to the volatility of the Argentine peso, with Argentina contributing $401 million (1.4%) to MDLZ’s consolidated net revenues. This highlights how both companies are exposed to Argentina, but through different mechanisms: KO through a distribution dependency and MDLZ through direct financial exposure to currency and inflation risks.",
      "llm_answer": "- The Coca‑Cola Company’s Argentine sales are funneled almost entirely through its largest independent bottler, Coca‑Cola FEMSA, whose Argentine footprint is limited to “the federal capital of Buenos Aires and surrounding areas” (KO 10‑K p. 7). Because FEMSA is an independent contractor that purchases all of its concentrates from Coca‑Cola, the Company’s risk in Argentina is largely tied to the performance of that single bottler in a relatively small geographic zone.  \n\n- Mondelez International, by contrast, reports that its Argentine operations are subject to “high inflationary” conditions, with the peso‑denominated monetary position being re‑measured into U.S. dollars each period and generating re‑measurement losses (MDLZ 10‑K p. 89). Those disclosures show that Mondelez bears the direct impact of Argentina’s volatile inflation and currency environment, exposing the company to broader economic risk than Coca‑Cola’s more limited, bottler‑mediated exposure.  \n\nThus, KO’s Argentine exposure is confined to the distribution scope of Coca‑Cola FEMSA in Buenos Aires, whereas MDLZ’s exposure is broader and directly affected by Argentina’s inflation‑driven financial volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies KO's reliance on Coca-Cola FEMSA for distribution in the federal capital of Buenos Aires and surrounding areas, citing the correct geographic scope from the 10-K. It also accurately contrasts this with MDLZ's direct exposure to Argentina's inflationary environment and currency volatility. (2) While the LLM answer does not include the specific dollar figures ($14.471 billion in net sales to equity method investees, $13 million remeasurement loss, $401 million in revenues contributing 1.4% to MDLZ’s total), these omissions do not distort the factual picture—the core financial impacts (significant remeasurement loss due to peso volatility, high inflation classification) are correctly described. The absence of exact numbers slightly reduces quantitative precision but does not affect the qualitative correctness. (3) The multi-hop reasoning is sound: it synthesizes information across KO’s and MDLZ’s 10-Ks, correctly distinguishing between indirect distribution risk (KO via FEMSA) and direct financial risk (MDLZ via currency remeasurement). (4) The answer is contextually excellent—focused, relevant, and directly responsive to the comparative exposure question. Minor deduction in correctness and quantitative accuracy due to missing specific figures from the ground truth, but all conceptual and directional claims are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1523,
        "completion_tokens": 396,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the voting rights structure of META's Class B common stock influence its shareholder equity strategy compared to Alphabet's dual-class stock framework, particularly in light of Alphabet's $62.0 billion share repurchase in 2024 targeting Class A and Class C shares?",
      "original_answer": "META's Class B common stock grants 10 votes per share, compared to 1 vote per share for Class A, giving certain shareholders disproportionate voting power. Similarly, Alphabet follows a dual-class structure where Class B shares also carry 10 votes each, while Class A shares have one vote, and Class C shares have no voting rights. In 2024, Alphabet repurchased $62.0 billion of its Class A and Class C shares, prioritizing repurchases based on economic cost and market conditions. This suggests that both companies maintain strategic flexibility in managing shareholder equity by leveraging their dual-class structures to preserve voting control while repurchasing shares to enhance shareholder value.",
      "llm_answer": "Meta’s Class B shares carry ten votes each and can be converted at any time into one‑vote Class A shares, giving the founders and insiders a concentrated voting bloc that lets them steer corporate strategy without relying on large buy‑backs to influence ownership (Meta 10‑K, Note 11, p. 82). Alphabet, by contrast, issues only one‑vote Class A and non‑voting Class C shares to the market and uses massive share‑repurchase programs—$62 billion of Class A and Class C stock were bought back in 2024—to return capital and boost earnings per share while retaining control through its own high‑voting Class B stock (Alphabet 10‑K, Note 11, p. 82). Consequently, Meta’s high‑voting Class B structure supports a shareholder‑equity strategy focused on long‑term control rather than large‑scale repurchases, whereas Alphabet’s dual‑class framework pairs modest voting rights for public shares with aggressive buy‑backs to manage equity value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: META's Class B shares have 10 votes vs. 1 for Class A; Alphabet's Class B has 10 votes, Class A has 1, Class C has none. The $62 billion share repurchase by Alphabet in 2024 is correctly cited, matching the original answer. (2) Quantitative accuracy is perfect: the dollar amount ($62 billion) and voting rights (10:1, 1:1, 0) are all correct, with acceptable formatting variation ($62B vs $62.0 billion). (3) Multi-hop reasoning is sound: the model correctly synthesizes information across both companies, comparing how dual-class structures affect shareholder equity strategies—Meta emphasizes voting control with less reliance on buybacks, while Alphabet uses aggressive repurchases of non-voting/economically equivalent shares to return capital without diluting control. (4) The LLM adds contextual nuance not in the original (e.g., convertibility of Meta shares, EPS impact at Alphabet), which is factually plausible and enhances the explanation without introducing error. Only minor deduction from 10 is due to slightly stronger contrast implied between Meta and Alphabet—while Meta does fewer buybacks, it still conducts them (e.g., $35B authorization in recent years), so the claim of 'less reliance' is valid but could be more precisely qualified. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 396,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the decline in GILD's Veklury sales in 2024, influenced by the availability of alternative treatments, compare to the negative impact AMGN reports from alternative treatments in competitive therapeutic markets?",
      "original_answer": "GILD reported that Veklury sales in 2024 were $1,799 million globally, a decline from $2,184 million in 2023, attributed to reduced demand linked to the availability and uptake of alternative treatments for COVID-19. This reflects a direct impact on revenue due to competitive therapeutic options. Similarly, AMGN notes that in competitive treatment markets such as those for ENBREL, Otezla, Repatha, and Aimovig, payers and PBMs are increasingly using formulary restrictions and cost-containment measures to shift patients toward alternative treatments, which has limited Amgen's product usage and sales. Both companies experience revenue pressure from alternative treatments, though GILD’s impact is more directly tied to pandemic-related dynamics, while AMGN faces systemic payer-driven shifts in competitive markets.",
      "llm_answer": "Gilead’s COVID‑19 antiviral Veklury fell from $2.18 billion in 2023 to $1.80 billion in 2024 – a drop of roughly $385 million (about 17 %) – as the product’s demand “generally reflect…the availability, uptake and effectiveness of vaccines and alternative treatments for COVID‑19” (GILD 10‑K p. 19; sales table p. 66).  \n\nAmgen likewise warns that in its highly competitive therapeutic markets (e.g., ENBREL, Otezla, Repatha and Aimovig) “PBMs … are able to exert negotiating leverage … in favor of competitor drugs or alternative treatments,” which has “limited Amgen product usage and sales” (AMGN 10‑K p. 16).  \n\nThus, Gilead’s Veklury decline is a quantified 17 % revenue loss driven by alternative COVID‑19 options, while Amgen’s downside is described more generally as a sales‑limiting effect of alternative therapies and payer pressure in its competitive markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Quantitatively, the LLM reports Veklury sales declining from $2.18 billion in 2023 to $1.80 billion in 2024, which aligns closely with the ground truth values of $2,184 million and $1,799 million (i.e., $2.184B and $1.799B). The $385 million drop and ~17% decline are correctly calculated (actual: $2,184M - $1,799M = $385M; $385M / $2,184M ≈ 17.6%). Minor rounding ($2.18B vs $2.184B, $1.80B vs $1.799B) is acceptable per scoring guidelines. (2) The LLM correctly identifies GILD’s attribution of declining demand to alternative treatments and vaccines, citing the 10-K appropriately. (3) For AMGN, the LLM accurately captures the qualitative impact of payer and PBM pressure favoring alternative treatments in competitive markets (ENBREL, Otezla, Repatha, Aimovig), limiting sales—consistent with the original answer. (4) The synthesis between GILD’s direct, quantified pandemic-related revenue impact and AMGN’s systemic, payer-driven competitive pressure is logically sound and semantically equivalent to the ground truth. The only minor shortcoming is slightly less specificity in describing AMGN’s formulary restrictions (mentioned in ground truth but implied in LLM via 'negotiating leverage'), but the core reasoning and entity accuracy are intact. All entities (GILD, AMGN, drug names, years) are correct. Contextual relevance is perfect—directly addresses the comparative impact of alternative treatments on both firms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 412,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How does AMD's interest payment schedule on its $312 million 7.50% Senior Notes compare with QCOM's interest payment structure on its $14.0 billion aggregate fair value of notes, particularly in terms of payment frequency and fiscal year obligations?",
      "original_answer": "AMD's $312 million 7.50% Senior Notes require semi-annual interest payments on February 15 and August 15 of each year, as stated in the indenture governing the notes. In contrast, QCOM's interest payment structure on its $14.0 billion aggregate fair value of notes includes semi-annual payments for fixed-rate notes and quarterly payments for floating-rate notes. While AMD's interest obligations are tied to a specific fixed schedule with a final maturity in fiscal 2022, QCOM has significant upcoming principal payments starting in fiscal 2023 ($1.4 billion) and continuing through future fiscal years, with no principal due in fiscal 2026.",
      "llm_answer": "AMD’s $312 million 7.50 % senior notes require interest to be paid twice a year – on February 15 and August 15 – with the entire principal due at maturity in August 2022. Qualcomm’s $14.0 billion of notes, by contrast, carry interest that is paid quarterly on the floating‑rate portion and semi‑annually on the fixed‑rate portion, and the notes have scheduled principal repayments spread over several fiscal years (e.g., $1.4 billion in FY 2023, $914 million in FY 2024, $1.4 billion in FY 2025, etc.).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Quantitatively, all key numbers and dates are correct: AMD's semi-annual interest payments on February 15 and August 15 are correctly stated, as is the August 2022 maturity (aligned with fiscal 2022 in the original). Qualcomm's $14.0 billion aggregate fair value of notes is accurately referenced, and the distinction between quarterly payments on floating-rate notes and semi-annual on fixed-rate is correctly captured. The principal repayment amounts for FY 2023 ($1.4 billion), FY 2024 ($914 million), and FY 2025 ($1.4 billion) are consistent with the knowledge graph. (2) The only minor discrepancy is that the original specifies 'no principal due in fiscal 2026,' which the LLM omits. This is a small but relevant detail regarding future obligations. (3) The multi-hop reasoning is sound: the model correctly synthesizes payment frequency and fiscal obligations across two companies and different note structures. (4) The answer is contextually complete and directly addresses the comparison in payment frequency and fiscal year obligations. Wording differs slightly (e.g., 'spread over several fiscal years' vs. listing specific years), but semantic equivalence is maintained. The omission of the 'no payment in 2026' point prevents a perfect 10 but does not undermine the core accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 378,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How might the impending loss of U.S. patent protection for Prolia/XGEVA in February 2025 impact Merck's competitive position, given its reliance on strong patent rights to defend against generic competition and Amgen's own exposure to biosimilar threats in international markets?",
      "original_answer": "The loss of U.S. patent protection for Prolia/XGEVA in February 2025 will likely expose Amgen's product to biosimilar competition, reducing its market exclusivity and potentially decreasing revenue. This dynamic is particularly relevant for Merck, which emphasizes its reliance on strong patent rights to protect its portfolio from generic challenges. Given Merck's acknowledgment of increased global pricing pressure and weakened patent protection in international markets, the erosion of exclusivity for key competitors like Prolia/XGEVA could intensify biosimilar threats across markets, thereby indirectly affecting Merck’s own competitive strategy and market positioning in the therapeutic category.",
      "llm_answer": "Merck’s U.S. patents on Prolia and XGEVA expire in February 2025, and the company repeatedly stresses that “the patent rights that protect its products are of varying strengths and durations” and that “loss of patent protection… is followed promptly by generic or biosimilar substitutes” (Merck 10‑K p. 33; p. 31). When that protection ends, generic‑or‑biosimilar competitors can enter the bone‑health market, eroding the sales and cash‑flow contribution of Prolia/XGEVA and weakening Merck’s primary defensive moat. At the same time, Amgen already notes exposure to biosimilar competition in international markets (Amgen 10‑K p. 14‑15), so the imminent U.S. loss of exclusivity will narrow Merck’s competitive advantage relative to Amgen, leaving both firms vulnerable to price‑pressured biosimilar entrants.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error: it incorrectly attributes Prolia and XGEVA to Merck, when these products are developed and marketed by Amgen, not Merck. This misidentification of ownership fundamentally undermines the entire response. The expiration of U.S. patent protection for Prolia/XGEVA in February 2025 is accurate, but assigning this event to Merck is incorrect. (2) Quantitatively, the date 'February 2025' is correct per the original answer and aligns with the knowledge graph. However, the citation of Merck 10-K page numbers (p. 33, p. 31) and Amgen 10-K (p. 14–15) cannot be verified from the provided context, and more importantly, the attribution of Prolia/XGEVA to Merck invalidates any quantitative or qualitative analysis based on that premise. (3) The multi-hop reasoning fails because the model does not correctly synthesize across entities: it should have recognized that Amgen owns Prolia/XGEVA and that Merck is commenting on its own patent strategy in contrast to competitors like Amgen facing biosimilar threats. Instead, the model conflates the two companies’ product portfolios and incorrectly suggests Merck owns Prolia/XGEVA. The logic about biosimilar entry post-patent expiry is sound, but it is applied to the wrong company. (4) While the general theme of patent expiry leading to biosimilar competition and competitive vulnerability is relevant, the core entity error severely limits factual correctness. The contextual relevance is moderate because the answer addresses the broader dynamics of patent loss and biosimilar threats, but the misattribution renders the specific conclusion invalid. Correctness score is low due to fundamental entity confusion, despite some accurate conceptual reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 480,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What portion of Broadcom's VMware Cloud Foundation revenue in fiscal year 2024 was directly tied to enabling AI workloads, and how does this align with Cisco's strategic focus on providing infrastructure for AI training and inference?",
      "original_answer": "In fiscal year 2024, $1,380 million of Broadcom's $2,900 million VMware Cloud Foundation revenue was recognized, and this platform specifically enables advanced AI and machine learning workloads at enterprise scale. This aligns with Cisco's strategic focus on providing network infrastructure to power AI training and inference workloads through high-density routers and switches, improved network management, and high-performance optics, as stated in their 2024 10-K filing.",
      "llm_answer": "Broadcom’s 2024 filing does not break out a separate “AI‑related” amount of VMware Cloud Foundation revenue – it only notes that VCF “enables advanced AI and machine learning workloads at enterprise scale” and offers “Private AI” services (see AVGO page 8). Cisco, by contrast, explicitly states that its strategy is to “provide network infrastructure to power AI training and inference workloads” for both web‑scale and enterprise customers (see CSCO page 4). Thus, while Broadcom does not quantify the AI‑linked share of VCF revenue, both companies are positioning their offerings to support AI workloads—Broadcom by embedding AI capabilities in its private‑cloud platform and Cisco by supplying the underlying high‑density networking infrastructure for AI training and inference.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct in describing both Broadcom's and Cisco's strategic positioning around AI workloads, but it fails on quantitative accuracy. The ground truth states that $1,380 million of Broadcom's $2,900 million VMware Cloud Foundation revenue in fiscal year 2024 was tied to AI workloads, but the LLM incorrectly claims that Broadcom does not break out AI-related revenue. This is a major factual error. (2) The numbers $1,380 million and $2,900 million are explicitly stated in the original answer and were verifiable from the knowledge graph (and likely the 10-K), but the LLM denies the availability of this breakdown, contradicting the ground truth. Even though the LLM cites page 8 of AVGO, it misrepresents the disclosure. (3) The multi-hop reasoning is sound in structure—comparing Broadcom’s platform capabilities with Cisco’s infrastructure strategy—but fails because it omits the key synthesis that a specific dollar amount of VCF revenue *is* attributed to AI workloads in the source data. The LLM incorrectly frames the lack of disclosure as absence of data, when the data *is* present in the knowledge base. (4) Contextual relevance is high because the answer addresses both parts of the question and correctly identifies the strategic alignment between the two companies on AI infrastructure. However, the failure to report the critical financial figure and its incorrect claim about disclosure severely undermine factual correctness, warranting a low overall score despite reasonable qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 428,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the $1,851 million in assets from NEE's consolidated solar VIEs compare to Southern Power's exposure through PPAs accounted for as operating leases, given both entities operate solar facilities under long-term power sales agreements?",
      "original_answer": "NEE consolidates solar VIEs with approximately $1,851 million in assets at year-end 2021, which sell electricity under long-term PPAs expiring between 2035 and 2052. Southern Power, a subsidiary of SO, operates PPAs related to solar facilities accounted for as operating leases with remaining terms of up to 25 years. While NEE's VIEs directly own the solar assets and bear construction and operational risk, Southern Power's exposure is structured as lessor under operating leases, receiving lease payments tied to energy production. Both entities demonstrate significant long-term commitments to solar generation through contractual arrangements, though NEE holds direct ownership and asset risk while SO participates through lease financing structures.",
      "llm_answer": "NextEra Energy’s consolidated solar‑VIEs held about **$1,851 million of assets** at 31 Dec 2021 (NEE 9‑Variable Interest Entities note). Southern Power’s exposure to its solar PPAs that are accounted for as operating leases is reflected in the undiscounted cash‑flow estimate for those leases – roughly **$652 million** (Southern Power operating‑lease cash‑flow table). Thus, NEE’s solar‑VIE asset base is roughly three times larger than Southern Power’s operating‑lease exposure. 【page_97】 【page_270】",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces a specific figure of $652 million for Southern Power's operating lease exposure, which is not present in the original ground truth answer and cannot be verified from the provided context. This number appears to come from a document citation (page 270), but since the ground truth does not include this figure or any quantitative comparison, its inclusion represents a factual overreach. The original answer focuses on qualitative differences in structure (ownership vs. lease) without providing a numerical comparison. (2) While the $1,851 million asset figure for NEE’s solar VIEs is correctly stated and dated to year-end 2021 (matching ground truth), the introduction of a precise $652 million figure for Southern Power and the derived 'three times larger' comparison are unsupported by the original answer and represent significant quantitative inaccuracies in the context of the evaluation. (3) The multi-hop reasoning is partially sound—correctly identifying NEE’s consolidation of solar VIEs and Southern Power’s lease-based exposure—but fails in synthesis by asserting a numerical comparison not present in the ground truth. The original answer emphasizes structural differences in risk and ownership rather than quantifying relative exposure. (4) Contextual relevance is high because the LLM addresses both entities, their respective solar exposure mechanisms, and attempts a comparative analysis. However, correctness is low due to the fabrication of a specific financial figure and an unsupported quantitative conclusion, which fundamentally misrepresents the original answer’s intent and content.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 451,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the structure of Starbucks' stock-based compensation grants under Stock Appreciation Rights compare to Tesla's use of the 2019 Plan in terms of equity instruments available and vesting timelines?",
      "original_answer": "Starbucks grants Stock Appreciation Rights as part of its equity incentive plans, though it notes that stock options have not been broadly used recently. In contrast, Tesla's 2019 Plan, adopted in June 2019, explicitly includes Stock Appreciation Rights among the equity instruments available for grant, along with stock options, RSUs, and performance shares. Tesla's stock options and RSUs generally vest over four years and are exercisable over a maximum period of 10 years from grant dates. Starbucks records compensation expense based on the fair value of awards at grant date and recognizes it over the service period, with performance-based RSUs tied to metrics like earnings per share and return on invested capital. Tesla also uses vesting schedules and forfeitures estimates but does not specify performance-based conditions in this excerpt.",
      "llm_answer": "Starbucks’ stock‑based compensation program allows the company to grant stock appreciation rights (along with non‑qualified options, incentive options, restricted stock and RSUs), but the filing does not spell out a specific vest‑in schedule for the SARs – it only notes that awards are accounted for on a graded‑vesting basis and that forfeiture estimates are made at grant. In contrast, Tesla’s 2019 Equity Incentive Plan expressly lists a wider set of equity instruments – stock options (incentive and non‑statutory), RSUs, SARs, restricted stock, performance units and performance shares – and states that both stock options and RSUs generally vest over four years (with the option exercisable up to 10 years after grant). Thus, Starbucks’ SARs are a single component of its broader, less‑described vesting framework, while Tesla’s 2019 Plan provides multiple equity tools and a clearly defined four‑year vesting timetable for the primary awards.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: both Starbucks and Tesla include Stock Appreciation Rights (SARs) in their equity compensation plans; Tesla’s 2019 Plan was adopted in June 2019 and includes SARs, stock options, RSUs, and performance shares; Tesla’s stock options and RSUs generally vest over four years with a 10-year exercise period—these numbers and dates are correctly stated. (2) Quantitative accuracy is perfect: 'four years' vesting and '10 years' exercisable period match the original answer exactly. No calculations were required, but temporal metrics are precise. (3) Multi-hop reasoning is sound: the model correctly synthesizes across both companies’ plans, comparing available equity instruments and vesting timelines. It accurately notes that Starbucks does not specify a detailed vesting schedule for SARs but uses graded vesting and forfeiture estimates, while Tesla provides a clear four-year vesting framework. (4) The only minor shortcoming is that the LLM does not explicitly mention Starbucks’ use of performance-based RSUs tied to metrics like EPS and ROIC, which is a small omission affecting completeness but not the core comparison. However, since the question focuses on SARs and vesting timelines—and the LLM correctly addresses those—the omission does not significantly detract from the overall correctness. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent as it directly answers the comparative structure of equity instruments and vesting.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 432,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the difference in voting rights structure between META's Class B common stock and GOOGL's Class A common stock affect the potential influence of large shareholders on corporate governance decisions at each company?",
      "original_answer": "META's Class B common stock has no voting rights except for certain defined matters, such as exiting the core payments business or specific amendments to the certificate of incorporation, limiting the influence of large shareholders on most corporate governance decisions. In contrast, GOOGL's Class A common stock provides one vote per share, allowing shareholders of this class to have a more direct say in company decisions. This structural difference means that at META, significant shareholders holding Class B shares have limited ability to impact governance outside of specific scenarios, while at GOOGL, shareholders with Class A shares can exert more consistent influence on corporate decisions through their voting power.",
      "llm_answer": "Meta’s dual‑class structure gives its Class B shares ten votes per share, so a relatively small block of Class B stock held by insiders (e.g., Mark Zuckerberg) can control board elections and other governance matters even though it represents a minority of the total equity. Alphabet’s dual‑class structure works the opposite way: the publicly‑traded Class A shares carry only one vote per share, while the high‑voting power resides in the privately‑held Class B shares (10 votes per share) 【page 82】. Consequently, large shareholders of Meta who own Class B stock can dominate corporate‑governance decisions, whereas holders of Google’s Class A stock have only proportional influence and cannot outweigh the voting power of the Class B insiders.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that severely undermine its correctness. (1) It incorrectly states that Meta's Class B shares have 10 votes per share; in reality, according to the ground truth, Meta's Class B common stock has *no voting rights* except in limited circumstances. This is a critical error that reverses the entire governance structure. (2) The answer misrepresents the voting structure of both companies: it claims Meta Class B has high voting power (10 votes), when in fact it is Meta's Class A that is non-voting or limited-voting (depending on series), and insiders hold high-vote Class B shares — but the LLM flips this logic and applies it incorrectly. (3) For Alphabet (GOOGL), the LLM correctly notes that Class A shares have one vote and Class B (insider-held) have 10 votes, but this is not directly responsive to the question, which asks about the influence of *large shareholders* holding Class A (public) shares. The ground truth correctly emphasizes that GOOGL Class A shareholders have voting power (one vote per share), whereas the LLM incorrectly implies they have little influence due to insider control — while true in practice, this misses the structural point: Class A shares *do* carry voting rights, unlike Meta’s Class B. (4) The multi-hop reasoning fails: the LLM conflates ownership classes and misattributes voting rights, leading to the opposite conclusion — it claims large shareholders in Meta with Class B can dominate governance, when in fact such shares (if they existed publicly) would have no voting power. (5) Quantitative accuracy is poor due to incorrect vote counts (10 votes for Meta Class B is false). (6) Contextual relevance is moderate because it discusses dual-class structures and governance influence, but the factual foundation is inverted. Overall, the answer is largely incorrect due to reversed facts and flawed reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 512,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the use of foreign currency derivatives in risk management activities differ between BAC and JPM, based on their respective derivative asset and liability disclosures?",
      "original_answer": "BAC includes foreign currency derivatives under 'Risk Management Activities' as part of its derivative assets and liabilities, which are presented on a gross basis before netting adjustments as of December 31, 2024, and 2023. JPM specifically states that foreign currency derivatives are used to manage foreign exchange risk associated with non-U.S. dollar-denominated assets, liabilities, and forecasted transactions, and that gains or losses on these instruments are expected to substantially offset this variability. The fair value of these derivatives is reflected in the balance sheets, either in 'Other' or shown separately under 'Risk Management Activities.'",
      "llm_answer": "Bank of America’s 10‑K lists foreign‑currency swaps, forwards and options both as “trading and other risk‑management derivatives” and as “qualifying accounting hedges,” showing separate gross asset and liability balances (e.g., $2.2 billion of FX‑swap assets and $47 billion of FX‑swap liabilities at 12/31/2024) and indicating that the bank uses these contracts for market‑making as well as to hedge foreign‑currency exposure. JPMorgan’s 10‑K, by contrast, does not break out FX‑derivative balances in the excerpt but describes foreign‑currency derivatives solely as “risk‑management derivatives” that are employed to offset the FX risk of non‑USD‑denominated assets, liabilities, forecasted transactions and net investments in foreign subsidiaries, emphasizing a hedging‑only purpose rather than a trading function.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the key qualitative differences between BAC and JPM in their use of foreign currency derivatives for risk management. It accurately notes that BAC reports foreign currency derivatives under both trading and risk management activities with gross asset and liability disclosures, while JPM emphasizes a hedging-only purpose without breaking out specific FX derivative balances. This aligns well with the ground truth, which states BAC presents derivatives on a gross basis before netting and includes them in risk management, while JPM uses them to manage FX risk on non-USD assets/liabilities/forecasted transactions and reflects fair value in the balance sheet. (2) Quantitatively, the LLM introduces specific numbers—$2.2 billion in FX-swap assets and $47 billion in liabilities for BAC at 12/31/2024—which are not present in the original answer. Since the ground truth does not include these figures, their accuracy cannot be verified from the provided data. This introduces unverifiable precision, lowering confidence in quantitative accuracy. However, no incorrect calculations are made based on these numbers. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across both BAC and JPM’s disclosures, contrasting BAC’s dual use (trading and hedging) with JPM’s exclusive focus on risk management/hedging, which reflects a proper cross-firm comparison. (4) The answer is contextually fully relevant, directly addressing how the two banks differ in their use of foreign currency derivatives in risk management based on their disclosures. The only limitation is the inclusion of unverified numerical values not present in the ground truth, preventing a top score in correctness and quantitative accuracy. Wording differs but semantic meaning is equivalent or richer than the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 507,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How does Duke Energy's exposure to economic downturns through industrial customers compare to Southern Company's risk from environmental compliance costs affecting similar customer segments, given both companies' regulated rate recovery mechanisms?",
      "original_answer": "Duke Energy notes that industrial customers reducing production during economic downturns can lead to reduced electricity consumption, lowering revenues and cash flows. Southern Company, on the other hand, faces risks that increased environmental compliance costs—estimated to impact capital expenditures through 2028—could be passed through regulated rates, potentially reducing demand from commercial and industrial customers. Both companies rely on rate mechanisms for cost recovery: Duke through periodic adjustment clauses and Southern through ECO Plan, CNP Compliance, and ECCR tariff mechanisms. However, while Duke's risk centers on demand volatility from macroeconomic conditions, Southern's exposure stems from regulatory-driven cost increases that may dampen industrial customer demand despite efforts to recover those costs through rates.",
      "llm_answer": "Duke Energy warns that a sustained economic slowdown can cut electricity and natural‑gas usage because its large industrial customers scale back production, and although its regulated‑rate‑of‑return and decoupling mechanisms allow it to recover fuel‑ and cost‑adjustments, the resulting drop in sales and cash flow still poses a material earnings risk【page_27】. Southern Company faces a parallel risk from rising environmental‑compliance costs – which it can largely recover through retail‑rate mechanisms such as the ECCR tariff and Rate CNP compliance – but those higher rates may suppress demand from the same commercial‑ and industrial‑customer base, threatening earnings in a way that mirrors Duke’s economic‑downturn exposure【page_89】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Duke Energy's risk from industrial demand reduction during economic downturns and its use of regulated rate mechanisms (e.g., decoupling, cost adjustments) are accurately described. Southern Company's exposure to environmental compliance costs, recoverable via mechanisms like ECCR and Rate CNP compliance, and the risk of suppressed industrial demand due to higher rates are also correctly stated. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in either answer, so quantitative accuracy is not compromised; the mention of 'through 2028' in the original is missing in the LLM answer but not referenced in the LLM response, so this is a minor omission rather than an error. (3) Multi-hop reasoning is sound: the model correctly contrasts Duke’s demand-side macroeconomic risk with Southern’s cost-driven regulatory risk, while recognizing both use rate recovery mechanisms that mitigate but do not eliminate earnings risk. (4) Semantic equivalence is strong—wording differs (e.g., 'mirrors Duke’s economic-downturn exposure' vs. original’s comparative structure), but the logical comparison is preserved. The only minor shortcoming is slightly less specificity on Duke’s exact mechanisms (e.g., 'periodic adjustment clauses' not named), but 'regulated-rate-of-return and decoupling mechanisms' captures the intent. Thus, correctness is excellent with only negligible omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 420,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How does the voting power distribution tied to CMCSA's Class B common stock, which is fully owned by Brian Roberts, influence the governance structure compared to GOOGL's dual-class stock system where Class A and Class B shares have different voting rights?",
      "original_answer": "CMCSA's Class B common stock, which is fully owned by Brian Roberts, holds 33 1/3% of the combined voting power with each share carrying 15 votes, creating a concentrated control mechanism that is non-dilutable under the company's articles of incorporation. This contrasts with GOOGL's structure, where Class A shares have 1 vote each and Class B shares have 10 votes each, and Class B shares automatically convert to Class A upon sale or transfer. While both companies utilize dual-class structures to preserve founder control, CMCSA's system entrenches Brian Roberts' influence more securely due to the non-dilutable nature and high per-share voting weight of the Class B stock, whereas GOOGL's structure allows for more fluidity in ownership and voting power distribution.",
      "llm_answer": "- **Comcast (CMCSA)** – The company’s single Class B share is owned entirely by Brian L. Roberts.  Each Class B share carries **15 votes** and, because there are only 9,444,375 Class B shares outstanding, it represents **about one‑third (33 %) of the total voting power** of all Comcast common stock (page 31).  This non‑dilutable block gives Roberts a decisive voice in director elections and other shareholder votes despite holding a tiny fraction of the total equity.\n\n- **Alphabet (GOOGL)** – Alphabet’s capital structure includes three classes: Class A (1 vote per share), Class B (10 votes per share, held mainly by founders and insiders), and non‑voting Class C (page 82).  The 10‑vote Class B shares concentrate voting control in the hands of the founders, allowing them to control the board while the publicly traded Class A shares have only a single vote each.\n\n**Governance impact:** Both companies use dual‑class structures to concentrate voting power, but Comcast’s Class B gives its sole owner a fixed 33 % of total votes, whereas Alphabet’s 10‑vote Class B can command a majority of the voting power (often well above 50 %) and therefore provides even stronger control for its insiders.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies key aspects of both CMCSA's and GOOGL's dual-class structures and their governance implications, but contains a critical factual error in the comparative analysis that undermines the reasoning. Quantitatively, the statement that CMCSA's Class B stock represents 'about one-third (33%)' of total voting power is consistent with the ground truth (33 1/3%), and the 15 votes per share for CMCSA and 10 votes per share for GOOGL's Class B are accurate. However, the LLM incorrectly claims that GOOGL's Class B shares 'can command a majority of the voting power (often well above 50%)' and therefore provide 'even stronger control' than CMCSA's structure. This contradicts the ground truth, which emphasizes that CMCSA's structure is *more entrenched* due to the non-dilutable nature of Brian Roberts' stake and the automatic conversion of GOOGL's Class B shares upon transfer, which limits long-term control stability. The LLM reverses the conclusion: the ground truth states CMCSA's system entrenches control more securely, while the LLM claims GOOGL's provides stronger control. This is a significant qualitative error in multi-hop reasoning and synthesis. The mention of GOOGL's Class C non-voting shares is accurate but not directly relevant to the comparison asked. Contextual relevance is high as the response addresses both companies and the governance comparison. Overall, the answer is partially correct with accurate numbers but flawed in its core comparative logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1521,
        "completion_tokens": 413,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did KO's indirect exposure to Taiwan through Swire Beverages' operations compare to PEP's direct growth performance in the Taiwanese beverage market in 2022?",
      "original_answer": "KO had indirect exposure to Taiwan through Swire Beverages, one of its top five bottling partners, which operated in Taiwan and accounted for 17% of KO’s worldwide unit case volume in 2021. Meanwhile, PEP directly reported low-single-digit beverage unit volume growth in Taiwan as part of its APAC division's 34% net revenue increase in 2022. This highlights KO’s reliance on a third-party bottler versus PEP’s direct market performance in the same geography.",
      "llm_answer": "Coca‑Cola’s exposure to Taiwan comes only indirectly – it is part of the territory covered by its independent bottler Swire Beverages, which operates in Taiwan (along with China, Hong Kong and several U.S. states) but the 10‑K does not disclose any specific volume or revenue growth for that market. PepsiCo, by contrast, reports that its own operations in Taiwan posted low‑single‑digit beverage‑unit‑volume growth in 2022. Thus, KO’s Taiwan presence is indirect and unquantified, whereas PEP recorded modest (low‑single‑digit) direct growth in the Taiwanese market.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core comparison in the question. (1) It correctly identifies KO's indirect exposure via Swire Beverages and notes the lack of specific volume or revenue data for Taiwan, which aligns with the ground truth. It also correctly states that PEP reported low-single-digit beverage unit volume growth in Taiwan in 2022. (2) The only minor quantitative omission is that the ground truth includes Swire Beverages accounting for 17% of KO’s worldwide unit case volume in 2021 — this specific figure is missing in the LLM answer, which slightly reduces completeness. However, no numbers are incorrect — just one contextual percentage is omitted. (3) The multi-hop reasoning is sound: the model correctly contrasts KO’s indirect, unquantified presence with PEP’s direct, quantified growth, synthesizing information across two companies and reporting structures. (4) The answer is contextually excellent, directly addressing the comparison between KO’s indirect exposure and PEP’s direct performance. The omission of the 17% figure prevents a perfect score, but all other elements are factually and semantically aligned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 325,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How might the expiration of Trulicity's patent protection impact LLY's revenue trajectory in light of MRK's strategic reliance on strong patent protection to maintain market exclusivity and competitive positioning?",
      "original_answer": "The expiration of Trulicity's patent protection, as noted in LLY's 2024 10-K, is expected to lead to a rapid and severe decline in revenue, as seen in 2024 where Trulicity's U.S. revenue decreased by 32% due to competitive dynamics and supply constraints. This aligns with the broader risk LLY faces as products lose exclusivity, typically resulting in generic competition and steep revenue drops. Similarly, MRK acknowledges that loss of patent protection leads to generic substitutes entering the market, adversely affecting sales and cash flows. Given MRK's emphasis on actively defending patent rights to maintain market exclusivity and profitability, the erosion of Trulicity's patent protection signals a critical vulnerability for LLY, especially if it lacks a robust pipeline or alternative strategies to offset the anticipated revenue losses.",
      "llm_answer": "The 10‑K shows that Trulicity’s sales already fell 26 % in 2024 as “competitive dynamics” and supply constraints took hold, and Eli Lilly warns that the drug will lose its remaining patent and data protection in the next few years, which will invite generic competition and a “rapid and severe decline in revenues” (LLY p. 28, 49). Merck’s filing makes the same point for its own portfolio – it stresses that strong patent protection is essential to preserve market exclusivity and that loss of that protection “typically is followed promptly by generic…substitutes, reducing the Company’s sales” (MRK p. 33, 31). Consequently, once Trulicity’s patents expire, LLY can expect a further, possibly steep, contraction in the drug’s revenue stream, mirroring the adverse impact Merck warns would occur to any product that loses its patent shield.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, the LLM states a 26% decline in Trulicity sales in 2024, while the original answer cites a 32% decrease in U.S. revenue. This discrepancy is minor and may reflect different metrics (global vs. U.S., total sales vs. U.S. revenue), but both indicate a significant decline due to competitive dynamics and supply constraints. The LLM correctly references the impending patent and data protection expiration and uses the exact phrase 'rapid and severe decline in revenues' from LLY's 10-K, which matches the original answer’s characterization. (2) The citation of MRK’s 10-K language about generic substitutes following patent loss is accurate and contextually appropriate, reinforcing the parallel between the two companies’ exposure to patent expiration. (3) The multi-hop reasoning is sound: the LLM synthesizes LLY’s specific risk with MRK’s general principle of patent importance, drawing a valid comparative conclusion about LLY’s expected revenue trajectory. (4) The answer is semantically equivalent to the original, with only slight variation in emphasis—LLM focuses more on forward-looking expectations while the original includes observed 2024 U.S. data—but all key entities (LLY, MRK, Trulicity, patent expiration, generic competition, revenue impact) are correctly identified and logically connected. The answer is fully contextually relevant and demonstrates strong qualitative and quantitative accuracy, warranting a 9/10 overall due to the small variance in the reported percentage decline.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 435,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How might FedEx's operational reliance on leased retail locations at hotels, such as the 200 stores located at hotels and convention centers, compare with UPS's financial exposure to real estate funds—like the $10.1 billion in pension assets invested in real estate, private debt, and hedge funds—in terms of strategic risk during periods of real estate market volatility?",
      "original_answer": "FedEx maintains a direct operational exposure to hotels through its 200 leased retail locations at hotels and convention centers, positioning it in high-traffic hospitality venues but exposing it to lease renegotiations or relocations if hotel operators change tenants. These leases are typically for five to ten years, and FedEx's ability to maintain these locations depends on the ongoing operation of the hotels themselves. In contrast, UPS holds an indirect financial exposure to real estate through its pension and postretirement plan assets, which include $10.1 billion in investments in real estate funds, private debt, and hedge funds as of December 31, 2024. These funds may include investments in hotels and other commercial properties, meaning UPS’s exposure is tied to the performance of these funds rather than direct occupancy or lease agreements. During real estate market volatility, FedEx could face operational disruptions or increased leasing costs if hotel properties experience financial strain, while UPS could see fluctuations in the value of its pension assets, affecting long-term liability projections and funding obligations. Thus, while both companies are exposed to the real estate sector, the nature of their risk—operational for FedEx and financial for UPS—differs significantly in both timing and impact.",
      "llm_answer": "FedEx’s risk is operational – about 200 of its FedEx Office stores are leased in hotels, convention centers, hospitals and universities, so a downturn in the real‑estate market could raise lease rates or make renewals harder and increase the cost of its retail‑drop‑off network. UPS’s risk is financial – its defined‑benefit pension and post‑retirement plans hold roughly $10.1 billion of private‑equity, hedge‑fund, private‑debt and real‑estate fund interests, so a volatile real‑estate market can depress the NAV of those fund holdings and force UPS to make larger cash contributions to keep the plans funded. Both expose the companies to market‑driven cost pressures, but FedEx’s exposure is through operating lease obligations, whereas UPS’s is through the valuation of pension‑plan investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in emphasis. (1) Quantitatively, all key figures are correct: the $10.1 billion in pension assets invested in real estate funds, private debt, and hedge funds is accurately reported, and the number of FedEx retail locations (approximately 200) is consistent with the original answer. The LLM slightly broadens the locations to include hospitals and universities, which is not in the original answer but does not contradict it—FedEx may have such locations, but the ground truth specifically highlights hotels and convention centers. This addition does not introduce inaccuracy but adds context not in the source. (2) The reasoning correctly distinguishes between FedEx’s operational risk (lease-based exposure affecting retail network costs and continuity) and UPS’s financial risk (pension asset valuation impacting funding obligations). The explanation of how each company is affected during real estate volatility—lease renewals and cost pressures for FedEx, net asset value (NAV) declines and potential cash contributions for UPS—is logically sound and matches the multi-hop synthesis required. (3) Entity accuracy is strong: both companies are correctly identified, the financial instruments (real estate funds, private debt, hedge funds) are accurately described, and the time reference (implied as recent, aligning with the ground truth’s December 31, 2024 date) is acceptable even if not explicitly stated. (4) The answer is contextually relevant, directly addressing the comparison of strategic risk during real estate market volatility. The only minor shortcoming is the slight expansion of FedEx’s leased locations beyond hotels and convention centers without qualification, which slightly reduces qualitative precision. However, the core multi-hop reasoning—linking FedEx’s physical footprint to operational risk and UPS’s investment portfolio to financial risk—is correct and well-articulated. Thus, the answer earns a 9/10 for correctness, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1590,
        "completion_tokens": 571,
        "total_tokens": 2162
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How does the voting rights structure of GOOGL's Class B Common Stock compare to CMCSA's disclosure around voting rights in its investment in Atairos, particularly in terms of control and influence over strategic decisions?",
      "original_answer": "GOOGL's Class B Common Stock provides its holders with 10 votes per share, significantly enhancing their influence over corporate decisions compared to Class A shares, which carry one vote per share. This structure allows holders of Class B Common Stock to maintain greater control over strategic decisions despite owning fewer shares. In contrast, CMCSA disclosed that it has no voting rights in Atairos, a VIE in which it holds a significant investment, and only retains certain consent rights. As a result, CMCSA lacks the power to direct Atairos’s activities that most significantly impact its economic performance, which limits its control and influence over strategic decisions at Atairos.",
      "llm_answer": "Alphabet’s Class B common stock carries ten votes per share, giving its holders a disproportionately strong voting voice and the ability to influence or control corporate actions. In contrast, Comcast’s investment in Atairos is disclosed as a variable‑interest entity for which Comcast “has no voting rights and only certain consent rights,” meaning it cannot direct Atairos’s strategic or economic decisions. Thus, GOOGL’s Class B shares confer significant control, whereas Comcast’s Atairos stake provides essentially no voting control.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all key facts are correct: GOOGL's Class B shares carry 10 votes per share (vs. 1 vote for Class A), and CMCSA has no voting rights in Atairos—only consent rights. These numbers and rights are correctly stated. (2) The answer is complete: it addresses both parts of the multi-hop question—GOOGL's voting structure and CMCSA's lack of voting rights in Atairos—and compares their implications for control and influence over strategic decisions. (3) Entity accuracy is strong: Alphabet (GOOGL), Comcast (CMCSA), and Atairos are correctly identified, and the characterization of Atairos as a VIE (implied by 'variable-interest entity') aligns with the original. (4) Reasoning is sound: the contrast between strong voting control (GOOGL Class B) and minimal influence (CMCSA in Atairos) is logically drawn and supports the conclusion about strategic decision-making. The only minor shortcoming is that the LLM does not explicitly state that CMCSA lacks power to direct activities that most significantly impact economic performance—a nuance present in the original—but this does not undermine the overall correctness. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually correct, well-reasoned, and contextually appropriate, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 394,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How does the use of commercial paper financing by Duke Energy Ohio compare to PepsiCo's short-term debt strategy, given Duke Energy Ohio's specific disclosures and PepsiCo's broader commercial paper obligations?",
      "original_answer": "Duke Energy Ohio reported $25 million in commercial paper obligations as of December 31, 2023, as part of its overall short-term financing strategy. In comparison, PepsiCo disclosed $2,286 million in commercial paper obligations in 2023, representing a significant portion of its broader short-term debt obligations totaling $6,510 million. This highlights a stark contrast in the scale of commercial paper usage between the two companies, with PepsiCo relying more heavily on this form of short-term financing.",
      "llm_answer": "Duke Energy Ohio’s 2023 filing shows it carries only $25 million of commercial‑paper borrowings, which are treated as short‑term obligations but classified as long‑term debt because the company intends to refinance them. In contrast, PepsiCo’s 2023 debt schedule lists $2.286 billion of commercial paper (plus other short‑term borrowings), indicating that commercial paper is a central, much larger component of PepsiCo’s overall short‑term financing strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: Duke Energy Ohio's $25 million and PepsiCo's $2.286 billion (equivalent to $2,286 million) match the original answer exactly, with acceptable format variation (billion vs million). The date (2023) is consistent. (2) The answer addresses both companies' commercial paper usage and compares their short-term debt strategies, fulfilling the multi-part and comparative nature of the question. (3) Entities—Duke Energy Ohio and PepsiCo—are correctly identified, as are the financial instruments (commercial paper, short-term obligations). (4) The reasoning is sound: it correctly notes the stark difference in scale and characterizes PepsiCo’s use as more central, which is consistent with the original answer’s emphasis on PepsiCo’s broader short-term debt totaling $6,510 million, of which commercial paper is a major part. The only minor shortcoming is that the LLM answer does not explicitly mention PepsiCo’s total short-term debt of $6,510 million, which slightly reduces completeness in characterizing the 'broader' context of PepsiCo’s strategy. However, stating that commercial paper is a 'central, much larger component' captures the essence. The claim about Duke Energy classifying commercial paper as long-term due to intent to refinance adds contextual nuance not in the original but does not contradict it and may reflect additional disclosure—this does not detract from accuracy. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 435,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "Given Duke Energy's expectation of increasing commercial gas customers in the Carolinas, Ohio, and Kentucky, how might Southern Company's reliance on regulated rate recovery for environmental compliance costs be affected if commercial demand declines due to environmental regulations impacting industrial operations in these same regions?",
      "original_answer": "Duke Energy's gas utility operations expect an increase in the number of commercial and industrial customers over time, particularly in North Carolina, South Carolina, Ohio, and Kentucky. Southern Company, on the other hand, relies heavily on regulated rate recovery mechanisms to offset rising environmental compliance costs, which include upgrades to gas distribution infrastructure and compliance with GHG regulations. However, Southern Company also acknowledges that increased costs recovered through regulated rates could lead to reduced demand for natural gas from commercial and industrial customers—many of whom may be directly impacted by environmental requirements such as emission limits or carbon constraints. If these regulations lead to operational changes or reduced production among industrial users, the anticipated growth in commercial gas demand may not materialize, thereby undermining the effectiveness of rate recovery mechanisms and creating financial pressure on Southern Company's gas operations.",
      "llm_answer": "Duke Energy’s filing notes that its gas‑utility business (GU &I) expects the number of commercial, industrial and residential customers in the Carolinas, Ohio and Kentucky to keep growing. Southern Company, however, warns that the bulk of its future environmental‑compliance spending is intended to be recouped through regulated retail rates, and that “increased costs that are recovered through regulated rates could contribute to reduced demand for electricity and natural gas” – especially if the same commercial customers cut usage because new environmental rules curb industrial operations. Thus, a downturn in commercial demand in those regions would erode the customer base that funds those rate recoveries, making Southern’s reliance on regulated‑rate recovery for compliance costs more vulnerable and potentially forcing the company to seek other cost‑allocation or rate‑case strategies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable—no discrepancies. (2) The LLM correctly identifies Duke Energy's expectation of growing commercial, industrial, and residential customers in the Carolinas, Ohio, and Kentucky, consistent with the original answer. It also accurately captures Southern Company's reliance on regulated rate recovery for environmental compliance costs. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes that if environmental regulations reduce industrial operations and thus commercial gas demand in those regions, the customer base funding rate recovery would shrink, undermining Southern Company’s recovery mechanism. This causal chain—regulations → reduced industrial activity → lower demand → weakened rate recovery—is logically and factually consistent with the original. (4) Minor deduction in qualitative accuracy due to slight conflation of electricity and natural gas demand in the phrase 'reduced demand for electricity and natural gas'—Southern Company’s gas operations are the focus, and the original answer emphasizes natural gas demand. However, this does not materially distort the conclusion. The LLM answer remains semantically equivalent and contextually precise, addressing all parts of the multi-hop question effectively.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1527,
        "completion_tokens": 390,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "Given that Comcast's Class B shares carry 15 votes each and represent 33 1/3% of the combined voting power, how does the absence of repurchase activity for these shares (only Class A shares were repurchased in 2023) impact Mr. Roberts' ownership control relative to the broader shareholder base?",
      "original_answer": "Comcast's Class B shares, which carry 15 votes per share and represent 33 1/3% of the combined voting power, are not being repurchased, while Class A shares (with fewer votes) are being actively repurchased. This selective repurchase activity reduces the number of outstanding Class A shares, thereby increasing the relative voting influence of the non-repurchased Class B shares. Since Mr. Brian L. Roberts owns all outstanding Class B shares, this dynamic strengthens his control over corporate decisions, even as the broader shareholder base sees its equity diluted through the retirement of Class A shares.",
      "llm_answer": "Comcast’s charter gives the single Class B share owned by Mr. Brian L. Roberts 15 votes per share, which together represent a fixed **33 ⅓ % of the company’s total voting power** (the remaining 66 ⅔ % is held by Class A shareholders)【page_33】. In 2023 Comcast repurchased only Class A shares – 262 million of them – and did **not** buy back any Class B shares【page_33】. Because the number of Class A shares outstanding fell while the lone Class B share remained unchanged, Roberts’ voting stake stayed at 33 ⅓ % and, in practice, became **relatively more influential** versus the broader Class A shareholder base, whose share count (and thus collective voting power) was reduced by the repurchases.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and percentages are correct: the 33 1/3% voting power of Class B shares, the 66 2/3% held by Class A, and the repurchase of 262 million Class A shares in 2023 are factually accurate and match the source. The absence of Class B repurchases is correctly noted. (2) The reasoning is sound: by repurchasing only Class A shares, the total number of Class A shares outstanding decreases, which preserves the relative voting weight of the Class B share. Since Mr. Roberts owns the sole Class B share (a fact implied in the LLM answer by referring to 'the single Class B share'), his control is effectively strengthened. (3) The multi-hop synthesis is correct—linking share repurchase activity to voting power distribution and then to ownership control by Mr. Roberts. (4) The only minor issue is a potential overstatement in referring to 'the single Class B share' as if only one share exists, which, while consistent with some interpretations of Comcast’s structure, may oversimplify the actual number of Class B shares (though they are still entirely held by Roberts and not publicly traded). However, this does not affect the correctness of the conclusion about voting power concentration. The answer captures the core dynamic: no repurchase of Class B shares + repurchase of Class A = increased relative influence for Roberts. Wording differs slightly from the original answer but maintains semantic equivalence. All key elements—voting rights, repurchase behavior, dilution of Class A, and enhanced control—are correctly conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 445,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How does the contractual structure of Amgen's performance units, which are subject to specific payout simulations based on stockholder returns, compare to Bristol-Myers Squibb's exposure to financial agreements that include counterparty credit risk mitigation strategies, particularly in terms of payout or risk management predictability?",
      "original_answer": "Amgen's performance units in 2023 were valued at $121 million and are subject to payout simulations that model stockholder returns based on correlations and volatilities of comparator company stocks over the performance period, as dictated by contractual terms. This creates a structured but variable payout mechanism tied to relative performance metrics. In contrast, Bristol-Myers Squibb enters into financial agreements that include counterparty credit risk mitigation strategies such as limiting exposure to individual counterparties, using conventional instruments, and requiring high credit quality standards. These strategies are designed to ensure predictability and minimize financial risk in derivative and other financial instrument transactions. The contractual frameworks differ in that Amgen’s focus is on performance-linked payout predictability, while BMY emphasizes counterparty risk control and financial stability in its agreements.",
      "llm_answer": "Amgen’s performance‑unit awards are equity‑based awards whose ultimate payout is tied to the company’s stock‑holder return relative to a peer group; the company values the awards with a “payout simulation” model that uses assumed volatilities, risk‑free rates and correlations to estimate the grant‑date fair value (see AMGN 10‑K pp. 126‑127). In contrast, Bristol‑Myers Squibb’s exposure to its financial‑instrument agreements is managed through explicit counter‑party‑credit‑risk controls—such as limits on exposure to any one counter‑party, reliance on high‑credit‑quality counterparties and the use of derivative‑hedge strategies—so that the risk of loss is largely contained and the impact on the financial statements is considered not material even if a counter‑party defaults (see BMY 10‑K pp. 97‑98). Thus, Amgen’s payout is inherently variable and dependent on market‑performance simulations, whereas BMS’s risk management is designed to make the financial‑agreement exposure far more predictable.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, while the original answer specifies Amgen's performance units were valued at $121 million in 2023, the LLM answer does not include this exact dollar figure. However, the absence of this number does not materially distort the comparison, as the focus of the question is on the contractual structure and predictability, not the specific valuation amount. All other financial and structural details are correctly represented. (2) The LLM accurately describes Amgen’s use of payout simulation models incorporating volatilities, correlations, and risk-free rates (per AMGN 10-K pp. 126–127), and BMS’s counterparty risk controls including exposure limits and credit quality requirements (per BMY 10-K pp. 97–98), confirming source alignment. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies, two types of financial instruments (performance units vs. derivative agreements), and contrasting objectives—Amgen’s market-linked payout variability versus BMS’s risk containment and predictability. (4) Semantically, the LLM conveys the same core contrast: Amgen’s variable, performance-driven payout mechanism versus BMS’s stable, risk-mitigated financial agreements. The only minor omission is the $121M valuation, which slightly affects completeness but not the overall correctness of the comparative analysis. Hence, a score of 9 is warranted for correctness, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1537,
        "completion_tokens": 428,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How does MetLife's exposure to derivatives governed by ISDA Master Agreements under the Orderly Liquidation Authority compare to Bank of America's resolution planning risks, given both companies' regulatory obligations under Dodd-Frank?",
      "original_answer": "MetLife manages credit risk in its derivatives transactions through ISDA Master Agreements that allow for close-out netting, which is subject to financial regulations such as the Orderly Liquidation Authority (OLA) under Dodd-Frank. This means that in the event of a counterparty's bankruptcy, MetLife can offset receivables and apply collateral without being subject to the automatic stay. Similarly, Bank of America Corporation is required to submit resolution plans to the FDIC and Federal Reserve that outline a 'single point of entry' strategy under the U.S. Bankruptcy Code or potentially the OLA. If Bank of America were resolved under the OLA, the FDIC could replace the corporation with a bridge holding company, and security holders could face significant losses. Both firms are therefore subject to Dodd-Frank provisions that alter the treatment of their financial obligations and risk profiles during insolvency, with MetLife exposed through its derivative contracts and BAC through its parent company resolution strategy.",
      "llm_answer": "MetLife’s derivative exposure is largely insulated by the ISDA Master Agreements that govern its OTC‑bilateral swaps; under the Orderly‑Liquidation Authority (Title II of Dodd‑Frank) the firm can close‑out and net‑set‑off those positions and apply collateral without the automatic stay that applies in bankruptcy. In contrast, Bank of America’s Dodd‑Frank‑mandated resolution plan subjects the whole holding company to “single‑point‑of‑entry” liquidation risk – the FDIC and Federal Reserve could impose stricter capital, leverage and liquidity limits, cut off funding from subsidiaries and, if an OLA‑based liquidation is used, equity holders could incur greater losses. Thus MetLife’s risk is confined to derivative netting under ISDA, whereas Bank of America faces broader systemic resolution‑planning and funding‑availability risks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in emphasis. (1) All factual elements are correct: MetLife's use of ISDA Master Agreements for close-out netting under the Orderly Liquidation Authority (OLA) is accurately described, including the ability to apply collateral and avoid the automatic stay. Similarly, Bank of America's resolution plan under Dodd-Frank, involving the 'single point of entry' strategy and potential losses for equity holders under OLA, is correctly outlined. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes regulatory obligations under Dodd-Frank across two different firms (MetLife and Bank of America), distinguishing between derivative-level risk (MetLife) and firm-wide resolution risk (BAC). The contrast between contractual risk mitigation (ISDA) and structural resolution planning is logically drawn. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., 'OTC-bilateral swaps', 'funding-availability risks'), these are contextually appropriate and do not distort meaning. One minor point: the original answer notes that BAC could be resolved under either the U.S. Bankruptcy Code or OLA, while the LLM focuses more heavily on OLA; this is a slight omission but does not undermine the overall correctness. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 444,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How does Nike's revenue from the Greater China region, which includes Taiwan, compare to Starbucks' store count in Taiwan specifically, and what might this suggest about their relative market presence in that geographic area?",
      "original_answer": "Nike generated $7,547 million in revenue from the Greater China region in 2022, which includes Taiwan along with mainland China and Hong Kong. In contrast, Starbucks operated 544 stores in Taiwan as of October 2, 2022. Given that Nike's revenue figure represents a broader regional performance across multiple countries while Starbucks' store count is specific to Taiwan, the comparison highlights different dimensions of market presence—Nike's being revenue-based across a larger geographic cluster, and Starbucks' being operationally focused with a localized footprint in Taiwan.",
      "llm_answer": "Nike reported $74.2 billion in net sales from its Greater China segment (which includes Taiwan) for fiscal 2022 (see NKE 10‑K page 25). Starbucks operated 544 licensed stores in Taiwan at the end of fiscal 2022 (see SBUX 10‑K page 12). Thus, Nike’s monetary footprint in the Greater China market is orders of magnitude larger than Starbucks’ physical footprint in Taiwan, suggesting Nike enjoys a far greater overall market presence in the region, while Starbucks’ presence there is limited to a few hundred store locations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in Nike's revenue for the Greater China region. The original answer (ground truth) states that Nike generated $7,547 million ($7.547 billion), but the LLM incorrectly reports $74.2 billion—over 9 times higher. This is a major quantitative inaccuracy. The Starbucks store count (544) is correct and matches the ground truth. (2) The fiscal year 2022 is correctly referenced for both companies, and the source documents (10-K pages) are plausibly cited, but the Nike revenue figure is grossly wrong. The format variation ($74.2 billion vs $7,547 million) does not explain the discrepancy—these values are not equivalent. (3) The reasoning attempts multi-hop synthesis by comparing Nike’s regional revenue to Starbucks’ localized store count and draws a conclusion about market presence. However, due to the incorrect Nike revenue, the comparison is misleading. The original answer correctly emphasizes that the two metrics reflect different dimensions of market presence (revenue across a broad region vs. physical footprint in a sub-region), while the LLM oversimplifies this by claiming Nike's 'monetary footprint' is orders of magnitude larger, which is not supported by accurate data. (4) Despite correct identification of entities (Nike, Starbucks, Greater China, Taiwan), fiscal year, and Starbucks store count, the severe error in Nike’s revenue undermines the factual foundation of the response. The contextual relevance is high because the structure and intent align with the question, but correctness is low due to the major number error. Thus, correctness_score is 4 (partially correct with significant errors), quantitative_accuracy is 3 (major number wrong), qualitative_accuracy is 5 (some correct reasoning but flawed synthesis), and contextual_relevance is 8 (on-topic and appropriately framed).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 507,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How does the $5.0 billion upfront payment from American Tower Corporation in March 2015 compare to the $2.8 billion received from Vertical Bridge in December 2024 in terms of Verizon's retained obligations and asset treatment related to the exclusive rights transactions?",
      "original_answer": "The $5.0 billion transaction with American Tower in 2015 and the $2.8 billion transaction with Vertical Bridge in 2024 both involved Verizon transferring exclusive rights to operate wireless towers while retaining ownership and depreciation responsibilities. In both cases, Verizon subleases capacity back from the acquiring entity and continues to include the towers in 'Property, Plant and Equipment - Net' on its balance sheet. However, the Vertical Bridge deal resulted in a $2.0 billion prepaid rent and $830 million financing obligation split based on usage, whereas the American Tower deal did not specify such a breakdown, indicating a potentially different structure in how the financing and lease obligations were allocated between the two transactions.",
      "llm_answer": "The March 2015 deal with American Tower gave Verizon a $5 billion cash payment, but Verizon simply kept the towers on its Property‑plant‑and‑equipment line and records a sub‑lease obligation of at least ten years; no separate prepaid‑rent asset or financing liability was created. In contrast, the December 2024 transaction with Vertical Bridge brought in $2.8 billion, and Verizon recognized $2.0 billion of prepaid rent plus an $830 million financing obligation (for the portion of the towers it continues to occupy), while also retaining the towers on PP&E and the related ground‑lease liabilities. Thus, the larger American Tower payment left Verizon with only a lease‑back commitment, whereas the smaller Vertical Bridge payment resulted in both a prepaid‑rent asset and a financing liability in addition to the retained tower assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $5.0 billion American Tower transaction in March 2015 and the $2.8 billion Vertical Bridge transaction in December 2024 are correctly identified, along with the treatment of retained assets on PP&E and sublease arrangements. The $2.0 billion prepaid rent and $830 million financing obligation from the Vertical Bridge deal are accurately reported. (2) Quantitative accuracy is perfect: all dollar amounts and dates match the original answer, including the absence of a prepaid rent or financing liability in the American Tower deal. (3) The multi-hop reasoning is sound—LLM correctly contrasts the two transactions in terms of accounting treatment, highlighting that only the Vertical Bridge deal resulted in a prepaid rent asset and financing obligation, while both kept towers on PP&E. (4) The only minor limitation is that the LLM does not explicitly mention that the financing obligation in the Vertical Bridge deal was 'split based on usage,' a nuance present in the original answer. However, stating it is 'for the portion of the towers it continues to occupy' captures the economic substance. Wording differs slightly but meaning is semantically equivalent. No factual errors; high contextual relevance and completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 371,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How does JPMorgan's operational risk capital estimation under Basel III, which includes fraud risk as a key component, compare to Citigroup's exposure to fraud-related losses in emerging markets, particularly in scenarios involving asset confiscation or loss of control in Russia?",
      "original_answer": "JPMorgan uses the Advanced Measurement Approach (AMA) under Basel III to estimate operational risk capital, incorporating internal and external losses, scenario analysis, and business environment metrics, with fraud being a key risk category. Meanwhile, Citigroup reports exposure to fraud and political instability in emerging markets, with a specific scenario in Russia involving potential losses of $1.6 billion in CTA (Cumulative Translation Adjustment) and $0.9 billion on intercompany liabilities if control of AO Citibank is lost. These figures highlight how both firms face fraud-related risks but experience them through different financial mechanisms and geographic exposures.",
      "llm_answer": "JPMorgan’s Basel III operational‑risk capital is calculated under the Advanced Measurement Approach (AMA) using a Loss‑Distribution‑Approach model that explicitly incorporates fraud‑related losses (e.g., payment‑fraud risk) as a key driver of the aggregate operational‑risk capital estimate 【page 155‑156】. In contrast, Citigroup’s emerging‑market fraud exposure is illustrated by a concrete geopolitical scenario – the possible loss of control of AO Citibank in Russia – which would require a $1.6 billion CTA write‑off and an additional $0.9 billion loss on inter‑company liabilities, i.e., roughly $2.5 billion of potential loss from asset confiscation 【page 64】. Thus, JPMorgan’s risk capital is a forward‑looking, model‑based buffer that includes fraud risk, whereas Citi faces a specific, material loss exposure of about $2½ billion tied to asset seizure or loss of control in an emerging‑market (Russia) environment.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, all numbers are accurate: the $1.6 billion CTA write-off and $0.9 billion intercompany liability loss are correctly reported, and their sum ($2.5 billion) is accurately implied. These figures match the original answer exactly, with acceptable formatting variations (e.g., $2.5 billion vs $2½ billion). (2) The answer is complete, addressing both JPMorgan's AMA-based operational risk capital estimation under Basel III and Citigroup's specific fraud-related exposure in Russia. It correctly identifies fraud as a key component in JPMorgan’s model and links Citigroup’s risk to a concrete geopolitical scenario involving AO Citibank. (3) Entity accuracy is strong: both firms are correctly named, with accurate references to AMA, CTA, intercompany liabilities, and the Russian context. The mention of AO Citibank and the specific loss mechanisms aligns with the ground truth. (4) The reasoning is sound and demonstrates proper multi-hop synthesis: it contrasts JPMorgan’s forward-looking, model-based capital estimation with Citigroup’s scenario-specific, realized loss exposure, highlighting different financial mechanisms (capital modeling vs. asset confiscation). (5) The semantic meaning is equivalent to the original answer, with enhanced clarity and precise sourcing (e.g., page references). Wording differences (e.g., 'payment-fraud risk' as an example) do not affect factual accuracy. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 420,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How might a prolonged geopolitical conflict involving Taiwan impact Qualcomm's chipset supply chain differently than Intel's operational footprint in the region, given Qualcomm's reliance on Taiwan-based foundry partners and Intel's $6.867 billion in 2023 revenue tied to the region?",
      "original_answer": "A prolonged geopolitical conflict involving Taiwan would impact Qualcomm and Intel through different mechanisms. For Qualcomm, the risk is operational, as the company explicitly states its 'business depends on our ability to receive consistent and reliable chipset supply from our foundry partners, particularly in Taiwan.' A disruption would 'severely limit or prevent us from receiving chipset supply,' directly threatening its product availability. In contrast, Intel's exposure is primarily financial, with $6.867 billion in 2023 revenue tied to Taiwan, but no explicit mention of reliance on Taiwan-based manufacturing in its disclosures. While both face risks from instability in Taiwan, Qualcomm's dependency is on supply continuity, whereas Intel's is on market demand and revenue generation in the region.",
      "llm_answer": "Qualcomm says its ability to ship chips “depends on … consistent and reliable chipset supply from our foundry partners, particularly in Taiwan,” so a prolonged China‑Taiwan conflict could cut off the wafers it outsources and immediately halt production of its Snapdragon and other integrated‑circuit products. Intel, by contrast, does not rely on Taiwanese fabs for its own manufacturing; the conflict would mainly erode the $6.867 billion of 2023 revenue it earns from customers in Taiwan, creating a financial hit but not a direct supply‑chain shutdown of its core chip‑making operations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: Qualcomm's reliance on Taiwan-based foundry partners for chipset supply is accurately cited with direct quotation support, and Intel's $6.867 billion in 2023 revenue tied to Taiwan is correctly stated. (2) Quantitative accuracy is perfect—$6.867 billion is reported exactly as in the original, and no calculations were required beyond accurate restatement. (3) Multi-hop reasoning is sound: the model correctly differentiates between Qualcomm’s operational/supply chain dependency and Intel’s financial/revenue exposure, synthesizing distinct risk types based on each company's business model and disclosures. (4) The answer addresses all parts of the question: it explains how the geopolitical conflict would affect Qualcomm’s supply chain and Intel’s regional revenue, maintains entity accuracy (Snapdragon mentioned as example product, correct years and figures), and preserves the nuanced contrast in risk exposure. Wording differs slightly but meaning is preserved with high precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 316,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How does RTX's valuation methodology for private equity limited partnerships differ from BA's approach to valuing Level 3 assets measured on a nonrecurring basis, given that both companies report these investments through fair value processes?",
      "original_answer": "RTX values its private equity limited partnerships on a quarterly basis using discounted cash flows, earnings multiples, and market multiples, with valuation adjustments reflecting changes in operating results, financial condition, or prospects of the applicable portfolio company. In contrast, BA applies an income approach based on discounted cash flows for Level 3 assets measured on a nonrecurring basis, such as impaired customer financing assets, which include operating lease equipment and investments in finance leases valued using median collateral values from third-party aircraft publications. While RTX actively adjusts valuations quarterly based on portfolio company performance, BA relies on third-party publications and adjusts values only under specific circumstances, such as unique aircraft attributes or expected net sales prices.",
      "llm_answer": "RTX values its private‑equity limited‑partnership interests **each quarter** by building its own models – discount‑cash‑flow analyses, earnings‑multiple and market‑multiple screens – and then adjusting the fair value for any change in the portfolio company’s results, financial condition or outlook.  \n\nBoeing, by contrast, treats Level 3 assets that are measured only on a **non‑recurring** basis (e.g., its customer‑financing aircraft assets) with a **market‑approach** that relies on third‑party aircraft‑value publications, taking a median collateral value and then applying upward or downward adjustments for specific aircraft condition.  \n\nThus, RTX relies on internally generated DCF/multiple models applied regularly, whereas Boeing relies on external market‑price publications and condition‑based adjustments applied only when a non‑recurring fair‑value measurement is required.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and structure. (1) It accurately captures RTX's quarterly valuation of private equity limited partnerships using discounted cash flows, earnings multiples, and market multiples, with adjustments based on portfolio company performance—this matches the original answer. It also correctly states that Boeing applies a nonrecurring measurement to Level 3 assets, specifically customer financing assets like operating lease equipment. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or ground truth, so quantitative accuracy is not applicable—scored 10 by default as no inaccuracies exist. (3) However, there is a subtle but notable error in reasoning: the LLM claims Boeing uses a 'market approach', while the ground truth specifies an 'income approach based on discounted cash flows' for Level 3 assets, even though median collateral values from third-party publications are used. This mischaracterization of the valuation methodology (market vs. income approach) affects the qualitative accuracy, as it misrepresents the core technique. The original answer emphasizes Boeing’s use of discounted cash flows, not market comparables as the primary method. (4) Despite this, the LLM answer remains contextually relevant and conveys a strong contrast between RTX’s proactive, model-driven quarterly updates and Boeing’s reliance on third-party data applied only when required. The synthesis across companies and valuation practices is sound overall, but the methodological mislabeling prevents a top score. Hence, correctness is 8 due to this key conceptual inaccuracy, while contextual relevance remains high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 474,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How does Netflix's use of forward contracts to manage foreign exchange risk on firm commitments compare to Disney's VAR model estimates in terms of potential one-day loss exposure, given the specific metrics disclosed in their respective financial reports?",
      "original_answer": "Netflix uses forward contracts to hedge foreign exchange risk on firm commitments related to foreign currency-denominated content assets, aiming to reduce cash flow volatility. However, Disney's Value at Risk (VAR) model estimates a maximum potential one-day loss of $255 million (as of September 28, 2024) across its interest rate, foreign exchange, commodities, and equity-sensitive instruments. While Netflix does not disclose a specific VAR metric, Disney's $255 million VAR figure provides a quantified estimate of its exposure, allowing for a comparative view of how each company assesses and manages financial risk in their operations.",
      "llm_answer": "Netflix discloses that it enters into forward contracts to hedge the foreign‑exchange risk on forecast‑revenue and firm‑commitment transactions, but it does not quantify the amount of exposure or the potential loss that could arise from those contracts. In contrast, Disney’s 10‑K provides a quantitative VAR estimate for its market‑sensitive instruments, reporting a combined‑portfolio one‑day‑loss potential of **$255 million** at fiscal‑year‑end 2024 (down from $284 million at fiscal‑year‑end 2023). Thus, Disney’s filing supplies a specific dollar‑amount risk metric, whereas Netflix’s filing only describes the hedging strategy without a comparable loss figure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Netflix uses forward contracts to hedge foreign exchange risk on firm commitments and forecasted transactions but does not disclose a VAR metric or quantify potential loss exposure. Disney reports a one-day potential loss of $255 million via its VAR model as of fiscal-year-end 2024, which matches the ground truth date (September 28, 2024). The prior year figure of $284 million is correctly noted, though not required for the question. (2) Quantitative accuracy is perfect: the $255 million figure is correctly cited, and no incorrect numbers are introduced. Format is consistent and clear. (3) Multi-hop reasoning is sound—LLM correctly contrasts Netflix’s qualitative risk management approach with Disney’s quantitative VAR disclosure, synthesizing information across both companies’ filings. (4) The answer is contextually relevant and directly addresses the comparison requested: while Netflix lacks a specific loss metric, Disney provides a concrete dollar amount, enabling a meaningful contrast in risk assessment methodologies. The only minor limitation is that the original answer notes Netflix’s hedging relates specifically to 'foreign currency-denominated content assets,' a detail slightly more precise than the LLM’s broader 'forecast-revenue and firm-commitment transactions.' However, this does not affect the core correctness. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 432,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did the corporate income tax rate reduction in the Philippines enacted in Q1 2021 impact AMD's tax provision compared to Texas Instruments' operational investments in the country, given both companies' exposure to international tax regulations?",
      "original_answer": "The corporate income tax rate reduction in the Philippines enacted in Q1 2021 had a favorable impact on AMD’s effective tax rate by partially offsetting increases from other tax factors, such as GILTI-related foreign tax credit limitations. Meanwhile, Texas Instruments had $370 million in property, plant, and equipment at its two sites in the Philippines as of December 31, 2021, indicating significant operational exposure that would be directly affected by the lower tax rate. AMD’s 2021 effective tax rate increased by 0.1 percentage point to 21.8%, with the Philippines tax reduction noted as a mitigating factor, while TXN’s capital investment in the country suggests a strategic commitment that would benefit from the lower corporate tax rate.",
      "llm_answer": "The Philippines corporate‑income‑tax cut that took effect in the first quarter of 2021 was reflected in AMD’s 2021 tax footnote – it helped offset other foreign‑tax detriments and contributed to a modestly lower effective tax rate, leaving AMD with a $513 million income‑tax provision for the year (versus a $1.2 billion benefit in 2020). By contrast, Texas Instruments’ 2021 filing shows that the company’s exposure to the Philippines is mainly through capital spending – about $370 million of property, plant and equipment was recorded at its Philippine sites – and its tax provision is driven by overall global tax positions rather than a direct benefit from the Philippine rate reduction. Thus, AMD’s provision was directly softened by the tax‑rate change, whereas TI’s Philippines operations are reflected as an operational investment with no comparable tax‑provision impact.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. While it correctly identifies that the Philippines corporate income tax rate reduction in Q1 2021 benefited AMD's tax position and notes Texas Instruments' $370 million in property, plant, and equipment (PPE) in the Philippines—matching the ground truth—the LLM incorrectly states AMD’s 2021 income tax provision as $513 million and contrasts it with a '$1.2 billion benefit in 2020'. These figures are not supported by the ground truth and contradict the original answer, which does not mention absolute tax provisions or benefits for AMD in those years. The ground truth states AMD’s effective tax rate increased slightly to 21.8% (up 0.1 percentage point), implying the tax provision likely increased, not decreased, and there is no mention of a $1.2 billion tax benefit in 2020. (2) The $370 million PPE figure for TI is accurate and correctly cited. However, the LLM invents specific tax provision amounts for AMD that are not in the original answer, failing the quantitative accuracy check. (3) The reasoning is partially sound: the LLM correctly infers that AMD experienced a direct tax benefit from the rate change, while TI’s exposure is operational (via capital investment), and thus the tax cut would affect TI more indirectly. This multi-hop synthesis—linking tax rate changes to tax provision for AMD and to operational investment for TI—is logically valid and aligns with the question’s intent. (4) Despite the strong contextual relevance and reasonable qualitative logic, the invention of unsupported financial figures significantly undermines factual correctness. The answer is semantically close but quantitatively flawed, warranting a moderate correctness score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 487,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How do GM's and McDonald's different approaches to affiliate relationships reflect their respective business models, particularly in terms of vehicle production and franchise operations?",
      "original_answer": "GM engages in transactions with nonconsolidated affiliates for the development, production, and marketing of trucks, crossovers, cars, and automobile parts, which are integral to its automotive manufacturing business model. These affiliates are primarily located in China and produce vehicles under the Baojun, Buick, Cadillac, Chevrolet, and Wuling brands. In contrast, McDonald's relies on affiliates for franchise operations, where revenues are generated through royalties based on a percentage of sales and initial fees. This reflects McDonald's asset-light business model centered on franchising and brand licensing. While GM's affiliate relationships are production-focused and tied to physical goods, McDonald's approach emphasizes service-based revenue through franchisee support and brand management, highlighting the distinct operational structures of the two companies.",
      "llm_answer": "GM’s affiliate relationships are mostly supply‑chain and joint‑venture arrangements that support vehicle production.  The company reports non‑consolidated affiliates that sell and buy parts, and it holds variable‑interest interests in battery‑cell joint ventures—relationships that give GM economic exposure to component and EV manufacturing while the affiliates remain outside the consolidated balance sheet because GM does not have voting control (page 77, 79).  \n\nMcDonald’s affiliate relationships are pure franchise arrangements: franchisees own and operate the restaurants and pay rent, royalties and advertising contributions, but McDonald’s does not have the power to direct their day‑to‑day activities, so they are not consolidated (pages 48, 46).  This reflects a business model built on licensing the brand and collecting fees rather than producing the product itself.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies GM's affiliate relationships as production- and supply-chain-focused, involving joint ventures and nonconsolidated affiliates for vehicle and component manufacturing, particularly in EVs and parts, which matches the original answer’s emphasis on development and production of vehicles and parts through affiliates in China under various brands. While the LLM does not explicitly name the brands (Baojun, Buick, etc.) or specify geographic focus (China), it captures the core production-oriented model. (2) For McDonald's, the LLM accurately describes the franchise-based model, emphasizing non-consolidation due to lack of control, and revenue via royalties, rent, and advertising—consistent with the asset-light, service- and fee-based model in the original answer. (3) The reasoning is sound and reflects multi-hop understanding: it contrasts GM’s manufacturing and component-focused joint ventures with McDonald’s franchise licensing model, correctly linking each to their respective business models. (4) No numeric data is present in either answer, so quantitative accuracy is not applicable—scored as 10 by default. Minor omission of specific brands and locations prevents a perfect 10 on correctness and qualitative accuracy, but the semantic meaning and strategic contrast are fully preserved. Contextual relevance is excellent as all parts of the question are addressed directly and accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 412,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "Given Alphabet's significant share repurchase activity of $62.0 billion in Class A and Class C shares in 2024, and the automatic conversion of Class B shares to Class A upon sale or transfer, how might the reduction in outstanding Class A shares impact the relative voting power of remaining Class B shareholders, especially in light of the fact that Class B shares carry 10 votes per share compared to 1 vote for Class A?",
      "original_answer": "Alphabet repurchased $62.0 billion of Class A and Class C shares in 2024, reducing the number of outstanding Class A shares. Since Class B shares convert automatically to Class A shares upon sale or transfer, this limits the ability of Class B holders to retain higher-vote shares if they transact. With fewer Class A shares in circulation due to buybacks, the relative voting concentration among remaining Class B shareholders—who hold 10 votes per share—would increase, potentially consolidating control among long-term holders.",
      "llm_answer": "Alphabet repurchased roughly $62 billion of Class A and Class C stock in 2024, retiring 73 million Class A shares and 306 million Class C shares (see page 82). Because each Class A share carries one vote while each Class B share carries ten votes, the retirement of a large number of one‑vote shares reduces the total pool of voting rights attached to Class A stock. Consequently, the remaining Class B shares represent a larger share of the overall voting power, so the relative influence of Class B shareholders rises as the outstanding Class A share count falls (page 82).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $62 billion repurchase amount is correct, and the breakdown into 73 million Class A and 306 million Class C shares, while not present in the original answer, does not contradict it and may come from a more detailed source (e.g., page 82 as cited). The absence of Class B share conversions in the numbers is acceptable since the repurchases targeted Class A and C. (2) The reasoning correctly identifies that reducing the number of one-vote Class A and C shares increases the relative voting power of the remaining ten-vote Class B shares, which is the core insight. (3) The multi-hop logic—linking share buybacks, reduction in voting pool, and increased relative influence of high-vote Class B shares—is sound and well-articulated. (4) The LLM omits the point about automatic conversion of Class B to Class A upon sale/transfer limiting Class B holders’ ability to retain high-vote shares, which is a minor omission from the original answer. However, the central conclusion about increased relative voting power is correct and well-supported. Wording differs but semantic meaning matches. Minor deduction from 10 due to this omission, but overall excellent performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 352,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How does the adoption of ASU No. 2020-01 impact the accounting treatment for equity securities by both Colgate-Palmolive and The Coca-Cola Company, particularly in light of the clarification provided by the standard on the interaction between equity securities, equity method investments, and derivative contracts?",
      "original_answer": "ASU No. 2020-01 clarifies the interaction between the accounting for equity securities under Topic 321, equity method investments under Topic 323, and derivative contracts under Topic 815. Colgate-Palmolive adopted this guidance effective January 1, 2021, and concluded that it did not have a material impact on its Consolidated Financial Statements. Similarly, The Coca-Cola Company, which is also subject to the same accounting standard, applies the clarified guidance to its equity securities, including the calculation of net unrealized gains and losses recognized during the year related to equity securities still held at the end of the year (as disclosed in its financial statements). Both companies benefit from the standard’s clarification on when observable transactions should be considered before applying or upon discontinuing the equity method, and how derivatives linked to equity securities should be accounted for without considering whether the underlying securities would be accounted for under the equity method or fair value option.",
      "llm_answer": "Both Colgate‑Palmolive and The Coca‑Cola Company reported that they adopted ASU No. 2020‑01 (“Investments‑Equity Securities, Equity‑Method Investments and Derivatives”) on January 1 2021 and that the adoption had **no material impact** on their consolidated financial statements【page 81】.  Consequently, each company continues to measure its equity‑security holdings at fair value, recognizing unrealized gains and losses in earnings (as shown by Coca‑Cola’s net unrealized equity‑security gains in 2021【page 80】), while any forward, option or swap contracts linked to those securities are accounted for under ASC 815 without regard to whether the underlying equity would be treated under the equity method【page 71】.  The clarification therefore leaves the accounting for equity securities and related derivatives unchanged for both firms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: both Colgate-Palmolive and The Coca-Cola Company adopted ASU No. 2020-01 effective January 1, 2021, and concluded the adoption had no material impact on their financial statements. The date and qualitative effect are correctly stated. (2) Quantitative accuracy is perfect: while no specific dollar amounts are mentioned in either answer, the LLM correctly references disclosures (e.g., Coca-Cola’s net unrealized gains in 2021) and does not introduce any incorrect figures. The mention of page numbers (e.g., page 81, 80, 71) suggests fidelity to source documents and supports traceability. (3) Multi-hop reasoning is sound: the LLM synthesizes information across accounting standards (ASC 815), entities (both companies), and concepts (equity securities, equity method, derivatives), correctly explaining that the standard’s clarification means derivatives are accounted for under Topic 815 without considering equity method applicability. (4) The only minor shortcoming is that the LLM slightly downplays the broader clarifying role of ASU 2020-01—such as the guidance on observable transactions affecting the transition into or out of the equity method—though it does mention the key point about derivatives. However, the core of the standard’s impact is accurately conveyed. Wording differs from the original but maintains semantic equivalence. Overall, the answer is factually correct, complete for the main points, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 425,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How does the difference in the Stress Capital Buffer (SCB) components of the CET1 capital ratio requirements between Goldman Sachs and Citibank reflect their respective approaches to regulatory capital adequacy under the Standardized Capital Rules as of December 2024?",
      "original_answer": "As of December 2024, Goldman Sachs is subject to a Stress Capital Buffer (SCB) of 6.2% under the Standardized Capital Rules, while Citibank’s required CET1 capital ratio under the same rules is 7.0%, which includes the 4.5% minimum CET1 requirement and a fixed 2.5% Capital Conservation Buffer. This indicates that Goldman Sachs faces a higher SCB-driven capital requirement, suggesting a potentially more stringent stress-based capital adequacy assessment compared to Citibank, which does not explicitly include an SCB in its stated CET1 requirement under the Standardized Approach.",
      "llm_answer": "Goldman Sachs’ CET1 requirement under the Standardized Approach incorporates a **Stress‑Capital‑Buffer component of about 6.2 %** (plus the 2.5 % capital‑conservation buffer and the 3.5 % GSIB surcharge), so the firm must hold a CET1 ratio of roughly 13.7 % to satisfy the rule. By contrast, Citibank’s CET1 requirement under the same approach is **only the statutory minimum of 4.5 % plus the fixed 2.5 % capital‑conservation buffer (total 7.0 %)**—the SCB applies only to the Citigroup holding company, not to the bank subsidiary. This difference shows Goldman Sachs relying on a larger, stress‑based cushion to meet regulatory adequacy, while Citibank meets the rule with the basic minimum buffers, reflecting a less stringent SCB‑driven approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key numbers are correct: Goldman Sachs' SCB of 6.2% and Citibank's 7.0% CET1 requirement (4.5% minimum + 2.5% Capital Conservation Buffer) are accurately reported. The LLM correctly notes that Citibank’s subsidiary does not include an SCB under the Standardized Approach, which is consistent with regulatory structure. (2) The calculation of Goldman Sachs’ total CET1 requirement (~13.7%) is logically derived (6.2% SCB + 2.5% CCB + 3.5% GSIB surcharge + 1.5% minimum? — though the 4.5% base is implied), but this total is not part of the original question or ground truth, so while the math is reasonable, it introduces an inference beyond what was asked. However, this does not detract significantly from correctness since the focus is on the SCB component difference. (3) The multi-hop reasoning is sound: the model correctly distinguishes between holding company and bank subsidiary applicability of SCB (Citigroup vs Citibank), and synthesizes that Goldman Sachs faces a higher stress-based requirement while Citibank meets only the standardized minimum. (4) The answer provides additional context (GSIB surcharge) not in the original answer, which enhances understanding but does not contradict facts. The core conclusion — that Goldman Sachs has a more stringent SCB-driven requirement — is correctly drawn and reflects the intended insight. Only minor deduction for introducing inferred total CET1 ratio not required by the question, but all stated facts remain accurate. Hence, high scores across all dimensions with a 9 on correctness due to slight over-elaboration without error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 458,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How do NextEra Energy's operational infrastructure investments in Indiana compare with Duke Energy Indiana's financing strategy through tax-exempt bonds as of December 31, 2023?",
      "original_answer": "NextEra Energy operates transmission infrastructure in Indiana, including 90 miles of lines and 5 substations operating at 161-345 kilovolts, as part of its broader multi-state network. Meanwhile, Duke Energy Indiana disclosed holding $285 million in tax-exempt bonds as of December 31, 2023, which represents a significant portion of its $435 million total debt portfolio. This contrast highlights different strategic focuses: NextEra's emphasis on physical infrastructure development in Indiana versus Duke Energy Indiana's reliance on tax-advantaged financing instruments to fund its operations.",
      "llm_answer": "NextEra Energy’s Indiana footprint consists mainly of operational transmission assets – about 90 miles of 161‑345 kV lines and five substations that are 100 % owned and already in service (see NEE 10‑K, page 40). By contrast, Duke Energy Indiana’s financing relies heavily on tax‑exempt debt, with roughly $300‑$350 million of tax‑exempt bonds outstanding at December 31 2023 (see Duke 10‑K, pages 163 and 165).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies NextEra Energy's operational infrastructure in Indiana (90 miles of 161-345 kV transmission lines and 5 substations), which matches the ground truth. However, the tax-exempt bond amount for Duke Energy Indiana is inaccurately reported as 'roughly $300-$350 million' when the ground truth specifies $285 million as of December 31, 2023. This is a significant quantitative deviation, especially since the exact figure is available in the source. Additionally, the LLM omits the contextual detail that these tax-exempt bonds represent a major portion of Duke Energy Indiana’s total $435 million debt portfolio, which weakens the comparative analysis. (2) The date (December 31, 2023) is correctly referenced, and the infrastructure metrics for NextEra are accurate. The $300–$350 million range is factually incorrect and not aligned with the $285 million disclosed in the 10-K. There is no indication of rounding or estimation justification. (3) The multi-hop reasoning is sound in concept—comparing NextEra’s physical infrastructure investments with Duke’s financing strategy—but the synthesis is weakened by the incorrect bond value and missing context about the proportion of total debt. The qualitative contrast is implied but less precise due to numerical inaccuracy. (4) The answer remains contextually relevant and addresses both companies and the core comparison. The qualitative reasoning is strong, but the quantitative inaccuracy reduces overall correctness. Hence, a score of 7 is justified: core facts are present, but key financial data is incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 440,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does Apple's reliance on third-party content providers for its App Store revenue model create different business risks compared to Microsoft's strategy of producing its own content, particularly in light of Apple's changes to alternative payment processing and Microsoft's emphasis on brand reputation tied to content decisions?",
      "original_answer": "Apple's App Store revenue model depends heavily on third-party content providers, with developers retaining most of the revenue while Apple keeps a commission. This model is vulnerable to changes in developer incentives and regulatory compliance, such as Apple's recent adjustments to alternative payment processing in the EU under the DMA, which could reduce commission revenue. In contrast, Microsoft produces its own content and highlights the importance of brand reputation tied to its content decisions, noting that backlash could arise from public scrutiny or dissatisfaction with product offerings. While Apple risks losing developer support due to shifting business terms, Microsoft faces brand-related risks from its own content choices, creating fundamentally different exposure points in their respective content strategies.",
      "llm_answer": "Apple’s App Store model depends on third‑party developers and content owners; if those partners pull their apps, demand higher licensing fees, or are constrained by new alternative‑payment rules (which could lower the commission Apple retains), Apple’s revenue and growth can be directly eroded【page_13】. In contrast, Microsoft generates much of its gaming and cloud revenue from content it creates or controls, so the chief risk is reputational—controversial content or brand‑related decisions can damage Microsoft’s globally‑recognized brand and thus affect demand for its products and services【page_32】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Apple's reliance on third-party developers, risks from alternative payment changes (e.g., in the EU under DMA), potential erosion of commission revenue, and contrast with Microsoft's self-produced content model are all accurately represented. The reputational risk Microsoft faces due to its brand sensitivity around content decisions is correctly identified. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) Multi-hop reasoning is sound: the model correctly synthesizes differences in business models (Apple’s platform vs. Microsoft’s owned content) and maps them to distinct risk profiles (developer dependency vs. brand reputation). The mention of page references (e.g., page_13, page_32) suggests grounding in source documents. (4) Minor deduction in qualitative accuracy due to slightly less explicit mention of regulatory context (DMA) compared to the original, though the implication of rule-based payment changes is present. Otherwise, semantic equivalence is strong, and the answer fully addresses all parts of the multi-faceted question. Contextual relevance is perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 363,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does the potential liability from tritium leakage at Southern Company's nuclear plants compare to the decommissioning fund shortfalls highlighted in NEE's disclosures, given both companies' exposure to nuclear health risks?",
      "original_answer": "Southern Company's nuclear facilities, which contributed approximately 26% and 28% of total KWHs generated for Alabama Power and Georgia Power respectively in 2021, face health risks including potential leakage of radioactive materials like tritium. These risks expose the company to potential liabilities that could exceed decommissioning trusts or insurance coverage. Similarly, NEE discloses that the cost of decommissioning its nuclear facilities could exceed the amounts available in decommissioning funds, leaving it exposed to additional financial risks. Both companies face comparable challenges in managing nuclear health risks, with Southern Company highlighting potential tritium exposure and NEE emphasizing the risk of decommissioning shortfalls, creating parallel financial exposures despite no direct business relationship.",
      "llm_answer": "Southern Company warns that a release of radioactive material – such as tritium – from its nuclear units could create “potential exposures in excess of insurance coverage” and could require “substantial operating and capital expenditures,” but it does not quantify a specific shortfall. In contrast, NEE’s filing explicitly states that the “cost of de‑commissioning nuclear generation facilities could exceed the amount available in NEE’s…de‑commissioning funds,” highlighting a measurable funding gap. Thus, Southern Company’s tritium‑leakage risk is described as an undefined liability that could surpass insurance, whereas NEE points to a concrete risk that its de‑commissioning trusts may be insufficient to cover future costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Southern Company's exposure to tritium leakage as a potential liability that could exceed insurance coverage, and NEE's explicit disclosure of decommissioning fund shortfalls. While the original answer includes generation percentages (26%, 28%) from Southern Company's subsidiaries, the LLM answer omits these specific figures but does not misrepresent any data. Since the question does not explicitly ask for those percentages, their absence does not undermine the core comparison. (2) No numerical inaccuracies are present; the LLM correctly refrains from quantifying Southern’s liability (as the source does not provide a number) and accurately reflects NEE’s disclosure of a measurable funding gap. (3) The multi-hop reasoning is sound: the model synthesizes risk disclosures from two separate companies (Southern Company and NEE), correctly contrasting the nature of their nuclear-related financial exposures—Southern’s undefined but potentially large liability from tritium leaks versus NEE’s concrete decommissioning shortfall risk. (4) The answer is contextually relevant and directly addresses the comparison of financial exposures related to nuclear health risks. The only minor shortcoming is the omission of the specific KWH contribution percentages from the original, which adds contextual depth but is not essential to the central comparison. Thus, the answer is factually correct, well-reasoned, and focused, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 423,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does the corporate income tax rate reduction in the Philippines, enacted in Q1 2021, impact both Altria's (MO) effective tax rate and Coca-Cola's (KO) capital investment strategy, given their respective exposures to the Philippine market?",
      "original_answer": "The corporate income tax rate reduction in the Philippines, enacted in Q1 2021, favorably impacted Altria's (MO) effective tax rate in 2021, contributing to a 0.1 percentage point increase to 21.8%. This suggests that Altria benefited from lower tax liabilities on its Philippine-related earnings. Meanwhile, Coca-Cola (KO) maintained a significant capital investment in the Philippines, with property, plant, and equipment in the country representing 10% of its consolidated PPE net as of December 31, 2021 and 2020. The tax cut likely improved the after-tax return on KO's Philippine operations, reinforcing its sustained capital commitment. Therefore, the tax reform positively influenced both companies’ financial positioning in the region, with MO seeing a direct tax benefit and KO maintaining a stable long-term asset base.",
      "llm_answer": "The 2021 corporate‑income‑tax cut in the Philippines shaved a small amount off the companies’ overall tax burden. In Altria’s filing the reduction is listed among the items that “partially offset” the other drivers of its 2021 effective‑tax‑rate increase, meaning the Philippines change helped keep Altria’s effective rate from rising further (the net effect was only a 0.1‑percentage‑point increase to 21.8% – see the effective‑tax‑rate reconciliation). For Coca‑Cola, the lower Philippine tax rate makes its existing Philippine assets more profitable and supports its capital‑spending plans – the company notes that property, plant and equipment in the Philippines represents roughly 10 % of its total PPE, a material base that it can now expand with a more favorable tax environment (see the PP&E breakdown).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and percentages are correct: the 0.1-percentage-point increase in Altria's effective tax rate to 21.8%, and Coca-Cola's 10% of PPE in the Philippines as of 2020 and 2021, are accurately reflected. The timing (Q1 2021 tax reform) is contextually correct and consistent with the knowledge graph. (2) The LLM correctly interprets that the Philippine tax cut partially offset other tax-increasing factors for Altria, resulting in a net small increase in its effective tax rate—this matches the ground truth's implication that the change was beneficial despite the overall rate increase. For Coca-Cola, the answer correctly links the tax environment to improved profitability and sustained capital investment, noting the materiality of its Philippine PPE. (3) Multi-hop reasoning is sound: the model synthesizes tax policy changes with company-specific financial disclosures (tax rate reconciliation and PPE breakdowns) for two different firms, correctly inferring strategic and financial implications. (4) Minor deduction in qualitative accuracy due to slightly less explicit clarity that Altria's rate would have risen more without the benefit (the answer says it 'helped keep from rising further', which is correct, but the original answer more clearly states it was a favorable impact contributing to the net result). However, this does not undermine correctness. Wording differs but semantic meaning is equivalent. No factual errors; high contextual relevance and completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 432,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How might Samsung's dual role as a supplier to NVIDIA for semiconductor wafer production and as a competitor to Qualcomm in the integrated circuit market impact Qualcomm's $12.8 billion in multi-year capacity purchase commitments, particularly if Samsung prioritizes its own product lines over external manufacturing demand?",
      "original_answer": "Samsung plays a critical role in NVIDIA's supply chain, producing semiconductor wafers for the company (Hop 1). At the same time, Samsung develops and produces its own integrated circuit products, directly competing with Qualcomm in this space (Hop 2). Qualcomm has $12.8 billion in multi-year capacity purchase commitments tied to its integrated circuit product manufacturing (Hop 3). If Samsung prioritizes its own competitive product lines over external manufacturing obligations, including those to Qualcomm, it could lead to capacity constraints or increased costs for Qualcomm. This would put pressure on Qualcomm’s ability to meet its manufacturing needs under existing commitments, potentially requiring renegotiation of terms or impacting margins if alternative suppliers must be sourced at higher costs.",
      "llm_answer": "Qualcomm’s 10‑K notes that it has $12.8 billion of multi‑year capacity purchase commitments for integrated‑circuit production, and that “cancellation of outstanding purchase commitments … would require payment of costs incurred … and may also trigger incremental fees or loss of amounts paid in advance due to capacity under‑utilization” (Qualcomm 10‑K p. 82).  Samsung is listed as one of the foundries that both NVIDIA and Qualcomm rely on for wafer fabrication (NVDA 10‑K p. 9), while Qualcomm also warns that “certain of our largest customers (for example, Samsung) develop their own integrated‑circuit products … and may compete with us” (Qualcomm 10‑K p. 19).  If Samsung gives priority to its own product lines, wafer capacity could become tighter or more expensive for Qualcomm, increasing the risk that Qualcomm will have to pay cancellation penalties or seek alternative suppliers, thereby jeopardizing the economics of its $12.8 billion commitment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Qualcomm has $12.8 billion in multi-year capacity purchase commitments (correctly cited from Qualcomm 10-K p.82), Samsung is a shared foundry partner for both NVIDIA and Qualcomm (supported by NVDA 10-K p.9), and Samsung competes with Qualcomm in integrated circuits (Qualcomm 10-K p.19). (2) Quantitative accuracy is perfect: the $12.8 billion figure is correctly stated with no calculation errors. (3) Multi-hop reasoning is sound: the model correctly synthesizes Samsung's dual role as supplier and competitor, and logically infers that prioritization of Samsung’s own products could lead to capacity constraints, cost increases, or penalties for Qualcomm. (4) The answer captures the economic risk to Qualcomm’s commitments, including potential cancellation fees and the need to source alternatives at higher cost—mirroring the original answer’s core conclusion. The only minor limitation is that it does not explicitly mention NVIDIA’s reliance on Samsung as a supplier (beyond citing the 10-K), but this is implied through context. Wording differs but semantic meaning and factual content are equivalent. No factual errors or omissions affect the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 356,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What is the impact of Lockheed Martin's commercial customer receivables on United Launch Alliance's financial position, given Boeing's equity stake in ULA and its reported income from the joint venture?",
      "original_answer": "Lockheed Martin reported $665 million in receivables from commercial customers as of December 31, 2024, which includes entities like ULA. ULA is a key commercial customer for Lockheed Martin through its Space segment, where Lockheed holds a 50% ownership interest. Boeing also holds the other 50% and reported $125 million in equity income from ULA in 2024. This suggests that ULA’s financial performance is significant to both companies, and Lockheed’s exposure to ULA through receivables and ownership could influence its contract asset management and overall liquidity. Therefore, any financial strain on ULA could affect both Lockheed’s $665 million commercial receivables and Boeing’s equity income.",
      "llm_answer": "Lockheed Martin’s receivables include about **$665 million from commercial‑type customers** (other‑government and commercial) as of 31 Dec 2024 【page_76】.  United Launch Alliance is a 50 %‑owned joint venture of Lockheed Martin and Boeing, and Boeing reports **$125 million of equity‑method earnings from ULA in 2024** (down from $44 million in 2023) 【page_42】.  The commercial receivables give Lockheed Martin cash that can be used to fund its half of ULA, while Boeing’s equal 50 % stake and its $125 million share of ULA income together bolster the venture’s overall financial position.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly reports the $665 million in commercial-type receivables from Lockheed Martin as of December 31, 2024, and Boeing's $125 million equity-method earnings from ULA in 2024, both of which match the ground truth in amount and year. These quantitative figures are accurate and properly attributed. 2) Quantitatively, all numbers are correct: $665 million receivables (Lockheed Martin), $125 million equity income (Boeing from ULA), 50% ownership stakes. The mention of Boeing’s prior year income ($44 million in 2023) is an addition not in the original answer but does not contradict it and may reflect actual data; however, it was not required for the question and doesn’t detract from accuracy. 3) The reasoning contains a partial misstep: the LLM suggests that Lockheed’s commercial receivables provide cash to fund its half of ULA, which is a plausible inference but not supported directly in the ground truth. The original answer emphasizes that ULA is a customer of Lockheed Martin (i.e., Lockheed sells to ULA), not that Lockheed uses receivables to fund ULA. This reverses the financial relationship and misrepresents the impact. The correct multi-hop logic is that Lockheed has both a customer relationship (receivables from ULA) and an ownership stake, so ULA’s financial health affects both its ability to pay receivables and the equity income to both parents. The LLM misses this dual exposure and instead frames receivables as funding ULA, which is not substantiated. 4) Despite this reasoning flaw, the LLM identifies the correct entities (Lockheed Martin, ULA, Boeing), ownership structure (50/50 JV), financial figures, and year. It remains contextually relevant and captures the significance of ULA to both firms. However, it fails to fully address the *impact* of receivables on ULA’s financial position — rather, it implies the opposite causal direction. Thus, while factually rich, the qualitative reasoning is partially flawed. Correctness score is 7 due to accurate data but incorrect causal interpretation; quantitative accuracy is high (9); qualitative accuracy is moderate (7) due to flawed synthesis; contextual relevance is strong (9) as it stays on topic and uses correct sources.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 593,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the invalidation of the '190 Patent in the CAR T litigation affect Gilead's amortization expense following its acquisition of Kite?",
      "original_answer": "The invalidation of the '190 Patent in August 2021 removed the risk of ongoing 27.6% running royalties on Kite’s Yescarta sales, which had been previously awarded to Juno and SKI. This resolution likely reduced Gilead’s contingent liabilities and improved the valuation of the acquired intangible assets. As a result, Gilead’s amortization expense for finite-lived intangible assets, which included Yescarta-related rights from Kite, was $1.7 billion in 2021, up from $1.2 billion in 2020, reflecting the clearer path to monetization of these assets post-litigation.",
      "llm_answer": "The Federal Circuit’s August 2021 decision that the ‘190 Patent was invalid forced Gilead to treat the Kite‑related intangible (axicabtagene ciloleucel) as a finite‑life asset and begin amortizing it.  As a result, Gilead’s aggregate amortization expense on finite‑life intangibles rose to about **$1.7 billion in 2021**, up from **$1.2 billion in 2020** after the acquisition of Kite.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly reports the key quantitative figures: amortization expense increased from $1.2 billion in 2020 to $1.7 billion in 2021, which matches the ground truth. The date of the Federal Circuit’s decision (August 2021) is also accurate. However, the reasoning is factually incorrect and misrepresents the accounting impact. The invalidation of the '190 Patent did not 'force Gilead to begin amortizing' the asset—Kite’s assets were already being amortized post-acquisition. Rather, the removal of the royalty risk (27.6% to Juno/SKI) improved the valuation outlook for the intangible assets, potentially affecting amortization assumptions (e.g., useful life or cash flow projections), but not triggering the start of amortization. The ground truth emphasizes that the increased amortization reflects a clearer path to monetization, not a new classification due to patent invalidation. This is a significant error in multi-hop reasoning: the model conflates patent invalidation with a change in asset classification, which is not supported by the facts. While the numbers are correct and contextually relevant, the causal logic is flawed, reducing qualitative accuracy. The answer addresses the effect on amortization expense but misattributes the cause, leading to a partially correct but misleading explanation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 367,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does Apple's revenue from Greater China in 2022 compare to Intel's revenue from Taiwan in 2021, given that Greater China includes Taiwan as one of its key markets?",
      "original_answer": "Apple reported $74,200 million in net sales from Greater China in 2022, which includes Taiwan. Intel reported $13,461 million in net revenue from Taiwan in 2021. This indicates that Apple's revenue from the broader Greater China region was significantly higher than Intel's revenue specifically from Taiwan during those periods.",
      "llm_answer": "Apple’s Greater‑China segment generated **$74.2 billion** of net sales in 2022 (Apple 10‑K, Note 11, “Greater China” net sales = $74,200 million)【page_52】.  \n\nIntel reported **$13.5 billion** of net revenue from Taiwan in 2021 (Intel 10‑K, “Taiwan” revenue = $13,461 million)【page_87】.  \n\nThus Apple’s 2022 Greater‑China revenue was roughly **5½ times larger** than Intel’s 2021 revenue from Taiwan.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Apple's 2022 revenue from Greater China as $74.2 billion ($74,200 million), matching the ground truth. It also accurately reports Intel's 2021 revenue from Taiwan as $13.5 billion ($13,461 million), with acceptable rounding. (2) The calculation comparing Apple's revenue to Intel's is correct: $74,200 million / $13,461 million ≈ 5.51, which supports the 'roughly 5½ times larger' characterization. All numeric values are factually accurate and properly cited to the respective 10-K filings. (3) The multi-hop reasoning is sound—information from two different companies (Apple and Intel), two different years (2022 vs 2021), and two different geographic segments (Greater China vs Taiwan) is correctly synthesized. The answer acknowledges that Greater China includes Taiwan but correctly compares Apple's broader regional revenue to Intel's country-specific revenue, as required by the question. (4) The answer is semantically equivalent to the ground truth, with added clarity in the comparison. All evaluation dimensions are fully satisfied, warranting top scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 319,
        "total_tokens": 1506
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How do UPS's derivative valuation practices involving yield curves and Boeing's approach to fixed income investments compare in terms of reliance on observable market data like credit spreads and interest rates?",
      "original_answer": "UPS relies on pricing models that use observable market data such as yield curves and foreign currency exchange rates for valuing derivatives, which are classified as Level 2. Similarly, Boeing's fixed income investments, including interest rate swaps, are valued using pricing models that incorporate verifiable observable market data like interest rates, yield curves at commonly quoted intervals, and credit spreads, also categorizing them as Level 2 when observable inputs are available. Both companies emphasize the use of market-observable inputs for Level 2 classifications, though UPS focuses on derivatives tied to foreign exchange and Boeing on fixed income instruments.",
      "llm_answer": "UPS values its interest‑rate and foreign‑currency derivatives (and its Level‑2 fixed‑income holdings) with pricing models that are driven by market‑observable inputs such as current yield curves, interest‑rate levels and credit‑spread data. Boeing’s fair‑value approach for its fixed‑income investments similarly relies on observable market information – benchmark yields, swap curves, rating‑agency spreads and inter‑dealer broker rates – rather than unobservable assumptions. Thus, both companies base their valuations on readily observable market data, though UPS emphasizes yield‑curve and credit‑spread inputs, while Boeing highlights benchmark yields, swap curves and rating‑agency spread inputs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: both UPS and Boeing use observable market data for valuing financial instruments, with derivatives and fixed-income investments classified as Level 2. The LLM correctly identifies that UPS uses yield curves, interest rates, and credit spreads for derivatives and fixed-income holdings, while Boeing relies on benchmark yields, swap curves, credit spreads (noted as rating-agency spreads), and inter-dealer broker rates. These inputs match the ground truth’s emphasis on observable market data. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but the description of valuation inputs is precise and factually consistent. (3) The multi-hop reasoning is sound—correctly comparing two companies’ valuation practices across different instruments (derivatives vs. fixed income) while highlighting common reliance on Level 2 inputs. The synthesis across entities is accurate. (4) The only minor deviation from the original answer is that the LLM slightly reframes UPS’s focus to include credit-spread data more explicitly than the original, which emphasizes foreign exchange and yield curves. However, this does not contradict the ground truth, as credit spreads are part of observable inputs and are plausibly used. The LLM also omits the explicit mention that both classify such instruments as Level 2 'when observable inputs are available,' but implies it by stating reliance on observable data. Overall, the answer is semantically equivalent, highly relevant, and factually correct with only negligible omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 466,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the use of discounted cash flow models for impairment testing by META compare to DIS's application of these models in valuing Level 2 derivatives, particularly in terms of the inputs and assumptions each company relies on?",
      "original_answer": "META uses discounted cash flow (DCF) models with Level 3 inputs to estimate the fair value of impaired operating lease ROU assets and leasehold improvements, incorporating assumptions such as expected downtime, projected sublease income, and discount rates reflecting risk levels. In contrast, DIS applies internal DCF models to value Level 2 derivatives using observable inputs like interest rates, yield curves, and foreign currency exchange rates. While both companies utilize DCF models, META relies on less observable (Level 3) assumptions, whereas DIS uses more market-based (Level 2) data, reflecting different applications and risk profiles in their respective financial reporting.",
      "llm_answer": "Meta Platforms says that it applies discounted‑cash‑flow (DCF) models when it tests long‑lived assets for impairment, using management’s own forecasts of future cash‑flows, growth assumptions and a risk‑adjusted discount rate that reflect the company’s expectations for the asset (i.e., largely unobservable, Level 3 inputs).  \n\nThe Walt Disney Company, by contrast, uses DCF models to value its Level 2 derivatives, but those models are driven by observable market data – current interest‑rate curves, yield‑curve spreads and foreign‑exchange rates – with only minimal, non‑material adjustments for counter‑party credit risk (see Disney’s fair‑value hierarchy discussion, page 119) 【DIS page 119】.  \n\nThus, Meta’s impairment DCF relies on internal, management‑derived assumptions, whereas Disney’s Level 2‑derivative DCF relies on market‑observable inputs. (Disney’s own impairment‑testing DCF, which uses Level 3 inputs such as expected downtime, projected sublease income and risk‑adjusted discount rates, is described in its lease‑asset impairment note 【DIS page 98】).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Meta uses DCF models with Level 3 inputs (unobservable, management-derived assumptions like growth and discount rates) for impairment testing of long-lived assets. Disney uses DCF models with Level 2 inputs (observable market data such as interest rates, yield curves, FX rates) for valuing derivatives. The distinction between Level 2 vs Level 3 inputs is correctly emphasized. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable in terms of calculations, but all referenced inputs are factually consistent. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies (META and DIS), two applications of DCF (impairment testing vs derivative valuation), and two levels of the fair value hierarchy (Level 2 vs Level 3). The LLM even adds contextual precision by referencing specific pages (e.g., DIS page 119 and 98), which supports traceability. (4) The only minor shortcoming is that the LLM introduces extra detail (Disney’s own impairment testing on page 98) not requested in the question, which slightly shifts focus but does not detract from correctness. Overall, the answer captures the core contrast in inputs and assumptions accurately and completely, warranting a 9/10 for correctness and qualitative accuracy. Contextual relevance is perfect—directly addresses the comparison asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 411,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the IQOS device supply constraint mentioned in PM's 2022 filing impact PM USA's ability to commercialize heated tobacco products in the U.S., considering the FDA authorization dependency and PM USA's role as a guarantor under Altria's financial structure?",
      "original_answer": "The IQOS device supply constraint due to the global semiconductor shortage, as reported in PM's 2022 filing, limited IQOS user growth in the second half of 2021 and contributed to the delay in resuming U.S. supply following the ITC import ban. PM USA, as the exclusive commercialization partner for PMI's heated tobacco products in the U.S., depends on FDA authorization for IQOS devices, including IQOS 3, which is under review. The cessation of IQOS device sales in the U.S. after November 29, 2021, due to the ITC cease-and-desist order, further disrupted PM USA’s product portfolio. Given PM USA's role as a guarantor of Altria's debt obligations, any prolonged inability to market IQOS devices could strain PM USA's financial position, particularly if it affects cash flows or dividend distributions to Altria, thereby increasing the risk of insolvency considerations under fraudulent conveyance laws.",
      "llm_answer": "The filing notes that a global semiconductor shortage left IQOS device inventory “tight” in the second half of 2021 and, even after a modest easing in Q4 2021, the company still does not have full visibility on device availability for 2022 ( page 28 ). Because the U.S. right‑to‑sell the heated‑tobacco system rests on FDA pre‑market authorizations – the original IQOS PMTA was approved in 2019 and a MRTP order in 2020, while the newer IQOS 3 MRTP is still pending – the lack of devices means PM USA cannot commercialize the product in the United States despite having the necessary FDA approvals ( page 36 ). At the same time, PM USA is the 100 %‑owned guarantor of Altria’s senior debt ( page 51 ); while the guarantees are “absolute and unconditional,” a prolonged supply shortfall could depress PM USA’s cash‑flow generation and therefore strain its ability to meet those guarantor obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All factual elements are correct: the global semiconductor shortage impacting IQOS device inventory in the second half of 2021 is accurately cited from PM's 2022 filing, and the lack of visibility into 2022 supply is correctly referenced. The FDA authorization context is properly detailed — the 2019 PMTA approval, 2020 MRTP order, and pending status of IQOS 3 MRTP — all factually sound and relevant. PM USA’s role as a 100% guarantor of Altria’s senior debt is correctly stated. (2) Quantitative accuracy is perfect: no incorrect numbers, dates, or financial figures are presented. The timeline (second half of 2021, Q4 2021) matches the original answer and source filing. (3) Multi-hop reasoning is strong: the model correctly links the semiconductor shortage → device supply constraints → inability to commercialize in the U.S. despite FDA approvals → financial risk due to PM USA’s guarantor role. The causal chain is logically sound and synthesizes across operational, regulatory, and financial domains. (4) The only minor omission is the explicit mention of the ITC cease-and-desist order and the November 29, 2021, sales cessation, which are part of the supply disruption context in the ground truth. While the LLM implies supply issues, it does not directly attribute the U.S. disruption to the ITC ban, which weakens the completeness of the causal explanation slightly. However, the core financial and operational implications — especially the risk to PM USA’s cash flow and guarantor obligations — are well articulated and semantically equivalent to the original. Contextual relevance is excellent, addressing all key dimensions of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 470,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the impact of biosimilar competition on BMY's revenue outlook compare to ABBV's exposure given that Humira alone accounted for 27% of ABBV's 2023 net revenues and faces direct biosimilar pressure globally?",
      "original_answer": "BMY faces significant risk from biosimilar competition, which threatens to rapidly erode revenues for products losing market exclusivity, especially as seen with Eliquis and Revlimid. Meanwhile, ABBV's Humira, which accounted for 27% of its 2023 net revenues, is under direct global biosimilar pressure. While both companies are exposed to biosimilar threats, ABBV has a concentrated risk tied to a single product, whereas BMY faces broader portfolio risk across multiple products.",
      "llm_answer": "Bristol‑Myers Squibb notes that biosimilar entrants will bite into several of its biologics, but the company’s revenue outlook is buffered by a broader product mix and no single drug accounts for a dominant share of sales. In contrast, AbbVie’s outlook is far more exposed – Humira alone generated roughly 27 % of AbbVie’s 2023 net revenues and is now confronting direct, worldwide biosimilar competition, making the loss of its exclusivity a material headwind to AbbVie’s future earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 27% figure for Humira's contribution to AbbVie's 2023 net revenues is correctly stated, matching the original answer. No other numerical values are present, and all are accurate. (2) The answer correctly identifies both companies (BMY and ABBV), the relevant drug (Humira), and the year (2023), satisfying entity accuracy. (3) The multi-hop reasoning is sound: it contrasts BMY’s broader biosimilar risk across multiple products (e.g., implied exposure via Eliquis, Revlimid) with ABBV’s concentrated risk in Humira, which is the core insight from the original answer. The LLM correctly synthesizes that ABBV has greater exposure due to revenue concentration, while BMY’s diversified portfolio mitigates single-product risk. (4) The wording differs slightly—LLM emphasizes 'buffered by a broader product mix' and 'material headwind'—but the semantic meaning and factual content are equivalent. The only minor shortcoming is that the LLM does not explicitly name BMY’s at-risk drugs (Eliquis, Revlimid) as in the original, slightly reducing qualitative completeness, but the conceptual contrast is preserved. All parts of the question are addressed with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 352,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How does the treatment of dividend equivalents on RSU awards differ between PM and PEP in terms of payout structure and vesting triggers, given PM's inclusion of dividend equivalents during vesting and PEP's cash payout upon vesting?",
      "original_answer": "PM includes dividend equivalents on RSU awards that accrue during the vesting period and are paid out as part of the RSU settlement, typically after three years or upon specific events like death, disability, or reaching age 58. PEP also accrues dividend equivalents on RSUs, but these are paid out in cash (without interest) only when the RSU vests and becomes payable. Unlike PM, which may vest RSUs upon age or disability, PEP ties payout strictly to the end of the service period or performance-based vesting for PSUs, with no mention of age-based triggers. This reflects a structural difference in how each company manages equity compensation benefits.",
      "llm_answer": "Philip Morris’ RSU awards accrue dividend equivalents that are treated as part of the RSU benefit itself – the equivalents are incorporated into the award’s value and are delivered together with the shares when the RSU vests. PepsiCo’s RSUs (and PSUs) also accrue dividend equivalents, but those equivalents are paid out separately in cash at the moment the award vests, rather than being bundled into the share‑based award.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core differences in dividend equivalent treatment between PM and PEP. (1) It correctly states that PM includes dividend equivalents as part of the RSU value and pays them upon vesting along with shares, while PEP pays dividend equivalents in cash at vesting. This aligns with the ground truth. (2) There are no numeric values, dates, or calculations in the question or answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies accrue dividend equivalents, but differ in payout structure (in-kind vs. cash) and implies different vesting triggers by contrasting PM’s age/disability vesting (implied in original) with PEP’s service/performance-based vesting. However, the LLM answer does not explicitly mention PM’s age 58 or death/disability vesting triggers or clarify that PEP lacks such triggers, which is a minor omission in completeness. (4) Despite this, the answer is contextually precise, directly addressing the payout structure and vesting implications. Wording differs from the original but maintains semantic equivalence. One point deducted from correctness and qualitative accuracy for missing the specific vesting trigger distinctions, but overall the response is factually correct and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 377,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How does GE's $1,410 million investment in illiquid real estate funds through its run-off insurance operations compare to BA's broader real estate investment strategy, particularly in terms of liquidity risk and fund structure?",
      "original_answer": "BA invests in a diversified portfolio of global real estate, including office, retail, apartment, and industrial properties, primarily through limited partnerships or fund structures that allow for varied market exposure. These investments are part of a broader asset allocation strategy that includes private equity, hedge funds, and real assets. In contrast, GE holds $1,410 million in illiquid real estate funds through its run-off insurance operations, which are measured at net asset value and generally not eligible for redemption without the general partner's approval. Both use fund structures that limit liquidity, but GE's exposure is more concentrated and less flexible, as distributions depend on the liquidation of underlying assets at the discretion of the fund's general partner, whereas BA's approach is more diversified and integrated within a broader investment framework.",
      "llm_answer": "GE’s 10‑K notes that $1,410 million of its run‑off insurance assets are held in limited‑partnership interests in private‑equity, infrastructure and **real‑estate** funds that are measured at NAV, are not redeemable and can be sold only with the general‑partner’s approval – the cash‑flow from these funds comes only when the GP liquidates underlying properties, making the position highly illiquid and exposing the insurance book to significant liquidity risk. By contrast, Boeing’s pension‑plan disclosure shows a **broader, diversified real‑estate strategy** that represents about 7 % of total pension assets and is also held in LP or similar fund structures, but the exposure is spread across many funds and is managed alongside short‑term assets and derivatives to meet cash‑flow needs, so its overall liquidity risk is lower and more actively mitigated than GE’s single, large, illiquid real‑estate holding.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all figures are correct: GE's $1,410 million investment is accurately cited, and Boeing's ~7% allocation to real estate (implied from broader disclosures) matches known pension asset allocations in the knowledge graph. No calculations were required, but the representation of amounts and structures is precise. (2) The LLM correctly identifies both companies' use of limited partnership (LP) structures and notes that both hold real estate via fund vehicles measured at net asset value (NAV), with restricted liquidity. It accurately emphasizes that GE’s position is non-redeemable and dependent on GP discretion for cash flows, highlighting high illiquidity. (3) The multi-hop reasoning is sound: it synthesizes GE’s run-off insurance investments with Boeing’s pension fund strategy, contrasting concentration vs. diversification, and correctly infers that Boeing’s integration of real estate within a broader, actively managed portfolio reduces overall liquidity risk. (4) Minor deduction in qualitative accuracy because the original answer notes BA’s exposure spans office, retail, apartment, and industrial properties—specific asset classes not mentioned in the LLM response—adding slightly more contextual depth. However, the LLM captures the essence of diversification and risk mitigation. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is perfect: all parts of the question (liquidity risk, fund structure, comparison) are addressed with appropriate focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 438,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How does BAC's exposure to equity market risk, as managed through derivative instruments, compare to MET's use of equity market derivatives in terms of notional value and sensitivity to a 10% decrease in equity prices?",
      "original_answer": "BAC discloses exposure to equity market risk through trading positions involving equity-linked instruments such as options, futures, and swaps. MET reports a notional value of $23,595 million for its equity market derivatives, with a sensitivity of $522 million to a 10% decrease in equity prices. While BAC does not specify exact notional amounts for its equity derivatives, it emphasizes the use of similar hedging tools. MET's quantified exposure highlights a direct sensitivity to equity market movements, which contrasts with BAC's broader market risk management approach that includes equity risk as one of several components.",
      "llm_answer": "MetLife’s 2023 filing quantifies its equity‑market hedge activity: the company holds about **$23.6 billion of equity‑market derivative notional** (mostly equity total‑return swaps, index futures and options) and the sensitivity table shows that a **10 % fall in equity prices would reduce the fair value of those positions by roughly $522 million**.\n\nBank of America’s 2023 filing does not give a comparable notional amount for its equity‑derivative positions.  It only reports the market‑risk VaR for the equity‑risk factor – **$18 million at the 99 % confidence level (and $8 million at 95 %)** – and provides no explicit “‑10 % equity‑price” sensitivity figure.  Thus, MetLife’s exposure is disclosed in both notional size and dollar‑loss impact, whereas Bank of America’s equity‑market exposure is presented only as a VaR figure with no notional‑or‑sensitivity amount.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: MET's notional value of $23,595 million is accurately reported as $23.6 billion (rounded), and the $522 million sensitivity to a 10% decrease in equity prices is exactly matched. BAC's lack of notional disclosure and reliance on VaR ($18 million at 99% confidence) are correctly stated, though the ground truth does not mention VaR—this additional detail from the LLM is consistent with typical risk disclosures and does not contradict the original answer. (2) The answer fully addresses the two-part question: comparison of notional values and sensitivity to a 10% equity decline. It correctly notes that MET provides both notional and sensitivity figures, while BAC does not disclose notional amounts or explicit sensitivity, only VaR. (3) Entities are accurate: BAC and MET (MetLife) are correctly identified, and the context of 2023 filings is appropriate (implied by the data). (4) Reasoning is sound: the LLM correctly synthesizes that MET offers direct, quantified exposure metrics, whereas BAC’s approach is more generalized and risk-factor-based. The only minor gap is that the original answer mentions BAC uses equity-linked instruments like options, futures, and swaps for hedging—information not included in the LLM response—hence a slight deduction in qualitative accuracy. However, the core multi-hop comparison is logically and factually sound. Semantic equivalence is maintained, and the answer is contextually excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 426,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How does Microsoft's operational footprint in Greater China compare to AMD's revenue concentration in Taiwan, and what does this suggest about their respective regional market strategies in 2022?",
      "original_answer": "Microsoft operates a regional center in Singapore that supports operations in Greater China, indicating a centralized approach to managing its activities across the region, which includes China mainland, Hong Kong, and Taiwan. AMD, on the other hand, reported $2,091 million in sales to Taiwan in 2022, highlighting a significant direct revenue contribution from the region. While Microsoft's presence in Greater China is part of a broader Asia-Pacific operational structure, AMD's financial data shows a more concentrated revenue exposure to Taiwan specifically, suggesting differing regional market strategies: Microsoft leans on regional hubs to support broad market access, while AMD has a pronounced financial dependency on Taiwan as a key market.",
      "llm_answer": "Microsoft’s 2022 filing shows that Greater China is served by a dedicated regional operations centre in Singapore (which also supports Japan, India and the rest of APAC) and by datacenters “throughout … Asia” (page 16), and the segment generated $74.2 billion of net sales – a 9 % increase year‑over‑year (page 25). AMD, by contrast, reports that sales to Taiwan accounted for $2.1 billion of its $16.4 billion external‑customer revenue in 2021 – roughly 13 % of total sales (page 78), indicating a relatively high concentration of revenue in that single market. Together, these disclosures suggest Microsoft pursues a broad, infrastructure‑heavy footprint across Greater China to support a diversified portfolio, while AMD’s strategy in 2022 relied heavily on a key regional hub (Taiwan) for a sizable share of its revenue.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. It states that Microsoft's Greater China segment generated $74.2 billion in net sales in 2022 with a 9% year-over-year increase, but this figure is not supported by the ground truth and appears to conflate Microsoft's overall Asia-Pacific or global revenue with Greater China specifically. The ground truth does not provide a revenue figure for Microsoft in Greater China, so this number is an overreach. Additionally, the LLM claims AMD's $2.1 billion in sales to Taiwan came from 2021 data (citing page 78), but the question and ground truth are focused on 2022, making this a critical temporal error. While $2.1 billion is close to the ground truth $2,091 million, the year mismatch undermines accuracy. (2) The calculation of AMD’s Taiwan sales as 13% of total revenue is plausible ($2.1B / $16.4B ≈ 12.8%), but again relies on 2021 data instead of 2022, so it fails the multi-year precision required. (3) The reasoning and synthesis are partially sound: the contrast between Microsoft’s regional hub model (Singapore supporting Greater China) and AMD’s revenue concentration in Taiwan is correctly identified and aligns with the ground truth. The interpretation that Microsoft uses infrastructure and hubs for broad access while AMD has high dependency on Taiwan is semantically equivalent and well-reasoned. (4) Contextual relevance is high—the answer directly addresses the comparison of operational footprint vs. revenue concentration and infers strategic differences. However, due to incorrect revenue figures for Microsoft and the use of 2021 data for AMD instead of 2022, the quantitative accuracy is significantly compromised, warranting a moderate correctness score of 6. The qualitative reasoning and structure are strong, but factual grounding in the correct year and metrics is lacking.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 517,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How does the dual-class stock structure at META, which affects the voting rights of Class A common stockholders, compare to NFLX's approach to shareholder voting rights in terms of investor influence over corporate governance decisions?",
      "original_answer": "META's dual-class common stock structure gives disproportionate voting power to Class B stockholders, such as Mark Zuckerberg, limiting the influence of Class A common stockholders on key corporate decisions, including board composition and change-of-control transactions. This contrasts with NFLX's one-share-one-vote policy, where each share of common stock entitles the holder to one vote on all matters, ensuring equal voting influence for all shareholders. The difference in voting rights structures reflects divergent approaches to corporate governance, with META prioritizing founder control and NFLX emphasizing broad shareholder participation.",
      "llm_answer": "Meta’s charter creates a dual‑class system in which the Class B shares held by Mark Zuckerberg carry enough voting power to control any shareholder‑approved matter even though he owns far fewer total shares than the public (the filing notes that “our dual‑class common stock structure … provides Mr. Zuckerberg with the ability to control the outcome of matters requiring stockholder approval” – Meta 10‑K p. 50). In contrast, Netflix operates a single‑class structure where each share of common stock carries one vote, so investors’ influence over corporate‑governance decisions is directly proportional to the number of shares they own (Netflix 10‑K p. 61).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies META's dual-class structure and its effect on voting power, specifically noting Mark Zuckerberg's control despite owning fewer total shares, which aligns with the original answer. It also accurately describes NFLX's one-share-one-vote policy. (2) There are no numerical values requiring verification (e.g., percentages, share counts), but the qualitative financial structure implications are correctly interpreted. (3) The multi-hop reasoning—comparing corporate governance structures across two companies using their respective 10-K filings—is sound and well-supported with direct citations to the source documents (Meta 10-K p.50, Netflix 10-K p.61), demonstrating proper synthesis. (4) The answer fully addresses the question by contrasting investor influence in both firms, captures the core distinction in governance philosophy, and maintains contextual relevance throughout. Wording differs slightly but meaning is preserved. All evaluation criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 314,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How does the expiration of patent rights for JNJ's pharmaceutical products impact their market exclusivity, and how does this compare to LLY's reliance on regulatory exclusivity extensions for maintaining competitive advantage in the U.S. market?",
      "original_answer": "JNJ notes that patent expirations are typically followed by the introduction of competing generic products, which can result in significant revenue and market share losses. Additionally, JNJ highlights that increasingly aggressive challenges to its patents may lead to a loss of market exclusivity sooner than expected. In contrast, LLY relies on regulatory exclusivity extensions—such as those granted for orphan drug designations or pediatric exclusivity—to maintain market exclusivity beyond patent terms. According to BMY’s 10-K, regulatory exclusivity can provide a market exclusivity period that expires beyond the patent term, offering a strategic buffer against generic competition. Thus, while JNJ faces declining sales due to patent erosion and legal challenges, LLY strategically leverages regulatory exclusivity to prolong its market protection.",
      "llm_answer": "- Johnson & Johnson’s market‑exclusivity is tied chiefly to the life of its patents; when a compound‑patent (or related use, formulation or process patent) expires, the company loses the legal right to block generic or biosimilar entry and, as the 10‑K notes, “there are usually very substantial and rapid declines in a product’s revenues” once that protection ends (see JNJ 10‑K p. 28 and p. 10).  The firm therefore tries to extend exclusivity through later‑expiring patents, settlements or data‑protection periods, but the loss of the core patent still threatens its sales.\n\n- Eli Lilly, by contrast, emphasizes reliance on FDA‑granted regulatory exclusivity and its extensions (orphan‑drug, pediatric, data‑package and other statutory exclusivity periods) to preserve a competitive advantage in the U.S. even after the underlying patents expire, as described in its 10‑K (pages 6, 9‑11, 34).  Thus, while JNJ’s exclusivity erodes with patent expiration, LLY’s strategy leans on regulatory exclusivity extensions to maintain market protection beyond the patent term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that JNJ's market exclusivity primarily depends on patent life, and upon expiration, generic competition leads to substantial revenue declines—consistent with the original answer's claim of 'significant revenue and market share losses.' The citation of JNJ’s 10-K (pp. 28, 10) supports this. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a traditional sense; however, all referenced document pages and exclusivity mechanisms are correctly stated, with no factual inaccuracies—thus scoring 10. (3) The LLM accurately contrasts JNJ’s vulnerability to patent expiration with LLY’s strategic use of regulatory exclusivity extensions (e.g., orphan-drug, pediatric), citing LLY’s 10-K (pp. 6, 9–11, 34), which matches the ground truth’s emphasis. It also correctly notes that regulatory exclusivity can extend beyond patent terms, providing a buffer against generics. The only minor omission is not explicitly mentioning BMY’s 10-K as a source for the general principle of regulatory exclusivity outlasting patents, which appears in the original answer. However, since the LLM directly attributes the strategy to LLY’s own disclosures, this does not undermine the factual correctness. (4) The reasoning is sound, multi-hop synthesis across companies and strategies is clear, and the comparison is logically structured and contextually precise. The answer fully addresses both parts of the question: JNJ’s patent-based exclusivity risks and LLY’s regulatory-based advantages. Therefore, the answer is semantically equivalent to the ground truth with only a slight reduction in qualitative accuracy due to the omitted BMY reference, which provides supporting context but is not essential to the core comparison between JNJ and LLY.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 514,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How does AMD's reduction in interest expense from convertible debt conversions compare with Nuance's outstanding convertible senior notes liability post-acquisition by Microsoft, and what does this imply about their respective capital structure strategies?",
      "original_answer": "AMD reduced its interest expense from $47 million in 2020 to $34 million in 2021 due to conversions of its 2.125% Convertible Senior Notes due 2026, indicating a proactive approach to reducing debt. Meanwhile, Nuance, which had issued $986 million in convertible senior notes in 2015 and 2017, had redeemed $985 million of those notes by June 30, 2022, leaving only $1 million outstanding. Microsoft, having acquired Nuance, now holds this remaining liability as part of its Intelligent Cloud segment. This suggests that AMD focused on reducing debt through voluntary conversions, while Nuance’s strategy under Microsoft involved largely redeeming its convertible notes, reflecting differing capital structure management approaches between the two companies.",
      "llm_answer": "AMD said its interest expense fell from $47 million in 2020 to $34 million in 2021 – a $13 million reduction – because holders converted its 2.125 % convertible senior notes due 2026, cutting the company’s debt and interest burden. After Microsoft acquired Nuance, only about $1 million of Nuance’s convertible senior notes remained on the balance sheet (the other $985 million had been redeemed), essentially wiping out that liability. Thus, AMD is trimming interest cost by converting existing convertible debt, while Microsoft eliminated almost all of Nuance’s convertible debt, reflecting AMD’s incremental deleveraging versus Microsoft’s more aggressive post‑acquisition balance‑sheet clean‑up.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key facts: AMD's interest expense decreased from $47 million in 2020 to $34 million in 2021 due to conversions of its 2.125% Convertible Senior Notes due 2026. Nuance had $986 million in convertible notes issued over 2015 and 2017, with $985 million redeemed by June 30, 2022, leaving $1 million outstanding post-acquisition by Microsoft. These figures match the ground truth exactly, with acceptable formatting (e.g., $47 million). (2) Quantitative accuracy is perfect: the $13 million reduction is correctly calculated ($47M - $34M), and the $985M redemption leaving $1M outstanding aligns with the original data. (3) The multi-hop reasoning is sound—LLM correctly synthesizes AMD’s debt conversion strategy with Nuance’s post-acquisition redemption under Microsoft, drawing a valid contrast between AMD’s incremental deleveraging and Microsoft’s aggressive balance sheet cleanup. The implication about capital structure strategies is logically derived and semantically equivalent to the ground truth. (4) Minor deduction in qualitative accuracy because the LLM omits explicit mention that Nuance issued $986 million in notes (though implied by stating $985M redeemed and $1M left), and does not specify Microsoft holds the liability in its Intelligent Cloud segment—minor contextual omissions but not critical to the core comparison. Otherwise, the answer is factually complete, contextually relevant, and correctly interprets the strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 416,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How does the $5.0 billion upfront payment from American Tower in 2015 for exclusive rights to 11,300 Verizon towers compare to the $4.827 billion transaction Crown Castle executed in 2013 for similar exclusive rights to AT&T's towers, considering both companies retained ownership and depreciation responsibilities?",
      "original_answer": "The $5.0 billion upfront payment from American Tower in 2015 for exclusive rights to 11,300 Verizon towers is slightly higher than the $4.827 billion Crown Castle paid in 2013 for 9,048 AT&T towers and the purchase of 627 towers. Both Verizon and AT&T retained ownership of the towers and continued to include them in Property, Plant and Equipment - Net on their balance sheets, depreciating them accordingly. In both cases, the companies subleased capacity back from the acquiring entity (American Tower or Crown Castle) for extended terms, with Verizon leasing back for a minimum of 10 years and AT&T subleasing for an estimated original term of 20 years.",
      "llm_answer": "The 2015 deal with American Tower gave the tower‑owner exclusive lease and operating rights to about 11,300 Verizon towers in exchange for an upfront $5.0 billion cash payment, but AT&T kept the towers on its balance sheet and continues to depreciate them. In the 2013 Crown Castle transaction AT&T received $4.827 billion for exclusive rights to roughly 9,000 AT&T towers (plus the purchase of 627 towers), also retaining ownership and depreciation of the assets. Thus, the American Tower payment was modestly larger—about $170 million more—while both arrangements left AT&T as the legal owner responsible for the towers’ depreciation.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $5.0 billion American Tower payment in 2015 for 11,300 Verizon towers and the $4.827 billion Crown Castle transaction in 2013, noting the $170 million difference. However, it incorrectly states that 'AT&T kept the towers on its balance sheet' in the Verizon deal — it was Verizon, not AT&T, that retained ownership and depreciation responsibilities for its own towers. This is a significant entity error. (2) Quantitatively, the dollar amounts ($5.0B and $4.827B) and the implied difference (~$173M, rounded to $170M) are acceptable. The number of towers (11,300 vs. 9,048) is partially accurate — the LLM says 'roughly 9,000' instead of the precise 9,048, which is a minor inaccuracy. The purchase of 627 towers by Crown Castle is correctly mentioned. (3) The multi-hop reasoning is mostly sound — the model compares two complex transactions involving tower rights, retained ownership, and depreciation. However, it fails to correctly attribute the balance sheet treatment to the right companies in both cases, confusing AT&T with Verizon in the first deal. This undermines the qualitative accuracy. (4) Contextual relevance is perfect — the answer directly addresses the comparison, financial terms, ownership, and depreciation. Due to the entity mix-up and slight omission of precise tower count, the correctness score is 7 rather than higher. The answer is mostly accurate in substance but contains a critical factual error in entity attribution.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 415,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How does Southern Power's use of tax equity partnerships for wind facilities, which are connected to long-term PPAs with up to 25-year terms, compare with Duke Energy's approach to structuring PPAs for its renewable VIEs, particularly in terms of monetizing federal tax credits like PTCs?",
      "original_answer": "Southern Power utilizes tax equity partnerships for its wind facilities, allowing a tax partner to capture most of the federal tax benefits, including PTCs tied to the first 10 years of energy production. These partnerships are consolidated using the HLBV method, and the associated PPAs have remaining terms of up to 25 years. The PPAs are critical in monetizing these tax credits through long-term revenue streams. Similarly, Duke Energy structures PPAs as part of its renewable VIEs, where it is the primary beneficiary and makes key decisions including PPA negotiations. These PPAs are also essential in monetizing tax credits, but Duke does so under a model involving third-party tax equity investors to finance eligible assets. Both companies rely on PPAs for revenue predictability, but Southern Power explicitly ties its PPA terms and tax equity structures to the PTC window, while Duke’s focus is on broader VIE financing and guarantees.",
      "llm_answer": "Southern Power funds its wind projects through tax‑equity partnerships that take essentially all of the federal tax benefits (ITCs and the first‑10‑year PTCs) and pairs those partnerships with long‑term PPAs—operating‑lease contracts that can run as long as 25 years—to lock in stable cash‑flow streams (see pages 97 and 268). Duke Energy, by contrast, places its renewable assets in VIEs and uses tax‑equity arrangements to transfer the PTCs to third‑party investors, but the PPAs are structured within those VIEs primarily as part of the financing package rather than as separate, long‑term lease‑type contracts (see pages 204 and 202). Thus, Southern Power relies on very long‑term PPAs to support its tax‑equity deals, whereas Duke’s VIE approach monetizes the credits through tax‑equity financing without the same explicit 25‑year PPA framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Southern Power uses tax equity partnerships to monetize federal tax benefits (PTCs for the first 10 years), pairs them with long-term PPAs up to 25 years, and relies on these for stable cash flows—consistent with the original answer. Duke Energy’s approach is accurately described as using VIEs with tax equity investors to transfer PTCs, with PPAs structured within the VIEs as part of financing. (2) Quantitatively, the mention of 'first-10-year PTCs' and 'up to 25 years' matches the ground truth exactly; no calculations are required, but timeframes are correctly preserved. (3) The multi-hop reasoning is sound: the model synthesizes Southern Power’s PPA-tax equity linkage and contrasts it with Duke’s VIE-based financing model, capturing the key distinction—Southern Power ties long-term PPAs explicitly to the PTC window, while Duke focuses on broader VIE financing. (4) The only minor gap is that the LLM does not explicitly mention Southern Power’s use of the HLBV method for consolidation or Duke’s role as primary beneficiary making key decisions, which are present in the original. However, these omissions do not detract from the core comparison about PPA structure and tax credit monetization. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect—directly addresses the comparison asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 397,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How do the differences in voting rights structures between CMCSA's Class B common stock and GOOGL's dual-class stock system affect their respective corporate governance models, particularly in terms of shareholder influence on major corporate decisions?",
      "original_answer": "CMCSA's Class B common stock has no voting rights, limiting shareholder influence on major decisions unless specific conditions are met, such as exiting the core payments business or undergoing a merger. In contrast, GOOGL's dual-class structure allows Class B stockholders to have 10 votes per share, significantly concentrating voting power in the hands of a few, while Class A stockholders have 1 vote per share and Class C stockholders have no voting rights. This creates a governance model at GOOGL where a small group of insiders can dominate decision-making, whereas CMCSA maintains a more uniform governance structure among its voting shareholders. The differential voting rights at GOOGL can lead to more decisive strategic direction but less democratic shareholder oversight compared to CMCSA.",
      "llm_answer": "- Alphabet’s (GOOGL) capital‑structure is explicitly described in its 10‑K: Class A shares carry one vote per share, Class B shares carry ten votes per share, and Class C shares carry **no voting rights** (see page 82). This dual‑class system concentrates decisive voting power in the relatively few Class B shareholders (the founders and insiders), while the large pool of publicly‑traded Class C holders cannot vote on any corporate matters, including mergers, amendments to the charter, or director elections.  \n\n- Comcast’s 10‑K shows that it also has a separate Class B common‑stock series (9,444,375 shares issued and outstanding as of 2024 – page 67), but the filing does not grant it any special voting multiplier; the only voting distinction noted is that the rights of each class are “identical, except with respect to voting” (see the note on Class A, Class B and Class C capital stock on page 82 for Alphabet, which parallels Comcast’s description of multiple classes). Consequently, Comcast’s Class B shares do not create the same level of voting concentration as Alphabet’s Class B; outside shareholders retain a more proportional influence over major corporate decisions.  \n\n**Effect on governance:** Alphabet’s structure gives a small group of insiders effective control over strategic actions, limiting the ability of ordinary shareholders to affect mergers, charter changes, or board composition. Comcast’s Class B shares, while a distinct class, do not carry a super‑voting premium, so shareholder influence on major decisions remains more broadly distributed among all stockholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: GOOGL's Class B has 10 votes per share, Class A has 1 vote, Class C has none; CMCSA's Class B has no super-voting rights and differs only in voting access. The description of governance implications—concentrated control at GOOGL vs. more distributed influence at CMCSA—is semantically equivalent to the original answer. (2) Quantitative accuracy is perfect: no incorrect numbers, percentages, or misstatements of share counts or voting ratios. The reference to 9,444,375 Class B shares for CMCSA is factually consistent with the 10-K and correctly used to show existence of the class without implying super-voting rights. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across both companies’ capital structures and draws a valid comparative conclusion about shareholder influence and governance models. It correctly infers that absence of a voting multiplier in CMCSA means less concentration than at GOOGL. (4) Minor deduction in qualitative accuracy due to slightly less explicit mention of CMCSA’s conditional voting triggers (e.g., merger or exit from core business), which are present in the ground truth and add nuance to when Class B might influence decisions. However, the core reasoning about broader shareholder influence remains valid. Wording differences do not affect meaning, and the answer fully addresses the comparative governance impact as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1628,
        "completion_tokens": 414,
        "total_tokens": 2042
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How might the difference in voting rights structures between GOOGL (with 1 vote per Class A share and 10 votes per Class B share) and NFLX (1 vote per common share) affect control dynamics, especially considering GOOGL's $62.2 billion in share repurchases during 2023?",
      "original_answer": "GOOGL's dual-class share structure, where Class B shares carry 10 votes per share compared to Class A's 1 vote, allows certain major shareholders to maintain outsized voting control despite owning a smaller economic stake. In 2023, GOOGL repurchased $62.2 billion of its Class A and Class C shares, which likely further consolidated voting power among remaining Class B shareholders. In contrast, NFLX maintains a one-share-one-vote structure, distributing control more evenly across all shareholders. This structural difference means GOOGL’s leadership has greater insulation from shareholder influence compared to NFLX, even as both companies manage capital through stock repurchases and equity grants.",
      "llm_answer": "Alphabet’s dual‑class structure gives a small group of insiders (the holders of Class B stock) ten votes for each share they own, while the much larger pool of publicly‑traded Class A and Class C shares carries only one vote per share.  Even after the company spent $62.2 billion in 2023 buying back Class A and Class C shares (see GOOGL 10‑K p. 81), the voting power of the Class B holders is largely unchanged, so control of the board and strategic direction remains concentrated in the hands of those insiders.  \n\nNetflix, by contrast, has a single‑class equity structure in which every share of common stock carries one vote (see NFLX 10‑K p. 58).  Consequently, voting power is directly proportional to economic ownership, making control more diffuse and less susceptible to concentration through share‑repurchase programs.  \n\nThus, Alphabet’s high‑vote Class B shares allow a minority of owners to retain decisive control despite large share‑repurchase activity, whereas Netflix’s one‑vote‑per‑share model ties control to the distribution of economic ownership.  ",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: GOOGL's dual-class structure (10 votes for Class B, 1 vote for Class A/C), NFLX's one-share-one-vote structure, and the $62.2 billion in 2023 share repurchases are all accurately cited. The dollar amount and year match the ground truth exactly, and format is consistent. (2) Quantitative accuracy is perfect: the $62.2 billion figure is correctly attributed to 2023 repurchases of Class A and C shares, with no calculation errors. (3) Reasoning is sound: the LLM correctly infers that repurchasing low-vote shares (A and C) does not dilute the voting power of Class B insiders, thus preserving concentrated control. It contrasts this effectively with NFLX’s structure, where control is proportional to ownership. (4) The only minor shortcoming is that the LLM does not explicitly state that the repurchases 'consolidated' voting power among Class B holders—a nuance present in the original answer—but this is implied in stating that control 'remains concentrated.' The answer cites 10-K page numbers (p.81, p.58), which adds credibility though not required. Overall, the response is factually correct, contextually relevant, and demonstrates strong multi-hop reasoning across corporate structures and capital allocation impacts on control.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 373,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What is the financial significance of BMY's retained royalty rights related to Byetta*, given its divestiture of the diabetes business and the trademark's current ownership by LLY?",
      "original_answer": "BMY retains royalty rights related to Byetta*, a product originally associated with Amylin, even after divesting its diabetes business. According to BMY's 2022 10-K, pretax income from such royalties was approximately $1.9 billion in 2021, and a decline in these royalty streams could adversely affect BMY's future financial performance. Although Eli Lilly (LLY) now holds the trademark for Byetta*, BMY still has financial exposure through its retained royalty rights, indicating a continued revenue relationship between BMY and LLY despite the divestiture.",
      "llm_answer": "BMS kept the right to receive royalties on the former diabetes products it sold, including the Byetta® brand (now owned by Eli Lilly).  Those retained royalty streams are material – they generated roughly $1.9 billion of pretax income for BMS in 2021 – so even though the trademark is now Lilly’s, the royalty rights continue to provide a significant source of revenue for BMS.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core financial significance of BMY's retained royalty rights related to Byetta*. (1) Quantitatively, it correctly states that the royalty streams generated approximately $1.9 billion in pretax income in 2021, matching the ground truth from BMY's 2022 10-K. The year (2021) and metric (pretax income) are accurate. (2) The answer addresses the key elements: BMS (BMY) retained royalty rights post-divestiture, the product (Byetta*) is now under LLY's trademark ownership, and these royalties remain a material revenue source. (3) The multi-hop reasoning is sound—linking BMY’s divestiture, continued royalty income, LLY’s current trademark ownership, and financial impact—but slightly omits the forward-looking risk mentioned in the original (i.e., that a decline in royalties could adversely affect future performance). (4) Entity names (BMS/BMY, Eli Lilly/LLY), product (Byetta*), and financial concept (pretax income from royalties) are correctly identified. Wording differs slightly (e.g., 'material' vs. 'significant'), but semantic equivalence is maintained. One minor point preventing a perfect 10 is the lack of explicit mention of future financial exposure, which is part of the full financial significance. Overall, the answer is factually correct, well-reasoned, and highly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 372,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How does the difference in capital buffer structures between Schwab and JPMorgan Chase affect their respective minimum total risk-based capital ratio requirements, considering Schwab's requirement includes both a 2.5% stress capital buffer and 2.5% capital conservation buffer while JPMorgan Chase applies only a 2.5% capital conservation buffer?",
      "original_answer": "Schwab's minimum total risk-based capital ratio requirement is 10.5%, which incorporates both a 2.5% stress capital buffer and a 2.5% capital conservation buffer above the base regulatory minimum. In contrast, JPMorgan Chase's minimum total risk-based capital ratio is also 10.5%, but this only includes a 2.5% capital conservation buffer without an additional stress capital buffer component. This reflects different regulatory treatments where Schwab is subject to both buffers while JPMorgan Chase only applies the capital conservation buffer.",
      "llm_answer": "- **Schwab:** The firm must meet a minimum **total risk‑based capital ratio of 10.5 %** (the regulatory floor of 8.0 % plus a 2.5 % stress‑capital buffer on the holding company and a 2.5 % capital‑conservation buffer on the bank subsidiary)【page_122】.  \n\n- **JPMorgan Chase:** For the bank subsidiary, the required **total risk‑based capital ratio is 10.5 %** (the same 8.0 % regulatory minimum plus only a 2.5 % capital‑conservation buffer)【page_291】.  \n\nThus, although Schwab’s buffers are split between a stress buffer and a conservation buffer, the combined effect yields the same 10.5 % minimum total risk‑based capital ratio that JPMorgan Chase meets with a single 2.5 % conservation buffer.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Schwab's 10.5% minimum total risk-based capital ratio is composed of an 8.0% regulatory minimum plus a 2.5% stress capital buffer and a 2.5% capital conservation buffer, totaling 10.5%. JPMorgan Chase’s requirement is also 10.5%, derived from the same 8.0% base plus only a 2.5% capital conservation buffer. These numbers match the original answer exactly. (2) Quantitative accuracy is perfect—percentages and calculations (8.0% + 2.5% + 2.5% = 10.5% for Schwab; 8.0% + 2.5% = 10.5% for JPMorgan) are correctly presented. Format variations (e.g., spacing in percentages) do not affect meaning. (3) The multi-hop reasoning is sound: the model correctly synthesizes that despite different buffer structures (Schwab having both stress and conservation buffers, JPMorgan only the conservation buffer), both firms end up with the same total capital requirement. This reflects proper cross-entity comparison. (4) The only minor shortcoming is that the LLM does not explicitly mention the regulatory distinction or 'different regulatory treatments' as highlighted in the original answer, which provides slightly richer context on why the structures differ. However, the core reasoning and factual content are preserved. Thus, while not perfectly verbatim in explanation, the semantic equivalence and factual correctness are strong, warranting a 9/10 on overall correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 411,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How does the transition from LIBOR to alternative reference rates impact both LMT's credit facility and GE's floating-rate debt and preferred stock, considering the accounting relief provided under ASU 2020-04?",
      "original_answer": "The transition from LIBOR to alternative rates impacts LMT’s credit facility and derivatives through fallback provisions like SOFR, with LMT expecting minimal financial impact due to ASU 2020-04's accounting relief that limits the effect of contract modifications. Similarly, GE’s floating-rate debt and preferred stock will transition to SOFR plus a spread adjustment under New York law, with any financial impact also being accounted for under ASU 2020-04. Both companies rely on the same accounting standard to ease the financial reporting burden during the LIBOR transition, despite differing in the types of financial instruments affected.",
      "llm_answer": "The credit facility that Lockheed Martin has with its banks already contains fallback language that will automatically switch the interest‑rate formula from LIBOR to an alternative benchmark (such as SOFR) when LIBOR is no longer published, and the company is applying the temporary expedients in ASU 2020‑04 so that the contract‑modification accounting impact is minimal – it does not expect a material effect on results, cash flow or balance‑sheet amounts. Similarly, General Electric’s floating‑rate debt and its LIBOR‑based preferred‑stock are subject to New York‑state statutory fall‑backs that will replace LIBOR with the “recommended benchmark” (SOFR + a spread) on cessation, and the transition will be accounted for under the relief provided by ASU 2020‑04, which limits any earnings or equity‑impact from the rate change.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: LMT’s credit facility and derivatives have fallback provisions to SOFR, with minimal financial impact due to ASU 2020-04; GE’s floating-rate debt and preferred stock transition under New York law to SOFR plus a spread adjustment, also accounted for under ASU 2020-04. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), but the qualitative financial impacts ('minimal', 'not material') align precisely with the original answer. (3) Multi-hop reasoning is sound: the response correctly synthesizes information across two companies (LMT and GE), different financial instruments (credit facility, debt, preferred stock), and a shared accounting standard (ASU 2020-04), showing how each is affected and mitigated. (4) The wording differs slightly but preserves full meaning—e.g., 'temporary expedients in ASU 2020-04' vs 'accounting relief provided under ASU 2020-04'—and adds useful detail (e.g., 'New York-state statutory fall-backs') without introducing error. All aspects of the question are addressed with high precision and contextual fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 340,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "What is the significance of CMCSA's issuance of 9,444,375 shares of Class B common stock in 2023, and how does this structure compare to GOOGL's dual-class system where Class B shares automatically convert to Class A shares upon sale or transfer?",
      "original_answer": "CMCSA issued 9,444,375 shares of Class B common stock in 2023, indicating a strategic move to maintain control while potentially raising capital without diluting voting power significantly. This mirrors GOOGL's dual-class structure, where Class B shares carry 10 votes per share and convert to single-vote Class A shares upon sale or transfer, preserving founder control. However, unlike GOOGL, which actively repurchased $62.2 billion of Class A and Class C shares in 2023, CMCSA's equity strategy appears more focused on maintaining a stable capital structure with no mention of a similar buyback program for Class B shares.",
      "llm_answer": "Comcast’s 2023 balance sheet shows that the company issued 9,444,375 shares of its Class B common stock (authorized 75 million, 9.44 million issued and outstanding) 【page_69】.  Because each Class B share carries ten votes, this relatively small issuance gives insiders a disproportionate voting stake and preserves the firm’s dual‑class control structure.  Alphabet’s dual‑class model is similar in that its Class B shares also have ten votes per share, but they are required to convert to one‑vote Class A shares automatically whenever they are sold or transferred, limiting the ability of non‑insiders to retain the high‑voting shares 【page_81】.  Thus, while both companies use ten‑vote Class B stock to concentrate voting power, Comcast allows the shares to remain Class B after transfer, whereas Google forces a conversion to the lower‑voting Class A on any sale or transfer.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the issuance of 9,444,375 Class B shares by CMCSA in 2023 is accurately reported, and the reference to Alphabet's Class B shares having 10 votes per share and converting to Class A upon sale is factually sound. The LLM correctly notes the voting differential and structural distinction in transfer rules. (2) The answer correctly identifies both companies (CMCSA and GOOGL), the relevant share classes, and the year (2023), satisfying entity accuracy. (3) The multi-hop reasoning is strong: it synthesizes CMCSA’s capital structure move with GOOGL’s dual-class system, correctly contrasting the transfer/conversion mechanisms. The only minor omission is that the original answer mentions GOOGL’s $62.2 billion share repurchase in 2023 and CMCSA’s lack of a similar buyback program—this contextual detail about capital allocation strategy is missing in the LLM response, slightly reducing completeness. However, this does not undermine the core comparison on share structure and control. (4) Despite this omission, the LLM captures the essential significance of the share issuance (maintaining insider control via high-vote shares) and accurately contrasts the two companies’ dual-class systems. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9/10 for correctness—excellent but not fully complete on peripheral context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 403,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How do the vesting-related financial commitments in MDLZ's multiemployer pension plans compare with WMT's equity compensation vesting schedules in terms of duration and cost recognition patterns?",
      "original_answer": "MDLZ has long-term financial obligations tied to multiemployer pension plans, with vesting periods governed by union agreements that result in multi-year liabilities such as a $526 million withdrawal liability paid over 19 years. These costs are recognized through ongoing contributions and interest accruals (e.g., $11 million in 2021). In contrast, WMT structures its employee incentives through equity compensation with defined vesting periods—such as restricted stock units that vest 25% annually over four years—with fair value discounted for expected dividends (e.g., 3.8% in fiscal 2022) and expensed ratably over the vesting term. While MDLZ's obligations are shaped by collective bargaining and multiemployer fund rules, WMT's vesting schedules are internally designed to align with shareholder interests and are accounted for as equity or expense over shorter, fixed timeframes.",
      "llm_answer": "MDL Z’s multi‑employer pension obligations are modest (e.g., $4 million contributed in 2021) and are recorded as expense when the cash contribution is made; the plans are described only in terms of eligibility and vesting rules but no multi‑year vesting schedule is applied to the cost. In contrast, Walmart’s equity‑compensation awards vest over several years – RSUs now vest 25 % per year over a four‑year period (previously 50 % after three years and the balance after five) – and the fair‑value cost of those awards is recognized ratably over the vesting period. Thus, MDL Z’s pension commitments are recognized immediately with no extended vesting horizon, whereas Walmart’s equity awards spread cost over a defined 3‑5‑year vesting term.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims MDLZ contributed only $4 million in 2021, whereas the ground truth states $11 million in interest accruals and a $526 million withdrawal liability over 19 years—this is a major quantitative error. The LLM also incorrectly states that MDLZ's pension costs are recognized only when cash is paid and that there is 'no extended vesting horizon,' which contradicts the ground truth that MDLZ has long-term, multi-year liabilities with ongoing cost recognition through contributions and interest. (2) The WMT portion is mostly accurate: the 25% annual vesting over four years and ratable expense recognition are correct. However, the LLM omits the detail about fair value being discounted for expected dividends (e.g., 3.8% in fiscal 2022), which is a relevant aspect of cost recognition. (3) The multi-hop reasoning is flawed: the LLM fails to correctly contrast MDLZ’s long-term, structured multiemployer pension obligations (with a 19-year payment plan) with WMT’s shorter, fixed equity vesting. Instead, it incorrectly frames MDLZ’s costs as immediate and non-vesting, missing the core of the comparison. (4) Scores justified as follows: Correctness is low (3/10) due to major factual and quantitative errors in MDLZ data and misrepresentation of cost recognition. Quantitative accuracy is very poor (2/10) due to wrong dollar amounts and omission of the $526M liability. Qualitative accuracy is partial (4/10) as WMT details are correct but MDLZ characterization is fundamentally wrong. Contextual relevance is acceptable (7/10) as the answer addresses the right companies and general topic, but with incorrect details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 464,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How does the combined capital buffer requirement above the minimum risk-based capital ratios for BAC under the Advanced Approach compare to MS's requirement, considering both institutions' application of the 2.5% Capital Conservation Buffer and the zero Countercyclical Capital Buffer?",
      "original_answer": "Both BAC and MS apply the 2.5% Capital Conservation Buffer and face a zero Countercyclical Capital Buffer under the Advanced Approach. For BAC, this buffer combines with a 2.5% G-SIB surcharge, resulting in a total buffer requirement of 5.0% above the minimum risk-based capital ratio. Similarly, MS also computes its capital buffer as the sum of the 2.5% Capital Conservation Buffer and the 2.5% G-SIB surcharge, leading to an identical total buffer requirement of 5.0% above the minimum risk-based capital ratio. Thus, both institutions have the same total capital buffer requirement above minimums under the Advanced Approach.",
      "llm_answer": "Both Bank of America and Morgan Stanley report a combined capital‑buffer requirement of **5.5 %** above the regulatory minimum risk‑based capital ratios under the Advanced Approach. This figure reflects the 2.5 % capital‑conservation buffer plus the 3.0 % G‑SIB surcharge, with the counter‑cyclical capital buffer set at zero for both firms.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its key quantitative claim. It states that both BAC and MS have a combined capital buffer requirement of 5.5%, based on a 2.5% Capital Conservation Buffer and a 3.0% G-SIB surcharge. However, the ground truth confirms that both institutions apply a 2.5% G-SIB surcharge (not 3.0%), resulting in a total buffer of 5.0% (2.5% + 2.5%), not 5.5%. This error directly impacts the correctness of the answer. (2) The calculation in the LLM answer is therefore flawed: 2.5% + 3.0% = 5.5% is mathematically correct, but based on incorrect input data. The correct calculation per the original answer is 2.5% (CCB) + 2.5% (G-SIB) = 5.0% for both banks. (3) The multi-hop reasoning is partially sound—LLM correctly identifies that the total buffer combines CCB, G-SIB, and CCyB, and notes that CCyB is zero for both. It also correctly attempts to compare the two institutions. However, it fails in synthesizing the correct G-SIB surcharge values, which are critical to the comparison. (4) While the structure and intent of the answer are relevant and logically organized, the core factual inaccuracy in the G-SIB surcharge percentage and resulting total buffer significantly undermines the correctness. The answer incorrectly implies both banks have a higher requirement due to a 3.0% surcharge, which is not supported by the data. Hence, correctness and quantitative accuracy scores are low, qualitative accuracy is moderate due to correct framework, and contextual relevance is high as it addresses the right concepts and comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 433,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How does the sensitivity of AVGO's $56.3 billion fixed rate senior notes to interest rate changes compare to ORCL's effective interest rate management through swaps, considering the role of interest rate swaps in converting fixed-rate debt to floating-rate as demonstrated by CSCO's $0.5 billion swap?",
      "original_answer": "AVGO's $56.3 billion in fixed rate senior notes is highly sensitive to interest rate changes, with a 50 basis point shift affecting fair value by $1.7 billion. In contrast, ORCL uses interest rate swaps to stabilize its borrowing costs, achieving an effective interest rate of 4.74% for fiscal 2024 and 2023 on its floating-rate debt after converting it to fixed-rate debt with a 3.07% base rate. CSCO's use of a $0.5 billion interest rate swap illustrates how such instruments convert fixed-rate debt into floating-rate debt to offset fair value fluctuations, aligning with AVGO's and ORCL's broader strategies to manage interest rate exposure through financial hedging instruments.",
      "llm_answer": "Broadcom’s $56.3 billion of fixed‑rate senior notes are directly exposed to market rates – a 50‑basis‑point rise or fall would shift their fair value by about $1.7 billion (roughly $3.4 billion per 1 % move) 【page_49】. Oracle, by contrast, uses interest‑rate swaps to reshape the economics of its debt – swapping fixed‑rate Euro notes to variable‑rate USD debt or converting floating borrowings to a fixed 3.07 % rate – so its effective interest cost is managed rather than its fair‑value exposure, as illustrated by Cisco’s $0.5 billion swap that neutralizes the fair‑value impact of fixed‑rate notes 【page_88】【page_89】. Thus, Broadcom’s notes remain highly rate‑sensitive, while Oracle’s swap program (mirroring Cisco’s approach) mitigates that sensitivity by converting the debt’s rate profile.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core multi-hop comparison between AVGO, ORCL, and CSCO regarding interest rate sensitivity and swap usage. (1) Quantitatively, it correctly states AVGO's $56.3 billion fixed-rate notes and the $1.7 billion fair value impact from a 50 bps shift, aligning with the ground truth. It also accurately references CSCO's $0.5 billion swap. However, it omits ORCL's effective interest rate of 4.74% for fiscal 2024 and 2023, which is a key metric in the original answer. Instead, it mentions Oracle converting floating borrowings to a fixed 3.07% rate, which matches the base rate but fails to clarify that this swap usage results in a stabilized effective rate of 4.74% after hedging — a meaningful omission affecting completeness. (2) The calculation implied in AVGO’s sensitivity ($1.7B per 50 bps ≈ $3.4B per 100 bps) is correctly extrapolated and reasonably presented. (3) The reasoning correctly synthesizes the role of swaps across companies: CSCO uses a swap to convert fixed to floating to manage fair value, while ORCL uses swaps to convert floating to fixed to stabilize costs. The comparison to AVGO’s lack of such mitigation is logically sound. (4) Entity accuracy is strong: AVGO (as Broadcom), ORCL, and CSCO are correctly identified with appropriate financial instruments. The answer is contextually relevant and well-structured, but the missing effective interest rate figure and slight conflation of ORCL’s swap mechanics (emphasizing rate conversion without clearly stating the outcome in effective rate terms) prevent a top score. Overall, the answer is factually solid with minor but notable omissions in quantitative detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 458,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How does the voting power distribution tied to Class B common stock at META compare to GOOGL's repurchase strategy across its multiple stock classes, given the interplay between voting rights and share structure?",
      "original_answer": "META's Class B common stock, which represents 33 1/3% of the combined voting power and has 15 votes per share, is non-dilutable and held entirely by a single individual, creating concentrated voting control. In contrast, GOOGL has a structure where Class B common stock has 10 votes per share and can be converted to Class A (1 vote per share), with no mention of non-dilutable voting power. Additionally, GOOGL actively repurchased $62.0 billion worth of shares in 2024 across both Class A and Class C shares, which have differing voting rights, suggesting a strategy that considers both capital allocation and governance dynamics.",
      "llm_answer": "Meta’s capital structure gives its insiders outsized control because each share of Class B common stock carries ten votes, so a relatively small number of Class B shares control a large share of the total voting power. Alphabet, by contrast, has three classes – Class A (one vote per share), Class B (ten votes per share, held only by insiders) and non‑voting Class C – and its share‑repurchase program has been used to buy back both voting Class A shares and non‑voting Class C shares (see Note 11, “Class A and Class B Common Stock and Class C Capital Stock” and the repurchase table) 【page_82】. Thus, while Meta’s voting power is concentrated in the high‑vote‑weight Class B shares, Alphabet’s repurchase strategy reduces the number of both voting and non‑voting shares without altering the underlying ten‑vote‑per‑share weighting of its Class B stock.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly regarding Meta's Class B voting rights. The ground truth states that Meta's Class B shares have 15 votes per share, not 10 as claimed by the LLM. Additionally, the LLM omits the specific detail that Meta's Class B stock represents exactly 33 1/3% of combined voting power and is non-dilutable—key points that underscore the structural entrenchment of control. These are significant quantitative and qualitative errors. (2) The dollar amount of Google's repurchases ($62.0 billion in 2024) is completely omitted in the LLM response, which fails to mention the scale or year of the repurchase activity despite its relevance to capital allocation strategy. While the LLM correctly notes that Alphabet repurchased both Class A and Class C shares, it does not specify the amount or year, weakening the quantitative foundation of the comparison. (3) The multi-hop reasoning is partially sound: the LLM correctly identifies the contrast between concentrated voting control (Meta) and repurchase dynamics across share classes (Alphabet), and understands that Alphabet’s Class B shares are high-vote and insider-held. It also correctly notes that repurchases include both voting (Class A) and non-voting (Class C) shares, which preserves the relative voting power of Class B—this reflects good qualitative synthesis. However, it misses the full interplay: GOOGL’s repurchase strategy actively reduces public float without diluting insider control, a nuance implied but not articulated. (4) Contextual relevance is high because the response directly addresses the core question about voting power and share structure interplay. Despite missing key numbers and containing an error in vote count, the overall framework of comparison is appropriate and logically structured. The answer would be stronger with accurate vote counts and inclusion of the $62.0B repurchase figure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 525,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How does Qualcomm's projected growth in generative AI-capable smartphone shipments by 2027 influence its strategic focus on AI and connectivity technologies, as compared to Salesforce's investment in generative and agentic AI across its CRM products?",
      "original_answer": "Qualcomm projects that 46% of smartphones sold in 2027 will be generative AI-capable, up from 19% in 2024, which directly informs its strategic focus on developing on-device AI and advanced connectivity technologies like 5G and 5G Advanced to support edge computing and AI workloads. Meanwhile, Salesforce is investing in generative and agentic AI across its CRM products, including the introduction of Agentforce, a new platform layer enabling autonomous AI agents for sales, service, marketing, and commerce. While Qualcomm's strategy centers on enabling AI at the device level through hardware innovation, Salesforce is embedding AI into its cloud-based CRM platform to enhance customer engagement and productivity. The convergence lies in their shared emphasis on AI capabilities—Qualcomm enabling them at the edge, Salesforce deploying them in enterprise workflows—though neither company has stated a direct business relationship or dependency.",
      "llm_answer": "Qualcomm notes that analysts expect 46 percent of smartphones sold in 2027 to be generative‑AI‑capable – up from 19 percent in 2024 – and it is using that outlook to double‑down on on‑device AI, low‑power compute and next‑generation connectivity (5G/5G‑Advanced) that will power those AI‑enabled handsets (see Item 1‑Business, “Artificial Intelligence” and “Advancing Connectivity”). In contrast, Salesforce’s 10‑K highlights its “investment in generative and agentic AI across all products” and the launch of Agentforce, which embeds AI agents into its cloud‑based CRM suite to improve customer‑facing workflows rather than to support a hardware‑driven market. Thus, Qualcomm’s strategy is driven by the anticipated surge in AI‑ready smartphones and the need for integrated chip‑level AI and connectivity, while Salesforce’s strategy is centered on layering generative/agentic AI functionality onto its software platform to enhance CRM services.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts from the ground truth: Qualcomm's projection of 46% of smartphones being generative AI-capable by 2027 (up from 19% in 2024), its strategic focus on on-device AI, low-power compute, and 5G/5G-Advanced, and Salesforce's investment in generative and agentic AI including the Agentforce platform. The comparison between Qualcomm's hardware-driven edge AI strategy and Salesforce's cloud-based CRM AI integration is accurately conveyed. (2) Quantitative accuracy is perfect: the percentages (46%, 19%) and years (2027, 2024) match the ground truth exactly. No calculations are required, but the temporal comparison is correctly framed. (3) Multi-hop reasoning is sound—information from both Qualcomm and Salesforce is synthesized to contrast their AI strategies across device and enterprise software domains. The LLM correctly infers that Qualcomm's strategy is driven by device-level AI adoption trends, while Salesforce's is focused on enhancing CRM workflows via AI agents. (4) The only minor shortcoming is the omission of the explicit statement that there is no direct business relationship or dependency between the two companies, which is included in the ground truth. However, this does not detract significantly from the overall correctness, as the question does not explicitly ask about inter-company relations. Wording differences (e.g., 'double-down', 'AI-enabled handsets') are semantically equivalent and acceptable. Thus, the answer is highly accurate, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 431,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How does Adobe's focus on enhancing user experience through AI-driven digital media tools align with Qualcomm's projections for generative AI-capable edge devices in 2027, particularly in relation to on-device AI processing and user interface improvements?",
      "original_answer": "Adobe emphasizes that the intuitiveness and visual appeal of user interfaces are key competitive factors in its Digital Media segment, particularly as it integrates AI capabilities for digital media generation and editing. Qualcomm projects that 46% of smartphones sold in 2027 will be generative AI-capable, up from 19% in 2024, and highlights that on-device AI processing enhances user experiences with immediacy, privacy, and personalization. Qualcomm’s advancements in edge AI processing and user interface technologies are positioned to support Adobe’s strategic direction by enabling more powerful, responsive, and secure AI-driven tools directly on devices, aligning with Adobe’s need to deliver best-in-class user experiences across platforms.",
      "llm_answer": "Adobe is betting on AI‑driven creative tools—such as Firefly‑powered generative‑AI features in Creative Cloud and a drag‑and‑drop, AI‑enhanced analytics workspace—to make content creation faster, more personalized and visually intuitive (ADBE p. 37; p. 14). Qualcomm’s outlook that roughly half of all smartphones and PCs will be “generative‑AI‑capable” by 2027, driven by on‑device AI engines that deliver low‑latency, privacy‑preserving processing (QCOM p. 7) and a broader push for on‑device AI in edge devices (QCOM p. 8), directly supports Adobe’s vision: the proliferating on‑device AI hardware will let Adobe’s AI‑rich interfaces run locally, giving users instant, context‑aware UI responses and richer creative experiences.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures Adobe's focus on AI-driven tools for enhancing user experience, citing specific examples like Firefly and Creative Cloud, and links this to improved personalization and visual intuitiveness—consistent with the original answer's emphasis on user interface quality. (2) Regarding quantitative accuracy, the LLM states that 'roughly half' of smartphones and PCs will be generative AI-capable by 2027, which is a reasonable approximation of Qualcomm’s projection of 46% (up from 19% in 2024). While the exact percentage (46%) is not cited, 'roughly half' is semantically acceptable and does not constitute a factual error. The LLM also correctly identifies the trend of on-device AI processing for low-latency and privacy-preserving benefits, matching the original answer’s emphasis on immediacy, privacy, and personalization. (3) The multi-hop reasoning is sound: the LLM synthesizes Adobe’s AI-driven UX strategy with Qualcomm’s edge AI projections, correctly inferring that on-device AI hardware will enable Adobe’s tools to run locally, enhancing responsiveness and user experience. This reflects proper cross-company, cross-document synthesis. (4) Minor deduction in quantitative accuracy due to rounding '46%' to 'roughly half' without stating the precise figure; otherwise, all entities (Adobe, Qualcomm, 2027, on-device AI, user interface improvements) are correctly identified and contextualized. The answer is fully relevant and conveys the same core alignment between Adobe’s strategic direction and Qualcomm’s technological enablement.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 447,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How does the treatment of dividend equivalents on RSU awards differ between Lockheed Martin's and Honeywell's compensation plans, based on the specific vesting terms and payment structures disclosed?",
      "original_answer": "Lockheed Martin discloses that dividend equivalents on vested stock units for non-employee directors may be paid on the first business day of April following the one-year anniversary of the grant, indicating a delayed payment structure tied to director tenure and stock ownership guidelines. In contrast, Honeywell does not specify a delayed payment schedule for dividend equivalents on RSUs, focusing instead on vesting periods ranging from three to six years with payment in common stock upon vesting. Additionally, Lockheed Martin’s Deferred Management Incentive Compensation Plan (DMICP) credits dividend equivalents as stock units at dividend payment times, while Honeywell’s RSU awards are more focused on performance-based vesting tied to company goals.",
      "llm_answer": "Lockheed Martin’s equity‑compensation table notes that directors may elect to defer payment of vested RSUs (and any dividend equivalents that have accrued on those units) until the first business day of April following the one‑year anniversary of the grant. Honeywell’s RSU description, by contrast, says RSUs vest and are paid in common‑stock on the vesting date and makes no reference to dividend‑equivalent credits or a separate deferred‑payment date. Thus, Lockheed Martin’s plan treats dividend equivalents as a payable component that can be deferred and paid on a specific post‑grant date, while Honeywell’s plan does not provide for dividend equivalents on its RSU awards.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the key difference in dividend equivalent treatment between Lockheed Martin and Honeywell, particularly regarding deferral and payment timing. It accurately notes that Lockheed Martin allows deferral of dividend equivalents until the first business day of April following the one-year anniversary of the grant, which aligns with the ground truth. The statement that Honeywell pays RSUs in stock upon vesting and does not reference dividend equivalents is also factually consistent. However, the LLM answer incorrectly implies that Honeywell does not provide dividend equivalents on RSUs at all, whereas the ground truth states that Honeywell does not specify a delayed payment schedule—implying dividend equivalents may still be credited but without explicit deferral details. Additionally, the LLM omits mention of Lockheed Martin’s DMICP crediting dividend equivalents as stock units at dividend payment times and Honeywell’s performance-based vesting tied to company goals, which are important qualitative distinctions in the compensation structures. These omissions reduce completeness and reasoning accuracy. Quantitative elements (dates, vesting periods) are correctly represented or reasonably interpreted, with no calculation errors. The answer remains contextually relevant and captures the core contrast, but lacks full depth in synthesizing all disclosed structural differences.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 392,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How does the reliance of Texas Instruments (TXN) on subcontractors for 40% of its assembly and test services compare with NVIDIA's (NVDA) exposure to third-party manufacturers, given the shared dependency on external production capacity and the risks highlighted by AMD's experience with third-party suppliers?",
      "original_answer": "Texas Instruments relies on subcontractors for 40% of its assembly and test services, supplementing internal capacity to meet customer demand. This external dependency aligns with NVIDIA’s reliance on third-party manufacturers for semiconductor fabrication, assembly, and testing, which exposes them to risks such as limited control over delivery schedules, quality assurance, and potential prioritization of other customers. AMD's experience highlights the vulnerability in this model, as their dependence on third-party manufacturers—including GF and ATMP joint ventures—can lead to supply disruptions, capacity constraints, and financial penalties if purchase targets are not met. Therefore, both TXN and NVDA face similar exposure to third-party production risks, though NVDA's exposure is amplified by the complexity of its products and global supply chain dependencies.",
      "llm_answer": "Texas Instruments says that in 2021 roughly 40 percent of its assembly‑and‑test workload was performed by subcontractors 【page_9】, putting a sizable portion of its supply chain outside its own fabs. NVIDIA’s filing likewise notes that a material share of its products is manufactured, assembled and tested by third‑party foundries and contract manufacturers, exposing it to the same capacity‑allocation, pricing and delivery‑risk dynamics that AMD describes for its own suppliers 【page_23】. Thus, while TI’s exposure is quantified at 40 % of assembly/test, NVIDIA’s exposure is similarly “material” and subject to the same risks of capacity shortages, price volatility and potential supply interruptions highlighted in AMD’s risk discussion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Texas Instruments relies on subcontractors for 40% of its assembly and test services, matching the ground truth exactly. It also accurately characterizes NVIDIA’s reliance on third-party manufacturers as 'material'—a term consistent with NVDA’s disclosures—even though no specific percentage is given, which aligns with the original answer’s acknowledgment of broader exposure. The reference to AMD’s experience with supply chain risks (capacity constraints, delivery risks) is appropriately synthesized and contextually accurate. (2) Quantitatively, the 40% figure is correct and properly attributed to TI’s 2021 operations per the source citation. While the original answer does not specify a year, the LLM’s inclusion of '2021' is a minor addition but not incorrect, as TI has maintained roughly this level of outsourcing in recent years. No calculations are required, and all numerical references are accurate. (3) The multi-hop reasoning is sound: the model correctly links TI’s subcontracting to NVDA’s third-party dependencies and references AMD’s experience to highlight shared risks—this tripartite comparison is logically structured and mirrors the intent of the question. The only minor shortcoming is that the LLM does not explicitly mention NVDA’s exposure being 'amplified by the complexity of its products and global supply chain,' a nuance present in the original answer that adds depth to the risk comparison. (4) Despite this slight omission, the LLM captures the core equivalence of third-party risk exposure and correctly uses 'material' to describe NVIDIA’s dependency, maintaining semantic equivalence. All entities (TXN, NVDA, AMD), their roles, and the nature of third-party risks are accurately represented. Contextual relevance is perfect—the answer directly addresses the comparative reliance and associated risks as framed by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 520,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What is the total estimated cost of Duke Energy Florida's 10 new solar facilities, and how does this investment relate to Southern Power's use of PPAs as operating leases with terms up to 25 years for similar renewable energy projects?",
      "original_answer": "Duke Energy Florida's 10 new solar facilities have an estimated total cost of $1 billion over the next three years. These facilities are part of a voluntary solar program approved by the FPSC in January 2021. Southern Power, a subsidiary of Southern Company, utilizes Power Purchase Agreements (PPAs) related to solar and wind facilities, which are accounted for as operating leases with remaining terms of up to 25 years. This indicates that both Duke Energy Florida and Southern Power are investing in long-term renewable energy infrastructure, with Duke making direct investments included in base rates and Southern Power leveraging PPAs as a financial mechanism to support similar projects.",
      "llm_answer": "Duke Energy Florida estimates the 10 new solar facilities will cost about **$1 billion** to build over the next three years. Southern Power, by contrast, acquires renewable‑energy capacity through power‑purchase agreements that it records as **operating‑lease PPAs with terms that can run as long as 25 years**, allowing it to secure similar solar (and wind) output without a comparable upfront capital outlay.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $1 billion estimated cost for Duke Energy Florida's 10 solar facilities over three years, matching the ground truth in both amount and timeframe. It also accurately states that Southern Power uses PPAs treated as operating leases with terms up to 25 years, which aligns with the original answer. (2) All numeric values are correct: $1 billion cost and 25-year PPA terms are factually accurate and consistent with the ground truth. No calculations were required, but the presentation of figures is precise and properly contextualized. (3) The multi-hop reasoning is sound—linking Duke Energy Florida’s direct investment model to Southern Power’s use of off-balance-sheet financing via PPAs demonstrates appropriate synthesis across entities. The contrast in financial approaches (upfront capital vs. lease-like agreements) is logically drawn and supports the implied comparison in the question. (4) The only minor shortcoming is that the LLM omits mention of the FPSC’s January 2021 approval of the voluntary solar program, a contextual detail present in the original answer. However, this does not affect the core factual accuracy or the comparative insight. The answer remains semantically equivalent in substance and highly relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 364,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How does the difference in voting rights structure between Netflix's common stock and Alphabet's Class C capital stock influence the strategic allocation of Alphabet's $62.0 billion share repurchase in 2024 between Class A and Class C shares?",
      "original_answer": "Netflix's common stock provides one vote per share, establishing a straightforward voting rights framework. In contrast, Alphabet's Class C capital stock carries no voting rights except as required by law, while Class A shares have one vote per share and Class B shares have 10 votes per share. Given this differentiated voting structure and Alphabet's 2024 repurchase of $62.0 billion in Class A and Class C shares, the lack of voting rights in Class C likely influences the company's repurchase strategy by prioritizing liquidity and cost efficiency over governance influence, allowing Alphabet to retire shares without diluting control held by voting-class shareholders.",
      "llm_answer": "Netflix’s common stock gives each share one vote (“The holders of each share of common stock shall be entitled to one vote per share” – NFLX 10‑K p. 60). Alphabet’s Class C capital stock, by contrast, carries no voting rights (“Class C capital stock has no voting rights, except as required by applicable law” – Alphabet 10‑K p. 82). Because Class C shares do not affect control, Alphabet can return capital without diluting voting power, so in 2024 it directed the bulk of its $62.0 billion buy‑back to non‑voting Class C shares ($50.2 billion for 306 million shares) and a smaller portion to voting Class A shares ($11.9 billion for 73 million shares) (Alphabet 10‑K p. 82).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Netflix's common stock has one vote per share, Alphabet's Class C shares have no voting rights, and Class A shares have one vote per share (Class B not directly relevant to repurchase allocation). The $62.0 billion total repurchase is correctly broken down into $50.2 billion for Class C and $11.9 billion for Class A, summing to $62.1 billion (a $0.1 billion rounding difference, negligible and likely due to reporting precision). (2) Quantitative accuracy is excellent: the figures match the original 10-K disclosures and are correctly attributed. The share counts (306 million and 73 million) are consistent with public filings. (3) Reasoning is sound: the LLM correctly infers that repurchasing non-voting Class C shares allows Alphabet to return capital without affecting control, which is a logical and well-supported conclusion from the voting structure. It adds specific transaction-level detail (amounts and shares) not in the original answer, enhancing precision. (4) The only minor shortcoming is that the original answer emphasizes the strategic rationale (liquidity, cost efficiency, avoiding dilution of control) more broadly, while the LLM focuses on the mechanical outcome. However, the core multi-hop synthesis—linking Netflix’s voting structure, Alphabet’s share classes, and the repurchase allocation based on voting rights—is fully correct and contextually appropriate. The answer is semantically equivalent and factually superior in granularity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 431,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How does the activation of voting rights for preferred stockholders in BAC due to dividend arrears compare to the limited voting rights of Class C common stockholders at V, particularly in the context of corporate governance during financial stress?",
      "original_answer": "At BAC, if dividends on certain preferred stock series are in arrears for three or more semi-annual or six or more quarterly periods, holders gain voting rights to elect two additional directors, which terminate once dividends are paid for at least two semi-annual or four quarterly periods following the arrearage. This mechanism serves as a governance safeguard for preferred stockholders during financial distress. In contrast, V’s Class C common stockholders have no general voting rights except in specific defined matters, such as exiting the core payments business or certain corporate restructurings, and they do not participate in amendments solely affecting preferred stock. Unlike BAC’s contingent voting rights tied to dividend performance, V’s Class C stockholders’ voting power is structurally limited and not directly linked to financial performance metrics like dividend arrears.",
      "llm_answer": "Bank of America’s preferred‑stock provisions state that if a series’ cash dividend falls into arrears for three or more semi‑annual (or six or more quarterly) periods, the holders of that series obtain “general voting rights” and may elect two additional directors until the arrears are cured 【page_142】. By contrast, Visa’s Class C common shareholders are barred from voting on virtually any matter; they can only vote on a few narrowly‑defined actions (e.g., a merger, a core‑payments exit or certain charter amendments) and never on the election of directors 【page_90】. Thus, during financial stress the activation of voting rights for Bank of America’s preferred holders can materially reshape board control, whereas Visa’s Class C holders remain largely powerless in corporate‑governance decisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: BAC preferred stockholders gain voting rights to elect two additional directors after three semi-annual or six quarterly dividend arrears, which terminate after two semi-annual or four quarterly periods of payment — this matches the original answer exactly. The LLM correctly notes that Visa’s Class C common stockholders have no general voting rights and can only vote on specific matters like a merger or exit from the core payments business. (2) Quantitative accuracy is perfect: the thresholds (3 semi-annual, 6 quarterly) are correctly stated, and no calculations are required beyond these counts, which are accurate. (3) The multi-hop reasoning is sound — the model correctly contrasts BAC’s performance-contingent voting rights with V’s structural, limited voting rights not tied to financial performance. The synthesis across two companies and governance mechanisms is logically coherent. (4) The only minor shortcoming is that the LLM does not explicitly mention that Class C voting rights at V do not extend to amendments affecting only preferred stock, a detail present in the original answer. However, this omission does not distort the overall meaning. The LLM captures the core contrast: BAC’s voting rights activate during financial stress as a safeguard, while V’s Class C holders remain largely excluded regardless of financial condition. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent — the answer directly addresses corporate governance during financial stress as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 447,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How does Disney's licensing revenue from Star Wars-branded merchandise influence its ability to fund content development for Disney+ in European markets where it competes with CMCSA's Sky Glass and XClass TV platforms?",
      "original_answer": "Disney earns licensing royalties from third-party products featuring Star Wars characters, which contributes to funding content development for its DTC services, including Disney+ in European markets. Disney+ includes Star Wars programming as a core content tile, which is critical to attracting subscribers in competitive regions like Europe. CMCSA competes in this market with its own video services and DTC-aligned platforms like Sky Glass and XClass TV, which integrate with its European broadband offerings. Therefore, licensing revenue from Star Wars enhances Disney's content investment capacity, directly supporting its competitive positioning against CMCSA’s integrated hardware and content strategy in Europe.",
      "llm_answer": "Disney’s licensing segment earns royalties on third‑party products that feature its characters—including the highly profitable Star Wars brand (see the “Licensing” description of major properties on page 22).  Those royalty cash flows are part of the broader revenue pool that Disney uses to finance its Direct‑to‑Consumer businesses, such as Disney+ (and its Star‑branded tile that carries Star Wars content in Europe, described on page 12).  By converting Star Wars merchandise sales into cash, Disney can invest in new European‑market Disney+ programming, giving it a financial footing to compete with Comcast’s Sky Glass and XClass TV platforms that are marketed to the same European viewers (see the competition discussion on Sky Glass and XClass TV on page 18).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. It correctly identifies that Disney earns licensing royalties from Star Wars-branded merchandise, which contributes to funding its Direct-to-Consumer (DTC) services like Disney+ in European markets. The answer correctly links this revenue stream to content investment, noting that Star Wars programming is a key content component on Disney+ in Europe (via the Star-branded tile), which helps attract subscribers. It also accurately identifies CMCSA (Comcast) as a competitor through its Sky Glass and XClass TV platforms, which are integrated with broadband services in Europe—aligning with the ground truth's emphasis on CMCSA’s integrated hardware-content strategy. There are no numeric values in the question or answers, so quantitative accuracy is scored as 10 by default (no errors possible). The only minor shortcoming is that the LLM answer refers to the 'Star-branded tile' carrying Star Wars content, while the original answer emphasizes 'Star Wars programming as a core content tile'—a slight nuance in framing, but not a factual error. The multi-hop reasoning is sound: connecting licensing revenue → funding DTC → content development → competitive positioning against CMCSA in Europe. All entities (Disney, Star Wars, CMCSA, Sky Glass, XClass TV, Disney+) are correctly identified and logically linked. The contextual relevance is perfect, addressing all parts of the multi-faceted question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 408,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How does the sensitivity of AXP's net interest income to a 200 basis point increase in interest rates relate to MS's use of interest rate caps in securitization transactions, considering the role of repricing risk in both firms' financial strategies?",
      "original_answer": "AXP estimates that a 200 basis point increase in interest rates would negatively impact its net interest income, based on its repricing risk assumptions which include the effect of interest rate caps or floors. This sensitivity is linked to the repricing dynamics of interest-rate sensitive assets and liabilities, where certain deposits reprice at lower magnitudes than benchmark rate movements. On the other hand, MS enters into interest rate caps as part of its securitization transactions, which are designed to manage interest rate exposure. These caps are subject to similar repricing risk dynamics, suggesting that both firms are managing interest rate volatility through derivative instruments, though in different business contexts—AXP through its core interest income and MS through structured finance activities involving SPEs.",
      "llm_answer": "American Express estimates that an instantaneous 200‑basis‑point rise in benchmark rates would cut its annual net‑interest income by about **$560 million** (Table 23, page 81).  The loss reflects the company’s **repricing risk** – the mismatch between how quickly its interest‑sensitive assets and liabilities reprice when rates move.  Morgan Stanley, by contrast, routinely **purchases interest‑rate caps** in its residential‑mortgage securitizations (page 128‑129), using the caps to hedge the same repricing risk on the assets it retains so that a rate increase does not erode the cash‑flow profile of those securities.  Thus, while AXP’s net‑interest income is directly vulnerable to a 200‑bp shock, MS seeks to neutralize that exposure through caps embedded in its securitization strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer correctly identifies AXP's sensitivity to a 200 basis point increase in interest rates and attributes it to repricing risk, and correctly notes MS's use of interest rate caps in securitization transactions to manage similar risks. However, the $560 million figure for AXP's net interest income impact is not present in the original answer (ground truth), which only states that AXP estimates a negative impact without specifying an amount. This introduces a specific numeric claim not supported by the ground truth, reducing quantitative accuracy. (2) The number $560 million is presented confidently with a citation (Table 23, page 81), but since the ground truth does not include this figure, it cannot be verified as correct in this context. The original answer intentionally omits any dollar amount, suggesting either that the value was not reported or not extracted. Thus, the inclusion of a precise number constitutes a factual overreach. (3) The multi-hop reasoning is sound: the LLM correctly links AXP’s repricing risk in net interest income to MS’s use of interest rate caps in securitizations, recognizing that both relate to managing interest rate exposure through derivatives and repricing dynamics. The contrast in business contexts—AXP’s core lending income vs. MS’s structured finance activities—is well articulated. (4) Despite the unsupported number, the qualitative reasoning and contextual relevance are strong. The answer captures the conceptual link between the two firms’ strategies and correctly frames repricing risk as a common challenge. The error is limited to an over-specific quantitative claim not present in the source, hence a score of 7/10 overall—core facts and logic are correct, but with a significant quantitative addition not grounded in the provided truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 489,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How does the impact of a weaker U.S. dollar on MDLZ's consolidated earnings compare to the favorable currency effects experienced by Coca-Cola's Europe, Middle East and Africa segment, given both companies explicitly call out exchange rate fluctuations involving the euro and British pound?",
      "original_answer": "MDLZ states that a weaker U.S. dollar benefits its consolidated earnings and net assets, as many subsidiaries operate in non-dollar functional currencies. KO specifically notes that a weaker U.S. dollar compared to the euro and British pound had a favorable impact on its Europe, Middle East and Africa segment. Both companies explicitly identify these two currencies as key drivers of their respective foreign exchange impacts, showing a direct parallel in how they are affected by similar currency dynamics.",
      "llm_answer": "MDL Z’s 2024 filing shows that foreign‑currency movements produced a **$1.5 billion currency‑translation loss** on its consolidated results (the “Currency translation adjustment” of $(1,453) million), indicating that a weaker U.S. dollar reduced its earnings. In contrast, Coca‑Cola explicitly notes that a **weaker U.S. dollar versus the euro and the British pound generated a favorable currency effect for its Europe, Middle East & Africa segment**, partially offsetting the overall 5 % revenue hit from foreign‑exchange headwinds. Thus, the weaker dollar hurt MDL Z’s consolidated earnings, while it provided a positive boost to Coca‑Cola’s EMENA segment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual and logical errors that undermine its correctness. (1) Quantitative inaccuracy: The claim that MDLZ experienced a '$1.5 billion currency-translation loss' due to a weaker U.S. dollar directly contradicts the economic logic in the original answer and likely misinterprets the filing. A weaker U.S. dollar typically benefits multinational companies like MDLZ with substantial non-dollar functional currency subsidiaries because translating stronger foreign currencies into dollars increases reported earnings. Currency translation adjustments (CTA) are part of other comprehensive income and may be negative during periods of dollar strength, not weakness. The LLM incorrectly interprets a negative CTA as evidence that a weaker dollar hurt earnings, when in fact, a weaker dollar should produce gains. (2) The original answer states that MDLZ benefits from a weaker dollar, aligning with standard FX dynamics, but the LLM contradicts this with incorrect data interpretation. (3) Entity and reasoning accuracy: While the LLM correctly identifies that Coca-Cola noted favorable effects from a weaker dollar versus the euro and pound in its EMENA segment, it falsely contrasts this with MDLZ being harmed, when both should benefit from similar FX movements. (4) Multi-hop synthesis fails: The question asks for a comparison of the impact of a weaker dollar on both firms, expecting recognition of parallel exposure to euro and pound. Instead, the LLM creates a false divergence. (5) The mention of a '5% revenue hit' and specific $1.453B loss is not corroborated by the ground truth and introduces unsupported specifics. These numbers may be hallucinated or misattributed. (6) Contextual relevance is moderate because the answer addresses currency impacts and the right companies and regions, but the conclusion is factually inverted. Overall, core financial reasoning is flawed, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 524,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How does the voting power concentration in MA's dual-class share structure compare to V's, given the relationship between their respective Class A and Class B shares and the 15-vote weighting per Class B share?",
      "original_answer": "MA's dual-class structure includes 907 Class A shares and 7 Class B shares outstanding, with Class B shares carrying 15 votes each, resulting in a voting power concentration of approximately 10.4% for Class B shares. V has 125 Class B shares outstanding as of September 30, 2024, against 1,733 Class A shares, and if following the same 15-vote weighting per Class B share from the intermediary evidence, Class B would hold approximately 68.5% of the voting power despite representing just 6.7% of total shares. This indicates significantly more concentrated control at V compared to MA.",
      "llm_answer": "Mastercard’s dual‑class structure is highly concentrated: only 125 Class B shares were outstanding at September 30 2024, but each carries 15 votes. Together those shares command roughly 1,875 votes versus 1,733 votes from the 1,733 Class A shares, giving the Class B stock about 52 % of the total voting power despite representing less than 0.2 % of the equity (see MA page 58).  \n\nVisa’s structure is less concentrated – its Class B shares also have a multiple‑vote right, but the number of Class B shares is far smaller relative to the much larger pool of Class A shares, so the Class B stock accounts for a far lower share of total voting power. In short, Mastercard’s voting power is more heavily weighted toward its tiny Class B block than Visa’s.   (MA page 58; voting‑weight premise per 15‑vote per Class B share).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual and quantitative errors that undermine its correctness. (1) It incorrectly assigns 125 Class B shares to Mastercard (MA), when the ground truth states MA has only 7 Class B shares and 907 Class A shares. The 125 Class B shares belong to Visa (V), not MA. This is a critical entity and numerical error. (2) It claims Mastercard’s Class B shares command about 52% of voting power, but with 7 Class B shares × 15 votes = 105 votes and 907 Class A shares × 1 vote = 907 votes, Class B should have ~10.4% voting power, not 52%. The 52% figure is both miscalculated and misattributed. (3) The answer incorrectly states that Visa’s structure is 'less concentrated' when, in fact, the ground truth shows Visa’s Class B holds ~68.5% voting power (125 shares × 15 = 1,875 votes) vs. 1,733 Class A votes, making it far more concentrated than MA’s. Thus, the comparison is reversed: V has more concentrated control than MA, but the LLM claims the opposite. (4) The citation of 'MA page 58' appears to be fabricated or misapplied, as the data provided does not align with the ground truth. (5) Multi-hop reasoning fails: the model conflates entities (swaps MA and V share counts), miscalculates voting power, and draws the inverse conclusion. While the premise of 15 votes per Class B share is correctly used, all downstream reasoning is flawed due to incorrect inputs. The answer is contextually relevant in discussing dual-class structures and voting concentration, but factually incorrect in execution.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 420,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How do the financial risks associated with nuclear power plants at NEE compare to those at Southern Company, particularly in terms of potential exposure from decommissioning costs exceeding available reserves?",
      "original_answer": "NEE and FPL face potential financial risks from decommissioning costs of their nuclear facilities possibly exceeding the available decommissioning funds. Similarly, Southern Company's subsidiaries Alabama Power and Georgia Power also face exposure if decommissioning costs exceed available reserves or insurance coverage. In both cases, the companies acknowledge that the financial impact could be material if the costs surpass the accumulated funds, which are subject to uncertainties in estimation and long-term planning.",
      "llm_answer": "Both NextEra Energy (NEE) and Southern Company acknowledge that the funds set aside for nuclear‑plant decommissioning may be inadequate. Southern Company’s filing states that “damages, decommissioning, or other costs could exceed the amount of decommissioning trusts or external insurance coverage,” while NEE’s filing warns that “the cost of decommissioning nuclear generation facilities could exceed the amount available in NEE’s … decommissioning funds.” Thus, each company faces a comparable financial‑risk exposure that decommissioning expenses could surpass the reserves they have earmarked.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies both NEE (and its subsidiary FPL, implied through context) and Southern Company as facing financial risks if decommissioning costs exceed available reserves. The core entities—NEE, Southern Company, and their respective nuclear decommissioning risk disclosures—are accurately represented. (2) There are no numeric values in the original or LLM answer requiring calculation, so quantitative accuracy is not compromised; all statements about potential cost overruns are consistent with the source. (3) The multi-hop reasoning is sound: the LLM synthesizes risk disclosures from both companies’ filings, correctly noting that both have acknowledged exposure due to uncertainties in decommissioning cost estimates. It supports each point with direct quotes from the filings, enhancing accuracy. (4) The answer is fully contextually relevant, directly addressing the comparison of financial risks related to decommissioning cost overruns. The only minor limitation is that the LLM does not explicitly name Alabama Power and Georgia Power (Southern Company subsidiaries), but this detail is secondary to the overall risk exposure conclusion. Wording differs slightly but meaning is preserved. No factual errors or omissions affect the correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 375,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How does the $9.9 billion valuation of UPS's pension plan investments in real estate funds compare to the valuation approaches used by General Dynamics for its Level 3 assets, given that both companies rely on valuation models through real estate or private equity fund investments?",
      "original_answer": "UPS valued its $9.9 billion in pension plan investments in real estate funds using net asset value (NAV) as a practical expedient, based on audited and unaudited financial reports from fund managers, with adjustments for investment activity between reporting dates. These real estate funds rely on valuation models, as stated in the second chunk, which notes that real estate funds use NAV based on such models and periodic appraisals. General Dynamics, on the other hand, disclosed that its Level 3 assets include direct private equity investments that are measured using unobservable inputs—essentially internal or fund-level valuation models. Thus, while both companies depend on valuation models for real estate or private equity fund investments, UPS relies on NAV with manager reporting and adjustments, whereas GD directly uses unobservable inputs for its Level 3 private equity holdings.",
      "llm_answer": "UPS says that the pension‑plan portion of its portfolio that is invested in real‑estate funds was valued at **$9.9 billion** as of 31 December 2023, using a net‑asset‑value (NAV) approach that relies on fund‑manager reports, periodic appraisals and adjustments for activity between reporting dates (a Level 3‑type measurement because the assets are not actively traded)【page_58】.  \n\nGeneral Dynamics, by contrast, classifies its Level 3 assets (which include direct private‑equity and other ill‑iquid investments) as being measured “using valuation models that incorporate significant unobservable inputs” rather than observable market prices【page_83】.  \n\nThus, while both companies depend on model‑based valuations for non‑traded investments, UPS provides a specific $9.9 billion NAV figure for its real‑estate fund holdings, whereas General Dynamics describes its Level 3 assets more generally as valued through internal models with unobservable inputs, without disclosing a comparable dollar amount.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $9.9 billion valuation by UPS as of December 31, 2023, is accurately reported, and no incorrect figures are introduced. Format variations (e.g., $9.9 billion vs. $9.9 billion) are acceptable. (2) The qualitative analysis correctly identifies that UPS uses NAV as a practical expedient based on fund manager reports, periodic appraisals, and adjustments—consistent with the ground truth. It also correctly states that General Dynamics measures its Level 3 assets using valuation models with significant unobservable inputs. (3) The multi-hop reasoning is sound: the model synthesizes information from two different companies (UPS and General Dynamics), compares their valuation approaches for non-traded investments (real estate funds vs. private equity), and highlights the distinction between NAV reliance (UPS) and direct use of unobservable inputs (GD). (4) The only minor shortcoming is that the LLM does not explicitly mention that both companies’ approaches ultimately rely on valuation models (though it implies this), and it omits the detail that UPS’s NAV-based approach is applied specifically within pension plan investments. However, these omissions do not undermine the core correctness. The answer remains semantically equivalent and contextually precise, addressing all key aspects of the comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 399,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "Given PepsiCo's 30% beverage revenue exposure in the Africa and Middle East region and Target's vendor arrangements where they only pay for merchandise after guest sale, what potential impact could a supply disruption in this region have on Target's inventory turnover and cash flow timing for beverage SKUs?",
      "original_answer": "A supply disruption in the Africa and Middle East region, which accounts for 30% of PepsiCo's beverage revenue, could delay product availability at Target. Since Target only pays vendors after merchandise is sold to guests, this delay could reduce inventory turnover for beverage SKUs during the disruption period. This would temporarily lower cash flow generation from beverage sales, as Target recognizes revenue only upon guest purchase and does not pay vendors until then.",
      "llm_answer": "PepsiCo derives about 30 % of its beverage revenue from the Africa‑Middle‑East (AMESA) region, so a supply interruption there would likely create shortages of PepsiCo‑branded drinks in Target stores. Because Target’s vendor contracts defer payment until the merchandise is sold, a stockout would shrink the inventory balance, depress the inventory‑turnover rate for those SKUs and postpone the related cash outflows—while at the same time reducing the cash inflows from guest sales—tightening the timing of cash flow for the affected beverage items.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 30% beverage revenue exposure in the Africa and Middle East region is correctly stated. No other numerical values require verification. (2) The reasoning correctly synthesizes multi-hop information: PepsiCo's regional revenue exposure → potential supply disruption → impact on product availability at Target → consequences for inventory turnover and cash flow timing under Target's vendor payment model. (3) The LLM accurately identifies the key entities (PepsiCo, Target), business models (revenue exposure, consignment-like vendor arrangement), and financial metrics (inventory turnover, cash flow timing). (4) The only minor shortcoming is a slight overemphasis on deferred cash outflows—while technically correct that payments are delayed due to unsold inventory, the primary cash flow impact emphasized in the ground truth is the reduction in cash inflows from lost sales, which the LLM mentions but frames as 'tightening the timing' rather than a net reduction in cash flow generation. This nuance slightly affects qualitative accuracy but does not undermine the overall correctness. Semantic equivalence is maintained, and the answer is fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 353,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How have LLY and AMGN responded differently to payer-driven pricing pressures on their high-cost biologics, particularly in light of access restrictions affecting Repatha and insulin products?",
      "original_answer": "LLY faces increasing public and private payer scrutiny on pricing, especially for insulin, with proposed legislation enabling government price negotiation and restrictive reimbursement policies like the Alzheimer’s Monoclonal Antibody NCD, which could materially affect revenue. In contrast, AMGN has responded to payer restrictions on Repatha—such as formulary exclusions, step therapy requirements, and copay accumulator programs—by reducing both net and list prices, discontinuing higher-priced NDCs in 2019, and directly partnering with payers to align on health outcomes. While LLY emphasizes regulatory and legislative uncertainty, AMGN has taken active pricing and partnership strategies to mitigate payer-imposed access barriers.",
      "llm_answer": "- **Eli Lilly (LLY)** – Faced with payer pressure on its high‑cost insulin portfolio, Lilly has leaned on product‑level tactics: it is bringing a biosimilar insulin (e.g., Basaglar) to market, expanding patient‑support and copay‑assistance programs, and emphasizing “value‑based” pricing to keep the drugs on formularies.  \n\n- **Amgen (AMGN)** – After payers began imposing step‑therapy and utilization‑management limits on its PCSK9 antibody Repatha, Amgen cut the drug’s net price, added larger rebates to PBMs and Medicare Part D plans, and introduced a lower‑list‑price National Drug Code to lower out‑of‑pocket costs, while also advancing its own biosimilar pipeline to offer cheaper alternatives.  \n\nThus, Lilly is countering pressure by adding a lower‑priced biosimilar insulin and patient‑aid programs, whereas Amgen has responded to Repatha restrictions by directly reducing list and net prices and increasing rebates.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of both companies' responses and contains no incorrect numbers, dates, or entities—ensuring high quantitative accuracy. It correctly identifies that Amgen reduced prices and rebates for Repatha and introduced a lower-priced NDC, and that Lilly is using biosimilars (e.g., Basaglar) and patient support programs. However, it omits key elements from the original answer: (1) AMGN’s direct partnerships with payers to align on health outcomes, which is a critical strategic differentiator; (2) the discontinuation of higher-priced NDCs in 2019, a specific and material action; and (3) LLY’s emphasis on regulatory and legislative uncertainty (e.g., government price negotiation, Alzheimer’s Monoclonal Antibody NCD), which contrasts with AMGN’s proactive pricing strategy. These omissions reduce completeness and weaken the multi-hop synthesis required to fully contrast the two firms’ strategic responses. While the LLM captures the general direction of each company’s response, it misses the deeper strategic distinction—LLY reacting to systemic pricing pressure through external advocacy and patient programs, while AMGN actively reshapes its pricing and payer relationships. The answer remains contextually relevant and semantically aligned in parts, but lacks full qualitative depth and completeness in cross-company strategic comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 385,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How do BAC and SCHW's approaches to meeting capital buffer requirements compare under the current regulatory framework where the Countercyclical Capital Buffer remains at zero?",
      "original_answer": "BAC applies a Stress Capital Buffer of 2.5% under the Standardized approach as of December 31, 2023, while SCHW's subsidiary CSB maintains a Capital Conservation Buffer of 2.5%. Both institutions benefit from the Federal Reserve's current setting of the Countercyclical Capital Buffer at zero, which reduces their overall capital requirements. However, BAC's capital strategy incorporates a G-SIB surcharge of 2.5% alongside its buffer requirements, whereas SCHW structures its capital to meet minimum ratios of 7.0%, 8.5%, and 10.5% for Common Equity Tier 1, Tier 1, and Total Risk-Based Capital respectively, inclusive of buffers.",
      "llm_answer": "Both firms are comfortably above the required buffers, but they get there in different ways.  \n\n* **Bank of America** reports the Basel III buffers that apply under the two calculation methods it uses. With the Counter‑cyclical Capital Buffer (CCyB) set at 0 %, its **Standardized‑approach buffer** is the sum of a 5.4 % (2023) capital‑conservation buffer, a 3.0 % G‑SIB surcharge and the zero CCyB – a total buffer requirement of **8.4 %** of risk‑weighted assets. Under the **Advanced‑approach** the buffer is 2.5 % (CET1 conservation) + 3.0 % G‑SIB + 0 % CCyB = **5.5 %**. BAC’s actual CET1 ratios (11.8 % under the Standardized approach and 13.4 % under the Advanced approach) comfortably exceed those minima.  \n\n* **Charles Schwab** (CSC) is a savings‑and‑loan holding company with a banking subsidiary (CSB). Its disclosures state that, with the CCyB also at 0, the firm must hold a **stress‑capital buffer of 2.5 %** (CSC) and its bank must hold a **capital‑conservation buffer of 2.5 %** (CSB). Including the regulatory minima, the required CET1 ratios are **7.0 %** (CSC) and **6.5 %** (CSB). Schwab’s reported CET1 ratios are 24.5 % for CSC and 37.9 % for CSB, far above the required levels.  \n\nThus, BAC meets its buffer requirements by combining the statutory SCB and G‑SIB surcharge (with CCyB = 0) under both approaches, while Schwab relies on a separate stress‑capital buffer (and a subsidiary’s conservation buffer) and also exceeds the required CET1 ratios by a large margin.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in key quantitative elements, particularly regarding BAC's buffer structure and percentages, which undermines the correctness score. According to the ground truth, BAC applies a Stress Capital Buffer (SCB) of 2.5% under the Standardized approach, not a 5.4% capital conservation buffer as claimed. The LLM incorrectly states BAC’s Standardized-approach buffer includes a 5.4% capital-conservation component and 3.0% G-SIB surcharge, whereas the ground truth specifies a 2.5% SCB and a 2.5% G-SIB surcharge (not 3.0%). This results in incorrect total buffer calculations (8.4% and 5.5% under two approaches), which are not supported by the original answer. Additionally, the ground truth does not mention an 'Advanced approach' for BAC or associated 13.4% CET1 ratio, introducing unverified details. For SCHW, the LLM correctly identifies the 2.5% stress-capital buffer for CSC and 2.5% capital-conservation buffer for CSB, aligning with the original answer, and correctly notes the CCyB is at zero. However, the required CET1 ratios cited (7.0% for CSC, 6.5% for CSB) are not in the ground truth, which instead states SCHW structures capital around minimum ratios of 7.0%, 8.5%, and 10.5% for CET1, Tier 1, and Total Risk-Based Capital, inclusive of buffers—this is misrepresented. The extremely high reported CET1 ratios (24.5%, 37.9%) appear to be fabricated or misattributed, as they are not in the original answer. While the LLM captures the high-level idea that both firms benefit from the zero CCyB and maintain buffers differently, the multi-hop synthesis is flawed due to incorrect numerical foundations and misattribution of regulatory frameworks. The reasoning structure is logical and contextually relevant, but the quantitative inaccuracies severely limit factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1538,
        "completion_tokens": 497,
        "total_tokens": 2035
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How does Southern Company's investment in solar facilities, which are connected to power purchase agreements (PPAs), compare with Duke Energy's reliance on PPAs in terms of renewable energy facility financing strategies and tax credit utilization timelines?",
      "original_answer": "Southern Company has approximately $1.2 billion of unutilized federal ITCs and PTCs as of December 31, 2021, which are expected to be fully utilized by 2024, and uses tax equity partnerships for solar and wind projects where the tax partner captures most of the federal tax benefits. These solar facilities are connected to PPAs that are accounted for as operating leases with remaining terms of up to 25 years. In contrast, Duke Energy negotiates PPAs as part of its commercial renewables strategy and enters into tax equity arrangements to finance renewable assets eligible for tax credits. Duke's PPAs significantly impact the economic performance of its renewable facilities, and Duke is the primary beneficiary of these VIEs due to its control over siting, PPA negotiation, and operations. The connection between Southern Company's solar investments and PPAs, and Duke's PPA-driven renewable financing, reveals differing approaches to leveraging long-term contracts and tax incentives in renewable energy development.",
      "llm_answer": "Southern Company treats its solar (and wind) projects that are tied to PP As as operating‑lease arrangements with terms of up to 25 years and finances them largely through tax‑equity partnerships; the company reports that the $1.2 billion of federal investment‑tax‑credit and production‑tax‑credit carryforwards it holds are expected to be fully used by 2024. By contrast, Duke Energy’s renewable assets are held in non‑consolidated VIEs that are funded with debt guarantees and tax‑equity structures, and the PP As are a central source of revenue for those VIEs, but the filing does not give a specific timeline for when its tax credits will be exhausted, indicating a project‑by‑project rather than a set‑date utilization schedule.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: Southern Company's $1.2 billion in unutilized ITCs and PTCs as of December 31, 2021, and the expectation that they will be fully utilized by 2024 are accurately reported. The 25-year PPA lease terms are also correctly stated. (2) The LLM correctly identifies both companies' use of tax equity partnerships—Southern for solar/wind projects and Duke for renewable assets—and notes that PPAs are central to revenue, particularly within VIE structures. (3) The qualitative reasoning is sound: it captures the multi-hop comparison between Southern’s operating lease treatment and tax equity use versus Duke’s VIE-based model with debt guarantees and PPA-driven economics. The observation that Duke lacks a fixed timeline for tax credit utilization (implying a project-by-project approach) is a reasonable inference from the absence of a specified date in the ground truth, and does not contradict it. (4) Minor omission: the LLM does not explicitly state that Duke is the primary beneficiary of the VIEs due to control over siting, PPA negotiation, and operations—a key differentiator in governance and economic alignment. However, this does not undermine the core accuracy of the financing and PPA strategy comparison. Overall, the answer is factually correct, contextually relevant, and demonstrates strong synthesis across entities and financial structures.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 408,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How might the automatic conversion of Class B shares to Class A shares upon transfer at Google, combined with Comcast's non-dilutable Class B voting structure, influence investor sentiment toward Meta's dual-class governance model that grants disproportionate voting control to its founder?",
      "original_answer": "Google's Class B shares automatically convert to Class A shares upon transfer, reducing long-term concentration of voting power. In contrast, Comcast's Class B shares retain 33 1/3% of voting power and are non-dilutable, preserving control. Meta's governance risks highlight concerns that its dual-class structure could make Class A stock less attractive to investors. When considering these three elements together, the contrast in how voting power is preserved or diluted across these companies may shape investor perceptions of governance fairness and control concentration, particularly in Meta's case where founder control remains strong despite lower ownership percentages.",
      "llm_answer": "Alphabet’s charter requires that every Class B share (which carries 10 votes) be converted to a one‑vote Class A share automatically when it is sold or transferred, so the voting weight of a holder can disappear at the moment of a trade 【page_81】.  By contrast, Comcast’s charter locks the 33 ⅓ % voting power of its 15‑vote Class B stock in place and bars any dilution from new issuances of other classes 【page_91】.  Seeing these two opposite safeguards – one that erodes founder‑controlled voting power on transfer and one that preserves it forever – may make investors more skeptical of Meta’s dual‑class structure, which gives Mark Zuckerberg disproportionate control despite his relatively small economic stake 【page_50】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Google's Class B shares convert to Class A upon transfer (with 10:1 voting differential implied), Comcast's Class B shares have 33 1/3% voting power and are non-dilutable, and Meta's structure gives Mark Zuckerberg disproportionate control despite a small economic stake. These match the original answer's substance. (2) Quantitative accuracy is perfect: percentages (33 1/3%), voting rights (10 votes, 1 vote), and structural terms (non-dilutable, automatic conversion) are correctly reported. Format variations (e.g., '33 ⅓ %' vs '33 1/3%') are acceptable. (3) Multi-hop reasoning is sound: the LLM synthesizes governance differences across Google, Comcast, and Meta, and correctly infers that this contrast may lead to investor skepticism toward Meta’s model—precisely the conclusion in the original answer. (4) The only minor shortcoming is that the LLM does not explicitly state that Google’s mechanism reduces long-term voting concentration or that Comcast’s preserves it 'forever'—phrasing that would strengthen the synthesis. However, these implications are clearly conveyed through context. Wording differs slightly but maintains semantic equivalence. No irrelevant or incorrect information is introduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 366,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "Given CVS's launch of Cordavis to co-produce biosimilars with pharmaceutical manufacturers, and UnitedHealth's (UNH) $12.5 billion in rebates receivable from those same manufacturers, how might the increased market availability of lower-cost biosimilars impact UNH's rebate structure and revenue recognition timing, considering rebates are based on product utilization and contract terms?",
      "original_answer": "CVS launched Cordavis to work directly with pharmaceutical manufacturers to commercialize and/or co-produce high-quality biosimilar products, aiming to increase market access and reduce costs. This initiative could increase the utilization of biosimilars, which are typically less expensive than branded biologics. UnitedHealth (UNH) has $12.5 billion in rebates receivable from pharmaceutical manufacturers as of December 31, 2024, which are accrued monthly based on utilization, historical data, and contract terms. Since rebates are influenced by the volume and type of products used, a shift toward greater biosimilar adoption could reduce the rebate amounts negotiated by manufacturers, especially if biosimilars are priced lower and displace branded drugs. Additionally, changes in utilization patterns may affect the timing and predictability of rebate collections for UNH, as lower-cost biosimilars may alter the dynamics of rebate accruals and payment cycles outlined in manufacturer contracts.",
      "llm_answer": "CVS’s new Cordavis unit is intended to “commercialize and/or co‑produce high‑quality biosimilar products” and, as the filing notes, “as access to biosimilars increases… it is expected to generate more competition… leading to lower costs and higher savings for our clients” (CVS 10‑K p. 12‑13). UnitedHealth already records “pharmaceutical manufacturer rebates… as they are earned… on a monthly basis… and generally receives them two to five months after billing,” with $12.5 billion of rebates receivable at year‑end (UNH 10‑K p. 50). If biosimilars displace higher‑priced originator drugs, the utilization‑based rebate calculations will shift – the per‑unit rebate rates may be lower for biosimilars, but the larger volume of lower‑cost drugs could either compress total rebate dollars or, if contracts include volume‑based incentives, increase them; in either case the timing of revenue recognition will move with the faster uptake of biosimilars, causing rebates to be accrued and recognized earlier (or, if uptake is slower, later) than under the current mix of products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: CVS's Cordavis initiative is accurately described as co-producing and commercializing biosimilars to increase access and lower costs, citing the correct context from the CVS 10-K. UnitedHealth’s $12.5 billion in rebates receivable as of year-end (December 31, 2024, implied by context) is correctly stated, along with the monthly accrual and 2–5 month collection timing, consistent with the UNH 10-K. (2) Quantitative accuracy is perfect: the $12.5 billion figure is correctly reported with no calculation errors. (3) The multi-hop reasoning is sound—linking CVS’s biosimilar expansion to changes in drug utilization, which affects UNH’s utilization-based rebate model. The answer correctly identifies that lower per-unit rebates on cheaper biosimilars could reduce total rebates, though volume incentives might offset this, and it appropriately addresses revenue recognition timing, noting that faster biosimilar uptake could accelerate rebate accruals. (4) The only minor shortcoming is that the original answer emphasizes the risk to rebate predictability and contract dynamics more explicitly, while the LLM focuses on timing shifts without fully elaborating on potential contractual renegotiations or reduced rebate rates due to lower list prices. However, the core reasoning and synthesis across CVS and UNH are robust, and the answer remains semantically equivalent in substance. Wording differences are acceptable and do not detract from accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1580,
        "completion_tokens": 428,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How might the SEC's Regulation Best Interest, which requires broker-dealers to act in the best interest of retail consumers, influence Goldman Sachs' compliance costs and competitive positioning against Morgan Stanley, given their differing approaches to consumer protection regulations and retail client expansion?",
      "original_answer": "Goldman Sachs faces increased compliance costs due to consumer protection regulations like Regulation Best Interest, which applies to its consumer-oriented activities, including transaction banking and retail client services. The MET_10k_2024.pdf evidence shows that Regulation Best Interest imposes conduct standards on broker-dealers when recommending securities, including variable insurance products, and that state-level extensions could allow private litigation, increasing legal exposure. Meanwhile, Morgan Stanley's 2024 10-K acknowledges intense competition in the U.S. and globally, particularly from firms offering similar products and services to retail and institutional clients, and notes that some competitors may operate under less stringent regulatory regimes. This suggests that while both firms are subject to Regulation Best Interest, Morgan Stanley may have a more established retail client infrastructure, giving it a competitive edge in adapting to the regulation with lower incremental costs compared to Goldman Sachs, which is expanding in this space and facing higher compliance investments.",
      "llm_answer": "Regulation Best Interest is explicitly called out in Goldman Sachs’ filing (page 61) as a source of “potentially…more costly” compliance and a possible trigger for additional litigation, which will raise the firm’s operating expenses in its consumer‑oriented businesses.  By contrast, Morgan Stanley’s 10‑K (pages 23‑24) notes that some competitors face “different and, in some cases, less stringent…regulatory regimes,” implying that its own broker‑dealer and wealth‑management platforms are subject to a lighter consumer‑protection burden and can devote more resources to retail‑client growth.  Consequently, the Best Interest rule is likely to increase Goldman Sachs’ compliance costs and could erode its price‑competitiveness relative to Morgan Stanley, which can expand its retail franchise with comparatively lower regulatory overhead.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Goldman Sachs explicitly cites Regulation Best Interest in its 10-K (MET_10k_2024.pdf, page 61) as increasing compliance costs and litigation risk, which matches the original answer's claim about increased legal exposure and operating expenses. (2) The reference to Morgan Stanley’s 10-K (pages 23–24) noting competitors may face less stringent regimes is consistent with the ground truth, though the LLM slightly reinterprets this to suggest Morgan Stanley itself benefits from a lighter burden—this is a nuanced inference but not unsupported, as the original implies Morgan Stanley competes with firms under lighter regimes, not necessarily that Morgan Stanley has lighter burdens. (3) The multi-hop reasoning is sound: the model correctly synthesizes that Goldman Sachs, as it expands into retail, faces higher incremental compliance costs under Regulation Best Interest, while Morgan Stanley, with a more established retail infrastructure, may adapt more efficiently. (4) All entities (Goldman Sachs, Morgan Stanley, Regulation Best Interest), regulatory implications, and strategic positioning are accurately represented. The only minor gap is that the LLM does not explicitly mention state-level extensions enabling private litigation, a detail in the original, but this does not undermine the core conclusion. No numerical inaccuracies exist—there are no figures to compute, and all references (page numbers, regulatory names) are correct. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9 for correctness and qualitative accuracy due to excellent synthesis and factual alignment, with a perfect 10 for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 485,
        "total_tokens": 2017
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does the voting power distribution tied to CMCSA's Class A and Class B common stock structure compare with GOOGL's approach to Class B common stock in terms of concentrated control, given that CMCSA's Class B stock carries 15 votes per share and GOOGL's Class B stock carries 10 votes per share?",
      "original_answer": "CMCSA's Class A and Class B common stock structure allocates 66 2/3% of the combined voting power to Class A shares held broadly, while the Class B shares, which carry 15 votes per share and are entirely owned by Brian L. Roberts, control the remaining 33 1/3% of voting power. In contrast, GOOGL's Class B common stock carries 10 votes per share, and although the company also maintains a dual-class structure, the voting power distribution is not explicitly quantified in the evidence provided. However, GOOGL's Class B shares can be converted to Class A shares upon sale or transfer, which could potentially dilute concentrated control over time—unlike CMCSA’s Class B shares, which are non-dilutable.",
      "llm_answer": "Comcast’s dual‑class structure gives each Class B share 15 votes, which—together with the 3.8 million Class A shares—means the single holder of all Class B shares (Brian L. Roberts) controls roughly one‑third (33 %) of the company’s total voting power, while Class A holders control the remaining two‑thirds. Alphabet’s dual‑class structure assigns 10 votes to each Class B share, also concentrating voting authority in a small group of insiders (the founders and early investors), but the filing only notes the 10‑vote per‑share weighting and does not quantify the exact share of total voting power. Thus, both companies use dual‑class shares to concentrate control, with Comcast’s Class B shares carrying a higher per‑share vote (15 vs. 10) and explicitly representing a sizable one‑third voting block.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Quantitatively, all numbers are correct: CMCSA's Class B shares carry 15 votes per share (vs. GOOGL's 10), and Brian L. Roberts controls approximately 33% of voting power, with Class A holding the remaining ~67%—this aligns with the ground truth's 33 1/3% and 66 2/3%. The LLM correctly notes that GOOGL does not provide a quantified voting power distribution in the evidence. (2) The mention of '3.8 million Class A shares' is not in the original answer and appears to be extraneous or potentially from an external source; however, it does not contradict the ground truth and doesn't affect the correctness of the voting power percentages, which are accurately represented as one-third and two-thirds. (3) Qualitatively, the reasoning is sound: the LLM correctly identifies that both companies use dual-class structures to concentrate control, highlights the higher per-share voting power in CMCSA (15 vs. 10), and notes the lack of explicit voting power breakdown for GOOGL. However, the LLM omits the point about GOOGL's Class B shares being convertible to Class A upon sale or transfer—a key distinction regarding potential dilution of control over time. This is a minor but relevant detail in comparing concentrated control mechanisms. (4) Contextual relevance is excellent: the response directly addresses the comparison of voting power concentration and correctly synthesizes multi-hop information across CMCSA and GOOGL. The omission of the convertibility feature prevents a perfect score, but the core facts, calculations, and synthesis are accurate and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 449,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does the increase in illicit trade prevalence in Turkey, which negatively impacted PM's cigarette volume growth, compare to PG's exposure to Turkey's foreign exchange volatility, and what does this reveal about the dual operational risks each company faces in the same market?",
      "original_answer": "PM reported that Turkey's cigarette market grew by 8.2%, primarily due to the easing of pandemic restrictions and increased tourism, but this growth was partially offset by a higher estimated prevalence of illicit trade. This illicit trade directly impacts PM's market dynamics by reducing legitimate sales volume and potentially eroding brand loyalty. Meanwhile, PG disclosed that Turkey is one of several countries where it faces significant foreign exchange exposure, with currency fluctuations having historically impacted its net sales, costs, and earnings. Given Turkey's economic instability, PG's exposure includes both transaction and translation risks that affect margins and cash flows. Together, these facts highlight that while PM is grappling with illicit trade undermining its cigarette sales in Turkey, PG is simultaneously facing financial risks from the country's volatile currency, illustrating how different types of market-specific risks—operational and financial—can concurrently challenge multinational corporations in the same geopolitical environment.",
      "llm_answer": "Philip Morris International said that in Turkey the market grew 8.2 percent in 2021, but that growth was “partially offset by a higher estimated prevalence of illicit trade,” which dampened cigarette‑volume growth (PM 10‑K p. 56). Procter & Gamble, by contrast, flagged Turkey as one of the countries where “significant exchange‑rate fluctuations” create translation and transaction exposure that can lower sales, margins and earnings (PG 10‑K p. 23‑24). Together, the two disclosures show that the same market poses two different operational risks: PM must contend with illegal‑trade‑driven volume erosion, while PG must manage foreign‑exchange‑driven financial volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: Turkey's cigarette market grew by 8.2%, illicit trade partially offset PM's volume growth, and PG faces significant foreign exchange exposure in Turkey due to exchange-rate fluctuations. These are properly attributed to PM and PG 10-K disclosures with correct page references. (2) Quantitative accuracy is perfect: the 8.2% market growth figure is correctly cited, and no calculations are required beyond accurate reporting of percentages and exposures. (3) Multi-hop reasoning is sound—LLM correctly synthesizes risks across two different companies (PM and PG) in the same market (Turkey), distinguishing between PM's operational risk (illicit trade reducing volume) and PG's financial risk (FX volatility affecting sales, margins, earnings). The answer captures the core contrast the question asks about: dual operational risks in the same market. (4) The only minor shortcoming is slight brevity compared to the original answer—e.g., it does not mention Turkey’s economic instability, transaction vs. translation risks in detail, or impacts on brand loyalty—but these omissions do not detract from the essential correctness. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is excellent, directly addressing all parts of the multi-faceted question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 387,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does JPMorgan's approach to identifying and managing transition risk compare to Bank of America's exposure to reputational risk in the context of their climate-related commitments, particularly given JPM's Firmwide Climate Risk Framework and BAC's $1.5 trillion sustainable finance goal?",
      "original_answer": "JPMorgan addresses transition risk through its Firmwide Climate Risk Framework, which includes setting policies, developing metrics and stress testing mechanisms, and establishing a climate risk data strategy to assess financial impacts. This structured approach is designed to integrate climate risk considerations across its business lines. In contrast, Bank of America identifies reputational risk as a potential consequence of failing to meet its climate-related commitments, such as its $1.5 trillion sustainable finance goal, which includes $1 trillion dedicated to supporting the transition to a low-carbon economy. While both institutions recognize climate risk broadly, JPMorgan emphasizes proactive identification and scenario-based analysis of transition risks, whereas BAC focuses on reputational risk mitigation tied to its public climate goals and stakeholder expectations.",
      "llm_answer": "JPMorgan tackles transition risk through a dedicated Climate Risk Management function that establishes a firm‑wide climate‑risk framework, sets policies, metrics and stress‑testing scenarios, and feeds the results to the Board’s Risk Committee and the Climate‑Risk Committee for ongoing oversight (page 148‑149). By contrast, Bank of America’s climate exposure is framed as a reputational‑risk issue – its $1.5 trillion sustainable‑finance goal and net‑zero commitments could trigger negative public perception if unmet, so the bank relies on its broader reputational‑risk policies, governance committees and reporting structures to monitor and mitigate that risk (pages 82‑84, 83).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all figures are correct: JPMorgan's Firmwide Climate Risk Framework and Bank of America's $1.5 trillion sustainable finance goal are accurately cited, with no calculation errors. The dollar amount matches exactly, and no incorrect numbers are introduced. (2) The LLM correctly identifies both entities—JPMorgan and Bank of America (BAC)—and their respective climate risk approaches, satisfying entity accuracy. (3) The reasoning is sound and reflects proper multi-hop synthesis: it contrasts JPMorgan’s proactive, structured transition risk management (including governance via Board and Climate-Risk Committees) with BAC’s reputational risk focus tied to public commitments. The LLM adds value by referencing specific governance structures and oversight mechanisms (e.g., reporting to committees), which are consistent with the context and enhance the answer without deviating from the truth. (4) Semantically, the answer conveys the same core comparison as the original: JPMorgan emphasizes internal risk frameworks for transition risk, while BAC emphasizes external accountability and reputational consequences. The only minor shortcoming is that the LLM does not explicitly mention BAC’s $1 trillion allocation within the $1.5 trillion goal for low-carbon transition support—a detail present in the ground truth—making the answer slightly less complete but not factually deficient. Overall, the response is contextually precise, factually correct, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 428,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does the timing of Microsoft's revenue recognition for hardware sales, which combines hardware and software as a single performance obligation, align with Cisco's average loan receivable terms for financing hardware purchases, and what is Cisco's total credit loss allowance for these financing arrangements as of July 29, 2023?",
      "original_answer": "Microsoft recognizes revenue for hardware sales at the point in time when ownership is transferred to resellers or end customers, treating the hardware and software as a single performance obligation. Cisco offers loan receivables with average terms of one to three years to finance hardware purchases. As of July 29, 2023, Cisco's total credit loss allowance for financing arrangements, including loan and lease receivables, was $72 million.",
      "llm_answer": "Microsoft records hardware‑related revenue — which it treats as a single performance obligation that bundles the device with its software — at the point in time ownership is transferred to the reseller or end‑customer (i.e., essentially immediately). Cisco’s financing of similar hardware purchases is structured as loan receivables with average terms of one to three years, so the cash‑flow period for Cisco extends well beyond Microsoft’s upfront revenue recognition. As of July 29 2023, Cisco’s total credit‑loss allowance for its financing receivables (loans $53 million + leases $19 million) was **$72 million**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the credit loss allowance is correctly stated as $72 million, with a precise breakdown of $53 million for loans and $19 million for leases, which sum to $72 million. The date (July 29, 2023) is correctly referenced. (2) The answer addresses all parts of the multi-hop question: Microsoft's revenue recognition timing (at point of ownership transfer, treating hardware and software as a single performance obligation), Cisco's average loan receivable terms (one to three years), and the total credit loss allowance as of the specified date. (3) Entities are correctly identified: Microsoft and Cisco are accurately associated with their respective financial treatments and metrics. (4) The reasoning is sound and synthesizes information across two companies and reporting contexts—Microsoft’s revenue recognition policy and Cisco’s financing terms and allowances—while highlighting the contrast in timing between upfront revenue recognition and extended financing. The semantic meaning is equivalent to the original answer, with added clarity in the breakdown of the $72 million allowance. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 353,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How might potential delays in FAA certification of Gulfstream's G700 aircraft impact FedEx's compliance costs under ICAO's 2028 production cutoff for non-compliant aircraft, given FedEx's reliance on fuel-efficient fleets to manage CORSIA obligations?",
      "original_answer": "Delays in FAA certification of Gulfstream's G700 aircraft could limit FedEx’s ability to acquire newer, more fuel-efficient aircraft before the 2028 cutoff date for non-compliant models, potentially increasing FedEx’s CORSIA compliance costs. FedEx noted in its 2023 10-K that its CORSIA-related expenses depend on factors including the fuel efficiency of its fleet and the availability of qualifying sustainable aviation fuels. Gulfstream’s 2023 inventory ramp-up for the G700 was explicitly tied to FAA certification timing, meaning a delay could slow the introduction of next-generation aircraft into FedEx’s fleet. This would prolong the use of older, less-efficient aircraft, increasing the company’s carbon offset or allowance purchase obligations under CORSIA and ETS, especially as free allowances are phased out by 2026.",
      "llm_answer": "The 10‑K notes that ICAO’s 2028 production‑cutoff will require any aircraft delivered after 1 January 2028 that does not meet the 2017 emissions standards to incur extra CORSIA‑related costs (offset purchases, sustainable‑fuel premiums, etc.), and FedEx’s strategy is to rely on newer, fuel‑efficient jets to keep those costs low【page_18】.  Gulfstream’s filing shows FedEx’s inventory of work‑in‑process rose in 2023 because it was “ramping‑up production of new Gulfstream aircraft models, including the G700 in anticipation of its certification from the FAA”【page_71】.  If FAA certification of the G700 is delayed, FedEx will be unable to add this efficient model as planned and may have to keep operating older, less‑efficient aircraft beyond the 2028 cutoff, thereby raising its CORSIA compliance expenses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2028 ICAO production cutoff, FedEx's reliance on fuel-efficient aircraft to manage CORSIA costs, Gulfstream’s 2023 ramp-up of G700 production tied to FAA certification, and the risk of increased compliance costs due to delayed certification. (2) Quantitative accuracy is perfect: no incorrect numbers, dates (e.g., 2028 cutoff, 2023 inventory increase), or financial figures are present. The answer correctly references the cause-effect relationship without introducing false metrics. (3) Multi-hop reasoning is sound: the model correctly synthesizes information from FedEx’s 10-K (CORSIA strategy and fleet efficiency) and Gulfstream’s filing (G700 production ramp-up dependent on FAA certification), linking FAA delay → delayed fleet modernization → continued use of less-efficient aircraft → higher CORSIA compliance costs. (4) The only minor shortcoming is the omission of explicit mention of the phase-out of free allowances under ETS by 2026, which adds nuance to the cost increase but is not central to the core causal chain. This does not detract significantly from the overall correctness. Wording differs but semantic meaning matches the original answer. Contextual relevance is excellent, directly addressing the question’s focus on certification delays, fleet compliance, and cost implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 392,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does the voting power distribution tied to Class A and Class B common stock at CMCSA compare to the voting rights structure of Class A and Class B common stock at GOOGL, particularly in terms of the per-share voting ratio?",
      "original_answer": "At CMCSA, Class A common stockholders hold 66 2/3% of the combined voting power, with each share of Class A common stock receiving a variable number of votes depending on the outstanding shares, while each share of Class B common stock has 15 votes and collectively holds 33 1/3% of the voting power. In contrast, at GOOGL, each share of Class A common stock has 1 vote, and each share of Class B common stock has 10 votes, though the specific ownership percentages of each class are not disclosed. This indicates that CMCSA's structure grants significantly more voting weight to Class B shares compared to GOOGL's 10:1 ratio.",
      "llm_answer": "- **Comcast (CMCSA)** – Each Class A share carries 1 vote, while each Class B share carries 15 votes (a 15‑to‑1 voting ratio). Class B stock accounts for roughly one‑third of the total voting power.\n\n- **Alphabet (GOOGL)** – Each Class A share carries 1 vote, and each Class B share carries 10 votes (a 10‑to‑1 voting ratio). Class B stock also represents about one‑third of the total voting power.\n\nThus, Comcast’s Class B shares have a higher per‑share voting weight (15 vs 1) than Alphabet’s Class B shares (10 vs 1).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding CMCSA's voting structure. According to the ground truth, CMCSA does not have a fixed 1 vote per Class A share; instead, Class A shares receive a variable number of votes such that they collectively hold 66 2/3% of the voting power, while each Class B share has 15 votes and collectively holds 33 1/3%. The LLM incorrectly states that each Class A share carries 1 vote, which misrepresents the actual variable-vote mechanism. This is a critical quantitative and structural error. For GOOGL, the LLM correctly identifies the 1-vote and 10-vote structure for Class A and Class B shares respectively, which aligns with the ground truth. (2) The claim that 'Class B stock accounts for roughly one-third of the total voting power' at both companies is partially correct for CMCSA (where it is exactly 33 1/3%) but unsupported for GOOGL, as the original answer explicitly states that ownership percentages for GOOGL classes are not disclosed. Thus, this inference is speculative. (3) The multi-hop reasoning is partially sound — the model correctly compares per-share voting ratios (15:1 vs 10:1) and draws a valid conclusion about relative voting weight. However, it fails to accurately represent CMCSA’s variable allocation mechanism, undermining the synthesis. (4) Despite correct identification of companies and general structure, the incorrect portrayal of CMCSA’s Class A voting rights and unsupported claim about GOOGL’s ownership distribution reduce the correctness and quantitative accuracy scores. Contextual relevance and qualitative reasoning remain strong due to proper framing and comparison logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 460,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA compare to GOOGL's dual-class structure, particularly in terms of the relative influence of holders of Class B shares?",
      "original_answer": "At CMCSA, holders of Class B common stock (owned entirely by Brian L. Roberts) have 15 votes per share and represent 33 1/3% of the combined voting power, while Class A common stockholders hold 66 2/3% of the voting power. In contrast, at GOOGL, Class B common stockholders have 10 votes per share, and upon conversion, these shares convert to Class A common stock, which has only one vote per share. This means that while both companies use a dual-class structure to concentrate voting power among certain shareholders, CMCSA’s Class B shares carry more per-share voting weight (15 votes vs. 10 votes) and are non-dilutable, giving the holder a fixed minority voting control compared to GOOGL’s structure, which allows for more fluidity through conversion.",
      "llm_answer": "- **Comcast (CMCSA)** – The single Class B share held by Brian L. Roberts carries 15 votes per share and, because there is only one such share, it accounts for **about one‑third (33 ⅓ %) of the total voting power** of the company’s common stock (Class A holders have the remaining 66 ⅔ %)【page_33】.  \n\n- **Alphabet (GOOGL)** – Alphabet’s dual‑class structure gives each Class B share **10 votes per share**, and the outstanding Class B shares (held primarily by founders and insiders) represent **roughly 51 % of the combined voting power**, thereby giving those holders majority control over corporate decisions【GOOGL 10‑K page 81】.  \n\n**Comparison:** While both companies grant extra voting rights to a small number of Class B shares, Comcast’s Class B stock provides only a one‑third voting stake, whereas Alphabet’s Class B stock confers a controlling majority (about 51 %). Consequently, holders of Alphabet’s Class B shares have a substantially greater relative influence on corporate governance than the sole Class B holder of Comcast.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains a critical factual error in the quantitative description of GOOGL's Class B voting power. According to the ground truth, the key point is that GOOGL’s Class B shares have 10 votes per share and convert to Class A (1 vote) upon sale, but the original answer does not state what percentage of voting power they hold—only the per-share voting rights and conversion mechanics. However, the LLM claims that GOOGL’s Class B shares represent 'roughly 51%' of voting power, which is not present in the ground truth and cannot be verified from the provided information. This introduces a significant inaccuracy. While CMCSA details (15 votes per share, 33 1/3% voting power) are correctly reported, the comparison hinges on an unsupported claim about GOOGL’s voting control. The reasoning framework is sound—comparing relative influence via dual-class structures—and entities (CMCSA, GOOGL, Class B shares) are correctly identified. The contextual relevance is high as it directly addresses the question’s focus on relative influence. However, the unsupported 51% figure undermines quantitative accuracy, and the conclusion that GOOGL’s holders have 'substantially greater influence' is not fully justified based on the ground truth, which emphasizes structural differences (non-dilutable vs. convertible) rather than a direct voting power majority claim. Thus, while the answer is well-structured and semantically close, it introduces a key unverified statistic, reducing its correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 413,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How does the FDA approval timeline for BMY's Zeposia in ulcerative colitis compare with the regulatory milestone achieved by MRK for Welireg in von Hippel-Lindau disease, and what were the respective impacts on each company's 2021 oncology and immunology portfolios?",
      "original_answer": "BMY received FDA approval for Zeposia in May 2021 for the treatment of moderately to severely active ulcerative colitis (UC), based on the Phase III True North trial, which demonstrated its efficacy and led to expanded market access in immunology. In contrast, MRK received FDA approval for Welireg (belzutifan) in August 2021 for the treatment of von Hippel-Lindau (VHL) disease, marking a key oncology milestone. The approval of Zeposia contributed to BMY's immunology pipeline growth, while Welireg's approval led to a $50 million milestone payment to former Peloton shareholders and positioned MRK more strongly in the oncology space with a novel HIF-2α inhibitor.",
      "llm_answer": "Bristol‑Myers Squibb’s S1P‑modulator Zeposia received its first U.S. FDA approval for ulcerative colitis in **May 2021** (with a later EU approval in November 2021), whereas Merck’s HIF‑2α inhibitor Welireg was cleared by the FDA for adult patients with von Hippel‑Lindau disease in **August 2021**. The Zeposia approval expanded BMY’s **immunology** franchise in 2021, adding a new, FDA‑approved UC therapy, while Welireg’s approval gave Merck a **new oncology** product in 2021 and triggered a $50 million milestone payment that reinforced its oncology pipeline and revenue outlook.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Zeposia FDA approval in May 2021 for UC (BMY), Welireg approval in August 2021 for VHL disease (MRK). (2) Quantitative accuracy is perfect: the $50 million milestone payment is correctly cited. Dates (May vs August 2021) are accurate and support the correct timeline comparison. (3) Multi-hop reasoning is sound: the answer correctly links Zeposia to BMY's immunology portfolio expansion and Welireg to MRK's oncology growth, including the strategic impact (novel HIF-2α inhibitor, pipeline reinforcement). (4) Entity accuracy is strong: correct drug mechanisms (S1P modulator, HIF-2α inhibitor), indications, and company names. The answer fully addresses both the timeline comparison and the impact on each company’s 2021 portfolios. Minor additional detail in the LLM answer (EU approval in Nov 2021) does not detract and adds context without introducing error. All criteria for a top score are met.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 291,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the vesting period structure for restricted stock at EMR compare to the vesting requirements in the multiemployer pension plans that UPS contributes to, given the differences in funding risk and benefit delivery mechanisms?",
      "original_answer": "EMR applies cliff vesting periods ranging from three to ten years for restricted stock awards, with compensation expense recognized ratably over these periods. In contrast, UPS contributes to multiemployer pension plans where vesting periods are defined by collective bargaining agreements and are tied to retirement, death, or termination benefits. These plans are subject to shared funding risks, where assets contributed by one employer may be used to fund benefits for employees of other employers, and UPS may face additional liabilities such as withdrawal liability or surcharge contributions if plans enter critical status. This highlights a fundamental difference in both the structure and risk exposure of vesting mechanisms between EMR’s equity-based compensation and UPS’s pension obligations.",
      "llm_answer": "Emerson’s restricted‑stock awards vest only after a single “cliff” of service – three years for RSUs and anywhere from three to ten years for restricted‑stock shares – and the company records the related compensation expense over that service period. UPS’s multi‑employer pension plans, by contrast, impose vesting rules that are set in the collective‑bargaining agreements (typically based on years of service or age) but the plans pay benefits from pooled plan assets; the employer’s risk is the funding shortfall that may be shared with other participating employers, not an individual employee‑level vesting schedule. Thus EMR’s vesting is a fixed, employee‑specific time horizon, while UPS’s vesting is governed by union‑negotiated plan rules and the benefit is delivered through a jointly‑funded pension fund that carries shared funding risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers and timeframes are correct: EMR's cliff vesting periods of 3 to 10 years for restricted stock and 3 years for RSUs match the original answer’s range of three to ten years. There are no calculations, so numerical precision is fully maintained. (2) The answer correctly identifies the entities: EMR (Emerson) and UPS, and accurately describes their respective vesting structures—EMR’s equity-based cliff vesting with ratable expense recognition, and UPS’s multiemployer pension plans governed by collective bargaining agreements. (3) The multi-hop reasoning is sound: it contrasts individual, fixed vesting schedules (EMR) with union-negotiated, pooled-fund pension vesting (UPS), and correctly highlights the shared funding risk in UPS’s plans, including potential withdrawal liability or surcharge contributions (implied through 'funding shortfall... shared with other employers'). (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'withdrawal liability' or 'critical funding status'—specific risk mechanisms noted in the original—but it does capture the essence of shared risk and potential employer liability. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect: it directly addresses the comparison in structure and risk exposure as required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 399,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does NFLX's exposure to data privacy risks under the Communications Act compare to CMCSA's regulatory obligations under the same Act, particularly in terms of potential financial penalties and operational constraints related to handling personal information?",
      "original_answer": "NFLX faces potential financial penalties and reputational damage due to unauthorized data breaches involving member personal information, including billing data, which could result in material costs and regulatory fines without insurance coverage. CMCSA, being subject to the Communications Act, must comply with privacy and data protection restrictions that govern the collection, use, and disclosure of personal information, which could lead to legal consequences if violated. Both companies are exposed to regulatory scrutiny and potential penalties under the Communications Act, though NFLX lacks insurance to mitigate such risks, whereas CMCSA’s obligations are framed within a broader regulatory compliance framework that includes audits and potential changes in law.",
      "llm_answer": "Both companies acknowledge that the Communications Act subjects them to privacy‑related rules, but the scope and impact differ. Netflix’s filing stresses that a breach of members’ personal or billing data could trigger regulatory investigations, breach‑notification requirements and civil or criminal fines under the Act, and that it would have to alter its data‑collection and‑use practices – a risk that could be “material” but is limited to its streaming platform. Comcast, by contrast, notes that its entire communications portfolio (broadband, video, spectrum, etc.) is governed by FCC rules and the Communications Act, exposing it to a broader set of enforcement actions, potentially larger civil penalties and ongoing operational constraints such as spectrum‑reallocation, network‑upgrade mandates and extensive compliance programs. Thus, while both face possible fines for mishandling personal information, Comcast’s regulatory obligations are wider and can impose heavier financial penalties and more extensive operational restrictions than Netflix’s more narrowly‑focused data‑privacy exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: both NFLX and CMCSA are subject to the Communications Act with differing scopes—NFLX faces risks primarily from data breaches involving personal and billing data, leading to potential regulatory fines and operational changes, while CMCSA has broader obligations due to its communications services portfolio. The absence of insurance coverage for NFLX is implied in the original answer and reasonably reflected in the LLM’s emphasis on material risk; CMCSA’s exposure to FCC rules, audits, and operational mandates like network upgrades and spectrum reallocation is accurately captured. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no errors present. (3) Multi-hop reasoning is sound: the model correctly synthesizes that both firms face regulatory penalties under the same Act but differ in scope and severity, drawing a valid contrast between NFLX’s platform-specific exposure and CMCSA’s enterprise-wide regulatory framework. (4) Semantic equivalence is strong—while the LLM uses more detailed operational examples (e.g., spectrum reallocation, network mandates), these are reasonable interpretations of 'broader regulatory compliance framework' in the original. The only minor gap is the explicit mention of 'reputational damage' and 'lack of insurance' for NFLX, which is slightly underemphasized but not contradicted. Overall, the response is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 436,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the commercialization of Platform 5 nicotine pouches in Sweden by PM compare to CCEP's role as a bottler for KO in the same market, particularly in terms of their respective market entry strategies and product dependencies?",
      "original_answer": "Coca-Cola Europacific Partners (CCEP) serves as a key bottler for The Coca-Cola Company (KO) in Sweden, handling the distribution of Coca-Cola trademark beverages under contractual agreements that require CCEP to purchase concentrates from KO. In 2021, KO's five largest bottlers, including CCEP, represented 41% of KO’s total worldwide unit case volume. Meanwhile, Philip Morris International (PM) launched its Platform 5 nicotine pouch product in Sweden in January 2022 under the Shiro brand, following the acquisition of AG Snus. This launch represents a direct market entry strategy by PM, contrasting with CCEP’s role as a contracted third-party distributor for KO, where product supply is dependent on KO’s concentrate pricing and availability. Both companies operate in Sweden, but PM’s strategy involves direct product innovation and brand acquisition, while CCEP relies on KO for product inputs and brand authorization.",
      "llm_answer": "Philip Morris entered Sweden by directly launching its own Platform 5 nicotine‑pouch product in January 2022 – a reformulated Shiro‑brand pouch that stems from its recent acquisition of AG Snus and is commercialized under PMI’s own reduced‑risk‑product strategy, with the product’s nicotine, flavors and substrate supplied by its own supply chain. In contrast, Coca‑Cola’s presence in Sweden is provided through CCEP, which acts only as an independent bottler that prepares, packages and distributes KO’s beverages under a bottling agreement and must purchase all concentrate/syrup from KO, so its market entry is a distribution partnership rather than a product‑development launch.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: PM launched Platform 5 in Sweden in January 2022 under the Shiro brand following the AG Snus acquisition, and CCEP acts as a bottler for KO, purchasing concentrate under contractual agreements. (2) Quantitative accuracy is perfect: the LLM correctly avoids introducing any incorrect numbers and accurately reflects the absence of specific percentages or financial figures in the original answer. The date 'January 2022' is correctly stated. (3) Multi-hop reasoning is sound: the model correctly contrasts PM’s direct market entry via product innovation and acquisition with CCEP’s role as a third-party distributor dependent on KO for product inputs. It synthesizes the distinction in market entry strategies (direct launch vs. distribution partnership) and product dependencies (own supply chain vs. reliance on concentrate purchases). (4) The only minor shortcoming is the omission of the contextual detail that CCEP was one of KO’s five largest bottlers representing 41% of global unit case volume in 2021—this is a secondary but relevant point about scale and strategic importance. However, this omission does not undermine the core comparison of market entry strategies and dependencies. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 412,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the 8% decline in UNH's Medicare Part D enrollment from 2023 to 2024 interact with the IRA's manufacturer discount requirements and reinsurance shifts to assess CVS's financial exposure under its Medicare Advantage contracts?",
      "original_answer": "The 8% decline in UNH's Medicare Part D enrollment from 3,315,000 in 2023 to 3,050,000 in 2024 suggests a reduction in the number of Part D beneficiaries served by UNH, which may reflect broader market adjustments under the IRA's redesign of Medicare Part D. The IRA introduced significant changes, including capping beneficiary out-of-pocket costs and reducing Federal reinsurance in the catastrophic phase starting January 1, 2025, which shifts more financial responsibility to Part D plans and manufacturers through required manufacturer discounts. For CVS, this creates a dual exposure: first, as a provider of Medicare Advantage plans, it must manage the financial risk associated with the reduced reinsurance and increased member cost-sharing volatility; second, the IRA's rebate mechanism, which Amgen began accruing for in 2022, introduces further pricing pressures that may impact the pharmacy benefit manager's (PBM) drug acquisition costs and rebate negotiations. Thus, the enrollment decline at UNH, combined with the IRA's structural changes and Amgen's experience with manufacturer discounts, collectively signal a complex risk environment for CVS under its Medicare contracts.",
      "llm_answer": "UnitedHealth’s UnitedHealthcare Medicare Part D stand‑alone enrollment fell from 3,315 thousand in 2023 to 3,050 thousand in 2024 – an 8 % drop (‑265 thousand)【page_31】.  The Inflation‑Reduction Act, which took effect on 1 Jan 2024, now requires manufacturers to provide larger discounts to Part D plans and, beginning 1 Jan 2025, reduces federal re‑insurance in the catastrophic phase, shifting more drug‑cost risk to the plans themselves【page_17】.  Because CVS’s Medicare Advantage contracts are priced on a fixed‑premium basis and cannot recoup cost overruns, the enrollment decline cuts premium revenue while the IRA‑driven discount and re‑insurance changes raise per‑member drug‑cost liabilities, amplifying CVS’s financial exposure under those contracts【page_40】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct and aligns closely with the ground truth. It accurately reports the 8% decline in UNH's Medicare Part D enrollment from 3,315,000 (or 3,315 thousand) in 2023 to 3,050,000 (3,050 thousand) in 2024, correctly calculating the 265,000 decrease. The dates for the IRA provisions are accurate: manufacturer discounts are in effect from January 1, 2024, and reduced federal reinsurance begins January 1, 2025. These numbers match the ground truth exactly, with acceptable formatting variation (thousands vs. full numbers).\n\n2) Quantitatively, all figures are correct. The 8% decline is consistent with the reported enrollment numbers (265k / 3,315k ≈ 8%). The LLM correctly identifies the shift in financial risk due to the IRA’s changes, particularly the reduced reinsurance and increased manufacturer discounts. No calculation errors are present.\n\n3) The reasoning is sound and reflects multi-hop synthesis: it connects UNH's enrollment drop (market trend) to the IRA's structural changes, then links those changes to CVS’s financial exposure through its Medicare Advantage contracts. The LLM correctly infers that fixed-premium contracts prevent cost pass-through, so higher per-member liabilities combined with lower enrollment (reduced revenue) increase financial risk. This logic is consistent with the ground truth, though it omits mention of Amgen’s rebate accruals, which is a minor contextual detail present in the original answer but not essential to the core financial exposure argument.\n\n4) The answer is semantically equivalent to the ground truth in all key aspects: enrollment decline, IRA provisions, risk shift to plans, and impact on CVS. The omission of Amgen and PBM-level rebate negotiations slightly reduces qualitative completeness but does not impair the central reasoning. Contextual relevance is excellent—the response directly addresses the interaction between enrollment trends, IRA policy changes, and financial exposure for CVS. Overall, this is a highly accurate, well-reasoned answer with only minor omissions that do not affect core correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 565,
        "total_tokens": 2077
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How does Southern Company's use of cost recovery mechanisms for environmental remediation at its natural gas utilities compare to Duke Energy's financial exposure from environmental remediation liabilities, given the differences in their regulatory and liability frameworks?",
      "original_answer": "Southern Company utilizes cost recovery mechanisms approved by state regulatory agencies to recover environmental remediation costs at its natural gas distribution utilities, allowing it to pass on prudently-incurred expenses—including those related to infrastructure replacement and environmental cleanup—to customers through regulated rates. In contrast, Duke Energy faces environmental remediation liabilities at various current and former sites, with $X million (hypothetical placeholder based on typical reporting) in reserves for probable and estimable costs, but without guaranteed regulatory recovery, meaning these costs are often expensed directly as operational expenses unless recovery is deemed probable. While Southern Company benefits from structured cost recovery riders, Duke Energy must manage uncertain future costs without assured cost pass-through, leading to greater financial exposure.",
      "llm_answer": "Southern Company’s natural‑gas distribution utilities operate under cost‑based rate regulation, so environmental‑remediation expenses can be recovered through state‑PSC‑approved cost‑recovery mechanisms and regulatory riders (see page 22). In contrast, Duke Energy records its remediation liabilities as probable‑cost reserves (e.g., $73 million for Duke Energy as of 12/31/2024 on page 163) and must bear those costs unless insurance or third‑party contributions are obtained, because the liabilities are not subject to a similar cost‑recovery framework. Thus Southern Company can shift remediation costs to ratepayers, while Duke Energy’s exposure remains a direct, non‑recoverable financial liability.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Southern Company uses state PSC-approved cost recovery mechanisms (e.g., regulatory riders) to pass environmental remediation costs to ratepayers, while Duke Energy must record liabilities as reserves without guaranteed recovery. This captures the core contrast in regulatory and liability frameworks. (2) The LLM provides a specific dollar amount—$73 million for Duke Energy as of 12/31/2024—citing page 163, which is plausible and consistent with typical reporting; however, the original answer uses a placeholder '$X million', so the specificity in the LLM answer cannot be fully verified but does not contradict the ground truth. The date (12/31/2024) is reasonable within context. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies, their regulatory environments, and financial treatment of remediation costs. It distinguishes between recoverable costs (Southern) and direct liabilities (Duke), reflecting accurate understanding of cost recovery frameworks. (4) Semantic equivalence is strong—wording differs but meaning matches. The only minor limitation is the introduction of a precise $73M figure not present in the ground truth, which, while plausible, adds specificity beyond the source. However, this does not constitute an error given the context. All entities (Southern Company, Duke Energy, PSC, regulatory riders, reserves) are correctly identified and used. The answer fully addresses the comparative aspect of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 435,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "What is the combined total of securities remaining available for future issuance under equity compensation plans approved by security holders for Caterpillar and Johnson & Johnson, and how does this compare to 3M's total available securities under similar plans?",
      "original_answer": "The combined total of securities remaining available for future issuance under equity compensation plans approved by security holders for Caterpillar (40,873,176) and Johnson & Johnson (111,042,139) is 151,915,315. This is significantly higher than 3M's total of 39,563,000 available securities under the same category.",
      "llm_answer": "Caterpillar reports 40,873,176 securities still available under equity‑compensation plans approved by its security holders, and Johnson & Johnson reports 111,042,139 such securities. Together they total **151,915,315** securities. 3M’s comparable pool is **39,563,000** securities, so the Caterpillar‑J J combined amount is about **112 million more** (roughly 3.8 times larger) than 3M’s total available securities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: Caterpillar's 40,873,176 and Johnson & Johnson's 111,042,139 securities are correctly reported. The sum, 151,915,315, is calculated correctly. 3M's available securities are accurately stated as 39,563,000. (2) The quantitative accuracy is perfect—calculations (sum and implied difference) are correct. The comparison stating the combined total is about 112 million more and roughly 3.8 times larger than 3M’s is logically sound and numerically accurate (151,915,315 - 39,563,000 = 112,352,315; ratio ≈ 3.84). (3) Entity accuracy is correct: all three companies (Caterpillar, Johnson & Johnson, 3M) are properly identified, and the metric—securities available under equity compensation plans approved by security holders—is correctly applied to each. (4) The multi-hop reasoning is strong: the model correctly aggregates data across two companies, computes the total, and compares it to a third company’s figure, providing both absolute and relative comparisons. (5) Semantic equivalence is maintained—the LLM conveys the same core information as the ground truth, with added clarity in the comparison (e.g., '3.8 times larger'), which enhances understanding without introducing error. All aspects of the question are addressed completely and accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 378,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How do Merck's Januvia and Janumet U.S. market exclusivity expiration timelines (May 2026) and IRA-imposed pricing constraints compare to Pfizer's regulatory exclusivity strategy, and what does this indicate about their respective post-2025 revenue protection mechanisms?",
      "original_answer": "Merck’s Januvia and Janumet are set to lose U.S. market exclusivity in May 2026 due to patent settlements and court rulings, with Janumet XR following in July 2026. Despite this, the IRA mandates government price-setting for Januvia starting in 2026 and for Janumet/Janumet XR in 2027, adding pricing pressure. In contrast, Pfizer relies on both patent rights and concurrent regulatory exclusivity periods upon drug approval to protect revenue beyond patent terms. This indicates that Merck is managing near-term exclusivity erosion through price adjustments and rebate reductions, while Pfizer’s strategy emphasizes regulatory exclusivity as a parallel shield alongside patents, suggesting divergent approaches to post-2025 revenue sustainability.",
      "llm_answer": "Merck’s filing makes clear that the sitagliptin‑based products Januvia and Janumet will retain U.S. market‑exclusivity only until May 2026, and that the Inflation‑Reduction Act will impose a government‑price ceiling on Januvia on 1 Jan 2026 (Janumet’s price cap begins 1 Jan 2027).  Consequently, Merck’s post‑2025 revenue from these diabetes drugs will be squeezed by both the imminent loss of patent protection and the IRA‑mandated price limits.  By contrast, Pfizer’s 10‑K emphasizes a regulatory‑exclusivity‑driven approach—leveraging orphan‑drug, pediatric and other data‑based exclusivities across a diversified pipeline—to extend protection well beyond 2025, indicating a comparatively stronger mechanism for preserving future revenues.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Merck's May 2026 exclusivity expiration for Januvia and Janumet and the IRA price-setting timeline, but introduces a specific date (1 Jan 2026) not present in the ground truth, which only specifies '2026' for Januvia and '2027' for Janumet/Janumet XR. The ground truth also notes Janumet XR's exclusivity ends in July 2026, which the LLM omits. These are minor but notable inaccuracies in date precision and completeness. (2) Quantitatively, the years 2026 and 2027 are correct, but the assignment of exact start dates (1 Jan) is unsupported by the ground truth and potentially incorrect—this reduces quantitative accuracy. The core financial and temporal facts (exclusivity loss in 2026, IRA pricing starting in 2026/2027) are directionally accurate. (3) The multi-hop reasoning is strong: the LLM correctly contrasts Merck’s vulnerability due to patent expiration and IRA pricing with Pfizer’s use of regulatory exclusivity as a strategic buffer. It accurately synthesizes across companies and strategies, capturing the divergent post-2025 revenue protection mechanisms. (4) The answer is contextually excellent—directly addressing each part of the question with clear comparison and strategic interpretation. Despite minor date inaccuracies and omission of Janumet XR, the core facts and synthesis are sound, warranting a high correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 390,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does the credit event risk associated with MS's investments in CLNs, which embed credit protection sold to issuers, compare to BAC's use of credit derivatives to mitigate commercial credit exposure, particularly in terms of how each firm manages counterparty risk through derivative instruments?",
      "original_answer": "Morgan Stanley (MS) invests in CLNs and CDOs, which are hybrid instruments containing embedded derivatives in which credit protection has been sold to the issuer of the note. If there is a credit event of a reference entity underlying the instrument, the principal balance of the note may not be repaid in full to the firm, indicating a direct exposure to counterparty risk. This contrasts with Bank of America (BAC), which actively purchases credit protection to cover both funded and unfunded portions of certain credit exposures as part of its commercial credit risk management strategy. BAC also uses credit derivatives to hedge risk, with changes in fair value recorded in other income. Both firms utilize credit derivatives, but MS assumes risk by investing in instruments where it has sold protection, while BAC mitigates risk by purchasing protection.",
      "llm_answer": "Morgan Stanley’s CLNs embed credit protection that the firm sells to the note‑issuer, so a credit event on the reference entity can leave Morgan Stanley with a shortfall on the principal.  Morgan Stanley limits that counter‑party risk by netting the CLN exposure against other credit‑derivative positions, posting cash collateral and applying market‑risk limits to the netted exposure (see the fair‑value net‑of‑cash‑collateral tables and the credit‑derivative risk‑mitigation discussion).  \n\nBank of America, by contrast, uses stand‑alone credit‑derivative contracts (primarily CDS) to purchase protection on its commercial loan portfolio and sometimes sells protection to offset cost; it manages the associated counter‑party risk through master netting agreements, cash‑collateral offsets and fair‑value accounting of the derivative assets and liabilities (see the commercial‑credit‑derivative and net‑ting/collateral disclosures).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies that Morgan Stanley (MS) sells credit protection through CLNs, exposing it to counterparty risk in the event of a credit event, while Bank of America (BAC) purchases credit protection via derivatives (e.g., CDS) to hedge commercial credit exposure. The LLM accurately contrasts MS's risk assumption with BAC's risk mitigation strategy. It adds valuable detail not in the original answer—such as MS using netting, cash collateral, and market-risk limits to manage exposure, and BAC using master netting agreements and fair-value accounting—consistent with typical risk management practices in SEC filings. These additions are contextually appropriate and plausible, enhancing completeness without introducing inaccuracies. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. The reasoning is sound and reflects proper multi-hop synthesis across both firms' derivative strategies. The only minor shortcoming is that the LLM does not explicitly mention BAC selling protection 'to offset cost,' which slightly nuances BAC’s strategy, but this does not undermine the overall correctness. Semantic equivalence is strong, and all entities (MS, BAC, CLNs, credit derivatives) are correctly identified and contrasted. The answer is fully relevant and responsive to the comparative question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 395,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How does the indemnification structure established by 3M in connection with Solventum's spin-off compare to RTX's indemnification arrangements for its financial guarantees, particularly regarding the transfer of liability and the recognition of potential losses?",
      "original_answer": "3M transferred certain liabilities to Solventum as part of the spin-off, including those related to the Bair Hugger and Federal False Claims Act/Qui Tam Litigation, with Solventum assuming indemnification and defense obligations. 3M records liabilities for legal proceedings when probable and estimable, and discloses possible losses when not accrued. Similarly, RTX is subject to indemnification for certain liabilities under its financial guarantees, which could affect its financial exposure. Both companies recognize indemnification rights or obligations as part of their liability management, but 3M explicitly transferred liability to a spun-off entity, whereas RTX retains exposure subject to third-party indemnification terms. This distinction affects how each company accounts for contingent liabilities and insurance receivables under ASC 450 and ASC 610-30.",
      "llm_answer": "3M’s spin‑off of Solventum transfers the bulk of the related liabilities to the new company, and the separation agreement requires Solventum to indemnify and defend 3M for those matters (e.g., the Bair Hugger and False‑Claims Act actions). In contrast, RTX’s guarantees remain on RTX’s books, but a portion of the third‑party guarantees are “subject to indemnification for our benefit,” meaning the counter‑party agrees to reimburse RTX if a loss materializes; RTX records a small carrying amount for the guarantees and accrues the most‑likely loss, while 3M records a large accrued liability (about $3.7 billion for the Combat‑Arms Earplug settlement) and notes that any loss beyond the accrual cannot be estimated. Thus, 3M shifts risk to the spin‑off and recognizes a substantial accrued exposure, whereas RTX retains the risk but mitigates it through indemnification and recognizes only the estimated probable loss.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core distinction between 3M's spin-off indemnification structure and RTX's financial guarantee arrangements, correctly identifying that 3M transferred liability to Solventum (including for Bair Hugger and False Claims Act litigation) while RTX retains exposure but has indemnification rights from third parties. The qualitative reasoning is sound: 3M shifts risk via structural transfer, whereas RTX mitigates risk contractually. However, the quantitative accuracy is compromised by introducing a $3.7 billion figure for a 'Combat-Arms Earplug settlement'—this specific number and association are not present in the original answer and cannot be verified from the provided ground truth. The original answer does not include any dollar amounts for 3M’s accrued liabilities, so this addition introduces unverified data. While the concept that 3M records a large accrued liability when probable and estimable aligns with ASC 450, the specific figure appears fabricated or misattributed. Additionally, the original answer references ASC 450 and ASC 610-30 in relation to accounting for contingent liabilities and indemnification rights, which the LLM omits, slightly reducing completeness. Despite this, the LLM correctly contrasts the accounting treatment (accruing probable losses, recognizing indemnification), and the overall synthesis across companies and structures is logically coherent and contextually relevant. Wording differences are acceptable and do not distort meaning. Thus, the answer is mostly correct with one significant quantitative inaccuracy, warranting a 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 443,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does the geographic revenue distribution of AMD in Taiwan compare to the potential supply chain risk NVIDIA faces through its foundry partners operating in the same region, given the geopolitical tensions mentioned in both companies' filings?",
      "original_answer": "AMD reported $1,841 million in sales to external customers from Taiwan in 2023, highlighting the region's significance in its revenue distribution. Meanwhile, NVIDIA explicitly states that its foundry partners—critical to its chipset supply—are primarily located in Taiwan, and a significant or prolonged geopolitical conflict involving China and Taiwan could severely limit or prevent NVIDIA from receiving chipset supply. This indicates that while Taiwan is a notable market for AMD's sales, it represents a core supply chain vulnerability for NVIDIA due to its dependency on foundry partners operating in the region.",
      "llm_answer": "AMD’s 2023 10‑K shows that sales to customers in Taiwan were $1.84 billion, roughly 8 % of its total $22.7 billion external‑customer revenue (AMD 10‑K page 71).  \n\nNVIDIA’s filing warns that its wafer supply is heavily dependent on a few foundries located in Taiwan; the company flags the “limited number and geographic concentration of global suppliers…foundries…in Taiwan” and notes that “geopolitical tensions involving China and Taiwan could severely limit or prevent…chipset supply from Taiwan” (NVIDIA 10‑K pages 18 & 17).  \n\nThus, while AMD already earns a modest but material share of its revenue from Taiwan, NVIDIA’s exposure is indirect – the same region houses the foundries that manufacture its chips, and any Taiwan‑China conflict could disrupt that supply chain and threaten NVIDIA’s production.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports AMD's $1.84 billion in sales to Taiwan in 2023, which aligns with the ground truth of $1,841 million (equivalent value, minor rounding difference). It also accurately calculates the percentage of total revenue (8%) based on AMD's $22.7 billion total external revenue, which is consistent with the source data. (2) The NVIDIA portion correctly identifies the geographic concentration of foundries in Taiwan and cites the specific risk language from its 10-K regarding geopolitical tensions with China potentially disrupting chipset supply. The use of quotes and page references adds precision. (3) The multi-hop reasoning is sound: the model correctly contrasts AMD’s direct revenue exposure (market demand in Taiwan) with NVIDIA’s indirect but critical supply chain dependency (manufacturing in Taiwan), synthesizing information from both companies’ filings. This captures the core of the question about comparative risk and exposure. (4) The only minor shortcoming is that the original answer emphasizes that Taiwan is a 'notable market' for AMD while being a 'core supply chain vulnerability' for NVIDIA—this nuance is slightly underemphasized in the LLM answer, though the concept is conveyed. No factual errors; numbers, sources, and logic are accurate. Hence, high scores across all categories with a 9 on correctness due to slight reduction in emphasis on the strategic contrast.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 397,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does NEER's 15-year weighted average contract term for repowered wind facilities influence long-term revenue predictability, and how might this structural advantage compare to Southern Power's reliance on power sales agreements where specific contract terms are not disclosed?",
      "original_answer": "NEER benefits from a 15-year weighted average remaining contract term on its power sales agreements tied to repowered wind facilities, which enhances revenue predictability by locking in long-term pricing and output commitments. In contrast, Southern Power discloses its reliance on power sales agreements but does not specify contract durations, limiting visibility into its own revenue stability. This difference suggests NEER may have a more transparent and structured approach to securing long-term cash flows from renewable assets, which could influence investor confidence and financial planning strategies.",
      "llm_answer": "NEER’s portfolio is ≈ 28,759 MW of contracted generation whose power‑sales agreements – including the remaining Production Tax Credit life for repowered wind – have a weighted‑average remaining term of about 15 years (NEE 10‑K p. 13). That long‑dated, disclosed contract base locks in cash‑flow expectations for a decade‑plus and markedly steadies NEER’s revenue outlook. By contrast, Southern Power’s earnings are driven by PPAs (see Southern Power 10‑K p. 81) but the filings do not disclose the length or renewal structure of those agreements, so the company’s long‑term revenue visibility is less transparent and more dependent on the unknown terms of its power‑sales contracts.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies NEER's 15-year weighted average remaining contract term for power sales agreements tied to repowered wind facilities, citing the NEE 10-K, which matches the original answer’s key fact. The mention of 'remaining Production Tax Credit life' adds context but does not distort the core fact. (2) The quantitative accuracy is strong: the 15-year figure is correct, and while the LLM adds a total contracted generation figure of ~28,759 MW not present in the ground truth, this number is plausible and does not contradict it; however, since this specific number was not in the original answer and wasn't required to answer the question, its inclusion is neutral—neither penalizing nor enhancing correctness. (3) The reasoning is sound: the LLM correctly contrasts NEER’s disclosed long-term contracts with Southern Power’s lack of disclosed contract terms, using appropriate citations (Southern Power 10-K p. 81), and draws a logical conclusion about revenue predictability and transparency. (4) The answer fully addresses both parts of the multi-hop question: NEER’s structural advantage in revenue predictability and the comparative opacity in Southern Power’s PPA terms. The semantic meaning and analytical depth are equivalent to the original answer, with slightly more detail on sourcing. Only a minor deduction from perfection due to the addition of an unsolicited metric (28,759 MW), which, while likely accurate, is not confirmed in the ground truth and slightly exceeds the scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 433,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does RTX's revenue recognition practices under FAR guidelines for U.S. government fixed-price contracts compare to Honeywell's exposure to contract termination risks under the same regulatory framework?",
      "original_answer": "RTX recognizes revenue in excess of billings under U.S. government fixed-price contracts due to performance-based or progress payments that typically cover only 80-90% of costs incurred, creating contract assets. These practices are governed by the FAR, which outlines allowable costs and payment structures. Honeywell, also subject to the FAR, faces unique risks such as the U.S. government's right to terminate contracts for convenience, which could impact its contract assets or liabilities similarly structured. Both companies are bound by the same FAR-regulated payment and cost frameworks, but Honeywell's risk profile includes potential contract termination that could disrupt revenue already recognized under FAR-compliant accounting practices.",
      "llm_answer": "RTX recognizes revenue on its U.S. government fixed‑price contracts in accordance with FAR by using a percentage‑of‑completion method (cost‑to‑date versus total estimated cost) and records contract assets because the government retains a portion of the price until final completion. In contrast, Honeywell’s 10‑K emphasizes that, under the same FAR framework, its government contracts carry the risk that the government can terminate them for convenience (or for performance failure) and may impose audits or price adjustments, exposing the company to potential contract terminations, penalties or loss of revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies RTX's revenue recognition practice under FAR using the percentage-of-completion method, which aligns with the ground truth's description of revenue in excess of billings due to progress payments covering 80-90% of costs. While the exact '80-90%' figure is omitted, the concept of retained payments and contract assets is accurately captured. (2) No specific numbers (dates, dollar amounts) are present in either answer, so quantitative accuracy is fully preserved. (3) The multi-hop reasoning is sound: the LLM correctly links RTX’s FAR-compliant revenue recognition to Honeywell’s exposure to termination risks under the same framework, noting both companies are subject to FAR but face different risk dimensions—RTX with payment timing and contract assets, Honeywell with termination for convenience and audits. (4) The LLM adds slightly more detail on Honeywell’s risks (e.g., audits, price adjustments, performance failure), which are consistent with FAR but not in the original; this does not detract from accuracy. The only minor omission is the explicit connection that Honeywell’s termination risk could impact contract assets similarly structured to RTX’s—this nuance is missing but does not invalidate the overall correctness. Semantic equivalence is maintained, and the answer is fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 396,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does the absence of voting rights associated with Alphabet's Class C Capital Stock compare to Comcast's relinquishment of voting rights in Hulu, particularly in terms of governance control and financial outcomes?",
      "original_answer": "Alphabet's Class C Capital Stock has no voting rights except as required by law, which allows the company to maintain control through higher-vote Class A and Class B shares while repurchasing non-voting shares to optimize capital structure. In 2024, Alphabet had $44.7 billion remaining available for Class A and Class C share repurchases. In contrast, Comcast relinquished substantially all voting rights in Hulu in 2019, giving Disney full operational control, and exercised a put option in 2023 to sell its interest for a minimum equity value of $9.2 billion. This resulted in a $8.6 billion payment from Disney (net of $557 million for prior capital calls) and a recorded investment value of $883 million as of December 31, 2024. Both companies strategically managed voting rights to influence governance and financial returns, albeit through different mechanisms and outcomes.",
      "llm_answer": "Alphabet’s Class C capital stock carries **no voting rights at all** (except those required by law), so holders of those shares have no say in board or corporate decisions; control of Alphabet remains with the 10‑vote Class B shares and the Board, while Class C investors still receive the same economic benefits (dividends and share‑repurchase proceeds).  \n\nComcast, by contrast, **gave up its board seats and virtually all voting rights in Hulu**, allowing Disney to assume full operational control; the relinquishment produced a concrete financial result for Comcast—a cash payment of about $8.6 billion (plus a tax gain) and a collateralized loan tied to the Hulu interest—whereas Alphabet’s non‑voting structure does not generate a comparable governance‑related cash event.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core governance and financial distinctions between Alphabet's non-voting Class C shares and Comcast's relinquishment of Hulu voting rights. It accurately states that Alphabet’s Class C shares have no voting rights (except as required by law) and that economic benefits are preserved, while control remains with higher-vote classes. It also correctly notes that Comcast gave up board seats and voting rights, enabling Disney’s full operational control. (2) However, there are minor quantitative inaccuracies: the LLM states Comcast received 'about $8.6 billion' but omits that this was net of $557 million for prior capital calls and fails to mention the $9.2 billion minimum equity value from the 2023 put option. It also omits Alphabet’s $44.7 billion remaining share repurchase authorization in 2024 and the $883 million recorded investment value for Comcast as of December 31, 2024—both key financial outcomes. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance structures (voting vs. economic rights) and contrasts strategic outcomes—Alphabet maintaining control while optimizing capital, versus Comcast exiting control for a financial payout. The comparison logic is valid and addresses both governance and financial dimensions. (4) Scores reflect high qualitative and contextual accuracy, with a slight deduction in quantitative accuracy due to missing or imprecise figures. The answer is semantically close to the ground truth but lacks full numerical completeness, warranting a correctness score of 8 rather than 9–10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 441,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "Given LLY's ongoing challenges scaling production of incretin products while relying on third-party manufacturers, and TMO's $26.92 billion in remaining performance obligations—many tied to contract manufacturing over 3-5 year durations—how might shared vulnerabilities in quality assurance and supply chain execution affect both companies' ability to fulfill long-term commitments?",
      "original_answer": "LLY is experiencing intermittent supply delays for incretin products like Mounjaro and Zepbound, with tight supply expected to persist until additional manufacturing capacity becomes operational 'in the next several years.' These production constraints are tied to reliance on third-party manufacturers, which face quality assurance risks that could lead to regulatory actions, product recalls, or delays in approvals. Meanwhile, TMO has $26.92 billion in remaining performance obligations, with a significant portion linked to contract manufacturing agreements that typically span 3-5 years. If third-party manufacturers fail to maintain quality standards or encounter capacity limitations—as AMD also highlights in its 10-K—both companies could face fulfillment risks: LLY may struggle to meet patient demand amid supply volatility, while TMO could face delays or defaults on long-term manufacturing contracts, impacting revenue recognition and customer relationships.",
      "llm_answer": "Both Eli Lilly and Thermo Fisher rely heavily on third‑party manufacturers, and each discloses that shortages, delayed deliveries, or low yields at those suppliers can force product‑allocation, missed shipments and higher unit costs (LLY “Product Supply” – intermittent delays and tight supplies of incretin medicines; AMD page 24 – dependence on third‑party suppliers for equipment, materials and yields). Because Thermo Fisher’s $26.9 billion of remaining performance obligations are largely tied to multi‑year contract‑manufacturing arrangements, any quality‑assurance failures or supply‑chain interruptions would similarly impede the timely fulfillment of those contracts, jeopardizing revenue recognition and potentially breaching long‑term commitments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: LLY faces intermittent supply delays for incretin products (Mounjaro, Zepbound) due to third-party manufacturing constraints, and TMO has $26.92 billion in remaining performance obligations (LLM rounds to $26.9 billion, which is acceptable). The reliance on third-party manufacturers and associated risks—such as quality assurance failures, supply chain interruptions, delayed deliveries, and low yields—are correctly identified and supported by references to LLY and AMD disclosures. (2) Quantitatively, the $26.9 billion figure is a negligible rounding of $26.92 billion and does not affect accuracy. No calculations are required, and all numbers are presented correctly. (3) The multi-hop reasoning is sound: the model correctly synthesizes LLY’s supply constraints, TMO’s long-term obligations, and AMD’s mention of third-party supplier risks to infer shared vulnerabilities in contract manufacturing. It logically connects quality or capacity issues to potential impacts on revenue recognition and contractual fulfillment for TMO, and supply volatility for LLY. (4) The only minor shortcoming is that the LLM does not explicitly state that LLY’s capacity expansion is expected 'in the next several years,' nor does it directly mention regulatory actions or recalls as a risk, which are included in the original answer. However, the core reasoning and factual content are substantively equivalent. Contextual relevance is excellent, addressing all aspects of the question with precise, focused analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 440,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "What was the total cumulative impairment charge recognized by NextEra Energy Resources on its investment in XPLR as of December 31, 2024, and how does this compare to the carrying value of the investment before the 2024 impairment?",
      "original_answer": "As of December 31, 2024, NextEra Energy Resources had recognized a cumulative impairment charge of $2.0 billion on its investment in XPLR, combining the $1.2 billion impairment from September 30, 2023, and the $0.8 billion impairment from December 31, 2024. The carrying value of the investment before the 2024 impairment was approximately $2.6 billion, which was then written down to $1.8 billion after the 2024 impairment.",
      "llm_answer": "NextEra Energy Resources recorded a **cumulative other‑than‑temporary impairment of about $0.8 billion** on its XPLR investment for the year ended December 31 2024. Before that 2024 write‑down, the equity‑method investment was carried at roughly **$2.6 billion** (which was reduced to an estimated fair value of about $1.8 billion after the impairment).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is significantly incorrect in its key quantitative claim. It states a cumulative impairment of $0.8 billion as of December 31, 2024, but the ground truth specifies a cumulative impairment of $2.0 billion, combining a $1.2 billion impairment from September 30, 2023, and an additional $0.8 billion in 2024. The LLM incorrectly treats the 2024 impairment as the total cumulative amount, omitting the prior $1.2 billion charge. (2) While the carrying value before the 2024 impairment ($2.6 billion) and the post-impairment value ($1.8 billion) are correctly stated, the failure to include the full cumulative impairment renders the overall answer misleading. The calculation of cumulative impairment is wrong: $1.2B + $0.8B = $2.0B, not $0.8B. (3) The multi-hop reasoning is flawed—the model fails to synthesize the two impairment events across 2023 and 2024, despite the question asking for the total cumulative charge as of the end of 2024. This is a critical error in a multi-hop financial question. (4) Contextual relevance is high because the answer addresses the right entities (NextEra Energy Resources, XPLR), time frame (December 31, 2024), and financial concept (impairment and carrying value), but the core factual inaccuracy in the cumulative charge severely undermines correctness. Hence, low scores for quantitative and qualitative accuracy, and a correctness score of 3 due to major factual omission and calculation error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 404,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How does the adoption of ASU 2022-04 by GE impact its transparency around supplier finance obligations compared to MMM's disclosures under the same standard, particularly in terms of confirmed invoice balances and presentation in financial statements?",
      "original_answer": "GE adopted ASU 2022-04 on January 1, 2023, which requires retrospective disclosures for supplier finance programs, with the annual roll-forward information applicable prospectively starting January 1, 2024. This means GE began disclosing key terms, balance sheet presentation, and confirmed amounts outstanding from its supplier finance programs in 2024. Similarly, MMM discloses that as of December 31, 2024 and 2023, its outstanding balances of confirmed invoices under supplier finance programs were approximately $0.3 billion each, and these amounts are included within accounts payable on MMM's consolidated balance sheet. Both companies now provide clearer visibility into their supplier finance obligations under the new standard, with MMM specifically quantifying its confirmed invoice balances and their classification in accounts payable, aligning with the enhanced disclosure requirements introduced by ASU 2022-04.",
      "llm_answer": "GE says it adopted ASU 2022‑04 on 1 Jan 2023 (with roll‑forward reporting beginning 1 Jan 2024) and that the change “did not have a material impact on the Company’s consolidated financial statements,” but it does not disclose the actual amount of confirmed invoices or show how the obligation is presented on the balance sheet. In contrast, 3M (MMM) follows the same standard by reporting the outstanding balance of confirmed invoices—about $0.3 billion at both 12/31/2024 and 12/31/2023—explicitly stating that the amounts are included in accounts payable and providing a roll‑forward of invoices confirmed and paid during the year. Thus, MMM’s filing is far more transparent, giving a concrete confirmed‑invoice balance and clear presentation, whereas GE’s filing merely notes adoption and material‑impact language without the detailed balance‑sheet or roll‑forward information.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: GE adopted ASU 2022-04 on January 1, 2023, with roll-forward disclosures starting January 1, 2024; MMM reported $0.3 billion in confirmed invoice balances as of December 31, 2023 and 2024; these amounts are included in accounts payable. These match the original answer exactly. (2) Quantitative accuracy is perfect: dates and dollar amounts ($0.3 billion) are correctly stated, and no calculations are required beyond accurate reporting. (3) The multi-hop reasoning is sound—LLM correctly compares GE’s lack of detailed disclosure (only noting adoption and materiality) with MMM’s full compliance, including specific balances and balance sheet presentation. It accurately infers that MMM provides greater transparency. (4) The only minor shortcoming is that the LLM slightly overemphasizes GE’s lack of disclosure without acknowledging that GE is following the phased implementation (retrospective disclosures starting in 2024, roll-forwards from 2024 onward), which may explain the absence of certain data in earlier filings. However, this does not make the answer factually incorrect—just slightly less nuanced in timing context. Overall, the answer is factually correct, comprehensive, and directly responsive to the question, with excellent semantic equivalence to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 384,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How does Altria's equity-method accounting for its Cronos investment expose it to financial risks tied to Cronos's compliance with FDA regulations, and how does this compare to Walmart's exposure through its pharmacy operations under the same regulatory framework?",
      "original_answer": "Altria's investment in Cronos is accounted for under the equity method, meaning its financial statements reflect Altria's share of Cronos's earnings or losses. Since Cronos operates in the cannabis-derived product space, it is subject to FDA regulations in the U.S., and any failure to comply could result in fines, penalties, or reputational harm, directly impacting Cronos's financial performance and, by extension, Altria's earnings. Walmart also faces exposure through its pharmacy operations, which must comply with FDA regulations governing the dispensing and sale of pharmaceuticals. Walmart notes that noncompliance could lead to significant sanctions and operational disruptions, mirroring the regulatory risk profile faced by Cronos. Both companies are thus financially exposed to the same regulatory framework, though through different business models and investment structures.",
      "llm_answer": "Altria records its 20 % stake in Cronos under the equity‑method (see Note 7, “investments in equity securities…accounted for under the equity method…using a one‑quarter lag” – page 60).  Because the equity‑method requires Altria to recognize its share of Cronos’s earnings (or losses) and any related contingencies, a failure by Cronos to comply with U.S. FDA (and other cannabis) regulations would flow through Altria’s income and could impair its access to capital, increase liability or cause reputational damage (page 16).  \n\nWalmart’s pharmacy business is owned and operated by the company, so it is directly subject to FDA, DEA and state pharmacy regulations; non‑compliance would expose Walmart to enforcement actions, fines, product recalls or operational shutdowns that would affect its results (pages 26 and 25).  Thus, Altria’s risk is indirect—through the financial results of an investee—whereas Walmart’s risk is a direct, operational regulatory exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 20% stake in Cronos is correctly stated, and while the original answer does not specify the percentage, this detail is consistent with public filings and adds precision without contradicting the ground truth. All referenced page numbers (60, 16, 26, 25) are plausible and contextually appropriate, though not verifiable without source documents; no incorrect numbers are present. (2) The qualitative reasoning correctly distinguishes between Altria’s indirect financial exposure via equity-method accounting and Walmart’s direct operational exposure through its pharmacy operations. It accurately identifies FDA (and additional DEA/state) regulatory risks for both, noting how noncompliance impacts financial results—Altria through investee performance, Walmart through direct sanctions. (3) The multi-hop reasoning is sound: it synthesizes accounting treatment (equity method), regulatory frameworks (FDA/DEA), and risk transmission mechanisms across two different companies and business models. (4) The LLM adds value by specifying the one-quarter lag and citing compliance risks beyond the FDA (e.g., DEA, state regulations), which enriches the comparison without straying from the core question. The only minor shortcoming is that the original answer emphasizes the similarity in regulatory risk *profile* despite different structures, a nuance slightly underemphasized in the LLM response. However, the core factual content, logic, and synthesis are correct and relevant. Thus, the answer earns a 9/10 for correctness—excellent but not perfect in mirroring the ground truth’s emphasis on parallel risk exposure under the same framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 471,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How does LLY's reliance on Cardinal Health for U.S. distribution impact CVS's consolidated financial exposure to Red Oak Sourcing, given Cardinal's dual role in the joint venture?",
      "original_answer": "LLY depends on Cardinal Health for 15-20% of its U.S. revenue through distribution, which makes Cardinal a critical link in LLY's supply chain. Cardinal also co-owns Red Oak Sourcing with CVS, a generic pharmaceutical sourcing entity that CVS consolidates due to its primary beneficiary status. As part of the Red Oak arrangement, Cardinal makes quarterly payments to CVS (e.g., $183 million annually as of 2021), which reduce CVS's inventory costs. Therefore, any disruption in Cardinal's ability to distribute LLY products could affect Cardinal’s financial health, which in turn could impact its ability to meet its financial commitments to Red Oak—and consequently, CVS’s consolidated financial position.",
      "llm_answer": "Eli Lilly notes that roughly 15‑20 % of its U.S. sales are shipped through Cardinal Health, making Cardinal a key wholesaler for Lilly’s products.  In CVS’s own filings, Cardinal is also a 50 % owner of the Red Oak Sourcing joint venture, but CVS is the primary beneficiary and receives quarterly payments from Cardinal that are recorded in cost of goods sold and are described as “immaterial.”  Consequently, while Cardinal’s performance is important to Lilly’s distribution, it does not materially increase CVS’s consolidated exposure to Red Oak; CVS’s risk is limited to its 50 % ownership stake and the modest, immaterial payments it receives from Cardinal.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several correct elements but diverges significantly from the ground truth in reasoning and conclusion, leading to a partially correct assessment. (1) Quantitatively, the 15-20% figure for LLY's U.S. sales through Cardinal Health is accurate and matches the original answer. The mention of quarterly payments from Cardinal to CVS aligns with the ground truth, though the LLM does not specify the $183 million annual amount cited in the original (a minor omission, not a factual error). (2) The entity identification is correct: LLY, Cardinal Health, CVS, and Red Oak Sourcing are all accurately named and their relationships (e.g., 50% JV ownership, CVS as primary beneficiary) are correctly stated. (3) However, the reasoning is flawed: the original answer emphasizes a risk transmission pathway—disruption in Cardinal’s distribution of LLY products could impair Cardinal’s financial health, thereby affecting its ability to make payments to Red Oak and ultimately impacting CVS’s consolidated financials. The LLM incorrectly downplays this linkage by asserting that the payments are 'immaterial' and that there is no material increase in CVS’s exposure. This contradicts the original’s logic, which hinges on the *interdependence* created by Cardinal’s dual role, regardless of payment size. (4) The LLM fails to synthesize the multi-hop chain: LLY → Cardinal (distribution) → Cardinal’s financial stability → Cardinal’s JV payments to Red Oak → CVS’s consolidated financials. Instead, it treats the relationships as siloed. While the answer is contextually relevant and factually grounded in parts, the incorrect conclusion about materiality and risk exposure undermines the qualitative accuracy. The answer is not irrelevant or factually baseless, but it misrepresents the core financial interdependency, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 504,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How does Oracle's use of its $6.0 billion commercial paper program for short-term financing compare to Cisco's debt structure, particularly in light of Cisco's $13.5 billion senior fixed-rate note issuance and the pari passu ranking of those notes with commercial paper obligations?",
      "original_answer": "Oracle utilizes a $6.0 billion commercial paper program for short-term financing, with $401 million in outstanding notes as of May 31, 2024, which mature through August 2024. These notes are unsecured and issued under a private placement exemption. In contrast, Cisco issued $13.5 billion in senior fixed-rate notes in February 2024, which are redeemable at any time with a makewhole premium and are ranked at par with Cisco’s own commercial paper obligations. This indicates that while both companies use commercial paper as part of their short-term financing strategies, Cisco has a significantly larger long-term debt component through its senior notes, which are hedged via interest rate swaps to manage interest rate exposure.",
      "llm_answer": "Oracle relies on its $6 billion commercial‑paper program as a short‑term funding source, issuing unsecured promissory notes that mature within a few months (about $401 million outstanding as of May 31 2024) and using the proceeds for general corporate purposes. Cisco’s debt picture is broader: it issued $13.5 billion of senior fixed‑rate notes and also maintains a commercial‑paper program, and the filing states that the senior notes rank “pari‑passu” with the commercial‑paper obligations, giving the notes the same seniority in the capital structure. Thus, Oracle’s financing is primarily short‑term CP, whereas Cisco’s structure combines large long‑term senior notes with CP that are equally senior to its short‑term paper.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: Oracle's $6.0 billion commercial paper program, $401 million outstanding as of May 31, 2024, short-term maturities, unsecured nature, and private placement issuance are accurately reflected. Cisco's $13.5 billion senior fixed-rate notes issued in February 2024, pari passu ranking with commercial paper, and the implication of equal seniority are correctly stated. (2) Quantitative accuracy is perfect: all dollar amounts ($6.0B, $401M, $13.5B), dates (May 31, 2024), and structural details (pari passu) are correct, with acceptable formatting variations (e.g., 'billion' vs 'B'). (3) Multi-hop reasoning is sound: the model correctly contrasts Oracle’s primarily short-term financing approach with Cisco’s hybrid structure combining long-term senior notes and commercial paper, both equally ranked. (4) The only minor omission is that the ground truth mentions Cisco’s use of interest rate swaps to hedge interest rate exposure on the notes, which the LLM answer does not include. This is a small but relevant detail about risk management, slightly reducing completeness and qualitative accuracy. However, the core comparison and all numerical and structural facts are correct, and the answer fully addresses the question’s intent. Contextual relevance is excellent, directly addressing the comparative debt structure as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 394,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How does Duke Energy's reliance on wind energy in its Commercial Renewables segment compare with Southern Company's strategic commitment to the Skookumchuck wind project, given the 136 MW nameplate capacity and 20-year PPA term associated with Skookumchuck?",
      "original_answer": "Duke Energy's Commercial Renewables segment relies on wind as one of several generation sources, alongside solar, fuel cells, and batteries, but does not disclose specific capacity figures for wind. In contrast, Southern Company's Skookumchuck wind project has a defined 136 MW nameplate capacity and is supported by a 20-year PPA, indicating a concrete long-term commitment to wind energy in a specific geographic location (Lewis and Thurston Counties, WA). While both companies are engaged in wind energy, Southern's detailed disclosure around capacity and contract duration provides clearer evidence of a targeted wind strategy compared to Duke's broader renewable portfolio approach.",
      "llm_answer": "Duke Energy’s Commercial Renewables segment draws on a diversified portfolio that includes wind, solar, fuel‑cell and battery resources, but the filing does not quantify how much of its generation comes specifically from wind. In contrast, Southern Company’s wind‑focused strategy is anchored by the Skookumchuck project—a 136 MW wind facility that is already under a 20‑year power‑purchase agreement—demonstrating a clearly defined, long‑term commitment to wind power.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Duke Energy's Commercial Renewables segment includes wind among other sources without disclosing specific wind capacity; Southern Company's Skookumchuck project has a 136 MW nameplate capacity and a 20-year PPA. These numbers match the original answer exactly. (2) Quantitative accuracy is perfect—136 MW and 20-year PPA are correctly reported with no calculation errors. (3) The multi-hop reasoning is sound: the model correctly contrasts Duke’s broad, unspecified renewable portfolio with Southern’s targeted, contract-backed wind investment, demonstrating synthesis across two companies and strategies. (4) The only minor shortcoming is that the LLM omits the geographic detail (Lewis and Thurston Counties, WA) mentioned in the original answer, which slightly reduces completeness but does not affect the core comparison. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent—the response directly addresses the comparative strategic commitment to wind energy as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 314,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How does the capital buffer requirement structure under the Advanced Approach for MS compare with SCHW's requirements, given the role of the Countercyclical Capital Buffer which is currently set at zero by the Federal Reserve?",
      "original_answer": "Morgan Stanley's (MS) capital buffer requirement under the Advanced Approach includes a fixed 2.5% Capital Conservation Buffer, a G-SIB capital surcharge, and the Countercyclical Capital Buffer (CCyB), which is currently set at zero by the Federal Reserve. Schwab (SCHW) is also subject to the same CCyB, which was zero as of December 31, 2023, and must maintain a 2.5% Capital Conservation Buffer. Therefore, both firms have identical Capital Conservation Buffer percentages and are influenced by the same CCyB policy, though SCHW is not subject to the G-SIB surcharge that applies to systemically important institutions like MS.",
      "llm_answer": "Under Morgan Stanley’s Advanced Approach the buffer that must be held above the regulatory minima is the sum of a 2.5 % capital‑conservation buffer, a 3.0 % G‑SIB surcharge and a Counter‑cyclical capital buffer that the Fed has set at 0 %, giving a total buffer requirement of **5.5 %** (see page 134). In contrast, Schwab’s banking subsidiaries are required only to hold a 2.5 % stress‑ or capital‑conservation buffer (no G‑SIB surcharge) and also face a 0 % CCyB, so their overall buffer is **about 2.5 % per subsidiary (roughly 5 % combined)** and the minimum capital‑ratio requirements already incorporate these buffers (see page 122).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the 2.5% Capital Conservation Buffer for both Morgan Stanley (MS) and Schwab (SCHW), and accurately notes that the Countercyclical Capital Buffer (CCyB) is set at 0% by the Federal Reserve for both, aligning with the ground truth. It also correctly states that MS, as a G-SIB, is subject to a G-SIB surcharge while SCHW is not. However, the LLM introduces a specific 3.0% G-SIB surcharge value and calculates a total buffer of 5.5% for MS, which is not present in the original answer (the ground truth does not specify the exact surcharge percentage). This introduces a quantitatively unsupported precision. Additionally, the claim that Schwab’s subsidiaries have a combined buffer of 'roughly 5% combined' is speculative and not in the original answer, which only confirms a 2.5% buffer per subsidiary without aggregation. While the core reasoning and entity identification are sound (MS vs. SCHW, G-SIB distinction, CCyB policy), the inclusion of unverified numerical values and the combined buffer interpretation reduce quantitative accuracy. The answer is contextually relevant and captures the key comparative structure, but overreaches in specificity where the ground truth is general.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 342,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does Disney's use of discounted cash flow models for valuing Level 2 derivatives compare to Meta's application of the same models in assessing impairment losses on operating lease assets, given Disney's $383 million impairment charge in fiscal 2024?",
      "original_answer": "Disney utilizes internal discounted cash flow models with observable inputs like interest rates and foreign exchange rates to value its Level 2 derivatives, ensuring fair value estimates remain accurate and counterparty risk is mitigated. Meanwhile, Meta applies discounted cash flow models with Level 3 inputs—such as projected sublease income and downtime assumptions—to estimate the fair value of impaired operating lease assets, which led to a $383 million impairment charge in 2024. While both companies use discounted cash flow techniques, Disney applies them in a Level 2 fair value context for derivatives, whereas Meta uses them in a Level 3 context for non-recurring asset impairments.",
      "llm_answer": "Disney values its Level 2 derivatives with internal discounted‑cash‑flow models that rely on observable market inputs such as interest‑rate curves, yield curves and foreign‑currency rates (see DIS 10‑K p. 119). In contrast, Meta estimates the fair value of operating‑lease right‑of‑use assets for impairment using discounted‑cash‑flow (income‑approach) models that depend on Level 3, unobservable assumptions – e.g., expected downtime, projected sub‑lease cash flows and risk‑adjusted discount rates (see META 10‑K p. 98). Thus, Disney’s DCF work is driven by market‑observable data for derivative pricing, whereas Meta’s DCF work incorporates more subjective, market‑participant assumptions to assess lease‑asset impairments, the latter unrelated to Disney’s $383 million impairment charge recorded in fiscal 2024 (DIS 10‑K p. 98).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Disney uses discounted cash flow (DCF) models with observable inputs (Level 2) for valuing derivatives, while Meta uses DCF models with unobservable, Level 3 inputs (e.g., sublease income, downtime assumptions) to assess impairment of operating lease assets. It accurately notes Disney’s $383 million impairment charge in fiscal 2024. All key facts align with the ground truth. (2) Quantitative accuracy is perfect: the $383 million impairment charge is correctly attributed to Disney in fiscal 2024, and no other numbers are misstated. Format variations (e.g., $383 million vs $383M) are acceptable and consistent. (3) The multi-hop reasoning is sound—correctly contrasting Disney’s Level 2 derivative valuation with Meta’s Level 3 impairment assessments, and clarifying that Meta’s DCF use is unrelated to Disney’s impairment charge. The synthesis across companies and valuation contexts is accurate and well-articulated. (4) The only minor shortcoming is a slight overemphasis on the irrelevance of Meta’s DCF to Disney’s charge, which, while true, slightly reframes rather than directly compares as the question implies. However, this does not detract from factual correctness. Overall, the answer is semantically equivalent to the ground truth with excellent precision and contextual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 378,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does the 8.2% increase in Turkey's total tobacco market volume, partly offset by higher illicit trade prevalence, impact PM's market share dynamics, and how does this compare to MO's exposure to illicit trade risks in the broader context of their respective tobacco businesses?",
      "original_answer": "PM's shipments in Turkey increased to 55.7 billion units in 2021 from 47.5 billion in 2020, contributing to a rise in its market share from 41.3% to 44.8%. This growth was partly offset by a higher estimated prevalence of illicit trade in Turkey, which negatively impacts legitimate sales and tax revenues. Similarly, MO highlights that illicit trade in tobacco products, including counterfeit goods and untaxed sales, adversely affects its business by reducing lawful sales and potentially triggering regulatory actions. While PM directly benefits from increased volume in Turkey despite illicit trade, MO emphasizes the broader systemic risks illicit trade poses to the tobacco industry, including brand dilution and loss of tax revenues that could lead to stricter regulations.",
      "llm_answer": "The 8.2 % rise in Turkey’s total tobacco‑market volume helped Philip Morris International increase its shipments there and lift its Turkey market‑share from about 41.3 % in 2020 to roughly 44.8 % in 2021 (a gain of roughly 3½ percentage points), contributing to a 1.1‑point rise in its overall Middle‑East‑and‑Africa regional share despite a higher estimated prevalence of illicit trade. Altria, by contrast, treats illicit trade only as a broad‑based risk that can erode sales, tax revenues and brand value across its markets, without citing any offsetting volume growth, indicating a comparatively greater exposure to illicit‑trade‑related losses in its tobacco business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key numbers are correct: PM's market share increased from 41.3% in 2020 to 44.8% in 2021 (a 3.5 percentage point gain), and this corresponds to shipment growth from 47.5 billion to 55.7 billion units. The 8.2% increase in Turkey’s total tobacco market volume is correctly contextualized. The LLM adds a detail not in the original—'1.1-point rise in its overall Middle-East-and-Africa regional share'—which is plausible and does not contradict the ground truth; however, this specific regional impact is not confirmed in the original answer, so it's an incremental addition rather than an error. (2) Entity accuracy is strong: Philip Morris International (PM) and Altria (MO) are correctly identified, with accurate timeframes (2020 to 2021). (3) Reasoning is sound: the LLM correctly synthesizes that PM benefited from volume growth in Turkey despite rising illicit trade, while MO (Altria) discusses illicit trade as a broad risk without offsetting gains, indicating higher net exposure. (4) The answer addresses all parts of the multi-hop question: impact on PM’s market share, role of illicit trade, and comparative exposure of MO. The only minor gap is that the original emphasizes MO’s concern about regulatory spillovers and brand dilution more explicitly, which the LLM summarizes as 'erode sales, tax revenues and brand value'—semantically equivalent but slightly less detailed. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 429,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does the redesign of the Medicare Part D program under the Inflation Reduction Act affect both CVS's financial exposure to Medicare Part D liabilities and AbbVie's pricing strategy for drugs like Imbruvica under Medicare Part D?",
      "original_answer": "The redesign of the Medicare Part D program under the Inflation Reduction Act shifts more claim liability to insurers like CVS, which could negatively impact their profitability due to increased financial risk and administrative complexity. At the same time, AbbVie is subject to government-set pricing for certain drugs, such as Imbruvica, starting in 2026, which will cap reimbursement rates at a statutory ceiling likely below current average prices, significantly affecting revenue projections. These changes create a dual pressure where CVS faces higher liability and AbbVie faces downward pricing pressure, both under the same regulatory framework.",
      "llm_answer": "The Inflation Reduction Act’s redesign of Medicare Part D moves much of the drug‑cost risk from the federal government to the benefit plans that administer the coverage, so CVS – which operates a large Medicare Part D PBM business – will bear a larger share of claim‑liability and related financial exposure. At the same time, the law gives the Department of Health and Human Services authority to set ceiling prices for single‑source drugs and replaces the old “coverage‑gap” discount with mandatory manufacturer rebates (10 % for beneficiaries below a $2,000 out‑of‑pocket threshold and 20 % above it), meaning AbbVie must price Imbruvica at a government‑determined level and provide those discounts, compressing its Medicare Part D revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that the Inflation Reduction Act shifts financial risk in Medicare Part D from the government to plan sponsors/PBMs like CVS, increasing their claim liability—this aligns with the original answer’s point about CVS facing higher financial exposure. (2) Regarding AbbVie, the LLM correctly states that the law enables government-set pricing and introduces mandatory rebates (10% below $2,000 out-of-pocket threshold and 20% above), which directly affects Imbruvica’s revenue. While the original answer specifies that government-set pricing for drugs like Imbruvica begins in 2026 and sets a statutory ceiling likely below current prices, the LLM omits the 2026 date and the explicit mention of a 'ceiling price below current average prices'—a minor omission affecting completeness but not core correctness. (3) The multi-hop reasoning is sound: the model connects regulatory changes to financial impacts on both CVS (as a PBM/insurer) and AbbVie (as a drug manufacturer), correctly synthesizing effects across entities and mechanisms. (4) Quantitatively, the percentages (10%, 20%) and the $2,000 threshold are accurate per the Inflation Reduction Act. The explanation of rebates and risk shift is factually correct. The only slight gap is the lack of explicit mention of 2026 as the start year for price setting, which is present in the ground truth and relevant for precision. However, the overall semantic meaning and financial implications are preserved. Hence, high scores across all categories with a 9 in correctness due to minor contextual omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 455,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does Boeing's use of third-party aircraft value publications for valuing impaired customer financing assets compare to RTX's quarterly valuation methodology for private equity limited partnerships, particularly in terms of reliance on unobservable inputs?",
      "original_answer": "Boeing derives the fair value of impaired customer financing assets, including operating lease equipment, by calculating a median collateral value from a consistent group of third-party aircraft value publications, which are based on market trades and other market factors. Management reviews these publications quarterly and may adjust values based on specific aircraft attributes. In contrast, RTX values private equity limited partnerships quarterly using discounted cash flows, earnings multiples, and market multiples, with valuation adjustments reflecting changes in operating results or financial condition of the portfolio companies. Both approaches rely on unobservable inputs typical of Level 3 assets, but Boeing leans more on consistent third-party market data while RTX applies more forward-looking financial modeling.",
      "llm_answer": "Boeing values its impaired customer‑financing assets (operating‑lease equipment and finance‑lease investments) by taking a median collateral value from a set of third‑party aircraft‑value publications and then adjusting for specific aircraft condition – a market‑approach that is classified as Level 3 because the inputs (the publications and condition adjustments) are not observable in an active market.  \n\nRTX, by contrast, values its private‑equity limited‑partnership interests each quarter using internal discounted‑cash‑flow models, earnings multiples and market multiples – also a Level 3 approach that relies on significant unobservable inputs, but the inputs are derived from the company’s own valuation models rather than external price publications.  \n\nThus, both companies depend on Level 3 (unobservable) inputs, but Boeing leans on external aircraft‑valuation data, whereas RTX relies on internally generated DCF and multiple‑based estimates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth. (1) All factual elements are correct: Boeing uses a median value from third-party aircraft valuation publications, adjusts for specific aircraft attributes, and classifies this as Level 3 due to unobservable inputs. RTX uses discounted cash flows, earnings multiples, and market multiples for quarterly valuations of private equity limited partnerships—also Level 3. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in the question or ground truth, so quantitative accuracy is not applicable in a numerical sense, but all qualitative metrics and classifications are correctly reported. (3) The multi-hop reasoning is sound: the model correctly synthesizes Boeing’s market-based, third-party-reliant approach with RTX’s model-driven, internally generated forward-looking estimates, and contrasts their use of unobservable inputs appropriately. (4) The only minor shortcoming is that the LLM omits the detail that RTX’s valuation adjustments reflect changes in portfolio companies’ operating results or financial condition—this contextual nuance is present in the original answer but only implied in the LLM version. Otherwise, the semantic meaning, entity accuracy (Boeing, RTX, customer financing assets, private equity partnerships), and contextual relevance are fully preserved. The comparison of reliance on external data (Boeing) vs. internal modeling (RTX) is clearly and correctly articulated.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 414,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does the voting power disparity between Class A and Class B common stock at META and GOOGL affect the concentration of corporate control, particularly given META's outstanding share structure and GOOGL's recent share repurchase activity?",
      "original_answer": "At META, Class A common stock has full voting rights while Class B common stock has no voting rights except in limited circumstances, which concentrates control among Class A shareholders. As of January 24, 2025, META had 2,189,898,148 shares of Class A common stock and 343,761,117 shares of Class B common stock outstanding, indicating a significant majority of voting power is held by Class A shareholders. In contrast, at GOOGL, Class B common stockholders have 10 votes per share compared to 1 vote per share for Class A, giving disproportionate voting control to Class B holders. GOOGL repurchased $62.0 billion of Class A and Class C shares in 2024, which could further consolidate voting power among remaining Class B shareholders by reducing the overall number of voting shares in circulation.",
      "llm_answer": "Meta’s capital structure gives all voting power to its 2.19 billion Class A shares (one vote each) while the 344 million Class B shares can vote only on a narrow set of matters and only with a conversion‑rate multiplier, so effective control rests almost entirely with the Class A holders. Alphabet, by contrast, issues a dual‑class system in which each of its roughly 120 million Class B shares carries ten votes, and the company’s aggressive repurchase of Class A and non‑voting Class C shares in 2022‑‑2024 has shrunk the pool of low‑voting stock, further amplifying the voting weight of the relatively few high‑voting Class B shares and tightening concentration of corporate control.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in numbers and timeframes, undermining its quantitative accuracy. While it correctly identifies the voting structure at META—Class A has full voting rights and Class B has limited rights—the share counts are slightly off: the ground truth reports 2,189,898,148 Class A and 343,761,117 Class B shares as of January 24, 2025, whereas the LLM rounds to 2.19 billion and 344 million, which is acceptable, but then incorrectly refers to Alphabet’s Class B shares as 'roughly 120 million', which is not supported by the ground truth and lacks sourcing. More critically, the LLM claims GOOGL repurchased shares between '2022--2024', while the original answer specifies $62.0 billion repurchased in 2024 only, making the LLM’s temporal scope incorrect. Additionally, the mention of Class C shares as 'non-voting' is accurate, but the original answer does not specify repurchases of Class C—only Class A and Class C collectively—so the characterization is partially speculative. (2) The dollar amount of repurchases ($62.0 billion) is omitted entirely in the LLM answer, a significant quantitative omission. The LLM also fails to explicitly state that GOOGL’s Class B shares have 10 votes per share compared to 1 for Class A—though it implies this with 'ten votes'—but misrepresents the effect by suggesting repurchases of Class C (non-voting) would affect voting concentration, when only reduction in voting shares (Class A) matters. The core logic of voting power concentration is sound, but the reasoning is weakened by incorrect numerical and temporal details. (3) The multi-hop reasoning—comparing dual-class structures and how repurchases affect control—is conceptually correct and well-synthesized. The LLM correctly infers that reducing low-vote shares amplifies high-vote share influence. However, it introduces unsupported details (e.g., 120 million Class B shares, multi-year repurchase program) not in the ground truth, reducing factual reliability. (4) Despite these issues, the answer addresses the core question about voting disparity and control concentration, and the overall narrative is relevant and logically structured, warranting moderate scores in qualitative accuracy and high in contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 609,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does PEP's 19% convenient foods unit volume growth in APAC, including low-single-digit growth in Taiwan, compare with PG's market position across Greater China, where Taiwan is explicitly included in its regional structure?",
      "original_answer": "PEP reported 19% convenient foods unit volume growth in APAC in 2022, with Taiwan contributing low-single-digit growth as part of that performance. In contrast, PG holds a leadership or significant market share position in many of its product segments across Greater China, a region that explicitly includes Taiwan according to Apple's segment reporting. This suggests PG maintains a strong competitive presence in the broader regional market, while PEP's exposure in Taiwan appears more modest but still positive.",
      "llm_answer": "PepsiCo’s convenient‑foods business in APAC posted a **19 % unit‑volume increase**, driven by double‑digit growth in China and Thailand and only low‑single‑digit growth in Australia, Indonesia and Taiwan.  \n\nProcter & Gamble, by contrast, does not cite a specific growth rate for the region but says it **holds a leadership or at‑least a significant‑share position in Greater China**—a geographic segment that expressly includes mainland China, Hong Kong and Taiwan.  \n\nSo, while PepsiCo is reporting strong, measurable volume expansion in APAC (including modest growth in Taiwan), P&G’s commentary focuses on its **dominant market‑share standing** across the Greater China region that also encompasses Taiwan.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies PEP's 19% convenient foods unit volume growth in APAC and notes low-single-digit growth in Taiwan, which aligns with the ground truth. However, it incorrectly lists Australia and Indonesia as having low-single-digit growth instead of only Taiwan, introducing a factual inaccuracy in entity-specific performance. The statement about PG's leadership or significant market share in Greater China, including Taiwan, is accurate and matches the original answer. (2) Quantitatively, the 19% growth figure is correct, and no calculations are required. The misattribution of low-single-digit growth to additional countries (Australia, Indonesia) beyond Taiwan is a qualitative and entity-level error, not a numerical one. (3) The multi-hop reasoning is mostly sound: the model correctly contrasts PEP's growth metrics in APAC (including Taiwan) with PG's market position in Greater China, where Taiwan is explicitly included. However, the synthesis is weakened by the incorrect expansion of low-growth markets. (4) The answer remains contextually relevant and captures the core comparison: PEP shows strong regional growth with modest contribution from Taiwan, while PG emphasizes market leadership in a region that includes Taiwan. Due to the misstatement about which countries had low growth, the answer is partially inaccurate on entity-specific details, warranting a score of 7 for correctness—core facts are right, but key details are flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 409,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How do the updated PCA Framework thresholds under Basel III affect capital requirements differently for banks like BAC and COF, particularly in terms of CET1 capital ratios and classification as well-capitalized institutions?",
      "original_answer": "Under Basel III, the PCA Framework thresholds were updated to require higher capital ratios for banks to be classified as well-capitalized. For COF, as a Category III institution, it must maintain a minimum CET1 capital ratio of 4.5%, Tier 1 capital ratio of 6.0%, and total capital ratio of 8.0%. However, to be considered well-capitalized under PCA, COF must meet higher thresholds: a CET1 capital ratio of 6.5% or more, Tier 1 capital ratio of 8% or more, and total risk-based capital ratio of 10% or more. Similarly, BAC is subject to these same PCA thresholds, with its CET1 capital regulatory minimum set at 4.5% under Basel III, but to be well-capitalized under PCA, it must maintain a CET1 ratio of 6.5% or more, reflecting the updated PCA requirements. This means both banks must hold significantly more capital to avoid PCA restrictions, impacting their capital planning and dividend capacity.",
      "llm_answer": "The Basel III “final‑rule” raised the PCA well‑capitalized bar for a CET1 ratio from 4.5 % to **6.5 %** (with a Tier 1 floor of 8 % and a total risk‑based floor of 10 %)【page_11】.  \n\nBank of America’s consolidated CET1 ratio was **11.8 % under the Standardized approach and 13.4 % under the Advanced approach** at 31 Dec 2023【page_146】—well above the new 6.5 % threshold, so the bank remains comfortably classified as well‑capitalized.  \n\nCapital One, a Category III insured depository institution, is subject to the same updated PCA thresholds; its disclosed CET1 ratio (which exceeds the 6.5 % minimum required for a well‑capitalized bank) therefore meets the higher bar, but because its CET1 is closer to the new floor than BAC’s, the change in the PCA framework has a relatively larger impact on Capital One’s capital cushion.【page_192】【page_11】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key numbers are correct: the updated PCA thresholds of 6.5% CET1, 8% Tier 1, and 10% total risk-based capital are accurately stated and match the original answer. The CET1 ratios for BAC (11.8% standardized, 13.4% advanced) are correctly reported with proper context and time reference (Dec 31, 2023). While the exact CET1 ratio for COF is not provided, the answer correctly notes it exceeds the 6.5% threshold and is closer to the floor than BAC’s, which is consistent with the ground truth implication that COF has a smaller capital cushion. (2) The regulatory minimums under Basel III (4.5% CET1) are implied through context, though not explicitly stated for COF—this is a minor omission but does not distort the overall accuracy. (3) The reasoning is sound: the LLM correctly synthesizes that both BAC and COF are subject to the same updated PCA thresholds, identifies COF as a Category III institution (matching ground truth), and draws a valid comparative conclusion about the relative impact on capital cushions. (4) The answer addresses all parts of the question: the effect of updated PCA thresholds, differences in impact between BAC and COF, and implications for CET1 ratios and well-capitalized classification. Wording differs from the original but maintains semantic equivalence. The only minor gap is the lack of explicit mention of COF’s regulatory minimum CET1 (4.5%), but this does not undermine the correctness of the overall response. Thus, the answer earns a 9/10 for correctness due to high factual accuracy, strong multi-hop reasoning, and excellent contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 459,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How does the sensitivity of NFLX's content amortization to viewing pattern assumptions compare to T's sensitivity analyses around pension discount rates and goodwill impairment assumptions?",
      "original_answer": "NFLX's auditor performed sensitivity analyses on content amortization assumptions, particularly focusing on historical and forecasted viewing hour consumption, which directly affects the timing of content amortization recognition. T's auditor, on the other hand, conducted sensitivity analyses on two key areas: pension discount rates tied to corporate bond credit quality and timing of benefit payments, and goodwill impairment assumptions such as terminal growth rates, EBITDA margins, and weighted average cost of capital (WACC). While both companies undergo sensitivity testing, NFLX's focus is on consumption-based amortization estimates, whereas T's analyses center on long-term financial obligations and asset valuations.",
      "llm_answer": "Netflix’s audit notes state that the company’s content‑amortization expense is driven by “historical and estimated viewing patterns” and that the auditors “performed sensitivity analyses to evaluate the potential changes in the content amortization recorded that could result from changes in the assumptions” 【page_40】.  \n\nIn contrast, AT&T’s audit highlights that its key sensitivities are the actuarial discount rates used to measure defined‑benefit pension and post‑retirement obligations and the assumptions underlying goodwill‑impairment testing (e.g., terminal growth rates, long‑term EBITDA margins and weighted‑average cost of capital) 【page_44】.  \n\nThus, Netflix’s sensitivity analysis centers on how viewing‑pattern estimates affect amortization timing, whereas AT&T’s focuses on how discount‑rate and goodwill‑impairment assumptions affect the measured value of pension liabilities and goodwill.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: NFLX's sensitivity analysis focuses on viewing patterns affecting content amortization timing, and T's (AT&T's) analyses involve pension discount rates and goodwill impairment assumptions like terminal growth rates, EBITDA margins, and WACC. The entities (Netflix/NFLX, AT&T/T), financial concepts, and audit context are correctly identified. (2) There are no numeric values requiring verification in this qualitative comparison, so quantitative accuracy is not applicable beyond correct use of financial terms—none are misstated. (3) The multi-hop reasoning is sound: the model correctly synthesizes auditor-reported sensitivities from two different companies and contrasts their nature—consumption-based amortization (NFLX) vs. long-term liability and intangible asset valuation (T). (4) The answer is semantically equivalent to the original, with only minor omissions: it does not explicitly mention 'corporate bond credit quality' or 'timing of benefit payments' under T's pension assumptions, which are present in the ground truth. However, 'actuarial discount rates' captures the core idea. This small omission prevents a perfect 10 but does not undermine the overall correctness. Contextual relevance is full, as the response directly addresses the comparative sensitivity analysis question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 390,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How does Adobe's localized field office presence in Taiwan compare to Apple's broader Greater China segment strategy, particularly given Apple's $74.2 billion in net sales attributed to that region which includes Taiwan?",
      "original_answer": "Adobe maintains a localized field office in Taiwan as part of its global operations, allowing it to directly engage with customers in that market. Apple, on the other hand, reports its financial performance for the broader Greater China segment, which includes Taiwan along with mainland China and Hong Kong, and generated $74.2 billion in net sales in 2022. While Adobe's approach focuses on direct local engagement through physical offices, Apple manages the region as a consolidated market with a unified strategy, reflecting its larger scale and different operational model.",
      "llm_answer": "Adobe’s 2022 filing lists a dedicated local field office in Taiwan, showing that the company maintains a specific on‑the‑ground presence there. Apple, by contrast, does not separate Taiwan but groups it with mainland China and Hong Kong in its “Greater China” segment, which the 10‑K reports generated $74.2 billion of net sales in 2022. Thus Adobe’s Taiwan footprint is a single, localized office, while Apple’s approach is a broader regional strategy that aggregates Taiwan with the rest of Greater China.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Adobe has a localized field office in Taiwan, and Apple includes Taiwan in its Greater China segment, which reported $74.2 billion in net sales in 2022. (2) The quantitative accuracy is perfect: the $74.2 billion figure is correctly cited with proper context and year (2022), matching the original answer. (3) The multi-hop reasoning is sound—LLM correctly contrasts Adobe’s localized operational presence with Apple’s consolidated regional reporting strategy, synthesizing information about two different companies’ geographic strategies. (4) The answer is contextually relevant, directly addressing the comparison between Adobe’s localized approach and Apple’s broader segment strategy. Wording differs slightly but meaning is preserved, and no critical information is omitted. All evaluation criteria are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 272,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How does Lockheed Martin's exposure to LIBOR-based financing instruments compare to 3M's preparedness for reference rate reform, given the provisions of ASU 2020-04 that both companies reference in their filings?",
      "original_answer": "Lockheed Martin (LMT) has credit facilities and derivative instruments referencing LIBOR-based rates and has adhered to the ISDA 2020 IBOR Fallbacks Protocol, expecting minimal financial impact from the transition to alternative rates by December 31, 2022. 3M (MMM) also reviewed its relevant arrangements and concluded that ASU 2020-04 would not have a material impact on its financial statements, indicating a similar low expectation of disruption. Both companies rely on ASU 2020-04 to ease the accounting burden of transitioning from LIBOR to alternative rates like SOFR, showing parallel preparedness despite differing financial structures.",
      "llm_answer": "Lockheed Martin acknowledges that its revolving credit facility and a portion of its derivative portfolio are currently tied to LIBOR, but the facility contains fallback language that will switch to alternative rates and the company has adopted the ISDA 2020 IBOR Fallbacks Protocol; consequently it expects only a modest accounting effect from the transition. 3M, on the other hand, says it has reviewed all of its contracts, applied the optional expedients in ASU 2020‑04 where needed, and concluded that the reference‑rate reform will not have a material impact on its results, indicating a more fully‑prepared position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) All key facts are correct: Lockheed Martin references LIBOR in its credit facility and derivatives, has adopted the ISDA 2020 IBOR Fallbacks Protocol, and expects minimal (described as 'modest') impact. 3M reviewed its contracts, applied ASU 2020-04 expedients, and concluded no material impact—consistent with the original answer. (2) There are no numeric values requiring calculation (e.g., dates like December 31, 2022 are not mentioned but not critical to the core comparison), so quantitative accuracy is intact. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across both companies and links their actions to ASU 2020-04. The only minor deviation is the characterization of 3M as being in a 'more fully-prepared position,' which introduces a subtle comparative nuance not present in the original answer—both companies are portrayed as similarly prepared with low expected impact. This slight overstatement in comparative preparedness prevents a perfect 10 but does not undermine factual correctness. (4) The answer is fully relevant, addressing all parts of the question: exposure to LIBOR, response to reference rate reform, and the role of ASU 2020-04. Overall, the semantic meaning matches the ground truth with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 374,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "What is the voting power distribution between Class A and Class B common stock at CMCSA, and how does the structure of Class B common stock's 15 votes per share impact overall shareholder control?",
      "original_answer": "At CMCSA, holders of Class A common stock have 66⅔% of the combined voting power, while the Class B common stock, which has 15 votes per share, represents 33⅓% of the combined voting power. This structure gives disproportionate voting control to the holder(s) of Class B common stock, despite their minority ownership on a share count basis.",
      "llm_answer": "Comcast’s voting power is split ≈ 66.7 % to Class A shareholders and ≈ 33.3 % to the single holder of Class B stock. Each Class B share carries 15 votes, so although Class B represents only a tiny fraction of total shares outstanding, it commands one‑third of all votes, giving its owner (Brian L. Roberts) disproportionate control over corporate decisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the percentages (66.7% and 33.3%) correctly reflect the 66⅔% and 33⅓% voting power distribution between Class A and Class B shares. The statement that Class B has 15 votes per share is correct. (2) The answer correctly notes that despite a small share count, Class B holds one-third of voting power, capturing the disproportionate control. (3) The reasoning is sound: it synthesizes the multi-hop concept that high votes per share lead to outsized control, even with minority economic ownership. (4) The only minor deviation is the introduction of 'Brian L. Roberts' as the single holder, which, while likely true, is not present in the original ground truth and adds unverified specificity. However, this does not contradict the original answer and is contextually reasonable. Wording differences (e.g., '≈' vs exact fractions) are semantically equivalent. All key elements—voting split, vote weight per share, and implications for control—are correctly and appropriately conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 310,
        "total_tokens": 1497
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How do the different uses of sensitivity analyses by CMCSA and NFLX reflect their distinct financial risk exposures, particularly given that both are audited by the same firm?",
      "original_answer": "CMCSA uses sensitivity analyses to assess its exposure to interest rate risk, which is critical given its reliance on derivative instruments like interest rate swaps that decreased consolidated interest expense by $56 million in 2023. In contrast, NFLX applies sensitivity analyses in the context of content amortization, a judgment-heavy process where changes in estimated viewing patterns can significantly affect the timing of amortization expenses. Both companies rely on the same auditor, who has served NFLX since 2012 and also reviews CMCSA’s market risk disclosures, suggesting a consistent audit approach despite the differing applications and financial impacts of sensitivity analyses at each firm.",
      "llm_answer": "Comcast’s 10‑K says it “monitor[s] our exposure to the risk of adverse changes in interest rates … through the use of techniques that include market valuation and sensitivity analyses” and it also runs a “hypothetical 10 % shift in currency exchange rates” to gauge foreign‑exchange impact (see CMCSA p.60‑61). In contrast, Netflix’s auditor notes that the audit “performed sensitivity analyses to evaluate the potential changes in the content amortization recorded that could result from changes in the assumptions” about viewing‑hour forecasts (see NFLX p.40). Thus, although both firms are audited by the same public‑accounting firm, Comcast uses sensitivity analysis to manage debt‑ and currency‑market risks, while Netflix uses it to assess the accounting‑estimate risk inherent in its content‑valuation model.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the distinct uses of sensitivity analyses by CMCSA and NFLX and links them to their respective financial risk exposures—interest rate and currency risk for CMCSA, and content amortization assumptions for NFLX—demonstrating strong qualitative accuracy and contextual relevance. It accurately references the use of sensitivity analyses in both companies’ filings and correctly notes the same auditor is involved. However, it omits the specific quantitative impact mentioned in the ground truth: CMCSA’s interest rate swaps reduced consolidated interest expense by $56 million in 2023. This missing figure is a key piece of quantitative evidence that strengthens the original answer’s claim about the financial significance of CMCSA’s risk management. While the LLM mentions a 'hypothetical 10% shift in currency exchange rates' (which aligns with typical sensitivity disclosures), this detail, though plausible, is not explicitly tied to a financial impact in the response and was not in the ground truth, making it a minor overreach without verification. The reasoning is sound and synthesizes information across both companies and the audit context appropriately. The core facts are correct, but the absence of the $56 million figure and lack of specific citation to the 2023 year reduces quantitative accuracy. Semantic equivalence is largely preserved, but the omission of a key financial metric prevents a top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 400,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How does the expiration timeline of Enbrel's key U.S. formulation patent in 2037 impact Pfizer's competitive positioning compared to AbbVie's regulatory exclusivity strategy for its biologics?",
      "original_answer": "Pfizer's Enbrel, marketed outside the U.S. and Canada, benefits from a U.S. formulation patent that expires in 2037, offering extended protection for its composition and preparation methods. This long runway could help Pfizer maintain market presence for Enbrel in key international markets by deterring biosimilar competition. In contrast, AbbVie relies on a broader regulatory exclusivity strategy, including 12-year exclusivity for biologics under the BPCIA and potential pediatric exclusivity extensions, which may allow it to manage competitive threats through both patent and regulatory mechanisms. While Pfizer’s formulation patent provides a specific technical barrier, AbbVie’s layered approach combines patent protection with statutory exclusivity to maximize market control post-approval.",
      "llm_answer": "Enbrel’s U.S. formulation patent does not expire until October 19 2027 (see the “Formulations …” line in the Amgen patent table, which lists a 2037 expiry) 【page_11】.  That far‑out patent horizon means that any biosimilar‑based challenge to the product cannot occur for more than a decade, giving Pfizer (which competes with Enbrel in the inflammation‑immunology space) a prolonged period of market protection.  By contrast, AbbVie’s biologics rely primarily on the statutory 12‑year BPCIA regulatory exclusivity described in its 10‑K (which can be eroded sooner by biosimilar approval and does not extend beyond the 12‑year window) 【page_9】, so AbbVie faces a comparatively shorter exclusivity window and greater exposure to biosimilar competition.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "(1) The LLM answer contains a critical factual error: it states that Enbrel’s U.S. formulation patent expires on October 19, 2027, but then references a 2037 expiry in parentheses, creating confusion. The ground truth clearly states the patent expires in 2037, not 2027. This is a major quantitative inaccuracy. (2) The date 2027 appears to be fabricated or misread; there is no support in the original answer for a 2027 expiration. The mention of 'October 19, 2027' is unsupported, and the parenthetical reference to 2037 does not correct the initial false claim. The BPCIA 12-year exclusivity is correctly noted, but the characterization of it as non-extendable contradicts the original answer, which mentions AbbVie’s potential use of pediatric exclusivity extensions. (3) The reasoning is flawed: the LLM incorrectly frames Pfizer as the marketer of Enbrel (it is Amgen; Pfizer markets it outside the U.S. and Canada under license), and misattributes competitive dynamics. The multi-hop synthesis fails—while both companies are in the immunology space, the comparison should focus on patent vs. regulatory strategy, not incorrect market roles. (4) Contextual relevance is moderate because the answer addresses patent and regulatory exclusivity in biologics, but factual errors in dates, entities, and strategic interpretation severely undermine correctness. The 2037 date is central to the question, and getting it wrong (especially stating 2027) invalidates the core of the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 408,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How would a potential shift from 0.5-percentage-point to 0.1-percentage-point increments in the G-SIB surcharge proposal impact JPMorgan Chase's capital requirements under a resolution scenario where the Parent Company enters bankruptcy, given the loss-absorbing structure of its eligible long-term debt?",
      "original_answer": "The proposed shift from 0.5-percentage-point to 0.1-percentage-point increments in the G-SIB surcharge under the Federal Reserve's proposal would likely allow for more granular calibration of capital requirements for systemically important institutions like JPMorgan Chase. For JPM, this could mean a more tailored capital burden, which would interact with its 'single point of entry' resolution strategy where losses would first be imposed on equity holders and then on unsecured creditors, including holders of eligible long-term debt. If this surcharge adjustment is adopted, JPM may experience either a marginal increase or decrease in required capital depending on its G-SIB score, which would influence how much loss-absorbing capacity it must maintain under its current regulatory framework.",
      "llm_answer": "The 10‑K notes that the G‑SIB surcharge is being evaluated under “Method 2,” which could move from 0.5‑percentage‑point steps to 0.1‑percentage‑point steps (page 60). Because the surcharge adds to the amount of loss‑absorbing “eligible LTD” that JPMorgan must hold to satisfy TLAC requirements, using finer 0.1‑point increments would raise the required capital much less than the current 0.5‑point increments. Consequently, in a resolution where the Parent Company files for Chapter 11, the smaller surcharge would lower the extra eligible‑LTD that must be issued to recapitalize the subsidiaries, reducing the overall capital buffer that would be needed in bankruptcy (page 15).",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains partial factual accuracy but introduces significant errors in reasoning and interpretation. (1) Quantitatively, the shift from 0.5- to 0.1-percentage-point increments is correctly identified, and the reference to Method 2 and page 60 of the 10-K is contextually plausible (though not verifiable here). However, the claim that 'finer 0.1-point increments would raise the required capital much less' is incorrect—smaller increments do not inherently reduce capital; they allow more granular calibration, which could result in higher, lower, or unchanged surcharges depending on the G-SIB score. The original answer correctly states that the impact could be a marginal increase or decrease. (2) The LLM incorrectly asserts that the change 'would raise the required capital much less,' implying a definite reduction, which contradicts the neutral, conditional stance of the ground truth. This misrepresents the regulatory mechanism. (3) The multi-hop reasoning fails: while the model connects G-SIB surcharge → eligible LTD → TLAC → resolution scenario, it incorrectly assumes directionality (i.e., that finer increments automatically reduce capital). It also mischaracterizes the resolution process by citing 'Chapter 11' for the Parent Company, whereas JPMorgan’s resolution strategy is based on Title I/Title II of Dodd-Frank and the Single Point of Entry (SPOE) model under bankruptcy court supervision, not standard Chapter 11. (4) The mention of recapitalizing subsidiaries and reducing the 'overall capital buffer' in bankruptcy oversimplifies and distorts the SPOE mechanism, where the parent’s debt is converted to equity to recapitalize, not to reduce capital needs. Thus, while the answer shows awareness of relevant concepts (G-SIB, TLAC, eligible LTD, resolution), its core conclusion is factually flawed, warranting a low correctness score despite some contextual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 513,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does LMT's use of a discounted cash flow approach in valuing Level 3 fixed income investments compare to HON's application of the same method in testing goodwill and indefinite-lived intangible assets, particularly in terms of the sensitivity to projected cash flows and discount rates?",
      "original_answer": "LMT applies the discounted cash flow approach to certain Level 3 fixed income investments, relying on projected annuity payments and a discount rate applied to those payments. This valuation method is used when observable market inputs are unavailable, and it introduces sensitivity to changes in these projected cash flows and discount assumptions. Similarly, HON utilizes a discounted cash flow approach for testing goodwill and indefinite-lived intangible assets, incorporating strategic and annual operating plans adjusted for terminal value assumptions. HON also performs sensitivity analyses on key estimates, including expected growth rates, sales volumes, and discount rates, to assess the impact of changes in assumptions. Both companies depend on forward-looking financial projections and discounting techniques, making their valuations highly sensitive to shifts in economic conditions and internal performance expectations.",
      "llm_answer": "Lockheed Martin (LMT) values its Level 3 fixed‑income holdings by “a discounted‑cash‑flow approach” in which the key drivers are the **projected annuity‑type cash payments and the discount rate applied to those payments** (see LMT 10‑K p. 88). The filing notes the inputs but does not describe a formal sensitivity test; the fair‑value estimate is simply described as being dependent on those projected cash flows and the chosen discount rate.\n\nHoneywell (HON) also uses a discounted‑cash‑flow model for goodwill and indefinite‑life intangible assets, but it **explicitly performs sensitivity analyses on the principal assumptions**—including the projected cash‑flow amounts, growth rates, and the discount rate—and states that changes in those assumptions could materially affect the fair‑value measurement and trigger an impairment (see HON 10‑K p. 47).\n\nThus, while both companies rely on DCF and recognize that the valuation hinges on cash‑flow forecasts and discount rates, LMT’s disclosure is limited to identifying the inputs, whereas HON’s disclosure emphasizes the sensitivity of the valuation to changes in those inputs and quantifies the potential impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: LMT uses a discounted cash flow (DCF) approach for Level 3 fixed income investments based on projected annuity payments and discount rates, while HON applies DCF to goodwill and indefinite-lived intangible assets with explicit sensitivity analyses on growth rates, sales volumes, and discount rates. The LLM correctly identifies that both companies rely on forward-looking projections and discounting, making valuations sensitive to assumptions. (2) There are no numeric values (e.g., percentages, dollar amounts) in either the original or LLM answer, so quantitative accuracy is not compromised—no calculations were required, and all referenced inputs match. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (LMT and HON), two asset types (Level 3 fixed income vs. goodwill/intangibles), and compares their use of DCF with emphasis on sensitivity analysis. The key distinction—that HON explicitly performs and discloses sensitivity tests while LMT only identifies inputs without formal testing—is accurately highlighted and supported by specific 10-K page references. (4) The LLM adds value by drawing a clearer contrast in disclosure practices than the original answer, which is semantically consistent and enhances understanding. Only a minor deduction from perfect score due to slightly stronger emphasis on disclosure differences than on the shared sensitivity to cash flows and rates, but this nuance is still present. Overall, the response is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1561,
        "completion_tokens": 463,
        "total_tokens": 2024
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does AT&T's use of discount rates tied to corporate bond credit quality in pension obligations compare to Netflix's reliance on forecasted viewing patterns in content amortization, given both are subject to auditor evaluation of significant assumptions?",
      "original_answer": "AT&T's pension obligations are sensitive to discount rates derived from corporate bonds' credit quality, which directly affects the measurement of $67,854 million in goodwill and postretirement liabilities. Netflix, on the other hand, relies on forecasted viewing patterns to amortize content assets, a process that is similarly judgmental and subject to auditor scrutiny. Both companies' financial statements depend heavily on significant assumptions—discount rates for AT&T and viewing forecasts for Netflix—that are evaluated by auditors using sensitivity analyses and comparisons to historical data. This highlights a parallel in how both firms manage subjectivity in long-term financial reporting, despite differing industries and asset types.",
      "llm_answer": "AT&T’s pension and post‑retirement calculations rely on discount rates that are built from the yields of corporate bonds matched to the company’s credit quality; auditors treat the selection of those bond‑based rates as a key actuarial assumption because the rates materially affect the measured obligation. Netflix, by contrast, amortizes its content assets using historical and forecasted viewing‑hour patterns, and auditors focus on the reasonableness of those usage forecasts as the pivotal assumption that drives the timing of content expense. Both companies therefore face auditor scrutiny of highly judgmental, assumption‑driven estimates, but AT&T’s assumptions are market‑rate‑based for pension liabilities, whereas Netflix’s are consumption‑pattern‑based for content amortization.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, no specific dollar amounts or dates are incorrect—the ground truth mentions $67,854 million in goodwill and postretirement liabilities, but the LLM answer does not include this figure. However, the omission is not a factual error, as the question does not explicitly require the dollar amount, and the LLM still correctly describes the nature and auditor evaluation of the assumptions. (2) The LLM accurately identifies both companies (AT&T and Netflix), the correct financial assumptions (discount rates tied to corporate bond yields for AT&T; forecasted viewing patterns for Netflix), and the fact that both are subject to auditor scrutiny. (3) The multi-hop reasoning is sound: it correctly synthesizes that while the industries and asset types differ, both companies rely on significant, judgmental assumptions that auditors evaluate—AT&T via market-rate-based discount rates, Netflix via consumption-pattern-based forecasts. (4) The semantic meaning fully aligns with the original answer, with only minor differences in emphasis (e.g., the LLM does not explicitly mention sensitivity analyses or historical comparisons, but does refer to auditor focus on 'reasonableness,' which implies similar evaluation methods). The answer is contextually precise, directly addressing the comparison of assumption types and auditor evaluation. The only reason for not scoring a 10 is the omission of the specific liability amount ($67,854 million), which was present in the ground truth and adds concrete quantitative context, though its absence does not impair the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 459,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does the adoption timeline of ASU No. 2023-07 differ between MO and PM, and what specific changes did each company implement in their segment reporting as a result?",
      "original_answer": "MO adopted ASU No. 2023-07 in 2024 and began including expanded footnote disclosures in Note 17, with interim disclosure requirements set to appear in Q1 2025. PM adopted the ASU retrospectively for the year ended December 31, 2024, and updated its segment reporting by incorporating the former Swedish Match segment into its four existing geographical segments starting in January 2024.",
      "llm_answer": "- **Adoption timing** – Altria (MO) only began applying the new ASU 2023‑07 in its 2024 annual filing and says the interim‑period disclosures required by the update will start with the first quarter of 2025. Philip Morris International (PM) had already incorporated the update in its 2024 filing (the change was made in January 2024), so its 2024 statements already reflect the ASU and no additional future‑quarter rollout is noted.  \n\n- **Segment‑reporting changes** – Altria’s adoption resulted in “expanded footnote disclosures” (Note 17) that provide the incremental segment information required by the ASU and will be presented in interim statements beginning Q1 2025. PM’s adoption was accompanied by a restructuring of its segment layout: the former Swedish Match segment was folded into the four existing geographic segments (Europe; SSEA‑CIS‑MEA; EA‑AU‑PM DF; Americas) while the Wellness & Healthcare segment remained unchanged, with prior‑year amounts re‑classified to match the new structure.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all dates and timelines are accurate: MO adopted ASU 2023-07 in 2024 with interim disclosures starting Q1 2025; PM adopted retrospectively for the year ended December 31, 2024, with changes effective January 2024. These match the original answer exactly. (2) The answer is complete, addressing both parts of the question: adoption timelines and segment reporting changes for both MO and PM. (3) Entity accuracy is perfect—correct company names (Altria/MO, Philip Morris International/PM), correct segment names (e.g., Europe; SSEA-CIS-MEA; EA-AU-PM DF; Americas), and correct footnote reference (Note 17 for MO). (4) The reasoning is sound and reflects proper multi-hop synthesis: it distinguishes between MO’s phased disclosure approach and PM’s structural segment reorganization, including the integration of the Swedish Match segment and reclassification of prior periods. (5) Semantic equivalence is maintained—while the LLM uses slightly more detailed phrasing (e.g., listing the geographic segments explicitly), the meaning and factual content are identical to the ground truth. No errors in facts, calculations, or logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 343,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does the inclusion of Pomalyst in the Inflation Reduction Act's (IRA) drug price negotiation program impact BMY's revenue outlook compared to PFE's exposure under the same IRA provisions, given both companies' reliance on Medicare Part D sales and regulatory exclusivity timelines?",
      "original_answer": "BMY faces potential revenue erosion for Pomalyst starting in 2027 due to its selection by HHS for government-set pricing under the IRA, which could accelerate prior to the expiry of its intellectual property protections. Similarly, PFE anticipates a net unfavorable revenue impact of approximately $1 billion in 2025 due to IRA-driven Medicare Part D redesign changes and faces additional IRA pricing pressures on products like Ibrance and Xtandi, which were selected for price negotiation effective 2027. Both companies are exposed to the IRA’s long-term financial implications, but BMY’s risk is specifically tied to Pomalyst’s regulatory exclusivity and market dynamics, while PFE’s exposure spans a broader portfolio affected by Part D redesign and inflation rebates.",
      "llm_answer": "Bristol‑Myers Squibb’s 2024 filing notes that the HHS has placed **Pomalyst (pomalidomide)** in the IRA’s first‑round “negotiation” list, so a government‑set price will apply beginning in **2027** (page 43). Because Pomalyst is still under regulatory exclusivity (its minimum U.S. exclusivity date is not listed, indicating it remains protected for several more years – see the “^^” entry in the exclusivity table, page 9), the company warns that the negotiation could **accelerate revenue erosion before that protection expires**.  \n\nPfizer, by contrast, does not have a single product singled out but flags a **broader IRA exposure**, estimating a **≈ $1 billion unfavorable revenue impact in 2025** from the Medicare Part D redesign and other IRA pricing rules (page 16). Like BMS, Pfizer’s sales are heavily weighted to the U.S. Medicare Part D channel (see its discussion of Part D redesign in the same section, page 16).  \n\nThus, BMS’s outlook is tied to a **targeted, later‑starting price‑negotiation hit on Pomalyst that could cut into its protected earnings**, whereas Pfizer faces an **earlier, portfolio‑wide hit that is already reflected in its 2025 revenue forecast**. Both companies’ reliance on Medicare Part D makes the IRA a material risk, but the timing and specificity of the impact differ.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Pomalyst is included in the IRA's first-round negotiation list with a government-set price starting in 2027; BMY warns of accelerated revenue erosion before exclusivity expires; PFE expects ~$1 billion unfavorable impact in 2025 due to IRA’s Part D redesign and broader pricing pressures; both companies have significant Medicare Part D exposure. (2) Quantitative accuracy is perfect: the $1 billion estimate for PFE in 2025 and the 2027 start date for Pomalyst pricing are correctly cited. Number formats and dates match or are semantically equivalent. (3) Multi-hop reasoning is sound—LLM correctly synthesizes BMY’s product-specific, later-impact scenario versus PFE’s earlier, portfolio-wide exposure, drawing on regulatory exclusivity, timing, and revenue channels. (4) The only minor shortcoming is that the LLM does not explicitly mention PFE’s IRA price negotiation on Ibrance and Xtandi (also effective 2027), which slightly reduces completeness compared to the original answer. However, the core contrast in timing, scope, and financial impact is well captured. Wording differs but meaning is semantically equivalent. Contextual relevance is excellent—directly addresses all parts of the multi-faceted question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1554,
        "completion_tokens": 368,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How does the exposure of MDLZ's Argentine operations, which contributed $401 million in 2021 net revenues, compare to KO's reliance on Arca Continental in Argentina, given that Arca Continental is one of KO's top bottlers and operates in northern Argentina?",
      "original_answer": "MDLZ's Argentine operations contributed $401 million in net revenues in 2021 and were subject to significant currency risk due to Argentina's highly inflationary status, resulting in a $13 million remeasurement loss in that year. Meanwhile, KO relies on Arca Continental, one of its top five bottlers, which operates in northern Argentina and contributes to KO's global unit case volume. Arca Continental is a key distribution partner in the region, and KO's bottler agreements require Arca to source concentrates exclusively from KO, making KO's exposure in Argentina indirect but strategically significant through this contractual relationship.",
      "llm_answer": "Mondelez’s Argentine business generated $401 million of net revenue in 2021 – about 1.4 % of the company’s total net revenues.  Coca‑Cola’s exposure to Argentina is indirect: the company’s fifth‑largest bottler, Arca Continental, operates in northern Argentina (as part of its broader footprint in Mexico, Ecuador, Peru and parts of the U.S.).  While Arca Continental is a key partner that helps supply the Argentine market, Coca‑Cola does not disclose a specific revenue amount for that region, so its Argentine exposure is tied to a major bottler rather than a quantified dollar figure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that MDLZ's Argentine operations generated $401 million in net revenue in 2021, matching the ground truth. It also accurately notes that Arca Continental is Coca-Cola's bottler operating in northern Argentina and identifies it as the fifth-largest bottler, which aligns with 'one of KO's top bottlers.' However, the ground truth includes a specific $13 million remeasurement loss due to currency risk in Argentina for MDLZ in 2021, which the LLM omits. This is a meaningful financial detail directly tied to MDLZ's exposure and is therefore a notable omission affecting completeness. (2) Quantitatively, all numbers are correct: $401 million is accurately cited, and the 1.4% of total revenue is a reasonable inference (based on MDLZ's ~$29B total revenue in 2021: 401/29000 ≈ 1.38%), so this calculation is acceptable even if not explicitly in the original. No incorrect figures are presented. (3) The multi-hop reasoning is sound: the LLM correctly distinguishes between MDLZ's direct operations and KO's indirect exposure via Arca Continental, and it synthesizes the relationship between KO and its bottler correctly, including the lack of disclosed regional revenue. The contractual exclusivity (Arca sourcing only from KO) is omitted, but the core logic of indirect exposure is well-reasoned. (4) The answer is contextually highly relevant, directly addressing the comparison of exposure between MDLZ and KO in Argentina. The omission of the remeasurement loss and contractual exclusivity slightly reduces qualitative and overall correctness, but the key facts and synthesis are accurate, warranting a score of 8 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 457,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How does BMY's engagement with the FDA's Fast Track Designation process inform the strategic value of LLY's acquisition of Prevail's PR006 gene therapy, given PR006's regulatory status and the CVR payment timeline tied to its approval?",
      "original_answer": "BMY's engagement with the FDA's Fast Track Designation process highlights the importance of expedited regulatory pathways in accelerating drug approvals and improving patient access to critical therapies. LLY acquired Prevail in 2021, including PR006, which was granted Fast Track Designation by the FDA for treating frontotemporal dementia with GRN mutations. The acquisition included a CVR entitling Prevail shareholders to up to an additional $4.00 per share (approximately $160 million total) upon the first regulatory approval of a Prevail product in specified countries by December 31, 2024. Given the Fast Track status of PR006, the likelihood of expedited approval may directly influence the timing and value of the CVR payout, thereby enhancing the strategic value of the acquisition if PR006 achieves regulatory approval within the stipulated timeline.",
      "llm_answer": "Bristol‑Myers notes that the FDA’s Fast‑Track tool “can … facilitate the development of certain drugs or expedite certain applications” (LLY 10‑K p. 18), showing the company’s belief that accelerated pathways materially reduce time‑to‑market risk and enhance the commercial value of a candidate. Eli Lilly’s acquisition of Prevail therefore targets a gene‑therapy (PR006) that already carries Fast‑Track designation, positioning it for a quicker regulatory decision and, if approved in the U.S., Japan, EU or U.K. by Dec 31 2024, will trigger the $4‑per‑share contingent‑value right (CVR) payment, with the CVR value eroding monthly thereafter until Dec 1 2028 (LLY 10‑K p. 70). Thus, BMY’s emphasis on Fast‑Track underscores the strategic premium Lilly places on PR006’s accelerated regulatory status and the tied‑to‑approval CVR upside.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in detail. (1) Quantitatively, all key numbers are correct: the $4.00 per share CVR payout (approximately $160 million total implied from ~40M shares), the Dec 31, 2024 deadline for full CVR value, and the erosion timeline until Dec 1, 2028 are consistent with the original answer and SEC filing details. The LLM correctly identifies PR006’s Fast Track Designation and ties it to the CVR trigger. (2) The only minor discrepancy is that the original answer specifies the CVR is for 'first regulatory approval in specified countries' by 2024, while the LLM lists the countries (U.S., Japan, EU, U.K.)—which is likely accurate but not explicitly confirmed in the ground truth. Additionally, the LLM introduces a detail not in the original—that the CVR value erodes monthly until 2028—which adds precision but was not part of the provided ground truth; however, this does not contradict it and may be correct per the 10-K. (3) The multi-hop reasoning is sound: the LLM correctly links BMY’s commentary on Fast Track (from LLY’s 10-K) to the strategic value of PR006’s expedited status and the time-sensitive CVR, demonstrating synthesis across regulatory, corporate, and financial domains. (4) Wording differs but semantic meaning aligns closely—both emphasize the strategic value of Fast Track in increasing the likelihood of timely approval and CVR realization. The answer is fully contextually relevant, directly addressing how BMY’s perspective informs LLY’s acquisition logic. Minor lack of explicit mention of frontotemporal dementia with GRN mutations slightly reduces completeness, but the core strategic linkage is preserved. Hence, a 9 is justified—excellent accuracy with slight over-precision on CVR erosion not fully verifiable from ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 505,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How does V's increase in Class A common stock shares from 1,594 in 2023 to 1,733 in 2024 compare with MA's Class B-to-A conversion mechanism, especially considering MA's disclosure that only 7 shares of Class B common stock were outstanding in 2024, to assess the differing dynamics of shareholder structure evolution in both companies?",
      "original_answer": "V reported an increase in Class A common stock shares from 1,594 in 2023 to 1,733 in 2024, indicating an expansion in its Class A shareholder base. Meanwhile, MA disclosed that only 7 shares of Class B common stock were outstanding in 2024, showing minimal remaining shares eligible for conversion into Class A. This contrast highlights different dynamics in shareholder structure evolution: V is seeing organic growth or issuance in its Class A shares, while MA's structure is shaped by its conversion rules, which require Class B holders (typically principal or affiliate customers) to convert and then divest Class A shares, limiting long-term Class B retention.",
      "llm_answer": "Visa’s 2024 Form 10‑K shows that the number of its Class A common‑stock shares rose from 1,594 in 2023 to 1,733 in 2024 – an increase of 139 shares (about an 8.7 % rise, driven largely by equity‑compensation issuances). In contrast, Mastercard’s 2024 filing notes that its Class B shares are convertible one‑for‑one into Class A shares, but only 7 Class B shares were outstanding in 2024, so the conversion mechanism can add at most a handful of shares to the Class A pool. Thus, Visa’s shareholder base is expanding through active new issuances, whereas Mastercard’s structure yields only a negligible change in voting‑share composition because the convertible Class B pool is extremely small.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in V's Class A shares from 1,594 to 1,733, a difference of 139 shares, and accurately calculates the percentage increase as approximately 8.7%, which is correct (139 / 1,594 ≈ 0.0871 or 8.71%). The number of outstanding Class B shares at MA in 2024 is correctly stated as 7. All numeric values and calculations are accurate. (2) The entity names are correctly interpreted: 'V' is Visa, 'MA' is Mastercard. The years (2023 and 2024) are correctly referenced, and the financial instruments (Class A and Class B common stock) are accurately described. (3) The multi-hop reasoning is sound: the answer contrasts Visa’s growth via new issuances (specifically citing equity compensation) with Mastercard’s limited conversion mechanism due to the near-exhaustion of Class B shares. It correctly infers that Mastercard’s structure allows only minimal future impact on Class A shares due to the tiny pool of convertible shares. (4) The original answer emphasizes that MA's conversion rules require divestiture after conversion, which the LLM omits. This is a minor but relevant nuance about shareholder dynamics—why Class B shares are not retained long-term. However, the core insight about differing structural evolution (organic issuance vs. constrained conversion) is preserved. The LLM adds useful context about equity compensation as a driver, which is consistent with typical 10-K disclosures and enhances the answer without contradicting the ground truth. Thus, the answer is factually correct, well-reasoned, and contextually complete, meriting a high score with only a slight deduction in qualitative accuracy for missing the post-conversion divestiture requirement.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 471,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How might Saudi Arabia's data localization requirements, which Adobe identifies as a risk to its international operations, affect NVIDIA's ability to deploy its H100 and L40S chips in the country under U.S. export control regulations?",
      "original_answer": "Saudi Arabia's implementation of data localization requirements mandates that data be stored and processed within the country, which Adobe notes could adversely impact its international business operations. NVIDIA, which relies on Saudi Arabia as a market for its high-performance chips like the H100 and L40S, faces U.S. export licensing restrictions on these products to Saudi Arabia under updated Country Group D4 rules. Since these chips require U.S. government approval for export and NVIDIA has not received such licenses for restricted products, the combination of Saudi regulatory requirements and U.S. export controls could significantly limit NVIDIA's ability to serve Saudi customers with these advanced AI chips, potentially reducing its market access and revenue opportunities in the region.",
      "llm_answer": "Adobe notes that Saudi Arabia is among the countries that are considering data‑localisation rules, which could force customers to store and process data inside the kingdom and therefore create a compliance risk for its international business【page_23】. At the same time, NVIDIA’s 2023‑24 export‑control filings state that U.S. licensing requirements now apply to any H100 or L40S chips shipped to “Country Group D5” – a group that explicitly includes Saudi Arabia – meaning the chips cannot be exported there without a U.S. export licence【page_27】. Consequently, the Saudi data‑localisation mandate could compound NVIDIA’s export‑control hurdle, potentially delaying or preventing the deployment of H100 and L40S accelerators in the country unless the required licences are obtained and the localisation obligations can be satisfied.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: Saudi Arabia's data localization requirements are correctly attributed to Adobe's risk disclosures, and U.S. export controls on NVIDIA's H100 and L40S chips are accurately tied to Country Group D5 (which includes Saudi Arabia). The LLM correctly notes that export licenses are required and that without them, deployment is restricted. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no errors in dates, figures, or calculations. (3) The multi-hop reasoning is sound: the model synthesizes Adobe’s disclosure on data localization with NVIDIA’s export control constraints, correctly identifying how the two regulatory regimes interact to create a compounded barrier. The only minor inaccuracy is the reference to 'Country Group D5'—the ground truth specifies 'D4', not 'D5'. This is a factual error in entity labeling, though the broader logic remains intact since both D4 and D5 relate to U.S. export control regimes. (4) Despite this small error, the answer is contextually relevant, comprehensive, and conveys the same core conclusion as the original: that the combination of localization rules and export controls limits NVIDIA’s market access. The answer is phrased clearly and appropriately, with correct use of citations (page references). The error in Country Group designation prevents a perfect score, but the overall correctness is high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 421,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How do FedEx's and GE's disclosures regarding the discontinuation of LIBOR reflect differing applications of the accounting relief provided by ASU 2020-04, as extended by ASU 2022-06?",
      "original_answer": "FedEx notes that there has been 'no material effect' from reference rate reform on its financial condition as of May 31, 2024, but continues to monitor contracts for potential application of ASU 2022-06, which extended the optional expedients in ASU 2020-04 through December 31, 2024. In contrast, GE explicitly states that the overall impact of LIBOR reform under ASU 2020-04 on its financial statements is 'immaterial.' This suggests that while both companies applied the same accounting framework (ASU 2020-04, extended by ASU 2022-06), FedEx maintained a more cautious stance with ongoing monitoring, whereas GE concluded the transition had no significant financial impact.",
      "llm_answer": "FedEx’s filing notes that, under the optional expedients of ASU 2020‑04 (as extended by ASU 2022‑06), it has been monitoring all LIBOR‑linked contracts but “there has been no material effect to our financial condition, results of operations, or cash flows” and it has not needed to record any adjustments. GE, by contrast, states that it evaluated the LIBOR‑discontinuation “in accordance with ASU 2020‑04” (implicitly using the extension) and concluded that the overall impact on its financial statements is immaterial, indicating that it has already applied the relief to its contracts and determined no material accounting impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: FedEx notes no material effect on financial condition, results of operations, or cash flows as of May 31, 2024, and continues monitoring under ASU 2020-04 as extended by ASU 2022-06. GE states the impact under ASU 2020-04 is immaterial. These points match the original answer. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct referencing of qualitative assessments like 'no material effect' and 'immaterial'—both used appropriately and consistently with source. (3) Multi-hop reasoning is sound: the model correctly synthesizes disclosures from two companies (FedEx and GE), identifies their differing applications of the same accounting framework (ASU 2020-04 extended by ASU 2022-06), and draws a valid contrast—FedEx maintains ongoing monitoring despite no current impact, while GE has concluded the impact is immaterial, suggesting a more final assessment. (4) Semantic equivalence is strong; the LLM captures the nuance that both companies used the same optional expedients but with differing levels of caution. The only minor shortcoming is that the LLM does not explicitly mention the December 31, 2024, extension date noted in the original answer, though it references the extension implicitly. This small omission prevents a perfect 10 but does not undermine the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 413,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How might geopolitical tensions involving Taiwan impact both Apple's and NVIDIA's supply chain operations, considering their reliance on manufacturing locations and foundry partners in the region?",
      "original_answer": "Apple's business is significantly impacted by geopolitical tensions involving Taiwan, as it relies heavily on outsourcing partners located in Taiwan for manufacturing critical components. A significant or prolonged conflict involving Taiwan could severely limit Apple's ability to manufacture and deliver products, creating delays and inefficiencies in its supply chain. Similarly, NVIDIA depends on foundry partners in Taiwan for chipset supply, and any disruption due to geopolitical tensions could severely limit or prevent NVIDIA from receiving this supply, which would have a material adverse impact on its business. Both companies face heightened risks due to their reliance on operations in a region with ongoing geopolitical instability.",
      "llm_answer": "Both Apple and NVIDIA depend heavily on Taiwan‑based partners – Apple’s contract manufacturers and component suppliers are located in Taiwan (and other East‑Asian hubs), while NVIDIA’s semiconductor wafers are fabricated by Taiwanese foundries.  A flare‑up in Taiwan‑China tensions could shut or restrict those facilities, forcing each company to confront delayed shipments, higher component prices and the need to re‑source or redesign products, which would pressure margins and product‑launch schedules.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth, with only minor differences in emphasis. (1) All key facts are correct: both Apple and NVIDIA rely on Taiwan-based manufacturing partners—Apple for contract manufacturing and components, NVIDIA for semiconductor fabrication via Taiwanese foundries. The answer correctly identifies that geopolitical tensions could disrupt operations, leading to delays, cost increases, and potential redesigns. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable; however, the absence of any incorrect figures supports a perfect score. (3) The multi-hop reasoning is sound: the model correctly synthesizes the shared supply chain risk between two different companies based on their reliance on Taiwanese operations, linking geopolitical instability to business impact. (4) The LLM slightly omits the phrase 'material adverse impact' used in the original and does not explicitly state that both face 'heightened risks due to ongoing instability,' but the meaning is preserved through descriptions of delays, margin pressure, and sourcing challenges. Wording differences do not affect factual correctness. Contextual relevance is perfect—the response directly addresses the question with precise, relevant information.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 370,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "What percentage of Broadcom's $24,156 million developed technology intangible asset from the VMware acquisition is specifically tied to VMware Cloud Foundation, and how does this compare to Oracle's net value of developed technology as a percentage of its total intangible assets?",
      "original_answer": "Of Broadcom's $24,156 million developed technology intangible asset from the VMware acquisition, a 'significant portion' is tied to VMware Cloud Foundation (VCF), though the exact percentage is not disclosed. Oracle's net value of developed technology was $1,276 million as of May 31, 2024, which represents approximately 18.4% of Oracle's total intangible assets of $6,890 million. While Broadcom emphasizes that a significant portion of its developed technology relates to VCF, Oracle's developed technology is a much smaller share of its overall intangible asset base, indicating differing strategic valuations of technology assets post-acquisition.",
      "llm_answer": "Broadcom’s filing states that a “significant portion” of the $24,156 million developed‑technology intangible asset acquired in the VMware merger relates to VMware Cloud Foundation, but it does **not disclose a specific dollar amount or percentage**, so the exact share cannot be calculated from the information provided.  \n\nOracle’s 2023 filing shows a net developed‑technology balance of $1,276 million against total net intangible assets of $6,890 million, meaning developed technology accounts for roughly **18 % (about 18.5 %)** of Oracle’s intangible‑asset base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that Broadcom does not disclose the exact percentage or dollar amount of the $24,156 million developed technology intangible asset tied to VMware Cloud Foundation, only that a 'significant portion' relates to it—this matches the ground truth. For Oracle, the LLM accurately reports the $1,276 million net value of developed technology and total intangible assets of $6,890 million, and calculates approximately 18.5%, which rounds to the ground truth's 18.4% (minor difference due to rounding is acceptable). (2) All numeric values are correct: $24,156 million (Broadcom), $1,276 million (Oracle), $6,890 million (Oracle total intangibles), and the derived percentage (~18.5% vs. 18.4%) are factually accurate with acceptable rounding. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from two different companies (Broadcom's VMware acquisition and Oracle's intangible asset breakdown) and compares the relative importance of developed technology within each firm’s intangible portfolio. It correctly infers that while Broadcom highlights VCF as significant, no exact percentage is available, whereas Oracle’s figure is quantifiable and smaller in relative terms. (4) The answer is contextually complete and relevant, addressing both sub-questions. The only minor shortcoming is that the LLM does not explicitly state the comparative strategic implication (differing valuations post-acquisition) as in the original answer, but the data is presented such that the comparison is clear. Hence, correctness is high but not perfect due to slightly less synthesized conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 450,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA compare to the relative stockholder ownership structure at GOOGL, particularly in terms of non-affiliate market value and class-based control mechanisms?",
      "original_answer": "At CMCSA, holders of Class B common stock, of which there are only 3 record holders, maintain 33⅓% of the combined voting power of the company’s common stock, with each share carrying 15 votes. This concentrated voting power is designed to preserve control, as the Class B shares are non-dilutable under the company's articles of incorporation. In contrast, GOOGL disclosed that as of June 30, 2021, the aggregate market value of shares held by non-affiliates was approximately $1,451.1 billion, with 300,754,904 shares of Class A common stock outstanding. While GOOGL’s structure also includes differentiated voting rights, the non-affiliate ownership suggests a more dispersed market-based control mechanism compared to CMCSA’s concentrated Class B structure.",
      "llm_answer": "Comcast’s Class B stock concentrates voting power – it carries 15 votes per share and, by charter, a **non‑dilutable 33 % of the combined voting power** of all Comcast common shares, with all of those shares beneficially owned by Chairman Brian L. Roberts (see CMCSA pages 35 & 38).  \n\nAlphabet’s ownership is split among three classes; the **44.6 million Class B shares (10 votes each) represent a small slice of total equity** but give insiders disproportionate control, while **non‑affiliates hold roughly $1.45 trillion of market value** in the company (see GOOGL page 2).  \n\nThus, Comcast’s Class B gives a fixed one‑third voting bloc to a single insider, whereas Alphabet’s Class B provides voting leverage to insiders despite the vast non‑affiliate market value held by public shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor discrepancies. (1) Quantitatively: The 33⅓% voting power at CMCSA is correctly stated as '33%' (acceptable rounding). The $1.45 trillion non-affiliate market value at GOOGL matches the ground truth $1,451.1 billion when rounded. However, the LLM incorrectly states '44.6 million Class B shares' — the original answer does not specify the number of Class B shares, only that 300,754,904 Class A shares were outstanding; thus, this figure is unsupported and likely incorrect. (2) Completeness: The LLM addresses both companies, their class-based control mechanisms, voting power concentration, and contrasts CMCSA’s fixed insider control with GOOGL’s broader non-affiliate ownership — satisfying the multi-part, multi-hop nature of the question. (3) Entity accuracy: CMCSA and GOOGL are correctly identified; references to Class B stock and voting rights are accurate. The date (June 30, 2021) from the ground truth is omitted in the LLM answer but not critical to the core comparison. (4) Reasoning: The synthesis between concentrated voting control (CMCSA) vs. insider leverage amid large public float (GOOGL) is logically sound and well-articulated. The unsupported '44.6 million' figure prevents a perfect score, but overall factual and semantic equivalence is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 380,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How does the difference in issued Class A and Class B common stock shares between CMCSA and META reflect on their respective equity structure concentration as disclosed in their 2024 filings?",
      "original_answer": "CMCSA disclosed that it issued 4,651,093,045 Class A common shares and 9,444,375 Class B common shares as of December 31, 2024, indicating a significantly higher proportion of Class A shares in its equity structure. META, on the other hand, reported 2,189,898,148 Class A common shares and 343,761,117 Class B common shares outstanding as of January 24, 2025, showing a much higher relative weighting of Class B shares. The evidence from Alphabet's filing clarifies that Class B shares carry 10 votes per share versus 1 vote for Class A, and that Class B shares automatically convert to Class A upon sale or transfer. This suggests META's equity structure maintains stronger voting rights concentration among fewer shareholders compared to CMCSA, where ownership appears more diffused due to the dominance of standard voting Class A shares.",
      "llm_answer": "Comcast’s 2024 balance‑sheet shows it has issued 4.65 billion Class A shares and only 9.44 million Class B shares (≈0.2 % of total)【page_67】, so virtually all of its equity and voting power resides in the one‑vote Class A stock. Meta’s filing reports 2.19 billion Class A shares and 343.8 million Class B shares (about 13‑14 % of the total)【page_1】, giving a sizable block of ten‑vote stock that concentrates voting power among a smaller group of shareholders. Thus, Meta’s dual‑class structure is far more concentrated in the high‑voting Class B shares than Comcast’s, where the high‑voting class is negligible.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct in all key aspects: it accurately reports the number of Class A and Class B shares for both CMCSA and META, with appropriate rounding (e.g., 4.65 billion ≈ 4,651,093,045; 343.8 million ≈ 343,761,117). The percentage estimate of Class B shares at ~13-14% of total shares for META is accurate (343.76M / (2,189.898M + 343.761M) ≈ 13.6%), and CMCSA's Class B shares are correctly characterized as negligible (~0.2%).\n\n2) Quantitative accuracy is excellent: all numbers align with the ground truth when accounting for rounding. The LLM uses 'billion' and 'million' consistently and correctly. No calculation errors are present.\n\n3) The reasoning correctly synthesizes multi-hop information: it contrasts the two companies' equity structures, infers concentration of voting power based on share class distribution, and correctly identifies that Class B shares carry superior voting rights (referencing 10 votes vs 1 vote, though this detail is attributed to 'Alphabet' in the original answer—here the LLM omits the source clarification but still applies the correct logic). The conclusion that META has a more concentrated voting structure due to a significant block of high-vote shares is sound and matches the ground truth.\n\n4) Minor qualitative shortcoming: the LLM does not explicitly cite that Class B shares automatically convert upon sale or transfer—a detail included in the original answer that reinforces the mechanism preserving control concentration. While not critical to the main conclusion, it is a small omission in completeness. Also, the LLM refers to 'Meta’s filing' without specifying the date (Jan 24, 2025), though the data is correct.\n\n5) Contextual relevance is perfect: the answer directly addresses the question about equity structure concentration and clearly explains how the distribution of share classes reflects differing levels of voting power concentration.\n\nOverall, the answer is highly accurate, well-reasoned, and conveys the same core insight as the ground truth, warranting a 9/10 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 556,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How does the exposure of CVS's Oak Street Health business to Medicare reimbursement risks compare to AbbVie's exposure under the IRA's price-setting provisions, given the IRA's impact on the Medicare program?",
      "original_answer": "CVS's Oak Street Health business derives a significant portion of its revenue from Medicare or Medicare Advantage plans and is exposed to risks such as reductions in reimbursement rates and changes in Medicare program rules. The IRA introduces new financial pressures on Medicare-participating drug manufacturers like AbbVie by enabling government price-setting for certain Part B and Part D drugs starting in 2026 and 2028, respectively. AbbVie specifically faces exposure as Imbruvica has already been selected for price-setting under the IRA, with government-dictated prices set to take effect in 2026. This regulatory shift under the IRA compounds the existing Medicare-related risks faced by CVS's Oak Street Health, as both are tied to the same evolving Medicare framework, albeit through different mechanisms—direct reimbursement risk for CVS and mandated pricing for AbbVie.",
      "llm_answer": "CVS’s Oak Street Health business is highly vulnerable to Medicare‑reimbursement risk because a large share of its revenue comes from Medicare and Medicare‑Advantage plans, so any cut in reimbursement rates or rule change to the Medicare program would directly reduce its earnings【page_47】. By contrast, AbbVie’s exposure to the IRA is limited to the drugs that the Department of Health and Human Services selects for government‑set pricing; the law caps prices for those single‑source products (e.g., Imbruvica) and could erode revenue on a product‑by‑product basis, but it does not affect the company’s entire revenue stream【page_19】【page_37】. Thus, Oak Street Health faces a broader, service‑level Medicare‑reimbursement risk, whereas AbbVie faces a narrower, product‑specific price‑setting risk under the IRA.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All key facts are correct: CVS's Oak Street Health relies heavily on Medicare/Medicare Advantage revenue, making it vulnerable to reimbursement changes; AbbVie faces IRA-related risks through government price-setting for specific drugs, notably Imbruvica, selected under the IRA with prices effective in 2026. While the LLM does not explicitly mention the 2026 and 2028 timelines for Part B and Part D drugs, it correctly identifies that the IRA’s impact is product-specific and cites Imbruvica as an affected drug, which matches the ground truth. (2) There are no numerical inaccuracies—no specific numbers (e.g., dollar amounts, percentages) are provided in either answer, so no calculation errors exist. The LLM correctly characterizes the nature of the risks without introducing false quantitative claims. (3) The multi-hop reasoning is sound: the model synthesizes information across two companies (CVS and AbbVie), two types of Medicare-related risks (reimbursement for providers vs. price-setting for drug manufacturers), and the role of the IRA in shaping those risks. It correctly distinguishes between systemic service-level exposure (CVS) and targeted product-level exposure (AbbVie). (4) The answer is semantically equivalent to the original, though slightly less detailed on the IRA’s phased implementation (2026/2028). However, this omission does not undermine the core accuracy. The use of citations (e.g., page_19, page_47) suggests grounding in source material. Overall, the response is concise, correct, and contextually appropriate, warranting a high score with only minor room for added detail on timing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 462,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How does Microsoft's inclusion of operating systems in its product revenue influence AMD's dependency on Microsoft's operating system support for its x86-based microprocessor and graphics products?",
      "original_answer": "Microsoft's product revenue includes operating systems, which are critical components for PC functionality. AMD relies on Microsoft to design and develop its operating systems to support AMD's x86-based microprocessors and graphics products. If Microsoft does not continue to support AMD's innovations through its operating systems, independent software vendors may avoid optimizing applications for AMD products, and customers may be less inclined to purchase PCs with AMD components, materially affecting AMD's business.",
      "llm_answer": "Microsoft’s product‑revenue definition explicitly lists operating systems as a component of its product sales 【page_62】. AMD’s filing notes that its x86‑based microprocessors and graphics products “depend partially on Microsoft designing and developing its operating systems to run on or support” those chips 【page_28】. Thus, because operating systems are a core revenue‑generating product for Microsoft, AMD’s ability to sell and market its processors and GPUs is materially tied to Microsoft’s continued support of those OSes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the core relationship described in the ground truth. It correctly identifies that Microsoft includes operating systems in its product revenue (citing page 62) and that AMD depends on Microsoft designing and developing its operating systems to support AMD's x86-based microprocessors and graphics products (citing page 28). The reasoning correctly links Microsoft's financial incentive (OS as a revenue-generating product) to its role in enabling AMD’s market success. There are no numeric values to verify, so quantitative accuracy is scored as 10. The qualitative accuracy is slightly reduced (9 instead of 10) because the LLM omits the downstream effects mentioned in the original answer—specifically, that lack of Microsoft support could lead independent software vendors to avoid optimizing for AMD and reduce customer demand. While the materiality of the dependency is implied, it is not explicitly stated. However, the core multi-hop logic (Microsoft’s OS revenue → incentive to support hardware → AMD’s dependency) is sound and well-synthesized. Contextual relevance is perfect, as the response directly addresses the influence of Microsoft’s product revenue structure on AMD’s business dependency.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 350,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How does Cisco's network infrastructure for AI training and inference workloads compare to Broadcom's support for enterprise-scale AI and machine learning workloads through VMware Cloud Foundation, particularly in terms of enabling multicloud architectures and Kubernetes integration?",
      "original_answer": "Cisco provides high-density routers, switches, and high-performance optics to scale network infrastructure for AI training and inference workloads, aiming to simplify data center operations across multicloud environments. VMware Cloud Foundation (VCF), produced by Broadcom, enables enterprise-scale AI and machine learning workloads by offering native Kubernetes support, allowing both virtual machines and containerized workloads to run on a single platform. VCF also provides license portability, enabling customers to move environments between on-premises and cloud endpoints, aligning with Cisco's vision of policy and operational consistency across multicloud architectures. Broadcom values VCF through developed technology using the multi-period excess earnings method, reflecting its strategic role in supporting AI workloads.",
      "llm_answer": "Cisco’s AI offering is centered on high‑density routers, switches and high‑performance optics that deliver the massive bandwidth and low‑latency connectivity needed to train and run inference models, and it is packaged within a multicloud data‑center strategy that adds policy‑ and operations‑consistency across on‑prem and cloud locations. Broadcom, by contrast, delivers AI/ML capability through VMware Cloud Foundation—a software‑defined private‑cloud stack that bundles compute, networking, storage and native Kubernetes on a single platform, with license‑portability that lets customers move workloads between on‑premises data centers and public‑cloud endpoints, thereby enabling enterprise‑scale AI in a true multicloud architecture.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Cisco's role in providing high-density networking hardware (routers, switches, optics) for AI workloads and its multicloud data center strategy are accurately described. Broadcom's delivery of AI/ML capabilities via VMware Cloud Foundation (VCF), including native Kubernetes support, license portability, and workload mobility across on-prem and cloud, is correctly represented. (2) There are no numeric values, dates, or financial figures in either answer that require verification—thus, quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the model correctly synthesizes Cisco’s infrastructure role with Broadcom’s software-defined approach through VCF and aligns both around multicloud and Kubernetes integration. The only minor omission is that the LLM answer does not explicitly mention Broadcom’s valuation of VCF using the multi-period excess earnings method, which appears in the original answer and reflects strategic importance. However, this detail is more financial than functional and does not undermine the technical comparison central to the question. (4) Semantic equivalence is strong—wording differs but meaning matches closely. Contextual relevance is excellent, directly addressing the comparison in terms of multicloud architectures and Kubernetes integration as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 396,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How does PayPal's use of pricing models for derivatives compare to Morgan Stanley's Level 3 valuation techniques, particularly in terms of reliance on unobservable inputs for fair value measurement?",
      "original_answer": "PayPal primarily uses Level 2 inputs for its derivatives, incorporating observable data such as currency rates, interest rate yield curves, option volatility, and equity prices in its pricing models, and did not have any Level 3 assets or liabilities as of December 31, 2024. In contrast, Morgan Stanley utilizes Level 3 classifications when unobservable inputs are significant, particularly for non-exchange-traded investments and certain secured financings where market liquidity is limited or unavailable. This indicates that Morgan Stanley has a greater reliance on internally derived assumptions for fair value measurement compared to PayPal, which avoids Level 3 classifications entirely.",
      "llm_answer": "PayPal measures its derivative positions with pricing models that are fed mainly by observable market data — currency rates, yield curves, option volatilities and equity prices – and therefore classifies the bulk of its derivatives at Level 2.  It reports that it had no recurring‑measurement assets or liabilities that required Level 3 (significant unobservable) inputs.  \n\nMorgan Stanley, by contrast, relies on Level 3 fair‑value techniques for certain instruments, using valuation models that incorporate material assumptions that are not observable in the market (e.g., proprietary DCF or option‑pricing inputs), which means its fair‑value measurements depend heavily on unobservable inputs and greater management judgment.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that PayPal uses Level 2 inputs based on observable market data (currency rates, yield curves, option volatilities, equity prices) and explicitly confirms no Level 3 assets or liabilities, aligning with the original answer's claim that PayPal had no Level 3 classifications as of December 31, 2024. (2) No specific numerical values (e.g., dollar amounts, percentages) are present in either answer, so quantitative accuracy is not compromised; the absence of Level 3 assets is correctly reported. (3) The multi-hop reasoning is sound: the model correctly contrasts PayPal’s reliance on observable inputs (Level 2) with Morgan Stanley’s use of Level 3 techniques involving unobservable inputs like proprietary DCF or option-pricing assumptions, demonstrating proper synthesis across the two companies’ valuation approaches. (4) The LLM captures all key qualitative distinctions: PayPal avoids Level 3 entirely, while Morgan Stanley employs Level 3 for less liquid instruments, requiring more management judgment. Wording differs slightly but meaning is preserved. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 341,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "Given that META's Class B common stockholders have limited voting rights on specific corporate actions, and CMCSA's Class A common stock is the primary voting share class, how might the ownership structure of 343,761,117 outstanding Class B shares at META affect the potential for shareholder-driven governance changes compared to CMCSA's 3,778,302,017 outstanding Class A shares?",
      "original_answer": "META's Class B common stockholders, of which there are 343,761,117 outstanding shares, possess limited voting rights, only applicable in specific corporate actions such as exiting the core payments business or certain mergers. This restricts their ability to influence broader governance decisions, which are largely controlled by Class A shareholders. In contrast, CMCSA's 3,778,302,017 outstanding Class A shares carry full voting rights, enabling more direct shareholder influence over corporate governance. As a result, shareholder activism or governance overhauls would face a higher threshold for success at META due to the constrained voting power of its Class B holders, compared to the more broadly distributed and influential Class A shareholder base at CMCSA.",
      "llm_answer": "Meta’s 343.8 million Class B shares (as of the filing) carry voting rights only on a narrow set of actions – such as a core‑payments exit, certain mergers or charter amendments – so even a large holder of Class B stock cannot influence most ordinary governance matters. By contrast, Comcast’s 3.78 billion Class A shares are the primary voting class and confer full voting power on all shareholder proposals, giving its Class A holders far greater ability to drive shareholder‑initiated governance changes. Consequently, Meta’s Class B ownership structure markedly limits the potential for broad shareholder‑driven reforms relative to Comcast’s fully voting Class A base.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor formatting differences in number presentation. (1) Quantitatively, the LLM correctly reports 343.8 million Class B shares for Meta (rounded from 343,761,117) and 3.78 billion Class A shares for CMCSA (rounded from 3,778,302,017), which are acceptable format variations and do not affect factual accuracy. (2) The answer addresses all parts of the question: it explains the limited voting rights of Meta's Class B shares (specific corporate actions like core payments exit, certain mergers), contrasts them with CMCSA's Class A shares having full voting rights, and draws the correct conclusion about reduced potential for shareholder-driven governance changes at Meta. (3) Entity accuracy is strong: Meta and CMCSA (Comcast) are correctly identified, share classes (Class B vs Class A) and their voting characteristics are accurately described. (4) The reasoning is sound and reflects proper multi-hop synthesis: it connects ownership structure to voting power, and then to implications for shareholder activism and governance reforms, correctly concluding that Meta’s structure creates a higher barrier for such changes compared to CMCSA. The only minor shortcoming is a slight omission of 'charter amendments' as one of the specific actions where Class B votes matter, which is mentioned in the original but only partially reflected in the LLM’s 'narrow set of actions'. This does not undermine the overall correctness but prevents a perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 425,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "What percentage of KO's non-U.S. unit case volume is attributable to sparkling soft drinks in territories where CCEP operates, and how does this compare to PM's operational presence in Portugal, one of CCEP's key markets?",
      "original_answer": "KO's non-U.S. unit case volume is 71% attributable to sparkling soft drinks in territories where CCEP operates, including Portugal. Meanwhile, PM has a manufacturing facility in Portugal, which is among its largest facilities producing over 30 billion units (cigarettes and heated tobacco units combined). This highlights KO's significant reliance on CCEP for sparkling beverage distribution in key international markets, while PM maintains a direct production footprint in one of those same strategic locations.",
      "llm_answer": "Coca‑Cola reports that **71 % of its non‑U.S. unit‑case volume is from sparkling soft‑drink categories** – the same mix that applies to the territories served by its CCEP bottler.  By contrast, Philip Morris International’s 2022 filing notes that it **operates a major manufacturing plant in Portugal**, one of the key markets where CCEP bottles Coca‑Cola products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth. (1) Quantitatively, the 71% figure for KO's non-U.S. unit case volume attributable to sparkling soft drinks in CCEP territories is correct. The mention of PM's major manufacturing plant in Portugal aligns with the ground truth, though the exact output of 'over 30 billion units' is omitted. (2) All numeric values presented are correct; no calculations were required beyond reporting the percentage, which is accurate. Format variations are acceptable and not an issue here. (3) The multi-hop reasoning is sound: the model correctly links KO’s volume data to CCEP-operated territories (including Portugal) and contrasts it with PM’s operational footprint in the same country. The entity names (KO, CCEP, PM), metrics (unit-case volume, manufacturing presence), and geographic focus (Portugal) are all correctly identified. (4) The answer is contextually relevant and directly addresses both parts of the question. The only minor omission is the lack of detail on PM’s production volume (over 30 billion units), which slightly reduces completeness but does not impair the overall correctness. Hence, a score of 9 is justified—excellent accuracy with a small gap in full detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 353,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "Given Cisco's reduced credit loss allowance for loan receivables from $103 million in 2022 to $53 million in 2023, how might this change impact their ability to finance technical support services, which are explicitly included in their loan receivables portfolio?",
      "original_answer": "Cisco's credit loss allowance for loan receivables decreased by 48.5% from $103 million in 2022 to $53 million in 2023. Since Cisco explicitly states that loan receivables include financing arrangements for technical support services, this reduction in credit loss allowance suggests improved credit quality or lower risk in these financing arrangements. A smaller allowance could indicate Cisco is more confident in the creditworthiness of customers receiving technical support financing, potentially enabling Cisco to expand financing options for technical support services with reduced financial risk. This could lead to more competitive financing terms for customers seeking technical support services.",
      "llm_answer": "Cisco’s loan‑receivable portfolio – which explicitly covers financing for the sale of hardware, software **and technical‑support services** – showed a credit‑loss allowance of $103 million for the 2022 year but was cut to $53 million for 2023 (see the “Allowance for credit loss” tables on page 84).  The roughly 50 percent reduction signals that Cisco now expects fewer defaults on these loans, freeing up capital and improving its credit quality, which should enhance its capacity and willingness to continue or expand financing of technical‑support services.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the reduction in Cisco's credit loss allowance from $103 million in 2022 to $53 million in 2023, matching the ground truth. The approximate 50% reduction is a valid rounding of the exact 48.5% decrease (calculated as (103-53)/103 ≈ 48.5%), so the percentage is reasonably stated as 'roughly 50 percent.' All entities (Cisco, loan receivables, technical support services, years 2022 and 2023) are accurate. 2) Quantitatively, the dollar amounts and implied percentage change are correct within acceptable rounding. No calculation errors. 3) The reasoning correctly links the reduced allowance to improved expected credit performance and connects this to increased capacity or willingness to finance technical support services, which aligns with the ground truth's logic about reduced risk and potential for expanded financing. The LLM omits the explicit mention of 'increased confidence in customer creditworthiness' and slightly less detail on 'competitive financing terms,' but the core inference about enhanced financing capacity is preserved. 4) The answer is highly relevant, directly addressing the impact of the allowance change on financing technical support services, with accurate multi-hop reasoning connecting financial metrics to business implications. The minor omission of nuanced forward-looking implications prevents a perfect 10, but overall accuracy and synthesis are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 394,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How does AT&T's Series B Preferred Stock structure, which grants limited voting rights only on specific merger-related matters, compare to Netflix's universal voting rights for common stockholders in terms of corporate governance influence?",
      "original_answer": "AT&T's Series B Preferred Stockholders have no voting rights except on specific merger-related matters where they can vote as a single class with each holder casting votes equal to the number of shares held. This contrasts with Netflix, where each share of common stock provides one vote on all matters to be voted upon by stockholders, giving common stockholders broader governance influence. AT&T's structure limits Series B Preferred Stockholders' influence to defined corporate actions, whereas Netflix's model ensures universal voting participation for common stockholders.",
      "llm_answer": "AT&T’s Series B preferred shares can vote only on a narrow set of actions – essentially any merger, consolidation or similar transaction in which the preferred holders would receive a different form of consideration than the common shareholders – and have no vote on any other corporate matters【page_90】. In contrast, every share of Netflix common stock carries one vote on **all** matters submitted to stockholders, giving common shareholders universal voting power over the company’s governance【page_61】. Consequently, AT&T’s preferred investors have a much more limited ability to influence corporate decisions than Netflix’s common shareholders, whose votes affect every governance issue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that AT&T’s Series B Preferred Stockholders have voting rights only on specific merger-related matters—specifically when they would receive different consideration than common shareholders—and no voting rights on other corporate matters. This aligns with the original answer’s description of limited, merger-specific voting rights. (2) The comparison to Netflix is accurate: each share of Netflix common stock carries one vote on all matters, providing universal voting rights. The LLM correctly emphasizes that this grants broader governance influence compared to AT&T’s restricted structure. (3) Multi-hop reasoning is sound—information from two different companies (AT&T and Netflix) and their respective stock structures is synthesized correctly to answer the comparative corporate governance question. (4) Minor difference in phrasing: the LLM specifies the condition for voting (different consideration in mergers), which adds precision not in the original but is consistent with it. No numeric values are present, so quantitative accuracy is 10 by default. Qualitative accuracy is 9 because while all facts are correct, the LLM slightly narrows the scope by focusing on 'different consideration' without explicitly stating that voting occurs as a single class with votes proportional to shares held (a detail in the original). However, this does not impair the overall correctness. Contextual relevance is perfect—the response directly addresses the governance influence comparison as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 438,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How does PayPal's risk of technological disruption from emerging payment methods like BNPL and cryptocurrency compare with Visa's strategic positioning as both partner and competitor to these alternative payment providers?",
      "original_answer": "PayPal faces significant risk from rapid technological changes, particularly in payment methods like BNPL and cryptocurrency, which could render its current offerings obsolete if not adopted timely. Visa, on the other hand, strategically partners with these alternative payment providers while also competing with them, leveraging its global network and security advantages to maintain relevance. This dual role allows Visa to adapt to the evolving payments landscape, whereas PayPal must invest heavily to keep pace or risk losing market share to these emerging platforms.",
      "llm_answer": "PayPal flags emerging payment‑method innovations—such as BNPL platforms and cryptocurrency‑based services—as a source of technological disruption that could erode the use of its own digital‑wallet and checkout products if it cannot quickly integrate or compete with those solutions (see its risk‑and‑compliance discussion of “tokenization” and the need to stay ahead of new payment technologies 【page_7】).  \n\nVisa, by contrast, treats the same alternative‑payment players as both collaborators and rivals: its filing notes that “alternative payments providers… may be both a partner and a competitor to Visa” and that Visa’s broad brand, network‑of‑networks strategy and new‑flow offerings are intended to capture volume from these providers while defending its core card business 【page_16】.  \n\nThus, PayPal’s exposure is framed primarily as a disruption risk, whereas Visa’s exposure is framed as an opportunity to partner with and compete against those same innovators.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. It correctly identifies PayPal's exposure to technological disruption from BNPL and cryptocurrency as a risk that could erode its core products if not addressed promptly, citing its need to stay ahead of innovations like tokenization (【page_7】). It accurately contrasts this with Visa’s dual role as both partner and competitor to alternative payment providers, referencing Visa’s strategic framing of these players as collaborators and rivals (【page_16】), and highlights Visa’s network advantages and adaptive strategy. There are no numeric values in the question or answers, so quantitative accuracy is scored as 10 by default. The qualitative reasoning is strong, demonstrating correct multi-hop synthesis between PayPal’s vulnerability and Visa’s strategic positioning using information from both companies’ filings. The only minor shortcoming is a slight lack of emphasis on Visa’s security advantages mentioned in the original answer, but the core strategic contrast is well captured. Contextual relevance is perfect—the response directly addresses the comparative strategic positioning asked in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 336,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How does the voting power per share of Netflix's common stock compare to the voting rights associated with Alphabet's Class A Common Stock, given both companies' disclosed equity structures?",
      "original_answer": "Netflix's common stock grants one vote per share, as stated in its 2023 10-K filing. Similarly, Alphabet's Class A Common Stock also provides one vote per share, as outlined in its 2023 10-K filing. This indicates that both companies offer equivalent voting power per share for their respective common stockholders, despite Alphabet having multiple stock classes with differing voting rights, such as Class B shares with 10 votes per share.",
      "llm_answer": "Netflix’s 2023 proxy statement states that each share of its common stock carries **one vote per share**【page_61】. Alphabet’s 2023 filing likewise notes that each share of **Class A common stock is entitled to one vote per share** (while Class B carries ten votes)【page_81】. Therefore, the voting power per share of Netflix’s common stock is identical to the voting rights of Alphabet’s Class A shares—both provide one vote for each share owned.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the voting rights per share—'one vote per share' for Netflix's common stock and Alphabet's Class A Common Stock—are accurately reported, with no numerical or factual discrepancies. The mention of Alphabet's Class B shares having ten votes per share is also factually correct and consistent with the 2023 10-K. (2) The answer is complete, addressing both companies' voting structures and directly comparing them as required by the question. (3) Entity accuracy is perfect: both Netflix and Alphabet are correctly identified, with proper reference to their respective stock classes and filings (2023 proxy statement and 10-K). (4) The reasoning is sound and demonstrates correct multi-hop synthesis—pulling data from two different companies' filings and concluding that their voting rights are equivalent for the specified share classes. (5) The semantic meaning is equivalent to the original answer, with slightly different phrasing but identical factual content. Minor formatting differences (e.g., use of em dash, bolding, page references) do not affect accuracy. All scores are maximized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 333,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How does the use of the parametric delta-gamma approximation technique by PM under normal market conditions compare with MDLZ's application of the same method, particularly in terms of their respective VAR estimates and risk exposure assumptions?",
      "original_answer": "Both PM and MDLZ utilize the parametric delta-gamma approximation technique in their VAR models under normal market conditions, with a 95% confidence interval and a one-day holding period. PM observed interest rate and forward currency rate movements primarily over the preceding quarter to determine interrelationships and calculate risk for their portfolio. MDLZ similarly observed interest rate, currency exchange, and commodity price movements over the prior quarter for VAR calculations at year-end. However, MDLZ specifically notes that the values of currency and commodity options do not change on a one-to-one basis with the underlying assets and were valued accordingly, while PM focuses on interrelationships between movements in interest rates and currencies. Both companies use VAR to estimate maximum potential one-day losses, but MDLZ provides specific disclosure of their VAR amounts at year-end, while PM focuses on the methodology and assumptions without disclosing a specific VAR figure.",
      "llm_answer": "PM I’s 2023 filing says it computes its one‑day, 95 %‑confidence VaR under normal market conditions with a “parametric delta‑gamma” approach that captures the non‑linear relationship between interest‑rate and foreign‑currency movements; the resulting fair‑value impacts are $297 million for interest‑rate instruments and $77 million for currency instruments (about $374 million total). By contrast, Mondelēz also uses a parametric delta‑gamma technique (applied to interest‑rate, currency and commodity exposures) and reports a combined VaR of $284 million at year‑end 2023 (average $315 million, high $444 million, low $255 million), assuming normal markets, a one‑day holding period and a 95 % confidence level. Thus, while both firms rely on the same approximation under identical market‑assumption parameters, PM I’s component‑level VaR figures are larger for its interest‑rate and currency exposures, whereas Mondelēz presents a lower aggregate VaR that reflects a broader but less volatile risk profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces data not present in the original ground truth. (1) Quantitative Accuracy: The LLM claims PM has VaR figures of $297M (interest rate), $77M (currency), and $374M total, and that Mondelēz (MDLZ) reported a combined VaR of $284M at year-end 2023 with average, high, and low values. These numbers are entirely fabricated and do not appear in the original answer. The ground truth explicitly states that PM does *not* disclose a specific VaR figure, while MDLZ does disclose year-end VaR—but no specific number is given in the provided truth. Thus, all numerical values in the LLM response are incorrect. (2) Completeness: While the LLM attempts to compare both companies' use of the delta-gamma method, confidence level, and holding period, it fails to accurately represent the nature of their disclosures—especially PM’s lack of a disclosed VaR amount. It also omits key qualitative distinctions, such as MDLZ’s note on non-linear option valuation and PM’s focus on interrelationships between interest rates and currencies. (3) Entity Accuracy: The companies (PM and MDLZ/Mondelēz) are correctly identified, and the context of 2023 filings is plausible but not confirmed in the ground truth, which does not specify a year. (4) Reasoning: The multi-hop synthesis is flawed because it invents precise VaR figures and performs comparisons based on false data. The conclusion that PM has 'larger component-level VaR' and MDLZ a 'lower aggregate VaR' is unsupported by the actual evidence. (5) Semantic Equivalence: The structure and intent of the answer are relevant and address the comparison question, but the factual core is invalid. The LLM fabricates numbers and creates a false sense of precision, undermining the entire response. Hence, the correctness score is low despite some contextual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 504,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How does Capital One's exposure to the Market Risk Rule, which adjusts capital ratios based on trading book risks, compare with JPMorgan Chase's regulatory capital requirements under Basel III, particularly in relation to their respective trading asset thresholds and VaR methodologies?",
      "original_answer": "Capital One (COF) is subject to the Market Risk Rule due to its trading assets and liabilities exceeding $1 billion or 10% of total assets, requiring adjustments to its risk-based capital ratios. This rule supplements the Basel III Capital Rules, which are also central to JPMorgan Chase's (JPM) regulatory capital framework. JPM calculates Regulatory VaR under Basel III with a 99% confidence level and a ten-business-day holding period, applying it to 'covered' positions. In contrast, COF’s capital adequacy is evaluated under Basel III standardized and proposed Expanded Risk-Based Approaches, with the latter phasing in by 2028. These differences highlight how both firms manage market risk capital requirements, with JPM using a more granular internal VaR model while COF must comply with both current and evolving Basel III standards.",
      "llm_answer": "Capital One states that, because its aggregate trading assets and liabilities exceed both the 10 %‑of‑total‑assets and the $1 billion thresholds, it is subject to the “Market Risk Rule,” which forces an adjustment to its risk‑based capital ratios to reflect trading‑book risk (the filing does not detail the VaR model used for that adjustment). JPMorgan Chase, which also exceeds the same trading‑asset thresholds, meets its Basel III capital requirements by calculating a separate regulatory VaR – a historical‑simulation model with a ten‑business‑day holding period and an approximate 99 % confidence level (in contrast to its internal 1‑day, 95 % VaR) – and incorporates that VaR‑based capital charge into its Basel III ratios. Thus, both firms are above the rule’s asset trigger, but JPMorgan explicitly discloses a ten‑day, 99 % VaR methodology, whereas Capital One only notes the rule’s applicability without a comparable VaR description.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Capital One (COF) exceeds both the $1 billion and 10% of total assets thresholds, triggering the Market Risk Rule, which adjusts risk-based capital ratios—this matches the original answer. JPMorgan Chase (JPM) uses a regulatory VaR model under Basel III with a 99% confidence level and a ten-business-day holding period, which is accurately stated. The LLM correctly notes that JPM’s internal VaR differs (1-day, 95%) but regulatory capital uses the more conservative measure. (2) Quantitative accuracy is perfect: thresholds ($1B, 10%), confidence level (99%), holding period (10 business days) are all correctly reported. (3) Multi-hop reasoning is sound: the answer synthesizes information across both firms, compares their regulatory treatment, and highlights the difference in VaR disclosure—JPM provides specific methodology while COF does not. (4) The only minor shortcoming is that the LLM omits mention of COF’s future compliance with the proposed Expanded Risk-Based Approaches phasing in by 2028, which is included in the ground truth and adds forward-looking context. However, this does not undermine the core comparison on current VaR methodologies and threshold triggers. Wording differs but semantic meaning is equivalent. Thus, the answer is factually excellent with only slight incompleteness on COF’s evolving Basel III framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 400,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How does Cisco's credit loss allowance for loan receivables tied to technical support services compare to Salesforce's reliance on third-party technical support providers, given both companies' exposure to service delivery risks?",
      "original_answer": "Cisco reported a $53 million credit loss allowance for loan receivables as of July 29, 2023, which includes financing arrangements specifically related to technical support services provided to customers. This indicates a financial risk exposure tied directly to service delivery outcomes. Meanwhile, Salesforce acknowledges its reliance on third parties to deliver technical support services to customers, stating that dissatisfaction with third-party service quality could harm its business and revenue recognition. While Cisco directly finances its technical support services and bears credit risk, Salesforce's risk manifests through potential third-party service failures affecting customer satisfaction and retention.",
      "llm_answer": "Cisco reports a **$50 million allowance for credit losses on its loan‑receivable portfolio**, which “represent financing arrangements related to the sale of our hardware, software, and services (including technical support and advanced services)” 【page_84】.  \n\nSalesforce, by contrast, does not disclose a comparable credit‑loss allowance; its filing instead notes that it **relies on third‑party providers to deliver technical‑support services**, exposing the company to service‑delivery risk but without a quantified allowance figure 【CRM_10k_2024 – pages 19‑20 (discussion of third‑party developers and service delivery risk)】.  \n\nThus, Cisco quantifies its support‑related credit risk with a $50 M allowance, whereas Salesforce’s exposure to support‑service risk is described qualitatively, with no specific allowance disclosed.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Cisco's credit loss allowance and its connection to technical support services, and accurately notes Salesforce's reliance on third-party providers without a disclosed allowance. However, the dollar amount for Cisco is slightly off: the ground truth specifies $53 million as of July 29, 2023, while the LLM reports $50 million. This discrepancy, though minor, affects quantitative accuracy. (2) The number $50 million does not match the ground truth $53 million; no calculation is involved, but the value must be factually correct. Format variation is acceptable, but the amount itself is inaccurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes Cisco’s financial risk via direct financing and credit allowance with Salesforce’s operational risk via third-party dependencies. It contrasts quantitative vs. qualitative risk disclosure appropriately. (4) Despite the small numerical error, the answer captures the core contrast in risk exposure and delivery models between the two companies, making it contextually excellent and qualitatively strong. The slight inaccuracy in the dollar figure prevents a top score in correctness and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 346,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How does the governance risk associated with META's dual-class structure, particularly its impact on investor confidence in Class A common stock, contrast with CMCSA's equity structure that includes Class B common stock but lacks a conversion mechanism tied to governance restrictions?",
      "original_answer": "CMCSA's equity structure includes 9,444,375 issued and outstanding shares of Class B common stock as of 2023, but unlike META, there is no indication that CMCSA ties governance rights or stock conversion to special investor restrictions. In contrast, META's dual-class structure grants Class B stockholders, including Mr. Zuckerberg, disproportionate control over corporate decisions, such as requiring a majority of Class B stock approval for any change in control until those shares represent less than 35% of combined voting power. META also notes that its status as a 'controlled company' could make its Class A common stock less attractive to some investors due to reduced corporate governance protections. This implies that while both companies have Class B shares, META's structural governance risks tied to its dual-class system are more pronounced and explicitly linked to investor sentiment toward Class A shares, unlike CMCSA where the Class B shares do not appear to carry similar governance-linked conversion or control features.",
      "llm_answer": "Meta’s dual‑class system gives Mark Zuckerberg control of the company through a small block of super‑voting Class B shares, and the charter only allows the Class B shares to lose their voting dominance once they fall below a 35 % voting‑power threshold (see Meta 10‑K p. 50).  That concentration of control creates a governance risk that could depress the market’s confidence in Meta’s publicly‑traded Class A stock.  By contrast, Comcast’s equity includes a modest amount of non‑voting Class B common stock (≈9.4 million shares issued, p. 69) but its charter provides no conversion or voting‑threshold mechanism linking Class B to governance, so the company does not face the same governance‑related investor‑confidence risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: Meta's dual-class structure gives Zuckerberg disproportionate control via Class B shares, with a 35% voting-power threshold for maintaining control (cited from Meta 10-K p.50), and this poses governance risks that may affect investor confidence in Class A shares. For CMCSA, the number of Class B shares is correctly reported as approximately 9.4 million (ground truth: 9,444,375), with no conversion or voting-threshold mechanism tied to governance (cited from p.69). (2) Quantitative accuracy is excellent: the ≈9.4 million figure is a valid rounding of 9,444,375, and the 35% threshold is exact. No calculations were required. (3) Multi-hop reasoning is sound: the model correctly contrasts Meta’s governance risks (controlled company, reduced investor confidence) with CMCSA’s lack of similar mechanisms, synthesizing across both companies’ 10-Ks. (4) The only minor shortcoming is that the LLM refers to CMCSA’s Class B shares as 'non-voting' without explicit confirmation from the source, while the ground truth states they exist but does not specify voting rights—this is a slight assumption, but reasonable in context. Otherwise, the answer is semantically equivalent, well-supported, and directly addresses the comparative governance risk question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 381,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How does AIG's valuation of RMBS using discounted cash flow models compare to MS's use of discounted cash flow in fair value estimation, particularly in terms of reliance on unobservable inputs?",
      "original_answer": "AIG values its RMBS portfolio using discounted cash flow models that rely heavily on unobservable inputs such as constant prepayment rate (ranging from 4.10% to 9.26%) and loss severity (ranging from 40.81% to 76.72%). Similarly, MS identifies discounted cash flow as a key valuation technique in estimating fair value for financial instruments and goodwill impairment testing, particularly for Level 3 assets which rely on significant unobservable inputs. MS notes that Level 3 assets represented 0.9% of total assets as of December 31, 2024, indicating a smaller but still material reliance on unobservable assumptions in their fair value measurements.",
      "llm_answer": "AIG values its residential‑mortgage‑backed securities (RMBS) with a discounted‑cash‑flow model that incorporates several unobservable assumptions – a constant pre‑payment rate, loss‑severity assumptions and a default‑rate (and the associated yield) – as shown in the Level 3 fair‑value tables (pages 119‑120). Morgan Stanley also uses discounted‑cash‑flow techniques for fair‑value measurement, but its disclosures stress that it relies first on observable market inputs and only resorts to unobservable inputs when market data are unavailable, meaning its DCF valuations are less dependent on judgment‑heavy assumptions than AIG’s RMBS valuation.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that both AIG and Morgan Stanley (MS) use discounted cash flow (DCF) models in fair value estimation and highlights the reliance on unobservable inputs, particularly for Level 3 assets. It accurately notes AIG's use of unobservable inputs such as constant prepayment rate and loss severity in RMBS valuation, aligning with the ground truth. However, the LLM omits specific numeric ranges for AIG's inputs (e.g., CPR 4.10%–9.26%, loss severity 40.81%–76.72%) and MS's Level 3 assets representing 0.9% of total assets as of December 31, 2024—both key quantitative details in the original answer. While the LLM qualitatively captures MS's preference for observable inputs and fallback to unobservable ones, it does not include the specific percentage of Level 3 assets, weakening quantitative accuracy. The reasoning is sound and the comparison is logically framed, showing understanding of multi-hop elements (comparing two firms' valuation approaches and input observability). Wording differs but meaning is largely equivalent, though missing precise figures prevents a higher score. Contextual relevance is strong as all parts of the question are addressed, albeit with incomplete data support.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 343,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How does the change in Cisco's allowance for credit losses on loan receivables tied to hardware financing compare to Microsoft's revenue recognition approach for hardware that is similarly interdependent with software, and what does this reveal about their respective financial exposures to integrated hardware-software offerings?",
      "original_answer": "Cisco's allowance for credit losses on loan receivables tied to hardware financing decreased from $103 million in fiscal year 2022 to $53 million in fiscal year 2023, indicating a reduction in expected defaults on financing extended for hardware sales. These loan receivables are explicitly tied to the sale of Cisco's hardware and third-party products. Meanwhile, Microsoft recognizes hardware revenue at the point of sale only when it is transferred to resellers or end customers, especially in cases where the hardware is highly interdependent with the operating system and cannot function without it, similar to Cisco's financing structure for integrated offerings. This reveals that while Cisco manages credit risk exposure through allowances on multi-year financing arrangements, Microsoft's financial exposure is more closely tied to point-of-sale recognition, with less direct credit risk but greater dependency on the performance of integrated software-hardware systems post-sale.",
      "llm_answer": "Cisco’s financing‑receivable footnotes show that the allowance for credit losses on loan receivables tied to its hardware‑financing programs fell from $53 million at July 29 2023 to $50 million at July 27 2024 – a $3 million reduction (see Cisco Note 9‑c, pages 84‑85). In contrast, Microsoft’s revenue‑recognition discussion states that when hardware cannot function without its software, the two are treated as a single performance obligation and the combined price is recognized at the point of transfer rather than over time (see Microsoft Note 19‑2, pages 62‑63). Thus, Cisco’s exposure is a modest, direct credit‑risk exposure on the financing it provides for hardware, whereas Microsoft’s exposure is primarily to the timing of revenue recognition for bundled hardware‑software sales, not to credit losses on customer financing.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. The ground truth states that Cisco's allowance decreased from $103 million in FY2022 to $53 million in FY2023, but the LLM incorrectly reports a decrease from $53 million in 2023 to $50 million in 2024. This misrepresents both the time period and the magnitude of the change, missing the full $50 million reduction over the correct fiscal years. The LLM also introduces a $3 million reduction that is not supported by the original answer or likely the source data in the context of the question’s focus. (2) The Microsoft portion is more accurate: it correctly identifies that hardware interdependent with software is treated as a single performance obligation and revenue is recognized at the point of transfer, aligning with the ground truth. However, the LLM omits the comparative insight that Microsoft has less direct credit risk but greater dependency on post-sale performance of integrated systems. (3) The multi-hop reasoning is partially sound—linking Cisco’s credit loss allowance to its financing model and contrasting it with Microsoft’s revenue recognition policy—but fails in synthesis because it uses incorrect financial data and timeframes for Cisco, undermining the validity of the comparison. (4) Contextual relevance is high because the answer addresses both companies, the correct financial concepts (allowance for credit losses, revenue recognition for bundled hardware-software), and cites appropriate notes. However, due to the critical error in Cisco’s numbers and the shift in fiscal years not aligned with the question, the correctness score is limited to 5—partially correct but with major quantitative flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 472,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How does AIG's $75 million loss from embedded derivatives in 2024 compare to MS's credit risk exposure through CDOs that contain similar hybrid instruments with embedded derivatives, given both firms' involvement in structured credit products?",
      "original_answer": "AIG reported a $75 million loss from embedded derivatives in 2024, indicating significant credit-related losses from these structured instruments. MS disclosed involvement in CDOs and CLNs that are classified as hybrid instruments containing embedded derivatives, where credit protection has been sold to the issuer. If a credit event occurs on the underlying reference entity, the principal balance of the note may not be repaid in full to the Firm. This parallels AIG’s exposure, as both firms face direct credit risk tied to the performance of reference entities in structured products, with MS’s CDOs posing similar potential for principal loss under credit events as seen in AIG’s realized loss.",
      "llm_answer": "AIG recorded a $75 million loss from embedded derivatives in 2024 (see the “Embedded derivatives” line in the DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS table). Morgan Stanley’s credit‑risk exposure to CDOs and other hybrid instruments is reflected in the “Other credit contracts” line of its credit‑protection table, which shows about $3 billion of fair‑value assets/liabilities tied to those structures. Thus, AIG’s loss is only a few‑percent of MS’s exposure—roughly 1/40th of the amount Morgan Stanley has at risk in those CDO‑type instruments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states AIG's $75 million loss from embedded derivatives in 2024, it introduces a figure of $3 billion in 'fair-value assets/liabilities' for Morgan Stanley's exposure in 'Other credit contracts', which is not present in the original answer (ground truth). The ground truth does not provide any quantitative value for MS's exposure—only a qualitative description of its involvement in CDOs and CLNs with credit risk from sold protection. Thus, the $3 billion figure and the resulting comparison (1/40th) are fabricated and unsupported. (2) The calculation comparing $75 million to $3 billion (implying ~2.5%) is mathematically correct only if the $3 billion figure were valid, which it is not. No such number exists in the ground truth, making the entire quantitative comparison invalid. (3) The multi-hop reasoning is partially sound in linking AIG’s embedded derivatives loss to MS’s structured credit products, but it fails to accurately synthesize the actual disclosed risks. The original answer emphasizes parallel risk structures (credit events leading to principal loss), while the LLM shifts focus to a false quantitative comparison. It also misrepresents MS’s exposure as a measured 'fair-value' amount rather than a contingent risk tied to credit events. (4) The contextual relevance is moderate because the answer addresses both firms and structured credit products with embedded derivatives, but the introduction of a non-existent metric severely undermines factual correctness. The qualitative description of MS’s instruments is somewhat aligned but lacks precision on the nature of sold credit protection. Due to major quantitative errors and unsupported claims, the correctness score is low despite some structural relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 496,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How does the duration of Disney's foreign exchange cash flow hedges for forecasted transactions compare to Google's hedge maturity periods, given both companies' use of option contracts to manage foreign currency exposure?",
      "original_answer": "Disney hedges its forecasted foreign currency transactions for periods generally not to exceed four years, while Google's foreign currency cash flow hedges have maturities of 24 months or less. Both companies use option contracts as part of their cash flow hedging strategies, with Disney reporting $9.9 billion in net foreign exchange cash flow hedges as of September 28, 2024, and Google holding $731 million in net accumulated gains on foreign currency cash flow hedges as of December 31, 2024.",
      "llm_answer": "Disney’s cash‑flow hedges of forecasted foreign‑currency revenues are limited to contracts that mature in **24 months or less** (the company notes that the option‑based collars it uses for these hedges have a maximum two‑year term). By contrast, Google’s foreign‑exchange contracts – which also include option‑based collars – are generally entered into with **shorter maturities, typically up to one year (and at most a few years, with the bulk under 12 months)**. Thus, Disney’s hedge horizon is longer than Google’s typical hedge maturity period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual errors in both quantitative and qualitative aspects. (1) QUANTITATIVE INACCURACY: The LLM incorrectly states that Disney's hedge maturities are '24 months or less' and uses the term 'option-based collars' with a 'maximum two-year term.' However, the ground truth states Disney hedges for periods 'generally not to exceed four years,' which is up to 48 months—significantly longer than the 24 months claimed. Additionally, the LLM reverses the comparative duration: it claims Disney has a longer horizon than Google, but with incorrect numbers, undermining the logic. Google’s maturities are correctly described as '24 months or less' in the ground truth, but the LLM describes them as 'typically up to one year' and 'at most a few years,' which, while not entirely inconsistent, introduces vagueness and implies Google may have shorter maturities than Disney, which contradicts the truth if Disney goes up to four years. (2) MISSING DATA: The LLM omits key financial figures from both companies—Disney’s $9.9 billion in net foreign exchange hedges and Google’s $731 million in net accumulated gains—which are central to the original answer and demonstrate material exposure. (3) ENTITY & REASONING ERROR: The multi-hop reasoning fails because the LLM misrepresents Disney’s hedge duration, leading to an invalid comparison. The conclusion that 'Disney’s hedge horizon is longer than Google’s' might align with the truth (4 years > 2 years), but it is based on incorrect premises (Disney = 2 years vs Google = up to 1 year), so the reasoning is flawed. (4) SEMANTIC NON-EQUIVALENCE: The answer distorts key facts and thus does not convey the same information. While both companies use option contracts (correctly noted), the LLM adds 'option-based collars' not specified in the ground truth, introducing unverified detail. Overall, the answer is partially relevant and attempts the comparison, but major factual inaccuracies in durations and missing financial data severely undermine correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 545,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How does the expected impact of the Global Minimum Tax on QCOM's fiscal year 2025 tax liabilities compare to INTC's exposure under the Pillar Two Model Rules, given the differing geographic distribution of their operations?",
      "original_answer": "QCOM expects minimal impact from the Global Minimum Tax starting in fiscal year 2025, as it does not operate materially in jurisdictions with tax rates below the 15% Pillar Two minimum. In contrast, INTC, which has a significant portion of its income taxed in non-US jurisdictions, is still evaluating the impacts of Pillar Two, particularly as several jurisdictions like the EU plan to adopt components starting in 2024. Both companies monitor Pillar Two developments closely, but INTC faces more immediate uncertainty due to its broader international tax footprint and ongoing legislative adoptions in key markets.",
      "llm_answer": "Qualcomm says that the OECD‑mandated 15 % global minimum tax (Pillar Two) will begin to apply in fiscal 2025, but because “substantially all of our income is taxed in the U.S.” it does not expect the rule to have a material effect on its 2025 income‑tax expense. Intel, by contrast, notes that a larger share of its earnings is taxed in non‑U.S. jurisdictions, so the Pillar Two model rules create a greater exposure to a higher effective tax rate—although the company also states that, given its current mix of jurisdictions, the impact is not expected to be material.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately states that QCOM expects minimal (non-material) impact from the Global Minimum Tax starting in fiscal year 2025 due to its U.S.-centric income, which matches the original answer. It also correctly contrasts this with INTC's greater exposure due to a larger share of non-U.S. earnings. (2) All quantitative elements—such as the 15% minimum tax rate and fiscal year 2025 applicability—are factually accurate and consistent with the ground truth. There are no calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies, their geographic tax profiles, and differential exposure under Pillar Two. However, the LLM answer slightly understates INTC's uncertainty by stating the impact 'is not expected to be material,' whereas the original answer emphasizes that INTC is still evaluating the impacts and faces 'more immediate uncertainty' due to ongoing legislative adoptions (e.g., EU in 2024). This nuance about evolving regulatory implementation and evaluation status is downplayed in the LLM response, reducing qualitative accuracy slightly. (4) Despite this, the answer remains contextually relevant, directly addressing the comparison of tax liability impacts based on geographic operations, and conveys the core contrast accurately. Minor omission of ongoing evaluation and jurisdictional adoption timelines prevents a perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 408,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How does the difference in voting power ratios between Alphabet's Class B to Class A conversion structure and Comcast's non-dilutable Class B voting rights affect the degree of founder control in corporate governance decisions?",
      "original_answer": "Alphabet maintains a 10:1 voting power ratio between Class B and Class A shares, with Class B shares converting automatically to Class A upon sale or transfer, which allows for dynamic founder control that can diminish with share transfers. In contrast, Comcast's Class B shares hold 33⅓% of voting power that is non-dilutable and convertible share-for-share into Class A, preserving a fixed level of control for Class B holders regardless of share issuance. This means Alphabet's structure allows for more fluid founder influence depending on shareholding behavior, while Comcast's design guarantees a minimum level of voting control that cannot be diluted, offering stronger long-term governance insulation for its Class B shareholders.",
      "llm_answer": "Alphabet’s dual‑class system gives each Class B share ten votes while a Class A share carries one vote, and the Class B shares can be converted share‑for‑share into Class A (a 10‑to‑1 voting multiplier). This concentration lets the founders hold a decisive majority of the voting power even as the number of Class A shares grows【page_81†L1-L4】.  \n\nComcast’s structure, by contrast, assigns 15 votes to each Class B share but the Class B stock as a whole represents only about one‑third of the company’s total voting power and that 33 % share is expressly non‑dilutable by issuing other classes【page_91†L1-L5】. Consequently, the controlling shareholder’s influence is limited to a fixed minority block rather than the controlling majority that Alphabet’s 10‑to‑1 ratio provides.  \n\nThus, Alphabet’s 10‑to‑1 voting‑power ratio gives founders far greater ability to dominate corporate‑governance decisions, whereas Comcast’s non‑dilutable 33 % block restricts founder control to a capped, minority share of the vote.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains significant factual inaccuracies in the quantitative details, particularly regarding Comcast's voting structure. While it correctly states Alphabet's 10:1 voting ratio and conversion mechanism (Class B to Class A upon transfer), it incorrectly claims Comcast's Class B shares have '15 votes each' — the ground truth does not specify per-share votes but emphasizes that Class B collectively holds 33⅓% of voting power in a non-dilutable manner. This misrepresentation undermines the quantitative accuracy. Additionally, the LLM implies Alphabet’s founders have a 'controlling majority' due to the 10:1 ratio, which may be contextually true but is not directly supported in the ground truth, which focuses on the dynamic nature of control versus fixed insulation.\n\n2) The ground truth highlights that Comcast’s Class B voting power is non-dilutable and convertible share-for-share into Class A, preserving a fixed minimum control level. The LLM correctly identifies the non-dilutable nature and 33% figure but misframes the mechanism by introducing a '15 votes per share' detail not present in the original and potentially misleading. No calculation errors occur, but the basis for comparison is flawed due to incorrect structural assumptions.\n\n3) The reasoning partially captures the multi-hop comparison: it contrasts Alphabet’s high-vote-per-share, transfer-triggered conversion model with Comcast’s capped but protected voting block. However, it mischaracterizes the implications — the ground truth emphasizes that Comcast’s structure guarantees minimum control (insulation), while Alphabet’s is more fluid and contingent on holding behavior. The LLM incorrectly frames Comcast’s 33% as a 'minority block' that limits control, whereas the original presents it as a strong, undilutable anchor — not necessarily majority, but highly protective.\n\n4) Despite these issues, the answer is contextually relevant and attempts a nuanced governance comparison. The qualitative reasoning is sound in structure but based on faulty input data. Semantic equivalence is partially achieved: core ideas of 'dynamic vs. fixed control' are approached, but precision is lacking. Hence, correctness is reduced to 6 due to key factual errors in voting mechanics, though the overall direction of analysis aligns with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 621,
        "total_tokens": 2079
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How does the indemnification agreement between PM USA and PMI affect Altria's (MO) financial exposure to tobacco-related litigation liabilities compared to PM's retained obligations through RBH deconsolidation?",
      "original_answer": "Under the Distribution Agreement, PMI indemnifies Altria and PM USA for liabilities related to tobacco products manufactured by PMI or contract manufactured by PM USA, while PM USA indemnifies PMI for liabilities related to its own manufactured products, excluding those made for PMI. Altria has not recorded a liability for this indemnification as its fair value is considered insignificant. Meanwhile, PM retains obligations tied to the deconsolidation of RBH, which involved reclassifications from accumulated other comprehensive losses. This structure limits Altria's direct financial exposure to PMI-related litigation, while PM faces ongoing impacts from RBH-related reclassifications.",
      "llm_answer": "The distribution agreement makes PMI the primary insurer of any tobacco‑product claims that arise from products it manufactures (or that are contract‑manufactured for PMI by PM USA); PM USA, in turn, only indemnifies PMI for claims on products it makes on its own.  Because the fair‑value of that indemnification is deemed “insignificant,” Altria records **no liability** for those claims on its balance sheet (MO 10‑K, p. 108).  By contrast, PMI retains the underlying litigation exposure – including the liabilities that remained on its books after the RBH deconsolidation, which are reflected in PMI’s accumulated other‑comprehensive losses and contingency disclosures (PMI 10‑K, p. 112).  Thus, Altria’s financial exposure is essentially transferred to PMI, while PMI continues to carry the residual tobacco‑litigation risk left from the RBH deconsolidation.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its factual assertions and correctly identifies the indemnification structure between PM USA and PMI, as well as Altria's lack of recorded liability due to the deemed insignificant fair value. It accurately references the Distribution Agreement and correctly states that Altria does not record a liability (semantic match to 'has not recorded a liability' in ground truth). The citation of MO 10-K p.108 and PMI 10-K p.112 adds contextual support, though these are not part of the ground truth verification but do not detract. However, there is a key mischaracterization: the LLM states that 'PMI retains the underlying litigation exposure – including the liabilities that remained on its books after the RBH deconsolidation,' which conflates PMI with PM USA/PM. The ground truth clarifies that it is PM (Philip Morris USA), not PMI, that retains obligations tied to RBH deconsolidation, which involved reclassifications from accumulated other comprehensive losses. This is a significant entity confusion in a multi-hop context: RBH deconsolidation impacts PM (a subsidiary of Altria, not PMI), and this error misattributes financial impacts to the wrong entity. While the core indemnification logic is sound and quantitative elements (e.g., 'no liability,' 'insignificant fair value') are accurate, the misattribution of RBH-related obligations to PMI instead of PM USA undermines the qualitative accuracy of the multi-hop synthesis. The answer remains contextually relevant and correctly frames Altria's reduced exposure, but the entity-level confusion prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 440,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How does the decline in Cisco's allowance for credit losses on loan receivables from $103 million in 2022 to $53 million in 2023 impact the financing of technical support services, and how does this compare to Adobe's approach in funding its technical support offerings?",
      "original_answer": "Cisco's allowance for credit losses on loan receivables decreased significantly from $103 million in 2022 to $53 million in 2023, indicating a reduced financial risk in their financing arrangements tied to hardware, software, and services—including technical support. This decline may suggest either improved credit quality of borrowers or a strategic reduction in financing extended for such services. Cisco offers financing, including loans and leases, for the sale of its products and services, which explicitly include technical support and advanced services. In contrast, Adobe funds its technical support through subscription entitlements and annual fee-based maintenance programs, providing customers with technical support, product help, and upgrades over 1- to 3-year terms. Unlike Cisco, Adobe does not rely on loan receivables but integrates support funding directly into its subscription and maintenance models.",
      "llm_answer": "Cisco’s loan‑receivable allowance fell from $103 million in 2022 to $53 million in 2023, a $50 million reduction. Because loan receivables are used to finance the sale of hardware, software and **technical‑support services** (see Cisco Note 9 (a)), the smaller allowance means Cisco expects fewer defaults, freeing cash and lowering the cost of financing its support offerings. Adobe, by contrast, does not rely on loan‑receivable financing; its technical‑support program is funded directly through **subscription entitlements and annual maintenance‑fee contracts** (see Adobe Technical Support description), so it does not manage a credit‑loss reserve for that purpose.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the decline from $103 million in 2022 to $53 million in 2023 is accurately reported, and the $50 million reduction is correctly calculated. (2) The entity identification is accurate—Cisco and Adobe are correctly referenced with appropriate fiscal years (2022 to 2023) and correct financial metrics (allowance for credit losses on loan receivables). (3) The reasoning is sound: the LLM correctly infers that the reduced allowance suggests lower expected defaults, which reduces financing costs and improves cash flow for Cisco’s technical support financing, which is tied to loan receivables. It also correctly contrasts this with Adobe’s model, noting that Adobe funds technical support via subscription entitlements and annual maintenance fees, not through loan receivables or credit-loss reserves. (4) The only minor shortcoming is a slight lack of detail compared to the original answer—specifically, the original mentions that Adobe’s support includes upgrades over 1- to 3-year terms, and that Cisco’s financing includes leases (not just loans). These are minor contextual omissions that do not affect the core correctness. Overall, the answer demonstrates strong multi-hop reasoning by synthesizing Cisco’s credit loss data with its financing model and contrasting it with Adobe’s subscription-based funding approach. Semantic equivalence is maintained, and the answer is fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 418,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How does the involvement of Citibank, N.A. as administrative agent in Caterpillar's 2022 5-Year Credit Facility compare with its role in Boeing's similarly named 2019 Five-Year Credit Agreement, particularly in terms of the amendment timelines and the syndication structure?",
      "original_answer": "Citibank, N.A. served as the administrative agent in both Caterpillar's 2022 5-Year Credit Facility and Boeing's 2019 Five-Year Credit Agreement. In Caterpillar's case, Amendment No. 1 to the 5-Year Facility was dated August 31, 2023, indicating a modification within one year of the original agreement. For Boeing, Amendment No. 1 to its Five-Year Credit Agreement occurred on August 25, 2022, nearly three years after the initial agreement on October 30, 2019. Additionally, Boeing's syndication structure included JPMorgan Chase Bank, N.A. as syndication agent and joint lead arranger alongside Citibank, N.A., while Caterpillar's syndication involved Citibank, N.A. and MUFG Bank, Ltd. in agent roles without a comparable dual lead arranger structure.",
      "llm_answer": "Both companies name Citibank N.A. as the administrative (or “agent”) bank on their five‑year revolving facilities, but the surrounding structures differ.  \n\n* Caterpillar’s five‑year facility was first executed on September 1 2022 and was amended once on August 31 2023 (about one year later). The agreement lists Citibank N.A. as the sole agent (with Citibank Europe and MUFG acting only as local‑currency agents) and does not identify a separate syndication agent.  \n\n* Boeing’s five‑year credit agreement was dated October 30 2019 and received its first amendment on August 25 2022 (roughly three years after signing). That deal names Citibank N.A. as administrative agent **and** JPMorgan Chase Bank N.A. as the syndication agent, with both banks serving as joint lead arrangers and book‑managers, indicating a more elaborate syndication structure.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: Citibank, N.A. served as administrative agent in both Caterpillar's 2022 5-Year Credit Facility and Boeing's 2019 Five-Year Credit Agreement. The amendment dates are accurate—August 31, 2023 (Caterpillar, ~1 year after original) and August 25, 2022 (Boeing, ~3 years after October 30, 2019). (2) Quantitative accuracy is perfect: dates match exactly, and the time intervals are correctly characterized. (3) Entity accuracy is strong: correct identification of Citibank, N.A., JPMorgan Chase Bank, N.A., and MUFG Bank, Ltd. (referred to as MUFG) in their respective roles. (4) The reasoning is sound and synthesizes multi-hop information correctly—comparing amendment timelines and syndication structures across two different companies and agreements. The LLM correctly notes that Boeing’s deal had a dual lead arranger structure with a syndication agent (JPMorgan), while Caterpillar’s did not, and that MUFG and Citibank Europe were only local-currency agents, not syndication agents. (5) Semantic equivalence is maintained: though phrased differently, all critical information from the original answer is preserved, with no omissions or distortions. The answer is concise, relevant, and fully addresses both parts of the question—amendment timelines and syndication structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 383,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How might a prolonged geopolitical conflict involving Taiwan impact both NVIDIA's and Qualcomm's supply chain reliability, given their shared dependency on foundry partners in the region?",
      "original_answer": "A prolonged geopolitical conflict involving Taiwan could severely disrupt both NVIDIA's and Qualcomm's supply chains, as both companies rely heavily on foundry partners located in Taiwan for critical semiconductor manufacturing. NVIDIA has explicitly stated that challenges in estimating demand could be exacerbated by geopolitical tensions involving Taiwan and China, which are significant to their revenue and supply continuity. Similarly, Qualcomm depends on consistent chipset supply from foundry partners in Taiwan, and a conflict could severely limit or prevent them from receiving these components, directly impacting their ability to manufacture and deliver products. Both companies face the risk of supply constraints, production delays, and potential revenue loss due to the geographic concentration of their manufacturing dependencies in a geopolitically sensitive region.",
      "llm_answer": "Both companies warn that a prolonged conflict over Taiwan could cripple the chip supply they obtain from Taiwanese foundries. Qualcomm states that its ability to receive “consistent and reliable chipset supply from our foundry partners, particularly in Taiwan” would be “severely limited or prevented” by a sustained China‑Taiwan war, creating a material adverse impact on its business 【page_35】. NVIDIA likewise notes that its “suppliers, contract manufacturers, and assembly partners … concentrated in Taiwan” are critical to its supply continuity and that “geopolitical tensions… involving Taiwan and China… could have a material adverse impact on us” by disrupting wafer and component deliveries 【page_17】【page_18】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies both NVIDIA and Qualcomm as being at risk due to their reliance on Taiwanese foundries, and accurately reflects each company's stated concerns from their SEC filings, including direct quotes and page references (e.g., Qualcomm's 'severely limited or prevented' chipset supply from Taiwan 【page_35】 and NVIDIA's concentration of suppliers in Taiwan 【page_17】【page_18】). (2) There are no numerical values in the question or answers that require verification (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not applicable in a traditional sense—however, the absence of incorrect numbers and proper representation of qualitative risk factors earns full marks. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies and their shared dependency on a geographically concentrated supply chain in Taiwan, linking geopolitical risk to supply chain disruption for both. (4) The answer is contextually precise, directly addressing the question about supply chain reliability and the impact of a prolonged conflict. Wording differs slightly from the original answer but conveys the same meaning with added citation detail (page numbers), enhancing credibility. All entities (NVIDIA, Qualcomm, Taiwan, foundry partners, geopolitical tensions) are correctly identified and logically connected. No omissions or inaccuracies present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 415,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does Boeing's indemnification risk exposure from U.S. government contracts compare with 3M's indemnification liabilities transferred to Solventum following the spin-off, particularly in relation to their respective legal proceedings and liability assumptions?",
      "original_answer": "Boeing discloses indemnification risks tied to U.S. government contracts where pension cost allocations under CAS may affect contract profitability. Meanwhile, 3M transferred indemnification obligations related to historical legal proceedings—such as the Bair Hugger and Federal False Claims Act litigation—to Solventum as part of the April 1, 2024 spin-off. Both companies face potential liabilities from legal proceedings, but Boeing's exposure is tied to contract cost allocations and uninsurable risks from defense and aerospace products, whereas 3M's transferred liabilities are now the responsibility of Solventum, which must indemnify and defend claims previously held by 3M.",
      "llm_answer": "Boeing notes that, although it sometimes receives indemnification from the U.S. government for work under government contracts, many of its high‑risk products (aircraft, missiles, cyber‑security systems, etc.) are not fully insurable and the indemnification “may be forced to bear substantial costs” and is limited outside the United States【page_20】.  \n\nIn contrast, 3M’s spin‑off of its health‑care business transferred to Solventum a set of liabilities together with “indemnification and defense obligations,” with Solventum agreeing to indemnify and defend 3M for those matters, thereby shifting the indemnification exposure away from 3M【page_84】.  \n\nThus, Boeing retains a potentially large, uncertain indemnification exposure on its government contracts, whereas 3M has largely removed comparable indemnification risk by assigning it to Solventum.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Boeing's indemnification risk from U.S. government contracts involving uninsurable defense and aerospace products (e.g., aircraft, missiles) is properly described, including the limitation of indemnification outside the U.S. and potential for bearing substantial costs. 3M's transfer of indemnification and defense obligations to Solventum in the spin-off is accurately portrayed, with correct emphasis on Solventum assuming responsibility to indemnify and defend 3M. (2) There are no numeric values, dates, or financial figures in dispute; the April 1, 2024 spin-off date is implied by context and consistent with the knowledge graph, though not explicitly mentioned in the LLM answer—this is a minor omission but does not detract significantly. (3) Multi-hop reasoning is sound: the model correctly contrasts Boeing’s retained risk with 3M’s transferred liability, synthesizing information across two companies and events (contractual risk vs. corporate spin-off). (4) Semantic equivalence is strong—while the LLM uses slightly different phrasing (e.g., 'shifting the indemnification exposure' vs. 'transferred indemnification obligations'), the meaning matches the original. The only reason for not scoring a 10 is the lack of specific mention of the legal proceedings (Bair Hugger, False Claims Act) that were transferred, which are part of the complete picture but not central to the core comparison. Overall, the answer is factually correct, contextually relevant, and logically structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 438,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does the voting power structure of CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, influence the governance risks associated with META's Class A common stock, particularly in light of META's controlled company status and dual-class structure?",
      "original_answer": "CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, holds 33⅓% of the combined voting power, with each share carrying 15 votes. This concentrated voting power allows the holder significant influence over corporate decisions. Similarly, META's governance structure gives its Class B common stockholders, including Mark Zuckerberg, outsized voting control, with the dual-class structure requiring a majority of Class B votes for any change in control until they fall below 35% of voting power. This setup increases governance risks for Class A shareholders, as it limits their influence and could deter investors, mirroring the concerns raised in META's 10-K about its 'controlled company' status making Class A shares less attractive.",
      "llm_answer": "Comcast’s capital structure gives Brian L. Roberts 100 % of the 9.44 million Class B shares, each carrying 15 votes, which alone provide 33.3 % of the company’s total voting power and are “generally non‑dilutable” (CMCSA 10‑K p. 33). That same super‑voting concentration is echoed at Meta, where Mark Zuckerberg’s Class B shares let him control the outcome of any stockholder vote despite owning far less than a majority of the equity, and the company’s “controlled‑company” status removes many Nasdaq‑mandated governance safeguards (Meta 10‑K p. 50). Consequently, the Comcast example underscores the governance risk to Meta’s Class A shareholders that a single controlling holder can dominate board composition, corporate decisions and anti‑takeover provisions, making the Class A stock potentially less attractive and less protected.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: Brian L. Roberts owns 100% of 9.44 million Class B shares of CMCSA, each with 15 votes, resulting in 33.3% of total voting power—this matches the known structure and is consistent with the 33⅓% stated in the original answer. The use of '33.3%' is an acceptable decimal approximation of '33⅓%'. (2) The answer correctly identifies the parallel governance risks at META, noting Mark Zuckerberg’s control via super-voting Class B shares and the implications of META’s 'controlled company' status under Nasdaq rules, citing the correct 10-K page (p. 50). (3) The multi-hop reasoning is sound: it draws a valid analogy between CMCSA’s concentrated voting structure and META’s dual-class system, correctly synthesizing how both structures concentrate control and reduce protections for Class A shareholders. (4) The LLM adds contextual detail not in the original (e.g., 'non-dilutable' shares, specific page citations) that enhances accuracy without introducing error. The only minor shortcoming is that it does not explicitly mention the 35% threshold for Class B voting power in META, which is a key condition in the original answer for when control could shift. However, the core governance risks and structural parallels are accurately conveyed, making the answer substantively correct and highly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 392,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does Coca-Cola's reliance on Arca Continental for beverage distribution in northern Argentina intersect with Procter & Gamble's foreign exchange risk exposure in the same country?",
      "original_answer": "Coca-Cola relies on Arca Continental for beverage distribution in northern Argentina, which accounts for a portion of its 17% worldwide unit case volume through bottling partners. Arca Continental's operations in northern Argentina expose Coca-Cola indirectly to macroeconomic risks in the country. Meanwhile, Procter & Gamble directly cites Argentina as one of the countries with significant exchange rate fluctuations that have historically impacted its financials, noting foreign exchange volatility in Argentina has significantly affected its net sales, costs, and earnings. This creates a shared exposure point where both companies face risks tied to Argentina’s economic environment, with Coca-Cola exposed through its supply chain dependency and P&G through direct market operations.",
      "llm_answer": "Coca‑Cola’s bottling system lists **Arca Continental** as the independent partner that bottles and distributes its beverages in **northern Argentina** (KO 10‑K, “Our five largest independent bottling partners… Arca Continental… northern Argentina”). Procter & Gamble notes that **Argentina is one of the countries where it has significant foreign‑exchange exposure**, with peso fluctuations affecting its translation and transaction results (PG 10‑K, “Foreign Exchange… Certain countries that recently had and are currently experiencing significant exchange‑rate fluctuations include Argentina…”). Thus, Coca‑Cola’s sales in northern Argentina depend on a bottler operating in a market where P&G is simultaneously vulnerable to Argentine‑peso volatility, linking both companies’ performance in that region to the same currency‑risk environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Coca-Cola relies on Arca Continental for distribution in northern Argentina, and Procter & Gamble explicitly identifies Argentina as a country with significant foreign exchange exposure due to peso volatility. These points are correctly attributed to their respective 10-K filings. (2) There are no numerical values requiring calculation in this question, but the qualitative metrics (e.g., 'significant exchange-rate fluctuations') are accurately represented; thus, quantitative accuracy is full. (3) The multi-hop reasoning is sound: the model correctly synthesizes that while Coca-Cola is indirectly exposed to Argentina's economic risks through its bottling partner Arca Continental, P&G faces direct exposure via its own operations, linking both to the same macroeconomic environment—specifically currency risk. The only minor shortcoming is that the LLM does not explicitly mention Coca-Cola’s 17% global unit case volume through bottlers (a detail in the original), but this is not essential to the core intersection being evaluated. (4) The answer is contextually precise, directly addressing how both companies’ exposures intersect in northern Argentina via foreign exchange risk, even if one is direct and the other indirect. Wording differs slightly from the original but maintains semantic equivalence. No factual errors or misattributions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 403,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How might the expiration of Alimta's patent protection impact Eli Lilly's oncology revenue stream compared to Amgen's exposure to patent-related risks for its biologics, given the differing regulatory frameworks governing small molecule drugs and biologics?",
      "original_answer": "The expiration of Alimta's patent protection is expected to result in a rapid and severe decline in Eli Lilly's revenue from the product due to the entry of generic competitors in the U.S. and other jurisdictions. This is typical for small molecule drugs like Alimta, where loss of exclusivity often leads to immediate and significant revenue erosion. In contrast, Amgen, which relies heavily on patent protection for its biologics, faces a different regulatory landscape where biosimilars may not enter the market as quickly due to manufacturing complexities and regulatory uncertainties, such as the FDA's stance on 'umbrella exclusivity'. However, Amgen still faces increasing biosimilar competition in the U.S., Europe, and elsewhere, which has had and could increasingly have a material adverse effect on its product sales. Thus, while both companies are exposed to patent-related risks, the speed and severity of revenue impact differ due to the nature of their product portfolios and the regulatory frameworks governing them.",
      "llm_answer": "Lilly notes that Alimta – a small‑molecule chemotherapy – has already lost or is about to lose its key patents, and that “the entry of generic competition for Alimta … will cause a rapid and severe decline in revenue for the product” (LLY 10‑K p. 25; 2021 sales fell 12 % to $2.06 bn, p. 44). By contrast, Amgen’s biologics are protected by the 12‑year BPCIA data‑exclusivity and additional regulatory hurdles that slow biosimilar entry; the company flags “potential earlier biosimilar competition” and “legislative and regulatory efforts” that could erode that protection (Amgen 10‑K p. 46‑47). Thus, the loss of Alimta’s patent is likely to produce a swift, steep hit to Lilly’s oncology revenue, whereas Amgen’s biologic portfolio faces a more gradual, regulatory‑mediated exposure to patent‑related risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Alimta, a small molecule drug, faces rapid revenue decline due to generic competition upon patent expiration, citing Eli Lilly's 10-K with a specific page reference and noting a 12% revenue drop in 2021 to $2.06 billion—consistent with the knowledge graph's expectation of severe revenue erosion. These numbers match or are reasonably inferred from the source data. (2) For Amgen, the answer correctly highlights the 12-year BPCIA data exclusivity and regulatory hurdles that delay biosimilar entry, reflecting the differing regulatory framework for biologics. It also notes Amgen’s own risk disclosures about potential earlier biosimilar competition, which matches the original answer’s emphasis on increasing but slower biosimilar pressure. (3) The multi-hop reasoning is sound: the model synthesizes information across two companies (Eli Lilly and Amgen), two drug types (small molecule vs. biologic), and two regulatory environments (generic vs. biosimilar pathways), correctly contrasting the speed and severity of revenue impact. (4) Minor deduction in quantitative accuracy is due to the lack of explicit mention of 'umbrella exclusivity' uncertainty cited in the ground truth, and the $2.06B figure, while plausible, is not directly tied to Alimta alone in all public reports—though it is reasonable in context. Otherwise, the answer is semantically equivalent, well-supported, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 415,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How does the impact of the OECD's Pillar Two Model Rules on Intel's non-US tax benefits compare to Microsoft's exposure under the global minimum tax, given the differences in their international tax strategies?",
      "original_answer": "Intel's tax benefits have increased due to a higher proportion of income taxed in non-US jurisdictions, and the company is actively evaluating the impact of Pillar Two Model Rules, which may begin in 2024 in several jurisdictions where Intel operates. In contrast, Microsoft acknowledges the global minimum tax as part of its broader regulatory exposure but does not expect a material increase in tax costs due to limited operations in jurisdictions below the 15% minimum rate. This suggests that while both companies are subject to Pillar Two, their exposure differs based on geographic tax strategy and operational footprint.",
      "llm_answer": "Intel says that because it does not have material operations in jurisdictions whose statutory rates fall below the 15 % Pillar‑Two floor, the OECD Pillar Two Model Rules are not expected to materially increase its global tax cost or erode the non‑U.S. tax benefits it currently enjoys. By contrast, Microsoft’s filing notes that it is subject to a variety of domestic and international tax proposals—including the OECD‑driven global minimum tax—and, given its broader worldwide footprint, it could see its effective tax rate rise as the minimum‑tax rules are adopted. Thus Intel’s exposure is essentially negligible, while Microsoft faces a potentially material increase in tax expense from the global minimum‑tax regime.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a fundamental factual reversal that severely undermines its correctness. According to the ground truth, Intel has a higher proportion of income in non-US jurisdictions and is actively evaluating Pillar Two's impact (with potential implications starting in 2024), while Microsoft does not expect a material increase in tax costs due to limited operations in low-rate jurisdictions. However, the LLM answer incorrectly states that Intel has 'not material operations in jurisdictions below 15%' and thus faces 'negligible' exposure, while claiming Microsoft could see a rise in tax rate due to its 'broader worldwide footprint'. This inverts the actual positions: the truth indicates Intel benefits more from non-US tax advantages (implying significant non-US operations) and is assessing impact, whereas Microsoft explicitly states limited exposure. The 15% Pillar Two floor reference is accurate (quantitative accuracy), and the companies and policy context are correctly identified (entity accuracy). The answer is contextually relevant and well-structured, but the core comparative reasoning is flawed—failing the multi-hop synthesis by reversing the exposure levels. This major qualitative error—misrepresenting which company is more exposed—results in a low correctness score despite accurate terminology and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 372,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How does KO's 2024 transfer of $523 million in surplus international pension assets to general assets affect its exposure to limited partnerships compared to PEP's continued use of limited partnerships in its pension investment strategy?",
      "original_answer": "KO's transfer of $523 million in surplus international pension assets to general assets in 2024 reduced its exposure to limited partnerships, as these assets were previously part of its pension plan investments, which include vehicles like limited partnerships (as seen in NEE's pension strategy). Meanwhile, PEP continues to maintain exposure to limited partnerships through its pension investments, as explicitly stated in its 2024 10-K, where it holds investments in limited partnerships and private credit funds valued based on net asset value. This indicates a strategic divergence: KO reduced its pension-linked alternative investments, while PEP maintains them as part of its diversified pension fund strategy.",
      "llm_answer": "Coca‑Cola’s 2024 transfer moved $523 million of surplus assets that were held in its overseas pension trusts into the company’s general‑asset pool, removing those assets – which were classified under the “limited‑partnerships and private‑credit funds” line in the fair‑value hierarchy (see PEP 10‑K page 99) – from the pension‑plan investment mix. PepsiCo, by contrast, still reports that its pension‑plan assets include investments in limited partnerships (see PEP 10‑K page 99), indicating it has not reduced that exposure. Thus, KO’s action lowers its pension‑plan exposure to limited‑partnership investments, whereas PEP continues to retain such exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $523 million transfer by KO in 2024 is accurately reported, and there are no calculation errors. (2) The entity identification is correct—KO (Coca-Cola) and PEP (PepsiCo) are properly referenced, and the use of PEP’s 10-K page 99 as a source for limited partnership exposure is factually supported. (3) The reasoning correctly synthesizes multi-hop information: it infers that removing surplus pension assets (which were invested in limited partnerships and private credit funds) reduces KO’s exposure to such vehicles, while PEP continues to hold them. This reflects a valid comparison between the two companies’ pension investment strategies. (4) The only minor shortcoming is that the LLM references PEP’s 10-K to classify KO’s asset types (i.e., attributing the 'limited partnerships and private credit funds' category to KO based on PEP’s disclosure), which slightly weakens the evidentiary chain. The ground truth more cautiously links this asset type to broader pension strategies (e.g., referencing NEE as an example). However, the overall conclusion—that KO reduced exposure while PEP maintained it—is sound and semantically equivalent. Thus, the answer is factually correct, contextually relevant, and well-reasoned, warranting a high score with only a slight deduction in qualitative accuracy for the sourcing nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 402,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How does the $17.3 billion increase in PFE's income from continuing operations in 2021 compared to 2020 relate to the role of patent rights in determining market exclusivity periods, especially when considering LLY's reliance on 12-year U.S. biologic data protection to safeguard revenue post-patent expiration?",
      "original_answer": "The $17.3 billion increase in PFE's income from continuing operations in 2021 compared to 2020 was partly due to factors like lower asset impairment charges and higher net gains on equity securities. However, PFE acknowledges that patent expirations could materially affect revenues, as patent rights are a key determinant of market exclusivity in the pharmaceutical industry. According to evidence, market exclusivity for pharmaceuticals is largely determined by patent rights and regulatory data protection. In the U.S., biologics benefit from a 12-year data protection period under the BPCIA, which LLY explicitly references as a critical mechanism to retain market exclusivity and protect revenues even after compound patents expire. This implies that while PFE's short-term financial performance saw a significant boost, the long-term sustainability of such gains for patented products will depend on both patent strength and complementary regulatory exclusivity mechanisms like those LLY relies on for its biologics.",
      "llm_answer": "Pfizer’s $17.3 billion jump in income from continuing operations in 2021 versus 2020 was “primarily attributable to higher revenues” that stemmed from products still protected by patents and other exclusivity rights 【page_36】—the same patents that “determine a product’s market exclusivity” by giving the innovator the right to exclude competitors 【page_7】. Eli Lilly’s strategy mirrors this logic: it counts on the 12‑year U.S. biologic data‑protection period granted under the BPCIA to preserve revenue after its patents expire 【page_10】. Thus, both companies’ earnings growth is closely tied to the ability of patent‑based and data‑protection exclusivity periods to shield their products from generic or biosimilar competition.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the $17.3 billion increase in PFE's income from continuing operations in 2021 vs. 2020, and accurately references the 12-year U.S. biologic data protection under the BPCIA that LLY relies on—both factually correct and consistent with the ground truth. Quantitative accuracy is perfect: the dollar amount and timeframes are correct, with no calculation errors. Contextual relevance is strong, as the answer addresses the relationship between market exclusivity, patents, and revenue protection for both PFE and LLY. However, the qualitative accuracy is significantly flawed: the LLM incorrectly attributes PFE’s $17.3 billion increase primarily to higher revenues from patented products, while the ground truth states it was largely due to lower asset impairment charges and higher net gains on equity securities—not revenue growth from patent-protected products. This misrepresents the primary driver of PFE’s financial performance, undermining the reasoning chain. While the answer correctly links patent rights and data protection to market exclusivity, it fails to accurately synthesize the actual cause of PFE’s income increase, leading to a flawed multi-hop inference. The conclusion that both companies’ earnings growth is tied to exclusivity mechanisms overstates the case for PFE in this specific period, making the reasoning partially incorrect despite correct entity and regulatory references.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 396,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How does the revenue-sharing arrangement between ESPN and Hulu, as reflected in Disney's 2024 financials, relate to the $8.6 billion payment Comcast received in late 2023 following the partial exit of its Hulu stake?",
      "original_answer": "Disney's ESPN receives fees from Hulu for the right to air its networks, as noted in the elimination section of Disney's 2024 financials. This relationship is central to Hulu's content costs and revenue model. In late 2023, Comcast exercised a put option, requiring Disney to buy its 33% stake in Hulu for $8.6 billion, which included a $9.2 billion minimum equity value less $557 million for prior capital calls. This payment reflects the financial value derived from Comcast’s stake in Hulu, which is partially driven by revenue streams like those from ESPN content licensing fees. Thus, the revenue-sharing mechanism between ESPN and Hulu underpins part of the valuation that led to the $8.6 billion payment to Comcast.",
      "llm_answer": "Disney’s 2024 results show that Hulu pays ESPN (and the linear‑networks business) fees for the right to carry ESPN’s channels on Hulu Live; those fees are recorded as segment revenue and then eliminated in the consolidated statement (the “Eliminations” line of $‑1.6 billion in 2024). The $8.6 billion that Comcast received in November 2023 was a one‑time cash payment for selling its roughly‑33 % equity stake in Hulu – a capital‑transaction that Disney recorded as an acquisition cost and related amortization, not as operating revenue from the ESPN‑Hulu fee arrangement. Thus, the ESPN‑Hulu revenue‑sharing is an ongoing intercompany service fee reflected in Disney’s segment eliminations, whereas the $8.6 billion is a separate, non‑recurring purchase of Comcast’s Hulu interest.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $8.6 billion payment from Disney to Comcast in November 2023, Comcast’s ~33% stake, and the $1.6 billion elimination (representing intercompany fees, including ESPN’s) in Disney’s 2024 financials are all factually accurate and match the knowledge graph. The format variations (e.g., $‑1.6 billion) are acceptable. (2) The answer correctly identifies the entities: Disney, ESPN, Hulu, Comcast, and the relevant financial instruments (revenue-sharing fees, put option execution). The fiscal year (2024 financials) and transaction timing (late 2023) are precise. (3) Reasoning is strong: the LLM correctly distinguishes between the ongoing intercompany revenue-sharing (reflected in segment eliminations) and the one-time capital transaction (Comcast’s stake sale), which is central to the multi-hop logic. It accurately frames the ESPN-Hulu fees as part of Hulu’s content cost structure and acknowledges their role in Hulu’s valuation, even if it emphasizes the separation of the two events more than the original answer. (4) While the original answer emphasizes that ESPN’s revenue-sharing contributes to Hulu’s valuation (thus underpinning part of the $8.6B), the LLM slightly downplays this linkage by focusing on the transactional separation. However, it does not deny the connection and correctly situates the fees within Hulu’s operating model. This minor omission in synthesis prevents a perfect 10, but the answer remains factually sound, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 441,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How do KO's and MDLZ's respective uses of financial assumptions differ in terms of the instruments they apply them to and the time periods over which the associated costs are recognized?",
      "original_answer": "KO uses the Black-Scholes-Merton option-pricing model to estimate the fair value of stock option awards, which are expensed on a straight-line basis over a typical four-year vesting period. This approach incorporates weighted-average assumptions such as volatility and expected term. In contrast, MDLZ applies weighted-average assumptions to determine net periodic postretirement healthcare costs, which are measured annually and reflect actuarial estimates for long-term obligations. The key differences are that KO applies these assumptions to equity-based compensation instruments with a fixed four-year expense recognition period, while MDLZ applies them to postretirement benefit liabilities that are recalculated annually based on updated actuarial estimates.",
      "llm_answer": "- **Coca‑Cola (KO)** – The company uses financial‑modeling assumptions (risk‑free rate, expected volatility, dividend yield, expected term) in a Black‑Scholes‑Merton valuation of **stock‑option awards**.  The resulting compensation cost is recorded as expense and is **amortized over a weighted‑average period of about 1.7 years** (see KO 10‑K p. 94‑95).  \n\n- **Mondelez (MDLZ)** – Mondelez applies assumptions (discount rate and health‑care cost‑trend rate) to **post‑retirement health‑care benefit plans**, projecting cash‑flow payments out to 2024‑2033.  The cost of those assumptions is taken as a **net‑periodic post‑retirement expense in the year incurred**, rather than being spread over multiple years (see MDLZ 10‑K p. 107).  \n\nThus, KO’s assumptions are tied to equity‑based instruments and are recognized over a short amortization window, whereas MDLZ’s assumptions are tied to post‑retirement benefit liabilities and are recognized in the period in which the service cost is incurred, with future payments projected over a longer horizon.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies the instruments and general nature of financial assumptions used by KO and MDLZ: KO uses Black-Scholes-Merton for stock options, and MDLZ applies assumptions to postretirement healthcare benefits. However, there are key factual inaccuracies in the quantitative details. The ground truth states that KO expenses stock options over a 'typical four-year vesting period' on a straight-line basis, but the LLM claims a 'weighted-average period of about 1.7 years', which contradicts the ground truth. This is a significant error in both number and implication (shorter vs. longer recognition). Additionally, the LLM states that MDLZ's net periodic cost is recognized 'in the year incurred' and not spread, which aligns with actuarial expense recognition, but fails to clarify that this cost is based on long-term actuarial estimates recalculated annually, missing a key nuance in the time-period aspect of cost recognition. 2) The 1.7-year amortization period cited for KO is incorrect per the ground truth (should be four years). The MDLZ projection period '2024–2033' is plausible but not mentioned in the original answer, making it extraneous and potentially misleading. The original answer emphasizes annual recalculation of actuarial estimates, not a fixed projection window. 3) The reasoning correctly differentiates between equity-based compensation (KO) and postretirement liabilities (MDLZ), and the multi-hop synthesis across companies and instruments is sound. However, the incorrect amortization period for KO undermines the validity of the comparison regarding expense recognition timing. 4) Despite the incorrect vesting period and some mischaracterization of MDLZ's time horizon, the answer captures the core contrast: KO applies assumptions to equity instruments with multi-year amortization, while MDLZ applies them to long-term benefit liabilities with annual expense recognition based on updated estimates. The contextual relevance is high as it directly addresses the question's focus on instruments and cost recognition periods, but the quantitative inaccuracy reduces overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 572,
        "total_tokens": 2035
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How might the expiration timeline of specific patent protections for Enbrel impact Pfizer's international revenue from the drug, given AbbVie's broader strategy around patent term restoration and regulatory exclusivity?",
      "original_answer": "The expiration timeline for Enbrel's U.S. patents begins in 2028 (fusion protein composition) and extends to 2037 for formulation methods, which could delay biosimilar competition internationally. However, AbbVie's strategy of seeking patent term restoration and leveraging regulatory exclusivity under the Hatch-Waxman Act—where patent extensions can add up to five years—may further extend protection in key markets. Pfizer, which markets Enbrel outside the U.S. and Canada, could see prolonged exclusivity in certain regions, potentially extending beyond 2028, thereby preserving revenue streams if biosimilar challenges are delayed or unsuccessful.",
      "llm_answer": "Amgen’s patent table shows that Enbrel’s U.S. patents run out in November 2028, April 2029 and October 2037, and no comparable foreign‑territory patents are listed (PFE 10‑K page 11). Because Pfizer relies on those patents to block biosimilar competition abroad, the loss of U.S. protection will likely open the international markets to biosimilars soon after 2028‑2029, eroding Pfizer’s overseas Enbrel sales. AbbVie’s 10‑K (page 9) explains that it routinely pursues patent‑term restoration and regulatory exclusivity to extend protection; without similar extensions, Pfizer’s international revenue from Enbrel is vulnerable to a steeper decline once the listed patents expire.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct dates (November 2028, April 2029, October 2037) which align with the general expiration timeline in the ground truth, though the ground truth does not specify exact months—this adds precision not in the original but is not contradicted. However, the key error is the claim that 'no comparable foreign-territory patents are listed' and that 'Pfizer relies on U.S. patents to block biosimilar competition abroad,' which misrepresents the relationship between U.S. patents and international market protection. The ground truth states that AbbVie’s strategy of patent term restoration and regulatory exclusivity may extend protection in key international markets, implying that Pfizer could benefit from extended exclusivity abroad. In contrast, the LLM concludes that international markets will open soon after 2028–2029 and that Pfizer’s revenue is 'vulnerable to a steeper decline,' which contradicts the more optimistic outlook in the ground truth about prolonged exclusivity. (2) Quantitatively, the dates are plausible and consistent with the 2028–2037 range, but the LLM introduces specific months not present in the ground truth, which may be from the 10-K but are not confirmed in the provided truth. The absence of financial figures (e.g., revenue impact) in both answers keeps quantitative accuracy neutral. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize that AbbVie’s patent extension strategies (e.g., Hatch-Waxman) could benefit Pfizer internationally, even though Pfizer markets Enbrel outside the U.S. The reasoning incorrectly assumes U.S. patent expiration directly triggers international biosimilar entry, ignoring regulatory and patent strategies that can delay such competition. (4) Contextual relevance is high—the answer addresses patent expiration, biosimilar competition, AbbVie’s strategy, and Pfizer’s revenue impact. However, due to the incorrect causal inference and contradictory conclusion about revenue erosion, the overall correctness is reduced to a mid-range score. The answer gets facts partially right but draws the wrong conclusion, warranting a 5/10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 581,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How does MET's stress testing approach, which factors in early policyholder withdrawal scenarios, influence its reliance on global funding sources like commercial paper compared to COF's liquidity framework that emphasizes diversified funding sources and liquidity reserves?",
      "original_answer": "MET's stress testing includes scenarios of early policyholder withdrawal, which directly impacts its reliance on global funding sources like commercial paper to meet liquidity needs under stress conditions. MET adjusts asset mix and maturities based on rolling 12-month forecasts and relies on alternatives such as commercial paper and credit facilities when anticipated liquidity is exceeded. Similarly, COF's Liquidity Framework emphasizes diversified funding sources and maintains a liquidity reserve of cash, high-quality unencumbered securities, and committed credit lines to withstand systemic and idiosyncratic liquidity events. Both companies use stress testing to inform their funding strategies, but MET's exposure to policyholder behavior introduces a unique risk factor that directly affects its funding source selection, aligning with AIG's defined liquidity stress scenarios that impact funding sources.",
      "llm_answer": "MetLife’s liquidity program explicitly runs cash‑flow stress tests that model “early contract‑holder and policy‑holder withdrawal” scenarios; because such runs can generate sudden, large cash needs, MetLife keeps a suite of “global funding sources—including commercial paper and various credit and committed facilities” ready to meet any short‑notice shortfall (see MET 10‑K p. 123‑124). In contrast, Capital One’s Liquidity Framework is built around a diversified funding mix and a sizable reserve of cash, high‑quality securities and committed credit lines, with stress‑testing used to confirm that these diversified sources and reserves can absorb liquidity shocks rather than relying on a specific market source such as commercial paper (see COF 10‑K p. 96‑98).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: MET's stress testing includes early policyholder withdrawal scenarios, which creates sudden liquidity needs, leading to reliance on global funding sources like commercial paper and credit facilities (as cited from MET 10-K p.123-124). COF’s framework emphasizes diversified funding and a liquidity reserve of cash, high-quality securities, and credit lines, with stress testing validating resilience without reliance on any single source like commercial paper (COF 10-K p.96-98). These points match the original answer. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (MET and COF), compares their liquidity strategies, and links stress testing approaches to funding source reliance. The only minor gap is that the original answer references AIG’s defined liquidity stress scenarios as a comparative benchmark, which the LLM omits. However, this is a supplementary point and does not undermine the core comparison. (4) The LLM answer is contextually precise, directly addressing how MET’s policyholder-driven risks influence its funding source selection versus COF’s diversified, reserve-based approach. Wording differs but semantic meaning and factual content are equivalent. Thus, the answer earns a 9/10 for correctness—excellent, with only a minor omission in cross-firm contextual linkage.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 438,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How does the adoption of ASU 2022-04 impact the comparability of supplier finance obligation disclosures between CAT and GE, particularly regarding the roll-forward requirements that GE began applying in 2024?",
      "original_answer": "GE adopted ASU 2022-04 on January 1, 2023, and began applying the annual roll-forward disclosure requirement prospectively starting January 1, 2024 (GE_10k_2024.pdf:page_47). This aligns with CL's explanation that ASU 2022-04 mandates disclosures including key terms, balance sheet presentation, and a roll-forward of confirmed obligations (CL_10k_2024.pdf:page_57). CAT, in its 2024 10-K (CAT_10k_2024.pdf:page_111), provides a roll-forward of its supplier finance obligations, showing $830 million outstanding at year-end 2024. The adoption of ASU 2022-04 enhances comparability between CAT and GE by standardizing how supplier finance obligations are disclosed, particularly with the new roll-forward requirement that GE implemented in 2024.",
      "llm_answer": "ASU 2022‑04 requires a buyer that uses supplier‑finance programs to disclose the total confirmed obligation and a roll‑forward of that amount. Caterpillar (see its “Supplier finance programs” note) adopted the standard in 2023 and already presents a roll‑forward for 2024, whereas GE only began providing the roll‑forward prospectively in the 2024 filing (the standard was adopted in 2023 but the roll‑forward requirement took effect 1 January 2024). Because GE’s roll‑forward data start in 2024, the two companies’ disclosures are not directly comparable for prior periods; the difference in timing of the roll‑forward requirement, not the substance of the obligations, limits comparability between CAT and GE.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies that ASU 2022-04 requires disclosure of a roll-forward of supplier finance obligations and that both CAT and GE adopted the standard in 2023. However, it incorrectly states that Caterpillar adopted the standard in 2023 and already presents a roll-forward for 2024 — while this is plausible, the ground truth does not confirm CAT’s adoption date, only that it provides the roll-forward in its 2024 10-K. More critically, the LLM contradicts the ground truth by concluding that the disclosures are *not directly comparable* due to timing differences, whereas the ground truth explicitly states that adoption of ASU 2022-04 *enhances comparability* because both companies now follow the same standardized disclosure, especially with GE implementing the roll-forward in 2024. This is a significant qualitative error in reasoning and conclusion. (2) There are no explicit numerical errors (e.g., dollar amounts like CAT’s $830M are not mentioned in the LLM answer, so no numeric inaccuracy), but the omission of this key data point from the ground truth reduces completeness and quantitative accuracy. Dates (2023 adoption, 2024 roll-forward start) are generally consistent with the ground truth. (3) The multi-hop reasoning is partially sound — the model connects ASU 2022-04 to both companies and recognizes GE’s prospective application starting January 1, 2024. However, it fails to synthesize that this alignment improves comparability, instead suggesting reduced comparability, which misrepresents the impact. (4) Contextual relevance is high — the answer addresses the core issue of disclosure comparability and roll-forward timing. However, due to the incorrect conclusion about comparability and missing key factual support (e.g., CAT’s $830M figure), the correctness score is moderate at 6. Quantitative accuracy is marked down due to omissions, not errors. Qualitative accuracy suffers from flawed reasoning in the final inference.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 549,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How does the valuation methodology for MDLZ's Level 1 financial assets, which include exchange-traded commodity futures, differ from PEP's treatment of exchange-traded commodity futures, particularly in terms of fair value determination and daily settlement practices?",
      "original_answer": "MDLZ determines the fair value of its Level 1 financial assets, including exchange-traded commodity futures, based on quoted market prices on commodity exchanges. In contrast, PEP notes that exchange-traded commodity futures are cash-settled on a daily basis and therefore not included in their fair value hierarchy tables. While MDLZ relies directly on observable exchange prices for valuation, PEP's daily cash settlement approach for these instruments results in their exclusion from balance sheet reporting, highlighting distinct operational and accounting treatments despite both companies engaging with the same class of financial instruments.",
      "llm_answer": "MDLZ classifies exchange‑traded commodity futures as Level 1 assets and measures them at fair value using the quoted market prices on the commodity exchanges. In contrast, PepsiCo’s exchange‑traded commodity futures are cash‑settled each day, so they are not recorded in the fair‑value hierarchy (they are excluded from the Level 1 table) and are not valued by quoted prices in the same way.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and conveys the key distinction between MDLZ and PEP in their treatment of exchange-traded commodity futures. It correctly states that MDLZ classifies these instruments as Level 1 and uses quoted market prices for fair value determination, which aligns with the ground truth. It also accurately notes that PEP excludes these instruments from the fair value hierarchy due to daily cash settlement, which is consistent with the original answer. The only minor shortcoming is that the LLM answer does not explicitly mention that PEP's exclusion is because the daily settlement eliminates the need for balance sheet reporting, a nuance present in the ground truth that enhances clarity on the accounting rationale. However, the core facts, entities (MDLZ, PEP, Level 1, exchange-traded commodity futures), and reasoning are correct. There are no numerical inaccuracies (quantitative accuracy is perfect), and the answer is fully relevant to the question. The reasoning is sound and reflects proper multi-hop synthesis across the two companies' accounting policies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 310,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How does the voting rights structure between Class A and Class B common stock at CMCSA compare with META's dual-class share structure?",
      "original_answer": "At CMCSA, Class A common stockholders hold 66 2/3% of the combined voting power, while Class B common stockholders collectively hold 33 1/3%, with each share of Class B having 15 votes. In contrast, META also maintains a dual-class share structure, with Class B common stock possessing superior voting rights, although the exact vote ratio per share is not disclosed in the evidence. META had 343,761,117 shares of Class B common stock outstanding as of January 24, 2025.",
      "llm_answer": "- **Comcast (CMCSA)** – The company has two classes of common stock. Each Class B share carries **15 votes** (whereas a Class A share carries one vote), giving the single holder of all Class B shares about **33 % of the total voting power** even though Class B represents only a tiny fraction of the shares outstanding (see CMCSA 10‑K Item 5, p. 31).\n\n- **Meta Platforms (META)** – Meta also uses a dual‑class structure, but its **Class B shares carry 10 votes per share** while Class A shares carry one vote. The Class B shares are held primarily by insiders (Mark Zuckerberg and related parties) and provide them **majority voting control** of the company (Meta 10‑K, Item 5, p. 29).  \n\nThus, both firms give insiders outsized voting power, but Comcast’s Class B shares have 15 votes per share (≈33 % of voting power), whereas Meta’s Class B shares have 10 votes per share and confer a controlling majority of the votes.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly regarding META's voting structure. While it correctly states that CMCSA's Class B shares have 15 votes per share and hold approximately 33 1/3% of voting power, it incorrectly claims that META's Class B shares have 10 votes per share. The original answer (ground truth) explicitly states that the exact vote ratio per share for META is not disclosed in the evidence, making this a critical error. Additionally, the LLM asserts that META’s Class B shares confer a 'controlling majority' and are held by insiders—information not present in the provided ground truth. The ground truth only confirms that META has a dual-class structure with superior voting rights for Class B shares and reports the number of Class B shares outstanding (343,761,117 as of January 24, 2025), which the LLM omits entirely. (2) Quantitative accuracy is compromised: the 10 votes per share for META is fabricated; the 33% voting power at CMCSA is approximately correct but lacks precision (should be 33 1/3%). The CMCSA data aligns with the ground truth, but the META vote ratio and majority control claim do not. (3) The reasoning shows partial multi-hop synthesis—correctly identifying both companies use dual-class structures and linking voting power to insider control—but fails on factual grounding for META due to unsupported details. (4) Contextual relevance is high as the response directly addresses the comparison question and maintains focus on voting rights structures. However, the inclusion of unverified specifics for META undermines correctness. The answer would score higher if it had acknowledged the lack of disclosed vote ratio for META, as the ground truth does.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 469,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How do AIG's and MetLife's exposures to CLOs differ in terms of their credit loss evaluation methodologies and unrealized loss recognition, given that both hold these instruments within structured products portfolios?",
      "original_answer": "AIG evaluates credit losses on CLOs by estimating future cash flows based on delinquency rates, default expectations, loss severity timing, and structural features like credit enhancement, with unrealized losses split between credit-related impairments and non-credit fair value changes recorded in OCI. MetLife, while also holding CLOs as part of structured products within AFS fixed maturity securities, limits its involvement to passive investment in trusts without substantial equity and does not appear to disclose the same level of detailed cash flow modeling for credit loss evaluation, instead focusing on maximum exposure to loss being limited to carrying amounts. AIG explicitly accounts for credit impairments under CECL with reversibility features, whereas MetLife emphasizes its passive investor status and lack of active management involvement in CLO structures.",
      "llm_answer": "- **AIG:**  CLOs are treated as “structured fixed‑maturity securities” and are evaluated under the CECL framework.  Management builds cash‑flow models that incorporate delinquency rates, expected defaults, loss severity, pre‑payment speeds and the security’s credit‑enhancement hierarchy; when a credit‑related decline pushes fair value below amortized cost an allowance for credit losses is recorded (limited to the amortized‑cost‑fair‑value gap) and any subsequent change in that allowance is reflected in net realized gains‑losses.  Fair‑value movements that are not credit‑related are shown as “unrealized appreciation (depreciation)” – a separate line that feeds into net investment income (e.g., $692 million of unrealized appreciation in 2024).\n\n- **MetLife:**  CLOs are included in its Level‑3 “fixed‑maturity securities AFS” and are priced using NAIC designations (or an internally‑developed rating until a NAIC rating is available).  The NAIC model estimates expected losses under a range of economic scenarios and, for post‑2013 issuances, does **not** incorporate the amortized‑cost basis.  Unrealized changes in the estimated fair value of these CLOs are recorded directly in net investment income as unrealized gains or losses (e.g., $931 million of net unrealized gains in 2024).  \n\nThus, AIG uses a CECL‑based allowance‑for‑credit‑loss approach with separate unrealized‑appreciation reporting, while MetLife relies on NAIC‑based expected‑loss modeling and recognizes CLO‑related unrealized losses immediately in net investment income.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some key differences between AIG and MetLife in their treatment of CLOs but introduces significant factual inaccuracies, particularly in quantitative and methodological details. (1) Quantitative Accuracy: The dollar amounts cited—$692 million of unrealized appreciation for AIG and $931 million of net unrealized gains for MetLife in 2024—are not present in the original answer and cannot be verified against the ground truth. These figures appear fabricated or misattributed, as the original answer does not include any specific dollar amounts related to unrealized gains or appreciation. This severely undermines quantitative accuracy. (2) Completeness: The LLM addresses both companies and attempts to contrast their methodologies, covering credit loss evaluation and unrealized loss recognition, which aligns with the question. However, it omits key qualitative distinctions from the ground truth—specifically, AIG’s use of reversibility features under CECL and MetLife’s emphasis on its passive investor status and structural limitation of exposure to carrying amounts. (3) Entity Accuracy: Companies (AIG, MetLife), instrument type (CLOs within structured products), and accounting frameworks (CECL, AFS) are correctly identified. The mention of NAIC pricing models for MetLife is plausible but not explicitly confirmed in the original answer, which does not reference NAIC or internal ratings. (4) Reasoning: The LLM correctly infers that AIG uses a cash flow modeling approach under CECL and separates credit and non-credit fair value changes, which matches the original. However, it incorrectly states that MetLife uses an 'NAIC model' that estimates expected losses under economic scenarios and does not incorporate amortized cost—a detail not supported in the ground truth. The original answer does not mention NAIC, internal ratings, or scenario-based modeling for MetLife, nor does it state that MetLife recognizes unrealized losses directly in net investment income. In fact, AFS securities typically record unrealized gains/losses in OCI, not net investment income, making this a material accounting error. (5) Semantic Equivalence: While the high-level contrast—AIG using detailed cash flow modeling under CECL vs. MetLife taking a more passive approach—is directionally correct, the specific mechanisms attributed to MetLife are unsupported. The LLM invents a detailed methodology for MetLife that isn’t in the original, while missing the actual differentiator: MetLife’s lack of active management involvement and its focus on limited loss exposure. Thus, despite reasonable structure and contextual relevance, the introduction of unverified quantitative data and incorrect accounting treatment lowers the correctness score to 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1624,
        "completion_tokens": 728,
        "total_tokens": 2352
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How does the Inflation Reduction Act's redesign of Medicare Part D affect CVS's ability to forecast medical cost trends and BMY's rebate accruals for the same program?",
      "original_answer": "The Inflation Reduction Act (IRA) redesigns Medicare Part D by reducing federal reinsurance in the catastrophic phase and shifting more costs to manufacturers like BMY starting in 2025, which increases their rebate obligations. This directly impacts BMY’s gross-to-net U.S. rebate accruals for Medicare Part D, as they must account for these new liabilities in their financial reporting. For CVS, the IRA’s changes to Medicare Part D contribute to the uncertainty in forecasting health care and benefit costs, especially as new cost-sharing obligations for manufacturers may alter utilization patterns and overall program dynamics. These shifts make it more challenging for CVS to predict medical cost trends and manage profitability in their Medicare-insured products.",
      "llm_answer": "The Inflation Reduction Act’s overhaul of Medicare Part D adds new discount‑and‑rebate requirements and shifts more claim liability to plans and manufacturers, which makes the health‑care cost trends that CVS must forecast for its insured‑benefits business far more volatile and harder to predict (CVS notes that “changes … as a result of the ACA and IRA” increase the difficulty of accurately detecting and forecasting medical‑cost trends). For Bristol‑Myers Squibb, the same redesign creates additional, uncertain rebate obligations under Medicare Part D, so its GT‑to‑net “U.S. rebate accruals” now rely on more complex assumptions about the law, discount schedules and inflation penalties (BMY’s audit note flags the GTN U.S. rebate accruals for Medicare Part D as requiring significant judgment because of the IRA‑driven redesign).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the IRA's redesign of Medicare Part D increases cost liability for manufacturers like BMY and introduces forecasting challenges for CVS. The LLM correctly identifies that the changes increase rebate obligations for BMY and complicate CVS's medical cost forecasting. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in either the original or LLM answer beyond the implicit 2025 effective date of IRA changes, which is contextually understood and not contradicted. The LLM does not introduce any incorrect numbers, so quantitative accuracy is full. (3) Multi-hop reasoning is sound: the answer connects the IRA’s policy changes to their financial impact on BMY (rebate accruals requiring significant judgment) and operational impact on CVS (increased volatility in cost forecasting), synthesizing across both companies and the regulatory context. The mention of CVS citing IRA and ACA changes and BMY’s audit note about judgment in GTN accruals adds document-level support consistent with knowledge graph sourcing. (4) Semantic equivalence is strong—while the LLM uses slightly different phrasing (e.g., 'discount-and-rebate requirements', 'volatile and harder to predict'), the meaning matches the original. One minor point preventing a perfect 10 is that the LLM does not explicitly mention the reduction in federal reinsurance or the catastrophic phase shift, which are key mechanisms in the IRA redesign; however, the downstream effects on rebates and forecasting are accurately captured. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 471,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How does JPMorgan Chase's exposure to Stress Capital Buffer requirements influence its capital distribution constraints compared to Charles Schwab's obligations under the Capital Conservation Buffer, given the composition of their respective regulatory buffer requirements?",
      "original_answer": "JPMorgan Chase is subject to a Stress Capital Buffer (SCB) as part of its regulatory capital requirements, which could increase based on stress loss estimates from the Federal Reserve’s Comprehensive Capital Analysis and Review. This buffer, along with the GSIB surcharge and countercyclical buffer (CCyB), contributes to JPMorgan’s total capital buffer requirement. On the other hand, Charles Schwab’s banking subsidiary, Charles Schwab Bank (CSB), is required to maintain a Capital Conservation Buffer (CCB) of 2.5%, which imposes restrictions on capital distributions if not met. According to regulatory definitions, the CCB is a fixed component of capital buffer requirements, whereas JPMorgan’s SCB is dynamic and tied to stress testing outcomes. Therefore, JPMorgan faces a more variable and forward-looking capital constraint tied to macroeconomic stress scenarios, while Schwab faces a static buffer requirement that acts as a floor to avoid distribution limitations.",
      "llm_answer": "JPMorgan Chase must hold a Stress Capital Buffer of 5.4 % (plus a 3 % G‑SIB surcharge, giving a total regulatory buffer of 8.4 % of CET1 at year‑end 2023) 【page 134】, and the firm’s 10‑K states that any shortfall in this buffer would “reduce the amount of common stock that JPMorgan Chase is permitted to repurchase, require the issuance of, or prohibit the redemption of, capital … and curtail the amount of dividends that may be paid” 【page 22】. By contrast, Charles Schwab’s banking subsidiary is subject only to a 2.5 % Capital‑Conservation Buffer and its holding company carries a 2.5 % stress buffer (with a zero CCyB), producing a much smaller total buffer (roughly 5 %‑6 % of CET1) and therefore imposes less stringent limits on dividends, share‑repurchases or bonus payments unless those buffers fall below the minimum 【page 122】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core conceptual distinction between JPMorgan Chase's dynamic Stress Capital Buffer (SCB) and Charles Schwab's static Capital Conservation Buffer (CCB), correctly identifying that JPMorgan faces more variable, stress-test-driven constraints while Schwab’s are more fixed. This aligns with the ground truth’s emphasis on SCB being forward-looking and tied to stress scenarios versus CCB as a fixed floor. However, the LLM introduces specific numerical values (e.g., 5.4% SCB, 3% G-SIB surcharge, total 8.4% CET1 buffer for JPMorgan; ~5%-6% for Schwab) that are not present in the original answer and cannot be verified from the provided ground truth. The original answer does not include any percentages or quantitative breakdowns, so these figures, while potentially accurate from the 10-Ks, go beyond the scope of the known truth and introduce unverifiable precision. Additionally, the claim that Schwab’s holding company has a 2.5% stress buffer is not mentioned in the ground truth, which only references the 2.5% CCB for Charles Schwab Bank. This adds detail not supported by the original answer, reducing quantitative accuracy. The reasoning is otherwise sound: it correctly links buffer shortfalls to capital distribution limits (dividends, buybacks) for both firms and distinguishes regulatory frameworks. The multi-hop synthesis—comparing two firms’ buffer types and their implications—is well executed and contextually relevant. While the conceptual comparison is accurate and complete, the inclusion of unsupported numeric values and surcharges lowers the correctness and quantitative accuracy scores. Semantic equivalence is mostly preserved in logic, but not in factual content due to added specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 471,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How do General Dynamics and Raytheon Technologies differ in their financial exposure to state and local income taxes on U.S. government contracts regulated by the FAR, especially considering GD's exclusion of these taxes from its tax provision and RTX's FAR-governed cost allowability and pricing mechanisms?",
      "original_answer": "General Dynamics excludes state and local income taxes allocable to U.S. government contracts from its tax provision, instead recognizing them in operating costs and expenses. This treatment is governed by the Federal Acquisition Regulation (FAR), which dictates how costs are allocated and allowed on government contracts. Raytheon Technologies, also subject to the FAR, structures its pricing under these contracts based on allowable costs, including mechanisms like performance-based payments and progress payments that influence revenue recognition patterns. The difference in financial exposure stems from GD directly expensing these taxes while RTX incorporates them into broader cost considerations under FAR-regulated pricing frameworks.",
      "llm_answer": "General Dynamics treats the state‑ and local‑income taxes that arise on U.S. government contracts as ordinary operating costs and **excludes them from its income‑tax provision**, so the taxes appear directly in earnings rather than as a separate tax charge. Raytheon Technologies, by contrast, records those taxes in its income‑tax expense but notes that, because the contracts are governed by the FAR, the taxes are **generally recoverable through contract pricing and are allocated to the contracts**, which limits the net financial impact of the taxes on the company.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and captures the key distinction between General Dynamics (GD) and Raytheon Technologies (RTX) regarding their treatment of state and local income taxes on U.S. government contracts governed by the Federal Acquisition Regulation (FAR). (1) The LLM correctly states that GD excludes these taxes from its income tax provision and instead treats them as operating costs, which aligns with the ground truth. RTX, in contrast, includes the taxes in income tax expense but recovers them through contract pricing under FAR, limiting net financial impact—this is semantically equivalent to the original answer’s description of RTX incorporating taxes into broader FAR-regulated cost and pricing mechanisms. (2) There are no numerical values in the question or answers, so quantitative accuracy is not applicable; however, the absence of any incorrect figures supports a perfect score. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies, their differing accounting treatments, and the role of FAR in cost allowability and recovery. The only minor shortcoming is that the LLM does not explicitly mention 'performance-based payments' or 'progress payments'—details included in the original answer—but these are supplementary to the core financial exposure difference. (4) The answer is highly contextually relevant, directly addressing the comparative financial exposure and regulatory framework. Overall, the response conveys the same meaning as the ground truth with high precision and appropriate nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 432,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How does the voting power distribution in META's dual-class structure, including the dividend initiation on Class B shares, compare with GOOGL's structure where Class B shares automatically convert to Class A upon transfer?",
      "original_answer": "META’s Class B common stock is entitled to a non-dilutable 33 1/3% aggregate voting power, with each share receiving 15 votes, and it now receives the same $0.50 per share quarterly dividend as Class A stock following META’s initiation of dividends in 2024. Class B shares can convert share-for-share into Class A common stock, subject to restrictions. In contrast, GOOGL’s Class B shares are entitled to 10 votes per share and automatically convert to Class A shares upon sale or transfer, ensuring a more fluid transition between voting tiers. Both companies maintain dual-class systems to preserve founder control, but the structural mechanics and dividend treatment differ significantly.",
      "llm_answer": "Meta’s dual‑class structure gives each Class B share ten votes versus one vote for a Class A share, so the 350 million Class B shares outstanding (≈3.5 billion votes) represent roughly 60 % of the total voting power (≈5.7 billion votes) while receiving the same $0.50‑per‑share cash dividend that was newly announced for both classes【page 57】. Alphabet’s (Google’s) structure is similar in that a Class B share also carries ten votes, but the charter requires every Class B share to convert automatically to a non‑voting Class A share when it is sold or transferred, limiting the tradable voting power to the original holders and preventing a permanent voting‑control premium【page 81】. Thus, Meta’s Class B holders retain a permanent voting majority and now earn the dividend, whereas Google’s Class B holders have the same voting weight on paper but lose it upon transfer, and no dividend distinction is noted.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it states that Meta's Class B shares have 'ten votes' each, but the ground truth specifies 15 votes per Class B share. This is a critical error in voting rights. Second, the LLM claims Class B shares represent 'roughly 60% of total voting power' based on 3.5 billion out of 5.7 billion votes, but this calculation and the underlying numbers are not supported by the ground truth, which only states that Class B has a non-dilutable 33 1/3% aggregate voting power — a direct contradiction. The dividend amount ($0.50 per share) and initiation in 2024 are correctly noted, though the LLM omits the year. (2) Quantitative accuracy is low due to incorrect vote count per share (10 vs 15), fabricated vote totals (3.5B and 5.7B), and incorrect voting power percentage (60% vs 33 1/3%). The $0.50 dividend is correct. (3) The qualitative reasoning is partially sound: the comparison to GOOGL’s automatic conversion upon transfer is accurate, and both companies’ use of dual-class structures to preserve founder control is correctly inferred. However, the LLM incorrectly implies Meta’s Class B has majority voting power, when the ground truth specifies only one-third (non-dilutable), undermining the synthesis. (4) Contextual relevance is high — the answer addresses both companies, their voting structures, dividend treatment, and transfer rules. Despite incorrect numbers, it attempts the correct multi-hop comparison. The core structural contrast (permanent voting retention at Meta vs conversion upon transfer at Google) is partially captured, but distorted by quantitative errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 452,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How does the use of a 95% confidence interval in the VaR model under normal market conditions impact the one-day loss estimation methodology for both Philip Morris's derivative instruments and Mondelez's currency and commodity exposures, given their shared reliance on the parametric delta-gamma approximation technique?",
      "original_answer": "Both Philip Morris (PM) and Mondelez (MDLZ) rely on the parametric delta-gamma approximation technique within their Value at Risk (VaR) models, which operate under the assumption of normal market conditions and a 95% confidence interval. This methodology estimates the potential one-day loss by observing interest rate and currency movements—PM excludes anticipated transactions and hedges in its calculation, while MDLZ includes currency and commodity instruments, explicitly noting the non-linear response of options in the computation. The shared modeling assumption limits both firms' risk assessments to typical market behavior, potentially underestimating losses during periods of market stress.",
      "llm_answer": "Both companies’ VaR models are built on the same premise: under normal‑market conditions they assume a one‑day holding period and calculate the loss that would not be exceeded with 95 % confidence. Using a parametric delta‑gamma approximation, they translate the observed relationships among interest‑rate, currency‑ and commodity‑price movements into a statistical return distribution; the resulting VaR figure therefore represents the maximum expected one‑day loss (fair‑value loss for Philip Morris’s interest‑rate‑sensitive instruments and pre‑tax earnings loss for Mondelez’s currency‑ and commodity‑sensitive exposures) that could occur with a 95 % confidence level.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key elements are correct: the 95% confidence interval, one-day holding period, and use of parametric delta-gamma approximation are accurately stated. These match the original answer exactly. (2) The LLM correctly identifies that both Philip Morris and Mondelez use the same core VaR methodology under normal market conditions, and it appropriately distinguishes the risk exposure types—interest-rate and currency for PM, currency and commodity for MDLZ—even specifying that Mondelez’s VaR relates to pre-tax earnings while PM’s relates to fair value, which adds precision not explicitly in the ground truth but consistent with typical reporting practices. (3) Regarding multi-hop reasoning: the LLM synthesizes shared methodology (delta-gamma, 95% confidence, normal conditions) and correctly maps it to each company’s specific risk factors, demonstrating sound cross-entity understanding. The only minor omission is that the original answer notes PM excludes anticipated transactions and hedges, and MDLZ accounts for non-linear option behavior—nuances not included in the LLM response, which prevents a perfect 10 on qualitative accuracy. (4) Despite these small omissions, the LLM captures the core impact of the 95% confidence interval and parametric method on one-day loss estimation, maintains semantic equivalence, and stays fully relevant to the question. Thus, correctness is scored 9 for high accuracy with minor detail gaps.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 419,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How do the embedded derivatives within CDOs referenced by Morgan Stanley compare in risk exposure to Bank of America's structured liabilities that also contain embedded derivatives, particularly in the context of credit events impacting their market-making activities?",
      "original_answer": "Morgan Stanley's involvement with CDOs includes hybrid instruments containing embedded derivatives where credit protection has been sold to the issuer of the note, exposing the firm to risk in the event of a credit event on the reference entity, which could result in the principal balance of the note not being repaid in full. Similarly, Bank of America's structured liabilities also contain embedded derivatives that are part of their market-making activities, and these derivatives are typically offset by gains or losses on hedging instruments. Both firms face credit risk tied to these derivatives, though the specific impact on Morgan Stanley is tied to the performance of the CDOs' underlying reference entities, while Bank of America's exposure is more broadly tied to the performance of their structured liabilities and the effectiveness of their hedging strategies.",
      "llm_answer": "Morgan Stanley’s CDO and CLN holdings contain embedded credit‑derivative features that transfer credit‑protection risk to the firm; if a reference entity experiences a credit event, the principal on the note can be reduced or not repaid, directly exposing the firm’s market‑making book to a loss on the underlying security. Bank of America’s structured liabilities also embed derivatives, but they are recorded under the fair‑value option and the firm’s market‑making gains and losses are generally offset by the offsetting gains or losses on those embedded derivatives, so the credit‑event risk is largely managed through hedge accounting rather than a direct principal‑shortfall exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Morgan Stanley's CDOs contain embedded derivatives where credit protection is sold, exposing the firm to principal loss upon a credit event; Bank of America's structured liabilities include embedded derivatives that are fair-value option liabilities, with gains/losses offset by hedging instruments. The distinction in risk exposure—direct principal shortfall for Morgan Stanley vs. managed risk via hedge accounting for Bank of America—is correctly captured. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not applicable but assumed correct by absence of error. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two firms, two financial instruments (CDOs/CLNs vs. structured liabilities), and compares their risk profiles in the context of credit events and market-making activities. (4) Semantic equivalence is strong—wording differs slightly (e.g., 'hedge accounting' vs. 'effectiveness of hedging strategies'), but the meaning is consistent. The only minor gap is that the LLM slightly overemphasizes 'hedge accounting' as a technical term not explicitly in the original, though the concept of offsetting gains/losses is present in both. This does not constitute a factual error but a slight shift in emphasis. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 421,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How does the global minimum tax under the OECD's Pillar Two model rules impact Salesforce's effective tax rate compared to Microsoft's projected tax liability, given the uncertainty around implementation timelines and jurisdictional adoption?",
      "original_answer": "Salesforce notes that global tax developments, including the OECD's Pillar Two model rules introducing a 15% global minimum tax, may have a material impact on its business, cash flows, or financial results. Microsoft, which currently operates with an effective tax rate of 19% (down to 18% in fiscal 2024), expects Pillar Two to apply to its operations starting in fiscal 2025 but does not currently estimate a material impact to its consolidated financial statements. However, uncertainty remains as to the final Pillar Two model rules and their adoption across jurisdictions, which could affect both companies differently depending on their global footprint and tax planning strategies.",
      "llm_answer": "Microsoft reports an effective tax rate of 18 % for FY 2024 (19 % for FY 2023) and notes that the OECD‑Pillar Two 15 % global minimum tax will begin to apply to Microsoft in FY 2025, but it “does not currently estimate a material impact” on its consolidated statements (MS 10‑K p. 47).  \n\nSalesforce, by contrast, only says that the Pillar Two rules “may include a new global minimum tax of 15 %” and that “there remains uncertainty as to the final Pillar Two model rules” and the timing of adoption in various jurisdictions (CRM 10‑K p. 29); it does not quantify any change to its effective tax rate, indicating that the company is still monitoring the development and does not expect a material effect at this time.  \n\nThus, while Microsoft expects the Pillar Two tax to start affecting its tax liability from FY 2025 (though currently immaterial), Salesforce’s effective tax rate remains unchanged in the disclosed period, with the impact of the global minimum tax remaining uncertain and not yet reflected in its tax expense.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All factual information is correct: Microsoft's effective tax rate is accurately reported as 19% in FY2023 and 18% in FY2024, with Pillar Two expected to apply starting in FY2025 and no current material impact—this matches the original answer. Salesforce is correctly described as noting uncertainty around Pillar Two and the potential for a 15% global minimum tax without quantifying the impact, which is consistent with the original. (2) Quantitative accuracy is perfect: percentages and fiscal years are correctly cited, and no calculations are required beyond accurate reporting of disclosed figures. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information from both companies’ 10-Ks, compares their differing levels of disclosure and expectations regarding Pillar Two, and draws a reasonable contrast—Microsoft has a timeline and immaterial expectation, while Salesforce remains in monitoring mode. (4) The only minor shortcoming is that the original answer explicitly notes Salesforce’s concern about material impact on 'business, cash flows, or financial results,' which the LLM slightly underemphasizes by stating 'does not expect a material effect at this time'—a subtle but important nuance in tone (Salesforce is uncertain, not dismissive). However, the LLM does convey the uncertainty adequately. Overall, the answer is factually correct, well-reasoned, and fully relevant to the comparative, multi-jurisdictional, and forward-looking nature of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 429,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How does Boeing's Five-Year Credit Agreement, which involves JPMorgan Chase Bank, N.A. as syndication agent, compare with Honeywell's credit agreement with JPMorgan Chase Bank, N.A. in terms of syndication structure and key banking partners?",
      "original_answer": "Boeing's Five-Year Credit Agreement, dated October 30, 2019, includes JPMorgan Chase Bank, N.A. as syndication agent alongside Citibank, N.A. as administrative agent, with both also serving as joint lead arrangers and joint book managers. Honeywell's Amended and Restated Five-Year Credit Agreement, dated March 20, 2023, also features JPMorgan Chase Bank, N.A., along with Wells Fargo Bank, National Association, as syndication agents, with Bank of America, N.A. serving as administrative and swing line agent. Both agreements involve JPMorgan Chase Bank, N.A. in a syndication role, but differ in the lead arranger structure and partner institutions involved.",
      "llm_answer": "Boeing’s five‑year credit facility names **Citibank, N.A.** as the administrative agent and **JPMorgan Chase Bank, N.A.** as the sole syndication agent – the two banks also serve as joint lead arrangers and joint book‑managers on the deal. Honeywell’s comparable five‑year credit agreement uses **Bank of America** as the administrative (and swing‑line) agent, while **JPMorgan Chase Bank, N.A.** and **Wells Fargo Bank, N.A.** act together as syndication agents. Thus Boeing relies on a single syndication partner (JPMorgan) alongside Citibank, whereas Honeywell employs a broader syndication structure that includes both JPMorgan and Wells Fargo, with Bank of America as the primary administrative bank.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All entities are correctly identified: Boeing's agreement correctly names Citibank, N.A. as administrative agent and JPMorgan Chase Bank, N.A. as syndication agent, with both as joint lead arrangers and joint book managers. Honeywell's agreement correctly identifies JPMorgan Chase Bank, N.A. and Wells Fargo Bank, N.A. as co-syndication agents and Bank of America, N.A. as administrative and swing line agent. (2) No numeric values (e.g., dates, dollar amounts) are present in either answer, so quantitative accuracy is not compromised; all referenced roles and structures are factually consistent with the original. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two different credit agreements, compares syndication structures, and identifies key differences in agent roles and participating banks. (4) The only minor shortcoming is that the LLM refers to JPMorgan Chase Bank, N.A. as the 'sole syndication agent' for Boeing, while the original answer does not use 'sole' but implies it by listing only one syndication agent. This is a reasonable inference and does not introduce inaccuracy. The LLM also omits the exact dates of the agreements (Oct 30, 2019, and March 20, 2023), but since the question does not explicitly ask for dates, this omission does not detract significantly from correctness. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 419,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How does the absence of the Countercyclical Capital Buffer requirement impact the total capital buffer requirements for both Bank of America and Morgan Stanley under the Advanced Approaches framework, given their respective G-SIB surcharges of 2.5% and inclusion of the 2.5% Capital Conservation Buffer?",
      "original_answer": "For Bank of America, the absence of the Countercyclical Capital Buffer (CCyB) means its total Common Equity Tier 1 (CET1) capital buffer requirement under the Advanced Approaches framework is the sum of its G-SIB surcharge of 2.5% and the 2.5% Capital Conservation Buffer, totaling 5.0%. Similarly, Morgan Stanley’s CET1 capital buffer requirement under the same framework is also the sum of its G-SIB surcharge (which is not quantified in the provided data but assumed to be included), the 2.5% Capital Conservation Buffer, and the zero CCyB. Therefore, the absence of CCyB directly reduces the total CET1 buffer requirement for both banks by the amount the CCyB would have otherwise contributed.",
      "llm_answer": "Because the counter‑cyclical capital buffer (CCyB) is set to 0 % for both firms, the only components that count toward the Advanced‑Approaches capital‑buffer requirement are the G‑SIB surcharge (2.5 %) and the mandatory capital‑conservation buffer (2.5 %). Consequently, the total buffer that each institution must hold under the Advanced Approaches is 5.0 % of risk‑weighted assets for both Bank of America (with a 2.5 % G‑SIB surcharge) and Morgan Stanley (also with a 2.5 % G‑SIB surcharge).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the absence of the Countercyclical Capital Buffer (CCyB) means it contributes 0% to the total capital buffer, and thus the total buffer for both banks is the sum of the 2.5% G-SIB surcharge and the 2.5% Capital Conservation Buffer, totaling 5.0%. This matches the ground truth quantitatively and conceptually. (2) All numeric values are accurate: 2.5% G-SIB surcharge for both banks, 2.5% Capital Conservation Buffer, and resulting 5.0% total buffer. Calculations are correct (2.5% + 2.5% = 5.0%). (3) The reasoning is sound and reflects proper multi-hop synthesis: understanding that under the Advanced Approaches framework, total CET1 buffer = G-SIB surcharge + Capital Conservation Buffer + CCyB (which is zero). The model correctly applies this logic to both Bank of America and Morgan Stanley. (4) The only minor limitation is that the original answer notes Morgan Stanley's G-SIB surcharge is 'not quantified in the provided data but assumed to be included', whereas the LLM confidently states it as 2.5%. While this value is correct in reality and consistent with the ground truth implication, the LLM does not reflect the uncertainty present in the source data. However, since the question states Morgan Stanley's G-SIB surcharge is 2.5%, the LLM is justified in using it. Thus, the answer is factually correct, complete, and contextually appropriate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 399,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "What was NVIDIA's effective tax rate in fiscal year 2022, and how does it compare to Apple's operating income margin in the Greater China region during the same period?",
      "original_answer": "NVIDIA's effective tax rate in fiscal year 2022 was 1.9%, significantly lower than the U.S. federal statutory rate of 21%, due in part to income earned in jurisdictions like Hong Kong that have lower tax rates. Meanwhile, Apple reported $31,153 million in operating income from $74,200 million in net sales in the Greater China region during fiscal year 2022, resulting in an operating income margin of approximately 42%. These metrics reflect different financial impacts from operating in the region, with NVIDIA benefiting from lower tax rates and Apple demonstrating strong profitability from its sales in the same market.",
      "llm_answer": "NVIDIA reported an annual effective tax rate of **1.9 %** for fiscal year 2022【page_52】.  \nApple’s Greater China segment generated **$31,153 million of operating income on $74,200 million of net sales**, giving an operating‑income margin of roughly **42 %** (31,153 ÷ 74,200)【page_52】.  \n\nThus, NVIDIA’s effective tax rate was far lower than Apple’s operating‑income margin in Greater China (1.9 % vs. about 42 %).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: NVIDIA's effective tax rate is correctly stated as 1.9%, and Apple's operating income ($31,153 million) and net sales ($74,200 million) in Greater China are exact. The calculated operating income margin of approximately 42% (31,153 ÷ 74,200 ≈ 0.4198 or 41.98%, rounded to 42%) is correct. (2) The answer addresses both parts of the multi-part question: it reports NVIDIA’s tax rate and compares it to Apple’s operating margin in Greater China. (3) Entity accuracy is perfect—correct companies (NVIDIA, Apple), correct metric names (effective tax rate, operating income margin), correct region (Greater China), and correct fiscal year (2022). (4) The reasoning is sound: the LLM correctly synthesizes data from two different companies and financial metrics, makes a valid comparison, and draws a logical conclusion about the relative magnitudes (1.9% vs. 42%). The semantic meaning is equivalent to the original answer, with only minor formatting differences (e.g., use of '【page_52】' for citation). No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 330,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How do BA's and UPS's uses of pricing models for valuing Level 2 assets differ based on the observable inputs they emphasize in their 2024 filings?",
      "original_answer": "BA values its fixed income investments categorized as Level 2 using pricing models that incorporate inputs such as benchmark yields, swap curves, and inter-dealer broker rates. These models are primarily income-based and rely on structured cash flow analysis and rating agency data. In contrast, UPS applies pricing models to value its Level 2 derivatives—mainly over-the-counter instruments—using market observable inputs like yield curves, foreign currency exchange rates, and investment forward prices. While both companies rely on observable market data for Level 2 classifications, BA emphasizes credit and yield-related inputs for fixed income instruments, whereas UPS focuses on currency and interest rate dynamics for its derivative positions.",
      "llm_answer": "Boeing (BA) states that its Level 2 fair‑value models are built on a wide range of observable market data – reported trades, broker quotes, benchmark yields and base spreads, plus swap‑curve rates, rating‑agency spreads, cash‑flow analyses and other broker‑derived inputs. In contrast, UPS explains that its Level 2 foreign‑currency and interest‑rate derivatives are valued with models that rely principally on a few core observable inputs: the relevant yield curves, the current foreign‑exchange rates and the forward‑price curves for the underlying currencies.  Thus, Boeing emphasizes a broader set of market‑observable inputs, while UPS concentrates on yield‑curve, FX‑rate and forward‑price information.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: BA uses observable inputs such as benchmark yields, swap curves, broker quotes, rating agency spreads, and cash flow analyses for its fixed income Level 2 assets—consistent with the original answer. UPS relies on yield curves, foreign exchange rates, and forward prices for its Level 2 derivatives, which matches the ground truth. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a traditional sense, but all descriptive metrics are correctly represented. (3) The multi-hop reasoning is sound: the model correctly identifies and contrasts the different types of Level 2 assets (fixed income vs. derivatives) and the differing emphasis in observable inputs (credit/yield-focused for BA vs. currency/interest rate dynamics for UPS). (4) The LLM slightly rephrases the distinction—describing BA’s approach as using a 'broader set' of inputs and UPS’s as more 'concentrated'—which is a valid interpretation but not explicitly stated in the original. This minor interpretive addition does not detract from accuracy. Overall, the answer is semantically equivalent, contextually relevant, and factually correct, warranting a high score with only a slight deduction in qualitative accuracy due to subtle framing differences.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 389,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How does the voting power disparity between Class A and Class B common stock at GOOGL compare to the uniform voting rights structure at NFLX, particularly in light of GOOGL's $62.2 billion share repurchase program in 2023?",
      "original_answer": "GOOGL's Class A common stockholders have 1 vote per share, while Class B common stockholders have 10 votes per share, creating a significant disparity in voting power. This contrasts sharply with NFLX, where each share of common stock carries exactly one vote, ensuring equal voting rights across all shareholders. Additionally, GOOGL's 2023 share repurchase program, which retired $62.2 billion worth of shares, primarily targeted Class A and Class C shares, potentially influencing the overall voting balance by reducing the number of shares that convert from Class B to Class A upon transfer, thereby preserving the voting control of existing Class B holders.",
      "llm_answer": "Alphabet’s capital structure gives Class A shares one vote each while Class B shares carry ten votes per share, creating a ten‑fold voting‑power gap between the two classes (see GOOGL Note 11). In contrast, Netflix is a single‑class company in which every share has the same voting right (one vote per share). Thus, even as Alphabet spent $62.2 billion repurchasing Class A and Class C stock in 2023, its voting power remains heavily weighted toward the small group that holds Class B shares, whereas Netflix’s shareholders all enjoy identical voting influence.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: GOOGL Class A has 1 vote/share, Class B has 10 votes/share, and NFLX has uniform 1 vote/share — this is stated clearly and precisely. The $62.2 billion share repurchase in 2023 is correctly cited. (2) Quantitative accuracy is perfect: the dollar amount ($62.2 billion), the years (2023), and the voting ratios (1:10) are all factually correct and match the original answer. Format variations (e.g., $62.2B vs $62.2 billion) are acceptable and do not affect accuracy. (3) The multi-hop reasoning is sound: the model correctly contrasts GOOGL’s dual-class structure with NFLX’s single-class structure and links the share repurchase to its impact on voting power concentration. It correctly notes that repurchases of Class A and C shares do not dilute Class B control, preserving disproportionate voting power — a nuanced but critical point implied in the original answer. (4) The only minor shortcoming is that the LLM does not explicitly mention that Class B shares convert to Class A upon transfer (a mechanism that helps preserve control), nor does it state that repurchases reduce the pool of shares that could dilute Class B voting power. This omission slightly weakens the qualitative depth but does not invalidate the core reasoning. Overall, the answer is semantically equivalent, contextually precise, and factually robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 395,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does ACN's classification of U.S. government debt securities as Level 2 assets affect comparability with AVGO's investment disclosures, given that such securities are typically categorized as Level 1 based on active market pricing?",
      "original_answer": "ACN classified its U.S. government debt securities as Level 2 assets totaling $9,765 million, which contrasts with AVGO's disclosures where Level 1 securities are described as being valued based on quoted prices in active markets. This is notable because the UPS evidence indicates that U.S. government debt securities are generally categorized as Level 1 due to quoted prices in active markets. AVGO’s disclosures explicitly differentiate Level 1 and Level 2 securities based on valuation methodology, suggesting that ACN’s choice to classify these assets as Level 2 could reduce transparency and comparability in investment valuation practices between the two firms.",
      "llm_answer": "Accenture (ACN) records the U.S. government, state and local debt securities held in its defined‑benefit pension plans as **Level 2** fair‑value assets (see ACN page 96), meaning they are valued using quoted prices for similar‑but‑not‑identical instruments or other observable inputs. Broadcom (AVGO), by contrast, treats “most U.S. government debt securities” as **Level 1** assets because they have quoted prices in active markets (AVGO page 80). Because Level 1 measurements are considered more reliable and liquid than Level 2, ACN’s classification reduces the direct comparability of its investment disclosures with AVGO’s, making ACN’s reported values appear less transparent and potentially more subject to valuation judgment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: ACN classifies U.S. government debt securities as Level 2 assets, while AVGO classifies them as Level 1 due to active market pricing. The dollar amount ($9,765 million) from the ground truth is not explicitly mentioned in the LLM answer, but the omission does not distort the comparison and may reflect summarization. (2) Quantitative accuracy is strong—no incorrect numbers or calculations are presented. The absence of the exact figure reduces completeness slightly but does not affect correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across ACN and AVGO filings, understands the implications of Level 1 vs. Level 2 classifications, and infers reduced comparability and transparency. It also correctly references the conceptual reliability difference between levels. (4) The answer is contextually relevant, directly addressing the impact on comparability and transparency. The only minor shortcoming is the lack of explicit reference to the UPS evidence indicating typical Level 1 classification, which slightly weakens the support for the general practice. However, the conclusion remains logically valid. Overall, the answer conveys the same core message as the ground truth with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 374,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does Colgate-Palmolive's adoption timeline for ASU 2022-04, which mandates detailed disclosures on supplier finance obligations, compare to Target's implementation of similar disclosures, particularly regarding the confirmed amount outstanding at year-end?",
      "original_answer": "Colgate-Palmolive adopted ASU 2022-04 beginning January 1, 2023, with the roll-forward information disclosure effective January 1, 2024. Target discloses its confirmed obligations outstanding under supplier finance programs within Accounts Payable on its Consolidated Statements of Financial Position, with early payment options available to vendors up to 120 days from the invoice date. While Colgate-Palmolive references Note 15 for program details, Target explicitly outlines the structure of its arrangements and vendor discretion in electing early payments, though exact confirmed amounts are not quantified in the provided excerpt.",
      "llm_answer": "Both Colgate‑Palmolive and Target began applying the supplier‑finance‑program disclosure requirements of ASU 2022‑04 on **January 1 2023**, and each started providing the required roll‑forward tables a year later (effective **January 1 2024**).  \n\nAt the end of their most recent fiscal years, Colgate‑Palmolive disclosed **about $3.4 billion** of vendor obligations eligible for early payment (the “confirmed amount outstanding”), whereas Target reported a **smaller confirmed balance of roughly $2.1 billion** at its year‑end.  Thus, while the adoption timing is the same for both companies, Colgate‑Palmolive’s confirmed supplier‑finance liability is materially higher than Target’s.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While both companies adopted ASU 2022-04 on January 1, 2023, and the roll-forward disclosures began January 1, 2024, this timing alignment is not confirmed in the ground truth for Target—only Colgate-Palmolive's timeline is explicitly stated. More critically, the LLM asserts specific numerical values: $3.4 billion for Colgate-Palmolive and $2.1 billion for Target as 'confirmed amounts outstanding.' However, the original answer states that Target does *not* quantify the exact confirmed amount in the provided excerpt. Thus, the $2.1 billion figure for Target is unsupported and incorrect. The $3.4 billion figure for Colgate-Palmolive is also not present in the ground truth, which only mentions that Colgate references Note 15 for program details but does not specify a dollar amount. (2) Quantitative accuracy is severely compromised—both dollar figures are fabricated or hallucinated, and the comparison between them is therefore invalid. Dates are partially correct for Colgate, but not fully verifiable for Target. (3) The multi-hop reasoning is flawed: the model incorrectly synthesizes that both companies have disclosed quantified confirmed amounts and that they are comparable, when in fact the ground truth emphasizes that Target does *not* provide such a quantification. The reasoning assumes data availability beyond what is supported. (4) Despite these issues, the answer is contextually relevant—it addresses adoption timelines and attempts to compare disclosures on confirmed amounts, which aligns with the question’s intent. However, the hallucinated numbers and unsupported comparisons drastically reduce correctness. Qualitative accuracy is low due to incorrect entity-attribute mapping (assigning unreported figures to Target), but the general structure of the response follows logical lines.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 510,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does BlackRock's exposure to operational risks through third-party technology partners like Microsoft compare to Mastercard's approach in managing similar reputational risks stemming from their own operational resilience strategies?",
      "original_answer": "BlackRock discloses that its reliance on key technology partners like Microsoft for hosting Aladdin on Azure introduces operational and execution risks, including infrastructure reliability, software security, and regulatory oversight, which could lead to reputational harm or legal liability if not managed properly. Operational risk is explicitly defined in the COF evidence as having the potential to result in reputational impact due to internal process failures, system issues, or external events. Mastercard identifies 'Reputational Impact' as a named risk factor in its 10-K and structures its risk management framework around it, listing 'Operational Resilience' as a core component of its reputational risk mitigation strategy. This suggests that while both firms recognize the reputational consequences of operational failures, BlackRock's risk is heightened by its dependency on external cloud providers, whereas Mastercard integrates operational resilience directly into its brand protection framework.",
      "llm_answer": "BlackRock flags its reliance on third‑party technology providers – most notably Microsoft Azure for its Aladdin platform – as a source of operational, execution and regulatory‑oversight risk that could spill over into reputational damage if the cloud service fails or is subject to a breach (see BLK page 28). Mastercard, by contrast, treats reputational risk as part of its broader “Information Security and Operational Resilience” framework, relying on internal disclosure‑control assessments, board‑level oversight of internal controls and an established operational‑risk program to mitigate the impact of service‑disruption events (see MA pages 25 and 109). Thus, BlackRock’s exposure stems mainly from external vendor dependence, whereas Mastercard manages similar reputational exposure through internal resilience controls and governance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: BlackRock's reliance on Microsoft Azure for Aladdin is accurately described as introducing operational, execution, and regulatory risks that could lead to reputational damage. Mastercard's integration of 'Operational Resilience' within its broader reputational risk framework is correctly characterized, including references to internal controls, board oversight, and its risk management program. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a traditional sense—however, the absence of any incorrect numbers or miscalculations supports a perfect score. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (BlackRock and Mastercard), identifies their differing approaches to operational and reputational risk, and contrasts external vendor dependence (BlackRock) with internal resilience strategies (Mastercard). (4) The only minor shortcoming is that the LLM does not explicitly name 'Reputational Impact' as a formally listed risk factor in Mastercard’s 10-K or directly cite the term 'operational risk' as defined in COF evidence, which slightly reduces qualitative completeness. However, the semantic meaning and core insight—that Mastercard embeds operational resilience into brand protection while BlackRock faces heightened risk due to third-party dependency—are fully preserved. Wording differs slightly but meaning is equivalent. Contextual relevance is perfect as the response directly addresses the comparative risk exposure and mitigation strategies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 465,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How significant was Cardinal Health as a customer for BMY in 2021, and what role does Cardinal play in CVS's generic pharmaceutical sourcing strategy through Red Oak Sourcing, LLC?",
      "original_answer": "Cardinal Health represented 20% of BMY's revenue in 2021, making it a significant customer relationship. CVS partners with Cardinal through Red Oak Sourcing, LLC, where both companies hold 50% ownership and jointly negotiate generic pharmaceutical supply contracts. This strategic arrangement enables CVS and Cardinal to leverage combined sourcing capabilities, though it does not involve inventory ownership by Red Oak. The shared sourcing venture highlights Cardinal's dual role as both a key BMY customer and a strategic partner in CVS's supply chain infrastructure.",
      "llm_answer": "In 2021 Cardinal Health accounted for roughly 20 percent of Bristol‑Myers Squibb’s global gross revenues, making it the single largest wholesale customer of BMY that year. At CVS, Cardinal is a 50 percent owner of Red Oak Sourcing, LLC – a joint venture that pools CVS’s and Cardinal’s sourcing and supply‑chain expertise to negotiate and secure generic‑drug supply contracts for both companies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) Quantitatively, the 20% figure for Cardinal Health's share of BMY's 2021 revenue is correct, and the 50% ownership in Red Oak Sourcing, LLC is accurately stated. (2) The answer correctly identifies all key entities: Cardinal Health, Bristol-Myers Squibb (BMY), CVS, and Red Oak Sourcing, LLC, with correct time frame (2021). (3) Multi-hop reasoning is sound: it connects Cardinal’s role as a major BMY customer and its strategic partnership with CVS via Red Oak. (4) The only minor omission is that the original answer notes Red Oak does not involve inventory ownership, and emphasizes the dual role of Cardinal more explicitly. While this adds context, its absence does not undermine the factual correctness or completeness of the core response. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually correct, well-reasoned, and fully relevant, meriting a high score with only slight deduction for minor contextual completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 302,
        "total_tokens": 1552
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How does the voting power of Class B common stockholders at META compare to that of NFLX common stockholders, given that META Class B shares are restricted to specific voting scenarios and each share carries a multiplier based on the conversion rate?",
      "original_answer": "META's Class B common stockholders have restricted voting rights, only applicable in specific scenarios such as exiting the core payments business, a merger, or certain amendments to the certificate of incorporation. In these cases, each Class B share's voting power is multiplied by the applicable conversion rate in effect on the record date. In contrast, NFLX common stockholders receive one vote per share on all matters requiring stockholder approval. This means that while META Class B shareholders have conditional voting rights with variable influence based on the conversion rate, NFLX shareholders have consistent, unconditional voting power proportional to their shareholding.",
      "llm_answer": "Meta’s Class B shares do not vote on most matters; they are only allowed to vote on a few defined actions (e.g., a merger, a spin‑off or certain charter amendments). When they do vote, each Class B share carries a multiplier equal to the conversion rate – effectively ten votes per share (Meta’s charter gives a Class B share ten votes). In contrast, every Netflix share carries one vote on every shareholder matter. Thus, a Meta Class B holder can wield up to ten times the voting power of a Netflix shareholder, but only in the narrow set of situations where Meta permits Class B voting.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that Meta's Class B shares have restricted voting rights, applicable only in specific scenarios like mergers or charter amendments, which aligns with the original answer's mention of 'specific scenarios such as exiting the core payments business, a merger, or certain amendments.' While the LLM omits 'exiting the core payments business,' it captures the essential narrow scope of voting rights. (2) The LLM accurately describes the voting multiplier based on the conversion rate, specifying 'ten votes per share' — this is consistent with known public filings where Meta’s Class B shares typically carry 10 votes per share upon conversion, so the quantitative detail is correct and acceptable even if not explicitly stated in the ground truth. (3) The comparison to Netflix is sound: NFLX common stockholders indeed have one vote per share on all matters, and the LLM correctly contrasts this with Meta’s conditional, high-vote structure. (4) The reasoning is logically sound and synthesizes the multi-hop elements (voting conditions, multiplier effect, cross-company comparison) appropriately. The only minor shortcoming is the omission of one specific voting scenario ('core payments business'), which slightly reduces completeness but does not affect the overall correctness. Wording differs but semantic equivalence is maintained. All entities (Meta, NFLX, Class B shares) are correctly identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 416,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How does the automatic conversion of Class B shares upon transfer at GOOGL contrast with META's structural protections that require Class B approval for change-of-control transactions, and what role does Mastercard's mandatory post-conversion Class A stock transfer mechanism play in evaluating dual-class governance frameworks?",
      "original_answer": "META requires that any change-of-control transaction must be approved by a majority of its outstanding Class B common stock voting as a separate class until those shares represent less than 35% of combined voting power. In contrast, GOOGL's Class B shares automatically convert to Class A shares upon sale or transfer, effectively limiting concentrated voting control over time. Mastercard's framework mandates that converted Class B shares become Class A shares that must be sold or transferred, creating a structural mechanism that prevents long-term retention of higher-vote shares. This contrast reveals different approaches to dual-class governance: META entrenches control through voting rights preservation, while GOOGL and Mastercard implement mechanisms that eventually dilute concentrated voting power through mandatory conversion and divestiture.",
      "llm_answer": "Alphabet’s charter lets a holder of Class B stock convert the 10‑vote shares into one‑vote Class A shares at any time and, by rule, the conversion occurs automatically whenever the shares are sold or otherwise transferred (page 81). Meta, by contrast, keeps its high‑voting Class B shares alive and entrenched – its certificate of incorporation requires a majority of the outstanding Class B stock to approve any change‑of‑control transaction until the B‑share voting power falls below a set threshold (see the anti‑takeover provisions on page 50). Mastercard adds a further safeguard to its dual‑class model: after a one‑for‑one conversion of Class B to Class A, the new Class A shares must be sold or otherwise transferred, preventing the former B‑holder from accumulating voting‑right‑rich Class A stock (page 99). Together, these features illustrate how automatic conversion (Alphabet) or mandatory post‑conversion divestiture (Mastercard) can dilute or eliminate the voting advantage of high‑voting shares, whereas Meta’s structure preserves that advantage until a formal Class B vote is obtained.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: GOOGL's Class B shares automatically convert to Class A upon transfer; META requires majority Class B approval for change-of-control transactions until Class B voting power falls below 35%; Mastercard mandates that after Class B converts to Class A, the shares must be sold or transferred. (2) There are no numeric values requiring calculation (e.g., percentages, dollar amounts), but the structural thresholds (e.g., 'below 35%') are correctly implied through context, and no incorrect numbers are present. (3) Multi-hop reasoning is sound: the answer synthesizes governance mechanisms across three companies (GOOGL, META, Mastercard), correctly contrasting entrenched control (META) with dilutive mechanisms (GOOGL and Mastercard). (4) The LLM captures the core insight: automatic conversion and mandatory divestiture erode long-term voting concentration, whereas Meta’s structure preserves it. Wording differs slightly but meaning is preserved, including correct use of terms like 'automatic conversion', 'mandatory post-conversion divestiture', and 'entrenched'. All parts of the question are addressed with precise, relevant information.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1535,
        "completion_tokens": 354,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How do MRK's pediatric market exclusivity opportunities compare with AMGN's regulatory exclusivity risks given recent changes to data protection periods for biologics?",
      "original_answer": "MRK benefits from six-month pediatric market exclusivity extensions that can apply to products like its high-risk adult COVID-19 treatment, potentially extending protection beyond patent expiration. In contrast, AMGN faces regulatory exclusivity risks as the FDA considers changes to biologic data exclusivity, including whether umbrella exclusivity applies, which could reduce the effective protection period for products like EPOGEN. These differences reflect MRK's proactive IP strategy versus AMGN's exposure to policy shifts in biologic exclusivity frameworks.",
      "llm_answer": "Merck (MRK) notes that its products can earn the statutory six‑month pediatric‑exclusivity extension, which adds to any existing patent term and can delay generic or biosimilar entry. Amgen (AMGN), by contrast, flags regulatory‑exclusivity risk: recent policy changes have removed the 10‑year data‑exclusivity requirement in the USMCA and the FDA is reconsidering “umbrella” protection for biologics, meaning the 12‑year BPCIA exclusivity period could be shortened and biosimilars may launch earlier. Thus MRK’s outlook centers on a modest, but certain, pediatric‑exclusivity boost, while AMGN faces uncertainty and possible erosion of its biologic data‑exclusivity protection.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key numbers and timeframes are correct: the six-month pediatric exclusivity for MRK and the 12-year BPCIA exclusivity for biologics (implied in AMGN's risk) are accurately cited. The mention of USMCA changes and FDA reconsideration of 'umbrella' protection reflects real policy dynamics, consistent with the knowledge graph. (2) The answer correctly identifies both companies (MRK and AMGN) and links them to the appropriate regulatory mechanisms—pediatric exclusivity for Merck and biologic data exclusivity risks for Amgen. (3) Multi-hop reasoning is sound: it synthesizes MRK’s proactive use of statutory extensions with AMGN’s exposure to regulatory shifts, contrasting certainty versus uncertainty in exclusivity outcomes. (4) Semantically, the LLM conveys the same core insight as the original: MRK gains modest, predictable extensions while AMGN faces potential erosion due to policy changes. The only minor shortcoming is that the original answer references specific products (e.g., EPOGEN) and contexts (high-risk adult COVID-19 treatment), which the LLM omits—this slight reduction in specificity prevents a perfect 10 but does not undermine factual correctness. Overall, the response is factually precise, contextually relevant, and logically structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 377,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How do MA's and V's dual-class stock structures differ in terms of voting power distribution and control concentration mechanisms, particularly regarding the balance between Class A and Class B shares?",
      "original_answer": "MA's dual-class structure grants Class B common stock 15 votes per share, with all outstanding shares held by Mr. Brian L. Roberts, representing 33⅓% of the combined voting power, while Class A common stockholders collectively hold 66⅔% of the voting power. In contrast, V's structure ties Class B common stock transferability and convertibility to the resolution of U.S. covered litigation, with conversion rates for Class B shares into Class A shares subject to adjustments based on follow-on offerings or litigation outcomes. Additionally, V's Class C common stock has no transfer restrictions, and its exchange program allows for partial release of restrictions on Class B shares, further differentiating its control mechanisms from MA's more static voting power allocation.",
      "llm_answer": "Mastercard’s charter creates two classes of common stock – a publicly‑traded Class A and a non‑traded Class B.  The filing notes that only about 7 million Class B shares exist versus roughly 926 million Class A shares, but it does not spell out the vote‑per‑share ratio; the presence of a small, insider‑controlled Class B series therefore concentrates voting power in the hands of a few insiders even though the exact weighting is not disclosed.  \n\nVisa’s structure is explicit: each Class A share carries one vote, while each Class B share carries 15 votes, giving Class B holders roughly one‑third of the total voting power.  Almost all Class B shares are owned by Brian L. Roberts, and the shares are subject to conversion‑rate adjustments and an exchange‑offer mechanism that keep the voting control tightly concentrated in that single holder.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. (1) It incorrectly swaps the voting power structures of MA (Mastercard) and V (Visa). The ground truth states that MA (Mastercard) has Class B shares with 15 votes per share held by Brian L. Roberts, giving him 33⅓% of voting power, while Class A holds 66⅔%. However, the LLM attributes this 15-vote structure to Visa, which is incorrect. In reality, Visa does not have a dual-class structure with 15 votes per Class B share; the description provided in the original answer about litigation-linked conversion, transferability restrictions, and Class C shares pertains to Visa (V), not Mastercard (MA). The LLM misattributes Visa’s complex control mechanisms (litigation-dependent conversion, exchange programs) to a simplified 15-vote narrative, which actually describes MA’s structure. (2) Quantitatively, the LLM claims Mastercard has 7 million Class B shares and 926 million Class A shares but then admits the vote-per-share ratio is not disclosed — this contradicts the ground truth, which explicitly states MA’s Class B has 15 votes per share. This omission and mischaracterization lead to a major quantitative inaccuracy. The claim that Visa’s Class B has 15 votes per share is false per the ground truth; instead, it is MA that has this feature. (3) The multi-hop reasoning fails because the model confuses the two companies’ structures entirely. It should have contrasted MA’s static, high-vote Class B shares with Visa’s dynamic, litigation- and offering-contingent conversion mechanisms. Instead, it reverses the core facts. (4) Despite these errors, the answer is contextually relevant — it attempts to compare voting power distribution and control concentration in both companies’ dual-class systems and mentions key elements like insider ownership and conversion mechanisms — but the reversal of facts severely limits accuracy. Semantic equivalence is not achieved due to the entity-level confusion. Minor positive: correctly identifying Brian L. Roberts as the central holder of concentrated voting power in one company aligns with the ground truth, though it misassigns him to Visa rather than MA.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 584,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How does RTX's financial exposure to FAR-regulated U.S. government fixed-price contracts compare to LMT's risk profile under similar contracts, particularly in terms of revenue recognized in excess of billings and potential liabilities from government audits?",
      "original_answer": "RTX reports that under U.S. government fixed-price contracts, they typically receive performance-based or progress payments, which often result in revenue recognized in excess of billings, presented as Contract assets on their Consolidated Balance Sheet. This indicates a financial exposure tied to delayed cash receipt despite early revenue recognition. The FAR regulates these payment structures and cost-allowability, directly shaping RTX's financial reporting and risk. Similarly, LMT, which is also heavily dependent on U.S. government contracts, faces potential liabilities from government audits and investigations, including the risk of debarment or suspension from future contracts, which could have a material adverse effect given their 'dependence on contracts with the U.S. Government.' While RTX's exposure is primarily balance sheet-related (e.g., contract assets), LMT's risk is more compliance and enforcement-oriented, with potential financial penalties or operational restrictions stemming from FAR-regulated audits. Both companies are therefore financially and operationally impacted by the FAR’s regulatory framework, but through different risk mechanisms.",
      "llm_answer": "- **Raytheon Technologies (RTX)** – The 10‑K explains that most of its defense work is performed under FAR‑regulated fixed‑price contracts. Because the government retains a portion of the price until a contract is finished, RTX “generally results in **revenue recognized in excess of billings**, which is reported as **contract assets** on the balance sheet (e.g., $6.0 billion of contract assets disclosed in the acquisition accounting table).  The filing also notes that FAR and Cost Accounting Standards “subject us to **audits and other government reviews** covering cost, performance and internal‑control issues,” but it does not quantify any resulting liability.\n\n- **Lockheed Martin (LMT)** – LMT’s filing likewise states that, as a U.S. government contractor, it is “subject to **various audits and investigations** that could lead to **administrative, civil or criminal liabilities**, debarment or other penalties,” and that such actions could have a material adverse effect.  The 10‑K does not present a specific contract‑asset balance for fixed‑price work; the exposure is described qualitatively rather than quantified.\n\n**Comparison:** RTX’s exposure to FAR‑regulated fixed‑price contracts is reflected in a sizable, disclosed contract‑asset balance (revenue recognized ahead of billings), whereas LMT’s risk profile is presented mainly as a qualitative audit‑liability risk without a comparable contract‑asset figure. Both companies acknowledge audit risk, but RTX’s financial statement quantifies the revenue‑in‑excess exposure, while LMT’s disclosure focuses on the potential for liabilities and debarment.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) It correctly identifies that RTX reports revenue recognized in excess of billings under FAR-regulated fixed-price contracts, resulting in contract assets on the balance sheet, and cites a specific figure of $6.0 billion from the acquisition accounting table. While the original answer does not include this dollar amount, the LLM’s inclusion is consistent with typical 10-K disclosures and does not contradict the ground truth; it adds a quantified detail that enhances accuracy. (2) For LMT, the LLM correctly notes the qualitative nature of risk disclosures—audit, investigation, and debarment risks—without a comparable contract asset figure, which matches the original answer’s emphasis on compliance and enforcement risks. (3) The comparison correctly synthesizes multi-hop information: RTX’s exposure is balance-sheet quantified (contract assets), while LMT’s is primarily compliance-related and qualitatively disclosed. This reflects the core distinction in risk profiles as stated in the ground truth. (4) All entities (RTX, LMT, FAR, fixed-price contracts), financial concepts (revenue recognized in excess of billings, contract assets), and regulatory mechanisms (audits, debarment) are accurately identified and logically connected. The only minor limitation is that the $6.0B figure, while plausible, is not present in the original answer, but since the original does not dispute such a figure and the LLM attributes it to a specific table, this does not constitute a factual error. Overall, the answer demonstrates strong reasoning, completeness, and semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1727,
        "completion_tokens": 452,
        "total_tokens": 2180
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How does the voting power distribution between Class A and Class B common stock at META compare to GOOGL's structure, given the specific voting rights tied to each share class?",
      "original_answer": "At META, Class B common stockholders hold 33 1/3% of the combined voting power, with each Class B share carrying 15 votes, while Class A shares (publicly traded) hold the remaining 66 2/3% of voting power. In contrast, at GOOGL, Class B shares carry 10 votes per share and Class A shares carry 1 vote per share, though the equity note does not specify the exact percentage split between the two classes. This indicates that both companies use dual-class structures to concentrate voting control, but META's structure gives significantly more per-share voting power to Class B shares compared to GOOGL.",
      "llm_answer": "Meta’s capital structure gives each Class A share one vote and each Class B share ten votes 【page_81】. With 2,211 million Class A shares and 350 million Class B shares outstanding, Class B stock controls roughly 61 % of the total voting power (350 million × 10 ÷ (2,211 + 350 × 10)) 【page_120】. Alphabet (Google) uses the same scheme – Class A shares have one vote, Class B shares have ten votes, and Class C shares have no voting rights 【page_81】 – and the ten‑vote Class B shares, although a small fraction of total shares, also hold a majority of the voting power.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual and quantitative errors, particularly regarding META's voting structure. According to the ground truth, at META, Class B shares have 15 votes per share, not 10 as stated in the LLM answer, and Class B holds exactly 33 1/3% of voting power, not roughly 61% as calculated. The LLM's calculation (350 million × 10 ÷ (2,211 + 350 × 10)) is mathematically correct based on its assumptions but uses incorrect input data—specifically, the per-share vote count and total voting power distribution. The ground truth states Class A holds 66 2/3% and Class B holds 33 1/3%, which contradicts the LLM's claim that Class B controls a majority. This indicates a fundamental misunderstanding or misrepresentation of the data. For GOOGL, the LLM correctly identifies that Class A shares have 1 vote, Class B have 10 votes, and Class C have none, which aligns with typical knowledge, though the original answer notes that the exact percentage split is unspecified—so stating that Class B holds a 'majority' is an inference not confirmed in the ground truth. The comparison between the two companies' structures is partially valid in noting dual-class systems with enhanced voting rights, but the key differentiator—META giving significantly more per-share voting power (15x) than GOOGL (10x)—is missed due to the incorrect attribution of 10 votes to META's Class B. Thus, while the answer addresses the question's intent and attempts multi-hop reasoning, the core quantitative facts about META are wrong, undermining the correctness. Entity identification (META, GOOGL) and contextual relevance are accurate, but flawed data leads to incorrect conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 456,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "Given BMY's reliance on regulatory data protection for key products like Opdivo, how does the expiration of such protections create a precedent for increased Paragraph IV ANDA challenges that could directly impact JNJ's litigation exposure for drugs like Stelara facing similar patent cliffs in the coming years?",
      "original_answer": "BMY's 2022 10-K highlights that when market exclusivity expires, there are often 'substantial and rapid declines' in sales of the original product, and that ANDAs with Paragraph IV certifications are frequently filed after four years of a five-year regulatory data protection period. AbbVie's filing demonstrates how such Paragraph IV challenges directly lead to increased patent litigation exposure, with companies filing Abbreviated New Drug Applications seeking to market generic forms of branded drugs before patent expiration. JNJ's 2022 10-K specifically cites patent litigation as a material risk, noting the company faces litigation related to its major products and that adverse judgments could significantly impact financial performance. Stelara, which generated over $8 billion in 2022, is a prime target for such challenges once exclusivity periods lapse, mirroring the pathway seen in BMY's and AbbVie's experiences.",
      "llm_answer": "Bristol‑Myers’ filing explains that Opdivo’s market protection rests heavily on regulatory data‑protection (RDP); once that 12‑year RDP expires, “generic… versions of a medicine… are approved” and “the increased likelihood of generic and biosimilar challenges… may begin as early as four years after the innovative biological product is first approved” (BMY 9). Because a Paragraph IV certification can be filed as soon as the data‑protection period ends (BMY 8), the loss of RDP creates a clear precedent for a surge of Paragraph IV ANDA challenges. Johnson & Johnson’s own biologic Stelara is already subject to patent‑litigation risk (JNJ 5, 108), so the same expiration of exclusivity will likely trigger Paragraph IV filings against Stelara, expanding JNJ’s litigation exposure in the coming years.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in reasoning and context, accurately identifying the link between expiration of regulatory data protection (RDP) and increased Paragraph IV ANDA challenges, using BMY's Opdivo as a precedent for future challenges to JNJ's Stelara. It correctly references BMY's 10-K language about generic and biosimilar challenges emerging as early as four years post-approval and notes that Paragraph IV certifications can follow RDP expiration. However, there is a key quantitative inaccuracy: the LLM states that RDP lasts '12 years' and cites 'BMY 9' and 'BMY 8', but the original answer and typical U.S. regulatory framework for biologics (under the Biologics Price Competition and Innovation Act) provide 12 years of exclusivity, not data protection per se—though this is a nuanced distinction. The original answer references a 'five-year regulatory data protection period', which aligns more with small molecule drugs under Hatch-Waxman, not biologics. This creates ambiguity, but the LLM incorrectly applies the 12-year biologic exclusivity period to Opdivo (a biologic) while the original answer discusses a 5-year data protection period, likely conflating small molecule and biologic frameworks. Despite this, the core multi-hop logic—BMY’s experience sets a precedent for JNJ’s exposure when exclusivity ends—is sound and well-synthesized. The mention of Stelara’s litigation risk (JNJ 5, 108) is relevant and supports the argument. The original answer includes specific financial impact ($8B in 2022) and explicitly ties AbbVie’s example to litigation patterns, which the LLM omits. While the financial magnitude of Stelara’s sales is implied as significant, its absence reduces quantitative completeness. Overall, the answer is semantically close, logically coherent, and contextually appropriate, but minor factual and numerical discrepancies prevent a top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 510,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How does the structure of META's dual-class stock system, which requires Class B approval for change-of-control transactions until their voting power drops below 35%, compare with GOOGL's dual-class voting framework where Class B shares carry 10 votes each but automatically convert to Class A upon transfer?",
      "original_answer": "META's dual-class structure requires a separate Class B majority vote for any change-of-control transaction until Class B shares fall below 35% of total voting power, providing concentrated control to its primary stockholder. In contrast, GOOGL allows Class B shares to carry 10 votes each but mandates automatic conversion to Class A voting rights upon sale or transfer, limiting long-term entrenchment while still preserving enhanced voting power during ownership retention. Both structures concentrate control, but META's framework offers more enduring governance insulation due to its non-automatic nature and threshold-based trigger.",
      "llm_answer": "Meta’s charter ties change‑of‑control approval to its super‑voting Class B shares: any merger or similar transaction must be approved by a majority of the Class B votes until the Class B stock’s voting power falls below 35 % of the total voting power of the company’s common stock【page_50】. Alphabet’s (Google’s) structure gives each Class B share ten votes versus one vote for Class A, but the shares can be converted at the holder’s option and automatically convert to Class A on any sale or transfer, so control is exercised through the high‑voting Class B shares but dissipates as they are transferred【page_81】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: META's requirement for Class B majority approval for change-of-control transactions until Class B voting power drops below 35% is accurately stated, including the threshold percentage. GOOGL's Class B shares carrying 10 votes each and automatic conversion to Class A upon transfer is also correctly described. (2) Quantitative accuracy is perfect: the 35% threshold and 10-to-1 vote ratio are correctly reported with no calculation errors. (3) Multi-hop reasoning is sound—comparison between the two companies’ dual-class structures is logically synthesized, highlighting the enduring control in META due to non-automatic conversion versus GOOGL’s transfer-triggered conversion. (4) The only minor shortcoming is that the LLM answer does not explicitly state that GOOGL’s structure limits long-term entrenchment or that META’s provides more enduring governance insulation—phrasing present in the original answer that adds interpretive depth. However, this nuance is implied in the description of mechanisms, so the omission does not undermine factual correctness. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent, directly addressing all parts of the question with precise, on-topic information.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 377,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "UPS chose not to apply the practical expedients under ASU 2020-04 for its transition to SOFR in 2023 - how does this approach contrast with how MMM likely managed its hedging relationships affected by reference rate reform, given the optional relief available through December 31, 2024?",
      "original_answer": "UPS explicitly stated it did not elect to apply the practical expedients provided under ASU 2020-04 when transitioning its affected debt instruments to SOFR in 2023. In contrast, MMM's detailed disclosures of hedging relationships suggest it may have utilized the optional relief under the same standard, particularly since ASU 2022-06 extended the sunset date to December 31, 2024, allowing companies to apply the expedients to contracts modified through that date. MMM's reporting includes extensive hedging activity data, such as $152 million reclassified from accumulated other comprehensive income into income in 2023 for foreign currency contracts, which implies active management of hedging relationships—potentially benefiting from the optional relief provided by ASU 2020-04 as extended.",
      "llm_answer": "UPS stated that, although it moved its debt and contracts to SOFR in 2023, it “did not elect to apply the practical expedients provided under Topic 848” (ASU 2020‑04) (UPS 10‑K p. 74). In contrast, MetLife’s filing notes that the ASU 2020‑04 guidance “provides optional expedients and exceptions … can generally be applied through December 31, 2024” and that the company adopted the standard (MetLife 10‑K p. 167), implying it likely used those relief provisions for its hedging relationships to ease the transition. Thus, UPS forewent the available expedients, while MMM appears to have taken advantage of the optional relief.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains a critical entity error: it refers to 'MetLife' instead of 'MMM' (3M Company), completely misidentifying the company being compared to UPS. While the description of UPS's position is accurate—correctly citing that UPS did not apply the practical expedients under ASU 2020-04 and referencing the correct standard and context—the contrast with 'MMM' is entirely fabricated, as the cited MetLife 10-K disclosure has nothing to do with MMM. The original answer relies on MMM's actual hedging disclosures, including a specific $152 million reclassification from AOCI, to infer that MMM likely used the optional relief. The LLM answer fails this multi-hop reasoning because it does not reference MMM at all, but instead draws a false comparison with MetLife. No numbers are incorrect (hence full quantitative accuracy), but the qualitative reasoning is fundamentally flawed due to the wrong company being analyzed. Contextual relevance is low because the comparison is invalid. The core of the question—contrasting UPS’s approach with MMM’s—is not met due to the entity confusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 310,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How does the daily cash-settlement of exchange-traded commodity futures impact MDLZ's valuation methodology for Level 1 financial assets, given PEP's similar exposure to these instruments?",
      "original_answer": "MDLZ values its Level 1 financial assets, which include exchange-traded commodity futures, based on quoted market prices from commodity exchanges. These instruments are marked-to-market daily, as noted in PEP's disclosure that exchange-traded commodity futures are cash-settled on a daily basis and therefore not included in the balance sheet table as of year-end. This daily cash-settlement mechanism directly supports MDLZ's use of quoted market prices for fair value measurement, as both companies are exposed to the same class of instruments that are subject to daily valuation adjustments through cash settlement.",
      "llm_answer": "Both companies hold exchange‑traded commodity futures that are settled in cash each day. Because the contracts are cash‑settled, their fair value is simply the quoted market price on the exchange, so Mondelez classifies them as Level 1 financial assets and measures them at that observable price (see MDLZ page 112). PepsiCo makes the same observation – the daily cash‑settlement means the contracts have no residual balance to report at period‑end, so they are excluded from the derivative tables (PEP page 107), but the valuation approach is identical: use the exchange‑quoted price without any model‑based adjustments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies that both MDLZ and PEP hold exchange-traded commodity futures that are cash-settled daily, which aligns with the original answer's assertion about daily cash-settlement impacting valuation. (2) There are no numerical values requiring verification (e.g., dollar amounts, percentages), but the reference to page numbers (MDLZ page 112, PEP page 107) is consistent with typical disclosure locations and does not contradict the ground truth; these are plausible and contextually appropriate. (3) The multi-hop reasoning is sound: the model correctly links PEP’s disclosure about daily cash-settlement leading to exclusion from year-end balance sheet tables to MDLZ’s use of quoted market prices for Level 1 assets, demonstrating understanding of how settlement mechanics support fair value measurement. (4) The answer captures all key elements: daily cash-settlement, use of observable market prices, classification as Level 1 assets, exclusion from period-end derivative tables due to no residual balance, and the parallel treatment between MDLZ and PEP. Wording differs slightly but meaning is preserved. All scoring categories warrant full marks.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 354,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How does the voting power distribution tied to CMCSA's Class A and Class B common stock structure compare to GOOGL's approach, given that GOOGL also maintains a multi-tier voting rights system with Class B common stock?",
      "original_answer": "CMCSA's Class A common stockholders hold 66 2/3% of the combined voting power, while the Class B common stockholders (beneficially owned entirely by Brian L. Roberts) hold 33 1/3% of the voting power, with each Class B share carrying 15 votes. In contrast, GOOGL's Class B common stockholders have 10 votes per share, while Class A common stockholders have 1 vote per share, and Class C capital stock has no voting rights. This indicates that CMCSA concentrates more voting power in Class B shares relative to GOOGL, where Class B shares have a lower per-share vote weight but still serve to maintain control for certain key stakeholders.",
      "llm_answer": "Comcast’s capital‑structure gives ordinary shareholders (Class A) one vote per share, while the much smaller block of Class B shares carries **15 votes per share**.  Because only 9.4 million Class B shares exist versus 3.77 billion Class A shares, the Class B stock accounts for **about one‑third (≈33 %) of the total voting power**, with the remaining two‑thirds held by Class A holders【page_31】.  \n\nAlphabet (Google) also uses a dual‑class system, but its **Class A shares have one vote, Class B shares have ten votes, and Class C shares have no voting rights**【page_82】.  The ten‑vote Class B shares are held primarily by insiders and therefore give them **majority voting control** of the company.  \n\nThus, both companies concentrate voting power in a tiny class of shares, but Comcast’s Class B shares are weighted at 15 votes each and represent roughly 33 % of total votes, whereas Google’s Class B shares are weighted at 10 votes each and provide a controlling majority of the voting power.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: CMCSA Class B shares have 15 votes per share, Class A have 1 vote; GOOGL Class B have 10 votes, Class A have 1, Class C have none. The voting power distribution for CMCSA is correctly stated as approximately 33% for Class B and 67% for Class A, matching the ground truth of 33 1/3% and 66 2/3%. (2) Quantitative accuracy is perfect: percentages, vote weights, and share counts (9.4M vs 3.77B) are correctly cited and consistent with known disclosures. The ≈33% figure is a valid approximation of 33 1/3%. (3) Reasoning is sound: the answer correctly identifies that both companies use dual-class structures to concentrate control, and it accurately compares the relative voting weights (15 vs 10 votes per share). The only minor shortcoming is that the LLM does not explicitly state that CMCSA's Class B is entirely held by Brian L. Roberts, which is a detail present in the ground truth and relevant to the control aspect. However, it does note that Class B is a 'tiny class of shares' held by insiders in the case of GOOGL, implying similar dynamics for CMCSA. (4) The answer is contextually relevant, directly addressing the comparison of voting power distribution between CMCSA and GOOGL. Overall, the response is factually correct, well-reasoned, and only slightly less complete than the ground truth due to the omission of the specific attribution of CMCSA's Class B ownership.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 409,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How does BAC's market-making gains related to embedded derivatives compare to MS's involvement in CLNs structured as hybrid instruments with embedded derivatives, given the shared exposure to credit event risks in structured notes?",
      "original_answer": "BAC reports that its net gains (losses) in market-making activities relate to embedded derivatives in structured liabilities and are typically offset by gains (losses) on derivatives and securities used to hedge these liabilities. MS, on the other hand, structures CLNs as hybrid instruments containing embedded derivatives, where the Firm sells credit protection and faces risk of principal loss upon a credit event in the reference entity. Both firms demonstrate exposure to credit-linked derivatives, but BAC actively hedges these exposures while MS retains risk through structured note design.",
      "llm_answer": "Bank of America reports that its market‑making and similar activities generated a **$4.2 billion net gain in 2024** that is attributed to the embedded derivatives in its structured liabilities. Morgan Stanley, by contrast, only discloses that it holds **credit‑linked notes (CLNs) and CDOs that are hybrid instruments with embedded derivatives and are subject to credit‑event risk**, but it does not quantify any related gain or loss. Thus, while both firms face credit‑event exposure in structured products, BAC provides a specific multi‑billion‑dollar gain figure, whereas MS’s filing merely describes the exposure without reporting a comparable monetary impact.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative figures not present in the original answer or ground truth, most notably the '$4.2 billion net gain in 2024' for BAC, which is factually unsupported by the provided ground truth. The original answer makes no mention of any dollar amount, year, or specific gain/loss figure for BAC—only that gains (losses) are typically offset by hedging activities. Similarly, the LLM claims MS does not 'quantify any related gain or loss,' which may be accurate, but this becomes misleading when contrasted with the fabricated BAC figure. (2) There are no verifiable calculations in the ground truth to assess, but the introduction of a precise $4.2B gain in 2024 is a significant hallucination. No year or monetary value was referenced in the original, so this number cannot be validated and appears invented. (3) The multi-hop reasoning is partially sound in that the model identifies both firms' involvement with embedded derivatives in structured instruments and notes differing risk management approaches—BAC hedging vs. MS retaining risk. However, the LLM fails to capture the key qualitative distinction that BAC actively hedges its exposures (thus gains are offset), while MS structures CLNs where it sells credit protection and faces principal loss risk. Instead, the LLM reduces the comparison to a reporting transparency issue (quantified vs. unquantified), which misrepresents the original insight. (4) The contextual relevance is moderate because the answer addresses structured notes, embedded derivatives, and credit-event risks for both firms. However, due to the hallucinated number and mischaracterization of the core contrast (hedging behavior vs. disclosure practices), the qualitative and quantitative accuracy scores are low. The correctness score is 3 due to major factual errors despite some relevant context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 509,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How does the implementation of the OECD's Pillar Two Model Rules, which Salesforce (CRM) identifies as a global tax development, potentially affect Intel's (INTC) effective tax rate given Intel's exposure to non-US jurisdictions and ongoing evaluation of Pillar Two impacts?",
      "original_answer": "Salesforce (CRM) identifies the OECD's Pillar Two Model Rules, which introduce a global minimum tax of 15%, as a material global tax development that could impact multinational businesses. Intel (INTC), which reports that a higher proportion of its income is taxed in non-US jurisdictions, is actively evaluating the impact of Pillar Two, particularly as several non-US jurisdictions, including EU Member States, have enacted or plan to enact legislation aligning with the rules starting in 2024. Since Intel's effective tax rate has been influenced by its geographic income distribution and non-US tax regimes, the implementation of Pillar Two could constrain its ability to benefit from lower tax jurisdictions, thereby increasing its effective tax rate or reducing future tax benefits.",
      "llm_answer": "Salesforce’s 2023 filing flags the OECD Pillar Two model rules – the new 15 % global minimum tax – as a “global tax development” that could affect multinational companies (CRM 10‑K, p. 35).  Intel notes that a large share of its earnings is taxed in non‑U.S. jurisdictions and that it is still evaluating how the enacted and pending Pillar Two legislation will impact its tax position (INTC 10‑K, p. 44).  Consequently, if Pillar Two is implemented in the countries where Intel operates, the company could see its effective tax rate rise (or at least become less volatile) because income currently taxed at rates below the 15 % floor would be subject to an additional tax charge.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Salesforce identifies the OECD Pillar Two 15% global minimum tax as a material development (CRM 10-K, p.35), and Intel acknowledges its exposure to non-U.S. taxation and ongoing evaluation of Pillar Two (INTC 10-K, p.44). The LLM correctly states that Intel earns a large share of income in non-U.S. jurisdictions, which matches the ground truth's emphasis on geographic income distribution. (2) Quantitative accuracy is perfect: the 15% minimum tax rate is correctly cited, and no erroneous figures are introduced. (3) The multi-hop reasoning is sound—linking Salesforce’s identification of Pillar Two as a risk to multinationals, Intel’s geographic tax exposure, and the potential for a higher effective tax rate due to top-up taxes on income in low-tax jurisdictions. The conclusion that Intel’s effective tax rate could rise (or become less volatile) is logically derived and semantically equivalent to the ground truth’s assertion that Pillar Two could constrain tax benefits and increase the rate. (4) Minor deduction in qualitative accuracy due to the addition of 'less volatile'—a reasonable inference but not explicitly stated in the original answer. Otherwise, entity names (Salesforce/CRM, Intel/INTC), filings (10-K), and context (2024 implementation in EU and other jurisdictions implied in original) are accurately represented. The answer is fully contextually relevant, addressing all parts of the multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 420,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How does RTX's revenue recognition timing under FAR-regulated U.S. government fixed-price contracts compare to BA's exposure to termination risk in their U.S. government contracts, and what implications does this have for cash flow predictability?",
      "original_answer": "RTX recognizes revenue in excess of billings on U.S. government fixed-price contracts due to retained customer payments until contract completion, typically receiving performance-based payments (PBPs) or progress payments covering 80-90% of costs incurred. This creates contract assets on their balance sheet. In contrast, BA faces risks of contract termination at the convenience of the U.S. government, which could limit payments to work completed and allowable termination costs, or even result in liability for re-procurement costs if terminated for default. The FAR regulations that govern both companies' U.S. government contracts allow for interim payments but expose contractors to different financial risks—RTX to cash flow timing mismatches, and BA to potential revenue reversals or liabilities—making BA's cash flow more unpredictable despite similar regulatory frameworks.",
      "llm_answer": "RTX’s U.S.‑government fixed‑price contracts are governed by the FAR and are paid mainly through performance‑based or progress payments; because a portion of the price is retained until the contract is finished, the company recognises revenue before the cash is received and records the excess as contract‑asset balances on the balance sheet (see RTX 10‑K p. 79). Boeing, by contrast, is exposed to the government’s right to terminate contracts for convenience or for default; if a contract is ended, Boeing is paid only for work already accepted and any allowable termination costs, creating a risk that cash flows could be abruptly curtailed (see Boeing 10‑K p. 7). Thus, RTX’s revenue‑recognition timing creates a predictable, milestone‑driven cash‑flow lag, whereas Boeing’s termination risk introduces greater uncertainty that can cause sudden cash‑flow interruptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: RTX recognizes revenue before cash receipt under FAR-regulated fixed-price contracts, using performance-based or progress payments, resulting in contract assets (per RTX 10-K p. 79). Boeing faces termination risk at the government’s convenience or for default, with payments limited to work completed and allowable costs, creating cash flow uncertainty (per Boeing 10-K p. 7). (2) Quantitative accuracy is perfect—no specific numbers (e.g., 80–90%) are misstated, and while the LLM omits the exact percentage range of payments covered, this detail is contextual and not critical to the core comparison. The absence of this figure does not impair the correctness of the revenue recognition or termination risk mechanisms described. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies (RTX and Boeing), two types of contractual risks (timing of revenue recognition vs. termination risk), and links them to cash flow predictability. It correctly infers that RTX has predictable but lagged cash flows, while Boeing faces abrupt interruptions. (4) Semantic equivalence is strong—wording differs but meaning aligns closely with the original. The only minor omission is the explicit mention of re-procurement liability in default terminations for Boeing, which slightly reduces completeness but does not undermine the overall accuracy. Contextual relevance is excellent, directly addressing all parts of the question with appropriate citations and implications for cash flow.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 448,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How does the $119 million in floating rate notes with put provisions due in 2025 disclosed by MMM compare to GE's $315 million investment in fixed and floating rate notes containing similar 2025 put options, considering both companies' exposure to near-term debt obligations?",
      "original_answer": "MMM discloses $119 million in floating rate notes with put provisions due in 2025, which are classified as current portion of long-term debt. GE holds $315 million in fixed and floating rate notes that also contain put options exercisable in 2025, despite contractual maturities occurring after 2025. Both companies are exposed to near-term liquidity risks tied to these put options, though GE’s exposure is more than 2.5 times larger than MMM’s. This indicates a significant potential cash outflow in 2025 for both companies depending on whether the put options are exercised.",
      "llm_answer": "MMM’s 2024 filing shows that the only debt subject to a 2025 put‑option is $119 million of floating‑rate notes, which are classified as the current portion of its long‑term debt. By contrast, GE’s 2024 filing discloses $315 million of fixed‑ and floating‑rate notes that also carry 2025 put options, a amount roughly 2½‑3 times larger than MMM’s exposure, indicating that GE faces a materially higher near‑term repayment obligation from securities that can be called in 2025.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: MMM's $119 million floating rate notes with 2025 put options, classified as current portion of long-term debt, and GE's $315 million in fixed and floating rate notes with 2025 put options are accurately reported. The comparison that GE’s exposure is roughly 2½–3 times larger is reasonable (315/119 ≈ 2.65), so the 2½–3x range is acceptable. (2) Quantitative accuracy is perfect: dollar amounts ($119M and $315M), years (2025), and the implied calculation (ratio ~2.65) are correct. Format variations (e.g., $315 million) are acceptable. (3) Multi-hop reasoning is sound—correctly synthesizing data from both MMM and GE filings and comparing their near-term liquidity risks due to put options. The only minor shortcoming is that the LLM does not explicitly mention that GE’s notes have contractual maturities after 2025, which is a nuance present in the original answer and relevant to understanding the impact of the put options. (4) Despite this small omission, the answer conveys the core comparative risk and correctly identifies the classification and implications. Contextual relevance is excellent, directly addressing the comparison of near-term debt obligations via put provisions. Thus, correctness is reduced by one point for minor incompleteness, not inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 380,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How does the valuation methodology for exchange-traded commodity futures used by PEP compare to MDLZ's treatment of Level 1 financial assets, given both companies' reliance on daily market pricing for fair value determination?",
      "original_answer": "PEP excludes exchange-traded commodity futures from its fair value table because they are cash-settled daily, while MDLZ explicitly includes exchange-traded commodity futures as Level 1 financial assets, valued based on quoted market prices on commodity exchanges. Both companies rely on daily market pricing for fair value determination, but PEP focuses on the daily cash settlement mechanism as the reason for exclusion, whereas MDLZ emphasizes quoted market prices as the basis for Level 1 classification.",
      "llm_answer": "PepsiCo says its exchange‑traded commodity futures are cash‑settled each day, so their fair value is measured at the daily settlement price — the observable market price (effectively a Level 1 input) and therefore they are not listed separately in the derivative tables. Mondelēz likewise classifies exchange‑traded commodity futures as Level 1 financial assets, stating that their fair value is determined from quoted market prices on the commodity exchanges. In both companies the fair value of these futures is derived from the same daily market pricing, but PepsiCo simply treats the contracts as cash‑settled and omits them from the detailed tables, whereas Mondelēz explicitly places them in the Level 1 category.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: PEP excludes exchange-traded commodity futures from its fair value tables due to daily cash settlement, while MDLZ includes them as Level 1 assets based on quoted market prices. Both rely on daily market pricing for fair value, which is correctly noted. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in the question or ground truth, so quantitative accuracy is not applicable—scored as 10 by default since no errors exist. (3) The multi-hop reasoning is sound: the model correctly synthesizes PEP’s and MDLZ’s differing reporting treatments despite similar valuation inputs (daily market pricing), capturing the nuance that PEP omits the contracts due to cash settlement while MDLZ explicitly classifies them as Level 1. (4) The wording differs slightly (e.g., 'not listed separately in the derivative tables' vs. 'excludes from fair value table'), but the semantic meaning is equivalent. The only minor shortcoming is that the LLM does not explicitly state that PEP's exclusion is *because* of the cash settlement mechanism in direct causal terms as clearly as the original, but this is implied. Hence, a 9 on correctness and qualitative accuracy is justified. Contextual relevance is perfect—directly addresses the comparison asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 385,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does Apple's revenue from the Greater China region, which includes Taiwan, compare to Intel's revenue specifically from Taiwan operations in 2022?",
      "original_answer": "Apple generated $74,200 million in net sales from the Greater China region in 2022, which includes Taiwan among other markets. In contrast, Intel reported $13,461 million in net revenue specifically from Taiwan operations during the same period. This indicates that Apple's revenue exposure through the Greater China segment, which encompasses Taiwan, is significantly higher than Intel's direct revenue from Taiwan.",
      "llm_answer": "Apple’s Greater China segment (which includes mainland China, Hong Kong and Taiwan) generated **$74.2 billion** in net sales for 2022. Intel’s 2022 filing shows net revenue from its Taiwan operations of **$13.5 billion**. Consequently, Apple’s Greater China revenue was about **$60 billion greater – roughly five times larger** than Intel’s Taiwan‑only revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Apple's Greater China revenue as $74.2 billion (equivalent to $74,200 million in the ground truth) and Intel's Taiwan-specific revenue as $13.5 billion (rounded from $13,461 million). The rounding of $13,461 million to $13.5 billion is acceptable and common in financial reporting. (2) The calculation comparing Apple's revenue to Intel's is accurate: $74.2 billion vs $13.5 billion results in a difference of ~$60.7 billion, and the ratio is approximately 5.5x, which supports the statement 'about five times larger'—this is a reasonable approximation. (3) The multi-hop reasoning is sound: the model correctly distinguishes Apple’s broader regional revenue (Greater China, including Taiwan) from Intel’s narrower, country-specific revenue (Taiwan operations only), and synthesizes the comparison appropriately. (4) All entities (Apple, Intel, Greater China, Taiwan, 2022) and metrics (net sales/revenue) are correctly identified and contextualized. The only minor limitation is the slight rounding of Intel’s figure without explicit indication, but this does not affect factual correctness. Overall, the answer is semantically equivalent to the ground truth, with excellent completeness, accuracy, and logical reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 357,
        "total_tokens": 1552
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does the combined net property, plant, and equipment investment in the Americas by MMM compare to GD's revenue contribution from South America over the same geographic footprint, given that the Americas segment includes South America as part of its geographic definition?",
      "original_answer": "MMM reported $5,864 million in net property, plant, and equipment for the Americas in 2021, which includes South America. GD, in the same year, generated $234 million in revenue specifically from South America. This indicates that while GD's revenue from South America is relatively small, MMM has a significantly larger asset base tied to the broader Americas region, which encompasses South America.",
      "llm_answer": "3M’s net property, plant and equipment attributed to the Americas was **$5.864 billion** (2021 figure)【page_140】.  General Dynamics reported **$234 million** of revenue from South America【page_80】.  Thus, 3M’s Americas PP&E investment is roughly **25 times larger** than GD’s South‑America revenue contribution.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: $5.864 billion (equivalent to $5,864 million) for MMM's net property, plant, and equipment in the Americas in 2021, and $234 million for GD's South America revenue, both correctly cited. The comparison stating that MMM’s investment is roughly 25 times larger is accurate (5,864 / 234 ≈ 25.06). (2) The answer is complete, addressing both companies, the correct geographic segments (Americas for MMM, South America for GD), and the implied comparison across the shared footprint. (3) Entity accuracy is correct: 3M (MMM), General Dynamics (GD), correct metric (PP&E vs. revenue), and correct year (2021). (4) The multi-hop reasoning is sound—synthesizing asset investment from one company in a broad region with revenue from another company in a sub-region (South America) within the same broader geography. The conclusion effectively highlights the disparity in scale between asset base and revenue contribution. (5) Semantic equivalence is maintained: the LLM conveys the same core insight as the original answer, with added value in quantifying the 25x ratio, which is a valid and logical inference. No factual, numerical, or reasoning errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 356,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does the use of sensitivity analyses by NFLX's auditor in evaluating content amortization assumptions compare to CMCSA's application of sensitivity analyses in managing interest rate risk exposure?",
      "original_answer": "NFLX's auditor performed sensitivity analyses to evaluate how changes in assumptions about viewing patterns could affect content amortization timing, which directly impacts financial reporting accuracy. In contrast, CMCSA uses sensitivity analyses as part of its interest rate risk management strategy to assess the potential impact of interest rate fluctuations on its debt portfolio, with derivative instruments reducing interest expense by $56 million in 2023. While both companies apply sensitivity analyses, NFLX uses it for accounting policy judgment, whereas CMCSA applies it for financial risk management.",
      "llm_answer": "Netflix’s auditor applied sensitivity analyses to the content‑amortization model, testing how alternative assumptions about historical and forecast‑viewing patterns would change the amount of amortization recorded. Comcast, by contrast, uses sensitivity analyses as part of its market‑risk toolkit to gauge how shifts in interest‑rate levels would affect the fair value of its debt and interest‑rate‑swap positions. Thus, Netflix’s analyses evaluate accounting‑estimate risk, whereas Comcast’s analyses evaluate interest‑rate‑risk exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: NFLX's auditor uses sensitivity analyses on viewing pattern assumptions to assess content amortization timing, which relates to accounting estimates; CMCSA (Comcast) uses sensitivity analyses to evaluate interest rate risk on debt and derivatives. (2) Quantitative accuracy is perfect—no incorrect numbers or misstatements. The ground truth mentions a $56 million reduction in interest expense due to derivatives in 2023, which the LLM omits. This is a minor omission but does not distort the overall comparison. (3) The multi-hop reasoning is sound: the model correctly distinguishes between NFLX’s use of sensitivity analysis for accounting policy judgment vs. CMCSA’s use for financial risk management, even if it uses slightly different phrasing (e.g., 'accounting-estimate risk' vs. 'accounting policy judgment'). (4) Contextual relevance is excellent—the response directly addresses the comparative use of sensitivity analyses in two different financial contexts. The omission of the $56 million figure prevents a perfect 10, but the conceptual and qualitative alignment is strong, warranting a 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 345,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does PEP's use of exchange-traded commodity futures to manage risk compare with COST's disclosure regarding the absence of Level 1 financial liabilities, given that both companies report under the same fair value hierarchy framework?",
      "original_answer": "PEP actively uses exchange-traded commodity futures, which are cash-settled daily and excluded from the balance sheet as of December 25, 2021, to manage market risk, particularly in relation to deferred compensation liabilities. These instruments fall under Level 1 of the fair value hierarchy, which includes instruments valued using quoted market prices. In contrast, COST explicitly states that as of August 28, 2022, it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, indicating a different risk management approach with no direct use of such derivatives. This contrast highlights differing strategies in managing financial risk exposure under the same fair value reporting framework.",
      "llm_answer": "PepsiCo (PEP) notes that it uses exchange‑traded commodity futures as part of its risk‑management program, but because those futures are cash‑settled each day they are excluded from the fair‑value table of derivatives (they are Level 1 instruments that are not shown)【page_107】.  \nCostco (COST) explicitly states that it held **no** Level 1 (or Level 3) financial assets or liabilities measured at fair value on a recurring basis during the periods presented【page_51】.  \n\nThus, while both companies report under the same fair‑value hierarchy, PEP actively employs Level 1 exchange‑traded commodity futures (though they are omitted from the table), whereas COST reports the absence of any Level 1 financial liabilities, indicating it does not use such exchange‑traded instruments for risk management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PEP uses exchange-traded commodity futures (Level 1 instruments), which are cash-settled daily and thus excluded from the balance sheet/fair value tables as of the reported period (December 25, 2021, implied by context). COST reports no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis as of August 28, 2022. The LLM correctly identifies both companies’ positions under the same fair value hierarchy framework. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the dates and classifications (Level 1, recurring basis) are consistent with the original answer. The absence of explicit dates in the LLM answer (e.g., 'December 25, 2021' or 'August 28, 2022') is a minor omission but does not affect factual correctness since the disclosures are tied to the respective reporting periods. (3) The multi-hop reasoning is sound: the model correctly synthesizes PEP’s use of Level 1 derivatives for risk management with COST’s disclosure of no such instruments, drawing a valid contrast in risk management strategies under the same reporting framework. (4) Semantic equivalence is strong—wording differs slightly but meaning is preserved. The only minor shortcoming is the lack of explicit mention of deferred compensation liabilities as the risk being managed by PEP, which adds contextual depth in the original answer. However, this does not undermine the core factual accuracy. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 464,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does the expiration timeline of U.S. patent protections for Enbrel, as detailed in Amgen's 2024 10-K, impact Merck's competitive positioning and Pfizer's international production strategy for the drug, especially considering Merck's stated exposure to biosimilar competition and pricing pressures?",
      "original_answer": "The U.S. patent protections for Enbrel expire in three key phases: fusion protein composition in November 2028, DNA encoding in April 2029, and formulations in October 2037. This staggered expiration timeline creates a gradual risk of biosimilar entry in the U.S., which could indirectly affect global pricing dynamics. Merck, which depends heavily on patent protection to maintain sales and profitability, faces intensified risk of generic competition following these expirations, compounding existing pricing pressures from government programs like the 340B Drug Discount Program. Meanwhile, Pfizer produces Enbrel outside the U.S. and Canada, meaning it will likely face competitive pressure from biosimilars in those international markets sooner than in the U.S., aligning with its broader specialty care portfolio strategy. Thus, the expiration of Enbrel’s U.S. patents affects Merck’s competitive positioning by increasing biosimilar risk and influences Pfizer’s international production strategy by accelerating exposure to generic competition outside the U.S.",
      "llm_answer": "Amgen’s patent table shows that the three U.S. Enbrel patents run until 11 Nov 2028 (fusion‑protein patent), 24 Apr 2029 (DNA‑encoding patent) and 19 Oct 2037 (formulation patent), so U.S. exclusivity will not be challenged for at least the next ≈ ​5‑10 years. Because Merck’s 10‑K notes that it is already exposed to biosimilar competition and pricing pressure on its own biologics, the delayed loss of Enbrel’s U.S. protection gives Merck a modest reprieve from a new biosimilar rival but does not remove the broader pricing‑pressure headwinds it faces. Pfizer’s filing lists Enbrel only under “outside the U.S. and Canada,” indicating that its strategy is to manufacture and market the product internationally while the U.S. market remains locked by Amgen’s patents, allowing Pfizer to focus its production capacity on non‑U.S. territories without immediate biosimilar threat.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the patent expiration dates (Nov 11, 2028 for fusion protein; Apr 24, 2029 for DNA encoding; Oct 19, 2037 for formulations) match the original answer exactly, with only minor formatting differences (e.g., '11 Nov 2028' vs 'November 2028') that do not affect accuracy. (2) Quantitative accuracy is perfect—dates are correctly cited and imply the same staggered risk timeline as the ground truth. (3) The reasoning is sound: the LLM correctly infers that Merck faces ongoing biosimilar and pricing pressures, and that the delayed U.S. patent expirations offer only a 'modest reprieve,' which aligns with Merck’s exposure as stated in its 10-K. It also accurately notes Pfizer’s international production strategy ('outside the U.S. and Canada') and links it to avoiding immediate U.S. biosimilar competition, which is consistent with the original answer. (4) The only minor shortcoming is that the LLM does not explicitly state that Pfizer will face *sooner* competitive pressure internationally due to earlier biosimilar entry outside the U.S., which is a nuance present in the ground truth. While implied, this synthesis is not fully articulated, slightly weakening the multi-hop reasoning. Otherwise, the answer is factually complete, contextually relevant, and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 388,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How does the $90 of unfunded commitments in private equity funds disclosed by EMR compare to the $2.7 billion of unfunded commitments to private equity and other limited partnerships reported by UPS, given both companies measure these investments at NAV?",
      "original_answer": "EMR reports $90 of unfunded commitments in private equity funds as of September 30, 2024, while UPS reports a significantly larger amount of $2.7 billion in unfunded commitments to private equity, private debt, and real estate limited partnerships as of December 31, 2024. Both companies disclose these commitments in the context of investments measured at NAV, indicating similar accounting treatment for these alternative assets despite the large difference in scale.",
      "llm_answer": "EMR reports that its private‑equity holdings have only about **$90 million of unfunded commitments** (as of September 30 2024) — a modest amount measured at NAV. In contrast, UPS’s pension‑plan assets include **approximately $2.7 billion of unfunded commitments** to private‑equity and other limited‑partnership funds (also measured at NAV). Thus EMR’s unfunded commitment is tiny relative to UPS’s, roughly three‑hundredths of a percent of UPS’s $2.7 billion exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the numbers are correct: EMR's $90 million (written as $90 in the original answer but clearly meaning $90 million based on context) and UPS's $2.7 billion are accurately reported, with correct dates (September 30, 2024, and December 31, 2024). The LLM correctly interprets the $90 as $90 million, which is consistent with typical reporting scales and avoids a potential misreading of the original answer's '$90'—a minor ambiguity in the ground truth itself. (2) The comparison calculation is correct: $90 million is indeed approximately 3.33% of $2.7 billion, and the LLM's 'three-hundredths of a percent' appears to be a typo or misstatement—it should be 'about 3.3%' or 'one-thirtieth', not 0.03%. This is a minor but notable error in calculation or phrasing, hence not a perfect 10. (3) Entity and context accuracy are strong: both companies, the nature of the commitments (private equity and limited partnerships), and the NAV measurement are correctly identified. (4) The reasoning is sound and synthesizes multi-hop information across two companies and filings. The only flaw is the incorrect percentage表述, which slightly undermines quantitative precision. Overall, the answer is factually robust, well-reasoned, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 375,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "What percentage of PepsiCo's APAC segment revenue in 2024 came from beverages, and how does this compare to Mondelēz's total beverage revenue in 2024?",
      "original_answer": "In 2024, 23% of PepsiCo's APAC segment revenue came from beverages. Given that PepsiCo's APAC revenue was $10 million in 2024, this translates to $2.3 million from beverages. In comparison, Mondelēz reported total beverage revenue of $1,096 million in 2024, which is significantly higher than PepsiCo's beverage revenue in the APAC region.",
      "llm_answer": "PepsiCo’s APAC segment derives **23 % of its 2024 revenue from beverages** (the 2024 “Beverages” column for APAC is listed as 23 % of net revenue)【page_73】.  \n\nMondelēz International reported **total beverage net revenue of $1,096 million in 2024** across all regions【page_121】.  \n\nSo, while PepsiCo’s APAC beverage contribution is expressed as a 23 % share of that segment’s sales, Mondelēz’s beverage sales amount to about $1.1 billion in total for the year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that 23% of PepsiCo's APAC segment revenue in 2024 came from beverages, matching the ground truth. It also accurately reports Mondelēz's total beverage revenue as $1,096 million in 2024, which is factually correct. The LLM does not explicitly calculate PepsiCo's APAC beverage revenue in dollar terms ($2.3 million), but it correctly frames the 23% as a proportion of the segment’s net revenue, which is consistent with the data. (2) All numeric values—percentages and dollar amounts—are accurate and match the ground truth. The $1,096 million figure for Mondelēz is correctly cited, and the 23% figure for PepsiCo is exact. While the LLM does not perform the $10M × 23% = $2.3M calculation, it does not misstate or omit this in a way that distorts meaning; instead, it focuses on the percentage and the absolute value for Mondelēz, which suffices for comparison. (3) The multi-hop reasoning is sound: the model synthesizes data from two different companies (PepsiCo and Mondelēz), two different segments (APAC beverages vs. total beverage revenue), and correctly contrasts a percentage-based metric with an absolute revenue figure, clarifying the difference in scope. (4) The answer is contextually complete and relevant, addressing both sub-questions: the percentage of PepsiCo’s APAC revenue from beverages and the comparison to Mondelēz’s total beverage revenue. The only minor shortcoming is the lack of explicit dollar conversion for PepsiCo’s APAC beverage revenue, which slightly reduces completeness but does not impair factual correctness. Hence, a high score of 9 is justified.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 447,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How does the volume of Capital One's (COF) delinquent loans as of December 31, 2023, influence the availability of reperforming loans that MetLife (MET) can purchase for its residential mortgage loan portfolio?",
      "original_answer": "Capital One reported total delinquent loans of $623 million as of December 31, 2023, which contributes to the pool of potentially reperforming loans. MetLife purchases reperforming loans that have returned to performing status after being delinquent for at least 12 months. The availability of such loans is directly influenced by the volume and characteristics of initial delinquencies, like those disclosed by Capital One, as these form the source pool for future reperforming loan opportunities.",
      "llm_answer": "Capital One reported total delinquent loans of about **$623 million** as of December 31 2023 (Table 3.8, “Total Delinquent Loans”)【page_161】. MetLife’s residential‑mortgage strategy relies on buying **reperforming loans**—loans that were previously delinquent but have returned to performing status for at least 12 months after modification【page_240】. Because the pool of delinquent loans at Capital One is relatively modest, the number of loans that can later become reperforming—and thus be available for MetLife to purchase—is correspondingly limited, constraining the supply of such assets for MetLife’s portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Capital One's total delinquent loans as $623 million as of December 31, 2023, matching the ground truth in both amount and date. The entity names (Capital One/COF and MetLife/MET) and the relevant financial metric (delinquent loans) are accurate. (2) The quantitative accuracy is perfect: the dollar amount ($623 million) and date (December 31, 2023) are correct, and no calculations are required beyond accurate reporting. Format variation (e.g., $623 million vs $623M) is acceptable and handled correctly. (3) The multi-hop reasoning is sound: the answer correctly links Capital One’s delinquent loans to the future pool of reperforming loans that MetLife targets, explaining that MetLife purchases loans that have been reperforming for at least 12 months after delinquency. It appropriately infers that a modest delinquent loan volume limits future reperforming loan supply, which aligns with the causal relationship described in the ground truth. The only minor shortcoming is that the original answer emphasizes that delinquent loans 'contribute to the pool' of potentially reperforming loans, while the LLM slightly strengthens this to suggest a direct constraint due to modest volume—this is a reasonable inference but not explicitly confirmed in the ground truth (e.g., we don’t know if $623M is objectively 'modest' in context). (4) Despite this slight interpretive leap, the core facts, entities, timing, and logical chain are correct and complete. The answer is highly relevant, directly addressing how COF's delinquencies affect MET's purchasing opportunities. Thus, correctness is rated 9/10, with full marks for quantitative accuracy and contextual relevance, and 9 for qualitative accuracy due to the minor interpretive addition.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 488,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How does the exposure of UNP's pension plan to limited partnerships investing in real estate compare with UPS's unfunded commitments to similar structures, given both companies' reliance on NAV-based valuations for these illiquid assets?",
      "original_answer": "UNP's pension plan holds interests in limited partnerships that primarily invest in privately-held companies and reports these using NAV-based valuations, while UPS has unfunded commitments totaling approximately $3.3 billion to limited partnerships focused on private equity, private debt, and real estate funds. Both companies rely on NAV as a practical expedient for valuing these illiquid investments, with UPS specifically noting the limited redemption provisions until the end of the partnership terms, typically 10 to 15 years from inception. This indicates that both firms face similar challenges in liquidity and valuation transparency for these alternative investments.",
      "llm_answer": "UNP’s pension plan does hold interests in limited‑partnerships that invest in real‑estate, but the amount is not disclosed separately – it is simply reflected in the plan’s overall asset base (about $43 billion of plan assets) and is valued using NAV. UPS, by contrast, reports explicit “unfunded commitments” to similar limited‑partnership interests of roughly **$3.3 billion**, also measured at NAV. Thus, UNP’s exposure is embedded in its funded pension assets, whereas UPS carries a distinct, unfunded NAV‑valued liability of $3.3 billion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $3.3 billion unfunded commitment by UPS is correctly reported, and while UNP does not disclose the specific amount of its pension plan's exposure to real estate-focused limited partnerships, the LLM correctly notes that it is embedded within the overall $43 billion plan assets and valued via NAV—this matches the knowledge graph's indication that UNP uses NAV-based valuations for such illiquid assets. (2) The comparison between UNP’s funded, NAV-valued holdings and UPS’s unfunded commitments is logically sound and factually correct. (3) Multi-hop reasoning is strong: the model correctly synthesizes that both companies use NAV as a practical expedient for valuing illiquid alternative investments (private equity, real estate, etc.), and it contrasts the nature of exposure—UNP as an asset within pension holdings, UPS as a future liability. (4) The only minor shortcoming is that the LLM does not explicitly mention UPS’s limited redemption provisions or the typical 10–15 year partnership terms, which are part of the original answer and add context about liquidity constraints. However, this omission does not undermine the core factual accuracy. Wording differs but semantic meaning is equivalent. All entities (UNP, UPS, limited partnerships, NAV, unfunded commitments) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 392,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How does AMD's reliance on third-party manufacturers for 7 nm and smaller node production impact its exposure to quality control risks compared to Cisco's approach of maintaining quality control through automated testing and ISO 9001-certified processes?",
      "original_answer": "AMD's reliance on third-party manufacturers like TSMC for 7 nm and smaller node production exposes it to risks related to manufacturing yields, delivery schedules, and quality assurance, as these manufacturers are responsible for implementing leading-edge process technologies and maintaining acceptable yields. In contrast, Cisco maintains quality control internally through automated testing equipment, burn-in procedures, and ISO 9001-certified manufacturing processes, which are designed to ensure product reliability and reduce variability. This difference suggests that AMD has less direct control over quality assurance in its supply chain compared to Cisco, which integrates quality control directly into its manufacturing procedures.",
      "llm_answer": "AMD depends on external wafer‑foundries—primarily TSMC for 7 nm and smaller nodes and other third‑party assemblers—for virtually all of its silicon production.  Because those suppliers control the process technology, yields and quality‑assurance procedures, AMD faces a material risk that manufacturing defects, low yields or other quality‑control problems could disrupt supply or increase costs (see AMD 10‑K pages 23‑25).  \n\nCisco, by contrast, uses contract manufacturers but insulates itself with extensive in‑house automated test equipment, burn‑in, statistical process controls and ISO 9001‑certified manufacturing procedures that are expressly designed to assure product quality and reliability (Cisco 10‑K page 9).  Consequently, Cisco’s exposure to quality‑control risk is managed through these standardized testing and certification processes, whereas AMD’s exposure is higher due to its reliance on third‑party fabs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AMD relies on third-party manufacturers like TSMC for 7 nm and smaller nodes, which introduces risks in yield, quality control, and supply—this is consistent with AMD's 10-K disclosures. Cisco uses contract manufacturers but maintains strong internal quality controls via automated testing, burn-in, statistical process controls, and ISO 9001 certification, as cited from its 10-K. There are no incorrect numbers, dates, or financial figures—thus, quantitative accuracy is perfect. (2) While no explicit numerical data (e.g., percentages, dollar amounts) appear in the question or answers, the use of document references (e.g., 'AMD 10-K pages 23–25', 'Cisco 10-K page 9') supports factual grounding and enhances credibility. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (AMD and Cisco), compares their manufacturing strategies, and evaluates the implications for quality control risk exposure. It identifies that AMD has less direct control due to reliance on external fabs, while Cisco mitigates risk through standardized internal processes. (4) The only minor shortcoming is that the LLM slightly expands on the original answer by mentioning 'statistical process controls' and 'in-house automated test equipment'—details not explicitly in the ground truth—though these are accurate per Cisco’s filings and do not detract from correctness. Overall, the answer is semantically equivalent, contextually relevant, and factually precise, warranting a 9/10 due to slight elaboration beyond the original answer without error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 459,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How does Comcast's lack of voting rights in Atairos compare to Alphabet's structure of Class C Capital Stock, which also carries no voting rights, particularly in terms of how each company manages governance influence versus financial exposure?",
      "original_answer": "Comcast does not have voting rights or the power to direct the activities of Atairos, which is classified as a VIE, and therefore does not consolidate it, limiting its governance influence while still being exposed to financial risk up to its investment balance and remaining unfunded capital commitment of $1.4 billion as of December 31, 2024. In contrast, Alphabet issues Class C Capital Stock, which carries no voting rights except as required by law, but the company actively manages these shares through large-scale repurchases—$62.0 billion in 2024—allowing it to maintain governance control through Class A and B shares while offering different voting structures to investors. Both entities separate voting rights from certain stakeholders, but Alphabet retains control through its dual-class share structure, whereas Comcast has no such governance influence over Atairos despite significant financial exposure.",
      "llm_answer": "Comcast’s stake in Atairos is held without any voting power – it cannot direct the VIE’s activities and its only risk is the amount of its equity investment and the $1.4 billion of unfunded capital it may still have to fund (the “maximum risk of financial loss”)【page_85】. Alphabet’s Class C capital stock likewise carries no voting rights, but Class C shareholders retain the same economic and dividend rights as Class A holders and their exposure is limited to the market value of the shares they own, with governance control residing in the 10‑vote Class B shares【page_82】. Thus, both companies separate voting influence from economic interest, but Comcast’s non‑voting position is tied to a specific VIE investment and a defined capital‑commitment risk, whereas Alphabet’s non‑voting shares simply forgo governance influence while maintaining full financial exposure to the company’s equity performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: Comcast has no voting rights in Atairos, which is a VIE, and its financial exposure includes its equity investment plus $1.4 billion in unfunded capital commitment as of December 31, 2024—this date is implied in the context and the amount is correctly stated. Alphabet’s Class C shares carry no voting rights, and governance is retained via Class B shares; the $62.0 billion in repurchases in 2024 is not mentioned in the LLM answer, which is a minor omission, but this does not distort the overall comparison. (2) Quantitative accuracy is perfect: the $1.4 billion unfunded commitment is correctly cited, and no incorrect numbers are introduced. (3) The multi-hop reasoning is sound—comparing Comcast’s lack of control over a VIE despite financial exposure to Alphabet’s structural use of non-voting shares within its own capital structure. The synthesis across entities (Comcast/Atairos vs Alphabet) and concepts (governance vs financial exposure) is logically coherent. (4) The LLM slightly under-elaborates on Alphabet’s active management via repurchases, which is a key differentiator in how Alphabet maintains control, but the essential contrast—Comcast lacks influence over an external entity while Alphabet structurally controls its own dual-class shares—is preserved. Wording differs but semantic equivalence is maintained. No irrelevant or incorrect information is introduced, and the response is fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 426,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How does Coca-Cola HBC's distribution footprint in Austria compare with Philip Morris's market presence in the same country, based on their respective operational disclosures?",
      "original_answer": "Coca-Cola HBC, as a key bottler for The Coca-Cola Company, operates in Austria and contributes to 41% of Coca-Cola’s total worldwide unit case volume through its five largest bottlers. Meanwhile, Philip Morris reports a market share of at least 15% in Austria, as part of its presence across approximately 100 markets globally. Both companies maintain a direct or dedicated distribution presence in Austria, with Coca-Cola HBC managing bottling and distribution of beverages, and Philip Morris leveraging its exclusive zonified and direct distribution strategies to maintain its competitive market position.",
      "llm_answer": "Coca‑Cola HBC lists Austria among the countries where it “has bottling and distribution operations,” indicating a direct, on‑the‑ground distribution footprint in that market. Philip Morris, by contrast, notes that it “has a market share of at least 15 % in … Austria,” showing a significant but non‑exclusive presence in the Austrian tobacco market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) Quantitative accuracy: The 15% market share for Philip Morris in Austria is correctly reported. While the Coca-Cola HBC 41% figure (of total worldwide unit case volume via its five largest bottlers) is not explicitly mentioned, this detail is contextual and not strictly necessary to answer the core comparison about distribution footprint vs. market presence. (2) Completeness: The LLM correctly identifies both companies' operational presence in Austria—Coca-Cola HBC with direct bottling and distribution operations, and Philip Morris with a measurable market share. It addresses the core of the question—comparing distribution footprint with market presence—even if it omits the broader context about Coca-Cola’s global bottler contribution. (3) Entity accuracy: Both companies and the country (Austria) are correctly identified, with accurate descriptions of their respective operations. (4) Reasoning: The multi-hop synthesis is sound—linking Coca-Cola HBC’s operational disclosure to physical presence and Philip Morris’s market share to competitive presence. The conclusion that Coca-Cola HBC has a direct distribution footprint while Philip Morris has a significant but non-exclusive presence is logically derived and contextually appropriate. (5) Semantic equivalence: The LLM conveys the same essential information as the original answer, with slightly less contextual detail but no factual errors. The omission of the 41% statistic does not detract from the core comparison being asked. Minor deduction in qualitative accuracy due to this partial contextual omission, but overall reasoning and correctness remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 467,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How does the deterioration in BAC's commercial real estate credit quality, particularly in office properties, influence MET's use of the Bornhuetter-Ferguson Method and its annual updates to unpaid claims assumptions for Protection Life and Health products?",
      "original_answer": "BAC experienced a deterioration in commercial credit quality during 2023, especially in the commercial real estate office property type, due to stagnant office space demand and evolving employment models (BAC chunk). MET updates its unpaid claims assumptions annually to reflect emerging trends in claim experience, including macroeconomic conditions (MET chunk). MET uses the Bornhuetter-Ferguson Method to estimate unpaid claims for Protection Life and Health products, relying on historical claims data and expected loss ratios, which are sensitive to economic shifts (Hop2 chunk). Therefore, a worsening macroeconomic environment—such as declining commercial real estate values and increased defaults in office properties—could affect MET’s claims estimation by altering expected loss ratios, particularly for long-duration Protection Health claims or experience-rated contracts where adverse claim experience is passed to sponsors (MET chunk). This creates a multi-hop chain where BAC's credit quality trends serve as an early indicator of macroeconomic deterioration that MET must incorporate into its actuarial models.",
      "llm_answer": "Bank of America reported that non‑performing commercial loans rose sharply in 2023, driven almost entirely by the commercial‑real‑estate office‑property segment (page 65). MetLife’s IBNR reserves for its Protection Life and Protection Health products are calculated with the Bornhuetter‑Ferguson method, which combines historical claim development with an “expected‑loss” factor that is re‑estimated each year to reflect emerging trends (page 196). Thus, the worsening office‑property credit quality at BAC serves as a macro‑economic warning that MetLife would incorporate when it updates the expected‑loss assumptions and credibility weights in its annual Bornhuetter‑Ferguson calculations, potentially leading to higher unpaid‑claims reserves for those products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: BAC's deterioration in commercial real estate credit quality in 2023, specifically in office properties, is accurately attributed to rising non-performing loans (cited from page 65), and MET’s use of the Bornhuetter-Ferguson method for Protection Life and Health products is correctly described with reference to page 196. (2) There are no numerical inaccuracies—while no specific dollar amounts or percentages are given in either answer, the qualitative financial trends (e.g., 'sharply rose') are consistent and appropriately vague given the source. (3) The multi-hop reasoning is sound: the LLM correctly links BAC’s credit deterioration as a macroeconomic signal to MET’s annual update of expected loss assumptions in its actuarial models, particularly through the Bornhuetter-Ferguson method. It captures the causal chain: economic stress → commercial real estate defaults → broader macroeconomic concerns → updated loss expectations → potential reserve increases. (4) The only minor shortcoming is that the LLM omits the specific mechanism about 'experience-rated contracts where adverse claim experience is passed to sponsors' and slightly less detail on how long-duration Protection Health claims are particularly sensitive. However, this does not undermine the core correctness. Wording differs but semantic meaning matches. The answer is contextually precise, directly addressing the influence of BAC's trends on MET’s modeling updates.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 425,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How does the voting rights structure of Netflix's common stock compare to Meta's, considering the influence of Class A Common Stock in both companies' governance frameworks?",
      "original_answer": "Netflix's common stockholders are entitled to one vote per share, creating a uniform voting rights structure. In contrast, Meta's Class A Common Stock also provides one vote per share, but Meta has a multi-tiered stock structure that includes Class B Common Stock with 10 votes per share, giving certain shareholders disproportionate voting power. This difference means that while both companies grant one vote per share for Class A Common Stock, Meta's governance framework allows for greater concentration of control through its Class B shares.",
      "llm_answer": "Netflix’s capital structure consists of a single class of common stock, and each share carries **one vote per share** (see Netflix 10‑K, “Voting Rights,” page 60). Meta, by contrast, has a dual‑class system: the filing lists both **Class A and Class B common stock** (Meta 10‑K, page 1), with Class A shares receiving one vote per share while Class B shares receive ten votes per share, giving the founders and insiders disproportionate voting power. Thus, Netflix’s governance is “one‑share‑one‑vote,” whereas Meta’s governance is dominated by the higher‑voting Class B shares, limiting the influence of its publicly‑traded Class A stock.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that Netflix has a single class of common stock with one vote per share, while Meta has a dual-class structure with Class A shares carrying one vote and Class B shares carrying ten votes per share. These voting rights are accurately represented. (2) All quantitative details are correct: 'one vote per share' for Netflix and Meta's Class A, 'ten votes per share' for Meta's Class B—no calculations are required, but the comparison is numerically sound. (3) The multi-hop reasoning is strong: the model correctly synthesizes governance structures across two different companies (Netflix and Meta), identifies the structural implications of their stock classes, and draws a valid contrast in control concentration. (4) The answer is contextually relevant, directly addressing the comparison of voting rights structures and the influence of Class A stock in both firms. Minor wording differences (e.g., 'one-share-one-vote' vs. 'uniform voting rights') do not affect factual equivalence. No errors in entities, metrics, or logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 321,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How does the fair value treatment of exchange-traded commodity futures under Level 1 financial liabilities differ between PEP and MDLZ, given that both companies cash-settle these instruments and include them in their respective liability portfolios?",
      "original_answer": "PEP explicitly states that exchange-traded commodity futures are cash-settled on a daily basis and therefore not included in the fair value hierarchy table as of December 25, 2021. In contrast, MDLZ includes exchange-traded commodity futures in its Level 1 financial liabilities, with fair value determined based on quoted market prices on commodity exchanges. Both companies treat these futures as part of their Level 1 liabilities, but PEP excludes them from reported tables due to daily cash settlement, whereas MDLZ continues to report them based on market pricing as of the balance sheet date.",
      "llm_answer": "Mondelez (MDLZ) lists its exchange‑traded commodity futures as **Level 1 financial liabilities** – they are measured at the quoted market price on the exchange and appear in the fair‑value table (e.g., $46 million of the $77 million commodity contracts).  \n\nPepsiCo (PEP) states that its exchange‑traded commodity futures are **cash‑settled daily and therefore are not included in the fair‑value hierarchy table**; they are excluded from the liability balances and are not presented as Level 1 liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that MDLZ includes exchange-traded commodity futures in Level 1 financial liabilities, using quoted market prices, and provides a specific example ($46 million of $77 million), which is consistent with the type of detail in the original answer, though the exact numbers are not in the ground truth — however, such illustrative figures may be drawn from actual filings and do not contradict the known facts. (2) It accurately states that PEP excludes these instruments from the fair value hierarchy table due to daily cash settlement, which matches the original answer’s key point. (3) The multi-hop reasoning is sound: the model correctly contrasts PEP’s exclusion (due to daily settlement) with MDLZ’s inclusion (based on market pricing at balance sheet date), capturing the core difference in reporting treatment despite similar underlying valuation. (4) All entities (PEP, MDLZ, Level 1, exchange-traded commodity futures) are correct, and the context of fair value hierarchy and cash settlement is properly applied. The only minor shortcoming is that the LLM implies PEP does not present these as Level 1 liabilities at all, while the ground truth clarifies both treat them as Level 1 in substance — PEP just excludes them from the table. This subtle distinction is slightly underemphasized, but not misrepresented. Quantitative accuracy is high — no incorrect numbers are presented, and the example figures are plausible and contextually appropriate. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 445,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How do the cost-sharing arrangements between Merck and Gilead for the development of HIV treatments combining islatravir and lenacapavir compare to Pfizer's cost-reduction initiatives, and what implications might this have on each company's financial exposure in long-acting HIV therapies?",
      "original_answer": "Merck and Gilead share global development and commercialization costs for HIV treatments combining islatravir and lenacapavir at a 60/40 split (Gilead/Merck), with equal revenue sharing until certain thresholds are met ($2.0 billion for oral and $3.5 billion for injectable combinations), after which Gilead's revenue share increases. In contrast, Pfizer's 2024 filing highlights enterprise-wide cost realignment and manufacturing optimization programs aimed at reducing costs and improving productivity. These initiatives carry risks such as potential disruption of ongoing business, including impacts on the delivery of their pipeline, which could include HIV-related R&D. While Merck and Gilead are jointly investing in a high-potential, long-acting HIV therapy with shared financial exposure, Pfizer is focusing on internal cost controls that may affect its ability to invest in or compete with such collaborative models. This contrast suggests differing strategic approaches to managing financial exposure in the evolving HIV treatment landscape.",
      "llm_answer": "Gilead’s agreement with Merck sets a fixed 60 % / 40 % split of all development‑ and commercialization‑costs for the long‑acting oral and injectable HIV combos (islatravir + lenacapavir), with revenue shared equally (rising to a 65 % share for Gilead once sales exceed $2 bn for the oral and $3.5 bn for the injectable product) and a royalty fallback if either party opts out 【page 74】. Pfizer’s “cost‑reduction initiatives” are internal programs (enterprise‑wide cost realignment and manufacturing optimisation) that aim to lower its own expense base rather than share costs with a partner, and their financial impact depends on whether the projected savings are actually realized 【page 30】. Consequently, Gilead and Merck each retain a proportional exposure to the HIV programme’s out‑lays and upside (60 % vs 40 % of costs), whereas Pfizer’s exposure is limited to the success of its internal efficiency drives, which could reduce overall spending but does not tie its financial risk to a specific HIV‑therapy partnership.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: the 60/40 cost split (Gilead/Merck), equal revenue sharing with Gilead's increased share after $2.0 billion (oral) and $3.5 billion (injectable) thresholds, and the reference to Pfizer's internal cost-reduction initiatives including enterprise-wide realignment and manufacturing optimization. The dollar amounts, percentages, and cost/revenue-sharing mechanics are all factually correct. (2) Quantitative accuracy is perfect: all numbers ($2.0 billion, $3.5 billion, 60%, 40%, 65%) match the ground truth, and no calculations are incorrect. (3) Multi-hop reasoning is sound: the model correctly contrasts Merck/Gilead's collaborative, shared-exposure model with Pfizer's internal cost controls, and infers differing financial exposure implications. The mention of a 'royalty fallback' adds detail not in the original but is plausible and does not contradict. (4) The only minor shortcoming is slightly less emphasis on the strategic implication about Pfizer's potential reduced competitiveness in long-acting HIV therapies due to lack of partnership, which is central to the original's conclusion. However, the core contrast in financial exposure is clearly conveyed. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent—every part of the question is addressed with precise, relevant information.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1554,
        "completion_tokens": 394,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does FDX's exposure to LIBOR-related hedging adjustments under ASU 2022-06 compare to UPS's use of hedging relationships, particularly in light of ASU 2022-06's extended sunset date through 2024?",
      "original_answer": "FDX has stated that reference rate reform, including ASU 2022-06, has had no material effect on its financial condition or results of operations as of May 31, 2024, though it continues to monitor contracts for potential application of the standard. ASU 2022-06 extends the sunset date for optional expedients and exceptions related to reference rate reform—including LIBOR transitions—to December 31, 2024. UPS, which designates derivative instruments in hedging relationships, including cash flow and fair value hedges, may benefit from the extended relief under ASU 2022-06 to manage LIBOR-related contracts through 2024 without significant accounting disruptions. Therefore, while FDX has not seen material impacts, UPS could be actively leveraging the extended ASU 2022-06 provisions in its hedging strategies.",
      "llm_answer": "FedEx notes that, although it monitors contracts that reference LIBOR, the optional expedients in ASU 2022‑06 have **not produced any material effect on its financial condition, results of operations or cash flows** as of May 31 2024. UPS, by contrast, describes a broad program of derivative‑based hedging (cash‑flow, fair‑value and net‑investment hedges) but does not disclose any material LIBOR‑related adjustment; the company’s hedging framework simply remains eligible for the same ASU 2022‑06 relief that now runs through December 31 2024. Thus, FedEx’s exposure is essentially immaterial, while UPS’s hedging activities are subject to the same extended sunset date but also appear to have no material impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: FDX (FedEx) reports no material effect from ASU 2022-06 as of May 31, 2024, and continues monitoring LIBOR-referencing contracts. The sunset date for ASU 2022-06 is correctly stated as December 31, 2024. UPS’s use of hedging relationships (cash flow, fair value, and net investment hedges) is accurately described. (2) Quantitative accuracy is perfect: dates (May 31, 2024; December 31, 2024) match exactly, and there are no numerical calculations required beyond correct date reporting. (3) Multi-hop reasoning is sound: the model correctly contrasts FDX’s immaterial exposure with UPS’s potential use of extended relief under ASU 2022-06, even though UPS does not disclose material adjustments. The synthesis across both companies and the accounting standard is logical and complete. (4) The only minor shortcoming is that the LLM slightly downplays UPS’s potential active use of the relief—ground truth suggests UPS 'could be actively leveraging' the provisions, while the LLM says impacts are 'not disclosed' and 'appear to have no material impact.' This is a subtle but acceptable difference in emphasis, not a factual error. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 366,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does the dual-class stock structure's impact on investor protections at META compare to the voting power differential in GOOGL's Class B common stock, especially given that Class B shares automatically convert to Class A upon sale or transfer?",
      "original_answer": "META's dual-class structure allows its controlling stockholder to maintain decision-making power even if they own significantly less than a majority of shares, which could make Class A common stock less attractive to investors due to reduced governance protections. In contrast, GOOGL's Class B common stock provides 10 votes per share compared to 1 vote per share for Class A, but these Class B shares automatically convert to Class A upon sale or transfer, potentially limiting long-term control by insiders. This conversion mechanism in GOOGL may offer more eventual governance balance compared to META's structure, where Class B shares can maintain control for extended periods unless their voting power drops below 35% of the combined voting power.",
      "llm_answer": "Meta’s filing explains that its dual‑class structure gives the controlling shareholder (Mr. Zuckerberg) a disproportionate voting bloc – Class B shares carry ten votes each and, under the company’s charter and Delaware law, can block or dictate shareholder‑approved actions even though they represent a small economic stake (see META 10‑K p. 50). In contrast, Alphabet’s filing notes that while Class B stock also carries ten votes per share, those shares may be converted at the holder’s option and automatically convert to one‑vote Class A shares on any sale or transfer, so the voting‑power premium is effectively confined to insiders and does not dilute the voting rights of the public shareholders (see GOOGL 10‑K p. 81). Thus Meta’s structure limits investor protections by concentrating control, whereas Alphabet’s automatic conversion mechanism preserves more typical one‑vote‑per‑share protection for market investors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Meta's Class B shares have 10 votes per share and enable outsized control by Zuckerberg, while GOOGL's Class B shares also have 10 votes but automatically convert to Class A (1 vote) upon sale or transfer. These details match the original answer and are consistent with the cited 10-K pages. (2) Quantitative accuracy is perfect: the 10-to-1 voting ratio for both companies is correctly stated, and no erroneous numbers or calculations are present. Format and references (e.g., page numbers) are appropriately included. (3) The multi-hop reasoning is sound—comparing Meta’s enduring control structure with Alphabet’s conversion mechanism that limits long-term insider dominance. The LLM correctly infers that Alphabet’s structure offers stronger eventual governance balance for public investors. (4) The only minor shortcoming is that the LLM does not explicitly mention Meta’s 35% combined voting power threshold, a specific safeguard noted in the ground truth. While this is a small omission, it slightly reduces completeness in the qualitative dimension. However, the core comparison and conclusion about investor protections remain accurate and well-supported. Wording differs but semantic equivalence is maintained. Contextual relevance is excellent, directly addressing the comparative governance implications of both dual-class structures.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 399,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does KO's use of option contracts to hedge forecasted transactions compare to MDLZ's disclosure of gains and losses on forecasted transactions in terms of financial impact and hedging strategy?",
      "original_answer": "KO utilizes option contracts as part of its broader hedging strategy to mitigate foreign currency exchange rate risk, commodity price risk, and interest rate risk, with the goal of reducing earnings volatility from market fluctuations. These contracts are designated as cash flow hedges, and the unrealized gains or losses are deferred in AOCI until the forecasted transactions occur. In contrast, MDLZ disclosed that in 2024, it recognized $106 million in gains on forecasted transactions through cost of sales, and $17 million through interest and other expense, net, indicating the financial impact of these hedging activities on specific income statement line items. While KO emphasizes a structured hedging approach with clear accounting treatment for deferred gains/losses, MDLZ provides more granular disclosure on the realized financial outcomes of its hedging activities on forecasted transactions.",
      "llm_answer": "Coca‑Cola (KO) hedges its forecast foreign‑currency transactions with option (and forward) contracts that are formally designated as cash‑flow hedges; the resulting gains or losses are first recorded in other‑comprehensive income and only re‑classified into earnings when the underlying transaction occurs, leaving only a modest $99 million of deferred gains for contracts maturing in the next year. Mondelez (MDLZ), by contrast, treats gains and losses on its forecast‑transaction hedges as “economic hedges” that are recognized directly in the income statement (e.g., $106 million in 2024, $17 million in 2023) affecting cost of sales, interest expense and SG&A. Thus KO’s approach smooths the financial impact through AOCI, while MDLZ’s approach results in immediate earnings volatility from the hedged forecasted transactions.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core contrast between KO and MDLZ in hedging strategy and financial impact, correctly identifying KO's use of cash flow hedges with gains/losses deferred in AOCI and MDLZ's more immediate income statement recognition. However, there are key quantitative inaccuracies: the LLM states MDLZ recognized $106 million in 2024 and $17 million in 2023, but the ground truth specifies only 2024 figures ($106 million in cost of sales and $17 million in interest and other expense), with no mention of 2023. This introduces a false temporal comparison. Additionally, the $99 million deferred gains figure for KO is not present in the original answer and appears to be fabricated or misattributed, undermining quantitative accuracy. On qualitative grounds, the reasoning is sound—correctly contrasting KO’s smoothing approach via AOCI with MDLZ’s direct income statement impact—and entities (KO, MDLZ, hedging types, financial line items) are accurately identified. The answer is fully contextually relevant, addressing both financial impact and strategy. While the core multi-hop synthesis (comparing accounting treatments and disclosures across firms) is logically executed, the inclusion of unsupported numbers reduces factual reliability, warranting a 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 361,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does the valuation approach for TMO's fixed income funds, which are reported as 'not subject to leveling', contrast with BMY's classification of fixed income funds under Level 2 in the fair value hierarchy, and what does this indicate about their respective reliance on observable market data for pension asset valuation?",
      "original_answer": "TMO reports its fixed income funds as 'not subject to leveling,' indicating that these assets are valued outside the standard fair value hierarchy and likely measured using methods other than quoted market prices or observable inputs. In contrast, BMY classifies its fixed income funds under Level 2, which means their valuation relies on observable market data, such as quoted prices for similar instruments or in nonactive markets. This contrast suggests that BMY's pension assets have a more structured and market-based valuation methodology for fixed income funds, while TMO's approach implies less direct reliance on standardized market inputs for these assets.",
      "llm_answer": "Thermo Fisher’s pension tables show its fixed‑income funds listed under “not subject to leveling,” meaning the funds are valued using a practical‑expedient NAV supplied by the fund manager rather than being placed in the fair‑value hierarchy (Level 1 or Level 2). By contrast, Bristol‑Myers Squibb classifies its fixed‑income funds as Level 2 assets, valuing them with observable market inputs such as interest‑rate curves, bond yields and comparable‑instrument prices. Thus, Thermo Fisher relies less on observable market data for those pension assets, while BMS’s valuation depends more directly on market‑observable information.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: TMO (Thermo Fisher) reports fixed income funds as 'not subject to leveling,' which the LLM correctly interprets as using NAV as a practical expedient, placing it outside the fair value hierarchy. BMY (Bristol-Myers Squibb) classifies its fixed income funds under Level 2, which the LLM accurately describes as relying on observable market inputs like interest-rate curves and comparable-instrument prices. (2) There are no numeric values in the question or answer requiring calculation, so quantitative accuracy is not applicable beyond correct use of terminology—this is handled perfectly. (3) Multi-hop reasoning is sound: the model correctly contrasts two companies' pension asset valuation approaches, synthesizing information about their respective use of observable data. (4) The only minor shortcoming is that the LLM does not explicitly state that Level 2 falls within the 'standard fair value hierarchy'—though this is implied—while the original answer emphasizes this structural point. However, the semantic meaning and practical implications are preserved. Wording differs slightly (e.g., 'practical-expedient NAV' adds detail not in the original but is factually correct), but the core reasoning and conclusion about differential reliance on observable market data are identical. Thus, the answer is factually complete and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 405,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How does the application of the Federal Acquisition Regulation (FAR) in cost-plus-fixed-fee contracts impact revenue recognition timing differences between LMT and BA for their respective U.S. Government contracts?",
      "original_answer": "LMT applies FAR to its U.S. Government contracts, which results in standalone selling prices being equal to the stated contract price, and revenue being recognized over time as control of work in process transfers continuously to the customer due to clauses allowing unilateral termination and payment for costs incurred plus profit. Similarly, BA notes that U.S. Government contracts can be terminated for convenience, entitling them to payment for completed work and allowable termination costs. This creates a comparable revenue recognition pattern for both companies under FAR-regulated cost-plus-fixed-fee contracts, where revenue is recognized progressively rather than at a point in time, but differences may arise based on contract-specific termination clauses and profit margin negotiations.",
      "llm_answer": "Both Lockheed Martin and Boeing say that U.S. government cost‑plus‑fixed‑fee contracts are governed by the FAR, which requires the price to be based on allowable costs plus a fixed fee.  Because the FAR clauses give the government ownership of work‑in‑process and allow termination for convenience, each company treats the contract as a single performance‑obligation and records revenue **over time** as costs are incurred and the work is performed.  Consequently, the FAR eliminates a “point‑in‑time” recognition difference – the timing of revenue recognition for their U.S. government contracts is essentially the same for LMT and BA, with any residual timing variation arising only from each company’s internal estimates of variable consideration or contract modifications.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that both LMT and BA apply the FAR to U.S. Government cost-plus-fixed-fee contracts, leading to revenue recognition over time due to government termination rights and ownership of work-in-process. This matches the original answer's core reasoning. (2) There are no numeric values in the question or answers requiring verification, so quantitative accuracy is not applicable in a traditional sense, but all factual assertions (e.g., FAR governance, termination for convenience, over-time recognition) are correct. (3) The multi-hop reasoning is sound: the model synthesizes the impact of FAR clauses (termination for convenience, payment for costs plus fee) with ASC 606 revenue recognition principles to conclude that both companies recognize revenue over time. It correctly infers that this minimizes timing differences between LMT and BA. (4) The only minor shortcoming is that the LLM answer attributes residual timing differences to 'internal estimates of variable consideration or contract modifications,' whereas the original emphasizes 'contract-specific termination clauses and profit margin negotiations' as sources of potential differences. This is a subtle but notable nuance—the original highlights structural contract terms, while the LLM focuses on estimation processes. Despite this, the overall semantic meaning and factual correctness remain strong. Contextual relevance is perfect: the response directly addresses the question about FAR’s impact on revenue recognition timing between the two companies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 442,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How does the structure of AbbVie's debt agreements with U.S. Bank National Association compare to Abbott Laboratories' use of Abbott Ireland Financing DAC as an issuer, particularly in terms of trustee roles and note issuance timelines?",
      "original_answer": "AbbVie has multiple Supplemental Indentures with U.S. Bank National Association serving as trustee, transfer agent, and registrar, with key agreements dated September 26, 2019 (Supplemental Indenture No. 6), November 21, 2019 (Supplemental Indenture No. 7), and May 14, 2020 (Supplemental Indenture No. 8 and 9). These agreements involve the issuance of various notes and are supported by Agency Agreements with Elavon Financial Services DAC. Similarly, Abbott Ireland Financing DAC, as issuer, has entered into Indentures with U.S. Bank National Association as trustee, including the September 27, 2018 Indenture and the November 19, 2019 Second Supplemental Indenture, under which specific notes such as the 1.500% Note due 2026 and the 0.100% Note due 2024 were issued. Both companies rely on U.S. Bank National Association in a trustee capacity, but AbbVie’s structure includes more frequent use of Elavon Financial Services DAC as a paying agent, while Abbott Ireland Financing DAC directly issues notes under its own entity name with Abbott Laboratories as guarantor.",
      "llm_answer": "AbbVie’s borrowing is structured through a series of primary and supplemental indentures that name U.S. Bank National Association as the **trustee (and, through Elavon, also the transfer‑agent/registrar and paying‑agent)**, with the first indenture dated Nov 8 2012 and subsequent supplements issued in 2015, 2016, 2017, 2018, 2019 and 2020. In contrast, Abbott Laboratories issues its notes through **Abbott Ireland Financing DAC as the issuer**, while **U.S. Bank National Association serves only as trustee**; the initial indenture was executed Sept 27 2018, followed by supplemental indentures in Sept 2018 and Nov 2019 and additional notes dated 2020. Thus, both companies rely on U.S. Bank as trustee, but AbbVie’s agreements are a longer‑running, directly‑between‑company series of indentures, whereas Abbott’s are limited to a few issuances by a separate DAC beginning in 2018.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core comparison between AbbVie and Abbott Laboratories' debt structures accurately in terms of entity roles and overall framework, but contains several date inaccuracies and omits key details. (1) Quantitatively, the LLM incorrectly lists a Nov 8, 2012 primary indenture for AbbVie and mentions supplements in 2015–2018, which are not in the ground truth; the correct AbbVie supplemental indentures are dated Sept 26, 2019 (No. 6), Nov 21, 2019 (No. 7), and May 14, 2020 (Nos. 8 and 9). The LLM also generalizes 'additional notes dated 2020' for Abbott without specifying the actual notes (e.g., 1.500% Note due 2026, 0.100% Note due 2024), and incorrectly states a Sept 2018 supplemental indenture when the ground truth only lists Sept 27, 2018 as the initial indenture and Nov 19, 2019 as the Second Supplemental Indenture. (2) The entity roles are mostly correct: U.S. Bank National Association is accurately identified as trustee for both, and Abbott Ireland Financing DAC is correctly noted as the issuer with Abbott Laboratories as guarantor (implied). The mention of Elavon Financial Services DAC as a paying agent for AbbVie aligns with the ground truth, though the LLM overgeneralizes its role across all years. (3) The reasoning is sound in comparing the structural differences—AbbVie’s direct, multi-year indenture series vs. Abbott’s use of a DAC issuer starting in 2018—but misses the nuance that both use U.S. Bank as trustee and that Elavon’s role is tied to agency agreements, not the indentures themselves. (4) Despite date inaccuracies, the answer is contextually relevant and conveys a correct high-level comparison. The core facts about trustee usage and issuer structure are preserved, warranting a 7 for correctness. Minor wording differences are acceptable under semantic equivalence, but incorrect dates and missing note specifics reduce quantitative accuracy to 6. Qualitative accuracy is higher due to correct entity mapping and logical synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 536,
        "total_tokens": 2048
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How does NVDA's dependency on foundries for advanced process node manufacturing at 7nm and smaller compare to AMD's reliance on larger wafers for competitive IC production, given both companies' exposure to TSMC's fabrication capabilities?",
      "original_answer": "NVDA depends on foundries like TSMC to manufacture its semiconductor wafers using advanced process node technologies such as 7nm and smaller, which are critical for producing high-performance GPUs and meeting customer demand. NVDA faces risks including supply shortages, yield issues, and delays if TSMC cannot scale production or implement new technologies effectively. Similarly, AMD relies on TSMC to produce wafers with competitive performance attributes, and specifically mentions the importance of transitioning to advanced manufacturing process technologies and increased wafer sizes to maintain cost efficiency and product competitiveness. Both companies are exposed to risks if TSMC fails to deliver sufficient quantities of 7nm or smaller wafers, which could increase per-unit costs, delay product launches, and harm customer relationships. This shared dependency on TSMC for leading-edge wafer production highlights a critical supply chain vulnerability affecting both NVDA and AMD.",
      "llm_answer": "NVIDIA’s most advanced GPUs and AI chips are manufactured exclusively at TSMC’s 7 nm and smaller nodes, so the company’s ability to launch and scale its flagship products is tightly bound to TSMC’s capacity and yields at those leading‑edge processes. AMD also uses TSMC for its own 7 nm‑plus designs, but the bulk of its competitive CPUs and GPUs that run on larger‑node ( > 7 nm) processes are sourced primarily from GlobalFoundries, meaning AMD’s overall exposure to TSMC is confined to its high‑performance, next‑gen products while its volume business relies on a different foundry.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but introduces significant factual inaccuracies that undermine its overall correctness. (1) Quantitatively, the reference to 7nm and smaller nodes is accurate for both NVDA and AMD, and the reliance on TSMC for advanced nodes is correctly identified—this earns a high quantitative accuracy score. However, no specific numbers (e.g., wafer size, cost figures, yield rates) are present in either answer, so verification is limited to process node sizes, which are correctly stated. (2) The critical error lies in the claim that AMD sources 'the bulk of its competitive CPUs and GPUs' on larger nodes (>7nm) from GlobalFoundries. This is outdated and incorrect: since around 2018, AMD has transitioned almost entirely to TSMC for both CPU and GPU production, including not only 7nm but also 6nm, 5nm, and other advanced nodes. Even mid-range and volume products are manufactured at TSMC, not GlobalFoundries. The assertion that AMD uses GlobalFoundries for volume production misrepresents current supply chain reality. (3) The multi-hop reasoning fails because the comparison hinges on a false premise—AMD does not significantly rely on larger wafers from non-TSMC foundries for competitive IC production. Both NVDA and AMD are heavily dependent on TSMC for leading-edge nodes, making their exposure far more similar than the LLM suggests. The original answer correctly emphasizes shared TSMC dependency and associated risks (supply, yield, cost, delays), while the LLM incorrectly frames AMD as having a diversified foundry strategy that reduces TSMC exposure. (4) Contextual relevance is moderate because the answer addresses the right topic—foundry reliance and process nodes—but the flawed entity and strategic understanding reduces its usefulness. The qualitative accuracy is low due to incorrect synthesis and outdated information about AMD's manufacturing strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 514,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "Given Philip Morris's ongoing regulatory challenges in Thailand stemming from the WTO panel decision on customs valuation of cigarette imports, and Colgate-Palmolive's manufacturing presence in Thailand, how might the unresolved customs and tax compliance issues in Thailand impact Colgate-Palmolive's operational costs or regulatory risk exposure in the country?",
      "original_answer": "The WTO panel decision found that Thailand lacked grounds to challenge the customs valuation of Philip Morris's cigarette imports and obligated Thailand to revise its customs and tax practices. However, Thailand has not fully complied, and the dispute remains unresolved due to the inoperability of the WTO Appellate Body. This regulatory inertia indicates a persistent risk of non-aligned customs enforcement in Thailand. Colgate-Palmolive operates manufacturing and warehousing facilities in Thailand, a country where customs and tax measures have proven resistant to international rulings. If Thailand continues to apply inconsistent or non-compliant customs valuation practices, Colgate-Palmolive may face increased scrutiny, higher import duties, or regulatory uncertainty affecting its cost structure and compliance burden in the country.",
      "llm_answer": "The WTO panel decision shows that Thailand’s customs‑valuation and tax rules for imported cigarettes remain unsettled and the government could still impose retroactive or higher duties while the dispute is unresolved【page_68】.  Because Colgate‑Palmolive operates a manufacturing facility in Thailand – listed among its major overseas plants【page_25】 – the company could be subject to the same ambiguous valuation rules for imported raw materials and packaging, leading to higher customs‑tax payments, additional compliance and audit costs, and an elevated risk of penalties or supply‑chain delays.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies the unresolved WTO dispute involving Thailand's customs valuation practices and notes the ongoing regulatory risk, aligning with the original answer's emphasis on non-compliance and regulatory inertia. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not compromised—no errors in calculations or figures. (3) The multi-hop reasoning is sound: it connects Philip Morris’s WTO case to broader customs enforcement risks in Thailand, then correctly infers that Colgate-Palmolive, as a manufacturer with local operations, could face similar risks for imported inputs. This synthesis across companies and regulatory context is logically valid and supported by the knowledge graph. (4) The LLM adds slightly more operational detail (e.g., 'imported raw materials and packaging', 'supply-chain delays') not explicitly in the original but reasonably implied by the risk of inconsistent customs enforcement. These additions enhance rather than distort the meaning. The only minor gap is that the LLM does not explicitly mention the inoperability of the WTO Appellate Body as a reason for non-compliance, which slightly reduces completeness in causal explanation—hence a 9 instead of 10 on qualitative accuracy. Overall, the response is highly relevant, factually correct, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 404,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How does the $265,000 decline in UNH's Medicare Part D enrollment from 2023 to 2024 relate to the IRA's redesign of Medicare Part D and Pfizer's projected $1 billion revenue loss in 2025 under the same program?",
      "original_answer": "The $265,000 decline in UnitedHealth's (UNH) Medicare Part D enrollment from 2023 to 2024 reflects a reduction in the number of beneficiaries in this program, which aligns with broader structural changes introduced by the Inflation Reduction Act (IRA). The IRA's redesign of Medicare Part D, effective in 2025, includes a $2,000 annual out-of-pocket cap for beneficiaries and a new Manufacturer Discount Program requiring 10% and 20% discounts in different coverage phases. These changes increase financial pressure on manufacturers like Pfizer (PFE), which projects a $1 billion revenue loss in 2025 due to IRA-related adjustments. The enrollment decline at UNH may indicate reduced attractiveness of Part D plans to beneficiaries or shifting market dynamics, which, when combined with the IRA's pricing pressures, could contribute to reduced revenue for manufacturers like Pfizer.",
      "llm_answer": "UnitedHealth’s 2024 filing shows that the number of people enrolled in its stand‑alone Medicare Part D plans fell by 265 thousand (‑8 %) versus 2023 (UNH 10‑K p. 31).  That drop occurs in the same environment the Inflation‑Reduction Act has begun to reshape Part D—capping beneficiary out‑of‑pocket costs, reducing federal reinsurance in the catastrophic phase and imposing new manufacturer‑discount and rebate requirements (Amgen 10‑K p. 17).  Because those IRA provisions shift more cost to drug makers, Pfizer projects a far larger, roughly $1 billion, year‑over‑year revenue loss in 2025 from the same redesign (Pfizer 10‑K p. 17), indicating that UNH’s enrollment decline is an early sign of the broader financial pressure the IRA will place on pharmaceutical manufacturers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct and aligns closely with the ground truth. It accurately reports the 265,000 decline in UNH's Medicare Part D enrollment (stating '265 thousand' and '-8%'), which matches the original answer's $265,000 figure (interpreted as 265,000 people, consistent with context). The $1 billion revenue loss by Pfizer in 2025 is correctly cited, along with the IRA's key provisions: out-of-pocket cap, manufacturer discounts, and cost shifts. 2) Quantitative accuracy is excellent: '265 thousand' is equivalent to 265,000; the -8% change is consistent with UNH’s reported drop; $1 billion figure matches exactly. No calculation errors. 3) Multi-hop reasoning is sound: the LLM correctly links UNH's enrollment decline to the broader IRA-driven changes in Medicare Part D, and connects those structural shifts to Pfizer’s projected revenue loss. It infers that enrollment trends may signal broader financial pressure on manufacturers, which is a reasonable interpretation supported by the original answer. The use of Amgen’s 10-K as a source for IRA provisions is acceptable as corroborating evidence, though not in the original answer. 4) The only minor shortcoming is that the LLM does not explicitly mention the 10% and 20% manufacturer discounts (though it refers to 'new manufacturer-discount and rebate requirements'), slightly reducing qualitative completeness. Otherwise, the answer is semantically equivalent, well-contextualized, and highly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 407,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How does Lockheed Martin's $4,863 million investment in private equity funds, which are valued using the NAV practical expedient, compare to FedEx's application of the same accounting policy for equity securities without readily determinable fair values?",
      "original_answer": "Lockheed Martin reports $4,863 million in private equity fund investments valued under the NAV practical expedient, which relies on unobservable inputs in valuation models of underlying securities and typically has terms between 8 and 12 years. FedEx also applies the NAV practical expedient to equity securities without readily determinable fair values, though it notes that for these investments, adjustments to cost are made only for observable price changes and impairments. While Lockheed Martin’s NAV-based private equity investments are part of a broader portfolio including real estate and hedge funds, FedEx specifically highlights immaterial annual and cumulative impairment adjustments under the measurement alternative for such equity securities.",
      "llm_answer": "Lockheed Martin reports $4,863 million of private‑equity fund investments that are measured at fair value using the NAV practical expedient (see the “Investments measured at NAV” table on page 88). FedEx applies the same NAV practical‑expedient only to a small subset of equity securities without readily determinable fair values – $37 million in 2024 (and $26 million in 2023) as shown in its Note 19 on equity securities (page 117). Thus, Lockheed Martin’s NAV‑valued exposure is roughly $4.9 billion, which is orders of magnitude larger than FedEx’s $37 million NAV‑valued equity‑security exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The LLM claims FedEx has $37 million in NAV-valued equity securities in 2024 and $26 million in 2023, citing Note 19 on page 117. However, this information is not present in the ground truth, which does not specify any dollar amounts for FedEx’s NAV practical expedient applications—only that FedEx applies the expedient and makes adjustments only for observable price changes and impairments, which are immaterial. The introduction of specific dollar figures for FedEx ($37M, $26M) is unsupported by the original answer and constitutes a hallucination. (2) The ground truth emphasizes qualitative differences in how each company applies the NAV practical expedient: Lockheed Martin uses it for private equity funds with long-term commitments (8–12 years), part of a broader alternative investment portfolio, while FedEx applies it to equity securities without readily determinable fair values and notes immaterial impairments. The LLM misses this nuanced comparison and instead fabricates a quantitative contrast. (3) While the LLM correctly identifies Lockheed Martin’s $4,863 million investment and the use of NAV practical expedient, it fails to mention the key qualitative aspects from the ground truth—unobservable inputs, term lengths, and the inclusion of real estate and hedge funds in Lockheed’s portfolio. (4) The reasoning is partially sound in structure—comparing scale and policy application—but flawed due to invented data. The conclusion that Lockheed’s exposure is 'orders of magnitude larger' is speculative and based on false premises. (5) Contextually, the answer is relevant and attempts a direct comparison, but the hallucinated numbers severely damage factual integrity. Quantitative accuracy is low due to unsupported figures; qualitative accuracy is moderate because the core concept of differing applications is touched on, but not fully captured; contextual relevance is high as the response stays on topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 542,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How does the voting power dilution mechanism in CMCSA's Class B to Class A common stock conversion compare with GOOGL's dual-class structure, particularly in light of GOOGL's $62.0 billion share repurchase in 2024 targeting Class A and Class C shares?",
      "original_answer": "GOOGL's 2024 share repurchase of $62.0 billion focused on Class A and Class C shares, which could indirectly impact ownership concentration by reducing the number of shares outstanding, while maintaining the dual-class voting structure where Class B shares retain 10 votes per share. In contrast, CMCSA's Class B common stock is convertible share-for-share into Class A common stock and holds 33⅓% of the total voting power, which is non-dilutable under their articles of incorporation. This means CMCSA's Class B stock maintains a fixed voting influence regardless of conversions or new issuances, whereas GOOGL's repurchase strategy may influence the economic value of shares without altering the 10:1 voting rights disparity between Class B and Class A shares.",
      "llm_answer": "Comcast’s charter fixes the voting split at 66 ⅔ % for Class A and 33 ⅓ % for Class B, and the 33 ⅓ % held by Class B is “generally non‑dilutable.” When a Class B share is converted share‑for‑share into Class A, the total voting power of each class remains unchanged because the conversion merely moves votes from the high‑vote (15‑vote) Class B shares into the lower‑vote Class A pool while preserving the 33 ⅓ %‑66 ⅔ % ratio.\n\nAlphabet’s dual‑class is different: each Class A share carries one vote, each Class B share ten votes, and Class C shares have no votes. The 2024 $62 billion repurchase of Class A and Class C shares reduces the number of low‑ or non‑voting shares outstanding, thereby raising the relative voting power of the unchanged Class B holders rather than converting any shares. Thus, Comcast’s conversion mechanism protects the voting split, whereas Alphabet’s structure allows voting power to shift upward for Class B through share repurchases, not through a conversion.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies GOOGL's $62.0 billion 2024 share repurchase targeting Class A and Class C shares, and accurately describes the dual-class structure (1 vote for Class A, 10 votes for Class B, 0 for Class C). It also correctly states that CMCSA’s Class B holds 33⅓% of voting power, which is non-dilutable. However, it introduces a significant factual error by claiming CMCSA Class B shares have 15 votes per share, which is not in the ground truth and is incorrect per public filings—CMCSA does not specify vote counts per share but instead allocates a fixed 33⅓% voting power to Class B. This misrepresents the mechanism as vote-weighted rather than proportionally fixed. (2) Quantitatively, the $62.0 billion repurchase amount, 33⅓% and 66⅔% splits, and year 2024 are all accurate. The error lies in the unsupported '15-vote' attribution, which lacks verification and distorts the reasoning. (3) The multi-hop reasoning is largely sound: the model correctly contrasts CMCSA’s fixed voting power preservation through conversion with GOOGL’s indirect voting power concentration via repurchases of non-convertible, low-vote shares. It captures the core distinction—CMCSA maintains a fixed split regardless of conversions, while GOOGL’s repurchases increase Class B’s relative control. However, the erroneous vote count undermines the qualitative accuracy of the CMCSA mechanism description. (4) Scores reflect that key facts and comparisons are correct (hence high contextual relevance and decent quantitative accuracy), but the introduction of a false voting ratio (15:1) reduces correctness and reasoning quality, preventing a higher score. Semantic equivalence is partially achieved, but the fabricated vote count is a material deviation from ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 487,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How does the revenue exposure of CVS through its 50% ownership in Red Oak Sourcing, LLC—which negotiates generic pharmaceutical supply contracts with Cardinal Health, Inc., compare to LLY's reliance on Cardinal Health as a top-three distributor accounting for 15–20% of its consolidated revenue?",
      "original_answer": "CVS has a 50% ownership stake in Red Oak Sourcing, LLC, which serves as a joint venture with Cardinal Health, Inc. to negotiate generic pharmaceutical supply contracts for both companies, though Red Oak does not hold inventory. Meanwhile, LLY relies on Cardinal Health, Inc. as one of only three U.S. wholesale distributors each accounting for 15–20% of LLY’s consolidated revenue, alongside McKesson and AmerisourceBergen. This means Cardinal plays a dual role—both as a strategic sourcing partner to CVS via Red Oak and as a critical distribution channel for LLY’s pharmaceutical products in the U.S. market.",
      "llm_answer": "CVS’s exposure to Cardinal Health is indirect – it owns 50 percent of Red Oak Sourcing, a joint‑venture that merely negotiates generic‑drug supply contracts for CVS and Cardinal and holds no inventory, so CVS’s revenue impact is limited to its share of any earnings from that venture. In contrast, Eli Lilly relies directly on Cardinal Health as one of its three top U.S. distributors, which together account for 15 to 20 percent of Lilly’s consolidated revenue. Thus, Lilly’s revenue dependence on Cardinal Health is materially larger and more direct than CVS’s modest, joint‑venture‑based exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the same core information as the ground truth with high precision. (1) All key facts are correct: CVS owns 50% of Red Oak Sourcing, LLC, a joint venture with Cardinal Health that negotiates generic drug supply contracts but holds no inventory. LLY (Eli Lilly) relies on Cardinal Health as one of three top U.S. distributors accounting for 15–20% of its consolidated revenue. These numbers and relationships match the original answer exactly. (2) Quantitative accuracy is perfect: the 50% ownership and 15–20% revenue reliance are correctly reported, with no calculation errors. Format variations (e.g., '15 to 20 percent' vs '15–20%') are semantically equivalent and acceptable. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across CVS’s indirect exposure via a joint venture and LLY’s direct revenue dependence, concluding that LLY’s reliance is more significant and direct. The reasoning about limited revenue impact for CVS due to the non-inventory, fee-for-service nature of Red Oak is a reasonable inference supported by context. (4) The only minor shortcoming is that the LLM slightly downplays the strategic importance of the Red Oak joint venture by emphasizing 'modest, joint-venture-based exposure' without fully echoing the original answer’s point about Cardinal playing a 'dual role'—as both a sourcing partner to CVS and distributor for LLY. While implied, this synthesis is more explicit in the ground truth. Otherwise, the answer is complete, contextually relevant, and accurately contrasts the nature and magnitude of exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 442,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 171,
      "question": "What is the difference in voting rights per share between Class B common stock disclosed by UPS and the common stock voting rights at Honeywell as of 2024?",
      "original_answer": "UPS's Class B common stock has 10 votes per share, while Honeywell's common stock has 1 vote per share, resulting in a 9-vote difference per share in favor of UPS's Class B shares.",
      "llm_answer": "UPS’s Class B common stock carries **10 votes per share**, while Honeywell’s common stock carries **1 vote per share**. The UPS Class B shares therefore have **9 more votes per share** than Honeywell’s common shares.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the voting rights per share are accurately stated: UPS Class B common stock has 10 votes per share, and Honeywell's common stock has 1 vote per share. The difference of 9 votes per share is correctly calculated. (2) The answer is complete, addressing both the voting rights at UPS and Honeywell and computing the difference as required by the question. (3) Entities are correctly identified: UPS and Honeywell are the right companies, and the stock classes (Class B for UPS, common stock for Honeywell) are accurately referenced. (4) The multi-hop reasoning—comparing voting rights across two different companies' filings—is sound and correctly synthesized. The conclusion that UPS Class B shares have 9 more votes per share is logically and factually correct. (5) The semantic meaning is equivalent to the original answer, with clear, precise wording. No factual, numerical, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1101,
        "completion_tokens": 288,
        "total_tokens": 1389
      },
      "error": null
    },
    {
      "question_id": 171,
      "question": "How does the maturity of AMGN's 3.625% 2024 Notes, which triggered the termination of $1.4 billion in associated interest rate swap contracts, compare with ABBV's use of interest rate swap contracts as cash flow hedges in 2024?",
      "original_answer": "AMGN's 3.625% 2024 Notes matured in 2024, which led to the termination of $1.4 billion in interest rate swap contracts that were hedging this fixed-rate debt. In contrast, ABBV did not have any active interest rate swap contracts designated as cash flow hedges in 2024, as the amount reported for that year was $0, compared to $6 million in 2022. This indicates a difference in hedging strategy between the two companies with respect to interest rate exposure on debt instruments.",
      "llm_answer": "Amgen’s 3.625 % notes were 2024‑maturing debt; when those notes were repaid the company terminated the related $1.4 billion of interest‑rate‑swap contracts (see AMGN page 149). In contrast, AbbVie did not have any interest‑rate‑swap contracts designated as cash‑flow hedges in 2024 – the interest‑rate‑swap line shows “‑” for cash‑flow‑hedge designations (see ABBV page 83), indicating that AbbVie’s swaps were used only as fair‑value hedges, not to hedge cash‑flow timing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AMGN's 3.625% notes matured in 2024, leading to termination of $1.4 billion in interest rate swaps used to hedge fixed-rate debt. ABBV had no interest rate swaps designated as cash flow hedges in 2024, consistent with the ground truth stating $0 for that year. (2) Quantitative accuracy is perfect: the $1.4 billion figure is correct, the 2024 maturity date is accurate, and the absence of cash flow hedge amounts for ABBV in 2024 matches the original answer. The LLM correctly interprets the '–' symbol on ABBV's page 83 as indicating zero value, which is consistent with financial reporting conventions. (3) The multi-hop reasoning is sound: the model correctly contrasts AMGN’s termination of swaps due to debt maturity with ABBV’s lack of cash flow hedges in the same year, synthesizing information across two companies and their respective filings. (4) The only minor shortcoming is that the LLM does not explicitly mention ABBV’s prior use of swaps (e.g., $6 million in 2022), which adds context to the change in hedging strategy. However, this omission does not undermine the core comparison. The answer correctly infers that ABBV’s swaps were used as fair-value hedges instead, which goes slightly beyond the original answer but remains plausible and relevant. Overall, the response is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 402,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 171,
      "question": "How did the adoption of ASU 2022-02 impact Capital One's reporting of financial difficulty modifications compared to JPMorgan's prior TDR disclosures, particularly in terms of modification types and their financial effects?",
      "original_answer": "The adoption of ASU 2022-02 eliminated the TDR framework and introduced FDMs, changing how Capital One reports loan modifications. Capital One noted that the types of modifications offered—such as interest rate reductions, term extensions, and principal reductions—remained the same, but they are now categorized and reported differently under FDMs. For JPMorgan, prior to the change, TDRs included similar modifications but were assessed under concession criteria. After the adoption, JPMorgan reported $136 million in FDMs for 2023, primarily involving term extensions and interest rate reductions that extended loan lives by 20 years and reduced the weighted-average rate from 7.21% to 4.44%. This shift reflects a more standardized reporting approach under ASU 2022-02, removing the previous TDR distinctions while maintaining the same types of borrower support.",
      "llm_answer": "The adoption of ASU 2022‑02 caused Capital One to stop classifying financially‑distressed loan concessions as “troubled‑debt restructurings” (TDRs) and instead report them as financial‑difficulty modifications (FDMs). The firm says the types of concessions – principal forgiveness, interest‑rate cuts, term extensions or payment delays – did not change, but they are now accumulated and performance is shown on a rolling‑12‑month basis; for 2023 the residential‑real‑estate FDMs totaled $136 million, lengthened the weighted‑average loan life by about 20 years and lowered the weighted‑average contractual rate from 7.21 % to 4.44 % (no material new commitments) 【page_99】【page_245】.  \n\nBy contrast, JPMorgan’s pre‑ASU disclosures continued to treat such concessions as TDRs and presented them by concession type (interest‑rate reductions, term extensions, principal forgiveness, etc.) together with their financial impact – e.g., reducing weighted‑average interest rates (from 4.75 % to 3.35 % in one year) and extending remaining contractual terms (from 22 to 38 years), plus reporting any charge‑offs and re‑default balances 【JPM_10k_2023 page 126】【JPM_10k_2023 page 245】.  \n\nThus, Capital One’s post‑ASU reporting aggregates the modifications into FDMs with a 12‑month performance view, while JPMorgan’s earlier TDR disclosures broke out each concession type and quantified their separate effects on rates, terms, charge‑offs and re‑defaults.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the conceptual shift from TDRs to FDMs under ASU 2022-02 and correctly identifies that modification types (interest rate reductions, term extensions, principal reductions) remained similar. It also correctly notes that Capital One now reports under FDMs with a rolling 12-month performance view. However, there are significant quantitative inaccuracies: the $136 million in FDMs, 20-year extension, and rate reduction from 7.21% to 4.44% are attributed to JPMorgan in the ground truth, not Capital One. The LLM incorrectly assigns these figures to Capital One's residential real estate FDMs, which misrepresents the data source. Additionally, the LLM fabricates a specific JPMorgan example (rate reduction from 4.75% to 3.35%, term extension from 22 to 38 years) that does not appear in the ground truth; while JPMorgan did report TDR disclosures, no such specific numbers are provided in the original answer. The qualitative reasoning is sound in comparing pre- and post-ASU reporting frameworks and highlighting differences in disclosure granularity, but the incorrect attribution of financial figures undermines factual correctness. The answer is contextually relevant and addresses the multi-hop elements (comparing Capital One’s current reporting with JPMorgan’s prior disclosures), but the quantitative errors—especially misassigning JPMorgan’s numbers to Capital One—are significant enough to reduce the correctness score despite accurate conceptual framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1597,
        "completion_tokens": 408,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How does the alignment of interest rate swap maturities with debt exposure differ between GD's hedging strategy and UPS's economic hedge approach, and what does this reveal about their respective risk management priorities?",
      "original_answer": "GD's hedging strategy involves interest rate swap contracts with a dollar-weighted two-year average maturity that generally matches the duration of the activities at risk, indicating a focus on closely aligning hedge instruments with underlying exposure timelines. In contrast, UPS uses interest rate swaps as economic hedges for portions of its outstanding debt but does not specify a maturity alignment, instead emphasizing the use of offsetting positions to terminate existing swaps and eliminate market valuation effects. This reveals that GD prioritizes duration-matching to manage interest rate risk over time, while UPS focuses on dynamic risk mitigation through offsetting transactions, reflecting different approaches to managing financial exposure.",
      "llm_answer": "General Dynamics explicitly matches the average maturity of its interest‑rate swaps to the life of the underlying debt or other cash‑flow exposures – “the dollar‑weighted two‑year average maturity of these instruments generally matches the duration of the activities that are at risk” (GD 10‑K p. 82). In contrast, United Parcel Service describes its swaps only as “intended to provide an economic hedge of portions of our outstanding debt” and notes that it periodically terminates and re‑designates swaps without tying their maturities to the debt schedule (UPS 10‑K p. 159). Thus, GD’s strategy emphasizes precise duration matching to eliminate interest‑rate risk, while UPS’s approach prioritizes a broader cost‑offset hedge rather than exact maturity alignment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: GD's 'dollar-weighted two-year average maturity' matching the duration of at-risk activities is accurately cited from the GD 10-K, and UPS's use of swaps as economic hedges without maturity alignment is correctly described. (2) There are no numerical values requiring calculation, but the reference to 'two-year average maturity' is factually consistent with the original answer and source. Format and sourcing (page numbers) are appropriately included. (3) Multi-hop reasoning is sound: the model correctly synthesizes information from both GD and UPS 10-K filings, contrasting GD’s duration-matching strategy with UPS’s dynamic termination and re-designation approach. The inference that GD emphasizes precise duration matching while UPS focuses on cost-offset and market effect mitigation is logically supported. (4) The only minor shortcoming is that the LLM answer does not explicitly mention UPS’s use of 'offsetting positions' to terminate swaps, though it does note termination and re-designation, which captures the essence. Wording differs slightly (e.g., 'cost-offset hedge' vs 'dynamic risk mitigation'), but the semantic meaning and strategic contrast are preserved. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 379,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How might Alphabet's share repurchase activity in 2023, which focused on Class A and Class C shares, impact the relative voting power of its undiluted Class B shares, and how does this compare to the non-dilutable 33 1/3% voting power structure of Class B shares at Comcast?",
      "original_answer": "Alphabet's 2023 share repurchase of $62.2 billion in Class A and Class C shares likely increased the relative voting power of its undiluted Class B shares, which are held by insiders and carry 10 votes per share. This mirrors the structure at Comcast, where Class B shares, held entirely by Brian L. Roberts, maintain a non-dilutable 33 1/3% of combined voting power despite having 15 votes per share. Both companies use dual-class structures to protect long-term strategic control, but Alphabet's repurchase activity may have amplified the concentration of voting power further by reducing the number of publicly traded shares.",
      "llm_answer": "Alphabet’s 2023 buy‑back removed roughly 528 million Class A (one‑vote) and Class C (no‑vote) shares from the market. Because only Class A shares carry voting rights, retiring those shares shrinks the total number of votes outstanding and therefore raises the proportion of votes controlled by the undiluted, ten‑vote Class B shares. By contrast, Comcast’s charter expressly fixes its Class B shares at 33 ⅓ % of the combined voting power (each Class B share has 15 votes), a percentage that is “generally non‑dilutable” and therefore is not affected by share‑repurchase activity.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly explains that Alphabet's share repurchase of Class A and Class C shares increases the relative voting power of Class B shares by reducing the total voting pool, and contrasts this with Comcast's fixed 33 1/3% non-dilutable voting structure. This captures the core multi-hop reasoning and conceptual comparison accurately.\n\n2) However, there are significant quantitative inaccuracies: the LLM states that Alphabet repurchased 'roughly 528 million' shares, which is not supported by the ground truth and introduces a specific figure absent from the original data. The ground truth reports a $62.2 billion repurchase amount, not a share count. The LLM also incorrectly claims that only Class A shares carry voting rights (implying Class C have no vote), which is technically correct, but fails to mention that Class C shares were included in the buyback despite having no votes — which the original answer correctly notes. More importantly, the LLM omits the actual dollar amount ($62.2 billion), a key factual metric from the ground truth.\n\n3) The reasoning about the effect on voting power concentration is sound: reducing publicly traded voting shares (Class A) increases the relative weight of Class B shares. The comparison to Comcast is well executed — correctly identifying that Comcast’s Class B voting power is contractually fixed at 33 1/3%, regardless of share activity, and that this differs from Alphabet’s dynamic structure amplified by buybacks. This shows strong qualitative and multi-hop reasoning.\n\n4) The answer is contextually fully relevant and addresses both parts of the question: the impact on Alphabet’s Class B voting power and the comparison with Comcast. While the conceptual explanation is strong, the introduction of an unsupported share count and omission of the $62.2 billion figure reduce quantitative accuracy. The answer would score higher if it had used the correct financial figure and avoided fabricating a share number.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 533,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How does the structure of Robert Iger's Rule 10b5-1 trading plan at DIS, including the number of shares and termination date, compare to Peggy Alford's plan at META, given both are governed by the same regulatory framework?",
      "original_answer": "Robert Iger's trading plan at DIS involves the potential sale of up to 372,412 shares of Disney common stock, with a termination date of December 17, 2024. Peggy Alford's plan at META provides for the sale of up to $1.2 million worth of META Class A common stock, with a termination date of November 15, 2025. Both plans were adopted under Rule 10b5-1(c), which provides an affirmative defense for insider trading activities conducted under a prearranged plan. The comparison shows that while Iger's plan focuses on a fixed number of shares tied to expiring options, Alford’s plan is value-based and has a longer duration.",
      "llm_answer": "Robert Iger’s Rule 10b5‑1 plan at Disney authorizes the sale of up to **372,412 shares** of Disney common stock and is slated to **terminate on December 17, 2024** (with an early‑termination provision). Peggy Alford’s Rule 10b5‑1 plan at Meta authorizes the sale of **up to $1.2 million worth of Meta Class A shares** and will **terminate on November 15, 2025** (also subject to early termination). Both plans rely on the same Rule 10b5‑1 affirmative‑defense framework, but Iger’s is share‑count‑based and ends a year earlier, while Alford’s is dollar‑value‑based and runs into late 2025.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: The number of shares (372,412) and termination date (December 17, 2024) for Robert Iger at DIS are correct. Peggy Alford’s plan correctly states a $1.2 million value cap and a November 15, 2025 termination date. Format variations (e.g., $1.2 million vs $1.2M) are acceptable and semantically equivalent. (2) Completeness: The answer addresses all parts of the question—structure (share count vs dollar value), number of shares/amount, termination dates, and the shared regulatory framework under Rule 10b5-1(c). (3) Entity accuracy: Companies (DIS/Disney and META/Meta), executive names (Iger, Alford), stock types (Class A common stock), and regulatory rule (Rule 10b5-1) are correctly identified. (4) Reasoning: The multi-hop comparison is sound—correctly contrasting Iger’s share-based plan tied to expiring options (implied context) with Alford’s value-based plan and noting the difference in duration. The observation that Alford’s plan runs longer is accurate (2025 vs 2024). (5) Semantic equivalence: While the LLM adds minor details (e.g., early termination provisions), these do not contradict the ground truth and are consistent with typical 10b5-1 plan structures. The core comparison—share-based vs value-based, dates, amounts, and regulatory basis—is preserved and accurately synthesized. All scores are maximized due to full factual alignment and correct multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 410,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How does the vesting timeline for equity awards at CL compare with PM's RSU vesting schedule, and what does this imply about the timing of compensation expense recognition for each company?",
      "original_answer": "CL issues stock options that generally vest ratably over three years, with a contractual term of eight years post-2019. In contrast, PM grants RSU awards that typically vest on the third anniversary of the grant date. For CL, this means compensation expense is recognized evenly over the three-year vesting period. For PM, the fair value of RSU awards is amortized to expense over the restriction period, which is typically three years after the award date, or earlier upon death, disability, or reaching age 58. As of December 31, 2023, PM had $160 million of total unrecognized compensation costs related to non-vested RSUs, expected to be recognized over a weighted-average period of approximately seventeen months. This indicates that while both companies align on a three-year vesting horizon, PM's structure allows for more accelerated expense recognition based on specific triggering events.",
      "llm_answer": "Colgate‑Palmolive’s equity awards (restricted‑stock units) vest over the employee’s requisite service period – the company states the fair‑value of RSUs is amortized “ratably over the requisite service period,” which is typically a three‑year horizon. Philip Morris International’s RSUs vest on the third anniversary of the grant (a three‑year restriction) and the grant‑date fair value is amortized over that three‑year period, with the remaining unvested balance expected to be recognized in roughly 17 months. Thus, both firms spread compensation expense over the vesting period, but PMI’s still‑unvested awards will be expensed more rapidly than Colgate‑Palmolive’s, whose expense is spread over the full three‑year service period.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that both CL and PM have a three-year vesting horizon and that compensation expense is amortized over this period. It accurately states that PM’s unrecognized compensation cost is expected to be recognized over approximately 17 months (matching the ground truth’s 'seventeen months'). However, it incorrectly characterizes CL’s equity awards as RSUs, while the ground truth specifies that CL issues stock options, not RSUs. This is a significant entity/financial instrument misidentification. (2) Quantitatively, the $160 million unrecognized cost and 17-month weighted-average period for PM are correctly reflected (implied in 'roughly 17 months'). The three-year vesting period is accurate for both. No calculation errors are present. (3) The multi-hop reasoning is partially sound: the model correctly infers that PM’s expense recognition may be faster due to the short remaining amortization period, implying acceleration relative to CL’s ratable three-year model. However, it misses PM’s specific early vesting triggers (death, disability, age 58), which are key to the implication about accelerated expense recognition. (4) The answer is contextually relevant and addresses the comparison of vesting timelines and expense recognition. Due to the mischaracterization of CL’s equity awards and omission of PM’s early vesting conditions, the qualitative accuracy is reduced. The correctness score is 7 because core financial facts and timing are correct, but key details about award types and triggering events are inaccurate or missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 436,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How do regulatory restrictions on product differentiation, such as flavor bans and standardized packaging, impact the ability of both PM and MO to maintain brand equity and pricing power in key international and U.S. markets?",
      "original_answer": "Regulatory restrictions on product differentiation, such as flavor bans and standardized packaging, significantly impair both PM and MO's ability to maintain brand equity and pricing power. PM faces specific risks from the EU's ban on characterizing flavors in cigarettes and roll-your-own tobacco, menthol bans in Turkey and Brazil, and potential future restrictions on slim cigarettes and flavor capsules. These limitations reduce PM’s ability to differentiate products, especially in international markets where they estimate illicit trade accounts for 8% of EU cigarette consumption, further eroding legitimate brand value and pricing control. Similarly, MO faces flavor bans in six U.S. states and the District of Columbia, including California’s broad restriction on menthol, mint, and wintergreen, which is currently delayed due to a referendum. These bans, along with proposed nicotine caps in Massachusetts, constrain MO’s ability to market differentiated products and maintain premium pricing. Both companies are also restricted in advertising and branding through global FCTC guidelines and domestic regulations like the State Settlement Agreements, which prohibit youth-targeted marketing and outdoor advertising, further limiting brand equity development and pricing flexibility.",
      "llm_answer": "Both PM and Altria (MO) note that government actions that ban characterising flavours (e.g., menthol) and impose plain‑ or standardized‑packaging, as well as limits on branding, advertising and product‑design, “could reduce our ability to differentiate these products in the market in the long term” and “may be reinforced by regulation that limits branding, communication and product differentiation” (PM p. 16, 42; Altria p. 16, 42). Because their premium‑price and mid‑price brands rely on distinct flavours, pack‑shape, colour and other brand cues, such restrictions compress the perceived value of each brand, make down‑trading more likely, and curtail the ability to raise prices, thereby threatening both firms’ brand‑equity and pricing power in key U.S. and international markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and conveys the central impact of regulatory restrictions on brand equity and pricing power for both PM and MO (Altria), aligning well with the ground truth. It correctly identifies that flavor bans, standardized packaging, and branding restrictions impair product differentiation, which in turn threatens brand equity and pricing power—especially for premium and mid-tier brands reliant on sensory and visual cues. The answer appropriately applies this to both U.S. and international markets and references specific regulatory mechanisms (e.g., menthol bans, plain packaging, advertising limits). However, it lacks the specific examples and geographic granularity present in the original answer, such as PM’s exposure to EU flavor bans, illicit trade in the EU (8%), menthol bans in Turkey and Brazil, or MO’s state-level restrictions in six U.S. states plus D.C., including California’s delayed menthol ban and proposed nicotine caps in Massachusetts. These omissions reduce completeness and specificity but do not introduce factual errors. No numbers are misstated—the LLM avoids citing specific figures rather than misquoting them, so quantitative accuracy is not penalized. The reasoning is sound and synthesizes the multi-hop logic (regulation → reduced differentiation → weakened brand equity/pricing), though with less evidentiary support than the original. Wording differences are acceptable under semantic equivalence, but the answer leans more on generalization. Contextual relevance is strong as it directly addresses the question’s focus on regulatory impact across both companies and markets.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1539,
        "completion_tokens": 452,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How does AIG's exposure to structured securities containing RMBS, as measured by their accounting treatment for credit losses and yield adjustments, compare to BAC's valuation risks associated with RMBS holdings under fluctuating prepayment speeds and default rates?",
      "original_answer": "AIG accounts for structured securities, including RMBS, by recalculating effective yields based on actual payments and updated prepayment expectations, adjusting amortized cost accordingly with a corresponding impact on net investment income. For non-high credit quality structured securities, AIG bases yields on expected cash flows that factor in credit losses and prepayments, and recognizes changes in expected cash flows through an allowance for credit losses. Meanwhile, BAC notes that a significant increase in default rates or loss severities would materially lower the fair value of RMBS long positions, while changes in prepayment speeds would have differential impacts depending on instrument seniority. This shows that while AIG focuses on yield and credit loss adjustments tied to expected cash flows, BAC emphasizes sensitivity to default and prepayment volatility in RMBS valuation.",
      "llm_answer": "AIG’s exposure to RMBS is reflected in its accounting by an allowance for credit‑losses on the securities and by “yield adjustments” that are recalculated each period to incorporate expected credit losses and prepayment assumptions (the yields on non‑high‑quality structured securities are based on expected cash‑flows that include both credit‑loss and prepayment estimates)【page_169】. In contrast, Bank of America values its RMBS holdings at fair value using discounted‑cash‑flow models that rely on unobservable inputs for pre‑payment speeds (0‑29 % CPR, weighted‑average 12 % CPR) and default rates (0‑3 % CDR, weighted‑average 1 % CDR); changes in those assumptions create valuation risk for the bank【page_160】【page_161】. Thus AIG measures risk through allowance and yield‑adjustment accounting, whereas BAC’s risk is driven by fair‑value model sensitivities to prepayment and default‑rate inputs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth. (1) All key facts are correct: AIG uses yield adjustments based on expected cash flows incorporating credit losses and prepayments, particularly for non-high-quality structured securities, and recognizes changes via an allowance for credit losses and amortized cost adjustments. BAC’s RMBS holdings are valued at fair value using discounted cash flow models sensitive to prepayment speeds (0–29% CPR, weighted average 12%) and default rates (0–3% CDR, weighted average 1%), which introduces valuation risk from assumption changes. These details match the ground truth in substance and specificity. (2) Quantitative accuracy is perfect: the CPR and CDR ranges and averages cited (0–29% CPR, 12% avg; 0–3% CDR, 1% avg) are correctly reported from the source pages and match the underlying data. No calculation errors. (3) Multi-hop reasoning is sound: the model correctly synthesizes AIG’s accounting treatment (income and allowance impacts) with BAC’s fair value sensitivity, contrasting two different risk frameworks—AIG’s yield-and-allowance approach vs. BAC’s model-driven valuation risk. (4) The only minor shortcoming is that the LLM does not explicitly mention BAC’s point about differential impact of prepayment speeds by instrument seniority, which is in the original answer. However, the emphasis on model sensitivity to prepayments and defaults captures the core idea. Wording differs slightly but maintains semantic equivalence. Overall, this is a factually correct, well-synthesized, and contextually appropriate response.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 441,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does Broadcom's valuation methodology for its developed technology in cybersecurity, which includes cloud security solutions, compare to Cisco's revenue recognition approach for its Cloud Security product category?",
      "original_answer": "Broadcom valued its developed technology in cybersecurity, including cloud security solutions, using the multiperiod excess earnings method under the income approach, which considers the present value of projected cash flows less charges for contributions from other assets. The economic useful life was determined based on the technology cycle and forecast cash flows. In contrast, Cisco recognizes revenue for its Cloud Security product ratably over the contract term as a single distinct performance obligation satisfied over time, particularly for SaaS arrangements. This highlights a difference in financial treatment—Broadcom focused on asset valuation through projected earnings, while Cisco emphasizes revenue recognition aligned with service delivery timelines.",
      "llm_answer": "Broadcom treats its cyber‑security developed technology – which covers data‑loss‑prevention, endpoint, web, email and **cloud‑security** solutions – as an acquired intangible that is **valued** using the **multiperiod excess‑earnings (income) approach**, i.e., the present value of the cash flows the technology is expected to generate over its estimated useful life.  \n\nCisco, by contrast, does not value the technology as an asset; it **recognizes revenue** from its **Cloud Security** (part of the End‑to‑End Security category) by treating hardware and perpetual software as distinct obligations recognized up‑front, while software licenses and SaaS are a single performance obligation with **revenue recognized ratably over the contract term**.  \n\nThus, Broadcom’s method is a fair‑value valuation of the technology’s future cash flows, whereas Cisco’s method concerns the timing of revenue recognition for cloud‑security products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Broadcom's valuation methodology for its developed cybersecurity technology, including cloud security, as the multiperiod excess earnings method under the income approach, which focuses on present value of projected cash flows less contributory asset charges—this matches the original answer. It also accurately notes the consideration of useful life based on technology cycle and cash flow forecasts. (2) For Cisco, the LLM correctly states that revenue for Cloud Security (within End-to-End Security) is recognized ratably over the contract term for SaaS and software licenses, distinguishing it from up-front recognition for hardware and perpetual software. This reflects the ground truth's emphasis on ratable recognition for SaaS as a performance obligation satisfied over time. (3) The multi-hop reasoning is sound: the model correctly synthesizes that Broadcom’s approach is asset valuation (fair value via future earnings), while Cisco’s is revenue recognition timing (aligned with service delivery), highlighting the conceptual difference. (4) Minor deduction in qualitative accuracy due to slightly less precise phrasing around 'single distinct performance obligation'—the LLM mentions ratable recognition but doesn’t explicitly state that Cisco treats SaaS and software licenses as a single obligation, which is a nuance present in the original. However, this does not distort the meaning. No numeric inaccuracies; all information is factually correct and contextually relevant. Wording differences are acceptable under semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 450,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does the voting power disparity between Class A and Class B common stock at META compare to GOOGL's dual-class structure, particularly in relation to the number of shares outstanding and the potential influence of high-vote shares on corporate governance decisions?",
      "original_answer": "At META, Class A common stock has 2,189,898,148 shares outstanding with one vote per share, while Class B common stock has 343,761,117 shares outstanding, each with voting rights only in specified circumstances and tied to the conversion rate. This creates a concentrated voting structure where Class B shares can exert significant influence during specific corporate events. Similarly, GOOGL's Class B common stock has 10 votes per share, giving disproportionate voting power to holders of this class, although the rights of Class A and Class B are otherwise identical. Both companies use dual-class structures to maintain control with certain stakeholders, but META's Class B shares only gain enhanced voting rights under defined conditions, whereas GOOGL's Class B shares have consistently higher voting power. This difference affects how corporate governance decisions are influenced at each company.",
      "llm_answer": "Meta Platforms reports that, as of January 24 2025, it had **2.19 billion Class A shares (1 vote each)** and **343.8 million Class B shares (10 votes each)** 【page 1】.  Because each Class B share carries ten votes, the Class B stock supplies roughly **3.44 billion votes versus 2.19 billion votes from Class A**, giving the Class B holders about **61 % of the total voting power** even though they own only about **14 % of the outstanding shares**.\n\nAlphabet (Google) also uses a dual‑class system: **Class A shares have one vote, Class B shares have ten votes, and Class C shares have no voting rights** 【page 82】.  The 10‑to‑1 voting multiplier is the same as Meta’s, and the filing notes that Class B shares are held primarily by founders and insiders, concentrating control in a relatively small block of high‑vote stock.  Although the exact number of Class A, B and C shares outstanding is not disclosed in the excerpts, the structure likewise lets a minority of shares wield a majority of voting power, mirroring Meta’s disparity and giving those high‑vote holders decisive influence over corporate‑governance decisions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual errors, particularly regarding META's Class B voting rights. The ground truth states that META's Class B shares have voting rights only in specified circumstances and are tied to conversion rates, not 10 votes per share. The LLM incorrectly asserts that Class B shares have 10 votes each, which fundamentally misrepresents the structure. This leads to incorrect vote calculations: 3.44 billion votes from Class B and 61% voting power are false, as Class B does not have standing voting power under normal conditions. (2) The numbers for Class A and Class B shares outstanding are approximately correct (2.19B vs 2.189B and 343.8M vs 343.76M), with acceptable rounding. However, the core calculation of voting power is invalid due to the incorrect voting rights assumption. (3) The qualitative comparison to GOOGL is partially sound—both companies use dual-class structures with high-vote shares held by insiders—but the LLM fails to capture the key distinction: GOOGL’s Class B shares consistently have 10 votes, while META’s Class B shares do not. This critical difference in corporate governance influence is misrepresented. (4) Contextually, the answer addresses the question’s intent—comparing voting disparities and governance influence—and correctly identifies the structural similarity in vote multipliers (where applicable). However, due to the central factual error about META’s voting rights, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the reasoning framework is logical but based on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1538,
        "completion_tokens": 440,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does Coca-Cola FEMSA's bottling operations in Argentina impact both KO's net sales to equity method investees and CL's organic sales growth in Latin America, considering KO's contractual pricing model with its bottlers?",
      "original_answer": "Coca-Cola FEMSA's operations in Argentina contribute to KO's $14,471 million in net sales to equity method investees in 2021 through the incidence-based concentrate pricing model, where bottler pricing and package mix directly affect the concentrate prices charged by KO. As Coca-Cola FEMSA bottles in Argentina (federal capital of Buenos Aires and surrounding areas), this relationship supports KO's financial dependency on equity method investees. Meanwhile, CL reported a 7.0% net sales increase in Latin America in 2021, with Argentina being one of the key growth drivers. Specifically, CL's Oral Care, Personal Care, and Home Care segments in Argentina benefited from favorable market conditions that also likely supported Coca-Cola FEMSA's operations, creating parallel growth effects across both companies' financial performance in the region.",
      "llm_answer": "Coca‑Cola FEMSA’s Argentine bottling operation is part of the equity‑method investees that The Coca‑Cola Company sells its concentrates to; the company’s incidence‑based pricing model ties the concentrate price to the bottler’s own pricing, volume and mix, so the Argentine sales are included in the $14.5 billion of net sales to equity‑method investees reported for 2021 (KO 10‑K p. 89, 7). Because FEMSA’s Argentine business contributed to the overall performance of its Latin‑American bottling network, it helped drive the 8 % organic sales growth in Latin America that Colgate‑Palmolive recorded in 2021, a growth that was led by Brazil, Mexico, **Argentina** and Colombia (CL 10‑K p. 40).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer correctly identifies Coca-Cola FEMSA's role as an equity method investee and explains KO's incidence-based pricing model, linking Argentine operations to KO's $14.5 billion in net sales to equity method investees in 2021 (matching the ground truth $14,471 million, rounded appropriately). However, it incorrectly states Colgate-Palmolive's (CL) organic sales growth in Latin America as 8%, while the ground truth specifies 7.0%. This is a clear factual error in a key metric. The mention of Argentina as a growth driver is correct and aligns with the original answer. (2) Quantitative accuracy is partially compromised: the $14.5 billion figure is an acceptable rounding of $14,471 million, but the 8% vs 7.0% discrepancy in CL's Latin America organic growth is significant and incorrect. No other numbers are misstated. (3) The multi-hop reasoning is sound—correctly connecting KO’s pricing model to FEMSA’s operations, and then linking regional performance to CL’s growth. It appropriately synthesizes across KO and CL 10-Ks, though the incorrect percentage undermines the precision of the conclusion. (4) Contextual relevance is high—the answer addresses both parts of the question: KO’s net sales to equity method investees and CL’s organic growth in Latin America, with proper reference to Argentina’s role. The qualitative reasoning is strong despite the numerical inaccuracy. Thus, correctness is reduced to 7 due to the material error in CL’s reported growth rate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 408,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does Abbott's investment in private equity funds, which are valued using NAV as a practical expedient, compare to Merck's use of NAV for measuring similar alternative investments, considering the typical redemption restrictions associated with these fund types?",
      "original_answer": "Abbott holds investments in private equity funds valued at NAV, with $555 million in unfunded commitments as of December 31, 2023, and these funds cannot be redeemed but will make distributions through liquidation over periods ranging from 2024 to 2033. These private equity funds are subject to NAV valuation practices consistent with those described in UPS's 10-K, where private equity funds typically have redemption restrictions until the end of the partnership term (10–15 years) and are valued at NAV adjusted for known cash flows. Merck similarly discloses NAV-based valuations for alternative investments, reporting $382 million in NAV-based assets in 2023, including private real estate and equity funds. Both companies rely on NAV as a practical expedient for illiquid alternative investments, but Abbott faces longer liquidation timelines and greater unfunded commitments compared to Merck's disclosed NAV-based portfolio.",
      "llm_answer": "Both companies rely on a net‑asset‑value (NAV) practical‑expedient to value their private‑equity‑type holdings. Abbott’s filing spells out that its private‑equity, private‑debt and real‑estate interests are limited‑partner stakes that cannot be redeemed until the partnership’s term ends (typically 10‑15 years, with only a thin secondary market), whereas Merck’s 10‑K simply notes that “certain investments … measured at NAV … are not classified in Levels 1‑3,” without describing any redemption limits. Thus, while the valuation approach is the same, Abbott explicitly highlights the long‑term, illiquid nature of those funds, whereas Merck’s disclosure does not detail the redemption restrictions.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that both Abbott and Merck use NAV as a practical expedient for valuing alternative investments and notes Abbott's disclosure of redemption restrictions. However, it omits key quantitative details from the ground truth: Abbott's $555 million in unfunded commitments and Merck's $382 million in NAV-based assets as of 2023. These figures are central to the comparison and are entirely missing, making the answer significantly incomplete. Additionally, the LLM incorrectly states that Merck’s 10-K does not describe any redemption limits—while Merck may not detail them, the ground truth does not claim this absence, and the comparison should have included Merck’s inclusion of private real estate and equity funds under NAV. (2) The quantitative accuracy is low because the two major dollar amounts ($555M and $382M) are not mentioned, and there is no reference to the liquidation period (2024–2033) for Abbott’s funds. These are critical data points in the original answer. (3) The reasoning is partially sound: the model correctly infers that both companies use NAV and that Abbott is more explicit about illiquidity. However, it fails to synthesize the multi-hop elements—specifically, comparing the scale of unfunded commitments and liquidation timelines between the two firms. The conclusion that Merck provides no detail on redemption restrictions is not fully supported by the ground truth, which does not make that claim. (4) Contextual relevance is high because the answer addresses the core valuation method and liquidity considerations. However, due to missing key numbers and incomplete comparative analysis, the correctness score is moderate—partially correct but with significant omissions that affect the depth and accuracy of the comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 490,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does BlackRock's management of Separate Account Assets, which are legally segregated and not subject to general creditor claims, impact AIG's reporting of equal and offsetting Separate Account Liabilities tied directly to contract holder account balances?",
      "original_answer": "BlackRock discloses that its Separate Account Assets, which include equity securities, debt securities, money market funds, and derivatives, are legally segregated and not subject to general claims of creditors. These assets are held to fund individual and group pension contracts and are offset by equal and offsetting liabilities on BlackRock’s consolidated statements of financial condition. AIG reports Separate Account Liabilities that directly reflect the contract holder's account balance in these assets, and they are required to be equal and offsetting to the total Separate Account Assets. Therefore, any changes in the valuation or composition of BlackRock's Separate Account Assets would directly influence AIG’s liability reporting, as AIG must mirror these asset values in its liabilities to reflect the contract holders' beneficial interest.",
      "llm_answer": "BlackRock holds the separate‑account assets in a wholly‑owned life‑insurance subsidiary and, by law, those assets are segregated from BlackRock’s general‑creditor pool. Because the assets are “legally segregated and not subject to general creditor claims,” AIG can record a matching liability for each contract‑holder balance that is “equal and offsetting to total separate‑account assets” (AIG Note 15, 2023 Form 10‑K). Thus the segregation guarantees that AIG’s separate‑account liabilities represent only the policy‑holder obligations and are fully backed by the separately held assets, without exposure to BlackRock’s other creditors.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and correctly identifies the legal segregation of BlackRock's Separate Account Assets and how this enables AIG to report equal and offsetting liabilities. It correctly references AIG's Note 15 and the 2023 Form 10-K, which supports the claim about AIG’s reporting practice, and accurately states that these liabilities mirror contract holder balances and are fully backed by segregated assets. There are no numeric inaccuracies (quantitative accuracy is perfect), and the context is highly relevant. However, the LLM introduces a detail not present in the ground truth: that BlackRock holds the assets in a 'wholly-owned life-insurance subsidiary,' which is not mentioned or implied in the original answer and cannot be verified from the provided knowledge. This adds potentially incorrect entity-specific information. Additionally, while the original answer emphasizes the dynamic impact of asset valuation changes on AIG’s liability reporting (i.e., direct mirroring due to valuation fluctuations), the LLM downplays this causal relationship and instead focuses on structural segregation and creditor protection. Thus, while the reasoning is sound in parts, it misses the full multi-hop synthesis—specifically, that changes in BlackRock’s asset values directly propagate to AIG’s liability measurements. This omission reduces qualitative accuracy. Overall, the answer is mostly correct with minor but notable gaps in completeness and precision of reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 415,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How does AbbVie's revenue recognition for Imbruvica sales in the U.S. reflect its cost-sharing arrangement with Janssen Biotech, and how does this compare to Johnson & Johnson's global commercialization strategy for the same drug?",
      "original_answer": "AbbVie recognizes 100% of Imbruvica sales in the U.S. as net revenue, while Janssen's share of profits is deducted as part of cost of products sold, indicating a co-exclusive commercialization model where AbbVie acts as the principal. Both companies share pre-tax profits and losses equally, with Janssen covering approximately 60% of development costs and AbbVie 40%. Meanwhile, Johnson & Johnson, through its subsidiary Janssen, holds exclusive rights to commercialize Imbruvica outside the U.S. and also shares pre-tax profits equally with AbbVie. This global division of commercial rights and cost-sharing creates a dual-market strategy where Janssen leverages its international infrastructure to drive global expansion of Imbruvica, while AbbVie leads in the domestic market.",
      "llm_answer": "AbbVie records all U.S. Imbruvica sales as “net revenue” because it is the principal seller to the end‑customer, but it then treats Janssen’s 50 % share of the pre‑tax profit as a cost of products sold – the amount shown as “Janssen’s share of profits (included in cost of products sold)” in its collaboration note 【page_68】. In contrast, Johnson & Johnson (through its Janssen subsidiary) holds the exclusive licence to commercialize Imbruvica outside the United States and co‑exclusive rights in the U.S., and it markets the drug worldwide as part of its Innovative Medicine segment, distributing it directly to retailers, wholesalers, hospitals and health‑care professionals globally 【page_8】【page_7】. Thus AbbVie’s U.S. revenue recognition reflects a profit‑sharing cost structure with Janssen, whereas J&J’s approach is a global, wholly‑owned commercialization model with exclusive rights outside the U.S.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that AbbVie recognizes 100% of U.S. Imbruvica sales as net revenue and deducts Janssen’s share as cost of products sold, reflecting the co-exclusive commercialization model. It accurately states the 50% pre-tax profit sharing, which aligns with the ground truth. However, it omits the specific cost-sharing breakdown for development costs (Janssen ~60%, AbbVie ~40%), a key quantitative and qualitative detail from the original answer. (2) Quantitatively, all mentioned percentages (50% profit share) are correct, and no incorrect numbers are introduced. The missing 60%/40% development cost split reduces completeness but does not introduce inaccuracy. (3) The reasoning is sound: the LLM correctly infers that AbbVie acts as principal in the U.S. and that J&J (via Janssen) has exclusive rights outside the U.S. It synthesizes revenue recognition practices and commercialization strategies across both companies. However, it incorrectly implies that J&J has a 'wholly-owned commercialization model' globally, which is misleading—while Janssen commercializes ex-U.S., profits are still shared equally with AbbVie, so it is not 'wholly-owned.' This mischaracterization affects qualitative accuracy. (4) Contextual relevance is high—the response directly addresses both parts of the question: AbbVie’s revenue recognition and the comparison to J&J’s global strategy. Despite minor omissions and one misstatement, the core multi-hop synthesis (U.S. vs. ex-U.S. roles, profit sharing, revenue treatment) is accurate and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 434,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How might a prolonged geopolitical conflict involving Taiwan impact both NVIDIA's supply chain execution and Apple's manufacturing operations, considering NVIDIA's dependency on foundry partners in Taiwan and Apple's reliance on manufacturing in the region?",
      "original_answer": "A prolonged geopolitical conflict involving Taiwan could severely disrupt NVIDIA's supply chain execution due to its dependency on foundry partners in the region, particularly for advanced GPU manufacturing. This could lead to production delays, inventory shortages, and an inability to meet customer demand, which NVIDIA has previously warned could damage customer relationships and reduce revenue. Similarly, Apple relies heavily on manufacturing operations in Taiwan, as part of its broader supply chain concentrated in the region. A disruption in Taiwan would likely delay product manufacturing and delivery, increase costs, and potentially force Apple to restructure its supply chain, which it has noted could be expensive and time-consuming. Both companies would face significant operational and financial risks due to their shared exposure to Taiwan's geopolitical stability.",
      "llm_answer": "A prolonged Taiwan conflict would threaten NVIDIA’s ability to obtain wafers from its Taiwan‑based foundry partners – the company warns that “geopolitical tensions … involving Taiwan … could severely limit or prevent us from receiving chip supply from Taiwan,” which would create capacity shortfalls, higher wafer prices and delayed product shipments (NVDA 10‑K p. 17‑18). Apple likewise notes that most of its manufacturing is outsourced to partners in Taiwan and that “geopolitical tensions … could … disrupt … supply‑chain … causing delays … and higher costs” to its iPhone, iPad and other product lines (AAPL 10‑K p. 9). Together, a sustained conflict could curtail NVIDIA’s supply‑chain execution and force Apple to face production stoppages, inventory shortages and margin pressure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth. (1) All key factual elements are correct: NVIDIA’s dependency on Taiwan-based foundries and the associated risks (e.g., capacity shortfalls, delayed shipments) are accurately described and directly supported by the cited 10-K reference (p. 17–18). Apple’s reliance on manufacturing partners in Taiwan and the risk of supply-chain disruption, delays, and higher costs are also correctly stated with reference to its 10-K (p. 9). (2) There are no numeric values, dates, or financial figures in either answer that require quantitative verification—both answers are qualitative in nature—so the quantitative accuracy is 10 as no errors exist. (3) The multi-hop reasoning is sound: the model correctly synthesizes risks across two companies (NVIDIA and Apple), linking their shared exposure to Taiwan through distinct but related supply chain roles (foundry for NVIDIA, final manufacturing for Apple). The conclusion that both face supply chain execution and production risks is logically derived. (4) The LLM answer omits a minor point present in the original: Apple’s note about the cost and difficulty of restructuring its supply chain. While the LLM mentions delays and higher costs, it does not explicitly reference the expense and time required to restructure, which slightly reduces completeness. However, this is a minor omission that does not undermine the core accuracy. Wording differs but semantic equivalence is preserved. Contextual relevance is perfect—the response directly addresses both parts of the question with precise citations and clear logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 448,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How does the use of pricing models for Level 2 fixed income investments by LMT compare to HON's use of pricing models for corporate bonds and government securities in terms of observable market data inputs and risk adjustments?",
      "original_answer": "LMT values its Level 2 fixed income investments using pricing models that rely on verifiable observable market data such as interest rates, yield curves, and credit spreads, or through bids from brokers and quoted prices of similar securities. In contrast, HON uses pricing models for corporate bonds, mortgage/asset-backed securities, and government securities that also incorporate observable inputs but may include unobservable adjustments for risks like credit and liquidity. This indicates that while both companies use pricing models involving market data, HON's valuations may involve more subjective risk-based adjustments not always present in LMT's Level 2 valuations.",
      "llm_answer": "Lockheed Martin’s Level 2 fixed‑income valuations are performed with pricing models that rely on **verifiable observable market data** – such as current interest‑rate and yield‑curve levels and quoted credit spreads or broker bids – and the description does not note any extra risk‑adjustment layer. Honeywell, by contrast, also uses pricing models (or broker bids or comparable quotes) for corporate bonds and U.S. government securities, but explicitly **adds adjustments for risks that are not observable**, such as credit‑ and liquidity‑risk premiums. Thus, Honeywell’s models incorporate additional risk adjustments beyond the observable inputs that LMT’s models use.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that LMT uses pricing models for Level 2 fixed income investments based on verifiable observable market data such as interest rates, yield curves, credit spreads, and broker bids, without mentioning unobservable risk adjustments. It contrasts this with HON, which uses pricing models for corporate bonds and government securities that incorporate observable inputs but also explicitly adds unobservable risk adjustments for credit and liquidity risk. (2) There are no numerical values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable in a traditional sense; however, all descriptive financial concepts (e.g., observable vs. unobservable inputs) are correctly represented, warranting a 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (LMT and HON), two sets of securities (Level 2 fixed income vs. corporate/government securities), and compares their use of observable data and risk adjustments. The only minor shortcoming is that the LLM omits HON's inclusion of mortgage/asset-backed securities mentioned in the original answer, which slightly reduces completeness. (4) The answer is fully contextually relevant, directly addressing the comparison asked in the question. Semantic equivalence is strong—wording differs but meaning matches. Thus, a 9 is justified for correctness due to high accuracy with a minor omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 421,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did the unfavorable foreign currency exchange rate impact from a stronger U.S. dollar affect Coca-Cola's (KO) Europe, Middle East and Africa segment in 2024, and how does this compare to the exposure risk described by Mondelez (MDLZ) under similar macroeconomic conditions?",
      "original_answer": "Coca-Cola (KO) reported that fluctuations in foreign currency exchange rates unfavorably impacted consolidated operating income by 11% in 2024, with a stronger U.S. dollar affecting several segments including Europe, Middle East and Africa. While the euro and British pound provided some offsetting benefit, the segment was still significantly affected by the stronger dollar. Mondelez (MDLZ) similarly noted that a stronger U.S. dollar relative to other functional currencies adversely affects its consolidated earnings and net assets, as the company translates non-U.S. dollar financials into U.S. dollars for reporting. Although KO quantified the impact (11% unfavorable), MDLZ emphasized the inherent unpredictability and volatility introduced by such currency movements, despite active hedging strategies.",
      "llm_answer": "Coca‑Cola said that a stronger U.S. dollar “unfavorably impacted” the Europe, Middle East and Africa (EMEA) segment in 2024, driving a **‑16 % foreign‑currency effect on that segment’s net operating‑revenue growth** and contributing to an overall **‑11 % hit to consolidated operating income** (the impact was partially offset by a weaker dollar versus the euro and pound).  \n\nMondelez describes the same macro‑economic exposure more generally: it is “primarily exposed to currency‑exchange‑rate risk” and notes that a stronger dollar creates translation losses (a **$1.5 bn negative currency‑translation adjustment in 2024**) and earnings volatility, which it tries to mitigate with hedges but cannot fully eliminate.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative figures not present in the ground truth, notably a '-16% foreign-currency effect on EMEA net operating-revenue growth' and a '$1.5 bn negative currency-translation adjustment in 2024' for Mondelez. These numbers are not supported by the original answer, which only states that Coca-Cola had an 11% unfavorable impact on consolidated operating income due to FX, without segment-level quantification for EMEA. The original answer does not mention any dollar amount for Mondelez’s currency impact, let alone $1.5 billion. These fabricated figures significantly reduce quantitative accuracy. (2) The LLM correctly identifies that a stronger U.S. dollar unfavorably impacted Coca-Cola’s EMEA segment and that Mondelez faces similar translation risks due to currency exposure. It also correctly notes partial offset from the euro and pound for KO and that MDLZ uses hedging strategies. These qualitative elements are consistent with the ground truth. (3) The multi-hop reasoning is sound in structure—comparing KO’s reported impact to MDLZ’s risk disclosure under similar macro conditions—but is undermined by the inclusion of unsupported numerical specifics. The model appears to conflate segment-level revenue growth effects (which may exist in external filings) with the provided ground truth, which only specifies consolidated operating income impact. (4) While the core narrative aligns and the entities, years, and general risk mechanisms are accurate, the invention of precise metrics (especially -16% and $1.5B) that are not in the source data constitutes a major factual deviation. Correctness score is reduced to 6 due to partial factual alignment but significant quantitative inaccuracies. Quantitative accuracy is low (4) due to unsupported numbers; qualitative accuracy is moderate (7) as reasoning and entity identification are correct; contextual relevance is high (9) as the response directly addresses the question’s scope and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 541,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How does the $365 million in long-lived assets that AVGO reported in Taiwan for fiscal 2024 compare to the risk QCOM highlighted regarding its reliance on foundry partners in Taiwan for chipset supply, particularly in the context of geopolitical tensions involving China and Taiwan?",
      "original_answer": "AVGO reported $365 million in long-lived assets in Taiwan for fiscal 2024, indicating a significant operational presence in the region. Meanwhile, QCOM explicitly stated that its business depends on receiving consistent and reliable chipset supply from foundry partners in Taiwan, and a significant or prolonged geopolitical conflict involving China and Taiwan could severely limit or prevent this supply, materially impacting QCOM’s business. This highlights that both companies have substantial exposure to Taiwan, but while AVGO’s exposure is reflected in its asset base, QCOM’s risk is operational and supply chain-dependent, making them vulnerable to the same regional geopolitical tensions in different ways.",
      "llm_answer": "Broadcom reported $365 million of long‑lived assets (property, plant and equipment) located in Taiwan for fiscal 2024【page_91】.  By contrast, Qualcomm warns that its business “depends on our ability to receive consistent and reliable chipset supply from our foundry partners, particularly in Taiwan,” and that a “significant or prolonged military or other geopolitical conflict involving China and Taiwan could sever…chipset supply”【page_35】.  Thus, Broadcom’s exposure in Taiwan is quantified as a $365 million asset base, whereas Qualcomm’s concern is an operational supply‑chain risk that could have a material adverse effect far beyond the dollar value of any single asset location.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, the $365 million in long-lived assets for AVGO (Broadcom) in Taiwan for fiscal 2024 is accurately reported, with correct dollar amount and fiscal year. (2) The citation of QCOM’s (Qualcomm’s) risk regarding foundry partners in Taiwan is factually accurate, including the specific language about 'consistent and reliable chipset supply' and the potential impact of geopolitical conflict involving China and Taiwan—this aligns with the original answer’s emphasis on supply chain vulnerability. (3) The multi-hop reasoning is sound: the model correctly contrasts AVGO’s direct asset exposure (tangible, balance sheet-level investment) with QCOM’s operational and supply chain risk (intangible but potentially high-impact), synthesizing information across two companies and risk types. (4) Entity names (AVGO as Broadcom, QCOM as Qualcomm), fiscal year (2024), and financial metric (long-lived assets) are all correctly identified. (5) The semantic meaning is equivalent to the original answer, with slightly more concise and precise wording, including appropriate use of citations. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 345,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How does Apple's reliance on manufacturing operations in Taiwan for a majority of its product assembly impact its exposure to regional geopolitical risks compared to Microsoft's business operations in Greater China through its regional center in Singapore?",
      "original_answer": "Apple's reliance on manufacturing in Taiwan for a significant portion of its product assembly increases its exposure to regional geopolitical risks, particularly given that Taiwan is included in Apple's Greater China segment, which is subject to trade policies and disputes that could result in tariffs, sanctions, and other business restrictions. Microsoft operates in Greater China through its regional operations center in Singapore, which supports logistics and vendor management across the region. However, unlike Apple, Microsoft's operations are not heavily dependent on localized manufacturing, reducing its exposure to supply chain disruptions tied to geopolitical tensions. Apple's outsourced manufacturing in Asia, including Taiwan, makes it more vulnerable to interruptions from tariffs, export controls, and public health crises, while Microsoft's regional center in Singapore primarily supports administrative and logistics functions, which can be more easily adapted or relocated if necessary.",
      "llm_answer": "Apple’s 10‑K notes that “substantially all” of its manufacturing is outsourced to partners in Asia, with a large share of product assembly performed in Taiwan (which is part of its Greater‑China segment). Because the bulk of Apple’s hardware supply chain is physically located in Taiwan, any cross‑strait tension, trade restriction or other geopolitical event affecting Taiwan could directly disrupt Apple’s production and margins. In contrast, Microsoft’s 10‑K states that its regional operations center in Singapore supports Japan, India, Greater China and the broader Asia‑Pacific, so Microsoft’s Greater‑China business is managed from outside the mainland‑Taiwan geopolitical hotspot, giving it a lower direct exposure to regional political risks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Apple outsources 'substantially all' of its manufacturing to Asia, with significant assembly in Taiwan, which is part of its Greater China segment—this matches the original answer's claim about Apple's exposure due to Taiwan's inclusion in the Greater China reporting segment. The characterization of Microsoft’s regional operations center in Singapore supporting Greater China (and broader Asia-Pacific) is also factually correct and consistent with the original. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; all statements are qualitative and correctly attributed. (3) The multi-hop reasoning is sound: the model correctly infers that Apple’s physical dependency on manufacturing in a geopolitically sensitive region (Taiwan) creates higher exposure, while Microsoft’s administrative/logistical setup in Singapore—outside the immediate cross-strait tension zone—results in lower direct risk. This synthesis across Apple’s supply chain structure and Microsoft’s operational footprint is logically valid. (4) The only minor shortcoming is that the LLM answer does not explicitly mention that Microsoft’s operations are not manufacturing-dependent, which slightly weakens the contrast in supply chain vulnerability. However, the implication is clear from context. Overall, the answer is semantically equivalent, factually correct, and highly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 423,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How did Nebraska's 2023 corporate tax rate reduction impact Union Pacific's deferred tax expense in relation to Boeing's exposure to federal appropriations delays as disclosed in their respective 10-K filings?",
      "original_answer": "Nebraska's 2023 corporate tax rate reduction contributed to a $114 million reduction in Union Pacific's deferred tax expense, as disclosed in their 2024 10-K filing. In contrast, Boeing highlighted in its 2024 10-K that delays in U.S. government appropriations, such as continuing resolutions or government shutdowns, could disrupt operations, delay new programs, and negatively impact revenue. While Union Pacific benefited from state-level tax legislation, Boeing faces regulatory and funding risks tied to federal legislation, which could impair its ability to execute contracts or deliver commercial airplanes.",
      "llm_answer": "Union Pacific said that the 2023 corporate‑tax‑rate cuts enacted by Nebraska (along with Iowa, Kansas and Arkansas) produced a **$114 million reduction in its deferred‑tax expense** for the year. In contrast, Boeing’s 10‑K only warns that **delays in federal appropriations create a risk of payment postponements and operational disruptions**, without quantifying a dollar‑amount impact. Thus, Nebraska’s tax change gave Union Pacific a measurable $‑114 million tax‑benefit, whereas Boeing’s appropriations risk remains a qualitative exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $114 million reduction in Union Pacific's deferred tax expense is correctly stated, matching the original answer. The absence of a quantified impact for Boeing is also accurately reflected. (2) The entities—Union Pacific, Boeing, Nebraska’s 2023 tax rate reduction, federal appropriations delays—are all correctly identified and contextualized with the appropriate companies and risks. (3) The multi-hop reasoning is sound: the model correctly synthesizes that Union Pacific benefited from a measurable tax reduction due to state-level changes (including Nebraska), while Boeing faces unquantified operational and financial risks from federal funding delays. (4) The only minor shortcoming is that the LLM omits mention of Iowa, Kansas, and Arkansas in the original context of the tax changes—though this detail is secondary to Nebraska, which was the focus of the question. Additionally, the LLM could have slightly expanded on Boeing’s risk beyond 'payment postponements' to include program delays and revenue impact as in the original, but the core qualitative contrast is preserved. Wording differences are within acceptable semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 348,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How might the expiration timelines of specific Enbrel-related patents in the U.S. influence MRK's strategic focus on maintaining patent protection for its own products, given the competitive dynamics in the biopharmaceutical industry?",
      "original_answer": "The expiration timelines for Enbrel-related patents in the U.S.—including the Fusion protein and pharmaceutical compositions patent expiring on 11/22/2028, the DNA encoding fusion protein and methods of making fusion protein patent on 4/24/2029, and the formulations and methods of preparing formulations patent on 10/19/2037—suggest a phased decline in AMGN's exclusivity for this product. This gradual patent erosion likely reinforces MRK's emphasis on actively protecting its own patents, as outlined in its 2024 10-K, where it states that loss of patent protection typically leads to generic substitutes and reduced sales. MRK acknowledges that political and regulatory pressures to encourage early approval of generics could further exacerbate this risk, making robust patent defense a strategic imperative to maintain market position and profitability in the face of increasing biosimilar competition.",
      "llm_answer": "The Enbrel portfolio is protected in the United States by three patents that do not expire until November 2028, April 2029 and October 2037 (see page 11). Because Merck’s 10‑K repeatedly notes that loss of patent exclusivity “is followed promptly by generic or biosimilar substitutes” and that “the Company actively protects its patent rights” amid intense biosimilar pressure (see pages 33 and 14), the relatively long Enbrel expiry window pushes Merck to concentrate resources on defending and extending those patents (e.g., through new formulations or method‑of‑use claims) to keep biosimilars out for as long as possible. In turn, this focus on safeguarding Enbrel’s exclusivity reinforces Merck’s broader strategy of maintaining robust patent protection for its other products as their own patents (e.g., Prolia 2025) approach expiration.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the three Enbrel-related patent expiration dates—November 2028, April 2029, and October 2037—which align with the ground truth dates of 11/22/2028, 4/24/2029, and 10/19/2037. Minor formatting differences (e.g., month-only vs. full date) are acceptable under semantic equivalence. However, the LLM incorrectly attributes the Enbrel patents to Merck (MRK), when Enbrel is developed and marketed by Amgen (AMGN), not MRK. This is a significant entity error. (2) Quantitatively, all expiration years and months are accurate, satisfying the requirement for date precision. The mention of Prolia’s 2025 expiration is contextually relevant to MRK’s portfolio but not part of the original question or answer and may be extraneous, though not factually incorrect. (3) The reasoning correctly infers that patent expirations lead to biosimilar competition and that MRK emphasizes patent protection as a strategic response. However, the multi-hop logic fails in synthesis: the LLM incorrectly implies that MRK is defending Enbrel patents, when in fact MRK would be responding to Enbrel’s patent expirations as a competitor, not a patent holder. The correct logic is that observing Enbrel’s phased exclusivity loss reinforces MRK’s urgency to protect its *own* products. (4) Despite the entity confusion, the answer captures the strategic rationale and competitive dynamics accurately, and the overall message about MRK’s patent defense strategy is consistent with the ground truth. Hence, correctness is reduced due to the misattribution of patent ownership, but not severely penalized as the strategic implication for MRK remains logically sound. Quantitative accuracy is high; qualitative accuracy is moderate due to flawed entity mapping; contextual relevance is strong as it addresses competitive dynamics and strategic focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 506,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How has AMD's revenue from operations in Taiwan compared to Apple's revenue contribution from Taiwan (as part of Greater China) in 2022, and what does this suggest about their relative market presence in the region?",
      "original_answer": "In 2022, AMD reported $2,091 million in revenue from operations in Taiwan. Apple, on the other hand, reported $74,200 million in net sales from the Greater China region, which includes Taiwan, China mainland, and Hong Kong. Since Taiwan is only a subset of Apple's Greater China segment, and no specific breakdown is provided for Taiwan's contribution within that region, we cannot directly compare the absolute revenue from Taiwan between the two companies. However, AMD's $2,091 million in Taiwan revenue represents a significant portion of its regional operations, whereas Apple's revenue in the broader Greater China region dwarfs AMD's exposure. This suggests that while Taiwan is a meaningful market for AMD, Apple's market presence and revenue scale in the broader Greater China region, including Taiwan, is substantially larger.",
      "llm_answer": "AMD reported $2.1 billion of sales to external customers whose billing location was Taiwan for the fiscal year ended December 25 2021 (its 2022 reporting year)【page_78】.  \n\nApple does not break out Taiwan separately; its Taiwan sales are rolled into the “Greater China” segment, which generated $74.2 billion of net sales in 2022【page_52】.  \n\nThus, AMD’s Taiwan revenue (~$2 billion) is a tiny fraction of Apple’s overall Greater China contribution (tens of billions of dollars), suggesting that AMD’s market presence in Taiwan is modest compared with Apple’s much larger footprint in the broader Greater China region.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies AMD's revenue from Taiwan as $2.1 billion (rounded from $2,091 million in the ground truth), which is factually accurate and matches the original data within acceptable rounding. Apple's Greater China revenue is correctly stated as $74.2 billion, matching the ground truth. The only minor discrepancy is the reference to AMD's fiscal year ending December 25, 2021, being labeled as its '2022 reporting year'—this is technically correct in corporate reporting contexts but could cause confusion; however, it does not constitute a factual error. (2) All numeric values are accurate: $2.1 billion ≈ $2,091 million and $74.2 billion = $74,200 million. No calculations were required beyond comparison, and the relative scale is correctly conveyed. (3) The multi-hop reasoning is sound: the model correctly notes that Apple does not break out Taiwan separately and that its revenue includes the broader Greater China region, making direct comparison impossible. It appropriately concludes that Apple’s regional footprint is much larger, which aligns with the ground truth’s interpretation. (4) The answer is semantically equivalent to the original—while slightly more concise and using rounded figures, it preserves all key facts, correct entities (AMD, Apple, Taiwan, Greater China), correct years (2022), and correct metrics (revenue from operations/sales). The conclusion about relative market presence is logically derived and consistent with the ground truth. Thus, the answer is highly accurate with only negligible wording nuances, warranting a 9/10 due to rounding and slight ambiguity in fiscal year labeling, but no material errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 460,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How does Alphabet's repurchase of Class C shares, which carry no voting rights, enable different capital allocation flexibility compared to Netflix's share repurchase strategy under its uniform voting rights structure?",
      "original_answer": "Alphabet's repurchase of Class C shares, which carry no voting rights, allows the company to return capital to shareholders while preserving insider control through the retention of higher-vote Class A and B shares. In 2023, Alphabet repurchased $62.2 billion of Class A and Class C shares, with an additional $36.3 billion remaining available under the repurchase authorization. In contrast, Netflix's capital stock carries uniform voting rights — one vote per share — meaning any significant share repurchase could potentially dilute voting control among existing shareholders. This structural difference implies that Netflix may need to be more cautious in its repurchase activity to avoid unintended shifts in governance, unlike Alphabet which can execute larger buybacks without affecting its core governance structure.",
      "llm_answer": "Alphabet can use its dual‑class structure to buy back only its non‑voting Class C shares.  Because Class C stock carries no voting rights, the repurchase reduces the number of outstanding equity‑interest units and lifts earnings‑per‑share without changing the voting power held by the Class A and Class B shareholders 【page 81】.  Netflix, by contrast, has a single‑class common stock in which every share has the same voting rights, so any share‑repurchase program reduces both the economic stake and the voting stake of all shareholders proportionally, giving the company less ability to separate capital‑return decisions from control considerations 【NFLX 10‑K pages 58‑63】.  Consequently, Alphabet’s ability to target non‑voting shares provides a distinct capital‑allocation flexibility that Netflix’s uniform‑voting‑rights repurchase strategy does not.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that Alphabet's repurchase of non-voting Class C shares allows capital return without diluting insider voting control, while Netflix's uniform voting structure means buybacks affect both economic and voting stakes proportionally. This captures the essential contrast in capital allocation flexibility. (2) Quantitative accuracy is perfect: although the LLM does not repeat the specific dollar figures ($62.2 billion repurchased, $36.3 billion remaining), it does not make any numerical claims, so there are no inaccuracies. The omission of these numbers is a minor completeness issue but does not detract from the conceptual correctness. (3) The multi-hop reasoning is sound—correctly linking share class structure (Alphabet’s dual-class vs Netflix’s single class) to governance implications of buybacks. The use of citation placeholders like 【page 81】 and 【NFLX 10-K pages 58-63】 suggests proper grounding, though exact alignment with source data cannot be verified here. (4) The answer is contextually fully relevant and semantically equivalent to the original in terms of logic and intent. The only reason for not scoring a 10 is the absence of the specific quantitative details present in the ground truth, which would have strengthened completeness. However, since the question does not explicitly ask for numbers, the conceptual explanation suffices for a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 410,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How does MET's exposure to non-agency pass-through mortgage-backed securities with $1,699 million in NQM and Alt-A loans compare to AIG's liquidity risk from mortgage assets, particularly in light of MET's $1,294 million in unrealized losses on pass-through securities versus AIG's concerns about valuing illiquid mortgage-related investments?",
      "original_answer": "MET holds $12,567 million in pass-through mortgage-backed securities, including $1,699 million in NQM and Alt-A loans categorized under non-agency RMBS, with $1,294 million in unrealized losses in 2024. These pass-through securities are directly secured by pools of mortgage loans, including lower-quality segments like NQM and Alt-A that carry elevated credit risk. AIG, meanwhile, faces liquidity risk from its mortgage and loan portfolio, particularly due to its holdings of less liquid assets like private equity, hedge funds, mortgage loans, and real estate. AIG explicitly warns that adverse market conditions or valuation volatility in these assets could lead to material losses if sold in stressed environments. Thus, while MET's exposure is more specifically defined and marked-to-market with known unrealized losses, AIG's risk lies in the uncertain valuation and potential illiquidity of its broader mortgage-linked investments, which could realize even greater losses under unfavorable market conditions.",
      "llm_answer": "MET’s RMBS portfolio includes $1.7 billion of non‑agency pass‑through securities that are classified as non‑qualified (NQM) and Alt‑A loans (Table on page 88), and the same portfolio shows a $1.3 billion unrealized loss on its pass‑through mortgage‑backed securities (page 88). By contrast, AIG does not quantify a specific loss; its 2024 filing warns that a large concentration in residential‑mortgage‑backed securities and other mortgage‑related assets could be difficult to value or sell in a stressed market, creating liquidity risk (pages 19‑21). Thus, MET’s exposure is expressed in concrete dollar amounts and already reflects sizable unrealized losses, whereas AIG’s risk is described more qualitatively as a potential inability to value and liquidate illiquid mortgage investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth in both quantitative and qualitative aspects. (1) Quantitatively, the LLM correctly reports MET's $1.7 billion (rounded from $1,699 million) in non-agency pass-through securities consisting of NQM and Alt-A loans, and the $1.3 billion unrealized loss (rounded from $1,294 million), both of which align with the original answer and are acceptable format variations. The year 2024 is implied contextually, though not explicitly stated in the LLM answer, which is a minor omission. (2) The LLM accurately contrasts MET’s quantified, marked-to-market exposures with AIG’s more qualitative liquidity risk disclosures, correctly noting that AIG does not provide specific loss figures but warns about valuation and liquidity challenges in stressed markets, particularly for mortgage-related and other illiquid assets. (3) The multi-hop reasoning is sound: the model synthesizes information across two companies (MET and AIG), compares their respective mortgage exposures, and draws a valid contrast between realized/unrealized losses versus potential liquidity risk from hard-to-value assets. (4) While the LLM omits the total size of MET’s pass-through securities ($12,567 million), this detail is not central to the specific comparison asked. It also does not mention AIG’s broader illiquid assets like private equity and real estate, but captures the essence of AIG’s liquidity risk. Wording differs but semantic meaning is equivalent. Minor rounding and omission of total portfolio size prevent a perfect 10, but overall correctness is very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 439,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How did the revenue contribution from beverage operations in the Asia Pacific region compare between Coca-Cola (KO) and PepsiCo (PEP) in 2021, based on their regional and product segment reporting?",
      "original_answer": "In 2021, Coca-Cola (KO) generated $4,682 million in third-party beverage revenue from its Asia Pacific (APAC) operations. PepsiCo (PEP) reported that 20% of its total revenue in the APAC region came from beverage operations, though the exact dollar amount is not disclosed. This indicates that while KO's APAC beverage revenue is directly quantifiable for 2021, PEP's APAC beverage revenue would require further calculation based on total regional revenue to determine the precise figure.",
      "llm_answer": "In 2021 Coca‑Cola’s Asia‑Pacific region generated **about $5.3 billion** in net operating revenue, which for Coca‑Cola is essentially all beverage revenue. PepsiCo’s Asia‑Pacific segment reported **$4.6 billion** of total net revenue, of which only **20 %** was from beverages – roughly **$0.9 billion**. Thus Coca‑Cola’s beverage revenue in Asia‑Pacific was roughly **five to six times larger** than PepsiCo’s beverage contribution in the same region.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Coca-Cola's 2021 third-party beverage revenue in APAC was $4,682 million ($4.682 billion), but the LLM states 'about $5.3 billion', which is incorrect. For PepsiCo, the ground truth confirms that 20% of APAC revenue came from beverages, but explicitly states the exact dollar amount is not disclosed. However, the LLM incorrectly calculates PepsiCo's beverage revenue as $0.9 billion (20% of $4.6 billion), which is unsupported because the $4.6 billion total APAC revenue figure is not present in the ground truth and cannot be assumed. (2) The calculation of $4.6 billion × 20% = $0.9 billion is mathematically correct, but based on false premises—using an unverified total regional revenue figure. The comparison that Coca-Cola’s revenue was 'five to six times larger' is therefore invalid due to incorrect inputs. (3) The multi-hop reasoning fails because the model fabricates PepsiCo’s total APAC revenue instead of acknowledging it is not disclosed, as required by the ground truth. It incorrectly synthesizes non-existent data to produce a precise comparative figure. (4) While the answer addresses the right entities (Coca-Cola, PepsiCo, APAC, 2021, beverage revenue) and attempts a relevant comparison, the core quantitative claims are factually wrong, severely undermining correctness. The contextual relevance is high because the structure and intent align with the question, but accuracy is critically compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 421,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How does Gilead's revenue-sharing structure with Merck for long-acting HIV products compare to Merck's royalty obligations to BMS and Ono for Keytruda sales, and what implications does this have for Merck's profitability from both partnerships?",
      "original_answer": "Gilead and Merck share global product revenues equally for long-acting HIV products until $2.0 billion (oral) or $3.5 billion (injectable) in net sales are surpassed, after which Gilead's share increases to 65%. Meanwhile, Merck pays BMS and Ono royalties of 6.5% through 2023 and 2.5% from 2024–2026 on global Keytruda sales, with BMS receiving 75% of those payments. In 2023, Merck recorded $212 million in alliance revenue from its collaboration with BMS on Reblozyl, which includes a 20–24% sales royalty. These structures indicate that Merck both shares in revenue from joint development (with Gilead) and pays significant royalties (to BMS and Ono), which directly affects its net profitability from these partnerships depending on the scale of product sales.",
      "llm_answer": "Gilead’s agreement gives Merck a 50 percent split of net product revenues for the long‑acting HIV combo (rising to 35 percent for Merck once sales exceed the $2 billion‑/ $3.5 billion‑thresholds), with development costs shared 60/40, whereas the Keytruda patent‑license requires Merck to pay a royalty of 6.5 percent of global sales (falling to 2.5 percent after 2023) that is allocated 75 percent to BMS and 25 percent to Ono. Consequently, the Gilead partnership can add significant upside to Merck’s earnings if the HIV products achieve high sales, while the Keytruda royalty is a fixed cost that directly erodes margin on an already‑profitable immunotherapy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the revenue-sharing percentages. It incorrectly states that Merck's share increases to 35% after the sales thresholds, when in fact Gilead's share increases to 65% (meaning Merck's drops to 35%). This misrepresents the financial impact on Merck. Additionally, the LLM mentions a 60/40 split in development costs, which is not present in the original answer and introduces unverified information. The royalty rates for Keytruda (6.5% through 2023, 2.5% from 2024–2026) and the 75/25 split between BMS and Ono are correctly stated. However, the LLM omits the Reblozyl alliance revenue ($212 million in 2023) and its associated 20–24% royalty, which is a key part of the original answer and relevant to Merck's overall partnership profitability. (2) Quantitative accuracy is compromised: the $2 billion (oral) and $3.5 billion (injectable) thresholds are correctly cited, as are the royalty percentages for Keytruda, but the misstatement of Merck’s post-threshold revenue share as 35% (instead of correctly noting it decreases to 35% due to Gilead’s increase to 65%) reflects a misunderstanding. The 60/40 cost split is unsupported. (3) The multi-hop reasoning is partially sound—LLM correctly contrasts revenue-sharing (upside) vs. royalty payments (cost), but fails to fully synthesize all three partnerships (Gilead, BMS, Ono, and implicitly BMS via Reblozyl). The omission of Reblozyl revenue weakens completeness. (4) Correctness score is 6 due to core errors in percentages and missing key data; quantitative accuracy is 5 due to critical percentage error; qualitative accuracy is 7 as logic and structure are reasonable despite errors; contextual relevance is 9 as the answer stays focused on the question’s intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 489,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How does BAC's investment in CDOs, which contain embedded credit default swaps that transfer risk through tranche structures, compare to AIG's $75 million loss from embedded derivatives in 2024, considering the role of credit events in triggering losses for both institutions?",
      "original_answer": "BAC invests in CDOs, which are hybrid instruments containing embedded derivatives where credit protection has been sold to the issuer. These structures pass credit event losses from junior tranches to more senior ones, exposing investors like BAC to cascading risk. AIG, in turn, reported a $75 million loss from embedded derivatives in 2024, which includes similar instruments like credit default swaps tied to reference entities. A credit event in the underlying reference entity would directly impact both BAC’s CDO value and AIG’s derivative exposure, linking their financial risks through the same type of structured credit mechanism.",
      "llm_answer": "Bank of America’s 10‑K shows that a portion of its trading‑account assets is held in structured‑credit products such as mortgage‑backed and asset‑backed securities (see the “Mortgagetradingloans, MBS and ABS” line in the trading‑account table) and that it carries a large net‑derivative position (‑$2.9 billion net derivative assets) that includes credit‑default‑swap (CDS) exposure (page 158).  Those CDOs embed CDS contracts that shift default risk down the tranche hierarchy, so a credit event on any reference obligor can cause the junior tranche – and therefore Bank of America – to incur a loss when the principal on the note is not fully repaid.\n\nAIG, by contrast, reported a concrete $75 million loss in 2024 that was recorded under “Embedded derivatives” (page 144).  The same filing explains that the loss arose from credit‑default‑swap‑type contracts in which a credit event (bankruptcy, failure‑to‑pay, restructuring, etc.) triggers a payment obligation (page 108).\n\n**Comparison:** Both institutions’ losses are tied to credit events that activate embedded CDS provisions in tranche‑structured securities.  AIG’s exposure is already quantified at $75 million for 2024, whereas Bank of America’s exposure is embedded in its broader trading‑account and derivative positions and is not disclosed as a specific loss amount; the risk remains contingent on future credit events in the underlying CDO reference entities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: AIG's $75 million loss in 2024 is accurately cited, and BAC's derivative position (-$2.9 billion net derivative assets) is correctly reported from its 10-K. No calculations were required, but the absence of a specific loss amount for BAC is properly noted as contingent, which matches the original answer’s implication that BAC’s risk is exposure-based rather than realized. (2) The entities—BAC, AIG, CDOs, CDS, credit events, tranches—are all correctly identified and contextualized. The years (2024 for AIG) are accurate. (3) The multi-hop reasoning is sound: the answer connects BAC’s investment in structured products with embedded CDS, explains tranche-based risk transfer, links AIG’s loss to similar mechanisms, and compares the two institutions’ exposures through the common trigger of credit events. It correctly distinguishes between BAC’s potential/contingent losses and AIG’s realized $75M loss. (4) The only minor shortcoming is that the original answer emphasizes the 'cascading risk' from junior to senior tranches more explicitly, while the LLM focuses on junior tranches absorbing losses—slightly less precise in describing the waterfall structure, but not incorrect. Overall, the answer is semantically equivalent, factually correct, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1548,
        "completion_tokens": 389,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "What specific roles does Citibank, N.A. hold in both 3M's May 2023 Five-Year Credit Agreement and Caterpillar's September 2022 credit facilities, and how do these roles differ in terms of administrative responsibilities across the two agreements?",
      "original_answer": "In 3M’s May 2023 Five-Year Credit Agreement, Citibank, N.A. serves as an administrative agent and joint lead arranger alongside JPMorgan Chase Bank, N.A., with responsibilities including coordination of the lending group and oversight of borrowing procedures. In Caterpillar’s September 2022 credit facilities, Citibank, N.A. acts as the Agent for both the 3-Year and 5-Year Facilities, and also as the Local Currency Agent through Citibank Europe plc, UK Branch, and Japan Local Currency Agent in coordination with MUFG Bank, Ltd. These roles differ in that Citibank holds multiple layered responsibilities in Caterpillar’s structure, including cross-border coordination, while at 3M it shares leadership with another bank without such international scope.",
      "llm_answer": "- **3M – May 2023 Five‑Year Credit Agreement:**  The agreement lists **Citibank, N.A. as the administrative agent** (the bank that handles the routine paperwork, draws, and communications for the facility).  \n\n- **Caterpillar – September 2022 credit facilities (the 3‑year and 5‑year facilities):**  The filing identifies **Citibank, N.A. as the Agent** for each facility (the party that receives notices, processes borrowings and repayments, and coordinates the lenders).  \n\n**Difference in administrative responsibilities:**  In the 3M agreement Citibank’s role is described specifically as “administrative agent,” which typically includes both the day‑to‑day administration and, in many similar agreements, additional duties such as syndication or lead‑arranger functions.  In Caterpillar’s facilities Citibank is named only as the “Agent,” meaning its responsibilities are limited to the core administrative tasks of managing the credit line and acting as the point of contact for the lenders, without the broader arranger or syndication responsibilities.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies Citibank, N.A.'s roles in both the 3M and Caterpillar agreements with accurate dates and entity names, satisfying quantitative and basic entity accuracy. It correctly states that Citibank, N.A. is the administrative agent in 3M’s May 2023 Five-Year Credit Agreement and the Agent in Caterpillar’s September 2022 credit facilities. However, the answer is partially incorrect in its qualitative interpretation of the roles and omits key multi-hop details from the ground truth. Specifically: (1) It fails to mention that in the 3M agreement, Citibank, N.A. also serves as a joint lead arranger alongside JPMorgan Chase Bank, N.A., which is a significant additional responsibility not captured in the LLM response. (2) For Caterpillar, the LLM omits Citibank’s layered roles as Local Currency Agent (via Citibank Europe plc, UK Branch) and Japan Local Currency Agent in coordination with MUFG Bank, Ltd.—critical details that explain the broader international administrative scope. (3) The reasoning about the difference in responsibilities is flawed: the LLM incorrectly suggests that being called 'Agent' versus 'administrative agent' implies a narrower role, but in standard credit agreements, 'Agent' often encompasses the same core duties as 'administrative agent', and in Caterpillar’s case, the role is actually more complex due to cross-border coordination. Thus, while the surface-level facts are present and dates/entities are correct, the synthesis and comparative analysis are inaccurate, leading to a misleading conclusion about the nature and scope of Citibank’s responsibilities. This constitutes a significant failure in multi-hop reasoning and qualitative accuracy, despite correct naming and dates.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 473,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "How does the use of option contracts by KO to hedge foreign currency exposure compare with PEP's foreign exchange risk management strategy, given the impact of these instruments on their respective foreign currency liabilities?",
      "original_answer": "KO uses option contracts as part of its derivative strategy to hedge foreign currency exchange rate risk, aiming to mitigate the impact of currency fluctuations on its financial performance. These contracts are designated as cash flow hedges and affect KO's foreign currency liabilities by deferring gains and losses in AOCI until the hedged transactions occur. Similarly, PEP actively manages foreign exchange risk through derivatives, including option and forward contracts, which are also used to hedge forecasted transactions and firm commitments. PEP reported that foreign exchange movements unfavorably impacted net revenue by 1.5 percentage points in 2024, highlighting the importance of these hedges. Both companies rely on option contracts to manage foreign currency liabilities, but KO specifically emphasizes the deferral of mark-to-market impacts in AOCI, while PEP focuses on offsetting exposure from its significant international operations (44% of revenue).",
      "llm_answer": "Coca‑Cola notes that it employs option contracts (along with forwards, swaps and collars) to hedge its foreign‑currency exposures, but the fair‑value of those contracts that sit against liabilities is relatively modest – about $14 million on accounts‑payable/ accrued expenses and $39 million on other non‑current liabilities in 2024 (roughly $53 million total). PepsiCo, by contrast, runs a much larger program that uses both forward and option contracts as cash‑flow hedges and cross‑currency swaps as fair‑value hedges of its foreign‑currency‑denominated borrowings, with net foreign‑exchange cash‑flow hedge notional of $9.9 billion in 2024 and the swap impact recorded in interest expense and AOCI, directly offsetting changes in its foreign‑currency liabilities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in quantitative details not present in the original answer, which undermines correctness. The original answer does not mention specific dollar amounts such as $14 million, $39 million, or $53 million for KO, nor a $9.9 billion notional for PEP—these figures are absent from the ground truth and appear to be fabricated or hallucinated. There is also no mention in the original answer of collars, cross-currency swaps being used as fair-value hedges, or their impact on interest expense, which the LLM introduces without support. While both answers agree that KO and PEP use option contracts as part of cash flow hedges, the LLM incorrectly implies a quantitative comparison (e.g., 'much larger program') not present in the original. The original emphasizes qualitative differences: KO’s deferral of mark-to-market impacts in AOCI vs PEP’s focus on offsetting exposure from international operations (44% of revenue), and PEP’s 1.5 percentage point revenue impact in 2024—details missing in the LLM response. The LLM captures the general idea that both firms use derivatives to manage foreign exchange risk, which supports contextual relevance, but fails on multi-hop synthesis by not incorporating PEP’s revenue impact or KO’s AOCI emphasis. The reasoning is partially sound but built on unsupported numbers, reducing qualitative accuracy. Overall, the answer is contextually aligned but factually divergent on key metrics, resulting in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 415,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 183,
      "question": "How does the use of discounted cash flow models by GE in assessing goodwill impairment risk compare with LMT's application of DCF in valuing Level 3 fixed income investments, particularly in terms of sensitivity to discount rate assumptions and projected cash flow estimates?",
      "original_answer": "GE uses a discounted cash flow (DCF) approach as part of its annual goodwill impairment testing, relying on cash flow forecasts, terminal value assumptions, and discount rates to estimate fair value. The company performs sensitivity analyses due to the material impact that changes in these assumptions could have on impairment determinations. Similarly, LMT applies DCF models to value certain Level 3 fixed income investments when observable market data is unavailable, using projected annuity payments and discount rates as key inputs. Both companies depend on forward-looking cash flow projections and discount rate assumptions, making their valuations sensitive to shifts in economic conditions or interest rate environments. However, GE’s DCF use is tied to internal strategic and operational planning, while LMT’s is externally focused on asset valuation within its pension fund investments.",
      "llm_answer": "GE says that its goodwill‑impairment test is based on a discounted‑cash‑flow (DCF) valuation of the reporting unit and that it “performs sensitivity analyses on key estimates and assumptions,” explicitly measuring how changes in the discount rate and the cash‑flow forecasts would affect fair value. Lockheed Martin’s Level 3 fixed‑income holdings are also valued with a DCF model, using projected annuity payments and a discount rate, but the filing only notes that these inputs are “significant” and does not describe formal sensitivity testing, making the valuation more directly dependent on the chosen rate and cash‑flow assumptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. It correctly identifies that GE uses DCF models in goodwill impairment testing and performs sensitivity analyses on discount rates and cash flow forecasts, which matches the original answer. It also accurately states that LMT applies DCF models to value Level 3 fixed income investments using projected annuity payments and discount rates. The distinction in focus—GE’s internal strategic use versus LMT’s external asset valuation in pension investments—is implied through the context of sensitivity testing, though not explicitly stated. The LLM correctly notes that while GE conducts formal sensitivity analyses, LMT’s filings only label inputs as 'significant' without describing such testing, making LMT’s valuations more directly dependent on assumptions. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (GE, LMT, DCF, Level 3 investments, goodwill impairment) are correctly identified and contextualized. The reasoning is sound and synthesizes multi-hop information across both companies’ uses of DCF. The only minor shortcoming is the lack of explicit mention of the terminal value assumption and the broader economic sensitivity mentioned in the original answer, but the core comparison on sensitivity to discount rates and cash flows is well captured. Hence, correctness is high but not perfect due to slight incompleteness in contextual nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 405,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How does the voting power distribution in CMCSA's Class A and Class B common stock compare to GOOGL's structure, given the repurchase activity and voting rights differences?",
      "original_answer": "In CMCSA, holders of Class A common stock collectively hold 66 2/3% of the combined voting power, while Class B common stock (held entirely by Brian L. Roberts) holds 33 1/3%, with each Class B share carrying 15 votes. In contrast, GOOGL's Class A shares carry 1 vote each, while Class B shares have 10 votes per share, giving disproportionate voting power to Class B holders in both companies. Additionally, GOOGL repurchased $62.2 billion of Class A and Class C shares in 2023, which could affect ownership concentration and voting dynamics, though CMCSA does not disclose such repurchase volumes for Class A shares directly.",
      "llm_answer": "- **Comcast (CMCSA)** – The company has two voting classes. Each Class A share carries one vote and the single outstanding Class B share (held by Mr. Roberts) carries 15 votes, together giving Class A about 66 % of the total voting power and Class B about 33 % (the “non‑dilutable” one‑third). All of the 2023 repurchases were of Class A stock, so the voting split remains essentially unchanged.  \n\n- **Alphabet (GOOGL)** – Alphabet also has a dual‑class structure, but the weighting is far more extreme: Class B shares have 10 votes each and, because the company repurchased only Class A and non‑voting Class C shares, the Class B holders retain roughly two‑thirds (or more) of the total voting power, while Class A (1 vote) and Class C (no vote) have negligible influence.  \n\nThus, Comcast’s voting power is divided roughly two‑thirds to Class A and one‑third to a high‑vote Class B, whereas Alphabet’s voting power is concentrated in its high‑vote Class B shares, which dominate the vote after the company’s Class A/C repurchases.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor omissions. (1) Quantitatively: The voting power split (66% vs 33%) for CMCSA is correctly stated and aligns with the ground truth (66 2/3% and 33 1/3%). The 15 votes per Class B share in CMCSA and 10 votes per Class B share in GOOGL are correctly reported. The $62.2 billion repurchase by GOOGL in 2023 is not explicitly mentioned in the LLM answer, which is a minor omission, but the fact that GOOGL repurchased only Class A and Class C shares (including non-voting Class C) is correctly noted, and the inference about increased concentration of voting power in Class B is sound. The statement that CMCSA repurchased only Class A shares in 2023 is accurate and supports the conclusion that the voting split remains stable. (2) Calculations: The implied reasoning that repurchasing lower-vote or non-voting shares increases the relative voting weight of Class B in GOOGL is logically correct. The two-thirds voting power for GOOGL's Class B is a reasonable approximation based on public disclosures, though not explicitly verified in the ground truth. (3) Multi-hop reasoning: The LLM successfully synthesizes information across CMCSA and GOOGL, comparing both voting structures and the impact of share repurchases on voting concentration. It correctly identifies that both companies use dual-class structures with disproportionate voting rights, but the effect is more pronounced in GOOGL due to repurchase strategy. (4) The only minor shortfall is the lack of the exact $62.2 billion figure for GOOGL’s repurchases, which was present in the original answer. However, this does not undermine the overall correctness, as the qualitative impact is accurately described. Wording differences (e.g., 'non-dilutable one-third') are semantically equivalent. Thus, the answer is factually strong, contextually relevant, and well-reasoned, warranting a 9/10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 525,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How does the 8.2% increase in Turkey's total cigarette market, driven by increased in-bound tourism, impact PM's business performance in comparison to CL's operational footprint in the same country?",
      "original_answer": "The 8.2% growth in Turkey's total cigarette market, attributed to the easing of pandemic-related measures and increased in-bound tourism (particularly by Turkish expatriates), positively contributed to PM's net revenues and shipment volumes in the region. PM reported favorable volume/mix and pricing variances in Turkey, which were key contributors to its Middle East & Africa regional performance. Meanwhile, CL operates manufacturing and warehousing facilities in Turkey as part of its global Oral, Personal and Home Care product segment, indicating a significant operational presence in the country. Therefore, while PM benefits from increased consumer activity linked to tourism, CL maintains a physical and ongoing business infrastructure in Turkey, suggesting differing but regionally aligned exposure to the country's economic dynamics.",
      "llm_answer": "The PMI filing notes that Turkey’s total cigarette market grew 8.2% in 2021, “mainly reflecting … increased in‑bound tourism” and that this growth helped lift PMI’s shipment volume and regional market‑share in the Middle East & Africa segment【page_56】. By contrast, Colgate‑Palmolive’s 2022 filing only lists Turkey as a location of one of its overseas manufacturing/warehousing facilities and provides no indication that the tourism‑driven market expansion is translating into higher sales or market‑share for its consumer‑goods brands【page_23】. Thus, the 8.2% market rise directly boosts PMI’s tobacco performance, while CL’s operational footprint in Turkey is limited to a production site with no disclosed performance impact.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 8.2% growth in Turkey's cigarette market in 2021 and attributes it to increased in-bound tourism, aligning with the ground truth. It accurately links this growth to PMI's (PM) shipment volume and market-share gains in the Middle East & Africa region, supported by a citation from page 56. The entity identification is correct—PMI (Philip Morris International) and CL (Colgate-Palmolive)—and the time frame (2021) is consistent with the source data. (2) Quantitatively, all numbers are accurate: the 8.2% market growth is correctly reported, and no calculations are required beyond accurate reporting. Format and references are properly handled. (3) The reasoning is mostly sound: the LLM correctly infers that PM benefits directly from the tourism-driven market expansion, while CL’s presence is operational (manufacturing/warehousing) with no disclosed sales impact. However, the LLM understates CL’s footprint by calling it 'limited to a production site' and misses the nuance in the ground truth that CL has a 'significant operational presence' in Turkey as part of its global Oral, Personal and Home Care segment. This downplays the strategic importance of the facilities. Additionally, the original answer emphasizes that CL’s exposure is structural (infrastructure), while PM’s is demand-driven—this comparative insight is partially lost. (4) Despite this, the LLM answer is contextually relevant, directly addressing both companies’ exposure to Turkey and correctly synthesizing multi-hop information from two different filings. The conclusion is logically supported, though slightly less nuanced than the ground truth. Hence, minor deduction in qualitative accuracy and overall correctness, but high marks for factual precision and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 488,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How might geopolitical tensions involving Taiwan impact both NVIDIA's ability to secure timely supply from its foundry partners and Qualcomm's operations in the region, given their shared dependency on Taiwanese manufacturing infrastructure?",
      "original_answer": "NVIDIA faces risks related to its dependency on foundry partners, particularly in Taiwan, where it relies on timely production capacity to meet customer demand. If geopolitical tensions involving Taiwan disrupt operations, NVIDIA may not be able to secure sufficient supply to fulfill orders on time, which could damage customer relationships and lead to revenue loss. Similarly, Qualcomm explicitly states that its business depends on receiving consistent chipset supply from foundry partners in Taiwan, and a significant or prolonged conflict involving Taiwan could severely limit or prevent this supply, materially impacting its business. Both companies are exposed to the same regional risk due to their reliance on Taiwanese manufacturing infrastructure, amplifying the cross-company impact of geopolitical instability in the region.",
      "llm_answer": "Both companies warn that a flare‑up over Taiwan – where the bulk of their wafer‑fabrication partners (TSMC and other foundries) are located – could choke the flow of chips. NVIDIA says that heightened Taiwan‑China tensions “could have a material adverse impact” on its ability to obtain wafers on time, raise prices or force capacity cuts, while Qualcomm notes that its “consistent and reliable chipset supply … particularly in Taiwan” could be “severely limited or prevented” by a prolonged conflict, jeopardizing its product‑manufacturing and regional operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: both NVIDIA and Qualcomm are correctly identified as reliant on Taiwanese foundries (e.g., TSMC), and the risks from geopolitical tensions involving Taiwan are accurately described. The LLM correctly captures NVIDIA's concern over material adverse impact on wafer supply, timing, pricing, and capacity, and Qualcomm's explicit risk of severely limited or prevented chipset supply. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model synthesizes shared dependency on Taiwanese manufacturing infrastructure and correctly infers cross-company exposure to the same geopolitical risk. The only minor shortcoming is that the LLM does not explicitly state that this shared dependency 'amplifies the cross-company impact,' though the implication is clearly present. (4) The answer is fully contextually relevant, directly addressing how geopolitical tensions could impact both companies' supply chains and operations. Wording differs slightly but maintains semantic equivalence. No hallucinations or inaccuracies. A score of 9 is justified due to slightly less explicit emphasis on the amplification of risk through shared infrastructure, but all key facts and logic are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 396,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How has the application of ASU 2020-04 impacted FDX's exposure to LIBOR-related contract modifications, and how does this compare to MMM's financial treatment of hedging relationships affected by reference rate reform?",
      "original_answer": "FDX has not experienced any material effect from reference rate reform, including ASU 2020-04, as of May 31, 2024, although it continues to monitor contracts that may be affected by LIBOR discontinuation. In contrast, MMM actively manages its hedging relationships, including those affected by reference rate changes, and reported $9 million in losses related to interest rate contracts in 2023, indicating active financial impact and accounting treatment under the ASU 2020-04 framework. This suggests that while FDX has not yet seen significant financial effects, MMM has recognized tangible impacts in its hedging activities tied to reference rate reform.",
      "llm_answer": "Applying ASU 2020‑04 allowed FedEx to use the optional expedients that “reduce the operational and financial impacts of contract modifications that replace LIBOR,” and the company reports that, as of May 31 2024, the reform has had **no material effect on its financial condition, results of operations or cash flows** and its exposure to LIBOR‑related modifications is therefore minimal. In contrast, 3M’s interest‑rate swaps that were originally tied to LIBOR remain designated as hedging instruments; the company continues to account for them under the hedge‑accounting rules—fair‑value‑hedge gains or losses flow through earnings, while cash‑flow‑hedge gains are recorded in OCI and later re‑classified to income—so the reform is reflected in the ongoing earnings and OCI impacts shown for those hedges.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that FDX has experienced no material effect from reference rate reform, including ASU 2020-04, as of May 31, 2024, matching the original answer's key point. It also accurately notes FDX's minimal exposure to LIBOR-related modifications. For MMM (3M), the LLM correctly identifies that the company continues to manage hedging relationships affected by reference rate reform and describes the ongoing accounting treatment under hedge accounting rules. While the LLM does not explicitly mention the $9 million in losses reported by MMM in 2023—a specific quantitative impact noted in the ground truth—it does convey that MMM has ongoing earnings and OCI impacts, implying active financial effects. (2) All dates (May 31, 2024) and financial concepts (fair value hedge, OCI, cash flow hedge) are correctly used. No incorrect numbers are presented; the only omission is the $9M loss figure, which is a minor but notable detail. (3) The multi-hop reasoning is sound: the LLM compares FDX’s lack of material impact with MMM’s continued hedge accounting and financial statement impacts, correctly contrasting their situations. It synthesizes information across both companies and the ASU 2020-04 framework appropriately. (4) The answer is contextually excellent, directly addressing both parts of the question—FDX’s exposure and MMM’s financial treatment—and explaining the differential impact of ASU 2020-04. The omission of the $9M loss slightly reduces completeness but does not undermine the overall correctness. Hence, a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 468,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How does the voting power distribution tied to CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, influence the governance structure compared to GOOGL's dual-class stock system where Class A and Class B shares have differential voting rights?",
      "original_answer": "CMCSA's Class B common stock, entirely owned by Brian L. Roberts, holds 33⅓% of the combined voting power with each share carrying 15 votes, creating a non-dilutable control mechanism. This contrasts with GOOGL's structure, where Class A shares (1 vote per share) and Class B shares (10 votes per share) allow insiders to maintain control while enabling broader public ownership. Both systems use dual-class structures to preserve founder/leadership control, but differ in the vote ratios and ownership concentration, with CMCSA's setup being more concentrated and structurally rigid due to the non-dilutable nature of Class B shares.",
      "llm_answer": "Comcast’s charter gives each Class B share ten votes versus one vote for a Class A share, and the 9.44 million Class B shares – all owned by Brian L. Roberts – account for roughly one‑third of the company’s total voting power (page 31, 82). This concentration of voting rights in a single insider means Roberts can effectively control board elections and major corporate decisions despite holding a small fraction of the equity.  \n\nAlphabet’s dual‑class structure similarly assigns ten votes to each Class B share and one vote to each Class A share, but the Class B stock is held by a group of founders and insiders and, while representing a modest share of total equity, provides them with a controlling majority of the voting power; public shareholders (Class A) have only one‑vote rights. Thus, both companies concentrate control through high‑voting shares, but Comcast’s power is vested in a single owner, whereas Alphabet’s is spread among several insiders.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct in conveying the governance implications of dual-class structures at CMCSA and GOOGL, with accurate qualitative comparisons about control concentration. However, there are key quantitative inaccuracies: the LLM states CMCSA Class B shares have 'ten votes' per share, while the ground truth specifies 15 votes per share. Additionally, the LLM mentions '9.44 million Class B shares' and 'roughly one-third' voting power, which aligns with the 33⅓% in the original answer, but the vote ratio error undermines the calculation basis. For GOOGL, the LLM correctly identifies the 10:1 vote ratio for Class B vs Class A shares, consistent with ground truth.\n\n2) Quantitative accuracy is compromised by the incorrect vote count (10 vs 15) for CMCSA's Class B stock. This affects the precision of the voting power mechanism description, even though the one-third voting power outcome is approximately correct. The share count (9.44 million) and one-third voting power figure may be factually derived from filings but are not in the ground truth, so their accuracy cannot be fully verified here. The GOOGL vote ratio is correct.\n\n3) The multi-hop reasoning is sound: the model correctly identifies that both companies use dual-class structures to concentrate control, contrasts CMCSA’s single-owner control (Roberts) with GOOGL’s group of insiders, and links high-vote shares to governance outcomes. It synthesizes across entities and structures appropriately.\n\n4) Despite the vote ratio error, the answer captures the core contrast: CMCSA has more concentrated, rigid control in one individual, while GOOGL spreads control among insiders. The explanation is contextually relevant and addresses all parts of the question. The correctness score is 7 due to the significant but not fundamental numeric error in vote count, which impacts the mechanistic understanding but not the overall conclusion about control concentration.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 525,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How does Amgen's remaining repatriation tax payment schedule under the 2017 Tax Act compare with Eli Lilly's cash payment obligations for the same tax provision as of December 31, 2023?",
      "original_answer": "Amgen has remaining scheduled repatriation tax payments under the 2017 Tax Act, which it is paying over an eight-year period beginning in 2018. Similarly, Eli Lilly made the election to pay the Toll Tax over the same eight-year period, with its future cash payments extending through 2025. Both companies are managing their obligations under the same regulatory framework introduced by the 2017 Tax Act, though the specific amounts differ based on their foreign earnings and individual tax calculations.",
      "llm_answer": "Amgen elected to pay its 2017‑Tax‑Act repatriation (toll) tax in eight installments and, as of December 31 2023, still owed $1.467 billion in 2024 and $1.834 billion in 2025—a total of **$3.301 billion** remaining. Eli Lilly’s corresponding cash‑payment obligation is much smaller, with a total of **$1.427 billion** remaining (about $634 million due in 2024 and $793 million in 2025). Thus, Amgen’s outstanding schedule is roughly $1.9 billion larger than Lilly’s cash‑payment liability.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific dollar amounts for both Amgen and Eli Lilly ($1.467B and $1.834B for Amgen; $634M and $793M for Lilly), which are not present in the original answer (ground truth). The ground truth does not provide any numerical figures for the remaining payments, only stating that both companies are paying over an eight-year period through 2025. Therefore, all quantitative claims in the LLM answer lack support from the ground truth and cannot be verified as correct. (2) The calculations (e.g., $3.301B total for Amgen, $1.427B for Lilly, and the $1.9B difference) are mathematically accurate based on the provided numbers, but since the numbers themselves are not in the original answer, this precision is unfounded. There is no indication in the ground truth that these specific figures are correct, making the quantitative accuracy low. (3) The qualitative reasoning correctly identifies that both companies are making payments under the 2017 Tax Act over an eight-year period ending in 2025, which aligns with the multi-hop synthesis required. The structure of the comparison—Amgen vs. Eli Lilly, payment schedules, installment framework—is logically sound and contextually appropriate. However, the addition of unsupported specifics undermines the validity. (4) Contextual relevance is high because the answer addresses the core comparison between Amgen and Eli Lilly regarding repatriation tax payments under the 2017 Tax Act, correctly framing the regulatory context and timeline. However, the correctness score is low due to the invention of precise financial data not present in the ground truth, which risks misinformation despite structurally sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 466,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 186,
      "question": "How does the risk of biosimilar competition following loss of exclusivity for Amgen's biologics compare to Bristol Myers Squibb's exposure, given the differing regulatory pathways and product portfolios in the U.S. and EU?",
      "original_answer": "Amgen's reliance on biologics such as 'Erbitux, Cyramza, Trulicity, Taltz, and Emgality' is at risk due to the potential entry of biosimilars, which could occur after 12 years of regulatory data protection in the U.S. However, litigation and expedited review processes like IPR could weaken patent protection and accelerate biosimilar entry. Similarly, Bristol Myers Squibb faces biosimilar threats to its biologics including 'Opdivo, Yervoy, Orencia, Reblozyl, and Empliciti,' with regulatory data protection lasting 12 years in the U.S., but also faces earlier generic competition in the EU under the '8+2+1' regime, where biosimilars can enter after 8 years of data exclusivity. Both companies are exposed to rapid revenue declines upon loss of exclusivity, but the timing and competitive intensity differ based on regional regulatory frameworks and the complexity of biosimilar development.",
      "llm_answer": "Amgen notes that, for its biologics, loss of patent or data exclusivity “may or may not result in the near‑term entry of competitor versions (i.e., biosimilars) due to many factors, including development timelines, manufacturing challenges and uncertainties regarding the regulatory pathways” (Amgen 10‑K p. 25).  The U.S. biosimilar pathway adds further uncertainty – a biosimilar can be filed only after the innovator has been on the market for four years, but the FDA may not approve it until 12 years after the original biologic’s approval (Amgen 10‑K p. 9).  \n\nBristol‑Myers Squibb’s biologic portfolio is more heavily weighted toward products that are subject to the EU’s “8 + 2 + 1” data‑protection regime, where a biosimilar can be authorized after eight years and may launch as early as the 10‑ or 11‑year mark, and where patents are not listed with the regulator (BMS 10‑K p. 8‑9).  Because the EU treats biologics the same as chemically‑synthesized drugs for patent enforcement, BMS faces a higher likelihood of earlier biosimilar competition in both the U.S. (through the BPCIA/Paragraph IV process) and the EU.  \n\n**Thus, Amgen’s risk of biosimilar entry after loss of exclusivity is more uncertain and potentially delayed by the longer U.S. data‑protection period, whereas Bristol‑Myers Squibb is more exposed to relatively sooner biosimilar competition because its products fall under the shorter EU “8 + 2 + 1” regime and the U.S. biosimilar litigation framework.**",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the key regulatory frameworks (12-year U.S. data protection, EU '8+2+1' regime) and applies them appropriately to Amgen and Bristol Myers Squibb (BMS), noting that BMS faces earlier biosimilar competition in the EU due to the shorter exclusivity period. It accurately references the U.S. Biologics Price Competition and Innovation Act (BPCIA) pathway, including the 4-year filing and 12-year approval timelines, and highlights litigation risks such as Paragraph IV certifications. However, there are factual inaccuracies in the product portfolios: the LLM does not list any specific biologics for either company, whereas the ground truth specifies 'Erbitux, Cyramza, Trulicity, Taltz, Emgality' for Amgen and 'Opdivo, Yervoy, Orencia, Reblozyl, Empliciti' for BMS—this omission reduces completeness and entity accuracy. Additionally, 'Cyramza' and 'Trulicity' are not Amgen products (Cyramza is Lilly, Trulicity is Lilly), so the original ground truth contains errors too, but the LLM fails to correct or reflect accurate portfolios. The claim that the EU treats biologics the same as small molecules for patent enforcement is contextually reasonable but oversimplifies complex regional differences. The conclusion that BMS faces earlier competition due to EU exposure is logically sound and aligns with the ground truth. Quantitative elements (8+2+1, 12-year protection) are correct, though the LLM’s suggestion that biosimilars may launch at the 10- or 11-year mark in the EU is slightly imprecise—launch typically occurs at year 8+2=10, with possible 1-year market protection extension, so this is acceptable. The multi-hop reasoning across U.S. and EU regulatory systems and company-specific exposure is present and mostly sound. Overall, the answer captures the core comparative risk but lacks product-specific accuracy and has minor overgeneralizations in regulatory interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1612,
        "completion_tokens": 517,
        "total_tokens": 2129
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How does Medtronic's exposure to Medicaid reimbursement policies compare to AbbVie's pricing pressures under the IRA, particularly in relation to their respective product portfolios and revenue risks?",
      "original_answer": "Medtronic faces increased price sensitivity from Medicaid reimbursement limitations, which affects hospitals' purchasing behavior and creates a need for competitively priced medical devices. AbbVie, on the other hand, is directly impacted by the Inflation Reduction Act (IRA), which allows the U.S. Department of Health and Human Services to set government prices for certain drugs like Imbruvica (selected in 2023 for pricing starting in 2026) and Vraylar and Linzess (selected in 2025 for pricing starting in 2027), potentially accelerating revenue erosion before patent expiration. While both companies face healthcare cost-containment pressures, Medtronic’s Medicaid exposure affects device pricing strategies, whereas AbbVie must navigate IRA-driven government pricing that could apply to more high-revenue products in the future.",
      "llm_answer": "Medtronic’s revenue risk from Medicaid comes from the broad cost‑containment environment that limits how much Medicare and **Medicaid** will reimburse for its medical‑device and therapy procedures – a pressure that affects many of its products but does not impose a statutory price cap. By contrast, AbbVie is exposed to **direct pricing caps under the Inflation Reduction Act (IRA)**, which allow the government to set ceiling prices for single‑source drugs and biologics reimbursed under Medicare Part B/D (and also generate higher Medicaid rebates), creating a more acute risk of revenue erosion for its high‑priced pharmaceutical portfolio. Thus, Medtronic faces general reimbursement‑sensitivity across its device line, whereas AbbVie faces targeted, legislated price reductions that could substantially cut earnings from its flagship drugs. (See Medtronic discussion of Medicare/Medicaid cost‑containment [page 13] and AbbVie’s IRA pricing‑pressure description [page 19]).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Medtronic faces Medicaid reimbursement pressures affecting device pricing without statutory price caps, while AbbVie is subject to direct government-imposed pricing under the IRA. The LLM correctly identifies that AbbVie’s drugs (Imbruvica, Vraylar, Linzess) are subject to IRA pricing, though it does not explicitly name them—however, it accurately describes the mechanism and impact. (2) There are no numeric values, dates, or calculations in the LLM answer that conflict with the ground truth; it omits the specific years (2023, 2025, 2026, 2027) mentioned in the original answer but does not misstate any timeline. This omission prevents a perfect score but does not undermine correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies face cost-containment pressures but through different mechanisms—reimbursement sensitivity for Medtronic vs. legislated price setting for AbbVie—and links these to their respective product types (devices vs. pharmaceuticals). (4) The answer is contextually excellent, directly addressing the comparison of exposure, product portfolios, and revenue risks. The inclusion of document page references adds credibility. The only minor shortcoming is the lack of specific drug names and IRA selection/implementation years, which were in the original answer, but the conceptual accuracy remains high. Hence, a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 427,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How does the $2.7 billion in unfunded commitments to private equity funds held by UPS compare to General Dynamics' use of NAV for valuing its Level 1 plan assets, given both companies rely on NAV as a practical expedient for alternative investments?",
      "original_answer": "UPS reports $2.7 billion in unfunded commitments to private equity and similar funds as of December 31, 2024, with contributions expected over 3 to 6 years. These investments are valued using NAV as a practical expedient due to the lack of readily determinable fair value. Similarly, General Dynamics (GD) uses NAV for its Level 1 plan assets, which include commingled equity and fixed-income funds valued using a unit price or NAV. Both companies rely on NAV for valuation, but UPS's private equity commitments carry longer redemption restrictions (10–15 year terms), whereas GD's NAV-based assets are generally redeemable monthly or quarterly. This suggests UPS has a less liquid exposure to NAV-based investments compared to GD.",
      "llm_answer": "UPS reports that, as of December 31 2024, it has unfunded commitments to private‑equity, private‑debt and real‑estate limited‑partnership interests of roughly **$2.7 billion** that will be contributed over the next three‑to‑six years【page_93】.  \n\nGeneral Dynamics, by contrast, does not have a comparable unfunded‑commitment figure; instead it values certain pension‑plan investments (e.g., real‑estate, equity and hedge‑fund holdings) at their **net asset value (NAV) as a practical expedient**, which appears in the fair‑value tables as modest NAV‑based amounts (e.g., $421 million of real‑estate funds, $37 million of equity funds, $1 million of hedge funds) that are treated as Level 1 assets【page_94】.  \n\nThus, UPS’s $2.7 billion represents a future cash‑outflow commitment, whereas General Dynamics’ NAV approach is a valuation method applied to existing plan assets and involves far smaller dollar amounts.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the $2.7 billion unfunded commitment by UPS as of December 31, 2024, and accurately notes that these commitments are for private equity, private debt, and real estate limited partnerships to be funded over 3–6 years. It also correctly states that General Dynamics (GD) uses NAV as a practical expedient for valuing certain pension plan assets, citing specific NAV-based amounts ($421 million in real estate, $37 million in equity funds, $1 million in hedge funds) as Level 1 assets. These numbers align with the ground truth in magnitude and context, earning high marks for quantitative accuracy.\n\nHowever, the LLM answer misses a key comparative insight from the original answer: the difference in liquidity and redemption terms between the two companies’ NAV-based investments. While it correctly distinguishes UPS’s unfunded commitments (future cash outflows) from GD’s use of NAV for existing assets, it omits that UPS’s private equity investments have 10–15 year terms with long redemption restrictions, whereas GD’s NAV-based funds are generally redeemable monthly or quarterly. This omission weakens the qualitative accuracy and full synthesis of the multi-hop comparison, which hinges not just on valuation method and commitment type, but also on liquidity profiles.\n\nAdditionally, the LLM implies GD has no unfunded commitments, which may be true but isn’t explicitly confirmed in the ground truth; the original answer focuses on the contrast in liquidity, not the presence or absence of commitments. The contextual relevance is high because the response directly addresses the comparison between UPS and GD regarding NAV usage and funding nature. Overall, the answer is factually sound on numbers and basic reasoning but lacks the deeper comparative insight on liquidity and investment horizon, which is central to the original answer’s conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 510,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How does CMCSA's issuance of Class B Common Stock in 2024 influence its shareholder voting rights structure, and how does this compare to META's dual-class framework as disclosed in their respective filings?",
      "original_answer": "CMCSA issued 9,444,375 shares of Class B Common Stock in 2024, which, as per the governance structure outlined in V_10k_2024.pdf, carries no voting rights except in limited circumstances such as exiting the core payments business or specific merger scenarios. This creates a tiered voting rights system where Class A shareholders maintain full voting control. Similarly, META's filing reveals a dual-class structure with Class A and Class B common stock, where Class A stockholders have full voting rights while Class B stockholders generally do not, except in defined events like a merger. Both companies thus concentrate voting power among a subset of shareholders, reinforcing control while allowing for differentiated capital structures.",
      "llm_answer": "CMCSA’s 2024 Form 10‑K shows that the company issued 9.44 million shares of Class B common stock (see the equity table on page 67).  The Class B shares are a separate, non‑controlling class that does not carry the same voting power as the company’s Class A common stock, so the new issuance adds equity capital without materially changing the overall voting balance, which remains dominated by Class A shareholders.  \n\nMeta Platforms, by contrast, operates a classic dual‑class system: its charter creates a Class A common stock that carries one vote per share and a Class B common stock that carries ten votes per share, giving insiders and founders a disproportionate share of voting power (as disclosed in the summary of share classes on page 1).  Thus, while CMCSA’s new Class B shares dilute voting influence only marginally, Meta’s structure concentrates voting authority in the higher‑voted Class B shares.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partial factual accuracy but includes a critical error in describing META's dual-class structure, which severely undermines the comparison. (1) Quantitatively, the CMCSA share issuance figure is approximately correct (9.44 million vs. ground truth 9,444,375), with acceptable rounding. However, the description of META’s voting rights is factually incorrect: the ground truth states that META’s Class B shares have no voting rights except in defined events like a merger, whereas the LLM claims Class B has ten votes per share and Class A has one—this is the inverse of the actual structure and misrepresents the governance model. (2) The answer fails the multi-hop reasoning requirement by drawing an incorrect contrast: it suggests CMCSA’s Class B is non-voting (correct) while portraying META’s Class B as super-voting (incorrect), when in reality both companies have non-voting or limited-vote Class B shares. (3) Entity accuracy is otherwise acceptable—CMCSA, META, Class A/B distinctions, and filing sources are correctly referenced. (4) Contextual relevance is strong as the response addresses shareholder voting rights and capital structure impacts for both firms. However, due to the fundamental mischaracterization of META’s voting framework, the qualitative reasoning and overall correctness are significantly compromised, warranting a low-to-mid score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 383,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How might the IRA's Medicare price-setting provisions impact revenue erosion timelines for Amgen's products that rely on federal reimbursement, especially in light of AbbVie's experience with Imbruvica and Vraylar being selected for government pricing starting in 2026 and 2027?",
      "original_answer": "The IRA's Medicare price-setting provisions could accelerate revenue erosion for Amgen's products that depend on federal reimbursement by imposing government-determined prices as early as nine or thirteen years post-FDA approval, depending on whether the product is a small molecule or biologic. This mirrors AbbVie's experience where Imbruvica was selected for price setting in 2026 and Vraylar and Linzess in 2027, leading to potential revenue declines before patent expiration. Amgen, which also relies heavily on Medicare reimbursement, faces similar risk as these policies reduce pricing flexibility and increase downward pressure on profitability.",
      "llm_answer": "The IRA gives the government the authority to set a ceiling price for single‑source drugs paid under Medicare Part B or Part D as early as nine years after FDA approval, and those prices take effect in the first year a product is selected (the first 10 drugs in 2026, the next 15 in 2027). AbbVie’s disclosure notes that Imbruvica will be subject to a government‑set price beginning in 2026 and Vraylar in 2027, which will “accelerate revenue erosion prior to expiration of intellectual‑property protections.” Amgen faces the same risk – its Otezla was selected for Medicare price‑setting beginning January 1 2027, and the company warns that future IRA price‑negotiations could similarly compress the timing of revenue decline for any of its federally reimbursed products, moving erosion forward to the 2026‑2027 window rather than waiting until patent expiry.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates and timelines are correct: Imbruvica subject to pricing in 2026, Vraylar in 2027, and Otezla (Amgen) starting January 1, 2027—consistent with IRA's rollout (first 10 drugs in 2026, next 15 in 2027). The 9-year mark for small molecules and implied 13-year timeline for biologics are contextually supported, though the LLM emphasizes the 9-year threshold without explicitly distinguishing biologics, which is a minor omission. (2) The answer correctly identifies all relevant entities: Amgen, AbbVie, Imbruvica, Vraylar, and Otezla, with accurate linkage to pricing timelines. (3) Multi-hop reasoning is sound: it connects AbbVie’s experience to Amgen’s risk, correctly inferring that IRA provisions compress revenue erosion timelines before patent expiry. It adds value by naming Otezla as a specific Amgen product affected—information consistent with the knowledge graph and enhancing specificity beyond the original answer. (4) The only minor gap is that the original answer notes Linzess (also AbbVie) being selected in 2027, which the LLM omits; however, this does not detract from the core reasoning. The LLM also correctly cites Amgen’s own warning about future negotiations, demonstrating synthesis of forward-looking risk. Overall, the answer is factually robust, contextually precise, and semantically equivalent to the ground truth with slightly enhanced detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 405,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 190,
      "question": "How does the number of securities remaining available for future issuance under equity compensation plans approved by security holders at Colgate-Palmolive compare to the total remaining available securities disclosed by Procter & Gamble, based on their respective disclosures?",
      "original_answer": "Colgate-Palmolive reported 37,028,000 securities remaining available under equity compensation plans approved by security holders, while Procter & Gamble disclosed a total of 133,185,995 remaining available securities across both Stock Options/SARs and RSUs/PSUs under the same category of approved plans. This indicates PG has a significantly larger pool of available securities for future issuance compared to CL.",
      "llm_answer": "Colgate‑Palmolive reports that 37,028 thousand shares (≈ 37 million) remain available for future issuance under equity‑compensation plans that were approved by its security holders (Item 12, page 61).  \n\nProcter & Gamble discloses that 119 million shares are available for future issuance under its 2019 Stock and Incentive Compensation Plan, which is the only plan that permits new grants (Item 12, page 69).  \n\nThus, P&G’s pool of shares that can still be issued is roughly three times larger than Colgate‑Palmolive’s (119 million vs ≈ 37 million).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Colgate-Palmolive's available securities as 37,028,000 (rounded to 37 million), which matches the ground truth. However, it reports Procter & Gamble's total remaining available securities as 119 million, which is incorrect—the ground truth is 133,185,995 across Stock Options/SARs and RSUs/PSUs. This is a significant quantitative error. (2) The number for P&G is underreported by over 14 million shares. While the LLM cites the 2019 Stock and Incentive Compensation Plan, it fails to include all components of P&G’s available pool as disclosed in the knowledge graph, suggesting incomplete synthesis. The comparison stating P&G’s pool is 'roughly three times larger' is approximately correct in magnitude but based on an inaccurate input. (3) The multi-hop reasoning is partially sound—LLM correctly compares the two companies’ available securities under shareholder-approved plans—but fails to fully aggregate P&G’s total available securities as required. It appears to rely on a partial figure from one plan rather than the total disclosed. (4) Correctness score is 6 due to major quantitative inaccuracy on P&G’s number, though core structure and Colgate data are correct. Quantitative accuracy is 5 because one key number is wrong. Qualitative accuracy is 7—reasoning and entity identification are sound, but synthesis is incomplete. Contextual relevance is 9—answer directly addresses the question and compares both firms appropriately.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 410,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 190,
      "question": "How does the joint commercialization of BMY's biologics in Taiwan compare with MRK's strategic spin-off of its biosimilars business, given Taiwan's regulatory requirement for local clinical trial data for biologics registration?",
      "original_answer": "BMY jointly commercializes biologics like Opdivo and Yervoy in Taiwan with Ono, where BMS handles supply and both parties share development costs and profits. This suggests a collaborative, market-access-focused strategy in Taiwan, which requires local clinical trial data for biologics registration. In contrast, MRK spun off its biosimilars business into Organon, signaling a strategic retreat from the biosimilars segment, which faces increasing global competition and regulatory complexity, including in markets like Taiwan that require additional local data for registration. Thus, while BMY maintains a direct and collaborative presence in Taiwan's biologics market, MRK has opted to divest its biosimilars portfolio, potentially avoiding the added burden of meeting such regulatory requirements in markets requiring local trials.",
      "llm_answer": "Bristol‑Myers Squibb (BMY) is jointly developing and commercializing its checkpoint‑inhibitor biologics (Opdivo and Yervoy) in Taiwan through a partnership with Ono, sharing development, manufacturing and sales responsibilities in that market【page_86†L31-L38】. Merck, by contrast, removed its biosimilars from its core portfolio by spinning them off into the independent company Organon in 2021【page_3†L13-L16】, thereby avoiding the need to directly meet Taiwan’s requirement that biologics obtain local clinical‑trial data for registration—a requirement that applies in Taiwan and other Asia‑Pacific markets【page_22†L9-L13】.  Thus, BMY is actively pursuing a collaborative go‑to‑market strategy in Taiwan despite the local data hurdle, whereas Merck has chosen to separate its biosimilars business altogether.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: BMY's joint commercialization of Opdivo and Yervoy in Taiwan with Ono, including shared responsibilities and collaboration, is accurately described. MRK's spin-off of its biosimilars business into Organon in 2021 is correctly dated and contextualized. (2) There are no numeric inaccuracies—dates (2021) and business actions (spin-off) are correct. The regulatory requirement for local clinical trial data in Taiwan is properly cited and linked to both companies' strategies. (3) The multi-hop reasoning is sound: the model correctly contrasts BMY’s active, collaborative market-entry strategy in Taiwan with MRK’s strategic divestiture of biosimilars via Organon, and connects both to the regulatory burden of local clinical data. The implication that MRK avoids direct responsibility for meeting Taiwan’s requirements through the spin-off is logically valid. (4) Semantic equivalence is strong—while the LLM uses slightly different phrasing (e.g., 'removed its biosimilars from its core portfolio' vs. 'strategic retreat'), the meaning is consistent with the original. One minor point preventing a perfect 10 is that the LLM does not explicitly name BMS (Bristol-Myers Squibb) as handling supply, though it mentions shared manufacturing. Also, 'Merck' is used instead of 'MRK' consistently, but this is acceptable as it refers to the correct entity. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 420,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 191,
      "question": "How does AAPL's 2022 revenue contribution from Taiwan, as part of its Greater China segment, compare to ADBE's operational presence in the same region?",
      "original_answer": "AAPL reported $74,200 million in net sales for its Greater China segment in 2022, which includes Taiwan among other regions. ADBE maintains a local field office in Taiwan as part of its global operations, indicating a direct market presence. While AAPL's exposure to Taiwan is embedded within its broader Greater China revenue, ADBE's operational footprint in Taiwan suggests a more targeted geographic strategy in the region.",
      "llm_answer": "Apple does not disclose a separate Taiwan‑only sales number – its 2022 net sales for the “Greater China” segment (which groups mainland China, Hong Kong and Taiwan) total **$74.2 billion**【page_52】. Adobe, by contrast, only notes that it maintains a **local field office in Taiwan** as part of its worldwide sales network【page_15】, without providing any Taiwan‑specific revenue figure. Thus Apple’s Taiwan contribution is rolled into a $74 billion regional total, whereas Adobe’s presence in Taiwan is described only as an operational office, not a quantified revenue amount.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that Apple does not disclose Taiwan-specific revenue and that its $74.2 billion (or $74,200 million) in net sales for the Greater China segment in 2022 includes Taiwan, mainland China, and Hong Kong. This matches the ground truth exactly in both value and context. The number is accurately presented as $74.2 billion, equivalent to $74,200 million. (2) For ADBE, the LLM correctly notes the presence of a local field office in Taiwan without any disclosed revenue, aligning with the ground truth's assertion of ADBE's operational presence. (3) The multi-hop reasoning is sound: the model correctly synthesizes that AAPL’s exposure to Taiwan is embedded within a broader regional figure, while ADBE has a direct operational footprint but no quantified revenue—thus contrasting revenue-based exposure vs. operational presence. (4) The only minor shortcoming is that the LLM does not explicitly use the phrase 'more targeted geographic strategy' as in the original answer, but it effectively conveys the same qualitative distinction by contrasting Apple’s aggregated revenue reporting with Adobe’s named operational office. All entities (AAPL, ADBE, 2022, Taiwan, Greater China) and metrics are correct. Wording differs slightly but maintains semantic equivalence. Quantitative accuracy is perfect, including correct dollar amount and format variation acceptance ($74.2 billion = $74,200 million).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 397,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 191,
      "question": "How do CMCSA and META differ in terms of the voting control concentration between Class A and Class B common stockholders, and what implications does this have for shareholder influence in corporate governance decisions?",
      "original_answer": "CMCSA's Class A common stockholders hold 66 2/3% of the combined voting power, while Class B stockholders (led by Brian L. Roberts) hold 33 1/3%, with each Class B share carrying 15 votes. In contrast, META's Class B common stock, though not publicly traded, holds significant voting rights, but the specific voting power percentage is not disclosed. However, META's Class A shares are publicly traded under the ticker META, and as of December 31, 2023, there were only 23 stockholders of record for Class B shares, indicating concentrated control. This means CMCSA maintains a structured balance of voting power, while META's control is more opaque and concentrated among fewer Class B holders.",
      "llm_answer": "Comcast’s charter gives each Class A share one vote and each Class B share fifteen votes; the single Class B holder (Brian L. Roberts) controls roughly one‑third of the total voting power (≈33 % of votes) while the 320,000+ Class A record holders hold the remaining ≈67 %【page 33】. Meta’s charter also gives Class A shares one vote and Class B shares ten votes; with 2,211 million Class A shares and 350 million Class B shares, Class B shareholders command about 60 % of the voting power despite owning fewer shares【page 120】. Thus, in both companies a small group of insiders (the sole Comcast Class B holder and Meta’s limited Class B owners) wields disproportionate influence over director elections and other governance matters, limiting the effective voting power of the broader public Class A shareholder base.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding META's voting structure and percentages. The ground truth states that META's Class B voting power percentage is not disclosed, but the LLM claims Class B holds 'about 60%' of voting power based on share counts (2,211 million Class A and 350 million Class B) and a 10:1 vote ratio. This calculation is flawed: assuming 1 vote per Class A and 10 votes per Class B, Class B voting power would be (350M * 10) / [(350M * 10) + (2,211M * 1)] = 3.5B / (3.5B + 2.211B) = 3.5B / 5.711B ≈ 61.3%, which matches the LLM's number. However, the ground truth explicitly states this percentage is *not disclosed*, meaning the LLM fabricated or inferred data not present in the source. Additionally, the LLM claims META Class B shares have 10 votes each, but the ground truth does not specify the vote ratio. For CMCSA, the LLM correctly states that Class B (Brian L. Roberts) holds ~33% and Class A ~67%, aligning with the 33 1/3% and 66 2/3% in the original answer. However, it incorrectly states there is a 'single Class B holder'—while Roberts is the primary holder, the ground truth says 'led by Brian L. Roberts', implying others may hold Class B shares. (2) The quantitative accuracy is low due to unsupported calculations for META and incorrect specificity (e.g., '2,211 million' and '350 million' shares are not in the ground truth). (3) The multi-hop reasoning is partially sound—comparing dual-class structures and their governance implications—but fails because it invents precise numbers for META that are not in the source. (4) Contextual relevance is high as the answer addresses both companies, their stock classes, and governance implications. However, the correctness score is low due to major factual and quantitative errors, especially the unsupported 60% voting power claim for META, which contradicts the ground truth's statement that the percentage is undisclosed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 530,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 191,
      "question": "How do LLY and MRK benefit differently from pediatric exclusivity provisions in the U.S. and EU regulatory frameworks?",
      "original_answer": "LLY benefits from pediatric exclusivity in the U.S. by receiving an additional six months of exclusivity added to data protection, orphan drug exclusivity, or non-expired patents. MRK, on the other hand, benefits in the U.S. through an additional six months of market exclusivity added to Orange Book-listed patents and regulatory data exclusivity, and in the EU through an additional six months added to the Supplementary Protection Certificate (SPC) term. This difference in application highlights how the U.S. framework ties pediatric exclusivity to both patents and data protection, while the EU framework applies it only to the SPC term.",
      "llm_answer": "- **Eli Lilly (LLY)** – Its 2023 filing spells out that the U.S. Food‑and‑Drug‑Administration Modernization Act can grant an extra **six‑month “pediatric exclusivity” period that is tacked onto any Orange‑Book‑listed patents (or data‑exclusivity) for a drug that completes the required pediatric studies**.  The filing also notes that the **EU provides a parallel six‑month extension that is added to the product’s Supplementary Protection Certificate (SPC) term**.  \n\n- **Merck & Co. (MRK)** – In its 2023 filing the company points out that the **U.S. pediatric‑exclusivity provision adds six months of market exclusivity to the patent or data‑exclusivity life of a product that satisfies the FDA’s pediatric‑study requirements**, but it does **not cite a comparable EU‑specific pediatric extension**, indicating that Merck’s primary benefit from pediatric exclusivity is the U.S. six‑month add‑on.  \n\nThus, Lilly gains a six‑month boost in both the United States and the European Union, whereas Merck’s disclosed benefit is limited to the six‑month U.S. pediatric‑exclusivity extension.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the six-month pediatric exclusivity in the U.S. for both LLY and MRK, which aligns with the ground truth. It also correctly notes that the EU provides a six-month extension tied to the Supplementary Protection Certificate (SPC), and it accurately associates this with LLY. However, the LLM answer incorrectly states that Merck does not cite a comparable EU-specific pediatric extension and concludes that MRK’s benefit is limited to the U.S. This contradicts the ground truth, which explicitly states that MRK benefits in the EU through a six-month extension to the SPC term. This is a significant factual error in entity-specific application of regulatory provisions, undermining the multi-hop comparison. While the quantitative elements (six-month durations) are accurate, the reasoning fails in synthesizing MRK’s EU benefits, leading to an incorrect comparative conclusion. The answer is well-structured and contextually relevant but misses a key differentiator in the question: how each company benefits differently across U.S. and EU frameworks. The ground truth emphasizes that both companies benefit in the U.S., but only MRK is explicitly described as benefiting in the EU via SPC—whereas the LLM incorrectly limits MRK’s benefit to the U.S. and implies LLY benefits in both, creating a reversal of the correct distinction.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 378,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 192,
      "question": "How does the change in EMR's foreign currency liabilities from 2023 to 2024 compare with the scale of LMT's foreign currency hedge exposure, and what might this indicate about their respective foreign exchange risk management strategies?",
      "original_answer": "EMR's foreign currency liabilities decreased from $22 billion in 2023 to $20 billion in 2024, a $2 billion reduction, while LMT maintained $7.5 billion in outstanding foreign currency hedges at the end of 2024. This indicates that LMT is proactively hedging a significant portion of its foreign exchange exposure, whereas EMR appears to be reducing its overall foreign currency liability position rather than necessarily increasing hedging activity. The use of option contracts by LMT suggests a strategy focused on offsetting earnings volatility from exchange rate fluctuations, while EMR's declining liabilities may reflect either reduced international operations or a shift in risk management approach.",
      "llm_answer": "Emerson’s foreign‑currency liabilities fell only modestly – the liability balance reported for its foreign‑currency contracts dropped from $22 million in 2023 to $20 million in 2024 (a $2 million decrease). Lockheed Martin, by contrast, maintains a far larger hedge program – its net foreign‑exchange cash‑flow hedges total about $9.9 billion of notional amount (up from $8.3 billion in 2023). The tiny change in Emerson’s liability versus Lockheed Martin’s multi‑billion‑dollar hedge exposure suggests Emerson’s FX risk is relatively limited and managed with small‑scale adjustments, while Lockheed Martin relies on a massive, actively managed hedge program to mitigate a much larger foreign‑exchange exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in scale and magnitude. It incorrectly reports EMR's foreign currency liabilities as $22 million and $20 million in 2023 and 2024 respectively, whereas the ground truth states $22 billion and $20 billion — a 1,000-fold difference. Similarly, it reports LMT's hedge exposure as $9.9 billion, which does not match the ground truth value of $7.5 billion. These quantitative inaccuracies severely undermine the answer's correctness. (2) Calculations are internally consistent (e.g., $22M to $20M is a $2M decrease), but based on wrong base figures. The LMT hedge increase from $8.3B to $9.9B is not supported by the original answer, which only states LMT had $7.5B in hedges at end-2024 with no prior year comparison. (3) The multi-hop reasoning is partially sound — the model attempts to compare EMR's liability reduction with LMT's hedge program and infer different risk management strategies — but the flawed data leads to incorrect conclusions. The original answer emphasizes EMR reducing liabilities vs. LMT actively hedging; the LLM misrepresents EMR's position as 'small-scale adjustments' due to the million-vs-billion error, fundamentally distorting the interpretation. (4) Contextual relevance is moderate: the structure addresses the comparison and strategic implication, but the severe numerical errors and incorrect entity metrics (especially magnitude) result in a misleading analysis. While the direction of reasoning (comparing liability changes to hedge programs) is appropriate, the factual foundation is unsound, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 444,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 192,
      "question": "How does the $3.6 billion in dividends paid by AENB to AXP in 2023 relate to the leverage ratio requirements that both AENB and WFC are subject to under federal banking regulations?",
      "original_answer": "The $3.6 billion in dividends paid by AENB to AXP in 2023 is directly tied to AENB's compliance with leverage ratio requirements, as AENB must consider the impact of such distributions on its regulatory capital ratios. AENB, as a subsidiary bank of AXP, is subject to federal banking regulations that restrict dividend payments if they would cause the bank to fall short of required leverage ratios. Similarly, WFC, as a large bank holding company, is also subject to leverage and supplementary leverage ratio requirements under Basel III and FRB rules, which constrain its ability to make capital distributions like dividends. Therefore, both AENB and WFC must ensure that any dividend payments comply with these leverage constraints, making the $3.6 billion distribution by AENB a function of its ability to maintain required capital levels under the same type of regulatory framework that governs WFC.",
      "llm_answer": "The $3.6 billion dividend that American Express National Bank (AENB) paid to its parent in 2023 had to be funded from retained earnings **without causing AENB’s Tier 1 leverage ratio to fall below the regulatory minimum of 9.5 %** (the bank’s reported Tier 1 leverage ratio for 2023)【page_66】.  Federal banking regulators impose the same leverage‑ratio floor on Wells Fargo (WFC), which must also stay above its required leverage and supplementary‑leverage ratios as part of the Basel III capital framework【page_4】.  Consequently, the dividend is permissible only because both AENB and WFC remain in compliance with their respective leverage‑ratio requirements; a dividend that would breach those ratios would be prohibited.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and percentages are correct: the $3.6 billion dividend amount and the 9.5% Tier 1 leverage ratio are accurately reported, with proper contextualization. The year 2023 is correctly referenced. (2) The entity identification is accurate—AENB, AXP, and WFC are correctly named and their regulatory contexts properly described. (3) The reasoning is sound and reflects multi-hop synthesis: the answer connects AENB’s dividend payment to its leverage ratio requirement, notes the regulatory constraint, and draws a valid parallel to WFC’s obligations under Basel III and federal rules. The citation of a 9.5% minimum leverage ratio (from page 66) adds precision not explicitly in the original answer but consistent with it, as the original refers to 'regulatory minimums' without specifying the number. This additional detail strengthens the response. (4) The only minor shortcoming is that the original answer emphasizes the structural similarity in regulatory frameworks governing both AENB and WFC more broadly, while the LLM focuses more narrowly on the leverage ratio floor. However, the core logic—that both banks must comply with leverage ratio requirements that constrain dividends—is fully preserved. The LLM answer is semantically equivalent and factually superior in specificity. Thus, the correctness score is 9 due to slightly narrower scope in framing, but quantitative accuracy is perfect, qualitative reasoning is strong, and relevance is complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 427,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 193,
      "question": "How does the geographic distribution of Microsoft's pre-tax income ($62.9B U.S. and $44.9B foreign in fiscal 2024) influence its exposure to the OECD's Pillar Two Model Rules, and how does this compare to Qualcomm's expected impact under the same Global Minimum Tax framework given their similar fiscal year 2025 implementation timeline?",
      "original_answer": "Microsoft's geographic distribution of pre-tax income shows significantly higher earnings in the U.S. ($62.9B) compared to foreign jurisdictions ($44.9B), which may reduce its exposure to the Pillar Two Model Rules since these rules target multinational enterprises with operations in low-tax jurisdictions. Microsoft notes it does not expect a material impact from Pillar Two. Similarly, Qualcomm acknowledges the global minimum tax framework will apply to them starting in fiscal 2025 and also states they do not expect a material impact on their financial statements, suggesting both companies anticipate minimal disruption from the same regulatory framework.",
      "llm_answer": "Microsoft’s FY 2024 pre‑tax earnings were $62.9 billion from U.S. operations and $44.9 billion from foreign operations (about 58 % U.S.‑derived and 42 % foreign).  Because the bulk of its foreign income is earned in jurisdictions with tax rates at or above the OECD Pillar‑Two floor (e.g., Ireland) and the company has “no material operations in jurisdictions with tax rates lower than the Pillar Two minimum,” it expects the Pillar‑Two rules – which will begin to apply to Microsoft in FY 2025 – to have no material impact on its consolidated tax expense.\n\nQualcomm likewise will be subject to the Pillar‑Two global minimum tax when it becomes effective in its FY 2025, but the filing excerpts do not quantify its geographic earnings split or project a specific tax impact.  The company notes that it is monitoring the rules, and, in the absence of disclosed low‑tax‑jurisdiction earnings, it similarly does not anticipate a material increase in its global tax cost, although any difference in exposure would depend on how much of Qualcomm’s earnings are generated in jurisdictions whose statutory rates fall below the 15 % floor.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All numeric values are correct: Microsoft's U.S. pre-tax income ($62.9B) and foreign income ($44.9B) are accurately reported, and the 58%/42% split is a correct calculation (62.9 / (62.9 + 44.9) ≈ 58.3%). The fiscal year 2025 implementation timeline for Pillar Two is correctly noted for both Microsoft and Qualcomm. (2) The answer correctly identifies that Microsoft expects no material impact due to lack of operations in low-tax jurisdictions, consistent with the original answer. It also correctly states Qualcomm’s expectation of no material impact, though with appropriate caution due to lack of disclosed geographic earnings—this nuance is fairly represented. (3) Multi-hop reasoning is sound: the model synthesizes Microsoft’s income distribution, Pillar Two applicability, and its impact assessment, then compares it to Qualcomm’s situation under the same framework. The only minor shortcoming is that the LLM adds detail not in the original (e.g., mention of Ireland), which, while plausible, is not confirmed in the ground truth and slightly exceeds the provided information. However, this does not introduce inaccuracy. (4) The answer is contextually complete and relevant, addressing both companies, the Pillar Two framework, geographic income implications, and comparative impact. Overall, the response is factually correct, well-reasoned, and semantically equivalent to the ground truth with only minor extrapolation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 413,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 193,
      "question": "How does WMT's $37.2 billion in unrecorded purchase obligations expose the company to financial risks that aren't captured by the VAR models used by peers like MDLZ?",
      "original_answer": "WMT has $37.2 billion in unrecorded purchase obligations as of January 31, 2025, which includes firm commitments for inventory, utility purchases, and capital expenditures. These obligations are legally binding but are not reflected on the balance sheet. However, according to DIS's 10-K filing, VAR models — like the one used by MDLZ — exclude forecasted transactions and firm commitments when estimating financial risk exposure. MDLZ's VAR model specifically uses a parametric delta-gamma approximation technique based on interest rate, currency, and commodity price movements to estimate potential one-day losses, but does not include firm commitments in its calculations. This means that while WMT has significant off-balance sheet obligations, companies using VAR models like MDLZ do not incorporate these types of commitments into their risk assessments, leaving WMT potentially more exposed to market volatility that isn't captured through standard VAR modeling practices.",
      "llm_answer": "Walmart discloses that it has **$37.2 billion of unrecorded purchase obligations** (‑ $15.9 billion due within the next year) that consist of firm‑commitments for inventory, capital‑expenditure, software, licenses and services 【page_45】.  These contracts create cash‑flow, commodity‑price, currency‑ and supply‑chain risks that must be met regardless of market movements, but the **VAR models used by peers such as Mondelēz explicitly exclude “anticipated transactions, currency trade payables and receivables, and net investments … that the instruments are intended to hedge”** 【page_65】 and are built only on the historical volatility of hedged derivatives 【page_60】【page_66】.  Consequently, Walmart’s large, off‑balance‑sheet purchase commitments expose it to liquidity and price‑risk shocks that are not reflected in the VAR‑based market‑risk metrics that MDLZ relies on.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $37.2 billion unrecorded purchase obligations are correctly stated, and while the LLM adds a detail about $15.9 billion due within the next year (not in the original answer), this does not contradict the ground truth and may reflect additional context from the source (page_45). No calculation errors are present. (2) The entities are correct: WMT (Walmart), MDLZ (Mondelēz), and the reference to DIS’s 10-K in the original is implicitly supported by the LLM’s citation of VAR model exclusions, even though DIS is not explicitly named — however, the core point that MDLZ’s VAR model excludes firm commitments is accurately conveyed. (3) The multi-hop reasoning is sound: the LLM correctly links WMT’s off-balance-sheet obligations to the limitations of VAR models used by peers like MDLZ, citing that such models exclude anticipated transactions and firm commitments (page_65), which matches the original’s logic. (4) The LLM enhances the answer with slightly more detail (e.g., software, licenses, services; specific risk types like supply-chain and currency risks), but the core message — that WMT’s exposure is not captured by VAR models — is preserved and semantically equivalent. The only minor gap is the omission of DIS as the source of the VAR model limitation, but since MDLZ’s model characteristics are correctly described, this does not undermine the conclusion. Thus, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 423,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 193,
      "question": "How does UNH's use of interest rate swaps to manage exposure to floating-rate liabilities compare with AMGN's use of similar instruments in relation to their respective $1.4 billion repayments of the 3.625% 2024 Notes?",
      "original_answer": "UNH uses interest rate swaps as part of its broader strategy to manage exposure to market interest rate fluctuations on both assets and liabilities, including $27 billion of floating-rate financial liabilities as of December 31, 2024. AMGN, on the other hand, specifically entered into interest rate swap contracts to convert fixed-rate coupons to floating-rate SOFR-based coupons, with $1.4 billion of such swaps maturing in 2024 in connection with the repayment of the 3.625% 2024 Notes. While both companies use interest rate swaps, UNH's application is broader in scope across its balance sheet, whereas AMGN's use is directly tied to specific debt instruments like the 3.625% 2024 Notes that were fully repaid in 2024.",
      "llm_answer": "Amgen’s 10‑K shows that the $1.4 billion of 3.625 % 2024 notes were fully hedged with interest‑rate‑swap contracts; the swaps (with a total notional of $1.4 billion) converted the fixed‑rate coupons to SOFR‑based floating rates and were terminated when the notes were repaid in 2024. UnitedHealth, by contrast, describes its swaps only in general terms – it uses interest‑rate swaps to match a portion of its $27 billion of floating‑rate liabilities with floating‑rate assets, but it does not tie any specific swap program to a $1.4 billion note repayment. Thus, Amgen’s swaps were directly linked to and unwinded with the 3.625 % note repayment, whereas UnitedHealth’s swaps are employed more broadly for overall floating‑rate exposure management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: $1.4 billion notional amount, $27 billion floating-rate liabilities for UNH, 3.625% 2024 Notes, and SOFR-based floating rates. Dates (2024 repayment and swap termination) are correctly stated. (2) The answer addresses all parts of the multi-hop question: it compares UNH’s and AMGN’s use of interest rate swaps in relation to the $1.4 billion 3.625% 2024 Notes repayment. It correctly notes that AMGN specifically hedged these notes with $1.4 billion in swaps that were terminated upon repayment, while UNH uses swaps broadly for managing floating-rate exposure without tying them to a specific $1.4 billion note repayment. (3) Entity accuracy is strong: correct company names (UnitedHealth/UNH, Amgen/AMGN), correct debt instrument (3.625% 2024 Notes), correct benchmark (SOFR), and correct financial terms (notional amount, hedging, floating-rate liabilities). (4) Reasoning is sound: the LLM correctly synthesizes that AMGN’s use is direct and transaction-specific, whereas UNH’s is part of a broader asset-liability matching strategy. The only minor shortcoming is that the LLM does not explicitly state that UNH’s floating-rate liabilities are $27 billion *as of December 31, 2024*—though the figure is correctly attributed. This slight omission in temporal precision prevents a perfect 10, but overall the answer is factually correct, well-reasoned, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 412,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 194,
      "question": "How does the potential acceleration of AMD's 3.924% Senior Notes Due 2032 in the event of an 'Event of Default' compare with Oracle's exposure to similar default-triggered obligations under their Revolving Credit Agreement, particularly in terms of debt repayment structure and maturity conditions?",
      "original_answer": "AMD's 3.924% Senior Notes Due 2032 could be accelerated upon an Event of Default, which would require AMD to repay $1.0 billion in aggregate principal issued in 2022, plus accrued interest. Oracle, under its Revolving Credit Agreement, also faces potential acceleration if an Event of Default occurs, with the full $6.0 billion facility becoming due unless terminated earlier. Unlike AMD's notes, which are unsecured senior obligations, Oracle's Revolving Facility allows borrowing, prepayment, and reborrowing until March 8, 2027, with interest rates tied to credit ratings. Both companies face significant financial obligations upon default, but Oracle's structure allows more flexibility in managing short-term liquidity.",
      "llm_answer": "AMD’s 3.924 % senior notes are unsecured, long‑term obligations that mature on March 1 2032, but the indenture provides that an “Event of Default” will accelerate the notes, requiring the company to repay the entire principal amount (plus accrued and unpaid interest) immediately. Oracle’s unsecured $6 billion revolving credit facility, by contrast, has a scheduled maturity of March 8 2027 for all borrowings, and the agreement states that if an event of default occurs the lenders may terminate the facility and accelerate the outstanding balance, making the whole loan due at once (or on the termination date). Thus, both instruments contain default‑triggered acceleration, but AMD’s acceleration applies to a fixed‑date senior‑note series, whereas Oracle’s applies to a revolving line that is otherwise due on a later, facility‑wide maturity date.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: AMD's 3.924% Senior Notes Due 2032 can be accelerated upon an Event of Default, requiring repayment of the $1.0 billion principal (issued in 2022) plus interest; Oracle's $6.0 billion Revolving Credit Facility matures on March 8, 2027, and can also be accelerated upon default. These numbers, dates, and dollar amounts are all correctly stated, with only minor formatting differences (e.g., 'March 1 2032' vs implied March 1, 2032 from 'Due 2032' in original). (2) Quantitative accuracy is perfect: $1.0 billion for AMD, $6.0 billion for Oracle, correct maturity dates (March 1, 2032 vs March 8, 2027), and correct interest treatment. (3) The multi-hop reasoning is sound: the model correctly compares two different debt instruments across companies, identifying both the commonality (acceleration upon default) and key structural differences (fixed-term notes vs revolving facility with reborrowing). (4) The only minor omission is that the original answer notes Oracle's interest rates are tied to credit ratings and that the facility allows prepayment and reborrowing—details not included in the LLM response. However, the core comparison on repayment structure and maturity conditions is accurately conveyed. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9 for correctness and qualitative accuracy due to this slight incompleteness, but full marks for quantitative and contextual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 418,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 195,
      "question": "How does the $31.0 billion of trust assets under reinsurance agreements at GE, which are subject to strict investment guidelines, compare to General Dynamics' $191 million in marketable securities held in trust as of December 31, 2021, in terms of investment policy and risk exposure?",
      "original_answer": "GE holds $31.0 billion in trust assets associated with reinsurance contracts and is subject to strict investment guidelines that include limitations on asset class concentration, issuer exposure, and duration variances, with a focus on diversification and credit quality while considering risk-based capital requirements. These trust assets are managed to support insurance liabilities and are reviewed periodically for asset allocation changes, including the potential inclusion of non-traditional asset classes. In contrast, General Dynamics held $191 million in marketable securities in trust as of December 31, 2021, governed by an investment policy that restricts purchases to investment-grade fixed-income securities with a maximum maturity of five years, indicating a more conservative and short-duration approach. This highlights a significant difference in scale and investment strategy between the two companies' trust asset management, with GE facing broader credit, interest rate, and reinvestment risks due to the larger and more diverse asset base.",
      "llm_answer": "GE’s run‑off insurance trusts hold about **$31 billion** of assets that are kept by an independent trustee and must be invested under **strict, contract‑specified guidelines** – limits on asset‑class concentration, single‑issuer exposure, duration matching, credit quality, liquidity and diversification, exposing the portfolio to credit, interest‑rate and even equity risk【page_50】.  \n\nGeneral Dynamics, by contrast, holds only **$191 million** of marketable securities in trust, which are limited to **investment‑grade fixed‑income securities with maturities of five years or less** and are used solely to meet workers‑compensation and pension obligations, resulting in a much narrower, lower‑risk investment policy【page_52】.  \n\nThus, GE’s trust assets are orders of magnitude larger and subject to a broader, more complex set of investment constraints and market risks, whereas GD’s trust holdings are modest in size and confined to a conservative, short‑term fixed‑income policy with limited risk exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: GE's $31.0 billion in trust assets under reinsurance agreements and General Dynamics' $191 million in marketable securities in trust as of December 31, 2021. The numbers are accurate and properly formatted ($31 billion = $31.0 billion; $191 million matches exactly). (2) Quantitative accuracy is perfect—both dollar amounts and time reference (implied 2021 via source page context) are correct. No calculations were required, but the comparison in scale (orders of magnitude) is appropriately emphasized. (3) The multi-hop reasoning is sound: the model correctly synthesizes investment policies across two different companies from distinct contexts—GE’s broader, diversified, and more complex reinsurance-related trust assets with exposure to credit, interest rate, and equity risk, versus GD’s narrow, conservative fixed-income policy limited to investment-grade securities with 5-year maturities. The LLM captures the core contrast in risk exposure and policy stringency. (4) Minor deduction in qualitative accuracy because the original answer includes additional nuance about GE’s periodic review for asset allocation changes and consideration of non-traditional asset classes, which the LLM omits. However, the essential elements—strict guidelines, diversification, credit quality, duration, and risk types—are all present. Contextual relevance is full, as the response directly compares investment policy and risk exposure as asked. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only minor detail omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1552,
        "completion_tokens": 449,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 195,
      "question": "How do the observable market data inputs used in Lockheed Martin's fixed income pricing models compare to the inputs used in PayPal's derivative valuations, given both institutions rely on Level 2 pricing methodologies?",
      "original_answer": "Lockheed Martin's fixed income investments categorized as Level 2 are valued using pricing models that incorporate verifiable observable market data such as interest rates, yield curves at commonly quoted intervals, and credit spreads. Similarly, PayPal values a majority of its derivative instruments using pricing models that consider observable inputs like currency rates, interest rate yield curves, option volatility, and equity prices. Both institutions rely on Level 2 methodologies, indicating a shared dependence on observable market factors to determine fair value, although applied to different asset classes—fixed income for Lockheed Martin and derivatives for PayPal.",
      "llm_answer": "Lockheed Martin’s Level‑2 fixed‑income valuations are built on observable market data such as prevailing interest rates, yield‑curve points, credit spreads and broker‑dealer bids or quoted prices of comparable securities. PayPal’s Level‑2 derivative valuations also use observable inputs, but they rely on currency exchange rates, interest‑rate yield curves together with option‑volatility measures and equity prices. Thus, while both firms depend on market‑observable data, Lockheed Martin’s models focus on fixed‑income‑specific inputs (rates, curves and spreads), whereas PayPal’s models incorporate a broader set that includes FX rates, equity prices and option volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: Lockheed Martin uses observable inputs like interest rates, yield curves, credit spreads, and broker-dealer bids or comparable securities (consistent with 'verifiable observable market data' in the original). PayPal uses currency rates, interest rate yield curves, option volatility, and equity prices—exactly matching the original. There are no numeric values to verify, so quantitative accuracy is perfect by default. (2) The answer is complete, addressing both companies, their respective asset classes (fixed income vs. derivatives), and the nature of Level 2 inputs. It correctly identifies that both use Level 2 methodologies based on observable data but applied to different financial instruments. (3) Entity accuracy is strong: company names, asset types, and valuation levels are correct. (4) The reasoning is sound and reflects proper multi-hop synthesis across the two firms and their distinct yet comparable valuation approaches. The only minor difference from the original is the inclusion of 'broker-dealer bids or quoted prices of comparable securities' in the LLM answer, which is not explicitly mentioned in the ground truth but is consistent with Level 2 pricing practices and does not contradict the original. This addition enhances completeness without introducing error. Thus, the answer earns a 9/10 for correctness and qualitative accuracy due to slight over-elaboration without factual deviation, while maintaining full quantitative and contextual fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 435,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 196,
      "question": "How does the sensitivity of AVGO's fixed rate senior notes to interest rate changes compare to the impact of CSCO's interest rate swap on their fixed-rate debt, given both companies' exposure to market interest rate fluctuations?",
      "original_answer": "AVGO's $56.3 billion in fixed rate senior notes as of November 3, 2024, would see a $1.7 billion change in fair value with a 50 basis point interest rate shift, while CSCO has an interest rate swap with a notional amount of $0.5 billion that converts a portion of its fixed-rate debt to floating, offsetting changes in fair value due to interest rate movements. CSCO’s swap specifically hedges a senior note due in fiscal 2025, whereas AVGO uses treasury rate lock contracts to hedge anticipated future debt issuances, indicating differing hedging strategies despite both managing interest rate risk on fixed-rate debt.",
      "llm_answer": "Broadcom’s (AVGO) fixed‑rate senior notes are quite sensitive to market rates – a 50‑basis‑point move up or down would alter the fair value of the notes by roughly $1.7 billion (and $1.4 billion for the prior‑year balance). Cisco (CSCO), by contrast, has entered into an interest‑rate swap that converts the fixed‑rate interest on the hedged portion of its senior notes to a floating rate, and the swap’s gain or loss “substantially offsets” the change in the notes’ fair value, effectively neutralizing the interest‑rate impact on that debt.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core comparison between AVGO and CSCO regarding interest rate sensitivity and hedging strategies. (1) Quantitatively, it correctly states that a 50-basis-point interest rate shift would change the fair value of AVGO's fixed-rate senior notes by $1.7 billion, matching the ground truth. However, it adds a detail not present in the original answer — a $1.4 billion impact for the 'prior-year balance' — which, while plausible, is not supported by the provided ground truth and introduces unverified information. CSCO's $0.5 billion notional swap is not explicitly quantified in the LLM answer, though the qualitative effect ('substantially offsets') is accurately described. (2) The entity names (AVGO, CSCO), financial instruments (fixed-rate senior notes, interest rate swap), and hedging outcomes are correctly identified. The fiscal 2025 maturity of CSCO's hedged note and AVGO's use of treasury rate locks for future issuances are omitted, reducing completeness. (3) The reasoning is sound: the LLM correctly infers that CSCO’s swap mitigates interest rate risk by converting fixed to floating rates, thereby offsetting fair value changes, while AVGO’s debt remains exposed, with value changes quantified. The synthesis across both companies’ strategies is logical and responsive to the comparative question. (4) The answer is contextually relevant and directly addresses the question’s focus on sensitivity and hedging impact. The omission of specific hedged debt maturities and AVGO’s treasury lock usage slightly weakens completeness, but the core multi-hop comparison — quantitative exposure vs. hedging effectiveness — is preserved. Minor deductions in quantitative and qualitative accuracy due to extraneous and missing details, but overall factual correctness is high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 493,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 196,
      "question": "How does BMY's joint research and commercialization obligations with Pfizer under the Eliquis alliance compare to Pfizer's financial commitments in its collaboration with Beam for in vivo base editing programs, particularly in terms of upfront payments and potential milestone obligations?",
      "original_answer": "BMY and Pfizer share joint research and commercialization responsibilities under the Eliquis alliance, with Pfizer receiving co-exclusive license rights in exchange for an upfront payment and potential milestone payments, which are being amortized over BMY’s co-promotion obligation period. Separately, Pfizer paid Beam $300 million upfront upon entering their collaboration for in vivo base editing programs and may pay up to an additional $1.05 billion in development, regulatory, and commercial milestone payments across three targets, for a total potential deal value of $1.35 billion. This shows that Pfizer’s financial commitment to Beam could significantly exceed its initial payments under the Eliquis alliance, depending on development progress and milestone achievements.",
      "llm_answer": "BMS’s Eliquis alliance with Pfizer does not involve a disclosed cash‑up‑front payment; Pfizer’s role is to fund roughly 50‑60 % of development costs and share profits and losses equally, with any milestone or sales‑based fees being unquantified in the filing. In contrast, Pfizer’s collaboration with Beam includes a defined $300 million upfront payment to Beam and, if all three target programs are exercised, up to $1.05 billion in additional development, regulatory and commercial milestone payments (total potential consideration of $1.35 billion).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the key financial figures in the Pfizer-Beam collaboration: a $300 million upfront payment and up to $1.05 billion in potential milestone payments, totaling $1.35 billion. These numbers match the ground truth exactly and are presented with acceptable formatting. However, the LLM incorrectly states that there was no disclosed upfront cash payment in the BMY-Pfizer Eliquis alliance, whereas the ground truth confirms that Pfizer *did* make an upfront payment (though it is being amortized over time). This omission or misrepresentation of a key fact in the multi-hop comparison reduces quantitative and qualitative accuracy. The LLM also introduces new details not in the ground truth—such as Pfizer funding '50–60%' of development costs and equal profit/loss sharing—which, while potentially accurate, are not supported by the provided ground truth and thus introduce unverified information. The reasoning is partially sound: it contrasts the defined, high-value commitment to Beam with the less transparent Eliquis arrangement, which aligns with the ground truth’s conclusion about potentially greater financial exposure to Beam. However, because the LLM mischaracterizes the Eliquis upfront payment and adds unsupported specifics, the multi-hop synthesis is weakened. Contextual relevance is strong—the response directly addresses the comparison of financial commitments in both collaborations as asked. Overall, the core Beam numbers are correct and the directional insight (Pfizer’s larger potential commitment to Beam) is preserved, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 440,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How do Texas Instruments' accounting practices for lease extension and termination options compare with Cisco's treatment of similar provisions in their customer financing arrangements, particularly regarding the impact on long-term liabilities and revenue recognition?",
      "original_answer": "Texas Instruments accounts for lease extension and termination options by recognizing lease assets and liabilities based on the present value of lease payments when it is reasonably certain they will be exercised, using their incremental borrowing rate. This affects long-term liabilities on their balance sheet. Cisco, on the other hand, includes similar extension and termination provisions in its customer financing arrangements, which are primarily collateralized and affect the timing of revenue recognition. Cisco also defers revenue on arrangements involving guarantees until the risk is removed. Both companies incorporate these options into their financial reporting, but with different implications: TXN affects liability valuation, while CSCO affects revenue timing and credit exposure.",
      "llm_answer": "Texas Instruments records lease extensions and termination options as part of the lease term only when it is “reasonably certain” the options will be exercised; the present‑value of the extended payments is added to the lease liability and the right‑of‑use asset, and the related expense is recognised on a straight‑line basis with no separate revenue‑deferral. Cisco, on the other hand, treats similar extension/termination provisions inside its customer‑financing leases as financing receivables – interest income is recognised over the lease period and any unearned income or guarantee exposure is recorded as a liability (or deferred revenue) that is released to revenue only when the service is performed or the guarantee is removed. Thus, TI’s approach mainly adjusts long‑term lease liabilities without affecting revenue, whereas Cisco’s approach creates long‑term financing receivables and a deferred‑revenue liability that directly impacts revenue recognition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Texas Instruments (TXN) includes lease extension/termination options in lease liabilities only when 'reasonably certain' they will be exercised, using present value of payments, impacting long-term liabilities but not revenue recognition. Cisco (CSCO) treats similar provisions in customer financing arrangements as financing receivables, recognizing interest income over time and deferring revenue related to guarantees until risk is removed. These points match the original answer in substance. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but all qualitative financial treatments are correctly described. (3) The multi-hop reasoning is sound: the model correctly synthesizes differences in accounting practices between two companies (TXN vs CSCO), links them to correct financial statement impacts (liabilities vs revenue recognition), and distinguishes between lease accounting (TXN) and customer financing arrangements (CSCO). (4) Minor deduction in qualitative accuracy due to slightly more detailed mention in the original about collateralization and credit exposure, which the LLM omits but does not contradict. However, the core contrast—TXN affecting liabilities, CSCO affecting revenue timing and deferral—is clearly and correctly conveyed. Wording differs but semantic equivalence is strong. No irrelevant or incorrect information is present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 429,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How does Disney's 73% stake in National Geographic influence the content differentiation strategy on Disney+, and what implications does this have for subscriber acquisition costs relative to YouTube's content licensing model?",
      "original_answer": "Disney's 73% stake in National Geographic allows it to integrate National Geographic-branded programming directly into Disney+ as a top-level tile within the interface, providing exclusive access to content that is not subject to third-party licensing fees (chunk 1 and chunk 2). This vertical integration reduces dependency on external content providers and lowers long-term content acquisition costs. In contrast, YouTube, as a digital video service competitor, relies more heavily on licensed and third-party content, which may involve ongoing licensing expenditures (chunk 3). This structural advantage could give Disney+ a cost edge in subscriber acquisition by leveraging proprietary content like National Geographic to attract and retain users at a lower marginal cost than YouTube.",
      "llm_answer": "Disney’s 73 % ownership of the National Geographic brand gives it direct control over that library, so National Geographic shows up as a top‑level “tile” on Disney+ (see DIS 10‑K p.12) and is counted as part of the company’s own domestic cable network portfolio (see DIS 10‑K p.78).  By pulling that premium nonfiction content in‑house rather than paying a third‑party licence, Disney can differentiate Disney+ with exclusive Nat Geo titles while keeping the cost of acquiring those titles low; the 2022 filing even notes that the company terminates external licences to shift content to its DTC services (DIS 10‑K p.81).  In contrast, YouTube’s video platform relies on licensing agreements with external owners for much of its premium inventory (Google 10‑K p.8‑9), meaning its subscriber‑acquisition cost structure includes those licence fees, making Disney’s owned‑content approach comparatively cheaper.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Disney's 73% stake in National Geographic, the use of Nat Geo as a top-level tile on Disney+, the cost advantage from avoiding third-party licensing, and the contrast with YouTube's reliance on licensed content are all accurately represented. The answer cites specific page numbers from the Disney (DIS) and Google (YouTube's parent) 10-K filings, enhancing credibility. (2) Quantitative accuracy is perfect: the 73% ownership stake is correctly stated, and no other numerical values (e.g., costs, subscriber numbers) are misstated. Format and references are precise. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across Disney’s vertical integration strategy, content cost structure, and competitive comparison with YouTube’s licensing model. It connects ownership → content control → cost savings → strategic advantage in subscriber acquisition. The only minor gap is that the original answer emphasizes the *implication for subscriber acquisition costs* more directly in terms of marginal cost advantage, while the LLM answer implies it but could make the cost comparison slightly more explicit. (4) Semantic equivalence is strong—wording differs but meaning matches. Contextual relevance is excellent, addressing both parts of the multi-part question: content differentiation strategy and implications for subscriber acquisition costs. Overall, this is a factually correct, well-supported, and logically structured response with only negligible room for improvement in emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 443,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How does the impact of regulatory exclusivity expiration timelines on BMY's biologic products compare to MRK's experience with Januvia family market exclusivity delays, considering the role of regulatory exclusivity in extending market protection beyond patent terms?",
      "original_answer": "BMY's biologic products, such as Opdivo and Yervoy, benefit from 12 years of regulatory exclusivity in the U.S., which prevents the FDA from approving biosimilars until 12 years after initial approval. This regulatory exclusivity can extend beyond patent terms and provide additional market protection. In contrast, MRK's Januvia family of products saw their key U.S. patent expire in January 2023, but due to favorable court rulings and settlement agreements on a later-expiring salt-form patent, MRK expects to maintain market exclusivity until May 2026 for Januvia and Janumet and July 2026 for Janumet XR. This shows that while BMY relies on the standard 12-year biologic exclusivity framework, MRK was able to extend market exclusivity for its chemical products through litigation and secondary patents, highlighting different strategies and outcomes tied to regulatory exclusivity mechanisms.",
      "llm_answer": "BMS states that each qualified biologic receives a **statutory 12‑year regulatory exclusivity** in the United U.S., so the company’s marketed biologics (e.g., Opdivo 2028, Breyanzi 2033, Abecma 2036, etc., as shown in its minimum‑exclusivity table) will remain protected for a full dozen years after first FDA approval—well beyond the life of any underlying patents. In contrast, Merck’s Januvia/Janumet family are small‑molecule drugs that only obtain the **five‑year chemical‑product exclusivity**; their market protection now depends on later‑expiring patents and settlement agreements that push U.S. exclusivity out to **May 2026 (Januvia) and July 2026 (Janumet XR)** despite the original compound patent having expired in 2023. Thus, BMS’s biologic exclusivity is driven by a long, predictable regulatory period that automatically extends protection beyond patents, whereas Merck’s extension for Januvia is the result of patent‑related litigation and settlements rather than a longer regulatory exclusivity term.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor discrepancies. (1) Quantitatively, the key dates and exclusivity periods are correct: the 12-year biologic exclusivity for BMY (BMS) and the May 2026 and July 2026 exclusivity end dates for Januvia/Janumet XR are accurately reported. However, the LLM incorrectly lists specific exclusivity end years for Breyanzi (2033) and Abecma (2036), which are not present in the original answer and not required to answer the question—this is extraneous but not factually incorrect. (2) The original answer focuses on Opdivo and Yervoy, while the LLM mentions different BMS biologics; this is a shift in example but does not undermine the correctness of the regulatory framework described. (3) The qualitative reasoning is sound: the LLM correctly contrasts the 12-year statutory biologic exclusivity (regulatory-based) with the 5-year chemical exclusivity for small molecules like Januvia, and accurately explains that Merck’s extension beyond the 2023 patent expiry resulted from litigation and settlements on secondary patents. (4) The multi-hop synthesis—comparing BMY’s regulatory-driven exclusivity with MRK’s patent-litigation-driven extension—is logically and factually sound. (5) Contextual relevance is excellent, directly addressing the role of regulatory exclusivity in extending protection beyond patents and contrasting strategies between biologic and small-molecule products. The only minor issue is the inclusion of unverified product-specific exclusivity dates not in the ground truth, which slightly affects precision but not overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 451,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How does MetLife's issuance of 40,000 shares of Series F preferred stock, with redemption terms tied to a 'rating agency event,' intersect with AIG's exposure to financial risks from potential rating downgrades, particularly given AIG's acknowledgment that a downgrade could limit its ability to write new business and impair customer retention?",
      "original_answer": "MetLife has issued 40,000 shares of Series F preferred stock, which includes a redemption clause triggered by a 'rating agency event'—defined as a change in rating criteria that lowers equity credit assigned to such securities. This creates a financial contingency for MetLife should credit agencies revise their treatment of these instruments. Similarly, AIG acknowledges in its 10-K that a downgrade in its Insurer Financial Strength ratings could materially impair its ability to write new business and retain customers. Therefore, both companies face strategic and operational risks tied to rating agency actions, with MetLife facing potential redemption obligations and AIG facing direct business constraints due to a potential loss of creditworthiness.",
      "llm_answer": "MetLife’s 40,000‑share Series F preferred issue can be redeemed “within 90 days after the occurrence of a ‘rating‑agency event’” at a make‑whole price plus accrued dividends (MetLife 10‑K p. 264). A “rating‑agency event” is defined as any change by a recognized rating organization that lowers the equity credit assigned to the security. AIG likewise warns that a downgrade by a rating agency could “limit their ability to write…new business and impair their retention of customers” (AIG 10‑K p. 85). Thus, a downgrade that triggers MetLife’s redemption obligation would also create the very rating‑driven business‑line and customer‑retention pressures AIG has identified, linking the two companies’ financial exposure to the same rating‑agency risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and terms are correct: MetLife issued 40,000 shares of Series F preferred stock, and the redemption clause is tied to a 'rating-agency event'—defined precisely as a change that lowers equity credit from a rating agency. The citation of specific 10-K pages (264 for MetLife, 85 for AIG) adds precision and matches the factual context. (2) The answer correctly identifies both companies, the nature of the financial instruments, and the shared risk factor—rating agency actions. (3) The multi-hop reasoning is sound: it connects MetLife’s contingent redemption obligation to AIG’s business risk from downgrades, noting that a single rating event could trigger financial and operational consequences across both firms. This synthesis is logically valid and reflects the core insight of the ground truth. (4) The only minor shortcoming is a slight overstatement in implying that a downgrade triggering MetLife’s redemption would 'also create' the same pressures at AIG—while both are exposed to rating risks, the causal link between the two companies’ exposures is correlative (same risk type) rather than direct (one causing the other). However, this does not undermine the overall correctness. Wording differs but semantic equivalence is maintained. All key facts, entities, and reasoning are accurate and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 391,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 198,
      "question": "How does the use of matrix pricing for U.S. Government Securities differ between LMT's portfolio as of December 31, 2021, and UPS's valuation methodology for similar assets, based on their respective Level 2 classifications?",
      "original_answer": "LMT reported $121 million in U.S. Government Securities as of December 31, 2021, which were classified under Level 2 inputs, indicating they were valued using matrix pricing or similar methods when broker quotes were unavailable. UPS also utilized matrix pricing for Level 2 marketable securities, including U.S. government debt, though the specific amount was not disclosed. Both companies rely on matrix pricing as a fallback when direct market data is not available, aligning with the broader accounting policy described by MO, which lists matrix pricing as a standard valuation technique for government securities when broker quotes are absent.",
      "llm_answer": "Lockheed Martin’s December 31 2021 portfolio lists U.S. Government securities as a **Level 2** fair‑value item (​$121 million) and states that their values are derived from pricing models that rely on observable inputs such as interest‑rate curves, broker bids and prices of comparable issues – essentially a matrix‑pricing approach. United Parcel Service, by contrast, classifies all U.S. government and agency debt securities as **Level 1** (quoted market prices) and uses matrix pricing only for assets that fall in its Level 2 bucket; therefore UPS does not apply matrix pricing to its U.S. Government securities.",
      "correctness_score": 4,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct in quantitative terms: it accurately reports Lockheed Martin's (LMT) $121 million in U.S. Government Securities as of December 31, 2021, classified as Level 2, and correctly describes matrix pricing using observable inputs like interest-rate curves and comparable prices. However, the qualitative reasoning is flawed. The LLM incorrectly claims that UPS classifies U.S. government and agency debt securities as Level 1 and does not apply matrix pricing to them. This contradicts the ground truth, which states that UPS *does* use matrix pricing for Level 2 marketable securities including U.S. government debt. The LLM’s assertion that UPS does not apply matrix pricing to U.S. Government securities is therefore factually incorrect. The ground truth confirms both companies use matrix pricing for such assets when direct quotes are unavailable, aligning their methodologies. The LLM fails in multi-hop synthesis by not recognizing that UPS’s use of matrix pricing applies to U.S. government securities within Level 2, despite the lack of a disclosed amount. While the LLM correctly identifies valuation techniques, it draws an erroneous contrast between LMT and UPS, undermining the core comparison asked in the question. Quantitative accuracy is high due to correct numbers and dates, but qualitative accuracy is low due to incorrect entity-methodology mapping and flawed reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 391,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 198,
      "question": "How does PM's use of market inputs for derivative valuations compare to MDLZ's approach for its real estate fund investments, given the differing levels of observability in their respective valuation models?",
      "original_answer": "PM values its derivative contracts using standard valuation models based on readily observable market inputs such as foreign exchange spot rates, interest rate differentials, and maturity dates. In contrast, MDLZ values its real estate fund investments using the present value of future cash flows, relying on unobservable inputs like projected operating performance and local market conditions. While PM's approach falls under Level 1 or 2 fair value measurements due to the use of observable data, MDLZ's real estate fund valuations are categorized as Level 3 due to the reliance on unobservable inputs that cannot be corroborated by market data.",
      "llm_answer": "PMI values its derivative contracts with “standard valuation models that use readily observable market inputs” – such as current FX spot rates, interest‑rate differentials and commodity spot‑ and futures‑prices – and classifies the contracts as Level 2 assets / liabilities. By contrast, Mondelēz’s real‑estate fund investments are measured at NAV using valuation models that rely on periodic appraisals, local‑market conditions and discounted‑cash‑flow assumptions; although they are also reported as Level 2, the inputs are less directly observable than the market‑quoted rates used by PMI. Thus PMI’s valuations are based on highly liquid, observable market data, while MDLZ’s real‑estate valuations depend more on model‑based estimates and appraisals that are comparatively less observable.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its description of PM's (PMI's) use of observable market inputs for derivative valuations, correctly identifying the use of FX spot rates, interest rate differentials, and commodity prices, and classifying these as Level 2. It also accurately describes MDLZ's (Mondelēz's) real estate fund valuation approach using appraisals, local market conditions, and discounted cash flows. However, there is a key factual error in the classification of MDLZ's real estate fund investments: the LLM states they are 'reported as Level 2', while the ground truth explicitly states they are Level 3 due to reliance on unobservable inputs. This misclassification undermines the accuracy of the comparison, as the core distinction in the original answer hinges on PM using Level 1/2 (observable) inputs versus MDLZ using Level 3 (unobservable) inputs. There are no numerical values to verify, so quantitative accuracy is 10. The reasoning is sound and contextually relevant, with good multi-hop synthesis between the two companies' valuation approaches, but the incorrect fair value level for MDLZ reduces qualitative accuracy. The answer captures the contrast in observability but misrepresents the official categorization, which is a significant but not fundamental error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 359,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 198,
      "question": "How does MetLife's repayment strategy for its junior subordinated debentures compare to AIG's obligations under the AIGLH-issued junior subordinated debentures, particularly in terms of liquidity constraints and deferral provisions?",
      "original_answer": "MetLife has provisions allowing it to defer interest payments on its junior subordinated debentures under certain conditions, which in turn triggers dividend stopper provisions. Additionally, MetLife is subject to replacement capital covenants that require it to raise specified replacement securities before repaying, redeeming, or purchasing the debentures. In contrast, AIG's obligations under the AIGLH-issued junior subordinated debentures include specific maturities such as $54 million of 8.5% debentures due in 2030, $142 million of 8.125% debentures due in 2046, and $31 million of 7.57% debentures due in 2045, all of which are guaranteed by AIG Parent. However, AIG does not guarantee any of the borrowings of AIGLH post-distribution of debentures, indicating a different liquidity risk profile compared to MetLife's structured repayment and deferral constraints.",
      "llm_answer": "MetLife’s junior‑subordinated debentures give the company an “elective‑deferral” right – it may postpone interest payments, but doing so triggers the dividend‑stopper provisions and, under its replacement‑capital covenants, MetLife can only repay, redeem or purchase the debentures after first receiving cash proceeds from the sale of designated replacement securities (see MetLife 10‑K p. 130).  MetLife backs this strategy with a sizable liquid‑asset pool ($5.4 billion at year‑end 2021; see p. 133), which it expects to be sufficient to meet its obligations.  \n\nIn contrast, the AIGLH junior subordinated debentures are simply guaranteed by AIG’s parent and carry no elective deferral feature; AIG’s ability to meet those obligations is limited by regulatory capital restrictions that lock up about $43.3 billion of statutory surplus (see AIG 10‑K p. 303), creating a liquidity constraint that does not allow the same kind of interest‑payment deferral that MetLife enjoys.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some key qualitative differences between MetLife and AIG regarding deferral provisions and liquidity constraints, but contains significant quantitative inaccuracies and omits critical details from the ground truth. (1) Correct elements: The LLM correctly identifies MetLife's elective deferral right, dividend stopper provisions, and replacement capital covenants. It also correctly notes that AIGLH debentures are guaranteed by AIG Parent and that AIG lacks a deferral feature. The contextual framing of liquidity constraints is relevant. (2) Quantitative errors: The LLM invents a $5.4 billion liquid-asset pool figure for MetLife not present in the original answer or supported by the cited knowledge graph; this number is factually unsupported in the provided context. Similarly, the $43.3 billion statutory surplus figure for AIG is not in the original answer and appears to be hallucinated or misattributed. The original answer specifies exact debenture amounts and maturities: $54M (8.5%, due 2030), $142M (8.125%, due 2046), and $31M (7.57%, due 2045) — none of which are mentioned in the LLM response. These omissions and fabrications severely undermine quantitative accuracy. (3) Multi-hop reasoning: The LLM synthesizes concepts across companies and correctly contrasts deferral capabilities and liquidity mechanisms, showing sound qualitative reasoning. However, it fails to incorporate the specific maturity structure and guarantee limitations (e.g., AIG not guaranteeing AIGLH borrowings post-distribution) that are central to the original answer’s comparison of risk profiles. (4) Justification: The correctness score is 6 due to correct conceptual framework but major factual gaps and hallucinated numbers. Quantitative accuracy is low (4) due to unsupported figures and missing precise debt tranches. Qualitative accuracy is 7 because the reasoning and entity identification (MetLife, AIG, AIGLH, debenture types) are mostly sound. Contextual relevance is high (9) as the response directly addresses the comparison asked, despite factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 557,
        "total_tokens": 2041
      },
      "error": null
    },
    {
      "question_id": 199,
      "question": "How does NVIDIA's competitive positioning against Samsung in the SoC and GPU markets influence Intel's strategic challenges in scaling its IFS Foundry Services, particularly given Intel's historical manufacturing delays and competitive pressures?",
      "original_answer": "NVIDIA competes with Samsung in the SoC and GPU markets, which are critical to automotive, gaming, and accelerated computing applications. Samsung is also a key competitor to Intel's IFS Foundry Services, which Intel established as part of its IDM 2.0 strategy to become a major foundry provider. Intel highlights that IFS must compete with established players like Samsung on multiple fronts including time-to-market, process performance, and ecosystem support. However, Intel's history of manufacturing delays, such as the setbacks with its 10nm and Intel 4 (formerly 7nm) process technologies, creates a disadvantage compared to Samsung's mature foundry capabilities. These delays have already impacted Intel's product competitiveness and gross margins, and could hinder IFS's ability to attract customers in a market where timely access to advanced processes is critical. Therefore, NVIDIA's competitive pressure on Samsung indirectly affects Intel's ability to scale IFS, as Samsung remains a dual threat both in end-product markets and in the underlying manufacturing ecosystem.",
      "llm_answer": "NVIDIA’s 10‑K notes that it competes with Samsung in both the discrete‑GPU market and the broader SoC market (e.g., automotive, gaming and data‑center chips)【page_15】.  Because Samsung is one of Intel’s chief rivals for its new “IFS” foundry business – offering more‑advanced process nodes, higher yields and faster time‑to‑market – NVIDIA’s ability to win design‑wins against Samsung adds pressure on Intel to attract the same customers while it struggles to scale capacity and meet demand.  Intel’s 10‑K acknowledges that its complex IDM‑2.0 operations have historically lagged (e.g., 10 nm and Intel 4 delays) and that under‑utilized or delayed capacity can erode market share, especially as competitors such as Samsung (and NVIDIA‑backed designs) deliver performance‑per‑watt and volume advantages【page_53】【page_54】.  Consequently, NVIDIA’s strong positioning versus Samsung magnifies Intel’s strategic challenge of catching up on technology, yield and timing as it tries to grow IFS services.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) All factual elements are correct: NVIDIA competes with Samsung in GPUs and SoCs (automotive, gaming, data center), Samsung is a key competitor to Intel's IFS foundry, and Intel faces challenges due to historical manufacturing delays (10nm and Intel 4). These delays impact time-to-market, yield, and capacity utilization, which are critical in attracting foundry customers. (2) There are no numeric values (e.g., dates, dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the LLM correctly infers that NVIDIA’s competitive pressure on Samsung indirectly affects Intel’s IFS by intensifying the competitive environment in which Samsung operates, thus raising the bar for Intel as it tries to scale. The mention of 'NVIDIA-backed designs' is a slight overreach—while NVIDIA designs chips, it does not typically back third-party foundry customers—but this does not materially distort the core logic. (4) The answer is contextually excellent, directly addressing how NVIDIA vs. Samsung dynamics influence Intel’s foundry ambitions, synthesizing across competitive product markets and manufacturing ecosystems. The use of specific 10-K page references adds credibility. Only a minor deduction in qualitative accuracy due to the slightly ambiguous 'NVIDIA-backed designs' phrasing. Overall, the answer is factually correct, comprehensive, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1545,
        "completion_tokens": 428,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 199,
      "question": "Given that Alphabet repurchased $62.0 billion in Class A and Class C shares in 2024, how does the difference in voting rights between Class A and Class B shares at both Alphabet and Comcast impact their respective share repurchase strategies, particularly in light of Comcast's concentrated ownership of Class B shares by a single individual?",
      "original_answer": "Alphabet's share repurchase strategy in 2024 focused on Class A and Class C shares, with $62.0 billion repurchased, while maintaining the balance between voting classes since Class B shares automatically convert to Class A upon sale. This preserves the concentrated voting power of Class B holders. Similarly, Comcast's Class B shares, which carry 15 votes per share and represent 33⅓% of the combined voting power, are entirely owned by Brian L. Roberts. This concentrated ownership influences Comcast's repurchase strategy, as repurchases of Class A shares increase the relative voting power of the Class B shares. Both companies manage their share structures to maintain governance control while returning capital to shareholders.",
      "llm_answer": "Alphabet’s 2024 buy‑back of $62 billion targeted only its publicly‑traded Class A shares (one vote each) and its non‑voting Class C shares, leaving the 10‑vote‑per‑share Class B stock—held by founders and not repurchased—intact and preserving their control (​GOOGL 10‑K p. 82​). Comcast likewise repurchased only its Class A common stock (one vote per share) in 2024, while its 15‑vote‑per‑share Class B shares, which represent a third of the voting power and are owned entirely by Brian L. Roberts, were not bought back (​CMCSA 10‑K p. 31​). Thus, in both firms the buy‑backs focus on lower‑ or non‑voting shares, allowing the concentrated, high‑voting Class B owners to retain full voting influence.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Alphabet repurchased $62.0 billion in Class A and Class C shares in 2024; Class B shares carry 10 votes and are held by insiders; Comcast's Class B shares have 15 votes per share and are fully owned by Brian L. Roberts, representing one-third of voting power. The LLM correctly notes that repurchases were limited to lower- or non-voting shares in both companies. (2) Quantitative accuracy is perfect: $62 billion is correctly cited, voting rights (10 and 15 votes per share), and ownership concentration (one-third voting power) match the ground truth. Minor phrasing difference: ground truth says '33⅓%' while LLM says 'a third'—semantically equivalent. (3) Multi-hop reasoning is sound: the LLM correctly infers that by repurchasing only non-voting or low-voting shares, both companies preserve the relative voting control of the high-vote Class B holders. It correctly identifies the strategic similarity between Alphabet and Comcast despite different ownership structures. (4) The only minor shortcoming is that the LLM does not explicitly mention the automatic conversion of Alphabet Class B to Class A upon sale—a nuance in governance mechanics noted in the ground truth. However, this does not undermine the core reasoning about control preservation. Overall, the answer is factually correct, well-reasoned, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 398,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 199,
      "question": "How does Amgen's focus on NSCLC therapies compare with Bristol Myers Squibb's recent FDA approval of Opdivo Qvantig in terms of administration method and potential market expansion for adult solid tumor indications?",
      "original_answer": "Amgen's 2024 disclosures highlight its strategic focus on NSCLC therapies, indicating a strong commitment to oncology innovation. Meanwhile, Bristol Myers Squibb's FDA approval in December 2024 for Opdivo Qvantig enables subcutaneous administration for most previously approved adult solid tumor indications of Opdivo, either as monotherapy, maintenance therapy, or in combination with chemotherapy or cabozantinib. This administration route offers a more convenient alternative to traditional intravenous delivery, potentially expanding market access and improving patient adherence. The combination of Amgen’s ongoing NSCLC development and BMS’s subcutaneous innovation in Opdivo Qvantig reflects divergent strategies in addressing the same therapeutic area, with BMS leveraging delivery mechanism improvements to enhance market positioning in solid tumor oncology.",
      "llm_answer": "Amgen’s pipeline is aimed at mutation‑specific NSCLC drugs such as Augtyro (ROS‑1‑positive NSCLC) and Krazati (KRAS‑mutated NSCLC), both of which are oral small‑molecule agents (see page 5). In contrast, Bristol‑Myers Squibb’s newly approved Opdivo Qvantig is a sub‑cutaneous formulation of nivolumab that can be used as monotherapy, maintenance or in combination for the majority of previously approved adult solid‑tumor indications (see page 44). Thus, Amgen’s NSCLC effort relies on oral, mutation‑targeted products with a narrower NSCLC focus, while BMS’s Opdivo Qvantig adds a convenient injection route and opens a broader market across many adult solid‑tumor cancers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Amgen's focus on mutation-specific NSCLC therapies (Augtyro for ROS1-positive, Krazati for KRAS-mutated) as oral agents is accurately described, and BMS's Opdivo Qvantig is correctly identified as a subcutaneous formulation of nivolumab approved for most adult solid tumor indications. The administration methods—oral for Amgen’s drugs vs. subcutaneous for Opdivo Qvantig—are correctly contrasted. (2) There are no numeric values, dates, or financial figures in the LLM answer, but the December 2024 FDA approval mentioned in the ground truth is not included in the LLM response; however, this omission does not affect the core comparison about administration and market expansion. (3) The multi-hop reasoning is sound: the model correctly synthesizes that Amgen is pursuing a targeted, NSCLC-specific strategy using oral drugs, while BMS is broadening market access across solid tumors via a more convenient delivery method. (4) The semantic meaning matches the original answer—both highlight divergent strategies: Amgen in precision oncology for NSCLC, BMS in delivery innovation for broader solid tumor use. The only minor gap is the lack of explicit mention of 'December 2024' approval, but since the question focuses on the comparison of administration and market implications rather than timing, this does not significantly detract. Wording differences are acceptable and do not impact factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 415,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 201,
      "question": "Given CMCSA's non-dilutable 33 1/3% voting power protection for Class B shares and the conversion mechanism to Class A shares, how does this structure limit GOOGL's influence despite its stake in Class A common stock?",
      "original_answer": "CMCSA's capital structure protects 33 1/3% of the voting power through Class B shares, which cannot be diluted by additional issuances of common stock. Each Class B share converts on a 1:1 basis into Class A shares, but this conversion is subject to restrictions. Meanwhile, GOOGL holds a stake in Class A common stock, which carries voting rights that could otherwise influence corporate decisions. However, due to CMCSA's structural protections, even if all Class B shares were converted to Class A, the non-dilutable voting safeguard would still preserve the 33 1/3% voting control, limiting GOOGL’s ability to shift governance outcomes through its Class A stake alone.",
      "llm_answer": "Comcast’s charter guarantees that the nine million Class B shares always control at least one‑third (33 ⅓ %) of the total voting power, and that this share‑for‑share conversion right into Class A stock cannot be diluted by issuing additional shares of any other class【page_91】. Because Class B votes are fixed and the conversion of B to A only adds more Class A shares (which each carry one vote) without eroding the 33 ⅓ % block, Alphabet’s ownership of Class A common stock can never give it a controlling vote – the non‑dilutable Class B voting tranche limits GOOGL’s influence regardless of its stake【page_81】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key figures are correct: the 33 1/3% voting power protection is accurately stated, and the 1:1 conversion mechanism from Class B to Class A shares is correctly described. The reference to nine million Class B shares, while not in the original answer, is consistent with external knowledge and does not contradict the ground truth; it adds specificity without introducing error. (2) The answer correctly explains that the Class B voting power is non-dilutable and that conversion to Class A does not erode this block, preserving the 33 1/3% control—this matches the core logic of the original. (3) The reasoning correctly synthesizes the structural limitation on GOOGL’s influence: despite holding Class A shares, GOOGL cannot overcome the protected voting tranche. The mention of Alphabet (GOOGL) not achieving a controlling vote is semantically equivalent to the original’s point about limited ability to shift governance outcomes. (4) The only minor gap is that the LLM does not explicitly state that the protection persists *even if all Class B shares convert*, which is a key multi-hop inference in the original. However, the implication is strongly present in the explanation about non-dilution and fixed voting power. Wording differs but meaning is substantively preserved. No factual errors; high contextual relevance and strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 401,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 201,
      "question": "How does the 13.2% increase in South Africa's total tobacco market volume, partly offset by higher illicit trade prevalence, affect both PEP's merger-related socioeconomic obligations and MO's illicit trade risk exposure in their respective international operations?",
      "original_answer": "The 13.2% increase in South Africa's total tobacco market volume, which was partly offset by higher illicit trade prevalence, directly impacts both companies through different mechanisms. For PEP, this market dynamic influences the scope and cost of their socioeconomic program obligations in South Africa, which are explicitly included in their merger and integration charges. For MO, the increased prevalence of illicit trade associated with this market growth contributes to the illicit trade risks outlined in their filings, which they state can lead to lost sales, brand dilution, and potential legal or regulatory actions against their distribution channels.",
      "llm_answer": "The 13.2 % rise in South Africa’s total tobacco volume expands the sales base that PepsiCo (PEP) must support through the socioeconomic programs tied to its Pioneer Foods merger – the larger market will increase the merger‑related liabilities and the associated tax‑benefit contribution noted in its 2021 acquisition‑integration charges. At the same time, the same market growth for Philip Morris International (MO) is “partly offset by a higher estimated prevalence of illicit trade,” which raises MO’s exposure to revenue loss, regulatory scrutiny and reputational risk from illicit‑trade activity in its Middle‑East‑and‑Africa operations.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical entity error: it incorrectly identifies PEP as PepsiCo, when in the context of the question and ground truth, PEP refers to British American Tobacco's subsidiary in South Africa (formerly Pioneer Foods), not PepsiCo. This fundamentally undermines the reasoning and factual basis of the answer. The 13.2% market volume increase is correctly cited, and the mention of higher illicit trade prevalence is consistent with the original answer. (2) Quantitatively, the 13.2% figure is accurate and properly referenced. However, the mention of '2021 acquisition-integration charges' introduces a specific date not present in the ground truth, which does not confirm or deny the timing—this is an unsupported addition. (3) The multi-hop reasoning fails due to the incorrect identification of PEP. The link between PEP’s merger-related socioeconomic obligations and the market volume increase is misrepresented because the answer assumes a PepsiCo merger context, which is false. For MO, the reasoning is partially sound: increased illicit trade is correctly tied to revenue loss and regulatory risks, aligning with MO’s stated risks in emerging markets. However, the geographic reference to 'Middle-East-and-Africa operations' adds specificity not in the original and slightly overreaches. (4) The correctness score is low due to the core entity misidentification, which invalidates the synthesis for PEP. Quantitative accuracy is high because the key percentage is correct and no mathematical errors are present. Qualitative accuracy is low due to flawed reasoning stemming from the wrong company assumption. Contextual relevance is moderate because the answer addresses the right themes (market growth, illicit trade, socioeconomic obligations, risk exposure) but applies them to the wrong corporate context for PEP.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 503,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 203,
      "question": "How do the legal risks associated with securities litigation in Slack's IPO compare to Meta's exposure from its privacy-related lawsuits, particularly in terms of procedural outcomes and potential financial liabilities?",
      "original_answer": "Slack faced securities litigation related to its IPO, where a motion to dismiss was partially granted and partially denied in 2020, followed by a Ninth Circuit reversal in 2025 that led to the dismissal of the complaint with prejudice, significantly reducing its legal exposure. In contrast, Meta faced a $725 million settlement in a consumer privacy class action, which was approved in 2023, and continues to face ongoing litigation and regulatory scrutiny, including a $5.0 billion FTC penalty paid in 2020 and pending appeals in several state attorney general cases. Unlike Slack's litigation, which was ultimately dismissed, Meta's legal challenges have resulted in substantial financial liabilities and ongoing regulatory constraints.",
      "llm_answer": "Slack’s securities‑class‑action claims stemming from its IPO were ultimately dismissed – the Ninth Circuit ordered the complaint dismissed with prejudice in February 2025 and the parallel state‑court actions remain stayed, leaving the company with no estimated monetary exposure for those suits. By contrast, Meta’s privacy‑related litigation has already produced concrete financial liabilities – a $725 million settlement of the consumer‑privacy class action (paid in 2023) and a $5 billion FTC penalty paid in 2020, with additional government and state actions still pending, indicating a far larger and still‑uncertain financial risk.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Slack's IPO-related securities litigation was dismissed with prejudice by the Ninth Circuit in February 2025, aligning with the '2025 reversal' and 'dismissal with prejudice' in the original answer; the procedural outcome significantly reduced Slack’s exposure. Meta’s $725 million privacy settlement (approved and paid in 2023) and $5.0 billion FTC penalty (paid in 2020) are accurately reported, including the ongoing nature of additional state and regulatory actions. (2) Quantitative accuracy is perfect: $725 million and $5 billion figures match exactly; dates (2020, 2023, 2025) are correct and consistent with the ground truth. (3) Multi-hop reasoning is sound: the model correctly contrasts Slack’s ultimately dismissed litigation (low financial risk) with Meta’s substantial, realized liabilities and ongoing exposure, synthesizing information across companies, legal domains (securities vs. privacy), and procedural outcomes. (4) The answer fully addresses the question’s focus on procedural outcomes and financial liabilities, with precise, relevant, and complete information. Minor wording differences (e.g., 'parallel state-court actions remain stayed') add detail without deviating from the truth. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 384,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 203,
      "question": "How does the difference in vesting timelines for RSU awards between PM and WMT affect the recognition period of compensation costs, given PM's $160 million in unrecognized RSU costs and WMT's shift from 25% annual vesting to 8% quarterly vesting?",
      "original_answer": "PM has $160 million in unrecognized compensation costs from non-vested RSU awards, which are expected to be recognized over a weighted-average period of seventeen months, typically over three years or upon specific events like death, disability, or reaching age 58. This vesting schedule aligns with PM's policy where RSU awards generally vest on the third anniversary of the grant date. In contrast, WMT shifted its vesting schedule for RSU awards in fiscal 2023 to an 8% quarterly vesting rate over three years, down from a previous 25% annual vesting rate over four years. This change in WMT's vesting schedule accelerates the recognition of compensation costs earlier in the vesting period compared to PM’s structure. As a result, WMT’s updated vesting approach leads to a more evenly distributed cost recognition over the three-year period, whereas PM's cost recognition is more back-loaded due to its cliff-vesting structure tied to specific events or the three-year anniversary.",
      "llm_answer": "Philip Morris’ RSU awards vest three years after the grant date, so the $160 million of un‑recognized RSU compensation is slated to be expensed over a weighted‑average period of about 17 months (roughly 1½ years).  \n\nWalmart’s change replaces the old 25 %‑per‑year, four‑year vesting (average expense period ≈ 2 years) with an 8 %‑per‑quarter vesting over three years, which front‑loads the vesting and therefore shortens the average recognition period – expense will now be recognized more quickly, roughly over the three‑year horizon with quarterly charge‑through rather than over a longer four‑year schedule.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with strong quantitative precision and sound reasoning. (1) All key numbers are correct: PM's $160 million in unrecognized costs, 17-month weighted-average recognition period, and three-year cliff vesting are accurately reported. WMT's shift from 25% annual vesting over four years to 8% quarterly over three years is correctly stated. (2) Quantitative accuracy is perfect: the LLM correctly infers that Walmart’s prior 25% annual vesting over four years implies an average recognition period of about 2 years (standard straight-line assumption), and the new 8% quarterly schedule over 12 quarters (3 years) front-loads expense recognition compared to PM’s back-loaded cliff vesting. The 17-month period for PM aligns with the ground truth’s 'weighted-average period of seventeen months'. (3) Multi-hop reasoning is strong: the LLM correctly contrasts the impact of vesting structures on compensation cost recognition—WMT’s change accelerates and smooths recognition, while PM’s is concentrated at the end of the period. However, the LLM omits mention of PM’s vesting upon specific events (death, disability, age 58), which is a minor but relevant detail affecting the recognition period. (4) Despite this omission, the answer captures the essential comparison: WMT’s shift leads to earlier, more even recognition, while PM’s is back-loaded. Wording differs but meaning is semantically equivalent. Contextual relevance is excellent—every part of the question is addressed with appropriate financial terminology and logical flow.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 440,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 204,
      "question": "How does the $620 million unrecognized tax benefit risk at Boeing compare to Lockheed Martin's assessment of Pillar 2's impact, given the OECD's global minimum tax framework and differing implementation timelines across jurisdictions?",
      "original_answer": "Boeing identifies a $620 million risk in unrecognized tax benefits related to federal tax matters under audit, with Pillar 2's global minimum tax of 15% potentially applying to its worldwide operations, though it expects minimal impact due to lack of material operations in low-tax jurisdictions. Meanwhile, Lockheed Martin also anticipates no material impact from Pillar 2 on its effective tax rate or consolidated results, despite the framework's phased implementation starting in 2024 and 2025. This assessment is complicated by the OECD's Pillar 2 model rules, which, while providing a framework, allow for varied national adoption timelines and potential modifications to domestic tax incentives, as noted by General Electric's evidence.",
      "llm_answer": "Boeing says that, because of the OECD‑mandated Pillar 2 global minimum‑tax rules, it could see as much as **$620 million of unrecognised tax‑benefit risk** materialising over the next year. Lockheed Martin, by contrast, notes that it **does not expect Pillar 2 to have a material impact on its effective tax rate or earnings** – it is simply monitoring the rule‑making and the staggered 2024‑2025 rollout in the various jurisdictions where it operates.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, the $620 million unrecognized tax benefit risk at Boeing is accurately reported, and the reference to Pillar 2's 2024–2025 implementation timeline is consistent with the original answer. No calculations are required, and all numbers and timeframes are correct. (2) Entity accuracy is strong: Boeing and Lockheed Martin are correctly identified with their respective assessments. (3) The reasoning is sound: Boeing faces a specific tax risk exposure, while Lockheed Martin expects no material impact—both responses reflect the uncertainty due to staggered jurisdictional implementation. However, the LLM omits a key nuance present in the original answer: Boeing's expectation of minimal Pillar 2 impact due to lack of material operations in low-tax jurisdictions, and the reference to General Electric’s evidence about national modifications to tax incentives, which adds context to the complexity of Pillar 2 adoption. While the core comparison is accurate, this missing context slightly weakens the completeness and depth of the multi-hop synthesis. (4) Despite these omissions, the answer remains factually correct, relevant, and conveys the essential contrast between the two companies’ risk assessments under Pillar 2, warranting a high correctness score with minor deduction for incomplete contextual synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 388,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 204,
      "question": "How will the implementation of ASU No. 2023-07 impact the way PepsiCo reports its newly reorganized segments starting in Q1 2025, and how does this align with Altria's adoption timeline and disclosure requirements under the same standard?",
      "original_answer": "PepsiCo will recast its historical segment reporting beginning in Q1 2025 to reflect its new organizational structure, which includes combining FLNA and QFNA into PepsiCo Foods North America and reorganizing international food businesses into Latin America Foods, EMEA, and Other International Foods. This aligns with ASU No. 2023-07, which requires incremental disclosures of disaggregated expense information by reportable segment. Altria adopted the standard in 2024 and included expanded disclosures in Note 17, with interim requirements to be implemented starting Q1 2025. Thus, both companies are aligning with the new standard's timeline for retrospective application and enhanced reporting beginning in 2025.",
      "llm_answer": "ASU 2023‑07 requires companies to disclose additional, disaggregated expense information for each reportable segment. PepsiCo’s 2024 filing notes that its historical segment data will be **re‑cast beginning in the first quarter of 2025** to reflect a new five‑segment structure (PepsiCo Foods North America, Latin America Foods, EMEA, Other International Foods and International Beverages Franchise) and, because of the ASU, those segments will now be presented with the expanded expense‑line‑item disclosures required by the update. Altria, by contrast, **adopted ASU 2023‑07 for its 2024 year‑end financial statements** (see Note 62) and will apply the interim‑reporting requirements starting in Q1 2025 (see Note 63), so its disclosure timeline is already in place and will run in parallel with PepsiCo’s first‑quarter‑2025 rollout of the new segment reporting.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor discrepancy in segment naming that affects completeness and entity accuracy. (1) Quantitatively, all dates and timelines are accurate: PepsiCo’s recasting begins Q1 2025, Altria adopted ASU 2023-07 in 2024 with interim requirements starting Q1 2025—both match the original answer. (2) The LLM correctly identifies the core requirement of ASU 2023-07—disaggregated expense disclosures by segment—and notes both companies’ alignment with the standard’s effective timeline. (3) However, the LLM incorrectly lists 'International Beverages Franchise' as a segment, which is not mentioned in the ground truth; instead, the reorganization combines FLNA and QFNA into PepsiCo Foods North America and splits international food into Latin America Foods, EMEA, and Other International Foods. This suggests a partial misrepresentation of PepsiCo’s new structure, possibly confusing beverage and food segments. (4) Despite this, the reasoning is sound: the model correctly synthesizes multi-hop information—PepsiCo’s structural changes tied to ASU implementation, Altria’s earlier adoption but parallel interim rollout—and draws a valid comparison. Wording differs but meaning is semantically close. The error is not in calculation or timeline but in entity specification, warranting a high but not top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 383,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 204,
      "question": "How does the expiration timeline of Merck's MK-7962 (sotatercept) patent protection in the U.S. compare to Pfizer's broader patent strategy for biologics, especially considering potential extensions in both portfolios?",
      "original_answer": "Merck's MK-7962 (sotatercept) has a base U.S. patent expiration of 2027, with potential additional protection extending to 2037 if patent term extensions (PTEs) are granted. This reflects a strategy of relying on both initial and extended patent coverage for biologics. Pfizer also leverages PTEs and supplementary protection certificates (SPCs), particularly in Europe, to extend exclusivity beyond basic patent expirations. Both companies utilize regulatory exclusivity and patent filings to maximize product lifecycle management, though Pfizer explicitly notes variability in extension outcomes due to external factors.",
      "llm_answer": "Merck’s sotatercept (MK‑7962) has a core U.S. compound‑patent that runs out in 2027, but method‑of‑use patents extend to 2037 and the biologic will receive the standard 12‑year data‑exclusivity period once approved. Pfizer’s biologics strategy, by contrast, leans on a layered set of extensions—patent‑term extensions, supplementary protection certificates, pediatric exclusivity and 12‑year data exclusivity (e.g., a biologic‑data exclusivity that runs to July 16 2023 → 2033)—which can keep its biologic patents protected well into the 2030s, giving Pfizer a longer overall protection horizon than Merck’s 2027‑based compound expiry.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies Merck's sotatercept (MK-7962) base patent expiration in 2027 and potential extension to 2037 via method-of-use patents and/or patent term extensions (PTEs), aligning with the ground truth. It also accurately notes the 12-year data exclusivity for biologics in the U.S., which is contextually correct. For Pfizer, the answer correctly describes a layered patent strategy involving PTEs, supplementary protection certificates (SPCs), pediatric exclusivity, and data exclusivity. However, the example date 'July 16, 2023 → 2033' is problematic: while it may be factually accurate for a specific Pfizer biologic, it is not mentioned in the ground truth and introduces unverified specificity, potentially misleading as a general illustration. 2) Quantitative accuracy is mostly correct: 2027 and 2037 for Merck are accurate. The 12-year data exclusivity is correct under the BPCIA. However, the claim that a 2023 exclusivity start extends to 2033 is off by one year (2023 + 12 = 2035), indicating a calculation error. This undermines quantitative precision. 3) The multi-hop reasoning is sound—comparing Merck’s patent timeline to Pfizer’s broader strategy—and correctly infers that Pfizer’s layered approach may yield longer protection. The synthesis across companies and strategies is appropriate and reflects understanding of lifecycle management. 4) Contextually, the answer is highly relevant, addressing both companies’ strategies and comparing their protection horizons. The main issues are the incorrect calculation in the Pfizer example and the introduction of an unverified date, which reduce quantitative accuracy. Despite this, core facts and strategic insights are correct, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 476,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 205,
      "question": "How do cost overruns under fixed-price contracts impact both Lockheed Martin's financial performance and GE's operational execution, given the sensitivity of these contracts to inflationary pressures and project complexity?",
      "original_answer": "Lockheed Martin reported cumulative reach-forward losses of $270 million and $280 million on two fixed-price contracts as of December 31, 2023, with potential for additional losses if cost overruns continue. These contracts are especially vulnerable to inflation, as noted in RTX's 10-K, which stated that rising material and labor costs can lead to losses on fixed-price contracts when overruns occur. Similarly, GE's operational execution is negatively impacted by cost overruns, particularly in large-scale projects such as those in its Power and Renewable Energy segments, where delays or technical issues can lead to contractual penalties and joint liability in consortiums. This highlights how both companies face significant financial and operational risks stemming from fixed-price contract structures under current economic and project execution conditions.",
      "llm_answer": "Lockheed Martin says that when the actual cost to complete a fixed‑price contract exceeds the price it bid, it must record a “reach‑forward” loss at the contract level; the company has already booked cumulative losses of roughly $270 million‑$280 million on two programs and warns that any further overruns would reduce segment operating profit and overall net earnings. GE notes that its fixed‑price aerospace and energy contracts are highly sensitive to inflation‑driven material, component and labor cost increases and to the technical complexity of large projects, so cost overruns can generate penalties, liquidated‑damage charges and cash‑flow strain that impair the company’s ability to execute projects on schedule and hit profitability targets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Lockheed Martin's cumulative reach-forward losses of $270 million to $280 million on two fixed-price contracts as of December 31, 2023 (implied by context), matching the ground truth. It accurately states that further overruns would reduce segment operating profit and net earnings, aligning with the financial impact described. For GE, the answer correctly links cost overruns to penalties, liquidated damages, and cash-flow strain affecting operational execution and profitability, consistent with the original answer’s emphasis on Power and Renewable Energy projects and consortium liabilities. (2) All numeric values are accurate and within acceptable formatting variations (e.g., 'roughly $270 million–$280 million' matches the exact figures in the ground truth). No calculations were required, but the range is correctly presented. (3) Multi-hop reasoning is sound: the model synthesizes Lockheed Martin’s financial exposure with GE’s operational risks under fixed-price contracts, connects both to inflationary pressures (material/labor costs) and project complexity, and references appropriate business segments without naming them explicitly. While the LLM does not mention RTX’s 10-K as a source for inflation sensitivity, it independently affirms the same risk, preserving factual integrity. It also omits explicit mention of 'joint liability in consortiums' for GE, a minor detail absent but not contradicting the core message. (4) The answer is contextually fully relevant, addressing both financial and operational impacts across both companies, and correctly attributes risks to inflation and technical complexity. The only minor gaps—lack of explicit segment names (Power/Renewables) and omission of RTX as a supporting source—prevent a perfect 10 but do not undermine factual correctness. Thus, the answer is semantically equivalent and highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 519,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 207,
      "question": "How does MDLZ's use of commodity futures for raw material price risk compare with COST's disclosure of Level 1 financial liabilities in terms of fair value measurement and derivative instrument exposure?",
      "original_answer": "MDLZ actively uses commodity futures to hedge against price risk for raw materials like cocoa, sugar, and wheat, with these instruments classified as Level 1 financial liabilities measured at fair value based on quoted market prices. In contrast, COST disclosed that it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis as of August 28, 2022, indicating no direct exposure to exchange-traded commodity futures like those used by MDLZ. This highlights a strategic difference in derivative usage and fair value exposure between the two companies.",
      "llm_answer": "MDLZ explicitly uses exchange‑traded commodity futures (and options) to hedge the price of raw‑material inputs such as cocoa, sugar, wheat and oils.  These contracts are classified as Level 1 financial assets because their fair value is taken from quoted market prices on the exchanges (see MDLZ ‑ page 94 and the Level 1 fair‑value amount of $46 million for commodity contracts on page 112).\n\nCostco’s 10‑K, however, does not report any Level 1 financial liabilities; its fair‑value disclosures are limited to Level 2 items such as forward foreign‑exchange contracts (see COST ‑ page 51) and the fair value of its long‑term debt is measured using market‑based inputs (page 43).  Consequently, Costco’s filing shows no direct exposure to exchange‑traded derivative liabilities, whereas Mondelēz’s filing highlights active use of Level 1 commodity futures to manage raw‑material price risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and classifications are correct: MDLZ's $46 million Level 1 commodity contracts are accurately cited (from page 112), and the reference to quoted market prices for exchange-traded futures is consistent with Level 1 classification. The absence of Level 1 financial liabilities at COST is correctly stated, with supporting references to forward foreign-exchange contracts (Level 2) and debt valuation (page 43). (2) The answer fully addresses the comparison between MDLZ’s use of commodity futures and COST’s lack of Level 1 liabilities, covering fair value measurement (Level 1 vs. Level 2) and derivative exposure. (3) Entity accuracy is strong: correct tickers (MDLZ, COST), correct financial instruments (commodity futures, forwards, debt), and accurate sourcing from 10-K pages. (4) Multi-hop reasoning is sound—correctly synthesizing MDLZ’s active hedging with Level 1 classification and contrasting it with COST’s lack of exchange-traded derivative liabilities. One minor point preventing a perfect 10: the LLM states that MDLZ’s commodity contracts are 'Level 1 financial assets,' while the ground truth refers to them as 'Level 1 financial liabilities.' This is a subtle but important classification difference in financial reporting (assets vs. liabilities), though in hedging contexts, the same instruments can be classified differently based on position (long/short). Given that the $46M figure on page 112 may reflect a net asset, the LLM’s characterization may be contextually justified, but the ground truth emphasizes liabilities. This nuance slightly affects qualitative accuracy but does not undermine the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 474,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 208,
      "question": "What is the total number of UPS Class A shares that are convertible into Class B shares, and how does this compare to the assets held in Lockheed Martin's nonqualified pension trust as of December 31, 2024?",
      "original_answer": "As of December 31, 2024, there were 4.6 billion UPS Class A shares that are fully convertible into Class B shares. Lockheed Martin reported $658 million in assets held in a separate trust for its nonqualified defined benefit pension plans as of the same date.",
      "llm_answer": "UPS’s Class A shares are fully convertible into Class B shares, and the company had **121 million Class A shares issued at year‑end 2024** that could be converted.  \n\nLockheed Martin reported that its **non‑qualified pension trust held about $658 million of assets as of December 31, 2024**.  \n\nThus, the UPS convertible share count (121 million shares) is a share‑quantity measure, whereas Lockheed Martin’s comparable figure is a dollar‑amount of roughly $658 million in pension‑trust assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains a major factual error in the UPS Class A share count: it reports 121 million shares, whereas the ground truth is 4.6 billion shares. This is a significant quantitative discrepancy (off by over 97%). The Lockheed Martin nonqualified pension trust asset figure of $658 million is correct and matches the ground truth. (2) The number for UPS shares is incorrect—121 million vs. 4.6 billion—making the quantitative accuracy very low. The date (December 31, 2024) is correctly used for both entities. (3) The reasoning correctly identifies that UPS Class A shares are convertible into Class B shares and that Lockheed Martin holds assets in a nonqualified pension trust, showing proper entity and metric identification. However, the core multi-hop comparison fails due to the incorrect UPS share number, undermining the synthesis. (4) Contextual relevance is high because the answer addresses both parts of the question and attempts a meaningful comparison between the two figures, even though one side of the comparison is factually wrong. The explanation of differing units (shares vs. dollars) is reasonable but does not compensate for the factual inaccuracy. Overall, the answer is partially on track but fundamentally flawed in a key data point.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 354,
        "total_tokens": 1557
      },
      "error": null
    },
    {
      "question_id": 209,
      "question": "How does the sensitivity of AVGO's fixed rate senior notes to interest rate changes compare to CSCO's use of interest rate swaps in managing similar debt exposure, given the specific fair value impacts and hedging strategies outlined?",
      "original_answer": "AVGO's fixed rate senior notes are highly sensitive to interest rate changes, with a 50 basis point increase in rates causing a $1.7 billion decline in fair value as of November 3, 2024. In contrast, CSCO actively manages this risk using an interest rate swap with a $0.5 billion notional amount, which converts fixed interest payments on a portion of its senior notes to floating rates based on SOFR, thereby offsetting changes in the fair value of the hedged debt. This indicates that while AVGO faces significant exposure due to the size of its unhedged fixed-rate debt ($56.3 billion), CSCO employs targeted hedging strategies to mitigate similar risks on its smaller fixed-rate debt base.",
      "llm_answer": "Broadcom’s (AVGO) fixed‑rate senior notes are materially sensitive to interest‑rate moves – a 50‑basis‑point shift in market rates would alter the fair value of the $56 billion of notes outstanding by roughly **$1.7 billion** (about $1.4 billion a year earlier). Cisco (CSCO) does not leave the exposure un‑mitigated; it entered a **$0.5 billion interest‑rate swap** that is accounted for as a fair‑value hedge, so the swap’s gain or loss “substantially offsets” the change in fair value of the hedged portion of its fixed‑rate senior notes, effectively neutralising the interest‑rate sensitivity for that slice of debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key numbers are correct: AVGO's $1.7 billion fair value impact from a 50 bps rate change, $56 billion (rounded from $56.3 billion, acceptable) in fixed-rate debt, and CSCO's $0.5 billion notional interest rate swap are all accurately reported. The mention of $1.4 billion a year earlier is additional context not in the original but does not contradict it. (2) Quantitative accuracy is perfect—no errors in figures or units, and format variations (e.g., $56 billion vs $56.3 billion) are within acceptable rounding. (3) Multi-hop reasoning is sound: the model correctly contrasts AVGO's unhedged exposure with CSCO's use of a fair-value hedge via an interest rate swap tied to SOFR (implied in 'floating rates' in original), even specifying the accounting treatment ('substantially offsets') which aligns with the hedging strategy. (4) The only minor omission is not explicitly naming SOFR as the floating rate benchmark, though 'floating rates' suffices contextually. Also, the original emphasizes CSCO’s strategy mitigates risk on a 'portion' of debt due to smaller notional vs total debt—this comparative nuance is slightly underdeveloped in the LLM answer. Otherwise, the response is factually correct, relevant, and synthesizes across both companies and financial instruments appropriately.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 385,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 209,
      "question": "How do PM and MDLZ differ in their application of the parametric delta-gamma approximation technique within their VAR models to estimate one-day loss under normal market conditions?",
      "original_answer": "PM applies the parametric delta-gamma approximation technique by observing interest rate and forward currency rate movements primarily over the preceding quarter for determining VAR at year-end, and over each of the four preceding quarters for average, high, and low VAR amounts during the year. MDLZ also uses the parametric delta-gamma method but extends its parameter estimation to include commodity price movements, in addition to interest rates and currencies. Furthermore, MDLZ observes movements over the prior quarter for year-end VAR calculations and across each of the four prior quarters for average VAR amounts, similar to PM, but explicitly accounts for the non-linear behavior of currency and commodity options in its computation.",
      "llm_answer": "Both companies use a parametric δ‑γ (delta‑gamma) approximation, but they apply it to different risk‑factor sets and in slightly different ways. Mondelēz (MDLZ) states that the δ‑γ technique is used to **derive the expected‑return distributions for interest‑rate, currency‑exchange and commodity price movements**, with parameters calibrated from the prior quarter (and the four quarters preceding each average‑VAR calculation). Philip Morris (PM) describes the same technique as being used to **capture the observed inter‑relationships between interest‑rate and currency movements (and to price the underlying positions)**, with no mention of a commodity component; its calibration also relies on the most recent quarter and the four‑quarter history for the high/low/average VAR figures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures all key differences between PM and MDLZ in their use of the parametric delta-gamma approximation within VAR models. (1) It correctly identifies that both companies use the delta-gamma method and calibrate parameters using the prior quarter for year-end VAR and the four preceding quarters for average/high/low VAR amounts—this matches the ground truth exactly. (2) Quantitatively, there are no numbers, dates, or financial figures to verify, but the temporal scope (prior quarter, four prior quarters) is correctly stated with no discrepancies. (3) The multi-hop reasoning is sound: the model correctly synthesizes that MDLZ includes commodity price movements in addition to interest rates and currencies, while PM only considers interest rates and currencies. It also correctly notes that MDLZ explicitly accounts for non-linear behavior of currency and commodity options—a nuance implied in the original answer by 'explicitly accounts for the non-linear behavior'—though the LLM rephrases it as part of deriving return distributions, which is semantically aligned. (4) The only minor shortcoming is that the LLM does not explicitly state that MDLZ 'explicitly accounts for the non-linear behavior of currency and commodity options' in the same direct way as the original answer; instead, it implies this through the mention of using delta-gamma to derive return distributions for those risk factors. This is a subtle but relevant distinction in risk modeling methodology. However, the core factual content, entity accuracy (PM vs MDLZ), and contextual relevance are fully preserved. Wording differences do not detract from correctness, and the answer fully addresses the comparative, multi-hop nature of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 478,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 209,
      "question": "How does Medtronic's emphasis on increasing global patient access to its therapies compare with Amgen's challenges in maintaining patient affordability under pressure from payers like Express Scripts, particularly in light of Express Scripts' role in negotiating deeper discounts that limit access to Amgen's products such as Repatha?",
      "original_answer": "Medtronic aims to expand global patient access to its therapies by leveraging its product pipeline and local presence, as stated in its 2024 10-K. In contrast, Amgen faces significant challenges in ensuring patient affordability for products like Repatha due to increasing payer pressure, particularly from large PBMs such as Express Scripts. Express Scripts, as part of the top six integrated health plans and PBMs controlling 94% of U.S. pharmacy prescriptions, utilizes Rebate Management Organizations to negotiate deeper discounts, which in turn leads to formulary restrictions and higher out-of-pocket costs for patients. This dynamic negatively affects Amgen's product sales and patient access, especially for Medicare patients who abandon prescriptions due to high co-pays, despite Amgen's efforts to lower the list price of Repatha. Therefore, while Medtronic's strategy positively impacts patient access, Amgen's ability to maintain access is constrained by the market power of entities like Express Scripts.",
      "llm_answer": "Medtronic’s 2024 filing stresses that “patients around the world deserve access to our life‑saving products” and that the company is using its global scale and local presence to broaden adoption of its therapies worldwide. In contrast, Amgen reports that U.S. payers—particularly large PBMs such as Express Scripts—are demanding ever‑deeper discounts and rebates on drugs like Repatha, which has forced the company to cut net and list prices yet still leaves out‑of‑pocket costs and payer restrictions limiting patient affordability and access. Thus, while Medtronic is actively pursuing expanded global access, Amgen is contending with payer pressure that curtails access to its products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core contrast between Medtronic's proactive strategy to expand global patient access and Amgen's challenges with payer-imposed affordability barriers, particularly from Express Scripts. (1) All factual elements are correct: Medtronic’s 2024 10-K emphasis on global access via local presence and scale is accurately represented; Amgen’s struggles with PBMs like Express Scripts demanding deeper discounts on Repatha are correctly described. (2) There are no numeric values (e.g., percentages, dollar amounts) in either the ground truth or LLM answer that conflict—both correctly avoid citing specific figures not present in the source material, so quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the model correctly synthesizes Medtronic’s strategic intent with Amgen’s market constraints involving Express Scripts and formulary dynamics. The only minor omission is that the LLM does not explicitly mention the 'top six PBMs controlling 94% of U.S. pharmacy prescriptions' or the specific impact on Medicare patients abandoning prescriptions due to high co-pays—details present in the ground truth that add contextual depth. However, this does not undermine the core correctness. (4) The semantic meaning fully aligns with the original answer, using different but equivalent phrasing (e.g., 'contending with payer pressure' vs 'constrained by market power'). Contextual relevance is excellent as it directly addresses the comparative dynamic asked in the question. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 453,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 210,
      "question": "How does Alphabet's share repurchase strategy prioritize certain stock classes relative to their conversion rights, and what might this imply about potential voting control considerations given that Class A shares are also publicly traded by another major corporation?",
      "original_answer": "Alphabet repurchased $62.2 billion of Class A and Class C shares in 2023, with $36.3 billion remaining available under the repurchase authorization as of December 31, 2023. Notably, Class B common stock—which carries 10 votes per share—can be converted to Class A shares at the stockholder's option or automatically upon sale or transfer. The company has focused repurchases on Class A and Class C shares rather than Class B, preserving the weighted voting power associated with Class B shares. Meanwhile, Class A common stock is also publicly traded by Comcast Corporation (CMCSA), suggesting Class A shares may represent a broader market standard for voting equity that could be strategically maintained for governance purposes.",
      "llm_answer": "Alphabet’s buy‑back program is limited to **Class A and Class C shares** – the two classes that carry one vote per share (or no vote for Class C) – and expressly **excludes Class B shares**, which carry ten votes each and may be **converted at any time into Class A shares** (or automatically convert on a sale or transfer)【page_81†L1-L5】. By retiring only the lower‑voting (or non‑voting) shares, the company preserves the voting power of the ten‑vote Class B stock while shrinking the pool of publicly‑traded Class A shares that are also held by other large investors; this suggests the repurchase is designed to maintain existing voting control rather than dilute it.",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Alphabet's share repurchases are limited to Class A and Class C shares, excluding Class B shares, which carry 10 votes per share and can be converted into Class A shares. It accurately explains the strategic implication of preserving voting control by retiring lower-voting or non-voting shares. However, the LLM omits the specific quantitative figures from the original answer: $62.2 billion in repurchases in 2023 and $36.3 billion remaining authorization as of December 31, 2023. While the absence of these numbers does not invalidate the reasoning, it represents a partial omission of factual detail, affecting quantitative completeness. (2) No incorrect numbers are presented, but the lack of specific dollar amounts reduces quantitative precision. The LLM does not attempt any calculations, so there are no calculation errors. Format variations are acceptable, but here the numbers are entirely missing. (3) The multi-hop reasoning is sound: the model correctly synthesizes information about share classes, voting rights, conversion mechanics, and strategic implications for voting control. It also implicitly recognizes the significance of Class A shares being publicly traded by another entity (though it doesn't name Comcast), linking reduced public float to control preservation. (4) The answer is contextually highly relevant and semantically aligned with the ground truth, with only the missing numeric details preventing a perfect score. The omission of Comcast (CMCSA) as the other corporation trading Class A shares is a minor gap in entity specificity but does not undermine the core reasoning. Overall, the answer is factually correct in its claims and logic, just less detailed in quantitative and entity-specific terms than the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 492,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 210,
      "question": "How might UnitedHealth Group's formulary restrictions on high-cost biologics, as demonstrated by Repatha's access challenges, impact Eli Lilly's ability to maintain revenue growth for its biologic therapies given their dependence on patient access?",
      "original_answer": "UnitedHealth Group, as one of the top six integrated health plans and PBMs controlling 94% of U.S. pharmacy prescriptions, has significant leverage to impose formulary restrictions and require prior authorization for high-cost biologics. This is exemplified by the access limitations placed on Repatha, which resulted in reduced patient affordability and use despite price reductions. Eli Lilly acknowledges that its revenue prospects for biologics are directly affected by patient access issues, including payer restrictions such as prior authorization and formulary exclusions. Given the concentration of payer power and the precedent set by Repatha’s access challenges, Eli Lilly’s ability to maintain revenue growth for its biologic therapies may be significantly constrained if similar restrictions are applied to its products.",
      "llm_answer": "UnitedHealth Group’s use of formulary limits, step‑therapy rules and prior‑authorization requirements that have curtailed patient access to the high‑cost PCSK9 antibody Repatha illustrates how payer‑driven restrictions can suppress demand for expensive biologics. Eli Lilly’s 10‑K notes that its biologic products and pipeline candidates are “highly dependent on patient access” and that “restrictions on pricing, coverage, or reimbursement… may have a material adverse effect” on sales. Consequently, similar UnitedHealth formulary constraints could blunt the growth of Lilly’s biologic revenues by reducing the number of patients who can obtain and stay on those therapies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: UnitedHealth Group's formulary restrictions, exemplified by Repatha's access challenges, are accurately described as involving prior authorization and step-therapy, which limit patient access to high-cost biologics. Eli Lilly’s dependence on patient access is correctly cited from its 10-K, with accurate reflection of risk language regarding pricing, coverage, and reimbursement. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly links UnitedHealth’s payer power (implied by its market position) to restrictions on Repatha, then connects that precedent to potential impacts on Eli Lilly’s biologic revenue growth. While the original answer explicitly mentions UnitedHealth’s market concentration (top six plan controlling 94% of prescriptions), the LLM captures the practical effect of that power without needing to cite the statistic, maintaining semantic equivalence. (4) The LLM omits the specific context about UnitedHealth being part of a concentrated payer market controlling 94% of prescriptions, which slightly reduces completeness but does not undermine the central argument. Wording differs but meaning is preserved. Thus, the answer is contextually relevant, factually correct, and well-reasoned, meriting a high score with only minor room for added detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 422,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 211,
      "question": "How does Oracle's use of its $3.0 billion commercial paper program compare with Cisco's treatment of its $9.0 billion in senior fixed-rate notes, particularly in light of their shared exposure to short-term debt financing mechanisms?",
      "original_answer": "Oracle maintains a $3.0 billion commercial paper program, which allows it to issue unsecured short-term promissory notes under a private placement exemption. As of May 31, 2022, Oracle had no outstanding commercial paper notes. Cisco, on the other hand, had $9.0 billion in principal amount of senior fixed-rate notes outstanding as of July 30, 2022, which rank at par with any commercial paper notes it may issue in the future under its short-term debt financing program. Cisco also uses interest rate swaps to convert fixed interest rates on $1.5 billion of these notes to floating rates based on LIBOR. This indicates that while Oracle actively manages short-term liquidity through a flexible commercial paper facility, Cisco has a larger, more structured long-term debt profile with embedded risk management through interest rate hedging.",
      "llm_answer": "Oracle relies on a dedicated $3 billion commercial‑paper program to meet its short‑term cash needs, issuing unsecured promissory notes on a private‑placement basis and keeping the program “on‑tap” for liquidity (the 10‑K notes that no commercial‑paper notes were outstanding at year‑end). Cisco, by contrast, does not use a commercial‑paper program; instead it carries $9 billion of senior fixed‑rate notes that are long‑term debt, redeemable at any time (subject to a make‑whole premium) and treated as a standard debt liability on its balance sheet. Both companies are therefore exposed to short‑term market conditions – Oracle directly through its CP program, and Cisco indirectly because its senior notes can be called or used to fund working‑capital needs – but Oracle’s exposure is explicit and short‑term, whereas Cisco’s exposure is embedded in a longer‑dated, fixed‑rate bond issue.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer gets key quantitative details correct: Oracle's $3.0 billion commercial paper program and Cisco's $9.0 billion in senior fixed-rate notes are accurately reported, and the absence of outstanding commercial paper for Oracle at year-end (May 31, 2022, in ground truth) is correctly reflected. However, a critical factual error undermines the qualitative accuracy: the claim that 'Cisco does not use a commercial-paper program' is incorrect. The ground truth states that Cisco's senior notes rank at par with any commercial paper notes it may issue in the future, implying the existence or potential use of a commercial paper program. This mischaracterization leads to flawed reasoning about Cisco’s short-term debt exposure. Additionally, the LLM omits key information about Cisco using interest rate swaps to convert $1.5 billion of fixed-rate debt to floating rates based on LIBOR—a major point in risk management strategy highlighted in the original answer. While the LLM correctly contrasts Oracle’s flexible short-term program with Cisco’s more structured long-term debt, it misrepresents the nature of Cisco’s short-term financing mechanisms. The reasoning is partially sound but based on an incorrect premise about Cisco’s commercial paper usage, weakening the multi-hop synthesis. Semantic equivalence is partially achieved on dollar amounts and general structure, but the omission of hedging and misstatement about Cisco’s program reduce factual fidelity. Contextual relevance is strong as the response directly addresses the comparison of short-term debt mechanisms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 433,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 211,
      "question": "How does the extension of ASU 2022-06's optional hedging relief until 2024 impact FedEx's and Caterpillar's management of LIBOR-related interest rate risk in their respective derivative instruments?",
      "original_answer": "ASU 2022-06 extends the optional expedients and exceptions for accounting related to reference rate reform, including LIBOR, until December 31, 2024. FedEx, which references this ASU, continues to monitor its contracts and hedging relationships affected by LIBOR, though it has not yet experienced a material impact. Caterpillar, which actively uses interest rate contracts as part of its risk management strategy, benefits from the extended relief by maintaining flexibility in accounting for LIBOR-based hedging relationships without disruption. The extension allows both companies to continue transitioning away from LIBOR without immediate accounting complications, supporting consistent treatment of derivative instruments tied to legacy rates.",
      "llm_answer": "The SEC’s decision to keep the ASU 2022‑06 optional‑hedging relief in place through Dec. 31 2024 lets both companies continue to treat LIBOR‑linked derivatives under the temporary expedients rather than having to re‑designate or unwind the hedges. FedEx notes that the relief “can generally be applied through December 31, 2024” and, to date, has had no material effect on its results, so it can keep its existing LIBOR‑based interest‑rate contracts in hedge accounting (FedEx 10‑K p. 93). Caterpillar’s risk‑management policy (Caterpillar 10‑K p. 75) relies on fixed‑to‑floating and floating‑to‑fixed interest‑rate contracts to match‑fund its debt‑asset profile, and the extension of the ASU 2022‑06 relief reduces the operational and accounting impact of replacing LIBOR in those contracts, allowing the company to maintain those hedges without costly modifications.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: the extension of ASU 2022-06 until December 31, 2024, is correctly stated, and both FedEx and Caterpillar are accurately described in terms of their use of the relief. (2) Quantitative accuracy is perfect: the date 'December 31, 2024' matches the ground truth, and no erroneous numbers are introduced. Format and citation of page numbers (e.g., FedEx 10-K p. 93, Caterpillar 10-K p. 75) are consistent with source-based reasoning and support factual grounding. (3) Multi-hop reasoning is sound: the answer synthesizes the impact of the ASU extension on both companies’ derivative accounting and risk management strategies. It correctly notes that FedEx has not experienced a material impact but can maintain hedge accounting, while Caterpillar benefits operationally and accountably in its active hedging strategy. The reasoning about avoiding re-designation or unwinding of hedges is logically consistent with the purpose of the expedients. (4) Semantic equivalence is strong—though the LLM uses slightly different phrasing (e.g., 'temporary expedients', 'match-fund its debt-asset profile'), the meaning matches the original answer. The only minor shortcoming is that the LLM attributes the decision to the 'SEC', which is incorrect—ASU standards are issued by the FASB, not the SEC. This is a small but notable entity/process error, preventing a perfect 10 on qualitative accuracy. Otherwise, the answer is complete, relevant, and correctly structured around the multi-entity, multi-hop nature of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 443,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "How does Boeing's use of Citibank, N.A. as administrative agent in its Five-Year Credit Agreement compare with Caterpillar's engagement of Citibank in its multi-facility credit agreements in terms of syndication structure and amendment activity in 2022 and 2023?",
      "original_answer": "Boeing's Five-Year Credit Agreement, dated October 30, 2019, and amended on August 25, 2022, involved Citibank, N.A. as administrative agent alongside JPMorgan Chase Bank, N.A. as syndication agent, with both also serving as joint lead arrangers and joint book managers. Caterpillar, on the other hand, had Citibank, N.A. acting as agent in both its 3-Year and 5-Year Facilities dated September 1, 2022, with additional roles for Citibank Europe plc and MUFG Bank, Ltd. in local currency management. Both companies saw Citibank play a central role in structuring and managing credit facilities, but Caterpillar’s agreements included more complex international components, while Boeing’s amendment in 2022 was a singular update to its existing agreement.",
      "llm_answer": "Boeing’s five‑year credit agreement names Citibank, N.A. solely as the administrative agent, with JPMorgan Chase acting as the syndication agent and joint lead arranger/book‑manager for a single bank syndicate; only one amendment to that agreement was filed in August 2022 and no further amendment is noted for 2023. In contrast, Caterpillar’s multi‑facility credit program (the 3‑year, 5‑year and 364‑day facilities) also uses Citibank, N.A. as the primary agent but relies on a broader syndicate that includes local‑currency agents (Citibank Europe and MUFG) rather than a distinct syndication agent, and it executed amendment No. 1 to both the 3‑year and 5‑year facilities in August 2023 (with the underlying facilities originally dated September 2022), showing active amendment activity in 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains minor inaccuracies and omissions. (1) Quantitatively, the dates and amendment details are mostly accurate: Boeing's amendment on August 25, 2022, is correctly noted (though the LLM omits the exact day, stating only 'August 2022', which is acceptable). Caterpillar's facilities dated September 1, 2022, and Amendment No. 1 in August 2023 are correctly reported. However, the LLM incorrectly references a '364-day facility' for Caterpillar, which is not mentioned in the original answer and lacks support in the ground truth, introducing a factual error. (2) Entity accuracy is strong: Citibank, N.A., JPMorgan Chase Bank, N.A., Citibank Europe plc, and MUFG Bank, Ltd. are correctly identified in their respective roles. (3) Reasoning and synthesis are sound: the LLM correctly contrasts Boeing’s simpler syndication structure (with a distinct syndication agent and joint arrangers) with Caterpillar’s more complex, internationally oriented structure using local currency agents. It also correctly identifies that Caterpillar had amendment activity in 2023 while Boeing did not, which addresses the comparative aspect of the question. (4) Completeness is mostly achieved, but the LLM omits that JPMorgan also served as joint lead arranger and joint book manager alongside Citibank in Boeing’s deal—instead implying JPMorgan acted alone in those roles, which misrepresents the syndication structure. The original answer emphasizes joint roles, which the LLM understates. (5) Despite these nuances, the core comparison—central role of Citibank, simpler vs. more international syndication, and differential amendment activity—is accurately conveyed. The answer remains contextually relevant and semantically close to the ground truth, warranting a high correctness score with minor deductions for structural misrepresentation and the unsupported mention of a 364-day facility.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 525,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "How does the dual-class stock structure at META, which gives Class B shareholders disproportionate voting control, compare to CMCSA's dual-class framework in terms of potential impact on investor confidence, especially given CMCSA's Class B to Class A conversion mechanism?",
      "original_answer": "META's dual-class stock structure gives Class B shareholders, such as Mark Zuckerberg, disproportionate voting control, which could make its Class A common stock less attractive to some investors. This is due to reduced corporate governance protections and potential conflicts of interest. Similarly, CMCSA has a dual-class framework where Class B common stockholders hold 33⅓% of the voting power, and each share of Class B stock is convertible, share for share, into Class A stock. The conversion mechanism in CMCSA could allow for shifts in voting control, much like META's structure, though CMCSA's Class B shares currently represent a much smaller total quantity (9,444,375 issued and outstanding). This structural similarity may affect investor confidence in both companies, especially if control remains concentrated in a minority of shareholders.",
      "llm_answer": "Meta’s 2023 filing makes clear that its dual‑class structure gives the small‑numbered Class B shares (controlled by Mark Zuckerberg) “the ability to control the outcome of matters requiring stockholder approval” even though they represent a tiny fraction of total equity 【page_50】. In contrast, Comcast’s 2023 filing shows that Class B shares carry 15 votes each but only account for about one‑third of total voting power (66 % A vs 33 % B) and are “convertible, share‑for‑share, into Class A common stock” under certain restrictions 【page_91】. Because Meta’s structure concentrates voting in a single insider, it can erode investor confidence, whereas Comcast’s limited‑control B‑class and its conversion feature provide a mechanism that can dilute that concentration over time, making the impact on confidence less severe.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies the core aspects of both META's and CMCSA's dual-class structures and their potential impact on investor confidence. It accurately notes META's concentration of voting power in Class B shares controlled by Mark Zuckerberg and CMCSA's share-for-share convertibility of Class B into Class A. However, there is a significant quantitative error: the LLM states that CMCSA Class B shares carry '15 votes each' and that Class A holds 66% of voting power, which contradicts the ground truth stating that Class B holds exactly 33⅓% of voting power (implying Class A holds 66⅔%). The '15 votes per share' figure is not mentioned in the ground truth and appears to be an unsupported addition from the filing context, making it a factual deviation. 2) The ground truth does not specify vote multiples per share, only the aggregate voting power split (33⅓% B, 66⅔% A), so introducing '15 votes' introduces inaccuracy. The LLM also omits the specific number of CMCSA Class B shares outstanding (9,444,375), a detail present in the original answer that adds precision. 3) The reasoning is sound in comparing the two structures: it correctly infers that META’s extreme concentration of control may harm investor confidence more than CMCSA’s more balanced and convertible structure. The synthesis across both companies is logical and addresses the multi-hop requirement (compare META and CMCSA structures with respect to investor confidence and conversion mechanisms). 4) Despite the numerical inaccuracy and omission of a key quantitative detail, the overall qualitative assessment and direction of comparison align with the ground truth. The LLM captures the essence that CMCSA’s conversion mechanism can dilute control over time, unlike META’s entrenched control. Thus, correctness is reduced primarily due to the vote-per-share error, but the core argument remains valid, warranting a 7/10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 515,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "What was The Coca-Cola Company's net sales to equity method investees in 2021, and which regions does Coca-Cola FEMSA specifically cover in its bottling and distribution operations?",
      "original_answer": "The Coca-Cola Company's net sales to equity method investees in 2021 were $14,471 million. Coca-Cola FEMSA operates in several countries including Mexico (central, southeast, and northeast), Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Venezuela, Brazil (parts of São Paulo, Minas Gerais, Mato Grosso do Sul, Paraná, Santa Catarina, parts of Rio Grande do Sul, Goiás, and Rio de Janeiro), Argentina (Buenos Aires and surrounding areas), and Uruguay.",
      "llm_answer": "In 2021 The Coca‑Cola Company reported net sales to its equity‑method investees of **$14.471 billion**.  \n\nCoca‑Cola FEMSA’s bottling and distribution footprint includes **Mexico (central, southeast and northeast regions), the Central‑American markets of Guatemala, Nicaragua, Costa Rica and Panama, and a broad South‑American presence – most of Colombia, all of Venezuela, Brazil (the states of São Paulo, Minas Gerais, Mato Grosso do Sul, Paraná, Santa Catarina, parts of Rio Grande do Sul, Goiás and Rio de Janeiro), Argentina’s Buenos Aires metropolitan area, and Uruguay**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the net sales amount of $14,471 million is accurately reported as $14.471 billion—this is a valid format conversion (1 billion = 1,000 million), so $14,471 million = $14.471 billion. (2) The regions covered by Coca-Cola FEMSA are completely and accurately listed: Mexico (central, southeast, northeast), Central American countries (Guatemala, Nicaragua, Costa Rica, Panama), South American presence in Colombia, Venezuela, Brazil (with correct states specified), Argentina (Buenos Aires metropolitan area), and Uruguay. The phrasing 'parts of Rio Grande do Sul' and specific state listings in Brazil match the ground truth. (3) The multi-hop reasoning is sound—correctly identifying both a financial figure from The Coca-Cola Company's 2021 reporting and synthesizing geographic operational data about an equity-method investee (Coca-Cola FEMSA). (4) All entities are correctly named and contextualized: The Coca-Cola Company, equity-method investees, Coca-Cola FEMSA, and the respective regions. There are no factual inaccuracies, omissions, or misstatements. The answer is semantically equivalent to the original, with slightly enhanced formatting and clarity. All scoring categories warrant full marks.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 362,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "How does the decline in Remicade sales due to biosimilar competition impact Merck's overall immunology segment revenue, and how does this compare to AbbVie's exposure to biosimilar pressures on biologics like Humira?",
      "original_answer": "Merck's Remicade sales declined by 9% in 2021 and 20% in 2020 due to biosimilar competition in Europe, where it lost market exclusivity in 2015. This decline directly affected its immunology segment, which includes Remicade and Simponi, both impacted by biosimilar pressures. In 2021, Remicade generated $299 million in international sales, contributing to the overall decline in the segment. AbbVie, on the other hand, faces similar biosimilar threats, particularly with Humira, which is now facing direct biosimilar competition in Europe and other countries. Unlike Merck, AbbVie continues to invest heavily in biologics infrastructure and emphasizes patent protection and regulatory exclusivity to delay biosimilar entry, particularly in the U.S. market.",
      "llm_answer": "- Merck’s immunology segment is made up almost entirely of Simponi and Remicade.  In 2021 Simponi generated $825 million and Remicade $299 million, versus $838 million and $330 million in 2020 (a 9 % drop in Remicade sales).  The segment’s total fell from ≈ $1,168 million in 2020 to ≈ $1,124 million in 2021 – a decline of roughly $44 million (about 4 %).  Thus the biosimilar‑driven loss in Remicade contributed only a modest reduction to Merck’s overall immunology revenue.\n\n- AbbVie’s flagship biologic, Humira, accounted for about 37 % of the company’s total net revenue in 2021 and is now facing direct biosimilar competition in Europe and elsewhere.  Because Humira represents a far larger share of AbbVie’s earnings than Remicade does of Merck’s immunology sales, the biosimilar pressure on Humira poses a considerably greater revenue risk to AbbVie than the Remicade decline does to Merck.  \n\n(See Merck immunology table – Remicade $299 M vs $330 M, total immunology $1,124 M vs $1,168 M [pages 61, 141]; AbbVie Humira ≈ 37 % of net revenue [page 6] and biosimilar competition discussion [page 13].)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Remicade sales declined from $330M to $299M in 2021 (a ~9% drop), matching the original answer’s claim of a 9% decline in 2021 (though the ground truth also notes a 20% drop in 2020, which the LLM omits). The immunology segment total is correctly calculated as ~$1,168M in 2020 (Simponi $838M + Remicade $330M) and ~$1,124M in 2021 (Simponi $825M + Remicade $299M), showing a $44M decline. These numbers are accurate and properly cited. (2) The comparison to AbbVie is strong: the LLM correctly identifies that Humira accounted for ~37% of AbbVie’s net revenue in 2021 and emphasizes the greater relative risk to AbbVie due to Humira’s outsized revenue contribution, which is consistent with the ground truth’s implication of higher exposure. (3) Multi-hop reasoning is sound—LLM synthesizes Merck’s segment composition, sales trends, and biosimilar impact, then contrasts with AbbVie’s broader strategic exposure. (4) Minor omission: the ground truth mentions Merck’s loss of market exclusivity in Europe in 2015 and ongoing biosimilar pressure on both Remicade and Simponi, which the LLM does not include. Also, AbbVie’s patent and regulatory strategies to delay biosimilars (especially in the U.S.) are noted in the original but not in the LLM answer. These are contextual nuances rather than factual errors. Overall, quantitative accuracy is perfect; qualitative and contextual accuracy are excellent with only slight incompleteness in background details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 427,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 213,
      "question": "How did Honeywell's investment in Garrett's Series B Preferred Stock, originally tied to indemnification agreements, impact its long-term receivables after the partial redemptions in late 2021, and what was the remaining present value of the unredeemed shares as of December 31, 2021?",
      "original_answer": "Honeywell received $375 million and 834.8 million shares of Garrett's Series B Preferred Stock as part of the resolution of indemnification and tax matters agreements following Garrett's emergence from bankruptcy. The Series B Preferred Stock was subject to mandatory redemptions, with the First Partial Redemption of $211 million completed on December 28, 2021, and a planned Second Partial Redemption of $200 million in early 2022. As of December 31, 2021, the present value of the remaining mandatory redemptions of the Series B Preferred Stock was $423 million, which was included in Honeywell’s long-term receivables and investments.",
      "llm_answer": "The first $211 million partial redemption on December 28 2021 left Honeywell’s investment in Garrett recorded as $34 million of short‑term investments and $423 million of “investments and long‑term receivables” on the balance sheet.  After that redemption, the present value of the Series B Preferred Stock that had not yet been redeemed was $207 million as of December 31 2021.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors, particularly in the present value of the unredeemed shares. The ground truth states that as of December 31, 2021, the present value of the remaining mandatory redemptions was $423 million, which was included in long-term receivables and investments. However, the LLM incorrectly states this present value as $207 million. Additionally, the LLM mentions $34 million in short-term investments, which is not supported by the original answer and appears fabricated. (2) Quantitative inaccuracies include: the $207 million figure for unredeemed shares is wrong (should be $423 million); the $34 million short-term investment is not mentioned in the ground truth. The only correct number is the $211 million first partial redemption on December 28, 2021. (3) The multi-hop reasoning is partially sound in that the model recognizes the partial redemption event and its impact on Honeywell's balance sheet, but it fails to correctly synthesize the financial impact post-redemption. It incorrectly implies that the remaining value is $207 million, which contradicts the ground truth that the remaining present value is $423 million after the $211 million redemption. The original total redemption obligation was $375 million ($211M + $200M planned), and the present value of the remainder being $423M suggests a time-value or discounting adjustment, which the LLM does not account for correctly. (4) The contextual relevance is high because the answer addresses the right entities (Honeywell, Garrett, Series B Preferred Stock), the correct event (partial redemption in late 2021), and the correct financial statement impact (long-term receivables). However, due to major quantitative and qualitative errors in the core financial figures, the correctness and accuracy scores are low.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 499,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 213,
      "question": "How does the voting power distribution in CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, relate to the repurchase activity and voting structure of GOOGL's Class A and Class B common stock, given the interplay between their respective share classes and repurchase programs?",
      "original_answer": "In CMCSA, Class B common stock has 15 votes per share and represents 33 1/3% of the combined voting power, which is entirely owned by Brian L. Roberts. This structure ensures concentrated voting control despite broader share repurchases of Class A stock. Similarly, GOOGL’s Class A shares carry one vote each, while Class B shares have 10 votes per share, and the company repurchased $62.2 billion of Class A and Class C shares in 2023, with $36.3 billion remaining under the repurchase authorization. These repurchases primarily affect the float of lower-vote shares, preserving the relative control of insiders who hold Class B stock. Thus, both companies maintain dual-class structures that insulate control while using share repurchases to manage capital allocation.",
      "llm_answer": "Comcast’s capital structure gives the single holder of its Class B stock – Brian L. Roberts – a fixed one‑third of the company’s total voting power (the Class B shares carry 15 votes each and represent 33 ⅓ % of all votes, while the much larger public‑held Class A shares provide the remaining 66 ⅔ %) and this control is untouched by the 2023 share‑repurchase program, which only bought back Class A shares. Alphabet’s structure is similar in effect: its insiders own the high‑voting Class B shares (10 votes per share) while the public holds only Class A (one vote) and non‑voting Class C shares, and the company’s repurchase program has been directed at Class A and Class C stock, reducing the number of low‑ or non‑voting shares without diluting the voting power of the concentrated Class B holders. Thus, in both firms the dual‑class design concentrates voting control in a small group of insiders, and the repurchase activities are aimed at the lower‑voting classes, preserving that concentration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: CMCSA's Class B stock has 15 votes per share and represents 33 1/3% of voting power, entirely held by Brian L. Roberts; repurchases targeted Class A shares only. For GOOGL, Class B shares have 10 votes, Class A have 1 vote, and repurchases in 2023 covered $62.2 billion of Class A and C shares with $36.3 billion remaining—these figures are accurately reflected in the original answer and correctly referenced in spirit, though the LLM does not explicitly state the dollar amounts. (2) Quantitative accuracy is strong: percentages (33 1/3%, 66 2/3%), vote weights (15, 10, 1), and structural details are correct. The only minor omission is the specific $62.2B repurchase amount and $36.3B remaining authorization from the original answer, which the LLM does not include—this prevents a perfect 10 on correctness. (3) Reasoning is sound: the LLM correctly identifies the multi-hop connection between dual-class structures and repurchase targeting of low-vote shares in both companies, concluding that insider control is preserved. (4) The answer is contextually relevant, directly addressing the interplay between voting power and repurchase activity across both firms. The synthesis is logically coherent and semantically equivalent to the original, with only the absence of exact dollar figures preventing full quantitative completeness. Thus, correctness is 9 due to partial omission of financial figures, but qualitative and contextual accuracy remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 428,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 213,
      "question": "How does the Value-at-Risk (VAR) calculation methodology under normal market conditions used by MDLZ compare to PM's approach, particularly in terms of the time horizon for observing interest rate and currency movements and the confidence interval applied?",
      "original_answer": "Both MDLZ and PM use a VAR model that assumes normal market conditions and applies a 95% confidence interval with a one-day holding period. However, MDLZ observes interest rate, currency exchange, and commodity price movements over the prior quarter for point-in-time VAR calculations and over each of the four prior quarters for average VAR amounts. Similarly, PM observes interest rate and forward currency rate movements primarily over the preceding quarter for point-in-time VAR and over each of the four preceding quarters for average, high, and low VAR amounts. This indicates a largely consistent methodology between the two companies, with both relying on quarterly historical data for risk estimation under normal market conditions.",
      "llm_answer": "Both companies compute VAR under “normal market conditions” with a **one‑day holding period and a 95 % confidence interval**.  \n\n- **MDLZ**: the parameters for interest‑rate, currency‑exchange (and commodity) movements are derived from **the prior quarter’s data** for the point‑in‑time VAR at year‑end, and from **each of the four preceding quarters** when calculating the average‑year VAR.  \n\n- **PM**: similarly, the interest‑rate and forward‑currency movements are taken **primarily from the preceding quarter** for the year‑end VAR, and **each of the four preceding quarters** for the average, high and low VAR figures.  \n\nThus, the time‑horizon (quarter‑back look‑back) and the 95 % confidence level are essentially the same for MDLZ and PM.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: both MDLZ and PM use a 95% confidence interval and a one-day holding period for VAR under normal market conditions. (2) The time horizons for data observation are correctly specified: MDLZ uses the prior quarter for point-in-time VAR and each of the four preceding quarters for average VAR; PM uses the preceding quarter for year-end VAR and each of the four preceding quarters for average, high, and low VAR amounts. These match the original answer exactly in substance. (3) The multi-hop reasoning—comparing two companies' VAR methodologies across time horizons and confidence levels—is sound and correctly synthesizes the required information. (4) Minor wording differences (e.g., 'preceding quarter' vs 'prior quarter') do not affect meaning and are acceptable under semantic equivalence. No factual, quantitative, or qualitative errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 281,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does Apple's reliance on China Mainland for manufacturing, as a component of its Greater China segment, compare with Microsoft's operational footprint in Greater China, particularly in terms of regional support infrastructure and localized product offerings?",
      "original_answer": "Apple relies heavily on China Mainland for manufacturing, which is a key part of its Greater China segment that also includes Hong Kong and Taiwan. This reliance exposes Apple to risks such as trade tensions, tariffs, and supply chain disruptions. Microsoft operates in Greater China through its regional operations center in Singapore, which supports Japan, India, Greater China, and Asia-Pacific. Microsoft also localizes many of its products to reflect local languages and conventions, modifying user interfaces and translating text to better serve the region. Both companies are significantly engaged in Greater China, but Apple's exposure is more supply-chain intensive while Microsoft's is more focused on localized customer engagement and regional support infrastructure.",
      "llm_answer": "Apple’s Greater‑China segment is anchored by physical assets in China Mainland – the bulk of its product‑manufacturing, retail stores and related infrastructure are located there, and “substantially all” of Apple’s manufacturing is performed by contract partners in China Mainland (Apple 10‑K, p. 9; segment note, p. 52). In contrast, Microsoft does not manufacture in Greater China; instead it supports the region from a Singapore‑based operations center that handles order processing, vendor management and logistics, and it relies on extensive product localization (language‑ and market‑specific UI, services) rather than on‑site production (Microsoft 10‑K, p. 16‑18).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Apple's heavy reliance on China Mainland for manufacturing through contract partners, noting that 'substantially all' of its manufacturing occurs there, which matches the original answer's emphasis on supply-chain intensity. It also accurately contrasts this with Microsoft's lack of manufacturing in Greater China and instead highlights Microsoft's Singapore-based operations center for regional support—consistent with the ground truth. The mention of product localization (language- and market-specific UI) is correct and reflects Microsoft's approach to customer engagement. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable in a traditional sense; however, the citation of specific 10-K pages (e.g., p. 9, p. 52, p. 16–18) adds precision and is consistent with source-based reasoning—no errors here. (3) The multi-hop reasoning is sound: the model synthesizes information across Apple’s and Microsoft’s operational models, correctly distinguishing supply-chain reliance from regional support infrastructure and localization strategies. (4) The only reason for not giving a perfect 10 is minor: the LLM omits explicit mention that Greater China includes Hong Kong and Taiwan (though this is implied by referencing the segment), and it doesn’t name the broader Asia-Pacific scope of Microsoft’s Singapore center as clearly as the original. However, these omissions do not detract significantly from the overall correctness. Semantic equivalence is strong, and the answer fully addresses the comparative aspect of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 462,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does UPS's use of pricing models for foreign currency derivatives (classified as Level 2) contrast with GE's use of Level 3 valuation techniques in its insurance and pension liabilities, particularly regarding the role of unobservable inputs?",
      "original_answer": "UPS primarily uses pricing models with observable inputs like yield curves and exchange rates for its foreign currency derivatives, which are classified as Level 2 due to reliance on market-observable data. In contrast, GE employs Level 3 valuation techniques—such as discounted cash flow (DCF) methodologies—for certain insurance and pension liabilities, where significant unobservable assumptions are required. This distinction highlights that while UPS’s derivatives are grounded in active market data, GE’s long-duration insurance contracts and postretirement benefit obligations require internal modeling with assumptions not corroborated by market data, resulting in a higher degree of estimation uncertainty.",
      "llm_answer": "UPS values its foreign‑currency forward and option contracts with internal pricing models that “maximize the use of market‑observable inputs such as interest‑rate curves, forward and spot currency prices,” so the contracts are placed in **Level 2** of the fair‑value hierarchy (see UPS Note 17, pages 136‑137). In contrast, GE’s insurance‑ and pension‑related liabilities are measured using “valuation techniques whose significant inputs are unobservable,” such as mortality, morbidity and other cash‑flow assumptions and a locked‑in discount rate, which places those liabilities in **Level 3** (see GE Note 46, page 46). Thus, UPS relies mainly on observable market data with little judgment, whereas GE’s valuations depend heavily on management‑derived, unobservable assumptions.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately captures that UPS uses observable market inputs (e.g., interest-rate curves, spot and forward currency prices) for its foreign currency derivatives, justifying their Level 2 classification, while GE uses significant unobservable inputs (e.g., mortality, morbidity, locked-in discount rates) for insurance and pension liabilities, placing them in Level 3. (2) There are no numerical values requiring calculation in this question; the references to Note 17 (UPS) and Note 46 (GE) align with the expected disclosure locations and are consistent with the knowledge graph. (3) The multi-hop reasoning is sound: the model correctly contrasts two companies (UPS and GE), two valuation levels (Level 2 vs Level 3), and two types of financial instruments (derivatives vs insurance/pension liabilities), synthesizing the role of observable vs unobservable inputs. (4) The answer matches the original in factual content, adds document-level detail (specific notes and page numbers), and enhances clarity without introducing errors. All scores are maximized due to complete accuracy, correct entity identification, logical reasoning, and full responsiveness to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 352,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does Coca-Cola's reliance on Swire Beverages for distribution in Hong Kong compare to Colgate-Palmolive's operational performance in the same market, given both companies' reported activities in the region?",
      "original_answer": "Coca-Cola relies on Swire Beverages for distribution in Hong Kong, where Swire is one of Coca-Cola's top bottling partners, contributing to a significant portion of Coca-Cola’s non-U.S. unit case volume, which totaled 83% of worldwide volume in 2021. In the same region, Colgate-Palmolive reported $2,867 million in Asia Pacific net sales in 2021, with growth led by the Greater China region, particularly in Oral Care categories such as toothpaste and manual toothbrushes. While Coca-Cola’s distribution strategy in Hong Kong is managed through its bottler partner, Colgate-Palmolive directly manages its operations and achieved 3.0% organic sales growth in Asia Pacific, driven by volume increases and cost savings. This comparison highlights differing market strategies—Coca-Cola through a key bottling partner versus Colgate-Palmolive through direct brand growth—within the same geographic region.",
      "llm_answer": "Coca‑Cola’s Hong Kong market is served through its partnership with Swire Beverages, which is listed among its five largest independent bottlers and is specifically responsible for bottling and distribution in Hong Kong (see KO 10‑K p. 7). By contrast, Colgate‑Palmolive does not rely on a single local partner; it reports its Hong Kong results as part of the Greater China area within the Asia‑Pacific segment, which posted a 6 % rise in net sales to $2.867 billion and a 9 % increase in operating profit to $844 million in 2021, driven by volume growth and positive foreign‑exchange effects (see CL 10‑K p. 42). Thus, Coca‑Cola’s presence in Hong Kong hinges on Swire Beverages’ distribution network, while Colgate‑Palmolive shows overall regional sales and profit growth that includes Hong Kong.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies Coca-Cola's reliance on Swire Beverages for distribution in Hong Kong and references the correct entity and partnership structure. It also correctly notes that Colgate-Palmolive includes Hong Kong in its Greater China/Asia-Pacific reporting segment. However, there are significant quantitative inaccuracies: the LLM states that Colgate-Palmolive’s Asia-Pacific operating profit increased 9% to $844 million, but this figure is not present in the ground truth and cannot be verified from the provided original answer. The original answer only mentions $2,867 million in Asia Pacific net sales and 3.0% organic sales growth—no operating profit figure is given. Additionally, the LLM claims a '6% rise in net sales' to $2.867 billion, but the original answer does not specify the percentage increase, only the total amount and that growth was driven by Greater China and Oral Care. 2) The net sales figure of $2.867 billion (or $2,867 million) is correctly stated and matches the ground truth. However, the additional financial figures (operating profit of $844 million, 6% sales increase, 9% profit increase) are not supported by the original answer and appear to be fabricated or misattributed. 3) The reasoning correctly contrasts Coca-Cola’s indirect distribution model via Swire with Colgate-Palmolive’s direct regional operations, which is a valid multi-hop synthesis. However, the comparison is weakened by the inclusion of unsupported financial metrics, undermining the reliability of the analysis. 4) The contextual relevance is high—the answer addresses both companies’ presence in Hong Kong, their operational models, and attempts a comparative analysis. Despite incorrect numbers, the core structure and intent align with the question. The qualitative reasoning is sound where facts are correct, but the introduction of unverified data reduces overall correctness. Thus, a score of 6 is justified: partially correct with key factual errors in financial reporting.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 538,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does BAC's investment in CDOs, which contain embedded derivatives, compare to JPM's valuation methodology for similar structured notes with embedded derivatives, particularly in terms of risk exposure and modeling techniques?",
      "original_answer": "BAC invests in CDOs that are part of its broader involvement with VIEs, and while the Corporation does not consolidate these vehicles, it recognizes maximum loss exposure tied to the value of its investment balances. These CDOs are linked to embedded derivatives, as noted in the context of hybrid instruments where credit protection has been sold to the issuer, exposing the investor to credit events. JPM, on the other hand, explicitly discloses that structured notes with embedded derivatives are valued using discounted cash flow analyses and models such as Black-Scholes or simulation models, depending on the derivative features. JPM also adjusts valuations for its own credit risk (DVA), indicating a more detailed and model-driven approach to managing the risk of these instruments. This comparison highlights differing approaches to both risk exposure and valuation transparency in handling similar financial products.",
      "llm_answer": "Bank of America’s CDO holdings are treated as investments in VIE‑issued ABS/CLOs; the firm measures them at fair value (often Level 3) using the value of the underlying pool and does not model the embedded optionality separately, and its loss exposure is limited to the amount invested (plus any off‑balance‑sheet liquidity commitments). JPMorgan, by contrast, values structured notes that contain embedded derivatives with a discounted‑cash‑flow approach that explicitly prices the optionality – using Black‑Scholes, Monte‑Carlo or other simulation models and observable/unobservable inputs, and then adjusts for its own credit risk (DVA), classifying the result as Level 2 or Level 3. Thus, BAC’s exposure is measured more simply as the net investment in the CDO, while JPM’s methodology captures a broader set of market‑risk sensitivities through sophisticated option‑pricing models.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: BAC's investment in CDOs tied to VIEs, non-consolidation, exposure limited to investment value, and lack of separate modeling for embedded derivatives are accurately described. JPM's use of discounted cash flow models, specific techniques like Black-Scholes and Monte Carlo simulations, use of observable/unobservable inputs, and DVA adjustments are all correctly reported. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not compromised—no discrepancies exist. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two firms (BAC and JPM), two types of instruments (CDOs vs. structured notes), and compares both risk exposure frameworks and valuation methodologies. The distinction between BAC’s simpler, investment-level exposure assessment and JPM’s granular, model-driven approach is logically drawn and well-supported. (4) Semantic equivalence is strong: while the LLM uses slightly more technical phrasing (e.g., 'Level 3', 'Level 2', 'optionality', 'simulation models'), it conveys the same core insights as the original—particularly that JPM employs a more detailed, transparent, and sophisticated modeling approach. The only minor shortcoming is that the LLM mentions 'off-balance-sheet liquidity commitments' and 'Level 2/Level 3' classifications, which, while plausible and consistent with SEC disclosures, are not explicitly in the ground truth. However, these do not contradict the original and add context without introducing error. Thus, the answer earns a 9/10 for correctness—excellent, but not perfectly aligned in every detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 483,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 215,
      "question": "How does the voting structure of CMCSA's Class B Common Stock compare to NFLX's common stock voting rights, given the specific limitations outlined in CMCSA's disclosure?",
      "original_answer": "CMCSA's Class B Common Stock has limited voting rights, only allowing votes on specific matters such as exiting the core payments business, certain consolidation or merger transactions, or amendments to the certificate of incorporation, and votes are calculated by multiplying shares held by the applicable conversion rate. In contrast, NFLX grants one vote per share on all matters to be voted upon by stockholders, providing more generalized voting power. CMCSA's disclosure also indicates that Class B Common Stock was issued and outstanding as of 2023, reinforcing the structured governance framework in place.",
      "llm_answer": "CMCSA’s Class B common stock does **not** carry the normal one‑vote‑per‑share entitlement – it is essentially non‑voting (or only votes on a narrow set of matters as described in the filing). In contrast, Netflix’s common stock gives **one vote for each share** on all shareholder matters, with no special limitations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) It accurately conveys that CMCSA's Class B Common Stock has limited voting rights—either non-voting or restricted to specific matters such as mergers, amendments, or exiting core business—while NFLX common stock provides one vote per share on all matters. This matches the original answer's core content. (2) There are no numeric values requiring calculation (e.g., dates, percentages, dollar amounts), so quantitative accuracy is not compromised; the mention of 'one vote per share' for NFLX is correct. (3) The multi-hop reasoning—comparing governance structures across two companies based on their SEC disclosures—is sound: the model correctly identifies the contrast in voting rights frameworks between CMCSA and NFLX. (4) The only minor shortcoming is that the LLM omits the detail about the conversion rate used in calculating CMCSA Class B votes and does not explicitly note that Class B shares were still outstanding as of 2023, which adds contextual completeness. However, these omissions do not undermine the central accuracy of the comparison. Wording differences (e.g., 'essentially non-voting' vs 'limited voting rights') are acceptable under semantic equivalence. Overall, the answer is highly accurate, relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 370,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 215,
      "question": "How does the treatment of embedded derivatives within CDOs by Morgan Stanley compare to JPMorgan Chase's valuation methodology for similar instruments, given their respective involvement in structured note products?",
      "original_answer": "Morgan Stanley treats CDOs as hybrid instruments containing embedded derivatives, where credit protection has been sold to the issuer of the note, and if there is a credit event of a reference entity, the principal balance of the note may not be repaid in full. JPMorgan Chase, on the other hand, values structured notes using discounted cash flow analyses that consider the embedded derivative features through models like Black-Scholes or simulation models, with adjustments for the Firm's own credit risk (DVA). Both firms recognize the complexity and risk associated with these instruments, but differ in how they disclose and value the embedded derivatives within their portfolios.",
      "llm_answer": "Morgan Stanley classifies CDOs that contain embedded derivatives as “hybrid” credit‑linked notes and records them at fair value within its investment‑securities portfolio, but the filing does not spell out a separate valuation model for the embedded component—it is simply treated as part of the overall fair‑value measurement of the instrument. JPMorgan Chase, by contrast, values structured‑note products (including CDO‑type instruments) with a discounted‑cash‑flow analysis that explicitly models the embedded derivative using Black‑Scholes, simulation or other option‑pricing techniques and then adjusts the result for its own credit risk (DVA), placing the fair value in Level 2 or Level 3 of the hierarchy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Morgan Stanley treats CDOs with embedded derivatives as hybrid instruments (specifically credit-linked notes) and records them at fair value, without detailing a separate valuation model for the embedded derivative—consistent with the original answer’s description of Morgan Stanley’s approach. (2) For JPMorgan Chase, the LLM accurately states the use of discounted cash flow analyses incorporating Black-Scholes or simulation models to value embedded derivatives in structured notes, including adjustments for DVA (debt valuation adjustment), which matches the ground truth. It also correctly notes the use of Level 2 or Level 3 in the fair value hierarchy, a detail not in the original answer but factually consistent and contextually relevant, adding precision without introducing error. (3) The multi-hop reasoning is sound: the model correctly contrasts the two firms’ methodologies—Morgan Stanley’s holistic fair value treatment versus JPMorgan’s explicit modeling of embedded derivatives—demonstrating synthesis across entities and concepts. (4) There are no numerical inaccuracies; the answer contains no figures but refers to qualitative modeling techniques and accounting treatments correctly. The only minor shortcoming is that the LLM does not explicitly mention the credit event risk to principal repayment in Morgan Stanley’s case, a nuance present in the original answer, but this does not undermine the core accuracy. Overall, the answer is semantically equivalent, contextually precise, and factually correct, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 451,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 216,
      "question": "How does Abbott's exposure to intellectual property risks, particularly regarding patent enforcement, intersect with AbbVie's legal actions through its subsidiary Forest Laboratories Holdings Limited to protect the exclusivity of Vraylar, and what implications does this have for both companies' pharmaceutical revenue streams?",
      "original_answer": "Abbott faces significant risks related to the expiration or loss of intellectual property protection, which could reduce future revenues and operating income. In parallel, AbbVie's subsidiary Forest Laboratories Holdings Limited is actively involved in patent enforcement litigation concerning Vraylar (cariprazine), seeking to prevent generic competition from companies like Sun Pharmaceutical and Aurobindo Pharma. This litigation, initiated in the U.S. District Court for the District of Delaware in December 2019, aims to preserve market exclusivity for Vraylar, a key pharmaceutical product. If successful, the enforcement of these patents would protect AbbVie’s revenue from Vraylar. However, if generic versions are allowed to enter the market, both companies could face competitive pressure—Abbott due to its reliance on strong IP protections and AbbVie through reduced exclusivity for Vraylar—highlighting the interplay between IP enforcement and pharmaceutical revenue sustainability.",
      "llm_answer": "Abbott warns that “the expiration or loss of intellectual‑property protection… could affect Abbott’s future revenues” and that “failure to … maintain intellectual‑property rights … may cause Abbott’s revenues and operating results to suffer”【page_12】.  By contrast, AbbVie – through its wholly‑owned Forest Laboratories Holdings Ltd. – is actively suing generic manufacturers to enforce the patents covering cariprazine (Vraylar), seeking declaratory and injunctive relief to keep the drug off the market【page_136】.  Thus, while Abbott’s financial outlook is vulnerable to any challenge that erodes its patent portfolio, AbbVie’s aggressive Vraylar litigation is aimed at preserving that product’s exclusivity and the associated revenue stream; the success or failure of each company’s patent enforcement directly influences the size and stability of their pharmaceutical earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Abbott's exposure to IP risks is accurately described, and AbbVie's litigation through Forest Laboratories Holdings Limited to protect Vraylar (cariprazine) is correctly identified. The involvement of generic competitors is implied through 'suing generic manufacturers,' aligning with the original mention of Sun Pharmaceutical and Aurobindo Pharma. (2) There are no numeric values, dates, or calculations in the question or answers that conflict; the LLM does not introduce any incorrect quantitative data. The absence of the specific December 2019 filing date and the U.S. District Court for the District of Delaware is a minor omission but does not detract from the overall correctness. (3) The multi-hop reasoning is sound: the LLM correctly links Abbott’s general IP vulnerability with AbbVie’s active patent enforcement for Vraylar, and draws a logical contrast in how each company is positioned regarding IP—passive risk vs. active defense—then ties this to pharmaceutical revenue implications. (4) The answer is contextually precise, directly addressing the intersection of IP risks and legal actions and their impact on revenue streams. Wording differs but semantic meaning matches the original. The only reason for not scoring a 10 is the slight lack of specificity on litigation timing and court, which are present in the ground truth but omitted in the LLM response—however, these are not central to the core inference about revenue implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 433,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 216,
      "question": "How does Citigroup's use of foreign currency forwards and cross-currency swaps in its net investment hedging strategy compare to Morgan Stanley's reliance on VaR models for managing market risk exposure in trading portfolios?",
      "original_answer": "Citigroup utilizes foreign currency forwards, cross-currency swaps, and options to hedge foreign exchange risk on equity investments in non-U.S.-dollar subsidiaries, recording changes in fair value in CTA within AOCI under ASC 815. In contrast, Morgan Stanley employs Value-at-Risk (VaR) models as a key risk management tool to estimate aggregate market risk exposure across trading portfolios, incorporating diversification and hedging effects, while acknowledging VaR's limitations in capturing extreme market events or liquidity constraints. Southern Company Gas, which connects the two entities, also uses weather derivative instruments and other risk management tools to mitigate weather-related revenue volatility in its gas marketing services segment, demonstrating a broader industry application of risk management frameworks.",
      "llm_answer": "Citigroup’s net‑investment‑hedge program is instrument‑focused: it designates foreign‑currency forwards, cross‑currency swaps, options and foreign‑currency‑denominated debt as hedges of the FX risk embedded in its non‑U.S. equity subsidiaries, recording the fair‑value changes of those contracts in the foreign‑currency translation adjustment (CTA) within AOCI【page_153】.  \n\nMorgan Stanley, by contrast, does not rely on specific hedge contracts for that purpose; instead it measures and controls its trading‑portfolio risk primarily through a Value‑at‑Risk (VaR) framework—historical‑simulation and Monte‑Carlo models that aggregate interest‑rate, credit‑spread, equity, FX and commodity exposures—using VaR (with stress‑testing and scenario analysis) as the central tool for daily market‑risk monitoring【page_59】【page_60】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Citigroup's use of foreign currency forwards, cross-currency swaps, options, and foreign-currency-denominated debt to hedge FX risk in non-U.S. equity subsidiaries, with fair value changes recorded in CTA within AOCI under ASC 815—consistent with the original answer. It also accurately describes Morgan Stanley’s reliance on VaR models (historical simulation and Monte Carlo) for measuring aggregate market risk in trading portfolios, including the integration of stress testing and scenario analysis. (2) There are no numeric values in the question or answer requiring quantitative verification, so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model correctly contrasts Citigroup’s instrument-based hedging strategy with Morgan Stanley’s model-based risk measurement approach. However, the LLM omits the mention of Southern Company Gas and its use of weather derivatives, which is part of the original answer and serves as a connecting entity demonstrating broader industry risk management practices. This omission slightly reduces completeness and qualitative accuracy, though it does not affect the core comparison asked in the question. (4) The response is contextually highly relevant, directly addressing the comparison between Citigroup’s hedging instruments and Morgan Stanley’s VaR framework. The inclusion of page references adds credibility. The omission of Southern Company Gas is minor in terms of the primary comparison but prevents a perfect score. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth on the main comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 470,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 217,
      "question": "How does Colgate-Palmolive's use of option contracts to hedge foreign exchange risk compare to Walmart's exposure through firm commitments, given the impact of these financial instruments on their respective cash flow stability?",
      "original_answer": "Colgate-Palmolive utilizes option contracts as part of its foreign exchange risk management strategy, hedging portions of its foreign currency purchases and firm commitments with contracts valued using observable market rates, aiming to minimize earnings volatility from currency fluctuations. These contracts, with a typical duration of no more than 12 months, are aligned with the company's policy of matching derivative terms to underlying exposures. In contrast, Walmart reports $37.2 billion in unrecorded purchase obligations as of January 31, 2025, including $15.9 billion due within one year, which includes firm commitments for inventory, utilities, and capital expenditures. These obligations are legally binding and expose Walmart to cash flow risks if market conditions change. The impact of Colgate's use of option contracts is to stabilize the U.S. dollar equivalent value of foreign currency transactions, while Walmart lacks such financial instrument protections on its firm commitments, leaving it more exposed to market volatility affecting its cash flow stability.",
      "llm_answer": "Colgate‑Palmolive hedges its foreign‑exchange exposure by entering into a mix of forward, swap and **option contracts** that cover the currency portion of its purchases, assets, liabilities and net‑investment in foreign subsidiaries; the contracts are generally short‑dated (≤ 12 months) and are accounted for at fair value, with gains and losses flowing through earnings to blunt the impact of currency moves on operating cash flow. In contrast, Walmart also uses **option and forward contracts**, but it explicitly ties them to its large **firm‑commitment** inventory and other forecasted transactions, maintaining net cash‑flow‑hedge notional of about **$9.9 billion** (2024) and deferring the mark‑to‑market results in AOCI until the underlying commitments occur, thereby providing a more extensive buffer against cash‑flow volatility from its sizable purchase obligations. Thus, while both firms rely on options to smooth earnings, Colgate’s hedges are smaller‑scale and focused on cost‑of‑goods and subsidiary exposure, whereas Walmart’s hedges are larger‑scale, linked to firm‑commitments, and designed to protect cash‑flow stability across its massive inventory‑purchase program.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitatively, it incorrectly states that Walmart uses option and forward contracts with a notional value of $9.9 billion (2024) tied to firm commitments, which directly contradicts the ground truth: Walmart does *not* use financial instruments like options or forwards to hedge its $37.2 billion in unrecorded purchase obligations, including $15.9 billion due within one year. The $9.9 billion figure appears fabricated or misattributed. (2) The answer falsely claims Walmart uses options and forwards linked to firm commitments and defers mark-to-market results in AOCI, implying active cash flow hedging—this is incorrect per the original answer, which states Walmart lacks such financial instrument protections. (3) Qualitatively, the reasoning is flawed: it draws a comparison suggesting Walmart has a more extensive hedging program than Colgate, when in fact the opposite is true—Colgate actively hedges FX risk with options, while Walmart’s firm commitments are *unhedged*. (4) The multi-hop synthesis fails: the core of the question is to contrast Colgate’s use of derivatives (options) to stabilize cash flows vs. Walmart’s exposure due to lack of such instruments on firm commitments. The LLM incorrectly aligns Walmart with active hedging, reversing the true relationship. (5) While the description of Colgate’s hedging strategy is partially accurate (use of options, short duration, fair value accounting), it adds unverified details like 'swap contracts' and 'net-investment in foreign subsidiaries' not in the original. (6) Contextual relevance is moderate—the answer addresses FX risk and cash flow stability, but the incorrect attribution of hedging practices to Walmart severely distorts the comparison. Overall, major factual and reasoning errors lead to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1588,
        "completion_tokens": 508,
        "total_tokens": 2096
      },
      "error": null
    },
    {
      "question_id": 217,
      "question": "How does the adoption timeline of ASU No. 2023-07 for segment reporting differ between TMO and CVS, and what specific disclosures were required by each company as a result of this new standard?",
      "original_answer": "TMO adopted ASU No. 2023-07 for its 2024 annual report and applied it retrospectively, resulting in increased disclosures in Note 11. CVS adopted the standard on January 1, 2024, for fiscal year reporting and is required to provide additional disclosures related to its reportable segments, including the CODM's title, how the CODM uses segment operating results, and alignment of interim reporting with annual requirements, as detailed in Note 19. Both companies applied the standard retrospectively to prior periods, but TMO implemented it specifically for the 2024 annual report while CVS also aligned it with interim reporting requirements starting after December 15, 2024.",
      "llm_answer": "- **Adoption timing** – Thermo Fisher said it **adopted ASU 2023‑07 on 1 January 2024** for its FY 2024 filing and the standard became effective for any interim periods that begin after 15 December 2024 (the company will apply it retrospectively to all prior periods). CVS indicated that it **adopted the same ASU for its 2024 annual report** (the first filing in which the guidance is applied) and will use it for subsequent interim periods.\n\n- **Disclosures required** –  \n  *Thermo Fisher* added a new “Segment Reporting” note (Note 19) that provides the CODM’s title and position, explains how the CODM uses the reported segment operating measure to evaluate performance and allocate resources, and discloses the newly‑required **significant segment expense items** for each reportable segment.  \n  *CVS* added comparable segment‑reporting disclosures (in its Note 11) that also identify the CODM, describe the CODM’s role in evaluating and resourcing segments, and present the **disaggregated segment expense information** required by the ASU.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies that impact correctness. It states Thermo Fisher (TMO) adopted ASU 2023-07 on January 1, 2024, but the ground truth specifies TMO adopted it for its 2024 annual report (which may not align exactly with a January 1 effective date) and applied it retrospectively. Conversely, CVS did adopt the standard on January 1, 2024, per the ground truth, but the LLM incorrectly reverses the specificity: it says TMO adopted on Jan 1, 2024, and CVS adopted for the 2024 annual report — this swaps the precise timing details. (2) Regarding disclosures, the LLM attributes Note 19 to Thermo Fisher and Note 11 to CVS, but the ground truth states TMO disclosed in Note 11 and CVS in Note 19 — the notes are swapped, which is a factual error. The types of disclosures (CODM title, use of segment results, disaggregated expenses) are correctly identified for both companies and align semantically with 'significant segment expense items' and 'disaggregated segment expense information'. (3) The multi-hop reasoning is partially sound — the model correctly identifies that both companies applied the standard retrospectively and added similar types of disclosures, which reflects synthesis across entities. However, the misattribution of adoption dates and note numbers indicates a failure in precise cross-document alignment. (4) The contextual relevance is high because the answer addresses both parts of the question (adoption timeline and disclosures) and attempts comparative analysis. However, due to swapped dates, note numbers, and misassigned details between TMO and CVS, the quantitative and qualitative accuracy are reduced to moderate levels despite capturing general trends correctly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 475,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "What was the impact of the Philippines' corporate income tax rate reduction on ACN's 2021 effective tax rate, and how does this compare to AMD's disclosure of tax reform effects in the same period?",
      "original_answer": "ACN benefited from the Philippines' corporate income tax rate reduction enacted in Q1 2021, which favorably impacted its 2021 effective tax rate of 21.8%, partially offsetting other unfavorable tax factors like GILTI-related foreign tax credit limitations. In contrast, AMD reported no impact from the Tax Reform Act in 2021, as shown by the $0 value in their tax provision table for that line item, indicating different exposure or geographic applicability of the reform.",
      "llm_answer": "The 2021 filing notes that the corporate‑income‑tax rate cut in the Philippines “partially offset” other upward pressures on the effective tax rate, limiting the increase to just 0.1 percentage point and leaving PMI’s (the company referenced) effective tax rate at 21.8 percent for the year. In AMD’s 2022 10‑K, the tax‑reform discussion appears only as a historic line‑item for 2019 (“Tax Reform Act”) and there is no mention of a 2021 impact, indicating that AMD did not record a material effect from tax‑reform measures in that period.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly identifies the company as PMI instead of ACN, which is a critical entity error. The original answer clearly states that ACN (Accenture) was the company affected by the Philippines' tax rate reduction. PMI (Philip Morris International) is unrelated and not mentioned in the ground truth. This misidentification undermines the entire response. (2) The quantitative claim that the rate cut 'limited the increase to just 0.1 percentage point' is not supported by the original answer, which does not quantify the exact offsetting effect—only that it 'partially offset' other unfavorable factors. The 21.8% effective tax rate is correctly cited, but the context around it is distorted. (3) The reasoning for AMD is partially correct: the LLM correctly infers no 2021 impact from the absence of a line item in AMD’s filing, aligning with the ground truth’s reference to a $0 value. However, the LLM cites the '2022 10-K' and refers to a 'historic line-item for 2019', which introduces ambiguity not present in the original answer that directly states AMD reported $0 impact in 2021. (4) The multi-hop synthesis fails because the LLM conflates two different companies (ACN vs PMI), breaking the chain of correct entity-document mapping. While the general structure of comparing tax reform impacts across firms is sound, the factual foundation is flawed. The contextual relevance is moderate because the answer addresses tax rate changes and cross-company comparison, but the wrong company attribution severely limits usefulness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 429,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does Honeywell's use of pricing models for valuing fixed income investments in its pension plans compare to 3M's valuation methodology, particularly in terms of reliance on observable versus unobservable inputs?",
      "original_answer": "Honeywell values its fixed income investments using pricing models, broker bids, or discounted cash flows, incorporating adjustments for credit and liquidity risks when necessary. 3M similarly uses pricing models that rely on observable inputs like interest rates and yield curves for Level 2 fixed income investments, while Level 3 investments depend on unobservable inputs such as projected annuity payments and discount rates. Both companies apply discounted cash flow techniques in certain cases and disclose the use of NAV practical expedients for certain fund types, though 3M explicitly categorizes its fixed income investments by valuation hierarchy levels, whereas Honeywell focuses on the nature of the valuation adjustments made.",
      "llm_answer": "Honeywell says that its corporate‑bond, mortgage‑backed and government‑security holdings in the pension plans are “valued either by using pricing models, bids provided by brokers or dealers, quoted prices of securities with similar characteristics, or discounted cash flows,” and that these valuations “include adjustments for certain risks that may not be observable such as credit and liquidity risks” 【page_110】.  \n\n3M’s pension‑plan assets are measured in the fair‑value hierarchy: Level 2 fixed‑income securities are valued “using yields currently available on comparable securities of issuers with similar credit ratings or valued under a discounted‑cash‑flow approach that utilizes observable inputs, such as current yields of similar instruments, but includes adjustments for certain risks that may not be observable such as credit and liquidity risks” 【page_75】.  \n\nThus, both companies base their valuations primarily on observable market data, but each adds unobservable adjustments for credit and liquidity; 3M additionally classifies any securities for which observable inputs are unavailable as Level 3, indicating a greater reliance on unobservable inputs for those assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: Honeywell uses pricing models, broker bids, and discounted cash flows, with adjustments for unobservable risks like credit and liquidity (page 110 reference). 3M uses observable inputs (e.g., yields on comparable securities) for Level 2 fixed income, and discounted cash flow with observable inputs but unobservable adjustments; Level 3 assets rely on unobservable inputs (page 75). These points match the original answer. (2) There are no numeric values requiring calculation, so quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the model correctly compares two companies' valuation methodologies, identifies their shared use of observable inputs and unobservable adjustments, and notes 3M’s explicit use of the fair value hierarchy (Level 2 vs Level 3), which Honeywell does not emphasize. The only minor omission is that the original answer mentions both companies disclose NAV practical expedients for certain funds, which the LLM answer does not include—this is a small completeness gap but does not undermine the core comparison. (4) The response is fully relevant, directly addressing the comparison of observable vs unobservable inputs in valuation methodologies. Wording differs but semantic meaning is equivalent. Thus, correctness is 9/10 due to one minor omission, but all critical elements are present and accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 403,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does the voting power distribution tied to Class B common stock conversion mechanisms at CMCSA compare with the share repurchase strategy for Class A and Class C shares at GOOGL, given the differing impacts on equity structure and shareholder control?",
      "original_answer": "At CMCSA, Class B common stockholders control 33 1/3% of the voting power, which is non-dilutable and convertible share-for-share into Class A common stock, while the voting power of Class A shares depends on the total number of Class A and Class B shares outstanding. This structure ensures continued influence by Class B holders. In contrast, GOOGL has repurchased $62.2 billion of Class A and Class C shares in 2023, with an additional $36.3 billion remaining under the repurchase authorization. These repurchases reduce the number of outstanding shares, increasing the proportional ownership of remaining shareholders, including those holding Class B shares, which carry 10 votes per share. Since Class B shares automatically convert to Class A upon sale or transfer, these repurchases indirectly influence the balance of voting control by reducing the total pool of shares subject to Class A voting calculations. Thus, while CMCSA’s structure protects Class B voting power through fixed percentages and conversion rules, GOOGL’s equity control dynamics are shaped by aggressive repurchases that affect the relative ownership and voting influence of remaining shareholders.",
      "llm_answer": "Comcast’s Class B shares carry 15 votes each and represent roughly one‑third of the company’s total voting power, but the stock is convertible share‑for‑share into Class A (one‑vote) shares; each conversion therefore shifts voting power from the high‑vote Class B pool into the lower‑vote Class A pool and can dilute the influence of the remaining Class B holders. Alphabet, by contrast, repurchases only its non‑voting Class C and one‑vote Class A shares, permanently retiring those shares and raising the ownership percentage of the remaining stock without altering the voting‑rights structure—its powerful Class B shares (which are not part of the buy‑back) retain the same voting concentration. Thus, Comcast’s conversion mechanism directly reshapes voting control, whereas Alphabet’s share‑repurchase program mainly trims equity and boosts per‑share metrics while leaving shareholder control essentially unchanged.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that CMCSA's Class B shares carry '15 votes each'—the ground truth does not specify vote counts per share but instead emphasizes that Class B holds 33 1/3% of total voting power, which is non-dilutable. There is no mention of 15 votes per share in the original answer, making this a significant error. Second, the LLM implies that conversion of Class B to Class A dilutes remaining Class B holders, but the original answer states the voting power of Class B is non-dilutable and fixed at one-third, so this reasoning is flawed. (2) Regarding GOOGL, the LLM claims repurchases do not alter voting rights structure—which is partially correct—but fails to mention the key quantitative data from the original: $62.2 billion repurchased in 2023 and $36.3 billion remaining authorization. These specific figures are entirely missing, and the answer does not note that repurchases increase proportional ownership of remaining shareholders, including Class B holders, thus indirectly affecting control. (3) The multi-hop reasoning is partially sound in comparing structural mechanisms (conversion vs. repurchase), but the synthesis is undermined by incorrect facts and omissions. The LLM incorrectly frames CMCSA’s mechanism as dilutive when it is designed to be non-dilutive, and it overlooks how GOOGL’s repurchases indirectly influence voting control by reducing the total share pool—specifically impacting the relative weight of Class A voting calculations. (4) The contextual relevance is high because the answer addresses the core comparison between voting structures and equity strategies. However, due to major quantitative errors, incorrect vote counts, and flawed reasoning about dilution and control dynamics, the correctness score is low. The qualitative accuracy is moderate because the general direction of analysis is reasonable, but the details are misleading.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1551,
        "completion_tokens": 530,
        "total_tokens": 2081
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does Altria's exposure to FCTC-driven advertising restrictions, as outlined in its 2022 10-K, compare to Philip Morris International's experience with implemented advertising bans in markets like Australia and Russia, and what implications does this have for their respective international marketing strategies?",
      "original_answer": "Altria acknowledges in its 2022 10-K that while the U.S. is a signatory to the FCTC, it is not a party to the agreement, and therefore FCTC-driven advertising restrictions have limited direct regulatory impact in the U.S. However, the document notes that the FCTC has called for and influenced advertising bans globally. In contrast, Philip Morris International (PMI) reports that in markets like Australia and Russia, governments have already banned the display of tobacco products at the point of sale, which severely restricts visibility and marketing potential. These bans align with FCTC guidelines recommending the prohibition of all forms of communication with adult smokers. Given that Altria's primary market remains the U.S., where such bans are not yet widespread, its international marketing strategy is less constrained compared to PMI, which operates more heavily in FCTC-compliant markets where advertising and product visibility restrictions are already enforced. This divergence suggests that PMI must adapt more aggressively to restrictive advertising environments, while Altria faces more potential future risk if the U.S. adopts similar FCTC-aligned policies.",
      "llm_answer": "Altria’s 2022 10‑K notes that, because the United States has not ratified the WHO Framework Convention on Tobacco Control, its exposure to FCTC‑driven advertising, marketing and sponsorship bans is limited to a few overseas markets (e.g., Australia and Russia) where governments have already prohibited point‑of‑sale displays and are considering broader advertising restrictions【page_42】. In contrast, Philip Morris International’s filing documents that full advertising bans are already in force in Australia and Russia, forcing the company to shift spend away from traditional media and retail‑display promotions to product‑innovation and reduced‑risk product positioning【PM_10k_2022 pages 17, 25, 30, 42, 43】. Consequently, Altria must remain vigilant for future FCTC‑driven limits but still retains more flexibility in its international marketing mix, whereas PMI’s strategy is already constrained and centered on alternative channels and product‑differentiation in markets where bans are active.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content, entities, and reasoning. (1) It accurately identifies that the U.S. has not ratified the FCTC, limiting Altria's current exposure to FCTC-driven advertising restrictions, while Philip Morris International (PMI) faces implemented bans in markets like Australia and Russia. The core facts about point-of-sale display bans and marketing constraints in those countries are correct. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the model correctly contrasts Altria’s limited current exposure due to U.S. market focus with PMI’s operational reality in FCTC-compliant markets. However, there is a minor inaccuracy: the LLM states Altria has exposure 'in a few overseas markets (e.g., Australia and Russia)', which is misleading because Altria’s primary operations are domestic and it does not have significant marketing activities in Australia or Russia—those examples are relevant to PMI, not Altria. This misattribution slightly undermines the qualitative accuracy. (4) Despite this, the overall comparison of strategic implications—Altria retaining more flexibility while PMI adapts to restrictive environments—is semantically equivalent to the original. The answer remains highly contextually relevant and captures the key strategic divergence. Thus, correctness is reduced to 8 due to the minor but notable error in attributing overseas market exposure to Altria.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1587,
        "completion_tokens": 445,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does Goldman Sachs' competitive disadvantage to JPMorgan in cryptocurrency offerings, influenced by Dodd-Frank compliance burdens, compare with Morgan Stanley's exposure to regulatory risks in emerging markets that could impact its cross-border cryptocurrency-related financial activities?",
      "original_answer": "Goldman Sachs faces a competitive disadvantage compared to JPMorgan due to Dodd-Frank compliance burdens that restrict its ability to offer cryptocurrencies and digital assets, as stated in its 2024 10-K filing. JPMorgan, as a competitor, offers these products, giving it a strategic edge in evolving financial markets. Meanwhile, Morgan Stanley's 2024 10-K highlights exposure to regulatory risks in emerging markets, where uncertain and rapidly changing laws could hinder its ability to structure and enforce cryptocurrency-related transactions across borders. Both firms face regulatory constraints, but Goldman Sachs' limitations are self-imposed due to U.S. regulatory frameworks, while Morgan Stanley's risks stem from external geopolitical and legal environments in foreign jurisdictions.",
      "llm_answer": "Goldman Sachs says that, because the Dodd‑Frank Act and related U.S. rules impose higher fees, compliance costs and activity limits, it cannot offer cryptocurrencies or related digital‑asset products that rivals such as JPMorgan can, putting it at a competitive disadvantage 【page_13】.  \n\nMorgan Stanley, by contrast, flags that its operations in emerging‑market jurisdictions are subject to “regulatory … scrutiny … of new technologies” and to uncertain, evolving local laws that could impede cross‑border cryptocurrency‑related financing and other activities 【page_23】【page_24】.  \n\nThus, Goldman’s disadvantage stems from U.S.‑centric regulatory burdens that restrict its crypto product suite, whereas Morgan Stanley’s risk comes from external, foreign‑market regulatory uncertainty that could disrupt any crypto‑related transactions it conducts abroad.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Goldman Sachs' competitive disadvantage due to Dodd-Frank compliance burdens restricting its cryptocurrency offerings is accurately described and contrasted with JPMorgan's ability to offer such products. Morgan Stanley's exposure to regulatory risks in emerging markets affecting cross-border crypto activities is also correctly represented. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer beyond the implied 2024 10-K context, which is consistent across both; thus, quantitative accuracy is not compromised. (3) The multi-hop reasoning—comparing regulatory constraints across two firms with different sources of risk (U.S. domestic framework vs. foreign regulatory uncertainty)—is sound and well-synthesized. The LLM correctly identifies that Goldman’s limitations are self-imposed due to U.S. rules, while Morgan Stanley faces external, jurisdictional risks. (4) Semantic equivalence is strong: the LLM uses slightly different phrasing (e.g., 'higher fees, compliance costs and activity limits' as elaboration on Dodd-Frank burdens) but does not introduce inaccuracies. One minor point preventing a perfect 10 is that the LLM does not explicitly name JPMorgan as the comparator in the same sentence as the product offering advantage, though it is clearly implied by context. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 421,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 219,
      "question": "How does the adoption of ASU 2022-04 impact the disclosure requirements for supplier finance obligations at both 3M and GE, particularly in terms of the roll-forward information introduced in 2024?",
      "original_answer": "The adoption of ASU 2022-04 requires companies like 3M and GE to disclose key terms, balance sheet presentation, and the confirmed amount outstanding under supplier finance programs. For 3M, this includes a $0.3 billion balance in confirmed invoices as of December 31, 2024, with $1.5 billion of invoices confirmed and paid during the year. GE adopted the standard on January 1, 2023, and in line with the ASU's phased requirements, began providing the annual roll-forward information in 2024. This roll-forward requirement, applicable prospectively from January 1, 2024, aligns both companies' disclosures to include changes in confirmed invoice balances over the reporting period, enhancing transparency in their accounts payable disclosures.",
      "llm_answer": "ASU 2022‑04 requires any buyer that uses a supplier‑finance (or supply‑chain‑finance) program to disclose, in addition to the usual balance‑sheet presentation, the key terms of the program and a **year‑by‑year roll‑forward** of the amounts that were confirmed, paid and otherwise adjusted during the year.  \n\n* **3M** – The company states that it adopted the standard on 1 January 2023 and that the roll‑forward provision became effective on 1 January 2024.  Consequently, its 2024 Form 10‑K includes a dedicated Note 16 that shows the outstanding confirmed‑invoice balance (≈ $0.3 billion at year‑end) and the 2024 activity (≈ $1.5 billion of invoices confirmed and $1.5 billion paid/adjusted).  \n\n* **GE** – GE likewise references the adoption of ASU 2022‑04 (see the “Supply Chain Finance Programs” discussion) and, because the standard is effective prospectively for the roll‑forward, GE must now provide a similar annual reconciliation of its supplier‑finance obligations beginning in 2024.  While the excerpt does not show the numeric roll‑forward, the impact is the same: GE’s 2024 10‑K must contain a note that lists the year‑end balance of confirmed invoices and a roll‑forward of the amounts confirmed, paid and any adjustments for 2024.  \n\nIn short, the ASU adds a mandatory roll‑forward table for supplier‑finance obligations; 3M has already presented that table for 2024, and GE is required to do the same for 2024 onward.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: ASU 2022-04 introduces roll-forward disclosures for supplier finance obligations, effective prospectively from January 1, 2024. Both 3M and GE adopted the standard on January 1, 2023, and began providing the annual roll-forward in 2024. The $0.3 billion year-end balance and $1.5 billion of invoices confirmed and paid during 2024 for 3M are correctly reported. (2) Quantitative accuracy is perfect: numbers match the original answer exactly (e.g., $0.3 billion, $1.5 billion), and the explanation of roll-forward activity is consistent. (3) Multi-hop reasoning is sound: the model correctly synthesizes adoption timing, phased implementation, and disclosure requirements across both companies. (4) The only minor shortcoming is that the original answer explicitly states GE adopted the standard on January 1, 2023, while the LLM says 'likewise' without reiterating the date—though this is implied and not incorrect. Wording differences (e.g., 'year-by-year roll-forward' vs 'roll-forward information') are semantically equivalent. Overall, the answer is factually complete, contextually relevant, and accurately reflects the impact of ASU 2022-04 on both firms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1557,
        "completion_tokens": 353,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 219,
      "question": "How does MDT's geographic revenue concentration in 'Other Countries' expose it to similar regulatory and reimbursement challenges as those impacting AMGN's drug pricing strategies in international markets?",
      "original_answer": "MDT reports $32.251 billion in net sales from 'Total other countries, excluding Ireland' in fiscal 2024, which represents the majority of its revenue outside the U.S. This significant international exposure subjects MDT to regulatory environments where governments increasingly control healthcare costs through reimbursement and coverage limitations. As outlined in the DHR filing, these limitations include direct price controls, reference pricing, and mandatory licensing, which tie reimbursement to outcomes and constrain revenue potential. Similarly, AMGN notes that many countries outside the U.S. apply price controls, therapeutic-reference pricing, and volume caps, which limit both pricing and market access for its biologics. Both companies face parallel pressures from global payers seeking cost predictability and imposing narrower coverage criteria, despite operating in different healthcare sectors.",
      "llm_answer": "Medtronic’s 10‑K shows that “Other Countries” (the rest‑of‑world markets) generate roughly $32 billion of net sales each year – a sizable share of total revenue – and the filing explicitly warns that foreign sales are vulnerable to “changes in local healthcare delivery, payment and reimbursement policies” and to government‑driven price controls and managed‑care purchasing (see MDT page 105 and page 21). Amgen’s 10‑K similarly notes that in most non‑U.S. markets governments are the primary payers and are imposing mandatory price controls, reference‑pricing, health‑technology‑assessment‑driven pricing and other reimbursement limits that pressure drug pricing (see AMGN page 18). Because Medtronic’s earnings depend heavily on those same “Other Countries,” it faces regulatory and reimbursement headwinds that are essentially the same forces shaping Amgen’s international drug‑pricing challenges.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, the LLM correctly reports MDT's revenue from 'Other Countries' as approximately $32 billion, which is consistent with the ground truth figure of $32.251 billion—minor rounding is acceptable. No other numerical values (e.g., fiscal year) are misstated. (2) The answer correctly identifies both MDT and AMGN as facing regulatory and reimbursement challenges in international markets due to government price controls, reference pricing, and health technology assessments. It cites relevant sections of the 10-Ks (e.g., MDT page 105, AMGN page 18), enhancing credibility. (3) The multi-hop reasoning is sound: it connects MDT’s geographic revenue concentration to similar systemic pressures faced by AMGN in non-U.S. markets, despite differing healthcare sectors (devices vs. biologics). (4) The core entities—Medtronic (MDT), Amgen (AMGN), international regulatory frameworks, and key financial exposure—are accurately identified and synthesized. The only minor shortcoming is the lack of explicit mention of 'outcomes-based reimbursement' or 'volume caps' as noted in the original, but the broader concepts of price controls and reimbursement limits are adequately covered. Wording differs slightly but maintains semantic equivalence. Overall, the response is factually correct, well-reasoned, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 392,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 219,
      "question": "How does the combined capital buffer requirement above the minimum risk-based capital ratios for SCHW and JPM compare, considering their respective application of countercyclical and capital conservation buffers?",
      "original_answer": "SCHW is subject to a stress capital buffer of 2.5% and a capital conservation buffer of 2.5%, with the countercyclical capital buffer at 0%, resulting in a total buffer requirement of 5.0% above the minimum risk-based capital ratios. JPM, on the other hand, applies a fixed capital conservation buffer of 2.5% and a stress capital buffer (SCB) of 2.9%, with the countercyclical buffer also at 0%, leading to a total buffer requirement of 5.4% above the minimum. Therefore, JPM has a slightly higher combined buffer requirement than SCHW due to its higher SCB. This comparison reflects how both firms are subject to similar regulatory buffer frameworks, but with firm-specific SCB and CCyB determinations.",
      "llm_answer": "Schwab’s capital buffers are modest – the firm carries a 2.5 % stress‑capital (or capital‑conservation) buffer and a 0 % counter‑cyclical buffer, so the total amount of CET1 capital it must hold above the regulatory minimum is about 2.5 %.  \n\nJPMorgan’s buffers are much larger. Under the Basel‑III Standardized approach the firm must hold an 8.4 % buffer (5.4 % SCB + 3.0 % G‑SIB surcharge + 0 % CCyB), and under the Advanced approach the buffer is 5.5 % (2.5 % capital‑conservation + 3.0 % G‑SIB surcharge + 0 % CCyB).  \n\nThus JPMorgan’s combined buffer requirement is roughly three‑to‑four times the size of Schwab’s, reflecting JPMorgan’s use of both a sizable SCB (and G‑SIB surcharge) whereas Schwab relies only on a 2.5 % buffer with no counter‑cyclical component.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, SCHW has a stress capital buffer (SCB) of 2.5% and a capital conservation buffer (CCoB) of 2.5%, totaling 5.0% above minimum requirements. However, the LLM incorrectly states that Schwab only has a 2.5% buffer, conflating or omitting the two separate 2.5% buffers, and incorrectly implies only one 2.5% buffer applies. For JPM, the ground truth specifies a SCB of 2.9% and CCoB of 2.5%, totaling 5.4%. The LLM incorrectly cites an 8.4% or 5.5% buffer, including a 3.0% G-SIB surcharge not mentioned in the original answer and not part of the buffer definition in the question (which focuses on countercyclical and capital conservation/stress buffers). The G-SIB surcharge is a separate regulatory requirement and was not included in the ground truth comparison. (2) Calculations are therefore incorrect: LLM says SCHW has 2.5% total buffer (should be 5.0%), and JPM has 5.5% or 8.4% (should be 5.4%). The comparison that JPM's buffer is 'three-to-four times' that of SCHW is false; the correct difference is only 0.4 percentage points (5.4% vs 5.0%), a 8% higher requirement, not 300–400%. (3) Multi-hop reasoning fails: the model does not correctly synthesize the two buffers for SCHW, omits the correct SCB for JPM (2.9%, not 5.4% or 2.5% standalone), and introduces extraneous elements (G-SIB surcharge, Basel-III approaches) not in the original data or question scope. (4) Contextual relevance is moderate because the answer addresses capital buffers and compares SCHW and JPM, but introduces irrelevant regulatory details and misrepresents core facts. Scores are low due to major quantitative and qualitative errors undermining the conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 476,
        "total_tokens": 1862
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 600,
    "successful_evaluations": 600,
    "failed_evaluations": 0,
    "average_correctness_score": 7.95,
    "average_quantitative_accuracy": 8.56,
    "average_qualitative_accuracy": 8.11,
    "average_contextual_relevance": 9.5,
    "score_distribution": {
      "excellent": 404,
      "good": 74,
      "fair": 86,
      "poor": 36
    }
  },
  "original_experiment_metadata": {
    "model": "gpt-oss-120b",
    "experiment": "e6_semantic_retrieval",
    "pattern": "qualitative_3hop_cross_company_type1",
    "total_questions": 600,
    "successful": 600,
    "failed": 0,
    "elapsed_seconds": 10554.75,
    "timestamp": "2026-02-03T23:21:56.671429"
  }
}